data_5vkv_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5vkv _Structure_validation_residue.Date_analyzed 2018-01-26 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.619 0.247 . . . . 0.0 110.365 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.55 102.18 9.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.902 0.382 . . . . 0.0 111.064 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.29 -18.79 61.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.916 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.31 -27.62 69.45 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.992 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.41 -48.26 82.52 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.778 0.323 . . . . 0.0 110.59 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.36 -45.69 92.05 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.774 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.19 -33.58 76.12 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.964 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.418 ' O ' HG21 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -66.69 -52.38 45.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.247 179.527 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.8 mp -61.33 -38.02 85.39 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.104 178.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.81 -43.03 99.88 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.468 178.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.3 -41.91 98.57 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 121.054 -0.593 . . . . 0.0 111.994 178.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.418 HG21 ' O ' ' A' ' 9' ' ' PHE . 48.2 t -64.59 -38.57 82.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.125 0.488 . . . . 0.0 109.839 178.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 60.1 mt -63.81 -41.17 97.94 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.5 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.6 m -65.46 -33.22 75.43 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.697 0.284 . . . . 0.0 110.877 179.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -69.35 -36.79 77.23 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.023 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.6 mp -90.5 -4.37 56.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.953 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.1 t -79.08 124.01 84.75 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.363 179.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.44 -8.63 22.72 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.691 2.261 . . . . 0.0 112.709 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.422 ' SG ' ' HZ ' ' A' ' 210' ' ' PHE . 1.0 OUTLIER -88.11 -14.48 38.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.954 179.756 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.6 t -116.98 -79.74 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.188 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.401 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 15.0 mt 51.15 82.61 0.24 Allowed Pre-proline 0 N--CA 1.466 0.351 0 O-C-N 123.709 0.631 . . . . 0.0 111.699 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -55.23 -24.08 40.08 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.99 2.46 . . . . 0.0 113.273 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.4 tp -64.36 -26.2 68.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.717 -0.22 . . . . 0.0 111.133 178.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.427 ' HB ' ' CD ' ' A' ' 26' ' ' PRO . 71.4 t -67.48 -61.14 4.81 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.162 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.427 ' CD ' ' HB ' ' A' ' 25' ' ' VAL . 19.3 Cg_endo -59.11 -35.19 98.49 Favored 'Trans proline' 0 C--N 1.361 1.185 0 C-N-CA 122.032 1.821 . . . . 0.0 112.559 178.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 20.2 m -64.9 -36.54 84.68 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.714 0.292 . . . . 0.0 111.002 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . 0.439 ' O ' ' HB2' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -66.53 -28.51 68.6 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.566 179.562 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 7.9 mt -85.06 -36.22 21.35 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.075 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -63.28 -44.05 96.18 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.549 178.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -73.63 -21.6 60.25 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.763 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.439 ' HB2' ' O ' ' A' ' 28' ' ' TYR . 2.1 tp -75.94 -18.85 59.18 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.4 179.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -89.59 -4.38 73.29 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.946 -0.645 . . . . 0.0 111.66 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.99 -59.46 4.94 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 121.161 -0.543 . . . . 0.0 112.666 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . 57.74 -113.28 0.72 Allowed 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 122.753 0.421 . . . . 0.0 111.024 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.11 -36.92 1.14 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.935 0.397 . . . . 0.0 110.725 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.11 18.08 11.85 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.094 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -111.77 96.96 35.53 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.514 0.197 . . . . 0.0 110.624 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -69.32 -32.04 21.21 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.507 2.138 . . . . 0.0 112.932 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.62 -44.37 90.75 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.132 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -73.79 -36.03 64.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.818 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -65.42 -42.24 92.71 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.165 178.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.49 -51.91 56.66 Favored 'General case' 0 C--O 1.227 -0.126 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.627 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.33 -42.0 73.19 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.244 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -64.07 -44.69 91.65 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.861 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.46 -40.41 89.39 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.62 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 55.5 mt -60.71 -48.57 88.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.573 179.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.65 -45.83 81.48 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.905 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.623 ' O ' HG22 ' A' ' 53' ' ' VAL . . . -59.84 -48.45 85.99 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.407 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.03 -41.75 90.52 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.55 0.214 . . . . 0.0 110.998 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -61.74 -44.26 98.13 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.078 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.12 -46.04 90.96 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.658 0.266 . . . . 0.0 111.11 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.623 HG22 ' O ' ' A' ' 49' ' ' GLY . 46.1 t -65.25 -42.23 93.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.098 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -64.29 -28.29 69.62 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.531 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -84.95 -46.61 11.08 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.896 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.87 -39.21 93.19 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.09 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.443 ' HB2' ' O ' ' A' ' 53' ' ' VAL . 1.0 OUTLIER -85.82 -19.07 31.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.487 179.386 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.415 ' O ' ' HB2' ' A' ' 61' ' ' PHE . . . -74.69 -26.69 66.73 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.203 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.68 -56.41 33.04 Favored Pre-proline 0 CA--C 1.54 0.59 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -65.65 -13.78 41.51 Favored 'Trans proline' 0 C--N 1.362 1.281 0 C-N-CA 122.305 2.004 . . . . 0.0 113.155 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.415 ' HB2' ' O ' ' A' ' 58' ' ' GLY . 8.2 m-30 -61.44 -17.94 56.63 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.651 0.262 . . . . 0.0 111.422 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 21.8 p -71.89 -41.34 68.08 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.135 0.493 . . . . 0.0 110.195 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.3 mt -88.48 -21.63 24.09 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.888 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.86 -17.9 64.06 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.901 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -63.43 -24.52 67.7 Favored Glycine 0 C--N 1.335 0.477 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.934 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.49 -21.82 76.64 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.149 179.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.69 -20.67 46.01 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.833 0.349 . . . . 0.0 110.631 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -64.32 -19.26 65.32 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.995 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -69.73 -17.62 63.46 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.814 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -97.27 -133.36 0.22 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.906 179.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -151.03 126.26 9.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.909 0.385 . . . . 0.0 110.841 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -134.59 37.71 3.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.598 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -66.88 -18.09 65.21 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.411 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.46 -18.06 65.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.398 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.4 mp -74.15 -22.86 59.25 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.624 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.19 -24.11 51.44 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.502 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.79 -33.56 68.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.888 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.509 ' O ' HG22 ' A' ' 82' ' ' VAL . 41.9 t -62.52 -36.76 76.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.729 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.67 -36.8 93.8 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.068 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.479 ' O ' HG23 ' A' ' 84' ' ' VAL . . . -66.34 -41.59 94.46 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.873 -0.679 . . . . 0.0 111.764 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.5 t -60.49 -43.88 95.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 120.83 0.348 . . . . 0.0 110.714 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.509 HG22 ' O ' ' A' ' 78' ' ' VAL . 47.1 t -63.91 -41.07 91.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.601 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.87 -43.16 99.55 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.771 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 80' ' ' GLY . 92.7 t -62.97 -44.95 99.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-O 120.832 0.349 . . . . 0.0 110.429 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.78 -41.46 97.74 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.72 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -66.52 -40.17 89.04 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.667 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -61.34 -39.52 97.35 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.997 -0.621 . . . . 0.0 111.893 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.5 -40.93 98.37 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.829 0.347 . . . . 0.0 110.698 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -71.72 -31.45 66.73 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.548 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 5.2 mtt -67.12 -27.59 67.46 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.473 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.74 -9.58 51.46 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.024 178.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.56 11.27 83.32 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.849 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.34 145.15 25.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.926 0.393 . . . . 0.0 110.842 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.324 -0.501 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.613 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.228 0 CA-C-O 120.889 0.376 . . . . 0.0 111.011 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.3 -13.66 43.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.299 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.448 ' N ' ' HD2' ' A' ' 110' ' ' PRO . 0.0 OUTLIER -66.85 -52.54 32.08 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.933 179.845 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' A' ' 109' ' ' ARG . 36.6 Cg_endo -65.18 -15.56 50.79 Favored 'Trans proline' 0 C--N 1.363 1.325 0 C-N-CA 122.069 1.846 . . . . 0.0 112.797 179.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.416 ' O ' ' HB2' ' A' ' 115' ' ' LEU . 0.5 OUTLIER -67.65 -39.64 84.58 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.682 179.857 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -69.28 -31.88 71.91 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.628 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -71.42 -46.16 60.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.888 0.375 . . . . 0.0 110.775 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -67.98 -39.16 83.34 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.063 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.416 ' HB2' ' O ' ' A' ' 111' ' ' LEU . 0.7 OUTLIER -65.23 -40.2 93.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.79 179.474 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.59 -33.62 76.36 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.705 0.288 . . . . 0.0 110.522 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -66.52 -48.85 60.15 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.21 178.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.44 -29.84 70.56 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.753 0.311 . . . . 0.0 110.713 178.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 52.7 m -61.89 -44.81 96.04 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.811 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.2 mt -69.87 -21.43 63.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.384 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -85.22 -40.86 16.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.484 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.1 mp -85.83 -33.06 21.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.741 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -80.55 92.24 1.41 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.392 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -81.69 132.87 35.31 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.894 0.378 . . . . 0.0 110.913 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.0 113.14 45.96 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.789 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -63.68 -22.37 69.95 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.827 2.351 . . . . 0.0 112.963 -179.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -70.45 -25.69 63.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.244 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.5 mm -103.1 2.37 10.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.111 0.482 . . . . 0.0 110.406 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -61.53 -59.64 9.51 Favored Glycine 0 CA--C 1.521 0.44 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.611 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -57.4 -34.78 98.51 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 122.72 2.28 . . . . 0.0 112.323 178.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 16.0 mm -67.83 -43.45 86.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.808 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.39 -37.37 66.01 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.465 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -61.38 -31.17 76.37 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 121.075 -0.583 . . . . 0.0 112.197 178.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.74 -21.91 62.48 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.908 0.385 . . . . 0.0 110.927 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 38.4 mm -79.58 -30.34 13.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.681 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.07 -39.26 94.2 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.574 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.11 -23.76 67.24 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.105 178.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.76 -33.5 19.92 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.743 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 23.6 p -80.3 -17.16 52.9 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.357 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -75.94 -29.23 58.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.98 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 21.8 m -100.15 2.91 10.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.266 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -173.43 -90.07 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.478 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 151.3 -152.58 24.34 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.431 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 167.52 63.01 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.264 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 1.7 t -62.25 -49.17 85.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.87 0.367 . . . . 0.0 110.672 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -65.82 -28.98 74.13 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.937 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.42 -44.06 83.97 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.809 0.338 . . . . 0.0 110.453 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.93 -42.37 99.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.384 179.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 34.4 mt -66.26 -39.25 89.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.385 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -61.58 -38.81 88.91 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.561 178.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -62.52 -47.59 83.24 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.654 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 17.6 mt -64.87 -46.9 90.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.382 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . 0.403 ' O ' HG23 ' A' ' 157' ' ' VAL . 0.2 OUTLIER -62.09 -37.7 86.05 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.951 179.28 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -60.13 -38.84 95.0 Favored Glycine 0 C--O 1.224 -0.518 0 C-N-CA 121.273 -0.489 . . . . 0.0 112.058 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -79.98 -26.31 40.0 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.678 0.275 . . . . 0.0 110.971 178.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -64.48 -37.46 87.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.153 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.539 ' O ' HG21 ' A' ' 161' ' ' VAL . 59.4 t -55.33 -62.73 3.91 Favored Pre-proline 0 CA--C 1.541 0.633 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.824 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.48 ' CD ' ' HB ' ' A' ' 157' ' ' VAL . 17.9 Cg_endo -59.68 -36.59 91.58 Favored 'Trans proline' 0 C--N 1.36 1.157 0 C-N-CA 122.123 1.882 . . . . 0.0 112.339 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.08 -44.82 96.78 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.271 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -66.11 -40.47 90.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.635 0.255 . . . . 0.0 110.708 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.539 HG21 ' O ' ' A' ' 157' ' ' VAL . 48.3 t -63.88 -45.43 97.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.499 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 60.9 t -65.07 -40.24 88.29 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.606 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -58.8 -41.7 87.36 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.547 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.97 -39.23 63.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.238 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -70.9 -27.65 63.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.739 0.304 . . . . 0.0 110.8 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -64.46 -18.75 65.05 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.532 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -62.77 -46.65 87.05 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.758 0.313 . . . . 0.0 111.044 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -78.24 -34.0 49.43 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.742 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.414 HG22 ' O ' ' A' ' 169' ' ' ILE . 58.1 mt -69.74 -23.1 25.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.921 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -59.69 -39.1 83.41 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.913 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -71.54 -23.8 77.59 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.674 179.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 60.2 t-105 -81.64 -37.89 26.81 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.423 0.154 . . . . 0.0 111.133 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.59 -38.04 59.23 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -87.47 -15.67 36.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.495 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.16 -27.59 18.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.466 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -53.47 -65.78 0.5 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.758 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 131.3 -124.47 4.11 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.806 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 2.7 mtt180 -100.26 0.6 40.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.675 0.274 . . . . 0.0 111.357 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 7.9 mt -66.81 -33.8 65.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.965 0.412 . . . . 0.0 110.844 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.47 -20.22 66.05 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.315 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 37.7 m170 -84.01 -21.45 31.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.83 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -73.1 -45.91 54.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.524 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 3.6 m -73.54 -19.57 18.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.186 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -65.11 -50.79 64.69 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.708 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 2.4 m -81.82 -28.08 9.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.506 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.2 tp -58.59 -50.72 72.8 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.19 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -62.21 -35.34 78.59 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.785 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -65.28 -42.33 96.26 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.193 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 94.8 t -62.55 -47.56 92.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 120.76 0.314 . . . . 0.0 110.724 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 39.5 t -62.18 -39.42 83.89 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.891 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.98 -46.52 87.9 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.841 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 55.8 t -66.51 -40.55 86.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.422 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 4.3 mt -60.98 -46.57 90.19 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.961 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 87.5 t -66.93 -41.1 87.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.801 0.334 . . . . 0.0 110.262 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -62.44 -43.46 99.01 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.742 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 3.6 p -72.93 -32.36 39.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 116.8 0.3 . . . . 0.0 111.279 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.85 -22.46 58.67 Favored 'General case' 0 C--N 1.334 -0.078 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.122 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.2 mp -84.76 -38.92 19.05 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.379 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -67.17 -47.75 70.03 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.127 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 81.3 p -84.42 -20.27 32.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.255 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -78.39 -48.78 7.16 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.245 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 57.3 -133.42 1.28 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.653 0.263 . . . . 0.0 111.501 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -81.25 84.11 6.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.916 0.388 . . . . 0.0 111.153 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 13.7 t -150.75 -161.61 1.37 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.651 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -59.71 -14.38 13.96 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 122.643 0.377 . . . . 0.0 111.795 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.03 -33.11 74.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.619 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -71.44 -28.69 64.14 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.996 0.427 . . . . 0.0 110.262 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.0 -21.21 31.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.781 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -66.97 -21.65 65.96 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.906 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . 0.422 ' HZ ' ' SG ' ' A' ' 20' ' ' CYS . 1.0 OUTLIER -67.2 -19.13 65.51 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.884 179.216 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 3.0 mt -86.21 -10.86 53.88 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.719 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.96 -21.86 36.98 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.98 0.419 . . . . 0.0 110.42 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 2.9 mt -87.5 -24.79 6.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.401 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.23 120.37 79.19 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.371 179.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.39 130.51 24.01 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.449 2.099 . . . . 0.0 112.718 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -68.94 -19.59 64.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.241 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 9.5 m95 -69.57 -18.58 63.65 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.332 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.69 -32.19 16.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.849 0.357 . . . . 0.0 110.28 179.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -74.49 -34.53 63.1 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.621 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 . . . . . 0 N--CA 1.463 0.182 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.871 179.419 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.457 -0.08 0 CA-C-O 120.876 0.369 . . . . 0.0 111.06 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.07 20.28 9.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.181 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.67 -34.0 76.9 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.126 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 16.9 mt -73.97 -47.83 34.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.544 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.03 -40.91 91.0 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.762 178.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.89 -48.39 76.86 Favored 'General case' 0 CA--C 1.523 -0.079 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.706 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.74 -36.45 74.35 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.161 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.4 ' O ' HG22 ' A' ' 13' ' ' VAL . 41.3 t80 -69.27 -52.04 31.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.336 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.74 -38.28 81.31 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.478 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.06 -44.62 97.11 Favored 'General case' 0 C--N 1.334 -0.077 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.801 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.08 -44.23 96.45 Favored Glycine 0 C--N 1.335 0.515 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.185 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.4 HG22 ' O ' ' A' ' 9' ' ' PHE . 11.8 t -70.11 -35.21 62.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.909 0.385 . . . . 0.0 110.327 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.16 -42.85 96.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.77 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.8 m -66.7 -33.28 75.28 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.816 0.341 . . . . 0.0 110.711 179.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -75.13 -32.52 61.37 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.502 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -94.59 -1.28 53.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.649 0.261 . . . . 0.0 111.31 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.4 p -62.67 143.94 96.36 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.355 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.06 -8.07 18.99 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.543 2.162 . . . . 0.0 112.812 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.413 ' O ' ' HB ' ' A' ' 21' ' ' VAL . 0.1 OUTLIER -63.63 -47.37 81.62 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.957 179.65 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.413 ' HB ' ' O ' ' A' ' 20' ' ' CYS . 96.1 t 71.11 137.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 O-C-N 123.769 0.668 . . . . 0.0 110.945 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -105.17 128.77 25.98 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.553 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -65.04 -18.51 62.13 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.631 2.22 . . . . 0.0 112.469 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.1 mt -74.27 -12.51 60.57 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.248 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.451 ' HB ' ' HD3' ' A' ' 26' ' ' PRO . 55.1 t -75.71 -60.21 1.09 Allowed Pre-proline 0 CA--C 1.542 0.661 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.451 ' HD3' ' HB ' ' A' ' 25' ' ' VAL . 60.4 Cg_endo -73.31 -34.1 6.39 Favored 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 121.836 1.69 . . . . 0.0 113.511 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.2 m -71.03 -18.18 62.59 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.21 -21.09 66.3 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.762 0.315 . . . . 0.0 111.199 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 6.0 mt -82.12 -52.84 6.6 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.833 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -62.41 -28.69 69.97 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.475 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -60.73 -43.24 98.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.766 178.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.07 -22.16 59.63 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.997 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -86.59 -9.57 74.99 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.245 178.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -108.49 -46.61 0.97 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 121.407 -0.425 . . . . 0.0 112.11 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -117.62 124.67 49.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.806 0.336 . . . . 0.0 110.503 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -77.63 86.84 3.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.099 0.476 . . . . 0.0 110.956 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -138.01 171.95 23.11 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.896 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 14.4 mtt180 -96.61 124.86 49.19 Favored Pre-proline 0 C--N 1.324 -0.528 0 C-N-CA 121.162 -0.215 . . . . 0.0 110.834 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.81 -30.57 77.09 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.905 2.404 . . . . 0.0 112.782 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.6 mp -63.98 -39.21 93.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.0 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.91 -37.14 67.34 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.224 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -65.04 -43.84 91.01 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.085 178.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.55 -49.42 73.51 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.647 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.76 -45.0 78.19 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.024 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -65.5 -45.28 84.19 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.21 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -62.65 -42.38 99.57 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.157 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 28.4 mm -65.29 -43.05 95.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.566 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.55 -44.01 97.41 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.283 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.448 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -61.64 -44.5 97.86 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.064 178.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -68.91 -36.69 78.3 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.606 0.241 . . . . 0.0 110.625 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -62.94 -42.42 99.68 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.46 178.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.87 -43.94 97.82 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.595 0.236 . . . . 0.0 110.578 178.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 49' ' ' GLY . 93.8 t -63.88 -43.37 97.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.726 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -63.6 -36.25 83.2 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.234 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -76.52 -44.48 34.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.017 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.08 -30.87 71.93 Favored 'General case' 0 C--O 1.226 -0.153 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.976 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -89.34 -20.51 23.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.791 0.329 . . . . 0.0 110.484 178.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -72.2 -31.2 64.09 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 121.191 -0.528 . . . . 0.0 112.507 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.2 mp -62.59 -57.21 23.54 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 111.452 0.168 . . . . 0.0 111.452 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -73.97 -13.6 23.89 Favored 'Trans proline' 0 C--N 1.359 1.116 0 C-N-CA 122.019 1.813 . . . . 0.0 112.454 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.81 -31.5 64.76 Favored 'General case' 0 N--CA 1.464 0.24 0 O-C-N 123.14 0.275 . . . . 0.0 111.334 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -64.35 -32.09 73.56 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.805 0.336 . . . . 0.0 110.867 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.82 -23.51 25.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.038 0.447 . . . . 0.0 110.148 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 14.7 mt -69.33 -17.96 63.76 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.963 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -59.87 -29.51 67.79 Favored Glycine 0 C--N 1.336 0.573 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.076 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.69 -29.5 61.28 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.908 178.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.3 mt -83.56 -21.39 32.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.904 0.383 . . . . 0.0 110.555 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.37 -19.25 65.86 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.446 179.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.87 -17.88 65.11 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.952 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -94.5 -110.14 0.12 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -162.19 148.65 13.38 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.683 0.278 . . . . 0.0 110.882 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.1 mmt-85 -124.24 53.32 1.43 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.939 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -75.88 -18.13 59.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.881 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -66.74 -26.94 67.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.003 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -76.94 -22.29 53.52 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.918 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.72 -32.39 72.15 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.038 0.447 . . . . 0.0 110.372 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.515 ' O ' HG22 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -73.19 -36.7 66.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.722 179.598 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.432 ' O ' HG21 ' A' ' 82' ' ' VAL . 20.8 t -58.3 -44.88 89.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.87 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.64 -39.76 97.01 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.923 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.525 ' O ' HG22 ' A' ' 84' ' ' VAL . . . -65.94 -38.63 94.37 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.079 -0.581 . . . . 0.0 111.924 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 77' ' ' ARG . 95.0 t -62.31 -42.86 97.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-O 120.777 0.322 . . . . 0.0 110.779 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.432 HG21 ' O ' ' A' ' 78' ' ' VAL . 47.0 t -62.74 -38.6 82.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.536 179.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 11.5 mt -64.57 -43.15 94.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.696 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.525 HG22 ' O ' ' A' ' 80' ' ' GLY . 42.9 t -66.41 -39.13 83.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.285 178.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.61 -43.1 99.49 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.657 178.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -67.03 -36.75 82.77 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.453 179.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -64.64 -39.97 97.16 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.712 178.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.9 mt -64.46 -36.76 85.22 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.728 0.299 . . . . 0.0 110.783 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -75.73 -31.5 59.63 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.474 179.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 2.8 tpt -69.14 -25.34 64.33 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.615 179.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.2 mt -69.06 -11.01 60.4 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.041 178.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.99 23.77 54.47 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.682 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.29 115.15 14.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.722 0.296 . . . . 0.0 110.761 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.387 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.589 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.401 ' C ' ' HD2' ' A' ' 110' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.797 0.332 . . . . 0.0 111.592 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.32 -33.69 67.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.021 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 30.8 mmt-85 -73.23 -52.94 5.07 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.034 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.401 ' HD2' ' C ' ' A' ' 107' ' ' THR . 35.6 Cg_exo -58.87 -29.06 89.1 Favored 'Trans proline' 0 C--N 1.362 1.277 0 C-N-CA 122.194 1.929 . . . . 0.0 112.604 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.74 -26.95 60.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.027 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -68.24 -32.95 76.95 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.777 -0.725 . . . . 0.0 111.487 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.69 -32.58 71.26 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.937 0.398 . . . . 0.0 110.585 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -71.36 -35.07 71.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.889 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.65 -33.55 72.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.577 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.25 -22.06 63.87 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.521 179.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -83.5 -34.36 19.91 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.527 178.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -69.28 -42.39 75.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.773 0.321 . . . . 0.0 111.222 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 6.1 p -65.91 -39.31 90.46 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.445 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.68 -21.92 63.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.865 0.364 . . . . 0.0 110.805 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -84.0 -36.34 23.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.798 179.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 53.2 mt -81.11 -39.37 25.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.36 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -81.56 -19.41 66.21 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.581 -0.819 . . . . 0.0 111.827 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 15.0 m95 63.41 -170.44 0.18 Allowed 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 123.027 0.531 . . . . 0.0 111.234 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.91 107.75 11.64 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.762 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -57.63 -23.15 55.67 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.041 2.494 . . . . 0.0 112.946 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 4.2 m -68.5 -20.21 64.57 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.027 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 6.4 mt -102.62 5.21 10.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.039 0.447 . . . . 0.0 110.079 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -57.15 -63.74 5.04 Favored Glycine 0 C--N 1.334 0.418 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.546 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -58.67 -37.13 95.74 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.426 2.084 . . . . 0.0 112.171 178.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 15.7 mt -64.71 -44.36 96.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.844 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.436 ' O ' HG21 ' A' ' 135' ' ' ILE . 3.2 tp -67.54 -42.53 82.54 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.285 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -61.56 -42.86 99.84 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.871 -0.68 . . . . 0.0 111.862 178.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -68.39 -34.3 75.8 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.764 0.316 . . . . 0.0 110.996 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.436 HG21 ' O ' ' A' ' 132' ' ' LEU . 0.0 OUTLIER -72.07 -26.21 24.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.099 179.875 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.2 -35.23 79.18 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.935 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.01 -22.43 66.93 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.811 178.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.2 tp -80.41 -42.83 22.04 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.222 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.445 ' HA ' ' O ' ' A' ' 142' ' ' GLY . 0.8 OUTLIER -69.59 -16.46 63.41 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.124 179.583 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.43 -26.44 61.84 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.737 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 2.0 t -98.26 -19.22 6.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.776 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' A' ' 139' ' ' THR . . . 153.47 -125.43 1.76 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.154 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 125.68 -152.23 17.91 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.264 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 173.58 169.25 35.71 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.138 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 3.6 m -75.18 -23.33 17.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.683 0.278 . . . . 0.0 111.378 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -62.38 -30.59 76.67 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.625 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.46 -49.36 71.74 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.678 0.275 . . . . 0.0 110.795 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.0 mp -63.52 -42.52 98.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.602 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.1 mt -62.08 -40.61 96.38 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.08 179.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.22 -44.04 97.47 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.852 0.358 . . . . 0.0 110.47 178.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -65.11 -38.45 90.71 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.023 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 23.1 mm -62.59 -46.62 95.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.16 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.51 -38.23 90.28 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.61 0.243 . . . . 0.0 110.769 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -59.28 -39.28 94.44 Favored Glycine 0 C--N 1.335 0.503 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.423 179.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.497 ' O ' ' HD2' ' A' ' 158' ' ' PRO . 0.4 OUTLIER -84.24 -21.76 31.05 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.763 0.316 . . . . 0.0 110.787 178.978 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -62.1 -43.27 99.2 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.445 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.494 ' HB ' ' HD3' ' A' ' 158' ' ' PRO . 0.3 OUTLIER -54.78 -57.03 21.13 Favored Pre-proline 0 N--CA 1.472 0.647 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.497 ' HD2' ' O ' ' A' ' 155' ' ' LEU . 38.1 Cg_exo -62.33 -40.37 40.74 Favored 'Trans proline' 0 C--N 1.359 1.106 0 C-N-CA 122.256 1.97 . . . . 0.0 112.681 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.7 -44.22 93.76 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.402 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.69 -44.19 82.39 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.058 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.436 HG22 ' O ' ' A' ' 157' ' ' VAL . 95.2 t -61.26 -44.72 98.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.62 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.5 ' O ' ' HB2' ' A' ' 166' ' ' ALA . 55.4 t -66.36 -46.37 87.12 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.162 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.87 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -54.33 -38.18 65.7 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.737 0.303 . . . . 0.0 111.801 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.3 mt -75.31 -47.19 28.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.616 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -70.2 -25.7 63.54 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.449 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.573 ' O ' ' HB2' ' A' ' 170' ' ' LYS . . . -64.6 -25.85 68.15 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.129 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -77.58 -42.3 35.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.843 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.57 -46.11 89.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.11 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 3.7 pt -75.66 -20.55 15.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.676 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.573 ' HB2' ' O ' ' A' ' 166' ' ' ALA . 0.2 OUTLIER -62.01 -41.35 97.97 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.916 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -64.95 -38.81 95.94 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.01 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -75.62 -30.23 59.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.6 0.238 . . . . 0.0 111.113 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.46 -32.68 71.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.088 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.77 -17.47 38.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.921 0.391 . . . . 0.0 110.818 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 67.5 mtm-85 -91.23 -24.49 19.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.91 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -59.36 -48.96 79.64 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.208 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 133.04 -130.95 5.93 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.587 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -99.37 -3.23 34.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.846 0.355 . . . . 0.0 111.159 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 4.1 mt -69.51 -32.19 51.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.248 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.41 -26.87 68.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.295 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 15.0 t60 -71.31 -29.7 65.34 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.742 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.432 ' O ' ' HB2' ' A' ' 186' ' ' LEU . 0.9 OUTLIER -68.58 -32.7 72.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.812 -179.929 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 2.9 t -76.6 -22.43 15.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.565 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.69 -46.4 25.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.562 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.503 ' O ' HG22 ' A' ' 189' ' ' VAL . 16.9 m -75.05 -26.37 19.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.744 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.56 ' O ' HG22 ' A' ' 190' ' ' VAL . 2.2 tp -60.32 -47.3 86.63 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.073 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -63.81 -33.81 76.51 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.867 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.441 ' O ' HG21 ' A' ' 192' ' ' VAL . . . -67.94 -42.93 84.43 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.086 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.503 HG22 ' O ' ' A' ' 185' ' ' VAL . 87.0 t -60.91 -44.35 97.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-O 120.776 0.322 . . . . 0.0 110.767 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . 0.56 HG22 ' O ' ' A' ' 186' ' ' LEU . 24.4 t -62.91 -42.22 95.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.903 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 1.1 mt -59.84 -42.72 94.22 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.732 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . 0.441 HG21 ' O ' ' A' ' 188' ' ' GLY . 65.4 t -67.59 -43.82 86.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.2 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.3 tp -58.44 -45.67 88.05 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.917 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 190' ' ' VAL . 70.4 t -62.61 -42.39 95.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.675 0.274 . . . . 0.0 110.546 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -62.18 -40.72 99.34 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.328 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 98.4 t -75.21 -41.13 44.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.543 0.211 . . . . 0.0 111.055 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.459 ' O ' ' HA3' ' A' ' 201' ' ' GLY . 1.8 mp -65.48 -23.62 66.95 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.155 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.54 -46.22 11.8 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.696 -0.229 . . . . 0.0 110.789 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -69.47 -49.38 55.37 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.932 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.69 -13.1 52.42 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.926 0.393 . . . . 0.0 111.108 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . 0.459 ' HA3' ' O ' ' A' ' 197' ' ' LEU . . . -88.66 -63.27 1.35 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.466 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 50.87 48.55 22.75 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.986 0.422 . . . . 0.0 111.548 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -119.84 150.44 40.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.931 0.396 . . . . 0.0 111.552 -179.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -74.71 -36.17 62.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.369 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -59.8 -27.09 66.28 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.918 0.389 . . . . 0.0 111.426 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 19.5 mt -67.25 -38.52 85.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.234 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -74.75 -29.26 61.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.258 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.31 -41.29 81.07 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.552 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -70.12 -27.39 64.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.768 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -72.56 -24.11 61.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.678 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.0 mp -81.2 -22.44 38.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.568 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.42 -7.5 58.44 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.69 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 27.9 mm -82.09 -14.99 12.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.114 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 1.7 m -65.98 118.19 49.86 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.429 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -57.7 128.73 30.31 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.305 2.003 . . . . 0.0 111.956 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -63.86 -17.03 62.75 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.247 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 7.8 m0 -70.08 -21.7 63.12 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.893 179.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 1.1 mt -89.08 -31.41 18.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.333 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -79.53 -24.81 41.95 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.316 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 1.9 mtt-85 . . . . . 0 N--CA 1.462 0.148 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.812 179.309 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.1 m . . . . . 0 CA--C 1.528 0.133 0 CA-C-O 121.079 0.466 . . . . 0.0 110.519 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -130.9 19.62 5.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.961 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.08 -34.39 76.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.055 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.06 -43.93 77.48 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.868 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.38 -42.42 98.68 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.751 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.51 -45.57 92.38 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.018 178.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.33 -33.69 76.3 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.929 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.406 ' O ' HG22 ' A' ' 13' ' ' VAL . 0.3 OUTLIER -69.19 -49.03 60.31 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.742 179.928 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.9 mt -58.71 -42.03 87.72 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.528 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.28 -41.74 99.03 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.267 178.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.46 -43.98 97.4 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 121.206 -0.521 . . . . 0.0 112.261 179.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.406 HG22 ' O ' ' A' ' 9' ' ' PHE . 98.2 t -62.71 -42.67 97.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.794 0.331 . . . . 0.0 110.192 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 14.1 mt -63.93 -42.09 97.46 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.465 179.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.532 ' O ' HG21 ' A' ' 21' ' ' VAL . 16.5 m -65.95 -41.37 91.35 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.773 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -62.75 -39.35 93.85 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.984 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 87.2 mt -80.59 -13.48 59.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.038 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.437 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 4.1 p -83.79 137.54 41.0 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.592 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 18' ' ' SER . 23.2 Cg_exo -65.36 -8.56 19.2 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.64 2.226 . . . . 0.0 112.46 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 64.2 m -65.35 -24.43 67.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.174 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.532 HG21 ' O ' ' A' ' 15' ' ' SER . 2.1 t -111.2 18.2 7.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.393 0.616 . . . . 0.0 110.269 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.423 ' HB2' ' O ' ' A' ' 19' ' ' PRO . 0.5 OUTLIER -72.1 -48.23 10.65 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.406 179.051 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -59.37 -15.11 27.98 Favored 'Trans proline' 0 C--N 1.362 1.283 0 C-N-CA 122.337 2.024 . . . . 0.0 112.734 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.51 -12.81 60.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.316 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 92.7 t -77.41 -57.92 1.01 Allowed Pre-proline 0 CA--C 1.54 0.574 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.122 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -63.43 -30.37 72.22 Favored 'Trans proline' 0 C--N 1.361 1.215 0 C-N-CA 122.21 1.94 . . . . 0.0 112.747 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.2 p -66.42 -32.11 73.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.603 -0.272 . . . . 0.0 110.933 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -65.28 -39.72 92.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.323 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.4 mt -67.47 -37.03 82.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.244 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -67.79 -38.62 83.59 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.949 178.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.585 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 6.5 m-85 -69.26 -38.76 78.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.366 178.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.3 mt -66.46 -34.71 78.54 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.512 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.2 4.34 86.26 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.934 -0.65 . . . . 0.0 111.825 178.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -91.4 56.31 3.15 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 121.319 -0.467 . . . . 0.0 112.265 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . 62.99 -101.06 0.09 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.072 0.549 . . . . 0.0 111.654 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 6.2 mtt85 -90.75 60.57 4.52 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.193 0.52 . . . . 0.0 111.036 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.585 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -103.28 75.91 0.29 Allowed Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.249 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 10.8 mtt180 -83.98 137.09 40.67 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-O 120.504 0.193 . . . . 0.0 110.924 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -56.7 -47.03 25.57 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.956 2.438 . . . . 0.0 112.714 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.9 mp -62.24 -38.85 90.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.167 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -70.57 -39.06 74.11 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.393 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -64.89 -45.75 84.66 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.223 178.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.98 -35.95 81.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.836 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.5 tp -67.48 -48.1 68.12 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.714 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -66.73 -28.09 68.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.463 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.478 ' O ' ' HB2' ' A' ' 50' ' ' PHE . 0.2 OUTLIER -64.18 -50.71 67.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.558 178.815 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 38.2 mt -65.09 -39.08 84.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.865 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -68.81 -52.08 33.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.128 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.414 ' O ' HG22 ' A' ' 53' ' ' VAL . . . -58.85 -43.45 96.61 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.17 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.478 ' HB2' ' O ' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -68.9 -36.8 78.47 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.542 0.21 . . . . 0.0 110.64 179.473 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -61.36 -45.71 95.88 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.541 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.43 -44.4 95.83 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.881 0.372 . . . . 0.0 110.78 179.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.414 HG22 ' O ' ' A' ' 49' ' ' GLY . 95.9 t -65.91 -45.13 92.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.034 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -63.43 -30.26 71.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.271 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -78.4 -44.74 24.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.756 0.312 . . . . 0.0 110.682 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.33 -30.97 71.49 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.65 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.08 -18.48 27.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.866 0.365 . . . . 0.0 110.287 178.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.497 ' O ' ' HB2' ' A' ' 61' ' ' PHE . . . -75.03 -29.44 60.68 Favored Glycine 0 C--N 1.331 0.276 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.13 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.92 -55.61 43.0 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-O 119.872 -0.108 . . . . 0.0 111.166 178.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -69.83 -12.86 33.61 Favored 'Trans proline' 0 C--N 1.358 1.047 0 C-N-CA 122.186 1.924 . . . . 0.0 112.626 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.497 ' HB2' ' O ' ' A' ' 58' ' ' GLY . 0.1 OUTLIER -50.18 -34.26 21.97 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 179.926 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.22 -40.3 93.48 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.087 0.47 . . . . 0.0 110.871 179.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.61 -19.64 32.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.635 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.56 -18.37 62.25 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.91 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -64.05 -32.19 83.35 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 121.01 -0.614 . . . . 0.0 111.757 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -81.22 -22.9 59.92 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.794 179.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -82.5 -20.52 36.59 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.642 0.258 . . . . 0.0 110.921 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.3 tp -67.01 -22.54 65.9 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.898 179.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -70.4 -38.45 74.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.861 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -123.1 62.96 1.0 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.139 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -78.36 153.11 31.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.804 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.1 mtp180 -109.1 130.09 55.48 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.111 -179.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . 0.442 ' O ' ' HG3' ' A' ' 77' ' ' ARG . 67.8 mt-30 -73.69 -21.86 60.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.859 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.13 -25.87 68.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.294 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -80.55 -30.25 37.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.723 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.06 -21.9 49.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.911 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.442 ' HG3' ' O ' ' A' ' 73' ' ' GLN . 88.0 mtt-85 -69.58 -23.09 63.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.201 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.407 ' O ' HG22 ' A' ' 82' ' ' VAL . 21.8 t -63.47 -36.37 76.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.878 0.37 . . . . 0.0 110.405 179.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -65.53 -35.43 91.24 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.712 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.444 ' O ' HG21 ' A' ' 84' ' ' VAL . . . -66.36 -38.48 93.66 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.324 178.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 58.4 t -59.95 -43.71 92.92 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-O 120.907 0.384 . . . . 0.0 110.1 178.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 78' ' ' VAL . 33.0 t -61.98 -39.66 84.48 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.448 179.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.07 -43.72 97.77 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.519 179.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.444 HG21 ' O ' ' A' ' 80' ' ' GLY . 97.2 t -62.95 -43.28 98.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-O 121.003 0.43 . . . . 0.0 110.05 178.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.5 mp -62.88 -40.42 97.49 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.467 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -63.47 -41.74 98.6 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -59.57 -40.32 96.18 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.7 178.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.8 mt -65.61 -37.22 85.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.753 0.311 . . . . 0.0 110.7 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -72.01 -36.05 69.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.912 0.387 . . . . 0.0 110.644 179.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 46.6 mmm -70.27 -22.03 62.91 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.86 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.1 mt -70.52 -2.99 15.77 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.084 178.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.67 10.71 66.98 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.916 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 17.3 mt -78.16 122.22 25.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.938 0.369 . . . . 0.0 110.569 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 . . . . . 0 C--N 1.326 -0.455 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.785 -179.361 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.919 0.39 . . . . 0.0 111.097 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.6 -20.56 50.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.975 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.406 ' N ' ' HD2' ' A' ' 110' ' ' PRO . 0.9 OUTLIER -77.89 -56.42 1.09 Allowed Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.665 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.406 ' HD2' ' N ' ' A' ' 109' ' ' ARG . 28.6 Cg_endo -62.35 -35.26 74.06 Favored 'Trans proline' 0 C--N 1.362 1.248 0 C-N-CA 122.012 1.808 . . . . 0.0 112.198 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -81.46 -21.85 38.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.085 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -68.4 -41.2 85.98 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.772 -0.728 . . . . 0.0 111.369 178.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -72.3 -33.9 67.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.741 0.305 . . . . 0.0 110.521 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.76 -36.17 72.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.076 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.1 tp -67.29 -48.46 67.57 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.711 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 12.0 mt -67.41 -29.54 69.06 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.448 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -72.68 -48.69 21.37 Favored Glycine 0 N--CA 1.451 -0.361 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 178.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.73 -36.33 80.67 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.75 0.31 . . . . 0.0 110.738 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 90.7 m -64.73 -43.24 94.03 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.884 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.76 -29.65 68.09 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.806 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -77.5 -31.66 53.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.004 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -79.16 -24.83 43.0 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.04 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -86.88 160.39 32.38 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.75 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -96.8 120.93 38.04 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 122.429 -0.454 . . . . 0.0 111.0 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.485 ' O ' HG21 ' A' ' 128' ' ' ILE . 0.2 OUTLIER -80.93 114.06 45.49 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.849 179.71 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -59.87 -16.94 41.02 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.763 2.308 . . . . 0.0 112.985 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 11.1 t -77.04 -26.55 53.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.753 0.311 . . . . 0.0 110.903 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.485 HG21 ' O ' ' A' ' 125' ' ' THR . 1.4 tp -99.98 -4.72 9.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.124 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -56.57 -64.38 4.45 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 115.942 -0.572 . . . . 0.0 113.159 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -58.13 -37.95 93.47 Favored 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 122.459 2.106 . . . . 0.0 112.413 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.494 ' O ' HG13 ' A' ' 135' ' ' ILE . 69.2 mt -61.94 -46.07 97.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.865 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.78 -39.97 95.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.001 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -62.94 -36.6 93.65 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.78 178.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -68.32 -39.9 81.83 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.576 0.227 . . . . 0.0 111.061 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.494 HG13 ' O ' ' A' ' 131' ' ' ILE . 70.4 mt -63.06 -32.97 58.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.075 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.37 -34.8 79.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.111 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -84.88 -22.07 29.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.904 178.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.9 -29.67 58.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.986 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -81.62 -16.22 52.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.04 0.448 . . . . 0.0 110.712 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -77.93 -28.6 49.7 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.666 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 7.3 m -102.6 4.87 10.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.986 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -169.68 97.73 0.13 Allowed Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.182 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -85.42 81.25 1.75 Allowed Glycine 0 CA--C 1.517 0.187 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.685 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -124.57 106.6 0.94 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.509 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -69.2 -23.77 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 121.011 0.434 . . . . 0.0 111.06 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -65.77 -30.36 77.07 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.139 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.26 -43.36 86.68 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.788 0.328 . . . . 0.0 110.62 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.57 -40.24 92.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.9 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.69 -42.04 87.09 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.335 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.82 -32.75 74.36 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.447 179.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -63.32 -49.88 72.22 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.741 179.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 10.2 mt -61.02 -44.35 98.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.989 0.423 . . . . 0.0 110.535 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.3 -34.04 74.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.409 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -59.92 -36.93 91.74 Favored Glycine 0 C--N 1.334 0.471 0 C-N-CA 121.267 -0.492 . . . . 0.0 112.105 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.53 ' C ' ' HD2' ' A' ' 158' ' ' PRO . 5.5 mt -86.36 -22.6 26.57 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 120.842 0.354 . . . . 0.0 110.97 178.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -61.21 -49.55 76.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.052 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.448 ' O ' HG21 ' A' ' 161' ' ' VAL . 0.3 OUTLIER -54.6 -51.59 77.24 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.331 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.53 ' HD2' ' C ' ' A' ' 155' ' ' LEU . 43.4 Cg_exo -58.96 -40.78 68.2 Favored 'Trans proline' 0 C--N 1.36 1.147 0 C-N-CA 122.138 1.892 . . . . 0.0 112.346 178.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . 0.425 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 2.6 m-85 -60.6 -40.38 91.59 Favored 'General case' 0 CA--C 1.522 -0.1 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.336 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -65.65 -43.38 89.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.794 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.448 HG21 ' O ' ' A' ' 157' ' ' VAL . 40.1 t -63.37 -44.04 98.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.809 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 84.9 t -67.73 -49.11 72.82 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.906 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.425 ' HB2' ' O ' ' A' ' 159' ' ' PHE . . . -57.98 -32.26 67.71 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.644 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.4 -48.79 54.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.301 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -71.27 -33.65 69.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.702 0.287 . . . . 0.0 110.82 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.414 ' O ' ' HB2' ' A' ' 170' ' ' LYS . . . -68.97 -21.03 64.2 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.019 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -72.31 -35.63 68.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.169 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 13.4 mmm180 -84.82 -42.71 14.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.23 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 3.3 tt -68.41 -19.99 24.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.277 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.425 ' O ' ' HB2' ' A' ' 174' ' ' ARG . 0.8 OUTLIER -57.46 -36.4 71.38 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.313 179.59 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -70.0 -30.28 70.13 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.579 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 1.4 m95 -86.82 -47.41 9.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.76 0.314 . . . . 0.0 111.469 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 4.7 mt -66.89 -16.49 64.35 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.701 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.425 ' HB2' ' O ' ' A' ' 170' ' ' LYS . 9.9 ttt-85 -56.79 -53.25 60.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.998 0.428 . . . . 0.0 110.984 178.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 8.1 mtm180 -93.77 -16.39 24.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.348 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -94.19 4.7 53.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.71 0.29 . . . . 0.0 111.554 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -83.13 9.5 60.58 Favored Glycine 0 CA--C 1.517 0.183 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.681 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 22.2 mtt180 -67.79 -38.65 83.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.943 0.401 . . . . 0.0 110.611 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -81.39 -29.5 10.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.467 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.95 -16.74 64.2 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.108 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' HIS . . . . . 0.409 ' O ' HG22 ' A' ' 185' ' ' VAL . 0.3 OUTLIER -57.27 -31.99 66.16 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.225 179.701 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.32 -44.2 88.61 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.045 0.45 . . . . 0.0 110.412 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 2.2 t -72.17 -19.67 19.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.781 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.79 -44.82 31.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.133 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.409 HG22 ' O ' ' A' ' 181' ' ' HIS . 46.7 t -67.64 -41.24 85.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.549 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.504 ' O ' HG23 ' A' ' 190' ' ' VAL . 0.3 OUTLIER -60.9 -47.9 84.26 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.739 179.504 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -62.35 -36.45 82.26 Favored 'General case' 0 N--CA 1.457 -0.092 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.384 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -64.0 -46.5 91.2 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.98 -0.629 . . . . 0.0 111.951 178.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 86.8 t -62.18 -48.95 86.06 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 CA-C-O 120.555 0.217 . . . . 0.0 110.616 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 186' ' ' LEU . 76.6 t -59.3 -38.33 74.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.898 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 2.7 tp -62.22 -46.07 90.49 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.778 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 61.7 t -66.19 -38.38 81.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.256 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 9.0 mt -59.05 -54.24 49.35 Favored 'General case' 0 C--N 1.334 -0.094 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.308 179.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 32.6 m -68.56 -29.74 44.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.861 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -66.65 -47.08 70.66 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.449 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.463 HG11 ' N ' ' A' ' 197' ' ' LEU . 6.1 p -72.17 -31.33 39.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-O 120.722 0.296 . . . . 0.0 110.79 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.463 ' N ' HG11 ' A' ' 196' ' ' VAL . 11.9 mt -67.52 -38.09 83.75 Favored 'General case' 0 N--CA 1.458 -0.069 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.238 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.77 -33.36 60.19 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 121.024 -0.27 . . . . 0.0 110.747 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -66.5 -47.16 73.89 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.792 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 10.1 t -81.76 -11.11 59.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.212 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -87.79 -51.77 3.15 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.557 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 53.87 37.83 27.38 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.037 0.446 . . . . 0.0 111.229 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -139.72 -167.58 2.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.692 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.48 56.21 1.37 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.686 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -82.37 -19.5 39.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.009 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 8.8 tp -70.65 -32.92 70.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.807 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -70.22 -40.79 74.31 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.017 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.8 -32.07 71.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.97 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . 0.449 ' O ' HG13 ' A' ' 213' ' ' ILE . 5.9 m-85 -80.84 -43.91 19.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.025 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -61.9 -32.7 73.11 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.458 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.77 -18.08 65.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.752 0.31 . . . . 0.0 111.188 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.48 -24.39 18.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.844 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 209' ' ' PHE . 1.9 mt -92.4 -19.05 7.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.276 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 88.3 m -70.48 120.01 76.02 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.716 179.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -72.17 151.26 54.87 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.4 2.066 . . . . 0.0 112.076 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.06 -16.27 63.65 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.35 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 15.0 m95 -70.13 -25.46 63.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.16 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 1.3 mp -82.68 -23.47 34.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.961 0.41 . . . . 0.0 110.311 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 59.6 mt-30 -78.17 -21.98 49.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.393 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 36.5 mmt-85 . . . . . 0 C--N 1.332 -0.176 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.954 179.541 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.845 0.355 . . . . 0.0 110.994 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.7 mt -73.66 -21.95 60.12 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.499 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.88 -30.47 69.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.648 179.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -74.39 -44.1 53.56 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.666 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -58.32 -46.52 86.0 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.726 179.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.85 -47.94 78.72 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.932 179.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.58 -40.61 83.65 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.295 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.84 -49.78 64.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.498 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 14.2 tp -57.5 -43.91 84.57 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.609 178.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.76 -45.88 91.98 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.062 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.8 -45.0 96.51 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.244 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 67.9 t -68.09 -39.42 81.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.521 0.2 . . . . 0.0 110.606 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.488 ' O ' ' HB2' ' A' ' 18' ' ' SER . 0.2 OUTLIER -61.16 -46.57 89.96 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.871 179.516 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 43.2 m -64.35 -36.12 83.09 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.728 0.299 . . . . 0.0 111.167 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -72.18 -38.39 69.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.746 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.48 -11.66 59.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.847 0.356 . . . . 0.0 111.115 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.488 ' HB2' ' O ' ' A' ' 14' ' ' LEU . 0.2 OUTLIER -87.05 134.08 37.62 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.387 179.239 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.94 -7.96 22.05 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.653 2.236 . . . . 0.0 112.537 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -106.28 147.27 29.35 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.481 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 6.5 t 60.65 65.69 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-O 121.384 0.612 . . . . 0.0 110.874 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 30.5 mt -109.07 116.68 55.06 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.285 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.11 -24.31 44.89 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.767 2.311 . . . . 0.0 112.688 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.81 -19.27 65.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.471 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 54.1 t -64.99 -60.15 8.65 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.291 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.92 -24.91 77.92 Favored 'Trans proline' 0 C--N 1.361 1.196 0 C-N-CA 121.985 1.79 . . . . 0.0 112.547 178.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.7 m -65.2 -39.83 93.35 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.844 0.354 . . . . 0.0 110.815 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -69.02 -31.24 69.91 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.739 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.83 -41.48 44.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.369 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -59.48 -41.95 90.97 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.041 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -73.99 -28.7 61.59 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.806 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.68 -28.9 64.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.267 179.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.461 ' O ' ' HD3' ' A' ' 110' ' ' PRO . . . -74.1 -32.18 58.79 Favored Glycine 0 N--CA 1.448 -0.567 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.066 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.69 83.86 1.52 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.328 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -124.5 -68.34 0.86 Allowed 'General case' 0 C--N 1.328 -0.341 0 O-C-N 122.923 -0.163 . . . . 0.0 111.246 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 18.8 mtt180 57.93 38.68 27.0 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.271 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -104.15 61.55 0.42 Allowed Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.359 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 58.38 82.82 0.23 Allowed Pre-proline 0 N--CA 1.468 0.451 0 C-N-CA 122.894 0.478 . . . . 0.0 111.522 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -57.36 -30.11 86.66 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.861 2.374 . . . . 0.0 112.586 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.9 -38.32 90.45 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.34 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -77.13 -37.12 54.72 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.499 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 19.9 t30 -65.59 -36.06 82.66 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.222 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.55 ' O ' HG12 ' A' ' 47' ' ' ILE . . . -61.61 -54.83 37.68 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.615 178.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 74.2 mt -56.23 -39.75 73.02 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.2 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -63.95 -45.89 87.16 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.826 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -63.91 -42.73 97.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.948 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.55 HG12 ' O ' ' A' ' 43' ' ' ALA . 48.8 mm -64.89 -41.08 91.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.656 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.3 tp -65.28 -45.98 82.29 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 179.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.565 ' O ' HG21 ' A' ' 53' ' ' VAL . . . -60.74 -42.94 99.62 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.755 179.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.18 -40.83 86.62 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.619 0.247 . . . . 0.0 110.959 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -62.06 -39.38 97.53 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.86 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.9 -47.92 73.2 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.459 0.171 . . . . 0.0 110.88 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.565 HG21 ' O ' ' A' ' 49' ' ' GLY . 57.8 t -61.87 -40.23 86.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.033 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.33 -45.86 78.85 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.323 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -68.18 -38.54 82.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.4 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.54 -32.95 74.62 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.12 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.29 -18.75 26.35 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.977 0.418 . . . . 0.0 110.802 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -79.24 -25.3 59.63 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 121.127 -0.558 . . . . 0.0 112.299 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.88 -56.41 29.11 Favored Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 111.464 0.172 . . . . 0.0 111.464 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -70.13 -14.03 34.44 Favored 'Trans proline' 0 C--N 1.362 1.253 0 C-N-CA 122.023 1.815 . . . . 0.0 112.646 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -63.76 -19.74 65.21 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.318 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.0 m -63.53 -45.14 91.95 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.012 0.434 . . . . 0.0 110.651 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.72 -21.18 24.0 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.102 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.93 -18.05 58.53 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.785 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -63.25 -26.31 69.23 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.067 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -78.75 -24.53 62.18 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.89 -0.672 . . . . 0.0 111.769 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 54.9 mt -87.35 -20.73 26.33 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.69 0.281 . . . . 0.0 110.652 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.5 -19.32 64.66 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.647 179.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -65.3 -17.45 64.52 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.837 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -84.33 179.07 7.53 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.268 0.556 . . . . 0.0 110.353 178.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -80.23 72.36 7.05 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.299 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 72' ' ' ARG . 8.0 mtt180 -114.26 25.3 11.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.386 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -78.38 -18.19 55.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.985 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.35 -20.21 65.96 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.469 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.4 -28.32 67.83 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.662 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.1 -23.53 28.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.428 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -64.66 -29.21 70.21 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.157 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.1 t -63.73 -21.41 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.625 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -66.58 -29.61 75.05 Favored Glycine 0 C--N 1.336 0.546 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.715 179.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.497 ' O ' HG21 ' A' ' 84' ' ' VAL . . . -74.23 -38.69 45.94 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.51 -0.852 . . . . 0.0 111.169 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.9 t -59.13 -48.87 85.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-O 120.825 0.345 . . . . 0.0 111.05 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.2 m -69.07 -31.35 49.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.107 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.72 -43.13 94.4 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.673 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.497 HG21 ' O ' ' A' ' 80' ' ' GLY . 74.1 t -65.54 -40.09 87.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.21 179.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.89 -41.02 95.21 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.636 179.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -66.25 -37.7 86.12 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.4 179.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -65.25 -39.65 96.16 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.713 178.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.53 -39.92 95.67 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.738 0.304 . . . . 0.0 110.654 179.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -71.62 -32.03 67.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.554 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.87 -19.81 61.23 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.903 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.48 -3.5 8.71 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.375 178.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 108.49 6.43 31.14 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.681 -0.771 . . . . 0.0 113.147 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.96 121.06 12.04 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 117.083 0.441 . . . . 0.0 110.499 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 6.9 mtt180 . . . . . 0 C--N 1.324 -0.522 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.663 -179.583 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.132 0 CA-C-O 120.926 0.393 . . . . 0.0 111.452 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.74 -2.48 58.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.062 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.462 ' N ' ' HD2' ' A' ' 110' ' ' PRO . 0.9 OUTLIER -64.39 -53.19 48.02 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.351 -179.745 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 109' ' ' ARG . 15.8 Cg_endo -57.88 -36.27 98.3 Favored 'Trans proline' 0 C--N 1.362 1.242 0 C-N-CA 122.171 1.914 . . . . 0.0 112.617 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -75.07 -31.11 61.16 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.34 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -74.48 -25.8 69.41 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 178.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -64.31 -36.77 85.19 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.802 0.334 . . . . 0.0 110.887 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.17 -40.71 71.1 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.652 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.9 tp -68.79 -36.08 77.82 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.349 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.14 -22.13 61.36 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.201 0.525 . . . . 0.0 110.22 178.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -80.27 -44.31 8.91 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.79 -40.07 96.2 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.522 0.201 . . . . 0.0 111.17 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.4 p -65.31 -38.94 91.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.967 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.69 -24.79 61.88 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.654 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -80.21 -35.02 36.87 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.952 0.406 . . . . 0.0 110.371 179.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 72.5 mt -78.46 -26.14 46.05 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.314 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -76.71 160.35 50.45 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.768 178.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 14.9 p90 -112.62 154.38 26.13 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.978 0.418 . . . . 0.0 110.86 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.564 ' HB ' ' SG ' ' A' ' 127' ' ' CYS . 0.8 OUTLIER -109.32 104.39 55.04 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.519 179.424 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.97 -18.26 56.44 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.115 2.543 . . . . 0.0 113.203 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . 0.564 ' SG ' ' HB ' ' A' ' 125' ' ' THR . 0.8 OUTLIER -64.88 -37.45 87.68 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.14 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 pt -103.45 4.79 10.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.24 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -58.89 -68.59 1.61 Allowed Glycine 0 C--N 1.334 0.472 0 CA-C-N 116.046 -0.525 . . . . 0.0 112.756 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.51 -31.61 92.63 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.348 2.032 . . . . 0.0 111.878 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 60.6 mt -63.69 -55.83 20.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.888 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.43 -34.7 77.76 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.708 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -61.88 -36.2 92.45 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.226 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -75.61 -36.7 60.19 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.833 0.349 . . . . 0.0 111.086 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 46.7 mm -70.48 -35.33 61.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.971 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.97 -30.17 70.74 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.118 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.88 -26.97 64.44 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.941 0.4 . . . . 0.0 110.75 178.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 8.7 mt -84.52 -38.75 19.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.893 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 16.0 p -70.11 -16.3 63.09 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.473 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -75.86 -29.48 58.57 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.791 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 2.1 t -96.81 -32.77 4.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.592 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -150.15 90.76 0.14 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.318 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -162.92 -97.59 0.12 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.601 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 111.56 -179.77 19.84 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.49 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 6.2 t -75.0 -31.11 24.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 120.67 0.271 . . . . 0.0 111.0 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -60.44 -32.67 78.35 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.669 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.87 -40.87 83.55 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.853 0.358 . . . . 0.0 110.426 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.42 ' O ' HG13 ' A' ' 152' ' ' ILE . 17.0 mt -62.35 -42.52 99.46 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.486 179.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 30.7 mt -65.77 -39.82 91.41 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.508 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.18 -40.11 96.58 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.385 178.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -61.49 -44.8 96.43 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.026 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.42 HG13 ' O ' ' A' ' 148' ' ' LEU . 53.9 mt -64.39 -49.0 82.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.633 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.55 -34.57 78.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.928 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . 0.406 ' O ' ' HD2' ' A' ' 158' ' ' PRO . . . -60.55 -44.82 97.34 Favored Glycine 0 C--O 1.223 -0.546 0 C-N-CA 121.176 -0.535 . . . . 0.0 112.189 179.088 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.45 -28.17 61.81 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.166 0.508 . . . . 0.0 110.561 178.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -64.4 -35.34 80.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.438 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.49 ' O ' HG21 ' A' ' 161' ' ' VAL . 96.7 t -55.38 -62.79 3.83 Favored Pre-proline 0 CA--C 1.542 0.643 0 O-C-N 123.272 0.358 . . . . 0.0 111.595 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.495 ' O ' HG23 ' A' ' 162' ' ' VAL . 18.0 Cg_endo -60.15 -36.09 89.96 Favored 'Trans proline' 0 C--N 1.359 1.127 0 C-N-CA 122.04 1.827 . . . . 0.0 112.225 179.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -59.66 -46.44 89.02 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-O 120.739 0.304 . . . . 0.0 110.944 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -63.57 -39.41 94.32 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.942 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.49 HG21 ' O ' ' A' ' 157' ' ' VAL . 52.8 t -61.27 -43.59 96.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-O 120.927 0.394 . . . . 0.0 110.321 179.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 158' ' ' PRO . 61.0 t -68.36 -38.58 79.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.647 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -58.56 -35.6 72.62 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.779 0.323 . . . . 0.0 111.313 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 17.1 mt -78.96 -42.63 26.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.194 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.78 -19.24 62.04 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.224 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.418 ' HB2' ' O ' ' A' ' 162' ' ' VAL . . . -66.01 -19.85 65.99 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.158 179.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -64.29 -39.76 94.58 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.782 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 16.5 mtt180 -69.16 -24.17 64.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.649 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 26.4 mt -83.38 -22.42 8.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.427 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -62.76 -38.17 89.49 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.749 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -75.85 -36.23 42.7 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.664 -0.779 . . . . 0.0 111.882 179.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 1.8 m95 -73.92 -26.95 60.79 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.525 0.194 . . . . 0.0 111.525 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 2.3 tp -57.49 -36.53 71.62 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.709 0.29 . . . . 0.0 111.367 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 1.1 mtp-105 -87.07 -20.45 27.11 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.136 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -83.78 -34.13 24.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.921 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -62.55 -65.19 0.72 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.793 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 79.78 -64.85 3.81 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.969 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 9.4 mtm180 -81.18 -40.14 24.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.722 0.296 . . . . 0.0 111.285 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 14.3 mm -69.04 -31.4 50.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.051 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -63.33 -26.64 68.86 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.048 0.452 . . . . 0.0 111.092 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -84.8 -22.01 29.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.128 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -75.63 -28.79 58.96 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.825 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 17.4 t -65.54 -25.37 36.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.703 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -82.41 -37.98 24.72 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.768 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.8 t -70.99 -46.3 68.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.891 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.476 ' O ' HG23 ' A' ' 190' ' ' VAL . 5.2 tp -62.32 -52.67 62.72 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.282 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -64.42 -35.09 79.79 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.02 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -62.41 -49.96 69.17 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.21 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 96.4 t -62.0 -46.99 95.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 120.479 0.181 . . . . 0.0 110.783 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 186' ' ' LEU . 85.9 t -59.33 -43.15 89.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.878 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 5.4 tp -58.43 -48.85 79.34 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.756 0.312 . . . . 0.0 111.228 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . 0.515 ' O ' HG23 ' A' ' 196' ' ' VAL . 41.4 t -66.06 -40.85 88.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.465 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . 0.441 ' O ' ' HB2' ' A' ' 197' ' ' LEU . 2.2 tp -58.77 -50.08 75.28 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.681 179.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 87.7 t -61.1 -39.75 83.41 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.434 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -57.86 -48.03 84.87 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.611 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 192' ' ' VAL . 4.2 t -73.87 -34.89 41.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.726 0.298 . . . . 0.0 110.517 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . 0.54 ' O ' ' HA3' ' A' ' 201' ' ' GLY . 0.5 OUTLIER -63.1 -28.31 69.99 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.714 179.236 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 65.0 mt -80.38 -42.54 22.65 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.818 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -70.79 -57.6 4.48 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 68.2 p -81.46 -9.26 59.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.803 0.335 . . . . 0.0 111.727 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . 0.54 ' HA3' ' O ' ' A' ' 197' ' ' LEU . . . -84.67 -54.21 3.0 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.436 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 28.5 m 67.23 -72.2 0.09 Allowed 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 122.845 0.458 . . . . 0.0 111.521 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -163.84 -50.19 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.523 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.91 -46.2 90.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.35 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -84.8 -19.52 32.41 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.738 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.1 mt -77.27 -36.86 54.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.889 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.98 -39.59 95.16 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.625 -0.261 . . . . 0.0 110.949 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.52 -37.82 73.67 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.342 178.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -87.04 -24.52 24.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.167 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -67.65 -17.19 64.51 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.978 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.0 mt -61.35 -30.84 70.77 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 121.019 0.437 . . . . 0.0 110.722 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 3.2 mtt180 -92.91 -3.61 54.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.711 179.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . 0.45 HG23 HD13 ' A' ' 213' ' ' ILE . 37.0 mm -103.21 -20.16 5.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.941 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.56 119.7 45.9 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.047 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.46 151.63 65.17 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.304 2.003 . . . . 0.0 112.254 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -64.61 -22.42 66.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.191 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 8.0 m-90 -63.55 -24.8 67.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.303 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 16.0 mt -89.53 -27.22 20.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.94 0.4 . . . . 0.0 110.399 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.04 -35.43 31.84 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.363 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 1.4 mtp180 . . . . . 0 C--N 1.331 -0.221 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.03 179.502 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.544 0.211 . . . . 0.0 110.943 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 8.2 mt -76.17 -20.94 57.08 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.505 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.75 -26.21 64.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.687 179.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.8 mt -77.4 -46.1 23.78 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.562 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -60.51 -39.81 89.13 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.796 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.76 -46.02 89.97 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.737 178.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.97 -35.12 79.11 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.769 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.444 ' O ' HG21 ' A' ' 13' ' ' VAL . 1.2 m-85 -65.56 -51.74 57.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.18 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.43 -39.02 82.18 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.29 178.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.23 -44.17 97.7 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.425 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.81 -42.9 99.8 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 120.888 -0.672 . . . . 0.0 111.835 178.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.444 HG21 ' O ' ' A' ' 9' ' ' PHE . 49.1 t -65.61 -41.31 90.38 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-O 120.719 0.295 . . . . 0.0 110.307 179.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.4 tp -63.99 -41.72 97.41 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.456 179.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 18.9 m -64.34 -35.78 81.98 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.726 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -72.04 -36.08 69.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.988 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.8 -4.86 59.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.811 0.339 . . . . 0.0 111.077 179.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.0 t -68.89 119.87 72.37 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.805 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -67.3 -8.07 20.89 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.84 2.36 . . . . 0.0 112.697 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 2.2 t -73.38 -25.31 60.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.841 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.4 m -130.82 5.78 2.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.666 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.77 -53.72 8.82 Favored Pre-proline 0 CA--C 1.538 0.504 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -68.97 -14.71 39.1 Favored 'Trans proline' 0 C--N 1.361 1.201 0 C-N-CA 121.888 1.725 . . . . 0.0 112.432 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.1 mp -81.28 -16.13 53.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.459 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.462 ' N ' ' HD2' ' A' ' 26' ' ' PRO . 95.0 t -62.86 -55.2 40.31 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-O 119.725 -0.179 . . . . 0.0 111.289 178.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 25' ' ' VAL . 14.4 Cg_endo -58.05 -33.06 96.87 Favored 'Trans proline' 0 C--N 1.362 1.246 0 C-N-CA 122.275 1.984 . . . . 0.0 112.505 178.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.54 -36.64 65.69 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.791 0.329 . . . . 0.0 110.943 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.0 -28.5 68.3 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.021 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 8.3 mt -63.06 -37.52 87.51 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.718 179.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.58 -35.52 67.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.065 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -66.75 -37.14 84.05 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.336 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.63 -15.18 60.83 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.23 178.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -67.65 -24.96 74.08 Favored Glycine 0 C--N 1.332 0.346 0 N-CA-C 111.77 -0.532 . . . . 0.0 111.77 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.53 -16.35 80.1 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.985 -0.626 . . . . 0.0 111.54 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -126.9 51.39 1.87 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.975 0.417 . . . . 0.0 109.988 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.7 70.79 1.4 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.39 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -146.48 84.95 0.18 Allowed Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.548 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.2 mtp180 66.4 91.25 0.08 OUTLIER Pre-proline 0 N--CA 1.467 0.416 0 C-N-CA 122.922 0.489 . . . . 0.0 111.16 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -64.09 -30.24 65.67 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.434 2.089 . . . . 0.0 112.466 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.4 mp -62.55 -40.83 98.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.279 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -72.47 -37.35 68.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.615 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -67.57 -43.8 79.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.393 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.05 -50.68 67.44 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.769 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.74 -42.68 75.75 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.219 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -63.85 -41.31 97.84 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.876 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.28 -41.47 94.15 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.37 179.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 54.6 mt -62.96 -42.43 96.6 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.943 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.31 -44.07 92.74 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.468 179.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.511 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -59.27 -43.71 97.04 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.862 -0.685 . . . . 0.0 111.693 178.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.02 -37.24 81.16 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.76 0.314 . . . . 0.0 110.242 179.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -63.17 -41.93 99.55 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 178.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.42 -45.99 87.38 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 120.509 0.195 . . . . 0.0 110.635 178.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 49' ' ' GLY . 24.7 t -63.41 -43.02 98.29 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.837 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -66.04 -28.2 68.67 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.426 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -82.82 -47.39 11.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.561 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.59 -35.71 80.4 Favored 'General case' 0 C--O 1.227 -0.109 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.85 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.402 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 0.9 OUTLIER -89.52 -18.35 26.82 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.792 0.33 . . . . 0.0 110.497 178.488 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.28 -35.68 83.12 Favored Glycine 0 C--N 1.33 0.204 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.41 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.404 ' CB ' ' HD3' ' A' ' 60' ' ' PRO . 0.5 OUTLIER -63.23 -55.63 34.65 Favored Pre-proline 0 CA--C 1.543 0.687 0 N-CA-C 111.49 0.182 . . . . 0.0 111.49 179.197 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.404 ' HD3' ' CB ' ' A' ' 59' ' ' LEU . 13.6 Cg_exo -70.47 -13.96 33.4 Favored 'Trans proline' 0 C--N 1.361 1.185 0 C-N-CA 122.517 2.144 . . . . 0.0 112.629 179.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.63 -25.74 64.92 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.119 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.5 -34.72 76.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.032 0.444 . . . . 0.0 110.403 178.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.57 -19.81 25.84 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.618 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.25 -17.78 64.94 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.863 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.32 -27.5 65.57 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.947 -0.644 . . . . 0.0 111.901 179.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -78.38 -22.06 68.46 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.582 179.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.9 mt -87.12 -20.56 26.89 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.646 0.26 . . . . 0.0 110.415 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.86 -19.42 62.6 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.916 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -60.45 -26.0 66.42 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.758 178.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -97.59 125.18 42.17 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -74.59 98.74 3.45 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.026 0.441 . . . . 0.0 111.419 -179.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -87.1 64.79 8.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.984 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -67.45 -19.79 65.41 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.135 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.0 t -69.99 -17.76 63.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.3 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.53 -22.51 30.13 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.883 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.44 -22.4 38.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.862 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.61 -27.14 66.65 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.92 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.3 t -63.0 -32.47 56.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.798 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -64.31 -34.98 91.37 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.033 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.464 ' O ' HG23 ' A' ' 84' ' ' VAL . . . -66.72 -38.9 93.49 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.666 179.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.9 t -62.53 -41.22 91.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-O 120.766 0.317 . . . . 0.0 110.462 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 40.5 t -63.8 -40.54 89.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.383 179.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.1 -42.72 99.65 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.718 179.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 80' ' ' GLY . 94.5 t -64.02 -43.52 97.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.392 179.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.86 -43.33 98.53 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.952 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -66.15 -43.53 86.72 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.743 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -62.83 -40.14 98.87 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.148 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.2 -36.45 83.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.724 0.297 . . . . 0.0 110.613 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -74.74 -30.09 61.38 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.283 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 28.5 mmt -67.07 -27.94 67.78 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.29 178.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.4 mp -66.96 -10.51 50.07 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.265 178.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.41 20.22 59.02 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.85 -0.69 . . . . 0.0 113.259 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -78.42 124.14 27.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.93 0.365 . . . . 0.0 110.594 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.679 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.169 0 CA-C-O 121.084 0.469 . . . . 0.0 111.054 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.25 -12.55 59.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.15 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.416 ' CB ' ' HD3' ' A' ' 110' ' ' PRO . 0.0 OUTLIER -74.26 -58.46 1.93 Allowed Pre-proline 0 CA--C 1.539 0.53 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -179.571 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.416 ' HD3' ' CB ' ' A' ' 109' ' ' ARG . 23.8 Cg_exo -64.8 -40.21 22.8 Favored 'Trans proline' 0 C--N 1.358 1.047 0 C-N-CA 122.055 1.837 . . . . 0.0 112.34 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -74.17 -30.6 62.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.642 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.472 ' O ' ' HB2' ' A' ' 116' ' ' LEU . . . -64.8 -40.71 97.55 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.909 -0.662 . . . . 0.0 111.974 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.51 -30.51 69.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.866 0.365 . . . . 0.0 110.919 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -80.5 -45.49 17.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.009 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.5 mt -65.66 -43.47 89.25 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.894 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 112' ' ' GLY . 1.9 mt -71.03 -22.87 62.09 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.944 0.402 . . . . 0.0 110.181 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -78.07 -46.13 9.6 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.22 -38.72 77.37 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.654 0.264 . . . . 0.0 111.304 178.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.3 p -68.55 -35.77 77.87 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.935 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.27 -33.1 61.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.478 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -71.27 -47.2 58.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.671 179.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.77 -24.01 60.89 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.834 179.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -78.88 89.03 1.16 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.944 -0.646 . . . . 0.0 111.73 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -59.3 126.29 27.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.082 0.468 . . . . 0.0 111.714 -179.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.513 ' O ' HG23 ' A' ' 128' ' ' ILE . 1.1 p -73.6 134.87 78.74 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.216 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -64.13 -19.27 65.91 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.757 2.305 . . . . 0.0 113.116 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 3.9 m -73.13 -14.95 61.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.089 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.513 HG23 ' O ' ' A' ' 125' ' ' THR . 3.7 tp -97.2 -3.95 9.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.363 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -51.79 -59.52 8.54 Favored Glycine 0 C--N 1.336 0.57 0 CA-C-N 115.894 -0.593 . . . . 0.0 113.091 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -56.73 -41.48 75.23 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.473 2.115 . . . . 0.0 112.236 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.482 HG21 HD12 ' A' ' 131' ' ' ILE . 25.1 mm -65.48 -47.34 87.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.003 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.07 -44.12 97.36 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.535 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -58.74 -38.5 92.08 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.837 178.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.48 -40.58 89.41 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.86 0.362 . . . . 0.0 110.665 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.462 HG13 ' O ' ' A' ' 131' ' ' ILE . 78.6 mt -65.4 -37.44 80.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.213 179.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . 0.452 ' HA ' ' OG1' ' A' ' 139' ' ' THR . 0.3 OUTLIER -64.1 -31.42 72.61 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.983 179.49 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.2 m -65.46 -30.88 71.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.994 0.426 . . . . 0.0 110.741 178.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 18.4 mt -83.39 -37.16 23.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.992 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.452 ' OG1' ' HA ' ' A' ' 136' ' ' LEU . 0.6 OUTLIER -72.3 -20.35 61.52 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.948 179.848 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -68.56 -27.52 66.15 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.549 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 2.0 t -94.13 -29.4 4.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.246 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 146.92 -95.16 0.17 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.552 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 100.33 -66.62 0.55 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.342 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 113.32 163.65 15.51 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.703 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 12.3 p -68.14 -25.59 32.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-O 120.801 0.334 . . . . 0.0 111.227 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -59.9 -34.29 82.33 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 121.161 -0.543 . . . . 0.0 112.708 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.99 -43.2 88.48 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.815 0.341 . . . . 0.0 110.424 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.52 -45.36 91.0 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.504 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.67 -40.36 95.28 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.979 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -61.15 -41.2 96.32 Favored 'General case' 0 C--O 1.226 -0.154 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.778 179.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -63.86 -43.54 95.81 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.985 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 59.4 mt -62.67 -50.84 78.16 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.733 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 71.6 mt -68.24 -32.71 73.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.463 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -60.69 -44.71 97.57 Favored Glycine 0 C--O 1.225 -0.415 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.355 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.69 -21.66 44.38 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.716 0.293 . . . . 0.0 110.954 178.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -65.89 -37.23 85.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.484 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.428 ' HB ' ' CD ' ' A' ' 158' ' ' PRO . 90.8 t -57.73 -59.15 13.95 Favored Pre-proline 0 CA--C 1.541 0.606 0 CA-C-O 119.518 -0.277 . . . . 0.0 111.685 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.508 ' O ' HG22 ' A' ' 161' ' ' VAL . 15.5 Cg_endo -59.26 -36.69 94.41 Favored 'Trans proline' 0 C--N 1.361 1.192 0 C-N-CA 122.142 1.895 . . . . 0.0 112.178 178.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -63.95 -38.15 90.02 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 120.548 0.213 . . . . 0.0 110.972 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.59 -49.31 69.29 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.47 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.508 HG22 ' O ' ' A' ' 158' ' ' PRO . 13.5 m -66.71 -32.67 59.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.06 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 3.9 t -67.73 -43.18 86.67 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 178.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -60.09 -34.02 72.88 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.96 178.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 11.2 tp -75.78 -45.39 36.48 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.827 179.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -69.15 -19.15 64.01 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.083 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.64 -19.07 64.57 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.984 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.49 -40.42 94.49 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.468 179.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 2.0 ttt85 -69.12 -36.24 77.29 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.438 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 18.0 mt -70.66 -30.16 41.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.377 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -60.97 -36.91 80.64 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.442 179.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -81.5 -34.37 25.72 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.6 -0.809 . . . . 0.0 111.61 178.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 27.8 t-105 -70.09 -25.84 63.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.893 -0.153 . . . . 0.0 111.393 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.38 -37.53 65.11 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.726 0.298 . . . . 0.0 111.522 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 2.6 mpp_? -87.08 -19.86 27.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.368 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 3.8 mtt85 -86.21 -37.03 19.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.547 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -59.08 -70.1 0.17 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.836 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 69.51 -83.3 0.27 Allowed Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.983 -0.627 . . . . 0.0 113.212 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.13 -40.38 82.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.546 0.212 . . . . 0.0 111.228 -179.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . 0.551 ' O ' HG23 ' A' ' 183' ' ' VAL . 22.6 mt -59.44 -46.14 93.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.811 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.06 -41.44 96.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.085 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -66.07 -32.49 73.99 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.259 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -70.27 -42.98 71.41 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.784 0.326 . . . . 0.0 110.834 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 179' ' ' ILE . 15.0 t -70.77 -19.97 21.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.828 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -67.56 -51.78 46.55 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.604 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.412 ' O ' HG22 ' A' ' 189' ' ' VAL . 5.3 t -75.37 -31.83 24.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.061 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.487 ' O ' HG22 ' A' ' 190' ' ' VAL . 0.6 OUTLIER -58.2 -47.91 81.96 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.912 179.78 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -63.08 -33.67 75.95 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.746 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -66.84 -45.74 80.89 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.41 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.412 HG22 ' O ' ' A' ' 185' ' ' VAL . 46.4 t -61.94 -47.6 92.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 120.736 0.303 . . . . 0.0 110.937 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . 0.487 HG22 ' O ' ' A' ' 186' ' ' LEU . 43.4 t -62.79 -40.98 90.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.774 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 3.7 mt -58.23 -45.96 86.77 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.321 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 81.8 t -64.4 -42.38 95.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-O 120.771 0.32 . . . . 0.0 110.537 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.59 -44.07 91.81 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.066 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.45 HG22 ' O ' ' A' ' 190' ' ' VAL . 78.2 t -64.2 -38.84 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.097 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -58.39 -44.04 95.43 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.233 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 61.8 t -73.56 -40.01 54.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-O 120.763 0.316 . . . . 0.0 110.681 179.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.39 -34.91 79.27 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.112 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.51 -41.11 48.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.071 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.7 -41.6 95.89 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.08 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 1.3 m -83.99 -13.76 52.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.982 0.42 . . . . 0.0 110.469 179.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -85.59 -49.32 4.4 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.55 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 4.7 m 70.57 -65.22 0.34 Allowed 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 122.946 0.498 . . . . 0.0 111.511 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' PHE . . . . . 0.407 ' C ' ' H ' ' A' ' 205' ' ' ALA . 4.9 t80 -154.19 161.31 41.92 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 5.8 m 73.72 -41.42 0.49 Allowed 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 122.98 0.512 . . . . 0.0 111.663 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . 0.407 ' H ' ' C ' ' A' ' 203' ' ' PHE . . . -60.98 -36.52 79.65 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.028 0.442 . . . . 0.0 110.862 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.06 -23.39 38.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.901 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -75.21 -50.09 17.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.171 -179.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 1.7 m -61.57 -33.71 74.33 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.876 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -74.44 -36.28 63.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.989 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -70.32 -29.59 66.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.876 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 6.1 mt -65.25 -18.03 64.98 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.915 0.388 . . . . 0.0 111.219 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 12.1 mtt180 -92.29 -6.05 51.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.42 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 8.1 mm -107.84 -12.47 10.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.69 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.43 128.12 66.98 Favored Pre-proline 0 C--O 1.233 0.192 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.78 179.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -56.8 143.45 90.68 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.557 2.171 . . . . 0.0 112.43 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -61.72 -25.7 67.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.846 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 -69.94 -22.29 63.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.949 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -81.48 -38.04 26.99 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.04 0.448 . . . . 0.0 109.81 179.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -71.47 -30.72 66.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.585 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.332 -0.191 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.05 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.225 0 CA-C-O 120.797 0.332 . . . . 0.0 111.007 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.72 148.32 42.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.869 0.366 . . . . 0.0 111.13 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.57 -26.8 64.65 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.307 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.2 mt -64.73 -47.53 77.94 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.978 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.68 -46.52 90.03 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.685 179.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.34 -45.54 93.07 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.023 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.435 ' HB1' ' O ' ' A' ' 150' ' ' ALA . . . -60.51 -43.3 97.24 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.015 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -62.62 -51.02 68.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.671 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.95 -40.21 88.2 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.702 179.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.47 -45.95 90.18 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.4 178.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.91 -42.98 99.57 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.018 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 93.0 t -64.69 -42.64 95.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-O 120.732 0.301 . . . . 0.0 110.579 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.69 -40.11 95.98 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.564 179.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.6 m -69.08 -32.67 72.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.907 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -68.03 -42.69 80.21 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.982 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -85.02 -9.43 58.03 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.534 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -66.04 119.17 59.3 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.771 0.319 . . . . 0.0 110.884 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.31 -8.21 18.41 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.802 2.334 . . . . 0.0 112.489 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 96.6 m -82.43 44.84 0.91 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.034 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -94.78 54.66 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.94 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.408 ' O ' ' HB ' ' A' ' 25' ' ' VAL . 0.3 OUTLIER -62.87 -51.19 73.25 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.464 -179.57 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.609 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 51.2 Cg_exo -57.18 -31.8 91.62 Favored 'Trans proline' 0 C--N 1.361 1.203 0 C-N-CA 122.192 1.928 . . . . 0.0 113.018 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.86 -13.31 60.54 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.458 ' HB ' ' HD3' ' A' ' 26' ' ' PRO . 3.3 t -64.98 -53.9 38.58 Favored Pre-proline 0 CA--C 1.543 0.712 0 CA-C-O 119.613 -0.232 . . . . 0.0 111.314 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.609 ' HD2' ' O ' ' A' ' 23' ' ' PRO . 23.6 Cg_exo -65.77 -21.92 57.57 Favored 'Trans proline' 0 C--N 1.361 1.191 0 C-N-CA 121.919 1.746 . . . . 0.0 112.346 178.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -63.85 -24.67 67.84 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.392 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -66.12 -31.94 73.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.009 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.1 mp -86.6 -22.74 26.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.161 0.505 . . . . 0.0 110.487 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -75.07 -20.05 59.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.339 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -82.18 -20.86 36.99 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.782 0.325 . . . . 0.0 110.779 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.47 -36.46 17.65 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.011 0.434 . . . . 0.0 110.288 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -92.32 4.45 77.11 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.054 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -93.45 52.2 2.4 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.647 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.58 126.06 30.32 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.536 -0.172 . . . . 0.0 110.536 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 17.9 mtp180 62.23 32.72 17.09 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.577 0.548 . . . . 0.0 110.933 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -102.36 -168.73 26.8 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.55 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.4 88.45 29.88 Favored Pre-proline 0 C--O 1.234 0.277 0 CA-C-O 120.559 0.218 . . . . 0.0 111.109 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.75 -33.95 96.17 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.684 2.256 . . . . 0.0 112.49 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.2 mt -62.17 -45.34 93.86 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.55 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -73.63 -39.84 64.23 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.026 -179.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.88 -42.67 97.43 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.832 0.349 . . . . 0.0 110.632 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.29 -51.55 59.97 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.835 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.29 -42.3 86.29 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.482 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -63.9 -42.85 97.33 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.49 0.186 . . . . 0.0 110.815 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.98 -42.08 94.86 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.706 179.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 91.0 mt -65.43 -42.55 93.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.231 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.44 -50.08 75.02 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.483 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.491 ' O ' HG22 ' A' ' 53' ' ' VAL . . . -59.2 -45.91 94.62 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.749 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -69.17 -37.71 78.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.654 0.264 . . . . 0.0 110.947 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -61.64 -43.61 99.04 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 121.086 -0.578 . . . . 0.0 111.821 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.57 -43.26 99.19 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.698 0.285 . . . . 0.0 110.674 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 49' ' ' GLY . 91.4 t -63.54 -43.94 98.49 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.043 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -65.76 -34.55 78.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.435 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -76.52 -43.33 39.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.703 0.287 . . . . 0.0 110.806 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.15 -28.87 69.12 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.907 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.05 -18.27 27.64 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.897 0.38 . . . . 0.0 109.976 178.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -74.91 -32.02 57.35 Favored Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.998 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.21 -56.25 37.26 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 179.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -72.84 -13.71 26.69 Favored 'Trans proline' 0 C--N 1.361 1.189 0 C-N-CA 122.266 1.977 . . . . 0.0 112.735 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.66 -23.59 63.19 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.328 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -65.8 -41.68 91.61 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.957 0.408 . . . . 0.0 110.539 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -88.63 -21.53 23.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.765 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.65 -18.19 45.44 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.427 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.59 -32.29 80.84 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 121.253 -0.499 . . . . 0.0 112.566 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -71.97 -31.6 64.26 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.91 179.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.6 mt -84.69 -23.76 29.26 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.723 0.297 . . . . 0.0 110.226 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.18 -19.4 64.78 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.92 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -58.66 -21.89 55.38 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.266 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -127.84 146.41 50.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.33 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 61.95 57.46 2.11 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 123.375 0.422 . . . . 0.0 111.716 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -89.17 -28.39 20.05 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.79 0.328 . . . . 0.0 111.238 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -69.68 -20.06 63.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.545 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -63.26 -32.58 74.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.51 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.4 mp -81.76 -21.79 37.63 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.674 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.01 -28.47 35.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.555 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . 0.415 ' O ' HG23 ' A' ' 81' ' ' VAL . 26.7 mtp85 -63.5 -39.02 93.33 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.994 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.8 t -60.69 -37.9 77.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.437 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -64.55 -39.45 96.82 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.858 -0.687 . . . . 0.0 111.604 179.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.412 ' O ' HG22 ' A' ' 84' ' ' VAL . . . -64.54 -42.94 97.22 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.896 -0.669 . . . . 0.0 111.596 179.11 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 77' ' ' ARG . 57.9 t -59.04 -42.95 87.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-O 120.806 0.336 . . . . 0.0 110.569 178.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 87.8 t -63.36 -38.74 82.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.414 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.3 mt -61.29 -42.3 98.42 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.527 179.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.412 HG22 ' O ' ' A' ' 80' ' ' GLY . 31.6 t -65.56 -43.53 94.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 120.941 0.4 . . . . 0.0 110.088 178.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.69 -40.38 96.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.604 179.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.33 -37.08 85.99 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.64 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -61.08 -42.21 99.71 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.699 178.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.46 -34.54 78.17 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.862 0.363 . . . . 0.0 110.605 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -70.0 -42.6 72.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.703 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.94 -24.22 63.32 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.938 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.71 -11.38 58.21 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.35 178.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.55 10.82 57.67 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.645 -0.788 . . . . 0.0 113.058 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.3 tp -77.92 125.06 28.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 117.04 0.42 . . . . 0.0 110.583 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.457 ' H ' ' HE ' ' A' ' 94' ' ' ARG . 0.3 OUTLIER . . . . . 0 C--N 1.326 -0.417 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.007 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.413 ' O ' ' HD2' ' A' ' 110' ' ' PRO . 0.6 OUTLIER . . . . . 0 N--CA 1.466 0.325 0 CA-C-O 121.046 0.451 . . . . 0.0 111.385 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.51 0.32 50.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.897 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.8 -51.77 73.48 Favored Pre-proline 0 CA--C 1.541 0.607 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.413 ' HD2' ' O ' ' A' ' 107' ' ' THR . 46.3 Cg_exo -58.29 -25.61 73.31 Favored 'Trans proline' 0 C--N 1.363 1.295 0 C-N-CA 122.241 1.96 . . . . 0.0 112.927 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.8 mt -68.46 -34.18 75.5 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.716 0.293 . . . . 0.0 110.588 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -66.85 -36.33 90.95 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.705 -0.76 . . . . 0.0 111.373 179.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -75.2 -35.43 61.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.707 0.289 . . . . 0.0 110.629 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -65.37 -47.04 77.76 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.001 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.8 mp -64.63 -39.08 93.07 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.539 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.425 ' O ' ' HB2' ' A' ' 120' ' ' LEU . 0.6 OUTLIER -69.49 -31.59 69.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.397 179.209 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -74.64 -44.18 26.94 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.909 -0.662 . . . . 0.0 111.487 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.21 -42.94 87.3 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.945 0.402 . . . . 0.0 110.819 178.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 3.0 m -73.2 -27.68 61.76 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.142 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.425 ' HB2' ' O ' ' A' ' 116' ' ' LEU . 0.3 OUTLIER -76.4 -37.09 57.62 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.74 0.305 . . . . 0.0 110.96 179.642 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -73.27 -37.85 66.14 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.843 0.354 . . . . 0.0 111.226 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.95 -19.48 37.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.017 0.436 . . . . 0.0 110.738 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -92.04 95.62 2.06 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.701 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 4.8 t-105 -80.34 130.98 35.55 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.026 0.441 . . . . 0.0 111.31 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.2 119.88 78.67 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.083 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.84 -15.98 48.7 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.98 2.454 . . . . 0.0 112.909 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 8.0 m -62.74 -26.79 68.87 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.783 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.4 mt -86.67 -0.83 7.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.785 0.326 . . . . 0.0 111.004 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -59.65 -65.04 3.69 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 121.174 -0.536 . . . . 0.0 112.738 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.4 -38.56 73.51 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.618 2.212 . . . . 0.0 112.194 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 61.6 mt -60.93 -41.61 89.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.164 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.6 mt -63.18 -33.32 75.23 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-O 120.687 0.279 . . . . 0.0 110.848 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -61.24 -38.07 95.05 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 121.118 -0.563 . . . . 0.0 111.967 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.53 -36.19 73.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.123 0.487 . . . . 0.0 109.967 178.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 45.6 mm -67.17 -42.41 88.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.337 179.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.67 -36.91 82.22 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.32 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 38.4 m -64.5 -38.34 90.68 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.252 178.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 7.8 mt -70.06 -30.83 68.18 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.618 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.1 m -79.99 -22.4 42.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.086 0.469 . . . . 0.0 110.551 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.18 -30.27 64.8 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.914 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 20.5 m -100.25 4.98 10.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.009 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 141.54 -92.6 0.18 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.46 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.98 -123.54 7.02 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.543 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 130.8 159.67 9.7 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.571 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 11.1 p -77.36 -23.41 14.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.684 0.278 . . . . 0.0 111.33 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -58.35 -37.52 87.81 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.745 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -68.62 -41.67 79.18 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.691 0.281 . . . . 0.0 110.423 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.416 ' O ' HG13 ' A' ' 152' ' ' ILE . 0.3 OUTLIER -60.86 -46.28 91.2 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.605 179.233 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.83 -40.63 95.5 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.729 179.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.435 ' O ' ' HB1' ' A' ' 8' ' ' ALA . . . -62.43 -41.18 98.52 Favored 'General case' 0 C--O 1.226 -0.168 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.771 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.4 ' O ' HD13 ' A' ' 155' ' ' LEU . 1.3 m-85 -60.61 -44.91 95.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.091 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.416 HG13 ' O ' ' A' ' 148' ' ' LEU . 23.9 mt -64.5 -44.06 96.91 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 CA-C-O 120.95 0.405 . . . . 0.0 110.341 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.92 -35.89 82.6 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.569 179.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . 0.435 ' O ' ' HD2' ' A' ' 158' ' ' PRO . . . -60.56 -46.08 95.08 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.143 179.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.4 HD13 ' O ' ' A' ' 151' ' ' TYR . 0.4 OUTLIER -69.38 -29.88 67.75 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.059 0.457 . . . . 0.0 110.754 178.651 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -63.43 -35.21 79.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.589 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.543 ' O ' HG23 ' A' ' 161' ' ' VAL . 95.1 t -55.38 -63.7 2.83 Favored Pre-proline 0 CA--C 1.543 0.685 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.462 ' CD ' ' HB ' ' A' ' 157' ' ' VAL . 19.1 Cg_endo -60.88 -36.38 83.83 Favored 'Trans proline' 0 C--N 1.359 1.109 0 C-N-CA 121.906 1.737 . . . . 0.0 112.384 179.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -58.08 -45.28 87.42 Favored 'General case' 0 N--CA 1.462 0.158 0 O-C-N 123.169 0.293 . . . . 0.0 111.19 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -70.47 -36.67 74.02 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.718 -0.219 . . . . 0.0 110.873 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 157' ' ' VAL . 96.5 t -64.91 -45.28 95.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-O 120.731 0.3 . . . . 0.0 110.692 179.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 68.9 t -65.8 -39.4 84.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.49 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -61.07 -34.82 75.5 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.28 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.8 -42.79 39.26 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.188 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -71.95 -19.23 61.93 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.374 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.09 -19.16 61.13 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.414 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -64.19 -43.05 96.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.765 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 2.6 mtp180 -73.03 -31.98 64.79 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.992 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 11.8 mt -72.83 -26.32 23.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.787 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.42 -30.92 71.95 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.968 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -70.89 -38.98 65.06 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.813 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -74.22 -24.07 59.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.63 0.252 . . . . 0.0 110.84 179.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 3.2 tp -59.71 -37.61 79.35 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.785 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 41.8 mtp180 -76.59 -21.86 55.02 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.816 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 -84.87 -32.19 23.34 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.943 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -65.16 -33.81 76.89 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.642 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 70.76 -98.77 0.71 Allowed Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.8 -0.714 . . . . 0.0 113.029 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -104.74 -6.01 20.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.558 0.218 . . . . 0.0 111.232 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 50.2 mm -64.58 -41.54 92.55 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 CA-C-O 120.671 0.272 . . . . 0.0 110.819 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' SER . . . . . 0.498 ' O ' ' HG3' ' A' ' 184' ' ' GLU . 0.0 OUTLIER -61.65 -33.77 74.53 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.12 179.831 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' HIS . . . . . 0.46 ' HA ' ' OE2' ' A' ' 184' ' ' GLU . 11.7 m80 -66.64 -32.28 73.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.245 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . 0.454 ' O ' ' HB2' ' A' ' 186' ' ' LEU . 4.9 m-85 -68.7 -41.43 79.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.75 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 1.6 t -68.47 -20.09 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 120.927 0.394 . . . . 0.0 111.023 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . 0.498 ' HG3' ' O ' ' A' ' 180' ' ' SER . 41.9 mt-10 -76.42 -47.15 24.1 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.502 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 6.1 t -77.11 -37.5 26.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.232 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.511 ' O ' HG22 ' A' ' 190' ' ' VAL . 0.6 OUTLIER -58.84 -48.91 79.69 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.616 -0.266 . . . . 0.0 111.431 -179.744 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -63.74 -33.52 75.83 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.873 0.368 . . . . 0.0 110.941 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.423 ' O ' HG22 ' A' ' 192' ' ' VAL . . . -65.95 -44.91 90.78 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.797 -0.715 . . . . 0.0 111.849 179.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 84.0 t -60.68 -43.98 96.13 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-O 120.484 0.183 . . . . 0.0 110.676 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . 0.511 HG22 ' O ' ' A' ' 186' ' ' LEU . 48.2 t -60.82 -47.7 92.13 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.099 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.027 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.42 -42.62 99.04 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.236 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 188' ' ' GLY . 71.9 t -65.59 -44.21 93.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.7 tp -58.54 -45.97 87.78 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.654 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.438 HG21 ' O ' ' A' ' 190' ' ' VAL . 78.8 t -63.21 -40.04 87.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.502 179.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -59.44 -45.05 96.15 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.304 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 22.4 t -71.57 -38.81 68.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-O 120.755 0.312 . . . . 0.0 110.675 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.99 -23.95 63.24 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.376 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.46 -41.73 16.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.746 -0.206 . . . . 0.0 110.895 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -68.55 -56.28 8.85 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.645 0.259 . . . . 0.0 111.37 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.41 -10.08 59.55 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.895 0.379 . . . . 0.0 111.306 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -91.05 -55.53 1.84 Allowed Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.262 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 18.8 m 68.37 -70.31 0.13 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.049 0.54 . . . . 0.0 111.528 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' PHE . . . . . 0.419 ' C ' ' H ' ' A' ' 205' ' ' ALA . 73.0 m-85 -97.63 160.86 14.06 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 23.6 m 74.24 -40.33 0.45 Allowed 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 122.781 0.433 . . . . 0.0 111.173 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . 0.419 ' H ' ' C ' ' A' ' 203' ' ' PHE . . . -75.57 -36.1 60.45 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.145 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.438 ' O ' ' HB2' ' A' ' 210' ' ' PHE . 0.4 OUTLIER -60.46 -44.79 95.51 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.364 179.906 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -71.65 -38.74 70.68 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.755 0.312 . . . . 0.0 111.181 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 62.1 m -64.34 -43.03 95.9 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.946 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -74.7 -30.91 61.71 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.237 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . 0.438 ' HB2' ' O ' ' A' ' 206' ' ' LEU . 0.1 OUTLIER -63.56 -24.53 67.84 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.257 -179.947 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.2 -22.25 65.74 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.884 0.373 . . . . 0.0 110.539 179.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.37 -7.05 51.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.917 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 2.5 mt -102.7 3.82 10.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.949 0.404 . . . . 0.0 110.901 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.88 117.84 61.43 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.785 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -72.16 120.83 7.05 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.25 1.967 . . . . 0.0 112.183 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . 0.543 ' HA ' ' OE1' ' A' ' 219' ' ' GLN . 1.9 mt-10 -65.01 -26.35 68.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.467 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 1.3 m-90 -72.67 -24.11 60.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.958 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.1 -33.27 24.38 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . 0.543 ' OE1' ' HA ' ' A' ' 216' ' ' GLU . 68.4 mt-30 -67.0 -30.3 70.37 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.363 179.075 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.332 -0.178 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.768 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.118 0 CA-C-O 120.861 0.362 . . . . 0.0 111.502 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.12 -6.78 34.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.203 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.47 -37.54 87.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.475 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.2 -45.19 70.52 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.495 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.64 -47.05 87.14 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.667 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.74 -42.8 99.45 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.635 178.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.17 -48.38 78.62 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.888 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.434 ' O ' HG21 ' A' ' 13' ' ' VAL . 5.5 m-85 -55.95 -46.45 78.55 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.617 178.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.81 -44.4 96.27 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.815 0.341 . . . . 0.0 110.525 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.39 -39.75 94.25 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.677 178.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.09 -41.13 99.36 Favored Glycine 0 C--N 1.334 0.429 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.065 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.434 HG21 ' O ' ' A' ' 9' ' ' PHE . 98.0 t -65.03 -36.43 77.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 178.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.1 tp -63.77 -43.17 97.17 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.791 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -35.05 79.06 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.793 0.33 . . . . 0.0 110.844 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.13 -28.84 63.52 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.889 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.35 -13.21 50.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.046 0.451 . . . . 0.0 110.632 178.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 61.6 m -85.82 135.86 37.33 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.364 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.63 -14.71 36.89 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.474 2.116 . . . . 0.0 113.027 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 6.3 t -90.16 132.9 35.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.352 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.1 t 61.46 65.28 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 O-C-N 123.724 0.64 . . . . 0.0 111.03 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.6 tp -109.78 105.34 57.07 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.896 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.473 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 28.1 Cg_exo -63.05 -15.34 47.29 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.989 2.459 . . . . 0.0 112.81 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.2 tp -77.95 -15.38 59.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.148 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.485 ' HB ' ' HD3' ' A' ' 26' ' ' PRO . 8.6 t -72.12 -52.35 7.43 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 116.684 -0.234 . . . . 0.0 111.327 179.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.485 ' HD3' ' HB ' ' A' ' 25' ' ' VAL . 22.9 Cg_exo -65.36 -38.68 25.38 Favored 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 122.029 1.82 . . . . 0.0 112.59 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.1 p -65.85 -33.57 76.16 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.707 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -62.56 -36.05 81.43 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.877 0.37 . . . . 0.0 110.769 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.46 -42.62 18.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.573 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -57.8 -36.36 72.09 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.51 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -71.32 -33.08 69.33 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.804 0.335 . . . . 0.0 110.884 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -79.75 -22.6 43.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.487 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -78.0 -24.87 63.24 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.199 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 110.29 43.46 1.08 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.715 -0.755 . . . . 0.0 113.004 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.42 96.36 9.06 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.702 0.286 . . . . 0.0 111.181 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.14 122.06 40.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.639 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 170.87 -158.21 29.66 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 111.673 -0.571 . . . . 0.0 111.673 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 2.2 mmt180 -103.67 118.78 56.61 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.845 0.322 . . . . 0.0 110.75 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.06 -27.0 42.62 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.65 2.233 . . . . 0.0 112.79 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.07 -34.89 77.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.13 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -71.41 -38.22 71.45 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.795 0.331 . . . . 0.0 110.289 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -64.88 -43.77 91.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.283 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.81 -41.01 88.22 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.658 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.58 -46.78 86.22 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.109 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -67.3 -36.28 81.18 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.871 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -65.18 -42.9 93.2 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.732 -0.213 . . . . 0.0 110.573 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 70.6 mt -60.42 -46.11 95.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.332 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.22 -42.44 93.44 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.472 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -60.44 -48.24 87.17 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 121.216 -0.516 . . . . 0.0 112.344 178.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.08 -34.85 75.78 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.734 0.302 . . . . 0.0 110.338 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -61.81 -46.44 94.15 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 178.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.58 -42.12 96.05 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 120.769 0.318 . . . . 0.0 110.463 178.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.6 t -62.69 -45.2 99.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.704 179.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -62.96 -33.41 75.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.466 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.96 -42.29 21.48 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 121.115 -0.234 . . . . 0.0 110.878 179.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.36 -37.1 85.97 Favored 'General case' 0 C--O 1.226 -0.168 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.08 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.39 -19.93 24.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.815 0.341 . . . . 0.0 110.86 179.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.22 -36.2 70.84 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.953 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.88 -57.63 22.94 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -67.95 -13.68 39.02 Favored 'Trans proline' 0 C--N 1.359 1.108 0 C-N-CA 122.583 2.189 . . . . 0.0 113.063 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -58.29 -20.58 43.95 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.698 0.285 . . . . 0.0 111.536 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 11.6 p -66.63 -47.82 71.39 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.148 0.499 . . . . 0.0 110.27 178.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.5 mt -81.63 -19.22 42.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.621 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.24 -18.21 59.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.524 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -69.94 -36.38 73.3 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.875 -0.679 . . . . 0.0 111.919 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.82 -25.71 64.19 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.806 -0.711 . . . . 0.0 111.711 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 mt -76.23 -20.54 57.34 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.633 0.254 . . . . 0.0 110.703 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 28.9 mt -63.83 -19.66 65.2 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.028 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -70.19 -17.67 63.16 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.775 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -95.52 39.84 1.12 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.558 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 73.4 160.87 0.24 Allowed 'General case' 0 N--CA 1.472 0.644 0 O-C-N 123.953 0.783 . . . . 0.0 111.149 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' A' ' 72' ' ' ARG . 3.1 ptt180 -139.22 12.05 2.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.38 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -69.4 -35.93 76.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.492 -179.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.19 -24.6 64.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.579 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.7 tp -82.56 -28.75 30.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.929 0.395 . . . . 0.0 110.798 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -79.85 -28.53 40.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.994 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -62.72 -34.84 78.01 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.277 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 18.7 t -59.78 -37.87 73.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.568 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -66.44 -33.56 85.15 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.983 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.475 ' O ' HG21 ' A' ' 84' ' ' VAL . . . -66.41 -43.82 91.74 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.851 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.0 t -62.24 -39.9 85.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-O 121.039 0.447 . . . . 0.0 110.373 179.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.5 t -64.64 -41.64 92.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.715 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.0 -40.85 90.62 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.603 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.475 HG21 ' O ' ' A' ' 80' ' ' GLY . 61.5 t -63.82 -43.98 98.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.207 178.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.81 -40.41 95.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.804 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -60.22 -43.66 95.81 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 178.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -65.38 -39.25 95.72 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.733 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . 0.417 ' O ' ' HB2' ' A' ' 91' ' ' LEU . 1.0 OUTLIER -62.68 -40.63 97.73 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.711 0.291 . . . . 0.0 111.024 179.368 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -72.3 -32.69 66.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.878 0.371 . . . . 0.0 110.665 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -73.45 -17.46 61.24 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.706 179.028 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.417 ' HB2' ' O ' ' A' ' 88' ' ' LEU . 5.5 mt -67.08 -10.05 45.87 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.478 178.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.6 13.91 64.36 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.675 -0.774 . . . . 0.0 113.209 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 24.5 mt -88.22 122.89 32.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.837 0.351 . . . . 0.0 110.578 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.369 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.912 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.23 0 CA-C-O 120.95 0.405 . . . . 0.0 111.246 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.54 -11.99 50.03 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.333 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.417 ' N ' ' HD2' ' A' ' 110' ' ' PRO . 10.6 ttp180 -62.81 -54.73 44.65 Favored Pre-proline 0 CA--C 1.539 0.527 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.417 ' HD2' ' N ' ' A' ' 109' ' ' ARG . 28.0 Cg_endo -63.0 -38.21 48.11 Favored 'Trans proline' 0 C--N 1.361 1.195 0 C-N-CA 121.93 1.754 . . . . 0.0 112.489 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.72 -42.46 70.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.865 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -63.66 -41.83 98.92 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.927 -0.654 . . . . 0.0 111.961 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.02 -36.86 80.64 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.906 0.384 . . . . 0.0 110.607 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -67.06 -44.59 79.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.992 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.04 -38.9 86.68 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.978 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.9 -37.33 85.82 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.97 0.414 . . . . 0.0 110.399 179.151 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -74.11 -36.49 51.2 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 121.002 -0.618 . . . . 0.0 111.75 179.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -55.25 -41.89 72.74 Favored 'General case' 0 N--CA 1.461 0.106 0 C-N-CA 122.362 0.265 . . . . 0.0 111.153 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.38 -46.41 86.6 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.828 179.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.07 -35.24 80.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.259 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -72.96 -29.74 63.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.994 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.2 mt -81.91 -27.4 33.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.667 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -78.1 138.38 21.23 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.05 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -82.86 -7.18 59.68 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 121.041 -0.264 . . . . 0.0 111.707 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.5 m 58.5 85.66 0.18 Allowed Pre-proline 0 C--O 1.233 0.187 0 O-C-N 123.508 0.505 . . . . 0.0 111.128 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -59.13 -17.77 40.42 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 123.063 2.509 . . . . 0.0 113.156 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 83.9 m -65.26 -43.21 92.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.071 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 11.6 pt -104.29 5.47 10.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.358 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -55.92 -67.35 2.26 Favored Glycine 0 CA--C 1.52 0.362 0 CA-C-N 116.122 -0.49 . . . . 0.0 113.112 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -62.5 -33.71 77.9 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.502 2.135 . . . . 0.0 112.101 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 26.9 mt -61.94 -40.09 85.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.031 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 6.3 mt -64.05 -29.32 70.47 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.682 0.277 . . . . 0.0 110.95 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -67.13 -30.16 75.39 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.902 -0.666 . . . . 0.0 111.778 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -79.74 -36.19 37.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.942 0.401 . . . . 0.0 110.355 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 45.3 mm -67.26 -30.93 50.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.711 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.61 -43.86 89.72 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.804 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.13 -24.77 62.34 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.077 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -76.21 -38.06 56.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.217 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.5 m -68.54 -18.03 64.28 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.942 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.27 -38.54 88.05 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.828 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 4.1 m -102.24 -22.59 4.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.017 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -129.37 78.79 0.38 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 121.018 -0.61 . . . . 0.0 112.063 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -111.18 121.36 5.77 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.533 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -156.16 141.6 8.12 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.178 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 6.3 t -66.84 -27.8 40.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-O 120.882 0.372 . . . . 0.0 110.875 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -62.38 -28.56 71.26 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.584 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -68.33 -52.82 29.11 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.706 0.289 . . . . 0.0 110.599 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 20.1 mt -62.53 -37.25 85.37 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.757 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.01 -44.38 89.4 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.479 179.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.88 -39.27 93.81 Favored 'General case' 0 C--O 1.225 -0.23 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.787 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -60.43 -47.54 85.65 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.069 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.427 HD13 HG21 ' A' ' 152' ' ' ILE . 48.5 mm -64.16 -44.86 97.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.455 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.27 -34.83 79.29 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.89 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -61.0 -41.22 99.36 Favored Glycine 0 C--O 1.225 -0.415 0 CA-C-N 115.976 -0.557 . . . . 0.0 112.386 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.43 ' O ' ' HD2' ' A' ' 158' ' ' PRO . 0.0 OUTLIER -82.69 -27.69 31.08 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.831 0.348 . . . . 0.0 110.915 178.77 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -62.57 -38.9 91.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.855 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.508 ' HB ' ' HD3' ' A' ' 158' ' ' PRO . 6.9 t -57.44 -57.63 23.83 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-O 119.322 -0.37 . . . . 0.0 111.791 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.508 ' HD3' ' HB ' ' A' ' 157' ' ' VAL . 38.0 Cg_exo -58.44 -40.67 72.74 Favored 'Trans proline' 0 C--N 1.361 1.229 0 C-N-CA 122.024 1.816 . . . . 0.0 112.244 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.65 -45.29 92.45 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.151 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -66.34 -41.07 90.11 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.684 -0.234 . . . . 0.0 110.73 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.439 HG22 ' O ' ' A' ' 157' ' ' VAL . 98.0 t -63.51 -46.57 94.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.716 179.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 158' ' ' PRO . 78.9 t -64.73 -43.69 96.52 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.718 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -60.88 -33.56 73.29 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.649 0.261 . . . . 0.0 111.658 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.2 tp -79.51 -45.89 18.45 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.096 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -68.3 -19.39 64.68 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.125 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -65.51 -18.92 65.68 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.029 179.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -59.99 -40.56 89.6 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.005 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 1.2 mmt85 -87.6 -32.97 19.04 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.89 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 46.9 mm -67.1 -31.64 54.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.004 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.93 -28.49 67.66 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.579 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -70.69 -37.23 67.28 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.296 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -86.84 -34.07 19.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.555 0.217 . . . . 0.0 110.816 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.87 -22.98 63.04 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.375 179.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -53.15 61.18 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-O 121.009 0.433 . . . . 0.0 110.167 178.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 7.3 mtm180 -78.57 -31.25 47.24 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.66 178.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -62.41 -41.07 98.4 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.494 179.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -42.52 -31.58 1.07 Allowed Glycine 0 C--N 1.34 0.765 0 O-C-N 123.91 0.756 . . . . 0.0 114.081 178.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 4.5 ttp180 -61.36 -56.46 20.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.105 0.479 . . . . 0.0 110.331 179.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -75.07 -27.75 20.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.011 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 19.5 m -71.27 -16.55 62.48 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.764 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -56.13 -37.35 69.33 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.764 0.316 . . . . 0.0 111.498 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -73.26 -24.56 60.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.118 0.485 . . . . 0.0 110.82 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 4.9 t -82.22 -21.7 9.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.249 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -70.06 -43.47 71.11 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.389 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 2.9 t -69.68 -41.92 80.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.81 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 4.6 mt -58.98 -48.67 80.74 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.084 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -63.48 -39.67 95.07 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.644 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.518 ' O ' HG23 ' A' ' 192' ' ' VAL . . . -62.91 -45.12 96.33 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.064 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 54.2 t -60.51 -47.54 92.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-O 120.645 0.259 . . . . 0.0 110.629 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 84.7 t -61.42 -44.06 97.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.95 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -57.0 -46.78 82.04 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.005 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 188' ' ' GLY . 45.0 t -67.05 -42.37 88.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.403 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.78 -42.64 89.46 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.037 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 58.6 t -61.8 -43.85 97.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 178.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -61.86 -41.27 99.62 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.107 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 61.2 t -68.63 -42.64 83.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.481 0.182 . . . . 0.0 110.814 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.27 -25.96 68.28 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.795 0.331 . . . . 0.0 111.403 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.68 -43.61 18.28 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.774 0.321 . . . . 0.0 110.385 178.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -71.2 -48.41 51.71 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.099 -0.501 . . . . 0.0 112.089 -179.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 69.3 p -84.2 -9.14 58.79 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.908 0.385 . . . . 0.0 111.314 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -87.09 -53.87 2.73 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.907 -0.664 . . . . 0.0 112.094 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 52.74 45.96 27.67 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.94 0.4 . . . . 0.0 111.634 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -151.05 -174.05 4.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.934 0.397 . . . . 0.0 110.911 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.26 10.46 10.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.67 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -58.63 -33.15 69.72 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.156 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.13 -37.63 45.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.816 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.1 -35.78 74.4 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.609 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 5.9 m -69.09 -35.12 76.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.269 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -71.74 -29.35 64.43 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.955 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -69.43 -21.83 63.71 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.198 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.95 -11.2 51.28 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.9 0.381 . . . . 0.0 110.625 179.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 17.4 mtt180 -91.23 -14.11 31.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.127 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 6.8 pt -102.35 -6.72 9.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.371 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 1.3 p -87.36 118.21 69.6 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.606 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -70.54 149.08 61.33 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.379 2.053 . . . . 0.0 112.491 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -63.34 -22.13 66.69 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.977 0.418 . . . . 0.0 111.335 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -66.51 -18.7 65.51 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.407 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.2 -22.61 55.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.973 0.416 . . . . 0.0 110.249 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -84.31 -30.25 25.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.163 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.856 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.529 0.153 0 CA-C-O 120.89 0.376 . . . . 0.0 111.264 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 15.0 mt -90.45 48.28 1.53 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.032 0.444 . . . . 0.0 111.115 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.3 -22.01 58.03 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.137 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.84 -38.84 89.94 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.645 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.27 -34.65 78.13 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.873 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.72 -49.27 66.59 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.697 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.7 -25.07 64.59 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.196 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.47 ' O ' HG22 ' A' ' 13' ' ' VAL . 0.3 OUTLIER -74.39 -50.83 17.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.068 179.823 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.9 mt -64.64 -34.65 78.79 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.424 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.81 -43.44 96.27 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.518 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.49 -42.85 98.83 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.744 178.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.47 HG22 ' O ' ' A' ' 9' ' ' PHE . 59.1 t -64.87 -41.91 93.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.932 0.396 . . . . 0.0 110.078 179.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.1 mt -63.12 -39.57 95.06 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.844 179.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 28.7 m -65.97 -36.35 83.1 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.991 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -73.47 -31.28 63.69 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.75 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.2 mt -83.88 -14.66 50.56 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.06 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 38.4 m -61.43 146.68 89.06 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.776 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.48 -20.23 48.12 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.788 2.326 . . . . 0.0 113.081 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.459 ' O ' ' HZ2' ' A' ' 124' ' ' TRP . 39.6 m -75.69 -38.81 58.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.427 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.2 t 55.6 -155.71 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 O-C-N 123.294 0.371 . . . . 0.0 110.025 -178.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.42 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 0.2 OUTLIER -173.62 -56.79 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.309 0 CA-C-O 119.328 -0.368 . . . . 0.0 111.326 179.606 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' A' ' 22' ' ' LEU . 21.5 Cg_endo -61.19 -15.19 38.27 Favored 'Trans proline' 0 C--N 1.364 1.388 0 C-N-CA 122.647 2.231 . . . . 0.0 113.787 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.3 tp -55.44 -46.75 76.71 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 123.207 0.317 . . . . 0.0 111.838 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -67.51 -55.44 14.76 Favored Pre-proline 0 CA--C 1.542 0.663 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -51.23 -44.19 44.42 Favored 'Trans proline' 0 C--N 1.362 1.282 0 C-N-CA 122.418 2.079 . . . . 0.0 113.469 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.1 p -64.15 -37.66 88.25 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.69 0.281 . . . . 0.0 111.566 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 12.2 m-30 -73.19 -35.96 66.47 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.741 0.305 . . . . 0.0 110.686 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -70.34 -32.12 69.7 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.895 0.379 . . . . 0.0 110.137 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -61.04 -46.62 89.98 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.047 178.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -64.77 -34.89 79.41 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.723 178.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.21 -38.15 81.63 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.647 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.85 -33.25 55.75 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.104 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.01 31.49 64.28 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.656 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -133.9 131.58 39.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.698 0.285 . . . . 0.0 111.062 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 4.1 mtp180 -88.4 67.87 8.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.839 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -74.94 150.82 41.62 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.812 -0.708 . . . . 0.0 111.844 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -69.95 115.27 32.07 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.715 0.258 . . . . 0.0 111.062 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -60.83 -20.46 66.47 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 123.042 2.495 . . . . 0.0 112.889 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.84 -34.9 76.8 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.225 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -68.9 -42.06 77.39 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.013 0.435 . . . . 0.0 110.406 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.92 -42.04 86.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.301 179.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.85 -44.69 92.39 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.041 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.04 -46.7 88.66 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.91 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -62.52 -39.45 93.59 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.861 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -67.08 -40.9 87.06 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.949 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 71.8 mt -60.84 -45.99 97.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-O 120.778 0.323 . . . . 0.0 110.317 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.91 -46.95 73.27 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.529 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.518 ' O ' HG22 ' A' ' 53' ' ' VAL . . . -58.54 -49.78 73.54 Favored Glycine 0 C--N 1.334 0.439 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.913 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.52 -35.35 77.36 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.703 0.252 . . . . 0.0 110.844 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -60.28 -48.41 86.26 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.509 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.79 -46.0 92.2 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.523 0.201 . . . . 0.0 110.922 178.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.518 HG22 ' O ' ' A' ' 49' ' ' GLY . 85.6 t -61.76 -44.06 98.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.186 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -62.72 -38.64 91.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.355 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -74.63 -40.36 61.55 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 120.634 0.254 . . . . 0.0 110.727 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.4 mt -64.41 -28.16 69.49 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.527 179.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.6 -19.91 24.36 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.469 178.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.59 -34.86 62.92 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 121.147 -0.549 . . . . 0.0 112.095 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.56 -56.16 37.94 Favored Pre-proline 0 CA--C 1.542 0.667 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 179.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.98 -13.81 29.06 Favored 'Trans proline' 0 C--N 1.36 1.154 0 C-N-CA 122.229 1.953 . . . . 0.0 112.961 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.59 -32.28 62.92 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 123.052 0.22 . . . . 0.0 111.379 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.28 -40.04 92.63 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.912 0.387 . . . . 0.0 110.73 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.2 mt -88.75 -19.4 26.11 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.705 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.9 tp -68.31 -17.36 64.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.779 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.27 -30.31 70.71 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.6 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.63 -22.11 73.24 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.588 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 tp -73.74 -19.86 60.67 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.689 0.281 . . . . 0.0 110.401 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.9 -22.85 60.29 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.158 179.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -76.01 -36.3 59.21 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.98 0.419 . . . . 0.0 110.416 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -122.3 70.64 0.98 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.915 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -61.4 125.96 25.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.374 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 18.3 mtm180 -78.88 100.64 7.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.435 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -69.56 -18.0 63.61 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.075 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.435 ' O ' HG21 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -61.45 -28.38 69.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.989 179.485 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 20.5 mt -67.68 -29.6 68.92 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.73 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -74.29 -32.22 62.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.45 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 9.6 ttt-85 -67.38 -39.65 85.65 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.487 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.435 HG21 ' O ' ' A' ' 74' ' ' THR . 18.1 t -59.98 -39.74 81.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.483 179.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.43 -39.9 98.25 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.862 -0.685 . . . . 0.0 111.672 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -64.43 -42.71 97.49 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.726 179.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 99.1 t -58.89 -44.41 90.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-O 120.825 0.345 . . . . 0.0 110.649 178.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 79.1 t -65.51 -40.66 88.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.488 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.55 -42.37 96.41 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.919 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 72.8 t -62.55 -46.22 96.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-O 120.774 0.321 . . . . 0.0 110.233 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.87 -40.77 94.19 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.675 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -65.32 -45.56 83.8 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.329 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -61.53 -39.38 97.26 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.202 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.8 mp -62.16 -42.51 99.33 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.693 0.282 . . . . 0.0 110.802 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -72.92 -31.99 65.02 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.979 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.31 -28.42 67.15 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.817 0.341 . . . . 0.0 110.881 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.67 -21.67 66.1 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.259 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.02 1.93 90.19 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.422 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.0 mt -97.21 160.1 14.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.999 0.399 . . . . 0.0 111.088 -179.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 3.1 mtp180 . . . . . 0 C--N 1.327 -0.39 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.303 179.432 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.806 0.336 . . . . 0.0 111.271 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.62 -20.88 56.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.649 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.48 -56.94 7.51 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -64.15 -33.34 61.33 Favored 'Trans proline' 0 C--N 1.36 1.171 0 C-N-CA 121.99 1.793 . . . . 0.0 112.411 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 17.3 mt -75.23 -22.31 58.0 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.939 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -64.91 -35.77 92.3 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.955 -0.641 . . . . 0.0 111.899 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.56 -32.91 71.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.982 0.42 . . . . 0.0 110.712 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -80.83 -39.8 25.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.739 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.94 -47.47 71.58 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.636 -0.257 . . . . 0.0 110.464 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.2 mp -65.75 -31.68 72.79 Favored 'General case' 0 CA--C 1.523 -0.076 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -70.63 -43.63 59.73 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.609 178.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.42 -45.49 87.33 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.638 0.256 . . . . 0.0 110.871 179.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 3.2 m -64.18 -41.12 97.23 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.621 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.05 -35.43 80.52 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.604 179.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.77 -39.69 94.04 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.75 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.24 -10.14 59.23 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.881 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -108.31 -0.49 33.18 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.851 179.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . 0.459 ' HZ2' ' O ' ' A' ' 20' ' ' CYS . 0.2 OUTLIER -94.17 -5.76 46.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.758 0.313 . . . . 0.0 110.8 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.13 -50.03 89.93 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.628 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.5 -25.1 79.86 Favored 'Trans proline' 0 C--N 1.361 1.232 0 C-N-CA 121.999 1.8 . . . . 0.0 112.176 178.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -70.15 -40.83 74.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.279 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.5 pt -96.09 4.82 8.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.832 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -57.14 -58.92 12.07 Favored Glycine 0 CA--C 1.52 0.363 0 CA-C-N 115.845 -0.616 . . . . 0.0 113.152 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.2 -25.59 78.69 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 122.635 2.223 . . . . 0.0 112.283 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 37.9 mm -80.21 -35.54 15.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.011 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 5.1 tp -61.64 -24.99 67.08 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.154 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -63.14 -34.6 90.4 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.119 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -81.77 -22.37 37.24 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.005 0.431 . . . . 0.0 110.721 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 52.3 mt -80.28 -33.16 13.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.193 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.56 -28.35 67.72 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.236 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -70.78 -20.19 62.63 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-O 120.828 0.347 . . . . 0.0 110.681 179.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 89.6 mt -80.22 -18.24 50.06 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.952 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -82.79 -17.34 44.49 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.946 0.403 . . . . 0.0 110.696 179.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -82.28 -22.62 35.63 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.191 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 2.4 m -99.48 4.07 10.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.261 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 148.33 98.03 0.19 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.682 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -82.25 80.31 1.79 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.608 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -100.59 142.45 15.84 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.745 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 6.6 m -74.67 -18.7 16.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-O 120.774 0.321 . . . . 0.0 111.448 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -65.0 -30.38 77.86 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 121.026 -0.606 . . . . 0.0 112.531 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.47 -44.11 83.63 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-O 120.779 0.323 . . . . 0.0 110.392 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . 0.447 ' O ' HG13 ' A' ' 152' ' ' ILE . 0.8 OUTLIER -62.09 -43.36 99.0 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.549 179.247 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.07 -42.21 89.71 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.927 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.28 -37.81 88.71 Favored 'General case' 0 CA--C 1.524 -0.05 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.532 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -61.09 -48.28 82.43 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.886 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 148' ' ' LEU . 42.0 mt -63.73 -45.01 98.49 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.566 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 4.7 tp -64.82 -38.59 91.5 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.621 0.248 . . . . 0.0 110.915 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -59.52 -42.38 97.63 Favored Glycine 0 C--N 1.334 0.428 0 CA-C-N 116.031 -0.532 . . . . 0.0 112.424 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.473 ' O ' ' HD2' ' A' ' 158' ' ' PRO . 0.4 OUTLIER -80.95 -25.05 37.68 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.836 0.318 . . . . 0.0 111.179 178.963 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -62.93 -38.82 92.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.652 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.504 ' HB ' ' HD3' ' A' ' 158' ' ' PRO . 4.8 t -57.58 -56.72 31.31 Favored Pre-proline 0 CA--C 1.545 0.771 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.504 ' HD3' ' HB ' ' A' ' 157' ' ' VAL . 33.4 Cg_exo -61.04 -35.43 87.21 Favored 'Trans proline' 0 C--N 1.36 1.141 0 C-N-CA 122.131 1.887 . . . . 0.0 112.236 178.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . 0.492 ' O ' ' HB1' ' A' ' 163' ' ' ALA . 4.9 t80 -61.73 -42.93 99.61 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.846 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -65.67 -38.15 88.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.627 0.251 . . . . 0.0 110.491 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.46 HG21 ' O ' ' A' ' 157' ' ' VAL . 91.7 t -60.82 -49.86 82.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.047 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 158' ' ' PRO . 11.8 m -72.64 -36.31 53.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 120.931 -0.308 . . . . 0.0 111.539 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.551 ' O ' ' HB2' ' A' ' 167' ' ' ASP . . . -57.79 -35.87 71.39 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 5.8 tp -80.05 -45.65 17.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.7 0.286 . . . . 0.0 111.048 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -65.36 -44.11 88.7 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.897 -179.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.472 ' O ' ' HB2' ' A' ' 170' ' ' LYS . . . -71.83 -19.15 62.02 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.388 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . 0.551 ' HB2' ' O ' ' A' ' 163' ' ' ALA . 14.1 t70 -76.63 -40.85 48.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.145 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 10.9 mmt-85 -69.55 -43.32 73.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.254 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 4.6 pt -76.32 -18.91 15.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 166' ' ' ALA . 0.0 OUTLIER -60.1 -33.42 72.08 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.697 -0.229 . . . . 0.0 111.56 -179.676 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -63.79 -38.53 96.3 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.586 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -86.66 -38.77 16.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.625 0.25 . . . . 0.0 111.26 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -65.16 -16.81 63.91 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.663 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.43 -52.56 65.1 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 120.806 0.336 . . . . 0.0 110.632 178.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.92 -30.52 14.72 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.619 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -84.79 4.97 30.45 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -81.15 33.58 2.44 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 121.146 -0.55 . . . . 0.0 113.348 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . 0.401 ' O ' ' HB2' ' A' ' 181' ' ' HIS . 0.4 OUTLIER -80.29 -38.79 30.08 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.916 0.389 . . . . 0.0 110.718 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 19.5 mm -73.27 -30.27 30.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.847 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.08 -16.95 64.65 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.375 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' HIS . . . . . 0.401 ' HB2' ' O ' ' A' ' 178' ' ' ARG . 3.3 m80 -61.89 -38.38 88.1 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.086 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -75.66 -27.6 58.41 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 121.031 0.443 . . . . 0.0 110.477 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 3.2 t -75.88 -18.54 15.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.47 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -83.4 -27.72 29.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.601 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.485 ' O ' HG23 ' A' ' 189' ' ' VAL . 51.2 t -63.13 -47.79 90.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.547 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.441 ' O ' HG22 ' A' ' 190' ' ' VAL . 1.0 OUTLIER -62.04 -40.66 96.48 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.796 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -62.49 -38.2 88.95 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.506 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.515 ' O ' HG21 ' A' ' 192' ' ' VAL . . . -68.67 -42.88 78.51 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.035 179.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 185' ' ' VAL . 88.7 t -61.84 -49.66 83.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-O 120.763 0.316 . . . . 0.0 110.671 179.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . 0.441 HG22 ' O ' ' A' ' 186' ' ' LEU . 50.4 t -63.35 -35.77 73.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.706 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.56 -46.83 83.46 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.804 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . 0.515 HG21 ' O ' ' A' ' 188' ' ' GLY . 22.5 t -62.53 -42.29 95.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.345 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 23.5 mt -64.2 -44.57 91.56 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.788 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 69.0 t -63.77 -40.37 88.82 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.366 179.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -57.82 -45.52 93.43 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.159 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 32.4 t -70.72 -40.09 76.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.682 0.277 . . . . 0.0 110.606 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.16 -39.04 93.52 Favored 'General case' 0 C--O 1.225 -0.205 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.044 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.4 mp -72.83 -30.74 64.27 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.497 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -59.12 -54.56 45.57 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.99 0.424 . . . . 0.0 111.055 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -89.19 -7.16 56.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.967 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -83.15 -4.56 89.71 Favored Glycine 0 N--CA 1.452 -0.256 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.712 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.64 68.64 0.1 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.674 0.39 . . . . 0.0 111.59 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -165.23 -73.05 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.398 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 6.8 t -158.22 12.19 0.18 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.104 0.478 . . . . 0.0 111.302 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -84.16 -16.01 45.06 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.191 -179.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . 0.472 ' O ' ' HB2' ' A' ' 210' ' ' PHE . 3.6 mt -74.89 -30.09 61.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.203 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.72 -34.87 76.35 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.169 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.19 -40.24 93.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.312 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -87.13 -26.6 23.54 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.25 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . 0.472 ' HB2' ' O ' ' A' ' 206' ' ' LEU . 0.2 OUTLIER -66.62 -21.16 66.12 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.142 179.764 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.43 -27.54 69.18 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.981 0.42 . . . . 0.0 110.782 179.163 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 5.4 mmm180 -92.3 -4.47 53.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.666 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 10.4 mm -103.55 -11.07 9.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.014 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.75 118.09 31.51 Favored Pre-proline 0 C--O 1.233 0.218 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.155 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -61.67 155.74 51.93 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.815 2.343 . . . . 0.0 112.476 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.94 -27.55 68.31 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.447 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -68.73 -28.28 66.69 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.765 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.22 -29.24 26.71 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -67.71 -38.02 83.06 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.163 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 42.4 mtp180 . . . . . 0 C--N 1.332 -0.155 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.058 179.375 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' SER . . . . . 0.445 ' HB2' ' OG ' ' A' ' 4' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.141 0 CA-C-O 120.494 0.188 . . . . 0.0 110.812 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 62.61 24.99 14.88 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 123.838 0.711 . . . . 0.0 111.771 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' SER . . . . . 0.445 ' OG ' ' HB2' ' A' ' 2' ' ' SER . 0.0 OUTLIER -75.45 -24.35 57.0 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.965 0.412 . . . . 0.0 111.028 179.702 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.6 mp -81.36 -42.87 19.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.383 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.39 -29.83 69.44 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.936 0.398 . . . . 0.0 110.532 179.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.65 -52.19 28.01 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.312 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.69 -27.85 69.53 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.995 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -69.66 -49.23 55.57 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.526 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.407 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 0.2 OUTLIER -65.26 -37.32 86.84 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.482 179.404 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.67 -46.1 80.38 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.764 0.316 . . . . 0.0 110.992 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -65.41 -43.32 95.1 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.323 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -66.92 -31.79 55.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 120.77 0.319 . . . . 0.0 111.005 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.407 ' HB2' ' O ' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -67.43 -50.51 59.06 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.154 179.703 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.7 m -67.87 -24.83 65.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.76 0.314 . . . . 0.0 110.776 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -72.66 -41.12 65.77 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.215 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.432 ' O ' HD12 ' A' ' 213' ' ' ILE . 11.7 mt -86.8 -7.86 57.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.107 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.64 130.02 91.82 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.404 178.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -71.15 -8.03 22.64 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.497 2.131 . . . . 0.0 112.829 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.8 m -66.85 150.46 49.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.06 0.457 . . . . 0.0 111.054 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -71.51 94.98 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.418 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -143.63 -54.37 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.376 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -66.25 -18.47 55.78 Favored 'Trans proline' 0 C--N 1.361 1.192 0 C-N-CA 122.256 1.971 . . . . 0.0 112.42 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.3 mt -88.02 -13.15 42.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.303 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.43 ' HB ' ' HD3' ' A' ' 26' ' ' PRO . 20.8 t -57.34 -50.1 90.09 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.627 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.43 ' HD3' ' HB ' ' A' ' 25' ' ' VAL . 52.0 Cg_exo -55.97 -40.63 83.85 Favored 'Trans proline' 0 C--N 1.363 1.318 0 C-N-CA 122.237 1.958 . . . . 0.0 112.907 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.75 -36.84 78.87 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.795 0.331 . . . . 0.0 111.406 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -77.46 -41.01 41.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.265 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.54 -22.75 66.16 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.012 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -64.94 -59.24 4.4 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 178.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -60.79 -33.22 72.65 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.099 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.2 mt -71.91 -16.38 62.11 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.879 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -93.7 -0.72 66.44 Favored Glycine 0 N--CA 1.452 -0.287 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 178.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 66.67 -109.31 2.84 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 121.403 -0.427 . . . . 0.0 112.704 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -119.13 10.58 12.13 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.011 0.434 . . . . 0.0 110.659 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -131.21 40.91 3.4 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.887 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -100.15 99.77 2.09 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.214 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.81 129.47 29.81 Favored Pre-proline 0 C--N 1.326 -0.414 0 O-C-N 122.804 -0.233 . . . . 0.0 110.85 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -65.18 -23.43 60.05 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.817 2.344 . . . . 0.0 112.84 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -66.02 -44.48 84.6 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.081 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -72.17 -33.36 67.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.226 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.423 ' O ' ' HB2' ' A' ' 46' ' ' PHE . 8.0 t-20 -65.23 -50.25 66.57 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.319 178.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.81 -39.7 94.86 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.879 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.38 -50.48 71.39 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.974 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -66.19 -36.82 84.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.069 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.446 ' O ' ' HB2' ' A' ' 50' ' ' PHE . 0.2 OUTLIER -63.51 -49.83 72.0 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.239 179.462 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 tt -65.97 -28.73 44.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-O 120.728 0.299 . . . . 0.0 110.895 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.75 -55.46 5.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.701 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.486 ' O ' HG21 ' A' ' 53' ' ' VAL . . . -57.54 -44.55 93.77 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.152 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.446 ' HB2' ' O ' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -70.92 -32.4 69.3 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 110.503 -0.184 . . . . 0.0 110.503 179.532 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -63.16 -48.62 78.18 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.517 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.28 -43.21 92.55 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.743 0.306 . . . . 0.0 110.752 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.486 HG21 ' O ' ' A' ' 49' ' ' GLY . 98.9 t -66.22 -43.3 91.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.029 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.7 -28.73 69.28 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.396 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -84.35 -45.07 13.16 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.526 0.203 . . . . 0.0 110.849 179.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.93 -39.16 93.52 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.198 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.33 -18.18 27.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.733 0.302 . . . . 0.0 110.381 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.95 -33.0 73.91 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 121.189 -0.529 . . . . 0.0 112.255 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.577 ' O ' HG23 ' A' ' 62' ' ' THR . 1.1 mm? -64.52 -57.69 16.21 Favored Pre-proline 0 CA--C 1.537 0.481 0 CA-C-O 119.453 -0.308 . . . . 0.0 111.509 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -67.86 -13.39 38.37 Favored 'Trans proline' 0 C--N 1.36 1.169 0 C-N-CA 122.064 1.842 . . . . 0.0 112.623 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -55.7 -27.46 50.4 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.619 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.577 HG23 ' O ' ' A' ' 59' ' ' LEU . 8.6 t -66.32 -32.74 74.32 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.929 0.395 . . . . 0.0 110.64 179.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.86 -20.42 24.64 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.855 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.5 mt -64.88 -17.42 64.28 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.2 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -63.32 -30.14 76.65 Favored Glycine 0 C--N 1.334 0.442 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.474 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.08 -24.88 70.32 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 121.02 -0.61 . . . . 0.0 111.686 178.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 tp -85.11 -20.87 29.67 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.689 0.28 . . . . 0.0 110.569 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.7 -19.58 64.03 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.977 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -64.22 -25.13 67.93 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.799 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -108.42 118.38 36.62 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -77.83 109.08 11.55 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.102 0.477 . . . . 0.0 110.92 -179.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.4 mmm180 -78.89 90.21 4.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.332 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -68.76 -18.28 64.18 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.821 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.8 t -67.94 -26.21 65.85 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.163 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.1 tp -69.24 -35.84 76.56 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.924 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.79 -34.69 78.75 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.378 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -69.73 -43.35 72.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.433 179.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 99.4 t -64.74 -45.24 95.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.187 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.73 -40.1 97.61 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.961 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -64.49 -38.64 96.03 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.796 178.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 40.9 t -62.12 -41.78 92.57 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-O 120.699 0.285 . . . . 0.0 110.579 179.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 67.9 t -60.5 -41.74 88.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.666 179.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.5 mt -64.32 -41.73 96.66 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.549 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 93.6 t -66.98 -41.6 87.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.285 178.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.74 -41.16 97.29 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.708 179.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -61.95 -41.21 97.73 Favored 'General case' 0 CA--C 1.523 -0.091 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 178.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -65.12 -40.6 97.0 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.852 -0.689 . . . . 0.0 111.812 178.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 53.8 mt -62.16 -38.23 88.23 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.808 0.337 . . . . 0.0 110.854 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -77.12 -30.42 55.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.659 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 8.9 mtp -72.3 -19.6 61.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.869 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.89 -7.06 25.11 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.132 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.79 19.16 48.97 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.913 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.77 130.51 43.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.808 0.304 . . . . 0.0 110.63 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.379 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.19 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.434 ' O ' ' HD2' ' A' ' 110' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.462 0.173 0 CA-C-O 121.237 0.542 . . . . 0.0 110.852 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.98 -1.63 33.01 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.213 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.9 ttp180 -62.03 -56.57 30.4 Favored Pre-proline 0 CA--C 1.54 0.583 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . 0.434 ' HD2' ' O ' ' A' ' 107' ' ' THR . 38.5 Cg_endo -66.79 -26.97 44.59 Favored 'Trans proline' 0 C--N 1.361 1.199 0 C-N-CA 121.865 1.71 . . . . 0.0 112.049 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.2 mt -70.73 -33.37 70.77 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.625 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -64.41 -41.53 98.02 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.435 178.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -73.96 -36.36 64.59 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 120.724 0.297 . . . . 0.0 110.442 178.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -66.19 -43.89 85.51 Favored 'General case' 0 C--N 1.334 -0.094 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.907 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.39 -34.37 78.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.984 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.17 -30.45 68.68 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.989 0.423 . . . . 0.0 110.093 179.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -80.83 -42.04 10.17 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 178.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.07 -42.9 95.54 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.621 0.248 . . . . 0.0 111.116 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 10.1 p -67.15 -38.56 85.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.049 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.82 -28.14 65.46 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.773 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -81.65 -34.41 30.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.833 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.84 -38.05 47.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.011 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -77.74 117.54 4.77 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.751 -0.737 . . . . 0.0 111.662 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . 0.528 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 77.8 m95 -67.59 143.3 56.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.704 0.288 . . . . 0.0 111.167 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.65 102.79 5.64 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.354 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.528 ' HD3' ' O ' ' A' ' 124' ' ' TRP . 57.3 Cg_endo -75.06 -16.85 19.85 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.705 2.27 . . . . 0.0 112.869 -179.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . 0.4 ' O ' HD11 ' A' ' 131' ' ' ILE . 0.8 OUTLIER -65.28 -48.02 74.63 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.112 -179.951 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.8 pt -101.56 5.42 10.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.535 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -58.91 -67.3 2.25 Favored Glycine 0 CA--C 1.52 0.362 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.933 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -62.26 -29.63 80.42 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.36 2.04 . . . . 0.0 112.286 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.4 HD11 ' O ' ' A' ' 127' ' ' CYS . 65.3 mt -66.73 -54.41 25.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.135 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 15.1 mt -73.73 -31.22 63.25 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.095 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -63.69 -36.47 93.38 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.216 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.04 -43.23 71.68 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.836 0.351 . . . . 0.0 111.008 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 23.2 mm -71.92 -29.85 34.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.194 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.47 -46.95 83.09 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.016 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.0 -22.69 67.03 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.868 0.366 . . . . 0.0 111.591 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . 0.54 ' O ' HG11 ' A' ' 141' ' ' VAL . 2.6 tp -86.13 -35.68 20.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.697 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 25.6 p -82.21 -20.01 38.61 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.354 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -82.84 -8.49 59.57 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.439 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . 0.54 HG11 ' O ' ' A' ' 138' ' ' LEU . 1.4 p -88.42 -8.0 10.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-O 121.163 0.506 . . . . 0.0 110.945 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -145.57 -64.28 0.02 OUTLIER Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.571 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 144.43 57.31 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.187 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -82.74 62.08 4.66 Favored Glycine 0 N--CA 1.453 -0.173 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.734 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 9.5 m -70.26 -25.51 27.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.833 0.349 . . . . 0.0 111.28 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -63.61 -30.69 78.38 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.252 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -67.35 -42.49 83.42 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.822 0.344 . . . . 0.0 110.233 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.99 -40.95 97.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.58 179.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.438 ' O ' HG13 ' A' ' 152' ' ' ILE . 0.6 OUTLIER -68.3 -42.1 79.94 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.452 179.233 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -66.31 -29.82 70.11 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.638 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -64.63 -57.78 8.14 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.053 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 149' ' ' LEU . 0.9 OUTLIER -63.26 -42.75 97.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.377 -179.377 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.08 -32.97 72.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.745 -0.207 . . . . 0.0 110.74 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -60.42 -41.11 98.42 Favored Glycine 0 C--O 1.223 -0.547 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.001 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 29.6 tp -80.29 -29.0 38.21 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.693 0.282 . . . . 0.0 110.8 178.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.3 -39.36 79.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.425 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.532 ' O ' HG21 ' A' ' 161' ' ' VAL . 49.8 t -57.28 -63.81 3.3 Favored Pre-proline 0 CA--C 1.542 0.671 0 O-C-N 123.253 0.345 . . . . 0.0 111.817 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.506 ' CD ' ' HB ' ' A' ' 157' ' ' VAL . 20.7 Cg_endo -60.43 -33.56 93.98 Favored 'Trans proline' 0 C--N 1.362 1.272 0 C-N-CA 122.188 1.926 . . . . 0.0 112.637 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.35 -44.74 95.27 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.631 -0.258 . . . . 0.0 110.938 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -69.36 -35.08 75.51 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.758 0.314 . . . . 0.0 110.358 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.532 HG21 ' O ' ' A' ' 157' ' ' VAL . 89.4 t -62.21 -47.34 93.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.214 178.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 158' ' ' PRO . 58.2 t -67.04 -41.97 87.91 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.609 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -57.37 -39.37 75.86 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.511 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -77.49 -40.96 41.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.206 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -70.3 -19.77 63.07 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.658 0.266 . . . . 0.0 111.159 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.59 -26.47 68.7 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.145 178.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -66.91 -38.31 85.99 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.551 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 6.1 mtp180 -65.83 -34.16 77.51 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.728 178.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 6.6 mt -75.3 -28.06 20.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.787 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.97 -36.76 77.83 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.197 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -61.38 -49.64 75.18 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.348 179.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 52.6 m95 -72.26 -26.26 61.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.808 0.337 . . . . 0.0 111.156 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.83 -23.75 61.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.958 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 14.8 mtp85 -75.82 -17.93 59.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.026 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.08 -43.83 95.22 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.063 0.459 . . . . 0.0 110.47 178.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -108.57 -76.55 0.61 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.116 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 98.51 -25.61 27.21 Favored Glycine 0 C--N 1.329 0.163 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.424 178.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 26.6 mtp180 -84.13 -10.56 57.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.966 0.412 . . . . 0.0 110.983 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 1.6 pt -76.84 -18.86 14.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.214 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.02 -22.27 65.56 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.432 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' HIS . . . . . 0.521 ' O ' HG21 ' A' ' 185' ' ' VAL . 0.1 OUTLIER -84.18 -23.0 30.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.935 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -72.83 -42.62 63.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.867 0.365 . . . . 0.0 110.66 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 4.4 m -71.5 -19.14 20.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.073 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -80.33 -37.56 32.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.608 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . 0.521 HG21 ' O ' ' A' ' 181' ' ' HIS . 91.6 t -68.98 -41.73 81.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.739 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.7 mp -61.25 -38.98 88.63 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.752 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -66.7 -36.28 82.12 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.16 178.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -66.35 -36.43 91.63 Favored Glycine 0 C--N 1.333 0.366 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.85 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 98.7 t -61.81 -52.86 55.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.846 0.355 . . . . 0.0 110.695 179.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . 0.434 ' O ' HG21 ' A' ' 194' ' ' VAL . 4.0 t -63.4 -31.2 51.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.977 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.34 -54.26 46.08 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.203 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . 0.413 ' O ' HG22 ' A' ' 196' ' ' VAL . 35.0 m -68.29 -30.66 48.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.822 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.77 -50.75 69.82 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.19 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . 0.434 HG21 ' O ' ' A' ' 190' ' ' VAL . 58.8 t -66.46 -37.99 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.124 0 CA-C-O 120.883 0.373 . . . . 0.0 110.215 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -59.55 -47.21 92.04 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.441 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.413 HG22 ' O ' ' A' ' 192' ' ' VAL . 91.4 t -72.08 -36.81 58.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.619 0.247 . . . . 0.0 111.022 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.32 -31.74 73.02 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.699 0.285 . . . . 0.0 111.211 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.33 -33.91 21.97 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.68 -0.236 . . . . 0.0 111.296 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -77.23 -47.22 20.76 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.4 -35.29 17.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.677 0.275 . . . . 0.0 111.627 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -83.55 -63.64 1.69 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.405 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' THR . . . . . 0.417 ' O ' ' HB2' ' A' ' 205' ' ' ALA . 0.2 OUTLIER 54.3 -148.29 0.47 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 122.403 0.281 . . . . 0.0 110.819 -179.878 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 48.55 -111.07 0.41 Allowed 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 179.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.44 30.94 6.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.829 0.347 . . . . 0.0 110.975 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . 0.417 ' HB2' ' O ' ' A' ' 202' ' ' THR . . . -69.71 -14.4 62.78 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.386 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.1 mt -77.58 -16.12 58.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.956 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -64.84 -36.03 83.04 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.198 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 75.6 p -62.59 -36.96 84.36 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.122 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . 0.463 ' O ' HG12 ' A' ' 213' ' ' ILE . 1.6 m-85 -87.04 -22.71 25.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.057 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.02 -16.29 61.32 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.542 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.49 -29.63 69.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.847 0.356 . . . . 0.0 110.731 179.271 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.88 -6.3 48.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.997 0.427 . . . . 0.0 110.355 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . 0.463 HG12 ' O ' ' A' ' 209' ' ' PHE . 11.1 mm -93.56 -3.68 10.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.743 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.46 116.98 29.91 Favored Pre-proline 0 CA--C 1.529 0.16 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.411 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -69.3 122.24 9.04 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.564 2.176 . . . . 0.0 112.994 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -74.04 -22.7 59.45 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.794 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -70.15 -24.54 63.18 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.955 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.402 HD23 ' HG ' ' A' ' 10' ' ' LEU . 1.8 mm? -76.13 -30.55 58.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.279 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -74.15 -23.15 59.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.059 179.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 5.2 mmm180 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.827 179.427 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.462 0.147 0 CA-C-O 120.608 0.242 . . . . 0.0 110.422 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.549 ' O ' ' HB3' ' A' ' 7' ' ' ALA . 0.3 OUTLIER -102.01 9.07 40.72 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.944 0.402 . . . . 0.0 110.43 179.333 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.89 -42.59 60.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.107 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.69 -42.25 64.44 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.793 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.54 -45.28 91.26 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.542 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ALA . . . . . 0.549 ' HB3' ' O ' ' A' ' 3' ' ' LEU . . . -59.41 -40.59 87.16 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.61 178.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 150' ' ' ALA . . . -61.02 -48.61 80.99 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.717 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -57.43 -46.82 83.14 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.776 179.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.0 mp -61.7 -45.8 92.43 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.509 178.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.25 -42.37 90.97 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.534 178.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.86 -44.28 98.26 Favored Glycine 0 C--N 1.334 0.417 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.887 178.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 74.4 t -63.5 -41.94 94.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-O 120.781 0.324 . . . . 0.0 110.517 179.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.94 -45.12 90.62 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.813 0.34 . . . . 0.0 110.522 179.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.9 m -64.42 -35.15 79.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.868 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -73.65 -34.13 64.82 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.327 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.6 mt -79.15 -14.86 58.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.979 0.419 . . . . 0.0 110.757 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.4 t -86.37 126.9 63.13 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.873 178.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -61.56 -14.84 37.75 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.784 2.323 . . . . 0.0 112.654 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 6.0 t -81.23 66.92 6.97 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.142 0.496 . . . . 0.0 110.633 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.1 m -89.98 161.53 2.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.864 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.65 -55.73 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.517 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -66.58 -22.52 50.93 Favored 'Trans proline' 0 C--N 1.361 1.202 0 C-N-CA 122.289 1.993 . . . . 0.0 112.89 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -74.17 -13.6 60.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.59 179.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.431 ' N ' ' HD2' ' A' ' 26' ' ' PRO . 73.7 t -74.51 -56.58 2.33 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-O 119.675 -0.202 . . . . 0.0 111.399 179.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' A' ' 25' ' ' VAL . 17.1 Cg_endo -57.54 -23.43 56.39 Favored 'Trans proline' 0 C--N 1.362 1.254 0 C-N-CA 122.614 2.209 . . . . 0.0 113.449 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.04 -24.86 66.51 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.721 0.296 . . . . 0.0 111.416 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -76.84 -38.07 54.45 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.907 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -82.94 -22.47 33.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.448 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -53.61 -28.7 34.05 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.438 178.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -62.35 -33.53 74.89 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 120.83 0.348 . . . . 0.0 110.854 178.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 21.9 mt -86.45 -22.99 26.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.622 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -93.94 3.27 70.27 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.999 -0.619 . . . . 0.0 111.683 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -81.59 65.7 3.97 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 121.399 -0.429 . . . . 0.0 112.505 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -89.62 -19.87 24.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.939 0.4 . . . . 0.0 111.188 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 9.4 mmm180 -109.51 -97.16 0.39 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.024 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 165.17 -176.38 40.87 Favored Glycine 0 N--CA 1.448 -0.5 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 4.9 ttm105 57.26 72.87 0.86 Allowed Pre-proline 0 N--CA 1.469 0.49 0 C-N-CA 122.575 0.35 . . . . 0.0 111.343 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.11 -23.99 39.15 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.487 2.125 . . . . 0.0 112.502 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.6 mt -66.26 -34.98 79.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.977 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -73.32 -37.57 66.11 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.03 -36.59 84.88 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.99 178.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.44 -47.19 82.9 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.331 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -56.01 -42.32 76.25 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.162 178.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.47 -37.66 77.38 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.6 0.238 . . . . 0.0 110.947 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -65.05 -48.34 74.15 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.324 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 13.3 pt -68.29 -27.91 38.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.678 0.275 . . . . 0.0 110.92 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.47 -51.35 29.76 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.484 ' O ' HG21 ' A' ' 53' ' ' VAL . . . -61.66 -43.85 98.71 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.081 179.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -67.32 -35.64 79.84 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.632 0.253 . . . . 0.0 110.609 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -63.08 -42.72 99.48 Favored Glycine 0 C--N 1.334 0.428 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.39 -44.88 92.71 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.672 0.273 . . . . 0.0 110.667 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.484 HG21 ' O ' ' A' ' 49' ' ' GLY . 26.5 t -65.49 -41.94 92.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.98 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.86 -34.68 78.95 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.917 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -76.56 -43.54 38.51 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.592 179.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.2 tp -61.12 -33.01 72.69 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.973 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.8 mt -89.73 -18.4 26.44 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.083 178.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -72.01 -32.04 63.75 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.334 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.18 -54.55 32.3 Favored Pre-proline 0 CA--C 1.543 0.69 0 N-CA-C 111.698 0.258 . . . . 0.0 111.698 179.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -67.46 -13.6 39.7 Favored 'Trans proline' 0 C--N 1.361 1.223 0 C-N-CA 122.559 2.172 . . . . 0.0 112.528 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.69 -20.87 37.07 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.387 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.3 p -62.04 -35.9 79.99 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.227 0.537 . . . . 0.0 110.45 178.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.4 -19.54 26.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.682 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 70.6 mt -75.38 -17.42 60.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.993 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.61 -31.18 78.98 Favored Glycine 0 C--N 1.334 0.422 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.912 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -77.23 -29.61 56.14 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.146 179.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 tp -76.88 -25.07 52.63 Favored 'General case' 0 N--CA 1.461 0.094 0 CA-C-O 120.784 0.326 . . . . 0.0 110.817 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.62 -19.25 65.2 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.945 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -71.29 -17.46 62.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.566 178.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.84 161.86 17.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.419 179.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 9.1 m-70 -82.26 77.27 9.08 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.043 0.449 . . . . 0.0 111.36 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.2 mmp_? -96.7 49.15 1.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.829 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -73.01 -22.16 60.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.865 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -65.26 -24.64 67.37 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.329 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.19 -23.16 44.04 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.734 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.96 -30.32 26.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.056 179.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.5 mmt-85 -60.27 -27.65 67.44 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.493 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.3 t -63.47 -26.46 40.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-O 120.964 0.411 . . . . 0.0 110.519 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -65.0 -34.81 90.87 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.919 -0.658 . . . . 0.0 111.824 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -66.93 -39.45 93.31 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.417 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.8 t -61.57 -40.35 86.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-O 120.875 0.369 . . . . 0.0 110.59 179.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 80.5 t -63.35 -39.68 86.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.386 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.98 -40.1 96.71 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.796 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 53.1 t -63.59 -44.09 98.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.222 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.58 -41.1 93.95 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.593 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -65.57 -42.94 91.24 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.331 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -61.98 -38.29 95.81 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.247 179.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.0 -38.47 91.05 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.813 0.339 . . . . 0.0 110.831 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -73.74 -30.14 62.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.345 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 6.7 mtp -71.11 -27.1 63.35 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.538 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 65.0 mt -63.82 -16.23 60.75 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.26 178.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.37 16.08 74.81 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.751 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.4 mp -77.4 137.85 38.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.918 0.39 . . . . 0.0 110.505 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 15.6 mtp180 . . . . . 0 C--N 1.325 -0.475 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.889 -178.939 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.532 0.252 0 CA-C-O 120.794 0.331 . . . . 0.0 111.404 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.74 -40.23 19.08 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.61 -56.53 34.69 Favored Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -60.91 -28.27 86.09 Favored 'Trans proline' 0 C--N 1.36 1.165 0 C-N-CA 122.32 2.014 . . . . 0.0 112.503 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.8 tp -69.09 -28.73 66.77 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.772 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -63.01 -33.79 88.21 Favored Glycine 0 C--N 1.336 0.572 0 C-N-CA 120.93 -0.652 . . . . 0.0 111.714 178.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -77.71 -34.17 52.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.94 0.4 . . . . 0.0 110.544 178.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -70.56 -38.35 74.12 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.708 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.29 -27.42 62.45 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.503 179.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.08 -44.88 94.46 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.305 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLY . . . . . 0.438 ' O ' ' HB1' ' A' ' 121' ' ' ALA . . . -71.65 -27.78 70.42 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.556 178.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.06 -48.45 65.55 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.674 0.273 . . . . 0.0 110.809 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 3.5 p -69.02 -31.88 71.0 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.866 0.365 . . . . 0.0 110.981 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -74.11 -39.88 63.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.778 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . 0.438 ' HB1' ' O ' ' A' ' 117' ' ' GLY . . . -65.16 -24.0 67.27 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.935 0.398 . . . . 0.0 110.962 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 43.5 mt -80.73 -18.36 48.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.477 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -95.78 81.23 0.81 Allowed Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 3.3 m0 -66.56 -82.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.729 0.3 . . . . 0.0 111.324 -179.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.57 65.84 13.12 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.575 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -74.76 -57.4 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.006 1.804 . . . . 0.0 112.492 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -86.06 -16.94 36.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.051 0.453 . . . . 0.0 110.466 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.2 mt -92.14 2.43 8.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.421 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -57.14 -60.68 8.59 Favored Glycine 0 CA--C 1.521 0.413 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.426 178.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.45 -35.03 97.13 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.459 2.106 . . . . 0.0 112.141 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ILE . . . . . 0.495 ' O ' HG13 ' A' ' 135' ' ' ILE . 19.1 mt -68.42 -49.18 68.44 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.956 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 tp -63.92 -34.48 78.05 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.755 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -61.17 -39.96 97.89 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.854 -0.689 . . . . 0.0 111.599 178.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -71.38 -30.95 66.73 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.82 0.343 . . . . 0.0 110.683 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ILE . . . . . 0.495 HG13 ' O ' ' A' ' 131' ' ' ILE . 79.7 mt -72.06 -31.87 41.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.642 179.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 7.7 mt -60.37 -35.8 76.55 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.908 179.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.5 -22.59 63.59 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.809 178.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.5 tp -81.65 -27.35 34.14 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.382 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.583 ' HA ' ' O ' ' A' ' 143' ' ' GLY . 0.3 OUTLIER -76.3 -17.36 59.47 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.631 179.401 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -71.82 -17.99 62.12 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.358 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 8.1 t -73.89 -28.8 24.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.984 0.421 . . . . 0.0 110.712 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 129.36 64.77 0.11 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.148 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.583 ' O ' ' HA ' ' A' ' 139' ' ' THR . . . 113.13 -152.25 18.04 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.16 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 115.73 20.45 5.36 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.378 -0.915 . . . . 0.0 112.729 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 11.7 p -66.12 -25.54 36.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 CA-C-O 120.961 0.41 . . . . 0.0 110.976 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -62.43 -30.32 75.98 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.093 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -67.4 -42.6 83.03 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.605 0.24 . . . . 0.0 110.503 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.8 tp -61.96 -43.75 98.19 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.512 179.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.519 ' O ' HG13 ' A' ' 152' ' ' ILE . 1.6 mp -67.95 -41.45 82.47 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.648 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.475 ' O ' ' HB3' ' A' ' 8' ' ' ALA . . . -64.52 -35.14 80.0 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.477 178.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -61.05 -54.66 42.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.421 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.519 HG13 ' O ' ' A' ' 149' ' ' LEU . 0.5 OUTLIER -63.8 -42.67 96.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.874 -179.778 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -64.44 -40.76 96.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.169 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -59.36 -41.51 96.99 Favored Glycine 0 C--N 1.334 0.429 0 CA-C-N 116.207 -0.451 . . . . 0.0 112.758 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 7.0 mt -80.59 -26.67 37.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.814 0.34 . . . . 0.0 111.016 178.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -62.7 -37.35 86.13 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.314 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.484 ' HB ' ' CD ' ' A' ' 158' ' ' PRO . 96.5 t -54.8 -63.66 2.69 Favored Pre-proline 0 CA--C 1.541 0.601 0 O-C-N 123.382 0.426 . . . . 0.0 111.642 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' PRO . . . . . 0.484 ' CD ' ' HB ' ' A' ' 157' ' ' VAL . 28.7 Cg_endo -62.65 -36.64 62.57 Favored 'Trans proline' 0 C--N 1.358 1.077 0 C-N-CA 121.765 1.643 . . . . 0.0 112.578 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -58.92 -48.27 82.07 Favored 'General case' 0 N--CA 1.462 0.134 0 O-C-N 123.017 0.198 . . . . 0.0 111.37 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -65.8 -39.28 90.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.958 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 92.9 t -63.61 -44.26 98.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.188 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.415 ' O ' ' HB1' ' A' ' 166' ' ' ALA . 71.8 t -66.17 -44.91 91.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.284 178.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -58.02 -35.55 71.42 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.885 0.374 . . . . 0.0 111.377 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.7 mt -69.12 -45.83 69.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.011 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.13 -34.47 68.59 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.926 0.393 . . . . 0.0 110.624 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ALA . . . . . 0.451 ' O ' ' HB2' ' A' ' 170' ' ' LYS . . . -69.93 -19.06 63.4 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.999 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -67.0 -26.34 66.74 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.372 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 1.1 tpt85 -79.19 -46.6 17.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.06 0.457 . . . . 0.0 110.668 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.423 HG12 ' HA ' ' A' ' 166' ' ' ALA . 20.7 pt -75.03 -18.77 16.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.288 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.456 ' O ' ' HG3' ' A' ' 174' ' ' ARG . 0.2 OUTLIER -57.44 -44.27 84.58 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.057 179.751 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -68.29 -25.36 74.69 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.672 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 1.3 m-90 -86.9 -41.08 14.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.658 0.266 . . . . 0.0 111.201 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.82 -16.63 62.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.581 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.456 ' HG3' ' O ' ' A' ' 170' ' ' LYS . 0.0 OUTLIER -52.44 -54.69 28.96 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.764 0.316 . . . . 0.0 111.342 179.197 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 14.8 mtm180 -94.12 -16.36 23.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.567 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -92.21 1.37 57.26 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.72 0.295 . . . . 0.0 111.635 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -85.09 55.43 4.96 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.599 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.5 -53.02 3.45 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.981 0.419 . . . . 0.0 110.41 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 7.3 pt -74.26 -22.18 17.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.339 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' SER . . . . . 0.421 ' O ' ' HG3' ' A' ' 184' ' ' GLU . 0.3 OUTLIER -66.51 -18.71 65.51 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.467 179.975 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' HIS . . . . . 0.433 ' HA ' ' OE2' ' A' ' 184' ' ' GLU . 0.0 OUTLIER -63.85 -32.6 74.17 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.03 179.918 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -80.23 -25.31 39.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.93 0.395 . . . . 0.0 110.62 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 11.9 t -74.67 -25.34 18.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.44 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' GLU . . . . . 0.433 ' OE2' ' HA ' ' A' ' 181' ' ' HIS . 32.7 mt-10 -74.41 -29.68 61.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.649 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 11.4 t -69.62 -48.89 63.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.688 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' LEU . . . . . 0.468 ' O ' HG21 ' A' ' 190' ' ' VAL . 2.7 mt -59.33 -43.18 92.77 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.841 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -68.9 -40.76 78.96 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.704 179.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.404 ' O ' HG22 ' A' ' 192' ' ' VAL . . . -62.69 -41.61 99.8 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.265 179.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 54.4 t -61.49 -52.41 61.44 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.103 0 CA-C-O 120.43 0.157 . . . . 0.0 110.803 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' VAL . . . . . 0.468 HG21 ' O ' ' A' ' 186' ' ' LEU . 54.8 t -58.16 -39.62 73.91 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.92 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 1.8 mt -61.71 -47.39 85.5 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.173 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' VAL . . . . . 0.404 HG22 ' O ' ' A' ' 188' ' ' GLY . 60.3 t -70.74 -35.89 62.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.657 0.265 . . . . 0.0 110.598 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.4 tp -59.83 -51.79 68.23 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.131 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 31.7 m -67.08 -29.61 46.71 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.585 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -65.36 -49.65 59.94 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.703 178.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 46.2 t -67.09 -37.74 79.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 O-C-N 122.744 -0.268 . . . . 0.0 110.328 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.53 -31.12 72.2 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.776 179.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.05 -29.78 58.15 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.075 0.464 . . . . 0.0 110.424 178.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -78.31 -41.17 34.51 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.602 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 66.9 p -86.24 -39.84 16.16 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -91.08 -4.74 68.6 Favored Glycine 0 C--N 1.329 0.174 0 C-N-CA 121.223 -0.513 . . . . 0.0 112.707 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.1 -142.44 0.56 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 122.69 0.396 . . . . 0.0 110.962 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -83.8 -11.41 57.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.769 0.319 . . . . 0.0 110.959 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.81 -43.23 80.15 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.46 179.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -74.55 -30.36 61.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.838 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 5.8 tp -73.17 -33.62 65.55 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.719 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -63.27 -41.38 99.01 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.786 0.327 . . . . 0.0 111.033 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 4.3 p -73.56 -25.36 60.34 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.076 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -87.44 -27.12 22.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.272 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -80.97 -15.64 55.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.494 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.17 -35.05 71.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.243 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.26 -6.37 55.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.245 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 4.6 mt -106.94 7.44 9.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.124 0.488 . . . . 0.0 110.801 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 2.3 p -61.49 122.33 69.98 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.865 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -60.16 145.9 97.47 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.367 2.044 . . . . 0.0 112.311 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -63.8 -21.16 66.29 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.329 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -73.2 -26.44 61.15 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.75 0.309 . . . . 0.0 110.913 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.21 -30.3 17.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.376 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.97 -22.79 63.12 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.518 179.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 1.2 ttp180 . . . . . 0 C--N 1.332 -0.189 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.729 179.132 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.1 mtp . . . . . 0 N--CA 1.487 1.422 0 CA-C-O 121.012 0.434 . . . . 0.0 110.561 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.58 137.31 36.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.365 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.55 102.18 9.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.902 0.382 . . . . 0.0 111.064 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.29 -18.79 61.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.916 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.31 -27.62 69.45 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.992 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.41 -48.26 82.52 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.778 0.323 . . . . 0.0 110.59 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.36 -45.69 92.05 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.774 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.19 -33.58 76.12 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.964 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.418 ' O ' HG21 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -66.69 -52.38 45.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.247 179.527 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.8 mp -61.33 -38.02 85.39 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.104 178.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.81 -43.03 99.88 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.468 178.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.3 -41.91 98.57 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 121.054 -0.593 . . . . 0.0 111.994 178.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.418 HG21 ' O ' ' A' ' 9' ' ' PHE . 48.2 t -64.59 -38.57 82.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.125 0.488 . . . . 0.0 109.839 178.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 60.1 mt -63.81 -41.17 97.94 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.5 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.6 m -65.46 -33.22 75.43 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.697 0.284 . . . . 0.0 110.877 179.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -69.35 -36.79 77.23 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.023 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.6 mp -90.5 -4.37 56.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.953 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.1 t -79.08 124.01 84.75 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.363 179.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -67.44 -8.63 22.72 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.691 2.261 . . . . 0.0 112.709 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.422 ' SG ' ' HZ ' ' A' ' 210' ' ' PHE . 1.0 OUTLIER -88.11 -14.48 38.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.954 179.756 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.6 t -116.98 -79.74 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.188 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.401 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 15.0 mt 51.15 82.61 0.24 Allowed Pre-proline 0 N--CA 1.466 0.351 0 O-C-N 123.709 0.631 . . . . 0.0 111.699 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -55.23 -24.08 40.08 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.99 2.46 . . . . 0.0 113.273 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.4 tp -64.36 -26.2 68.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.717 -0.22 . . . . 0.0 111.133 178.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.427 ' HB ' ' CD ' ' A' ' 26' ' ' PRO . 71.4 t -67.48 -61.14 4.81 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.162 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.427 ' CD ' ' HB ' ' A' ' 25' ' ' VAL . 19.3 Cg_endo -59.11 -35.19 98.49 Favored 'Trans proline' 0 C--N 1.361 1.185 0 C-N-CA 122.032 1.821 . . . . 0.0 112.559 178.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 20.2 m -64.9 -36.54 84.68 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.714 0.292 . . . . 0.0 111.002 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.439 ' O ' ' HB2' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -66.53 -28.51 68.6 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.566 179.562 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 7.9 mt -85.06 -36.22 21.35 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.075 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -63.28 -44.05 96.18 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.549 178.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -73.63 -21.6 60.25 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.763 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.439 ' HB2' ' O ' ' A' ' 28' ' ' TYR . 2.1 tp -75.94 -18.85 59.18 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.4 179.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -89.59 -4.38 73.29 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.946 -0.645 . . . . 0.0 111.66 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.99 -59.46 4.94 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 121.161 -0.543 . . . . 0.0 112.666 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . 57.74 -113.28 0.72 Allowed 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 122.753 0.421 . . . . 0.0 111.024 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.11 -36.92 1.14 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.935 0.397 . . . . 0.0 110.725 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.11 18.08 11.85 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.094 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -111.77 96.96 35.53 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.514 0.197 . . . . 0.0 110.624 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -69.32 -32.04 21.21 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.507 2.138 . . . . 0.0 112.932 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.62 -44.37 90.75 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.132 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -73.79 -36.03 64.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.818 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -65.42 -42.24 92.71 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.165 178.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.49 -51.91 56.66 Favored 'General case' 0 C--O 1.227 -0.126 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.627 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.33 -42.0 73.19 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.244 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -64.07 -44.69 91.65 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.861 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.46 -40.41 89.39 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.62 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 55.5 mt -60.71 -48.57 88.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.573 179.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.65 -45.83 81.48 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.905 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.623 ' O ' HG22 ' A' ' 53' ' ' VAL . . . -59.84 -48.45 85.99 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.407 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.03 -41.75 90.52 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.55 0.214 . . . . 0.0 110.998 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -61.74 -44.26 98.13 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.078 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.12 -46.04 90.96 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.658 0.266 . . . . 0.0 111.11 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.623 HG22 ' O ' ' A' ' 49' ' ' GLY . 46.1 t -65.25 -42.23 93.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.098 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -64.29 -28.29 69.62 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.531 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -84.95 -46.61 11.08 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.896 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.87 -39.21 93.19 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.09 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.443 ' HB2' ' O ' ' A' ' 53' ' ' VAL . 1.0 OUTLIER -85.82 -19.07 31.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.487 179.386 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.415 ' O ' ' HB2' ' A' ' 61' ' ' PHE . . . -74.69 -26.69 66.73 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.203 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.68 -56.41 33.04 Favored Pre-proline 0 CA--C 1.54 0.59 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -65.65 -13.78 41.51 Favored 'Trans proline' 0 C--N 1.362 1.281 0 C-N-CA 122.305 2.004 . . . . 0.0 113.155 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.415 ' HB2' ' O ' ' A' ' 58' ' ' GLY . 8.2 m-30 -61.44 -17.94 56.63 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.651 0.262 . . . . 0.0 111.422 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 21.8 p -71.89 -41.34 68.08 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.135 0.493 . . . . 0.0 110.195 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.3 mt -88.48 -21.63 24.09 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.888 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.86 -17.9 64.06 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.901 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -63.43 -24.52 67.7 Favored Glycine 0 C--N 1.335 0.477 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.934 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.49 -21.82 76.64 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.149 179.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.69 -20.67 46.01 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.833 0.349 . . . . 0.0 110.631 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -64.32 -19.26 65.32 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.995 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -69.73 -17.62 63.46 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.814 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -97.27 -133.36 0.22 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.906 179.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -151.03 126.26 9.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.909 0.385 . . . . 0.0 110.841 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -134.59 37.71 3.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.598 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -66.88 -18.09 65.21 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.411 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.46 -18.06 65.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.398 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.4 mp -74.15 -22.86 59.25 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.624 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.19 -24.11 51.44 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.502 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.79 -33.56 68.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.888 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.509 ' O ' HG22 ' A' ' 82' ' ' VAL . 41.9 t -62.52 -36.76 76.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.729 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.67 -36.8 93.8 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.068 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.479 ' O ' HG23 ' A' ' 84' ' ' VAL . . . -66.34 -41.59 94.46 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.873 -0.679 . . . . 0.0 111.764 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 21.5 t -60.49 -43.88 95.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 120.83 0.348 . . . . 0.0 110.714 179.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.509 HG22 ' O ' ' A' ' 78' ' ' VAL . 47.1 t -63.91 -41.07 91.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.601 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.87 -43.16 99.55 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.771 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 80' ' ' GLY . 92.7 t -62.97 -44.95 99.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-O 120.832 0.349 . . . . 0.0 110.429 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.78 -41.46 97.74 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.72 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -66.52 -40.17 89.04 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.667 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -61.34 -39.52 97.35 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.997 -0.621 . . . . 0.0 111.893 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.5 -40.93 98.37 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.829 0.347 . . . . 0.0 110.698 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -71.72 -31.45 66.73 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.548 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 5.2 mtt -67.12 -27.59 67.46 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.473 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.74 -9.58 51.46 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.024 178.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.56 11.27 83.32 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.849 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.34 145.15 25.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.926 0.393 . . . . 0.0 110.842 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -106.75 140.82 21.73 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.613 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.29 -36.07 22.18 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.705 2.27 . . . . 0.0 112.671 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.7 ttp85 -98.81 104.93 17.01 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.445 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 3.3 m95 -83.03 63.51 7.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.295 0.569 . . . . 0.0 111.061 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -168.75 55.42 0.21 Allowed Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.447 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.0 t -81.88 122.77 37.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.88 0.372 . . . . 0.0 111.139 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.12 175.77 8.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.943 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.4 mt -109.03 175.59 5.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.255 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.79 55.27 3.29 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.453 0.644 . . . . 0.0 110.596 -179.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -99.28 178.51 4.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.02 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -111.75 156.48 21.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.676 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -167.71 -69.33 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.021 -0.609 . . . . 0.0 111.936 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 62.28 -93.58 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 122.883 0.473 . . . . 0.0 111.484 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.62 62.78 7.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.889 0.376 . . . . 0.0 111.011 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.3 -13.66 43.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.299 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.448 ' N ' ' HD2' ' A' ' 110' ' ' PRO . 0.0 OUTLIER -66.85 -52.54 32.08 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.933 179.845 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.448 ' HD2' ' N ' ' A' ' 109' ' ' ARG . 36.6 Cg_endo -65.18 -15.56 50.79 Favored 'Trans proline' 0 C--N 1.363 1.325 0 C-N-CA 122.069 1.846 . . . . 0.0 112.797 179.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.416 ' O ' ' HB2' ' A' ' 115' ' ' LEU . 0.5 OUTLIER -67.65 -39.64 84.58 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.682 179.857 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -69.28 -31.88 71.91 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.628 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -71.42 -46.16 60.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.888 0.375 . . . . 0.0 110.775 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -67.98 -39.16 83.34 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.063 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.416 ' HB2' ' O ' ' A' ' 111' ' ' LEU . 0.7 OUTLIER -65.23 -40.2 93.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.79 179.474 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.59 -33.62 76.36 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.705 0.288 . . . . 0.0 110.522 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -66.52 -48.85 60.15 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.21 178.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.44 -29.84 70.56 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.753 0.311 . . . . 0.0 110.713 178.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 52.7 m -61.89 -44.81 96.04 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.811 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.2 mt -69.87 -21.43 63.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.384 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -85.22 -40.86 16.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.484 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.1 mp -85.83 -33.06 21.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.741 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -80.55 92.24 1.41 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.392 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -81.69 132.87 35.31 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.894 0.378 . . . . 0.0 110.913 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.0 113.14 45.96 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.789 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -63.68 -22.37 69.95 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.827 2.351 . . . . 0.0 112.963 -179.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -70.45 -25.69 63.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.244 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.5 mm -103.1 2.37 10.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.111 0.482 . . . . 0.0 110.406 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -61.53 -59.64 9.51 Favored Glycine 0 CA--C 1.521 0.44 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.611 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -57.4 -34.78 98.51 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 122.72 2.28 . . . . 0.0 112.323 178.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 16.0 mm -67.83 -43.45 86.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.808 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.39 -37.37 66.01 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.465 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -61.38 -31.17 76.37 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 121.075 -0.583 . . . . 0.0 112.197 178.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.74 -21.91 62.48 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.908 0.385 . . . . 0.0 110.927 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 38.4 mm -79.58 -30.34 13.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.681 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.07 -39.26 94.2 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.574 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.11 -23.76 67.24 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.105 178.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.76 -33.5 19.92 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.743 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 23.6 p -80.3 -17.16 52.9 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.357 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -75.94 -29.23 58.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.98 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 21.8 m -100.15 2.91 10.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.266 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -173.43 -90.07 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.478 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 151.3 -152.58 24.34 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.431 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 167.52 63.01 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.264 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 1.7 t -62.25 -49.17 85.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.87 0.367 . . . . 0.0 110.672 -179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -65.82 -28.98 74.13 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.937 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.42 -44.06 83.97 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.809 0.338 . . . . 0.0 110.453 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.93 -42.37 99.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.384 179.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 34.4 mt -66.26 -39.25 89.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.385 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -61.58 -38.81 88.91 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.561 178.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -62.52 -47.59 83.24 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.654 179.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 17.6 mt -64.87 -46.9 90.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.382 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . 0.403 ' O ' HG23 ' A' ' 157' ' ' VAL . 0.2 OUTLIER -62.09 -37.7 86.05 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.951 179.28 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -60.13 -38.84 95.0 Favored Glycine 0 C--O 1.224 -0.518 0 C-N-CA 121.273 -0.489 . . . . 0.0 112.058 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -79.98 -26.31 40.0 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.678 0.275 . . . . 0.0 110.971 178.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -64.48 -37.46 87.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.153 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.539 ' O ' HG21 ' A' ' 161' ' ' VAL . 59.4 t -55.33 -62.73 3.91 Favored Pre-proline 0 CA--C 1.541 0.633 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.824 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.48 ' CD ' ' HB ' ' A' ' 157' ' ' VAL . 17.9 Cg_endo -59.68 -36.59 91.58 Favored 'Trans proline' 0 C--N 1.36 1.157 0 C-N-CA 122.123 1.882 . . . . 0.0 112.339 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.08 -44.82 96.78 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.271 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -66.11 -40.47 90.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.635 0.255 . . . . 0.0 110.708 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.539 HG21 ' O ' ' A' ' 157' ' ' VAL . 48.3 t -63.88 -45.43 97.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.499 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 60.9 t -65.07 -40.24 88.29 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.606 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -58.8 -41.7 87.36 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.547 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.97 -39.23 63.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.238 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -70.9 -27.65 63.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.739 0.304 . . . . 0.0 110.8 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -64.46 -18.75 65.05 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.532 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -62.77 -46.65 87.05 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.758 0.313 . . . . 0.0 111.044 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -78.24 -34.0 49.43 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.742 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.414 HG22 ' O ' ' A' ' 169' ' ' ILE . 58.1 mt -69.74 -23.1 25.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.921 179.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -59.69 -39.1 83.41 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.913 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -71.54 -23.8 77.59 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.674 179.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 60.2 t-105 -81.64 -37.89 26.81 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.423 0.154 . . . . 0.0 111.133 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.59 -38.04 59.23 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -87.47 -15.67 36.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.495 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.16 -27.59 18.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.466 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -53.47 -65.78 0.5 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.758 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 131.3 -124.47 4.11 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.806 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 2.7 mtt180 -100.26 0.6 40.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.675 0.274 . . . . 0.0 111.357 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 7.9 mt -66.81 -33.8 65.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.965 0.412 . . . . 0.0 110.844 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.47 -20.22 66.05 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.315 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 37.7 m170 -84.01 -21.45 31.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.83 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -73.1 -45.91 54.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.524 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 3.6 m -73.54 -19.57 18.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.186 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -65.11 -50.79 64.69 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.708 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 2.4 m -81.82 -28.08 9.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.506 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.2 tp -58.59 -50.72 72.8 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.19 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -62.21 -35.34 78.59 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.785 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -65.28 -42.33 96.26 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.193 179.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 94.8 t -62.55 -47.56 92.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 120.76 0.314 . . . . 0.0 110.724 179.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 39.5 t -62.18 -39.42 83.89 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.891 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.98 -46.52 87.9 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.841 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 55.8 t -66.51 -40.55 86.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.422 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 4.3 mt -60.98 -46.57 90.19 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.961 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 87.5 t -66.93 -41.1 87.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.801 0.334 . . . . 0.0 110.262 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -62.44 -43.46 99.01 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.742 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 3.6 p -72.93 -32.36 39.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 116.8 0.3 . . . . 0.0 111.279 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -74.85 -22.46 58.67 Favored 'General case' 0 C--N 1.334 -0.078 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.122 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.2 mp -84.76 -38.92 19.05 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.379 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -67.17 -47.75 70.03 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.127 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 81.3 p -84.42 -20.27 32.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.255 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -78.39 -48.78 7.16 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.245 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 57.3 -133.42 1.28 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.653 0.263 . . . . 0.0 111.501 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -81.25 84.11 6.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.916 0.388 . . . . 0.0 111.153 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 13.7 t -150.75 -161.61 1.37 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.651 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -59.71 -14.38 13.96 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 122.643 0.377 . . . . 0.0 111.795 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.03 -33.11 74.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.619 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -71.44 -28.69 64.14 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.996 0.427 . . . . 0.0 110.262 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.0 -21.21 31.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.781 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -66.97 -21.65 65.96 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.906 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . 0.422 ' HZ ' ' SG ' ' A' ' 20' ' ' CYS . 1.0 OUTLIER -67.2 -19.13 65.51 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.884 179.216 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 3.0 mt -86.21 -10.86 53.88 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.719 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.96 -21.86 36.98 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.98 0.419 . . . . 0.0 110.42 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 2.9 mt -87.5 -24.79 6.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.401 179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.23 120.37 79.19 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.371 179.215 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.39 130.51 24.01 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.449 2.099 . . . . 0.0 112.718 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -68.94 -19.59 64.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.241 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 9.5 m95 -69.57 -18.58 63.65 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.332 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.69 -32.19 16.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.849 0.357 . . . . 0.0 110.28 179.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -74.49 -34.53 63.1 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.621 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -75.91 -8.76 57.69 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.871 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -94.15 11.18 30.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.317 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.23 124.96 56.29 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.434 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -69.46 -32.46 19.76 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.59 2.193 . . . . 0.0 112.493 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.907 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.4 mtm . . . . . 0 N--CA 1.484 1.253 0 CA-C-O 120.696 0.284 . . . . 0.0 110.638 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -116.07 179.87 3.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.876 0.369 . . . . 0.0 111.06 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.07 20.28 9.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.181 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.67 -34.0 76.9 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.126 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 16.9 mt -73.97 -47.83 34.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.544 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.03 -40.91 91.0 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.762 178.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.89 -48.39 76.86 Favored 'General case' 0 CA--C 1.523 -0.079 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.706 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.74 -36.45 74.35 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.161 179.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.4 ' O ' HG22 ' A' ' 13' ' ' VAL . 41.3 t80 -69.27 -52.04 31.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.336 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.74 -38.28 81.31 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.478 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.06 -44.62 97.11 Favored 'General case' 0 C--N 1.334 -0.077 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.801 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.08 -44.23 96.45 Favored Glycine 0 C--N 1.335 0.515 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.185 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.4 HG22 ' O ' ' A' ' 9' ' ' PHE . 11.8 t -70.11 -35.21 62.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.909 0.385 . . . . 0.0 110.327 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.16 -42.85 96.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.77 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.8 m -66.7 -33.28 75.28 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.816 0.341 . . . . 0.0 110.711 179.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -75.13 -32.52 61.37 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.502 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -94.59 -1.28 53.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.649 0.261 . . . . 0.0 111.31 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.4 p -62.67 143.94 96.36 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.355 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.06 -8.07 18.99 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.543 2.162 . . . . 0.0 112.812 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.413 ' O ' ' HB ' ' A' ' 21' ' ' VAL . 0.1 OUTLIER -63.63 -47.37 81.62 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.957 179.65 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.413 ' HB ' ' O ' ' A' ' 20' ' ' CYS . 96.1 t 71.11 137.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 O-C-N 123.769 0.668 . . . . 0.0 110.945 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -105.17 128.77 25.98 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.553 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -65.04 -18.51 62.13 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.631 2.22 . . . . 0.0 112.469 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.1 mt -74.27 -12.51 60.57 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.248 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.451 ' HB ' ' HD3' ' A' ' 26' ' ' PRO . 55.1 t -75.71 -60.21 1.09 Allowed Pre-proline 0 CA--C 1.542 0.661 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.451 ' HD3' ' HB ' ' A' ' 25' ' ' VAL . 60.4 Cg_endo -73.31 -34.1 6.39 Favored 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 121.836 1.69 . . . . 0.0 113.511 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.2 m -71.03 -18.18 62.59 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.21 -21.09 66.3 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.762 0.315 . . . . 0.0 111.199 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 6.0 mt -82.12 -52.84 6.6 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.833 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -62.41 -28.69 69.97 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.475 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -60.73 -43.24 98.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.766 178.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.07 -22.16 59.63 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.997 -179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -86.59 -9.57 74.99 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.245 178.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -108.49 -46.61 0.97 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 121.407 -0.425 . . . . 0.0 112.11 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -117.62 124.67 49.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.806 0.336 . . . . 0.0 110.503 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -77.63 86.84 3.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.099 0.476 . . . . 0.0 110.956 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -138.01 171.95 23.11 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.896 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 14.4 mtt180 -96.61 124.86 49.19 Favored Pre-proline 0 C--N 1.324 -0.528 0 C-N-CA 121.162 -0.215 . . . . 0.0 110.834 -179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -55.81 -30.57 77.09 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.905 2.404 . . . . 0.0 112.782 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.6 mp -63.98 -39.21 93.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.0 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.91 -37.14 67.34 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.224 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -65.04 -43.84 91.01 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.085 178.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.55 -49.42 73.51 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.647 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.76 -45.0 78.19 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.024 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -65.5 -45.28 84.19 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.21 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -62.65 -42.38 99.57 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.157 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 28.4 mm -65.29 -43.05 95.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.566 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.55 -44.01 97.41 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.283 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.448 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -61.64 -44.5 97.86 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.064 178.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -68.91 -36.69 78.3 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.606 0.241 . . . . 0.0 110.625 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -62.94 -42.42 99.68 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.46 178.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.87 -43.94 97.82 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.595 0.236 . . . . 0.0 110.578 178.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 49' ' ' GLY . 93.8 t -63.88 -43.37 97.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.726 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -63.6 -36.25 83.2 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.234 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -76.52 -44.48 34.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.017 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.08 -30.87 71.93 Favored 'General case' 0 C--O 1.226 -0.153 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.976 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -89.34 -20.51 23.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.791 0.329 . . . . 0.0 110.484 178.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -72.2 -31.2 64.09 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 121.191 -0.528 . . . . 0.0 112.507 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.2 mp -62.59 -57.21 23.54 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 111.452 0.168 . . . . 0.0 111.452 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -73.97 -13.6 23.89 Favored 'Trans proline' 0 C--N 1.359 1.116 0 C-N-CA 122.019 1.813 . . . . 0.0 112.454 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -56.81 -31.5 64.76 Favored 'General case' 0 N--CA 1.464 0.24 0 O-C-N 123.14 0.275 . . . . 0.0 111.334 179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -64.35 -32.09 73.56 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.805 0.336 . . . . 0.0 110.867 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.82 -23.51 25.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.038 0.447 . . . . 0.0 110.148 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 14.7 mt -69.33 -17.96 63.76 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.963 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -59.87 -29.51 67.79 Favored Glycine 0 C--N 1.336 0.573 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.076 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.69 -29.5 61.28 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.908 178.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.3 mt -83.56 -21.39 32.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.904 0.383 . . . . 0.0 110.555 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.37 -19.25 65.86 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.446 179.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.87 -17.88 65.11 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.952 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -94.5 -110.14 0.12 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -162.19 148.65 13.38 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.683 0.278 . . . . 0.0 110.882 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.1 mmt-85 -124.24 53.32 1.43 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.939 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -75.88 -18.13 59.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.881 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -66.74 -26.94 67.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.003 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -76.94 -22.29 53.52 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.918 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.72 -32.39 72.15 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.038 0.447 . . . . 0.0 110.372 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.515 ' O ' HG22 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -73.19 -36.7 66.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.722 179.598 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.432 ' O ' HG21 ' A' ' 82' ' ' VAL . 20.8 t -58.3 -44.88 89.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.87 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.64 -39.76 97.01 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.923 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.525 ' O ' HG22 ' A' ' 84' ' ' VAL . . . -65.94 -38.63 94.37 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.079 -0.581 . . . . 0.0 111.924 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.515 HG22 ' O ' ' A' ' 77' ' ' ARG . 95.0 t -62.31 -42.86 97.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-O 120.777 0.322 . . . . 0.0 110.779 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.432 HG21 ' O ' ' A' ' 78' ' ' VAL . 47.0 t -62.74 -38.6 82.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.536 179.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 11.5 mt -64.57 -43.15 94.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.696 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.525 HG22 ' O ' ' A' ' 80' ' ' GLY . 42.9 t -66.41 -39.13 83.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.285 178.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.61 -43.1 99.49 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.657 178.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -67.03 -36.75 82.77 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.453 179.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -64.64 -39.97 97.16 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.712 178.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.9 mt -64.46 -36.76 85.22 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.728 0.299 . . . . 0.0 110.783 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -75.73 -31.5 59.63 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.474 179.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 2.8 tpt -69.14 -25.34 64.33 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.615 179.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.2 mt -69.06 -11.01 60.4 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.041 178.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.99 23.77 54.47 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.682 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.29 115.15 14.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.722 0.296 . . . . 0.0 110.761 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.01 138.47 87.5 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.589 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.4 164.5 33.95 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.494 2.129 . . . . 0.0 112.333 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -88.78 159.45 17.75 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.541 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 59.2 m95 62.63 34.43 14.98 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.35 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -143.86 47.11 0.8 Allowed Glycine 0 C--N 1.33 0.222 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.796 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.9 t -108.52 -37.13 3.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.91 0.386 . . . . 0.0 111.097 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.57 -24.16 24.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.858 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.96 133.91 38.07 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.098 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.07 -177.52 3.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.903 0.383 . . . . 0.0 110.8 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -100.1 77.08 1.96 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.171 0.51 . . . . 0.0 110.549 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -89.25 136.87 32.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.779 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 162.82 -165.4 36.33 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.875 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -115.96 -19.19 10.48 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.005 0.431 . . . . 0.0 110.841 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.401 ' C ' ' HD2' ' A' ' 110' ' ' PRO . 0.0 OUTLIER -90.79 13.7 15.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.592 -179.712 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.32 -33.69 67.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.021 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 30.8 mmt-85 -73.23 -52.94 5.07 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.034 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.401 ' HD2' ' C ' ' A' ' 107' ' ' THR . 35.6 Cg_exo -58.87 -29.06 89.1 Favored 'Trans proline' 0 C--N 1.362 1.277 0 C-N-CA 122.194 1.929 . . . . 0.0 112.604 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.74 -26.95 60.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.027 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -68.24 -32.95 76.95 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.777 -0.725 . . . . 0.0 111.487 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.69 -32.58 71.26 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.937 0.398 . . . . 0.0 110.585 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -71.36 -35.07 71.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.889 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.65 -33.55 72.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.577 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.25 -22.06 63.87 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.521 179.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -83.5 -34.36 19.91 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.527 178.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -69.28 -42.39 75.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.773 0.321 . . . . 0.0 111.222 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 6.1 p -65.91 -39.31 90.46 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.445 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.68 -21.92 63.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.865 0.364 . . . . 0.0 110.805 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -84.0 -36.34 23.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.798 179.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 53.2 mt -81.11 -39.37 25.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.36 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -81.56 -19.41 66.21 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.581 -0.819 . . . . 0.0 111.827 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 15.0 m95 63.41 -170.44 0.18 Allowed 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 123.027 0.531 . . . . 0.0 111.234 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.91 107.75 11.64 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.762 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -57.63 -23.15 55.67 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.041 2.494 . . . . 0.0 112.946 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 4.2 m -68.5 -20.21 64.57 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.027 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 6.4 mt -102.62 5.21 10.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.039 0.447 . . . . 0.0 110.079 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -57.15 -63.74 5.04 Favored Glycine 0 C--N 1.334 0.418 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.546 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -58.67 -37.13 95.74 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.426 2.084 . . . . 0.0 112.171 178.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 15.7 mt -64.71 -44.36 96.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.844 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.436 ' O ' HG21 ' A' ' 135' ' ' ILE . 3.2 tp -67.54 -42.53 82.54 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.285 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -61.56 -42.86 99.84 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.871 -0.68 . . . . 0.0 111.862 178.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -68.39 -34.3 75.8 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.764 0.316 . . . . 0.0 110.996 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.436 HG21 ' O ' ' A' ' 132' ' ' LEU . 0.0 OUTLIER -72.07 -26.21 24.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.099 179.875 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.2 -35.23 79.18 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.935 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.01 -22.43 66.93 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.811 178.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.2 tp -80.41 -42.83 22.04 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.222 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.445 ' HA ' ' O ' ' A' ' 142' ' ' GLY . 0.8 OUTLIER -69.59 -16.46 63.41 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.124 179.583 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.43 -26.44 61.84 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.737 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 2.0 t -98.26 -19.22 6.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.776 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' A' ' 139' ' ' THR . . . 153.47 -125.43 1.76 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.154 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 125.68 -152.23 17.91 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.264 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 173.58 169.25 35.71 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.138 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 3.6 m -75.18 -23.33 17.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.683 0.278 . . . . 0.0 111.378 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -62.38 -30.59 76.67 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.625 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.46 -49.36 71.74 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.678 0.275 . . . . 0.0 110.795 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.0 mp -63.52 -42.52 98.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.602 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.1 mt -62.08 -40.61 96.38 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.08 179.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.22 -44.04 97.47 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.852 0.358 . . . . 0.0 110.47 178.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 14.3 m-85 -65.11 -38.45 90.71 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.023 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 23.1 mm -62.59 -46.62 95.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.16 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.51 -38.23 90.28 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.61 0.243 . . . . 0.0 110.769 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -59.28 -39.28 94.44 Favored Glycine 0 C--N 1.335 0.503 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.423 179.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.497 ' O ' ' HD2' ' A' ' 158' ' ' PRO . 0.4 OUTLIER -84.24 -21.76 31.05 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.763 0.316 . . . . 0.0 110.787 178.978 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -62.1 -43.27 99.2 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.445 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.494 ' HB ' ' HD3' ' A' ' 158' ' ' PRO . 0.3 OUTLIER -54.78 -57.03 21.13 Favored Pre-proline 0 N--CA 1.472 0.647 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.497 ' HD2' ' O ' ' A' ' 155' ' ' LEU . 38.1 Cg_exo -62.33 -40.37 40.74 Favored 'Trans proline' 0 C--N 1.359 1.106 0 C-N-CA 122.256 1.97 . . . . 0.0 112.681 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.7 -44.22 93.76 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.402 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.69 -44.19 82.39 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.058 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.436 HG22 ' O ' ' A' ' 157' ' ' VAL . 95.2 t -61.26 -44.72 98.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.62 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.5 ' O ' ' HB2' ' A' ' 166' ' ' ALA . 55.4 t -66.36 -46.37 87.12 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.162 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.87 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -54.33 -38.18 65.7 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.737 0.303 . . . . 0.0 111.801 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.3 mt -75.31 -47.19 28.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.616 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -70.2 -25.7 63.54 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.449 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.573 ' O ' ' HB2' ' A' ' 170' ' ' LYS . . . -64.6 -25.85 68.15 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.129 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -77.58 -42.3 35.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.843 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.57 -46.11 89.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.11 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 3.7 pt -75.66 -20.55 15.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.676 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.573 ' HB2' ' O ' ' A' ' 166' ' ' ALA . 0.2 OUTLIER -62.01 -41.35 97.97 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.916 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -64.95 -38.81 95.94 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.01 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -75.62 -30.23 59.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.6 0.238 . . . . 0.0 111.113 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.46 -32.68 71.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.088 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.77 -17.47 38.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.921 0.391 . . . . 0.0 110.818 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 67.5 mtm-85 -91.23 -24.49 19.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.91 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -59.36 -48.96 79.64 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.208 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 133.04 -130.95 5.93 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.587 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -99.37 -3.23 34.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.846 0.355 . . . . 0.0 111.159 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 4.1 mt -69.51 -32.19 51.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.248 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -62.41 -26.87 68.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.295 179.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 15.0 t60 -71.31 -29.7 65.34 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.742 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.432 ' O ' ' HB2' ' A' ' 186' ' ' LEU . 0.9 OUTLIER -68.58 -32.7 72.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.812 -179.929 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 2.9 t -76.6 -22.43 15.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.565 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.69 -46.4 25.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.562 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.503 ' O ' HG22 ' A' ' 189' ' ' VAL . 16.9 m -75.05 -26.37 19.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.744 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.56 ' O ' HG22 ' A' ' 190' ' ' VAL . 2.2 tp -60.32 -47.3 86.63 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.073 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -63.81 -33.81 76.51 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.867 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.441 ' O ' HG21 ' A' ' 192' ' ' VAL . . . -67.94 -42.93 84.43 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.086 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.503 HG22 ' O ' ' A' ' 185' ' ' VAL . 87.0 t -60.91 -44.35 97.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-O 120.776 0.322 . . . . 0.0 110.767 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.56 HG22 ' O ' ' A' ' 186' ' ' LEU . 24.4 t -62.91 -42.22 95.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.903 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 1.1 mt -59.84 -42.72 94.22 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.732 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . 0.441 HG21 ' O ' ' A' ' 188' ' ' GLY . 65.4 t -67.59 -43.82 86.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.2 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.3 tp -58.44 -45.67 88.05 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.917 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 190' ' ' VAL . 70.4 t -62.61 -42.39 95.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.675 0.274 . . . . 0.0 110.546 179.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -62.18 -40.72 99.34 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.328 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 98.4 t -75.21 -41.13 44.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.543 0.211 . . . . 0.0 111.055 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.459 ' O ' ' HA3' ' A' ' 201' ' ' GLY . 1.8 mp -65.48 -23.62 66.95 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.155 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.54 -46.22 11.8 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.696 -0.229 . . . . 0.0 110.789 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -69.47 -49.38 55.37 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.932 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.69 -13.1 52.42 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.926 0.393 . . . . 0.0 111.108 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.459 ' HA3' ' O ' ' A' ' 197' ' ' LEU . . . -88.66 -63.27 1.35 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.466 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 50.87 48.55 22.75 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.986 0.422 . . . . 0.0 111.548 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -119.84 150.44 40.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.931 0.396 . . . . 0.0 111.552 -179.245 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -74.71 -36.17 62.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.369 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -59.8 -27.09 66.28 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.918 0.389 . . . . 0.0 111.426 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 19.5 mt -67.25 -38.52 85.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.234 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -74.75 -29.26 61.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.258 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.31 -41.29 81.07 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.552 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -70.12 -27.39 64.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.768 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -72.56 -24.11 61.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.678 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.0 mp -81.2 -22.44 38.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.568 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.42 -7.5 58.44 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.69 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 27.9 mm -82.09 -14.99 12.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.114 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 1.7 m -65.98 118.19 49.86 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.429 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -57.7 128.73 30.31 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.305 2.003 . . . . 0.0 111.956 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -63.86 -17.03 62.75 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.247 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 7.8 m0 -70.08 -21.7 63.12 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.893 179.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 1.1 mt -89.08 -31.41 18.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.333 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . 0.465 ' O ' HD22 ' A' ' 222' ' ' LEU . 45.6 mt-30 -79.53 -24.81 41.95 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.316 179.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 1.9 mtt-85 -79.04 -0.88 33.14 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.812 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -89.33 13.68 12.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.996 0.427 . . . . 0.0 110.918 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . 0.465 HD22 ' O ' ' A' ' 219' ' ' GLN . 0.5 OUTLIER -65.82 141.44 97.69 Favored Pre-proline 0 C--O 1.234 0.277 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.583 179.194 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -79.61 52.97 4.52 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.305 2.003 . . . . 0.0 112.6 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 5.5 m . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.247 -0.882 . . . . 0.0 111.538 -179.837 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.6 mmm . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 121.108 0.48 . . . . 0.0 110.536 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.1 m -80.97 60.02 4.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.519 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -130.9 19.62 5.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.961 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.08 -34.39 76.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.055 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.06 -43.93 77.48 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.868 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.38 -42.42 98.68 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.751 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.51 -45.57 92.38 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.018 178.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.33 -33.69 76.3 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.929 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.406 ' O ' HG22 ' A' ' 13' ' ' VAL . 0.3 OUTLIER -69.19 -49.03 60.31 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.742 179.928 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.9 mt -58.71 -42.03 87.72 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.528 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.28 -41.74 99.03 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.267 178.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.46 -43.98 97.4 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 121.206 -0.521 . . . . 0.0 112.261 179.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.406 HG22 ' O ' ' A' ' 9' ' ' PHE . 98.2 t -62.71 -42.67 97.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.794 0.331 . . . . 0.0 110.192 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 14.1 mt -63.93 -42.09 97.46 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.465 179.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.532 ' O ' HG21 ' A' ' 21' ' ' VAL . 16.5 m -65.95 -41.37 91.35 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.773 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -62.75 -39.35 93.85 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.984 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 87.2 mt -80.59 -13.48 59.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.038 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.437 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 4.1 p -83.79 137.54 41.0 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.592 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 18' ' ' SER . 23.2 Cg_exo -65.36 -8.56 19.2 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.64 2.226 . . . . 0.0 112.46 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 64.2 m -65.35 -24.43 67.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.174 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.532 HG21 ' O ' ' A' ' 15' ' ' SER . 2.1 t -111.2 18.2 7.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.393 0.616 . . . . 0.0 110.269 179.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.423 ' HB2' ' O ' ' A' ' 19' ' ' PRO . 0.5 OUTLIER -72.1 -48.23 10.65 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.406 179.051 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -59.37 -15.11 27.98 Favored 'Trans proline' 0 C--N 1.362 1.283 0 C-N-CA 122.337 2.024 . . . . 0.0 112.734 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.51 -12.81 60.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.316 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 92.7 t -77.41 -57.92 1.01 Allowed Pre-proline 0 CA--C 1.54 0.574 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.122 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -63.43 -30.37 72.22 Favored 'Trans proline' 0 C--N 1.361 1.215 0 C-N-CA 122.21 1.94 . . . . 0.0 112.747 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.2 p -66.42 -32.11 73.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.603 -0.272 . . . . 0.0 110.933 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -65.28 -39.72 92.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.323 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.4 mt -67.47 -37.03 82.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.244 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -67.79 -38.62 83.59 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.949 178.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.585 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 6.5 m-85 -69.26 -38.76 78.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.366 178.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.3 mt -66.46 -34.71 78.54 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.512 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.2 4.34 86.26 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.934 -0.65 . . . . 0.0 111.825 178.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -91.4 56.31 3.15 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 121.319 -0.467 . . . . 0.0 112.265 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . 62.99 -101.06 0.09 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.072 0.549 . . . . 0.0 111.654 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 6.2 mtt85 -90.75 60.57 4.52 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.193 0.52 . . . . 0.0 111.036 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.585 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -103.28 75.91 0.29 Allowed Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.249 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 10.8 mtt180 -83.98 137.09 40.67 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-O 120.504 0.193 . . . . 0.0 110.924 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -56.7 -47.03 25.57 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.956 2.438 . . . . 0.0 112.714 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.9 mp -62.24 -38.85 90.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.167 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -70.57 -39.06 74.11 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.393 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -64.89 -45.75 84.66 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.223 178.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.98 -35.95 81.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.836 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.5 tp -67.48 -48.1 68.12 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.714 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -66.73 -28.09 68.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.463 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.478 ' O ' ' HB2' ' A' ' 50' ' ' PHE . 0.2 OUTLIER -64.18 -50.71 67.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.558 178.815 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 38.2 mt -65.09 -39.08 84.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.865 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -68.81 -52.08 33.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.128 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.414 ' O ' HG22 ' A' ' 53' ' ' VAL . . . -58.85 -43.45 96.61 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.17 178.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.478 ' HB2' ' O ' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -68.9 -36.8 78.47 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.542 0.21 . . . . 0.0 110.64 179.473 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -61.36 -45.71 95.88 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.541 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.43 -44.4 95.83 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.881 0.372 . . . . 0.0 110.78 179.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.414 HG22 ' O ' ' A' ' 49' ' ' GLY . 95.9 t -65.91 -45.13 92.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.034 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -63.43 -30.26 71.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.271 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -78.4 -44.74 24.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.756 0.312 . . . . 0.0 110.682 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.33 -30.97 71.49 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.65 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.08 -18.48 27.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.866 0.365 . . . . 0.0 110.287 178.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.497 ' O ' ' HB2' ' A' ' 61' ' ' PHE . . . -75.03 -29.44 60.68 Favored Glycine 0 C--N 1.331 0.276 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.13 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.92 -55.61 43.0 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-O 119.872 -0.108 . . . . 0.0 111.166 178.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -69.83 -12.86 33.61 Favored 'Trans proline' 0 C--N 1.358 1.047 0 C-N-CA 122.186 1.924 . . . . 0.0 112.626 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.497 ' HB2' ' O ' ' A' ' 58' ' ' GLY . 0.1 OUTLIER -50.18 -34.26 21.97 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 179.926 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.22 -40.3 93.48 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.087 0.47 . . . . 0.0 110.871 179.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.61 -19.64 32.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.635 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.56 -18.37 62.25 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.91 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -64.05 -32.19 83.35 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 121.01 -0.614 . . . . 0.0 111.757 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -81.22 -22.9 59.92 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.794 179.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -82.5 -20.52 36.59 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.642 0.258 . . . . 0.0 110.921 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.3 tp -67.01 -22.54 65.9 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.898 179.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -70.4 -38.45 74.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.861 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -123.1 62.96 1.0 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.139 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -78.36 153.11 31.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.804 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.1 mtp180 -109.1 130.09 55.48 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.111 -179.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . 0.442 ' O ' ' HG3' ' A' ' 77' ' ' ARG . 67.8 mt-30 -73.69 -21.86 60.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.859 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.13 -25.87 68.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.294 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -80.55 -30.25 37.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.723 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.06 -21.9 49.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.911 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.442 ' HG3' ' O ' ' A' ' 73' ' ' GLN . 88.0 mtt-85 -69.58 -23.09 63.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.201 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.407 ' O ' HG22 ' A' ' 82' ' ' VAL . 21.8 t -63.47 -36.37 76.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.878 0.37 . . . . 0.0 110.405 179.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -65.53 -35.43 91.24 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.712 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.444 ' O ' HG21 ' A' ' 84' ' ' VAL . . . -66.36 -38.48 93.66 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.324 178.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 58.4 t -59.95 -43.71 92.92 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-O 120.907 0.384 . . . . 0.0 110.1 178.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 78' ' ' VAL . 33.0 t -61.98 -39.66 84.48 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.448 179.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.07 -43.72 97.77 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.519 179.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.444 HG21 ' O ' ' A' ' 80' ' ' GLY . 97.2 t -62.95 -43.28 98.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-O 121.003 0.43 . . . . 0.0 110.05 178.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.5 mp -62.88 -40.42 97.49 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.467 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -63.47 -41.74 98.6 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -59.57 -40.32 96.18 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.7 178.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 10.8 mt -65.61 -37.22 85.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.753 0.311 . . . . 0.0 110.7 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -72.01 -36.05 69.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.912 0.387 . . . . 0.0 110.644 179.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 46.6 mmm -70.27 -22.03 62.91 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.86 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 4.1 mt -70.52 -2.99 15.77 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.084 178.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.67 10.71 66.98 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.916 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 17.3 mt -78.16 122.22 25.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.938 0.369 . . . . 0.0 110.569 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 -117.43 135.47 23.22 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.785 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -69.92 104.64 1.38 Allowed 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 122.712 2.275 . . . . 0.0 112.587 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -80.02 -22.88 41.93 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.808 179.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 10.8 t-105 -131.03 121.83 25.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.725 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 179.3 -131.08 1.62 Allowed Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.891 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -96.96 93.01 3.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.961 0.41 . . . . 0.0 111.083 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.5 52.69 2.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.355 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.64 78.39 1.13 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.192 0.52 . . . . 0.0 110.527 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.58 173.33 11.84 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.618 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -92.21 -6.23 50.97 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.019 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 61.84 -157.59 0.33 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.297 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 91.44 -132.92 11.52 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.255 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -124.54 15.36 8.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.926 0.393 . . . . 0.0 110.838 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.18 2.37 52.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.097 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.6 -20.56 50.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.975 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.406 ' N ' ' HD2' ' A' ' 110' ' ' PRO . 0.9 OUTLIER -77.89 -56.42 1.09 Allowed Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.665 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.406 ' HD2' ' N ' ' A' ' 109' ' ' ARG . 28.6 Cg_endo -62.35 -35.26 74.06 Favored 'Trans proline' 0 C--N 1.362 1.248 0 C-N-CA 122.012 1.808 . . . . 0.0 112.198 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -81.46 -21.85 38.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.085 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -68.4 -41.2 85.98 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.772 -0.728 . . . . 0.0 111.369 178.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -72.3 -33.9 67.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.741 0.305 . . . . 0.0 110.521 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.76 -36.17 72.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.076 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.1 tp -67.29 -48.46 67.57 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.711 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 12.0 mt -67.41 -29.54 69.06 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.448 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -72.68 -48.69 21.37 Favored Glycine 0 N--CA 1.451 -0.361 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 178.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.73 -36.33 80.67 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.75 0.31 . . . . 0.0 110.738 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 90.7 m -64.73 -43.24 94.03 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.884 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.76 -29.65 68.09 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.806 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -77.5 -31.66 53.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.004 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -79.16 -24.83 43.0 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.04 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -86.88 160.39 32.38 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.75 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -96.8 120.93 38.04 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 122.429 -0.454 . . . . 0.0 111.0 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.485 ' O ' HG21 ' A' ' 128' ' ' ILE . 0.2 OUTLIER -80.93 114.06 45.49 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.849 179.71 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -59.87 -16.94 41.02 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.763 2.308 . . . . 0.0 112.985 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 11.1 t -77.04 -26.55 53.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.753 0.311 . . . . 0.0 110.903 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.485 HG21 ' O ' ' A' ' 125' ' ' THR . 1.4 tp -99.98 -4.72 9.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.124 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -56.57 -64.38 4.45 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 115.942 -0.572 . . . . 0.0 113.159 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -58.13 -37.95 93.47 Favored 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 122.459 2.106 . . . . 0.0 112.413 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.494 ' O ' HG13 ' A' ' 135' ' ' ILE . 69.2 mt -61.94 -46.07 97.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.865 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.78 -39.97 95.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.001 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -62.94 -36.6 93.65 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.78 178.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -68.32 -39.9 81.83 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.576 0.227 . . . . 0.0 111.061 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.494 HG13 ' O ' ' A' ' 131' ' ' ILE . 70.4 mt -63.06 -32.97 58.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.075 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.37 -34.8 79.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.111 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -84.88 -22.07 29.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.904 178.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.9 -29.67 58.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.986 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -81.62 -16.22 52.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.04 0.448 . . . . 0.0 110.712 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -77.93 -28.6 49.7 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.666 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 7.3 m -102.6 4.87 10.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.986 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -169.68 97.73 0.13 Allowed Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.182 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -85.42 81.25 1.75 Allowed Glycine 0 CA--C 1.517 0.187 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.685 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -124.57 106.6 0.94 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.509 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -69.2 -23.77 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 121.011 0.434 . . . . 0.0 111.06 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -65.77 -30.36 77.07 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.139 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.26 -43.36 86.68 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.788 0.328 . . . . 0.0 110.62 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.57 -40.24 92.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.9 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.69 -42.04 87.09 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.335 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.82 -32.75 74.36 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.447 179.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -63.32 -49.88 72.22 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.741 179.034 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 10.2 mt -61.02 -44.35 98.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.989 0.423 . . . . 0.0 110.535 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.3 -34.04 74.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.409 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -59.92 -36.93 91.74 Favored Glycine 0 C--N 1.334 0.471 0 C-N-CA 121.267 -0.492 . . . . 0.0 112.105 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.53 ' C ' ' HD2' ' A' ' 158' ' ' PRO . 5.5 mt -86.36 -22.6 26.57 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 120.842 0.354 . . . . 0.0 110.97 178.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -61.21 -49.55 76.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.052 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.448 ' O ' HG21 ' A' ' 161' ' ' VAL . 0.3 OUTLIER -54.6 -51.59 77.24 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.331 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.53 ' HD2' ' C ' ' A' ' 155' ' ' LEU . 43.4 Cg_exo -58.96 -40.78 68.2 Favored 'Trans proline' 0 C--N 1.36 1.147 0 C-N-CA 122.138 1.892 . . . . 0.0 112.346 178.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.425 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 2.6 m-85 -60.6 -40.38 91.59 Favored 'General case' 0 CA--C 1.522 -0.1 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.336 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -65.65 -43.38 89.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.794 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.448 HG21 ' O ' ' A' ' 157' ' ' VAL . 40.1 t -63.37 -44.04 98.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.809 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 84.9 t -67.73 -49.11 72.82 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.906 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.425 ' HB2' ' O ' ' A' ' 159' ' ' PHE . . . -57.98 -32.26 67.71 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.644 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.4 -48.79 54.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.301 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -71.27 -33.65 69.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.702 0.287 . . . . 0.0 110.82 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.414 ' O ' ' HB2' ' A' ' 170' ' ' LYS . . . -68.97 -21.03 64.2 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.019 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -72.31 -35.63 68.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.169 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 13.4 mmm180 -84.82 -42.71 14.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.23 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 3.3 tt -68.41 -19.99 24.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.277 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.425 ' O ' ' HB2' ' A' ' 174' ' ' ARG . 0.8 OUTLIER -57.46 -36.4 71.38 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.313 179.59 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -70.0 -30.28 70.13 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.579 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 1.4 m95 -86.82 -47.41 9.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.76 0.314 . . . . 0.0 111.469 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 4.7 mt -66.89 -16.49 64.35 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.701 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.425 ' HB2' ' O ' ' A' ' 170' ' ' LYS . 9.9 ttt-85 -56.79 -53.25 60.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.998 0.428 . . . . 0.0 110.984 178.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 8.1 mtm180 -93.77 -16.39 24.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.348 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -94.19 4.7 53.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.71 0.29 . . . . 0.0 111.554 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -83.13 9.5 60.58 Favored Glycine 0 CA--C 1.517 0.183 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.681 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 22.2 mtt180 -67.79 -38.65 83.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.943 0.401 . . . . 0.0 110.611 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -81.39 -29.5 10.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.467 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.95 -16.74 64.2 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.108 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . 0.409 ' O ' HG22 ' A' ' 185' ' ' VAL . 0.3 OUTLIER -57.27 -31.99 66.16 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.225 179.701 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.32 -44.2 88.61 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.045 0.45 . . . . 0.0 110.412 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 2.2 t -72.17 -19.67 19.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.781 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.79 -44.82 31.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.133 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.409 HG22 ' O ' ' A' ' 181' ' ' HIS . 46.7 t -67.64 -41.24 85.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.549 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.504 ' O ' HG23 ' A' ' 190' ' ' VAL . 0.3 OUTLIER -60.9 -47.9 84.26 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.739 179.504 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -62.35 -36.45 82.26 Favored 'General case' 0 N--CA 1.457 -0.092 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.384 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -64.0 -46.5 91.2 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.98 -0.629 . . . . 0.0 111.951 178.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 86.8 t -62.18 -48.95 86.06 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 CA-C-O 120.555 0.217 . . . . 0.0 110.616 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 186' ' ' LEU . 76.6 t -59.3 -38.33 74.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.898 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 2.7 tp -62.22 -46.07 90.49 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.778 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 61.7 t -66.19 -38.38 81.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.256 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 9.0 mt -59.05 -54.24 49.35 Favored 'General case' 0 C--N 1.334 -0.094 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.308 179.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 32.6 m -68.56 -29.74 44.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.861 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -66.65 -47.08 70.66 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.449 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.463 HG11 ' N ' ' A' ' 197' ' ' LEU . 6.1 p -72.17 -31.33 39.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-O 120.722 0.296 . . . . 0.0 110.79 179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.463 ' N ' HG11 ' A' ' 196' ' ' VAL . 11.9 mt -67.52 -38.09 83.75 Favored 'General case' 0 N--CA 1.458 -0.069 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.238 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.77 -33.36 60.19 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 121.024 -0.27 . . . . 0.0 110.747 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -66.5 -47.16 73.89 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.792 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 10.1 t -81.76 -11.11 59.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.212 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -87.79 -51.77 3.15 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.557 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 53.87 37.83 27.38 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.037 0.446 . . . . 0.0 111.229 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -139.72 -167.58 2.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.692 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.48 56.21 1.37 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.686 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -82.37 -19.5 39.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.009 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 8.8 tp -70.65 -32.92 70.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.807 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -70.22 -40.79 74.31 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.017 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.8 -32.07 71.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.97 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . 0.449 ' O ' HG13 ' A' ' 213' ' ' ILE . 5.9 m-85 -80.84 -43.91 19.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.025 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -61.9 -32.7 73.11 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.458 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.77 -18.08 65.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.752 0.31 . . . . 0.0 111.188 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.48 -24.39 18.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.844 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . 0.449 HG13 ' O ' ' A' ' 209' ' ' PHE . 1.9 mt -92.4 -19.05 7.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.276 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 88.3 m -70.48 120.01 76.02 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.716 179.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -72.17 151.26 54.87 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.4 2.066 . . . . 0.0 112.076 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.06 -16.27 63.65 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.35 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 15.0 m95 -70.13 -25.46 63.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.16 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 1.3 mp -82.68 -23.47 34.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.961 0.41 . . . . 0.0 110.311 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 59.6 mt-30 -78.17 -21.98 49.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.393 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 36.5 mmt-85 -81.4 -2.88 51.07 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.954 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -94.36 -9.07 36.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.995 0.426 . . . . 0.0 110.762 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 1.3 mt -95.09 135.66 23.31 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.689 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -70.07 77.29 1.19 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.68 2.253 . . . . 0.0 112.745 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 2.5 m . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.277 -0.868 . . . . 0.0 111.061 -179.966 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.485 1.298 0 CA-C-O 120.852 0.358 . . . . 0.0 110.738 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -114.61 23.93 12.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.994 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.7 mt -73.66 -21.95 60.12 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.499 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.88 -30.47 69.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.648 179.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -74.39 -44.1 53.56 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.666 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -58.32 -46.52 86.0 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.726 179.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.85 -47.94 78.72 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.932 179.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.58 -40.61 83.65 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.295 179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.84 -49.78 64.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.498 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 14.2 tp -57.5 -43.91 84.57 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.609 178.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.76 -45.88 91.98 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.062 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.8 -45.0 96.51 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.244 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 67.9 t -68.09 -39.42 81.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.521 0.2 . . . . 0.0 110.606 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.488 ' O ' ' HB2' ' A' ' 18' ' ' SER . 0.2 OUTLIER -61.16 -46.57 89.96 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.871 179.516 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 43.2 m -64.35 -36.12 83.09 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.728 0.299 . . . . 0.0 111.167 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -72.18 -38.39 69.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.746 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.48 -11.66 59.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.847 0.356 . . . . 0.0 111.115 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.488 ' HB2' ' O ' ' A' ' 14' ' ' LEU . 0.2 OUTLIER -87.05 134.08 37.62 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.387 179.239 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.94 -7.96 22.05 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.653 2.236 . . . . 0.0 112.537 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -106.28 147.27 29.35 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.481 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 6.5 t 60.65 65.69 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-O 121.384 0.612 . . . . 0.0 110.874 -179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 30.5 mt -109.07 116.68 55.06 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.285 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.11 -24.31 44.89 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.767 2.311 . . . . 0.0 112.688 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.81 -19.27 65.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.471 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 54.1 t -64.99 -60.15 8.65 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.291 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.92 -24.91 77.92 Favored 'Trans proline' 0 C--N 1.361 1.196 0 C-N-CA 121.985 1.79 . . . . 0.0 112.547 178.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.7 m -65.2 -39.83 93.35 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.844 0.354 . . . . 0.0 110.815 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -69.02 -31.24 69.91 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.739 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.83 -41.48 44.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.369 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -59.48 -41.95 90.97 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.041 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -73.99 -28.7 61.59 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.806 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.68 -28.9 64.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.267 179.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.461 ' O ' ' HD3' ' A' ' 110' ' ' PRO . . . -74.1 -32.18 58.79 Favored Glycine 0 N--CA 1.448 -0.567 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.066 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.69 83.86 1.52 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.328 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -124.5 -68.34 0.86 Allowed 'General case' 0 C--N 1.328 -0.341 0 O-C-N 122.923 -0.163 . . . . 0.0 111.246 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 18.8 mtt180 57.93 38.68 27.0 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.271 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -104.15 61.55 0.42 Allowed Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.359 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 58.38 82.82 0.23 Allowed Pre-proline 0 N--CA 1.468 0.451 0 C-N-CA 122.894 0.478 . . . . 0.0 111.522 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -57.36 -30.11 86.66 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.861 2.374 . . . . 0.0 112.586 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.9 -38.32 90.45 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.34 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -77.13 -37.12 54.72 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.499 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 19.9 t30 -65.59 -36.06 82.66 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.222 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.55 ' O ' HG12 ' A' ' 47' ' ' ILE . . . -61.61 -54.83 37.68 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.615 178.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 74.2 mt -56.23 -39.75 73.02 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.2 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -63.95 -45.89 87.16 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.826 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -63.91 -42.73 97.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.948 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.55 HG12 ' O ' ' A' ' 43' ' ' ALA . 48.8 mm -64.89 -41.08 91.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.656 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.3 tp -65.28 -45.98 82.29 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 179.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.565 ' O ' HG21 ' A' ' 53' ' ' VAL . . . -60.74 -42.94 99.62 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.755 179.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.18 -40.83 86.62 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.619 0.247 . . . . 0.0 110.959 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -62.06 -39.38 97.53 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.86 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.9 -47.92 73.2 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.459 0.171 . . . . 0.0 110.88 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.565 HG21 ' O ' ' A' ' 49' ' ' GLY . 57.8 t -61.87 -40.23 86.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.033 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.33 -45.86 78.85 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.323 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -68.18 -38.54 82.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.4 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.54 -32.95 74.62 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.12 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.29 -18.75 26.35 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.977 0.418 . . . . 0.0 110.802 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -79.24 -25.3 59.63 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 121.127 -0.558 . . . . 0.0 112.299 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.88 -56.41 29.11 Favored Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 111.464 0.172 . . . . 0.0 111.464 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -70.13 -14.03 34.44 Favored 'Trans proline' 0 C--N 1.362 1.253 0 C-N-CA 122.023 1.815 . . . . 0.0 112.646 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -63.76 -19.74 65.21 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.318 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.0 m -63.53 -45.14 91.95 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.012 0.434 . . . . 0.0 110.651 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.72 -21.18 24.0 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.102 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.93 -18.05 58.53 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.785 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -63.25 -26.31 69.23 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.067 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -78.75 -24.53 62.18 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.89 -0.672 . . . . 0.0 111.769 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 54.9 mt -87.35 -20.73 26.33 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.69 0.281 . . . . 0.0 110.652 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.5 -19.32 64.66 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.647 179.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -65.3 -17.45 64.52 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.837 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -84.33 179.07 7.53 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.268 0.556 . . . . 0.0 110.353 178.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -80.23 72.36 7.05 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.299 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 72' ' ' ARG . 8.0 mtt180 -114.26 25.3 11.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.386 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -78.38 -18.19 55.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.985 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.35 -20.21 65.96 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.469 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.4 -28.32 67.83 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.662 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.1 -23.53 28.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.428 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -64.66 -29.21 70.21 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.157 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.1 t -63.73 -21.41 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.625 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -66.58 -29.61 75.05 Favored Glycine 0 C--N 1.336 0.546 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.715 179.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.497 ' O ' HG21 ' A' ' 84' ' ' VAL . . . -74.23 -38.69 45.94 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.51 -0.852 . . . . 0.0 111.169 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.9 t -59.13 -48.87 85.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-O 120.825 0.345 . . . . 0.0 111.05 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.2 m -69.07 -31.35 49.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.107 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.72 -43.13 94.4 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.673 179.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.497 HG21 ' O ' ' A' ' 80' ' ' GLY . 74.1 t -65.54 -40.09 87.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.21 179.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.89 -41.02 95.21 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.636 179.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -66.25 -37.7 86.12 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.4 179.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -65.25 -39.65 96.16 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.713 178.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.53 -39.92 95.67 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.738 0.304 . . . . 0.0 110.654 179.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -71.62 -32.03 67.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.554 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.87 -19.81 61.23 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.903 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.48 -3.5 8.71 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.375 178.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 108.49 6.43 31.14 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.681 -0.771 . . . . 0.0 113.147 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.96 121.06 12.04 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 117.083 0.441 . . . . 0.0 110.499 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 6.9 mtt180 -125.69 143.09 43.94 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.663 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -77.05 -178.33 4.5 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.353 2.036 . . . . 0.0 112.047 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 77.5 mtt-85 -85.79 -46.3 10.79 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.98 0.419 . . . . 0.0 111.376 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -122.97 164.74 17.94 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.61 -179.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -173.1 -106.73 0.2 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.374 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.4 p -121.78 -44.32 2.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.899 0.38 . . . . 0.0 110.813 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.92 84.26 4.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.313 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.38 68.66 8.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.865 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 17.7 mtt180 70.71 -72.15 0.12 Allowed 'General case' 0 N--CA 1.471 0.624 0 O-C-N 123.819 0.699 . . . . 0.0 111.205 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -102.98 166.22 10.57 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.22 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 62.15 54.64 2.63 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 123.562 0.539 . . . . 0.0 110.896 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -85.62 124.4 6.8 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.855 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -109.34 161.37 15.34 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.909 0.385 . . . . 0.0 111.121 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.01 90.1 5.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.452 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.74 -2.48 58.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.062 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.462 ' N ' ' HD2' ' A' ' 110' ' ' PRO . 0.9 OUTLIER -64.39 -53.19 48.02 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.351 -179.745 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 109' ' ' ARG . 15.8 Cg_endo -57.88 -36.27 98.3 Favored 'Trans proline' 0 C--N 1.362 1.242 0 C-N-CA 122.171 1.914 . . . . 0.0 112.617 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -75.07 -31.11 61.16 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.34 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -74.48 -25.8 69.41 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 178.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -64.31 -36.77 85.19 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.802 0.334 . . . . 0.0 110.887 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.17 -40.71 71.1 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.652 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.9 tp -68.79 -36.08 77.82 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.349 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.14 -22.13 61.36 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.201 0.525 . . . . 0.0 110.22 178.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -80.27 -44.31 8.91 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.79 -40.07 96.2 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.522 0.201 . . . . 0.0 111.17 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.4 p -65.31 -38.94 91.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.967 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.69 -24.79 61.88 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.654 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -80.21 -35.02 36.87 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.952 0.406 . . . . 0.0 110.371 179.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 72.5 mt -78.46 -26.14 46.05 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.314 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -76.71 160.35 50.45 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.768 178.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 14.9 p90 -112.62 154.38 26.13 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.978 0.418 . . . . 0.0 110.86 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.564 ' HB ' ' SG ' ' A' ' 127' ' ' CYS . 0.8 OUTLIER -109.32 104.39 55.04 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.519 179.424 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.97 -18.26 56.44 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.115 2.543 . . . . 0.0 113.203 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . 0.564 ' SG ' ' HB ' ' A' ' 125' ' ' THR . 0.8 OUTLIER -64.88 -37.45 87.68 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.14 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 pt -103.45 4.79 10.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.24 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -58.89 -68.59 1.61 Allowed Glycine 0 C--N 1.334 0.472 0 CA-C-N 116.046 -0.525 . . . . 0.0 112.756 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.51 -31.61 92.63 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.348 2.032 . . . . 0.0 111.878 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 60.6 mt -63.69 -55.83 20.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.888 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.43 -34.7 77.76 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.708 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -61.88 -36.2 92.45 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.226 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -75.61 -36.7 60.19 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.833 0.349 . . . . 0.0 111.086 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 46.7 mm -70.48 -35.33 61.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.971 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.97 -30.17 70.74 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.118 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.88 -26.97 64.44 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.941 0.4 . . . . 0.0 110.75 178.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 8.7 mt -84.52 -38.75 19.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.893 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 16.0 p -70.11 -16.3 63.09 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.473 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -75.86 -29.48 58.57 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.791 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 2.1 t -96.81 -32.77 4.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.592 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -150.15 90.76 0.14 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.318 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -162.92 -97.59 0.12 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.601 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 111.56 -179.77 19.84 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.49 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 6.2 t -75.0 -31.11 24.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 120.67 0.271 . . . . 0.0 111.0 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -60.44 -32.67 78.35 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.669 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.87 -40.87 83.55 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.853 0.358 . . . . 0.0 110.426 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.42 ' O ' HG13 ' A' ' 152' ' ' ILE . 17.0 mt -62.35 -42.52 99.46 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.486 179.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 30.7 mt -65.77 -39.82 91.41 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.508 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.18 -40.11 96.58 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.385 178.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -61.49 -44.8 96.43 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.026 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.42 HG13 ' O ' ' A' ' 148' ' ' LEU . 53.9 mt -64.39 -49.0 82.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.633 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.55 -34.57 78.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.928 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . 0.406 ' O ' ' HD2' ' A' ' 158' ' ' PRO . . . -60.55 -44.82 97.34 Favored Glycine 0 C--O 1.223 -0.546 0 C-N-CA 121.176 -0.535 . . . . 0.0 112.189 179.088 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.45 -28.17 61.81 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.166 0.508 . . . . 0.0 110.561 178.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -64.4 -35.34 80.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.438 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.49 ' O ' HG21 ' A' ' 161' ' ' VAL . 96.7 t -55.38 -62.79 3.83 Favored Pre-proline 0 CA--C 1.542 0.643 0 O-C-N 123.272 0.358 . . . . 0.0 111.595 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.495 ' O ' HG23 ' A' ' 162' ' ' VAL . 18.0 Cg_endo -60.15 -36.09 89.96 Favored 'Trans proline' 0 C--N 1.359 1.127 0 C-N-CA 122.04 1.827 . . . . 0.0 112.225 179.11 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -59.66 -46.44 89.02 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-O 120.739 0.304 . . . . 0.0 110.944 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -63.57 -39.41 94.32 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.942 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.49 HG21 ' O ' ' A' ' 157' ' ' VAL . 52.8 t -61.27 -43.59 96.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-O 120.927 0.394 . . . . 0.0 110.321 179.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 158' ' ' PRO . 61.0 t -68.36 -38.58 79.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.647 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -58.56 -35.6 72.62 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.779 0.323 . . . . 0.0 111.313 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 17.1 mt -78.96 -42.63 26.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.194 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.78 -19.24 62.04 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.224 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.418 ' HB2' ' O ' ' A' ' 162' ' ' VAL . . . -66.01 -19.85 65.99 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.158 179.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -64.29 -39.76 94.58 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.782 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 16.5 mtt180 -69.16 -24.17 64.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.649 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 26.4 mt -83.38 -22.42 8.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.427 179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -62.76 -38.17 89.49 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.749 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -75.85 -36.23 42.7 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.664 -0.779 . . . . 0.0 111.882 179.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 1.8 m95 -73.92 -26.95 60.79 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.525 0.194 . . . . 0.0 111.525 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 2.3 tp -57.49 -36.53 71.62 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.709 0.29 . . . . 0.0 111.367 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 1.1 mtp-105 -87.07 -20.45 27.11 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.136 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -83.78 -34.13 24.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.921 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -62.55 -65.19 0.72 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.793 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 79.78 -64.85 3.81 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.969 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 9.4 mtm180 -81.18 -40.14 24.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.722 0.296 . . . . 0.0 111.285 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 14.3 mm -69.04 -31.4 50.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.051 -179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -63.33 -26.64 68.86 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.048 0.452 . . . . 0.0 111.092 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -84.8 -22.01 29.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.128 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -75.63 -28.79 58.96 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.825 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 17.4 t -65.54 -25.37 36.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.703 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -82.41 -37.98 24.72 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.768 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.8 t -70.99 -46.3 68.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.891 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.476 ' O ' HG23 ' A' ' 190' ' ' VAL . 5.2 tp -62.32 -52.67 62.72 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.282 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -64.42 -35.09 79.79 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.02 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -62.41 -49.96 69.17 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.21 179.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 96.4 t -62.0 -46.99 95.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 120.479 0.181 . . . . 0.0 110.783 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 186' ' ' LEU . 85.9 t -59.33 -43.15 89.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.878 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 5.4 tp -58.43 -48.85 79.34 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.756 0.312 . . . . 0.0 111.228 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . 0.515 ' O ' HG23 ' A' ' 196' ' ' VAL . 41.4 t -66.06 -40.85 88.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.465 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . 0.441 ' O ' ' HB2' ' A' ' 197' ' ' LEU . 2.2 tp -58.77 -50.08 75.28 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.681 179.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 87.7 t -61.1 -39.75 83.41 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.434 179.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -57.86 -48.03 84.87 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.611 179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 192' ' ' VAL . 4.2 t -73.87 -34.89 41.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.726 0.298 . . . . 0.0 110.517 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . 0.54 ' O ' ' HA3' ' A' ' 201' ' ' GLY . 0.5 OUTLIER -63.1 -28.31 69.99 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.714 179.236 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 65.0 mt -80.38 -42.54 22.65 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.818 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -70.79 -57.6 4.48 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 68.2 p -81.46 -9.26 59.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.803 0.335 . . . . 0.0 111.727 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . 0.54 ' HA3' ' O ' ' A' ' 197' ' ' LEU . . . -84.67 -54.21 3.0 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.436 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 28.5 m 67.23 -72.2 0.09 Allowed 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 122.845 0.458 . . . . 0.0 111.521 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -163.84 -50.19 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.523 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.91 -46.2 90.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.35 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -84.8 -19.52 32.41 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.738 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.1 mt -77.27 -36.86 54.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.889 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.98 -39.59 95.16 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.625 -0.261 . . . . 0.0 110.949 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.52 -37.82 73.67 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.342 178.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -87.04 -24.52 24.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.167 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -67.65 -17.19 64.51 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.978 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.0 mt -61.35 -30.84 70.77 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 121.019 0.437 . . . . 0.0 110.722 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 3.2 mtt180 -92.91 -3.61 54.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.711 179.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . 0.45 HG23 HD13 ' A' ' 213' ' ' ILE . 37.0 mm -103.21 -20.16 5.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.941 -179.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.56 119.7 45.9 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.047 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.46 151.63 65.17 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.304 2.003 . . . . 0.0 112.254 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -64.61 -22.42 66.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.191 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 8.0 m-90 -63.55 -24.8 67.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.303 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 16.0 mt -89.53 -27.22 20.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.94 0.4 . . . . 0.0 110.399 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.04 -35.43 31.84 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.363 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 1.4 mtp180 -74.66 -7.26 52.68 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.03 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -87.92 -9.56 53.28 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.991 0.424 . . . . 0.0 110.301 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 23.7 mt -89.51 129.19 48.06 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.29 179.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.63 -38.57 93.02 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.836 2.358 . . . . 0.0 112.626 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.024 -0.989 . . . . 0.0 110.599 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 121.099 0.476 . . . . 0.0 110.84 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.97 155.72 18.51 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.943 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 8.2 mt -76.17 -20.94 57.08 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.505 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.75 -26.21 64.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.687 179.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.8 mt -77.4 -46.1 23.78 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.562 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -60.51 -39.81 89.13 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.796 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.76 -46.02 89.97 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.737 178.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.97 -35.12 79.11 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.769 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.444 ' O ' HG21 ' A' ' 13' ' ' VAL . 1.2 m-85 -65.56 -51.74 57.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.18 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.43 -39.02 82.18 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.29 178.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.23 -44.17 97.7 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.425 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.81 -42.9 99.8 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 120.888 -0.672 . . . . 0.0 111.835 178.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.444 HG21 ' O ' ' A' ' 9' ' ' PHE . 49.1 t -65.61 -41.31 90.38 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-O 120.719 0.295 . . . . 0.0 110.307 179.202 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.4 tp -63.99 -41.72 97.41 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.456 179.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 18.9 m -64.34 -35.78 81.98 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.726 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -72.04 -36.08 69.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.988 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.8 -4.86 59.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.811 0.339 . . . . 0.0 111.077 179.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.0 t -68.89 119.87 72.37 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.805 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -67.3 -8.07 20.89 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.84 2.36 . . . . 0.0 112.697 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 2.2 t -73.38 -25.31 60.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.841 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.4 m -130.82 5.78 2.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.666 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -70.77 -53.72 8.82 Favored Pre-proline 0 CA--C 1.538 0.504 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -68.97 -14.71 39.1 Favored 'Trans proline' 0 C--N 1.361 1.201 0 C-N-CA 121.888 1.725 . . . . 0.0 112.432 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.1 mp -81.28 -16.13 53.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.459 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.462 ' N ' ' HD2' ' A' ' 26' ' ' PRO . 95.0 t -62.86 -55.2 40.31 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-O 119.725 -0.179 . . . . 0.0 111.289 178.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 25' ' ' VAL . 14.4 Cg_endo -58.05 -33.06 96.87 Favored 'Trans proline' 0 C--N 1.362 1.246 0 C-N-CA 122.275 1.984 . . . . 0.0 112.505 178.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.54 -36.64 65.69 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.791 0.329 . . . . 0.0 110.943 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.0 -28.5 68.3 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.021 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 8.3 mt -63.06 -37.52 87.51 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.718 179.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.58 -35.52 67.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.065 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -66.75 -37.14 84.05 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.336 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.63 -15.18 60.83 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.23 178.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -67.65 -24.96 74.08 Favored Glycine 0 C--N 1.332 0.346 0 N-CA-C 111.77 -0.532 . . . . 0.0 111.77 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.53 -16.35 80.1 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.985 -0.626 . . . . 0.0 111.54 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -126.9 51.39 1.87 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.975 0.417 . . . . 0.0 109.988 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.7 70.79 1.4 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.39 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -146.48 84.95 0.18 Allowed Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.548 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.2 mtp180 66.4 91.25 0.08 OUTLIER Pre-proline 0 N--CA 1.467 0.416 0 C-N-CA 122.922 0.489 . . . . 0.0 111.16 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -64.09 -30.24 65.67 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.434 2.089 . . . . 0.0 112.466 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.4 mp -62.55 -40.83 98.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.279 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -72.47 -37.35 68.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.615 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -67.57 -43.8 79.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.393 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.05 -50.68 67.44 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.769 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.74 -42.68 75.75 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.219 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -63.85 -41.31 97.84 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.876 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.28 -41.47 94.15 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.37 179.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 54.6 mt -62.96 -42.43 96.6 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.943 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.31 -44.07 92.74 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.468 179.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.511 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -59.27 -43.71 97.04 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.862 -0.685 . . . . 0.0 111.693 178.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.02 -37.24 81.16 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.76 0.314 . . . . 0.0 110.242 179.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -63.17 -41.93 99.55 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 178.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.42 -45.99 87.38 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 120.509 0.195 . . . . 0.0 110.635 178.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 49' ' ' GLY . 24.7 t -63.41 -43.02 98.29 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.837 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -66.04 -28.2 68.67 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.426 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -82.82 -47.39 11.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.561 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.59 -35.71 80.4 Favored 'General case' 0 C--O 1.227 -0.109 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.85 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.402 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 0.9 OUTLIER -89.52 -18.35 26.82 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.792 0.33 . . . . 0.0 110.497 178.488 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.28 -35.68 83.12 Favored Glycine 0 C--N 1.33 0.204 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.41 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.404 ' CB ' ' HD3' ' A' ' 60' ' ' PRO . 0.5 OUTLIER -63.23 -55.63 34.65 Favored Pre-proline 0 CA--C 1.543 0.687 0 N-CA-C 111.49 0.182 . . . . 0.0 111.49 179.197 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.404 ' HD3' ' CB ' ' A' ' 59' ' ' LEU . 13.6 Cg_exo -70.47 -13.96 33.4 Favored 'Trans proline' 0 C--N 1.361 1.185 0 C-N-CA 122.517 2.144 . . . . 0.0 112.629 179.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.63 -25.74 64.92 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.119 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.5 -34.72 76.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.032 0.444 . . . . 0.0 110.403 178.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.57 -19.81 25.84 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.618 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -67.25 -17.78 64.94 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.863 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.32 -27.5 65.57 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.947 -0.644 . . . . 0.0 111.901 179.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -78.38 -22.06 68.46 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.582 179.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.9 mt -87.12 -20.56 26.89 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.646 0.26 . . . . 0.0 110.415 179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.86 -19.42 62.6 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.916 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -60.45 -26.0 66.42 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.758 178.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -97.59 125.18 42.17 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -74.59 98.74 3.45 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.026 0.441 . . . . 0.0 111.419 -179.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -87.1 64.79 8.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.984 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -67.45 -19.79 65.41 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.135 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.0 t -69.99 -17.76 63.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.3 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.53 -22.51 30.13 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.883 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.44 -22.4 38.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.862 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.61 -27.14 66.65 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.92 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.3 t -63.0 -32.47 56.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.798 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -64.31 -34.98 91.37 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.033 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.464 ' O ' HG23 ' A' ' 84' ' ' VAL . . . -66.72 -38.9 93.49 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.666 179.286 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.9 t -62.53 -41.22 91.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-O 120.766 0.317 . . . . 0.0 110.462 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 40.5 t -63.8 -40.54 89.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.383 179.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.1 -42.72 99.65 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.718 179.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 80' ' ' GLY . 94.5 t -64.02 -43.52 97.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.392 179.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.86 -43.33 98.53 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.952 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -66.15 -43.53 86.72 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.743 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -62.83 -40.14 98.87 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.148 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.2 -36.45 83.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.724 0.297 . . . . 0.0 110.613 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -74.74 -30.09 61.38 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.283 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 28.5 mmt -67.07 -27.94 67.78 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.29 178.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.4 mp -66.96 -10.51 50.07 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.265 178.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.41 20.22 59.02 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.85 -0.69 . . . . 0.0 113.259 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -78.42 124.14 27.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.93 0.365 . . . . 0.0 110.594 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.449 ' NH2' ' HA ' ' A' ' 96' ' ' ARG . 0.2 OUTLIER -128.24 122.07 21.86 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.679 -179.494 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -73.68 104.95 1.91 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.329 2.019 . . . . 0.0 112.417 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . 0.449 ' HA ' ' NH2' ' A' ' 94' ' ' ARG . 76.2 mtp180 -77.88 -20.46 52.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.455 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 8.6 m95 65.83 -90.44 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 O-C-N 123.746 0.654 . . . . 0.0 111.922 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.99 71.31 1.32 Allowed Glycine 0 C--N 1.329 0.19 0 C-N-CA 120.791 -0.719 . . . . 0.0 111.997 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.73 -89.64 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.84 0.352 . . . . 0.0 111.329 -179.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.87 150.61 20.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.752 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.1 tp -85.4 79.13 9.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.947 0.403 . . . . 0.0 110.546 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 49.1 mtp180 -127.58 179.4 5.52 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.549 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -117.68 121.99 42.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.922 0.392 . . . . 0.0 110.872 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -96.04 75.59 3.06 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.341 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -86.87 70.03 2.98 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.676 -0.773 . . . . 0.0 111.843 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -120.56 153.78 36.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.913 0.387 . . . . 0.0 111.113 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.43 71.39 10.71 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.054 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.25 -12.55 59.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.15 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.416 ' CB ' ' HD3' ' A' ' 110' ' ' PRO . 0.0 OUTLIER -74.26 -58.46 1.93 Allowed Pre-proline 0 CA--C 1.539 0.53 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -179.571 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.416 ' HD3' ' CB ' ' A' ' 109' ' ' ARG . 23.8 Cg_exo -64.8 -40.21 22.8 Favored 'Trans proline' 0 C--N 1.358 1.047 0 C-N-CA 122.055 1.837 . . . . 0.0 112.34 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -74.17 -30.6 62.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.642 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.472 ' O ' ' HB2' ' A' ' 116' ' ' LEU . . . -64.8 -40.71 97.55 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.909 -0.662 . . . . 0.0 111.974 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.51 -30.51 69.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.866 0.365 . . . . 0.0 110.919 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -80.5 -45.49 17.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.009 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.5 mt -65.66 -43.47 89.25 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.894 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 112' ' ' GLY . 1.9 mt -71.03 -22.87 62.09 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.944 0.402 . . . . 0.0 110.181 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -78.07 -46.13 9.6 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.22 -38.72 77.37 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.654 0.264 . . . . 0.0 111.304 178.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.3 p -68.55 -35.77 77.87 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.935 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.27 -33.1 61.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.478 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -71.27 -47.2 58.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.671 179.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.77 -24.01 60.89 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.834 179.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -78.88 89.03 1.16 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.944 -0.646 . . . . 0.0 111.73 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -59.3 126.29 27.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.082 0.468 . . . . 0.0 111.714 -179.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.513 ' O ' HG23 ' A' ' 128' ' ' ILE . 1.1 p -73.6 134.87 78.74 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.216 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -64.13 -19.27 65.91 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.757 2.305 . . . . 0.0 113.116 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 3.9 m -73.13 -14.95 61.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.089 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.513 HG23 ' O ' ' A' ' 125' ' ' THR . 3.7 tp -97.2 -3.95 9.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.363 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -51.79 -59.52 8.54 Favored Glycine 0 C--N 1.336 0.57 0 CA-C-N 115.894 -0.593 . . . . 0.0 113.091 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -56.73 -41.48 75.23 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.473 2.115 . . . . 0.0 112.236 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.482 HD12 HG21 ' A' ' 131' ' ' ILE . 25.1 mm -65.48 -47.34 87.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.003 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.07 -44.12 97.36 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.535 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -58.74 -38.5 92.08 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.837 178.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.48 -40.58 89.41 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.86 0.362 . . . . 0.0 110.665 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.462 HG13 ' O ' ' A' ' 131' ' ' ILE . 78.6 mt -65.4 -37.44 80.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.213 179.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . 0.452 ' HA ' ' OG1' ' A' ' 139' ' ' THR . 0.3 OUTLIER -64.1 -31.42 72.61 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.983 179.49 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.2 m -65.46 -30.88 71.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.994 0.426 . . . . 0.0 110.741 178.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 18.4 mt -83.39 -37.16 23.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.992 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.452 ' OG1' ' HA ' ' A' ' 136' ' ' LEU . 0.6 OUTLIER -72.3 -20.35 61.52 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.948 179.848 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -68.56 -27.52 66.15 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.549 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 2.0 t -94.13 -29.4 4.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.246 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 146.92 -95.16 0.17 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.552 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 100.33 -66.62 0.55 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.342 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 113.32 163.65 15.51 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.703 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 12.3 p -68.14 -25.59 32.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-O 120.801 0.334 . . . . 0.0 111.227 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -59.9 -34.29 82.33 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 121.161 -0.543 . . . . 0.0 112.708 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.99 -43.2 88.48 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.815 0.341 . . . . 0.0 110.424 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.52 -45.36 91.0 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.504 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.67 -40.36 95.28 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.979 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -61.15 -41.2 96.32 Favored 'General case' 0 C--O 1.226 -0.154 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.778 179.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -63.86 -43.54 95.81 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.985 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 59.4 mt -62.67 -50.84 78.16 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.733 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 71.6 mt -68.24 -32.71 73.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.463 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -60.69 -44.71 97.57 Favored Glycine 0 C--O 1.225 -0.415 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.355 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.69 -21.66 44.38 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.716 0.293 . . . . 0.0 110.954 178.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -65.89 -37.23 85.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.484 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.428 ' HB ' ' CD ' ' A' ' 158' ' ' PRO . 90.8 t -57.73 -59.15 13.95 Favored Pre-proline 0 CA--C 1.541 0.606 0 CA-C-O 119.518 -0.277 . . . . 0.0 111.685 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.508 ' O ' HG22 ' A' ' 161' ' ' VAL . 15.5 Cg_endo -59.26 -36.69 94.41 Favored 'Trans proline' 0 C--N 1.361 1.192 0 C-N-CA 122.142 1.895 . . . . 0.0 112.178 178.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -63.95 -38.15 90.02 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 120.548 0.213 . . . . 0.0 110.972 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.59 -49.31 69.29 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.47 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.508 HG22 ' O ' ' A' ' 158' ' ' PRO . 13.5 m -66.71 -32.67 59.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.06 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 3.9 t -67.73 -43.18 86.67 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 178.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -60.09 -34.02 72.88 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.96 178.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 11.2 tp -75.78 -45.39 36.48 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.827 179.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -69.15 -19.15 64.01 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.083 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.64 -19.07 64.57 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.984 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.49 -40.42 94.49 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.468 179.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 2.0 ttt85 -69.12 -36.24 77.29 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.438 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 18.0 mt -70.66 -30.16 41.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.377 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -60.97 -36.91 80.64 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.442 179.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -81.5 -34.37 25.72 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.6 -0.809 . . . . 0.0 111.61 178.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 27.8 t-105 -70.09 -25.84 63.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.893 -0.153 . . . . 0.0 111.393 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.38 -37.53 65.11 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.726 0.298 . . . . 0.0 111.522 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 2.6 mpp_? -87.08 -19.86 27.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.368 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 3.8 mtt85 -86.21 -37.03 19.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.547 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -59.08 -70.1 0.17 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.836 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 69.51 -83.3 0.27 Allowed Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.983 -0.627 . . . . 0.0 113.212 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.13 -40.38 82.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.546 0.212 . . . . 0.0 111.228 -179.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . 0.551 ' O ' HG23 ' A' ' 183' ' ' VAL . 22.6 mt -59.44 -46.14 93.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.811 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.06 -41.44 96.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.085 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -66.07 -32.49 73.99 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.259 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -70.27 -42.98 71.41 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.784 0.326 . . . . 0.0 110.834 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 179' ' ' ILE . 15.0 t -70.77 -19.97 21.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.828 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -67.56 -51.78 46.55 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.604 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.412 ' O ' HG22 ' A' ' 189' ' ' VAL . 5.3 t -75.37 -31.83 24.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.061 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.487 ' O ' HG22 ' A' ' 190' ' ' VAL . 0.6 OUTLIER -58.2 -47.91 81.96 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.912 179.78 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -63.08 -33.67 75.95 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.746 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -66.84 -45.74 80.89 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.41 179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.412 HG22 ' O ' ' A' ' 185' ' ' VAL . 46.4 t -61.94 -47.6 92.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 120.736 0.303 . . . . 0.0 110.937 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.487 HG22 ' O ' ' A' ' 186' ' ' LEU . 43.4 t -62.79 -40.98 90.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.774 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 3.7 mt -58.23 -45.96 86.77 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.321 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 81.8 t -64.4 -42.38 95.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-O 120.771 0.32 . . . . 0.0 110.537 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.59 -44.07 91.81 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.066 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.45 HG22 ' O ' ' A' ' 190' ' ' VAL . 78.2 t -64.2 -38.84 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.097 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -58.39 -44.04 95.43 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.233 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 61.8 t -73.56 -40.01 54.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-O 120.763 0.316 . . . . 0.0 110.681 179.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.39 -34.91 79.27 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.112 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.51 -41.11 48.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.071 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.7 -41.6 95.89 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.08 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 1.3 m -83.99 -13.76 52.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.982 0.42 . . . . 0.0 110.469 179.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -85.59 -49.32 4.4 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.55 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 4.7 m 70.57 -65.22 0.34 Allowed 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 122.946 0.498 . . . . 0.0 111.511 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' PHE . . . . . 0.407 ' C ' ' H ' ' A' ' 205' ' ' ALA . 4.9 t80 -154.19 161.31 41.92 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 5.8 m 73.72 -41.42 0.49 Allowed 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 122.98 0.512 . . . . 0.0 111.663 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . 0.407 ' H ' ' C ' ' A' ' 203' ' ' PHE . . . -60.98 -36.52 79.65 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.028 0.442 . . . . 0.0 110.862 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.06 -23.39 38.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.901 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -75.21 -50.09 17.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.171 -179.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 1.7 m -61.57 -33.71 74.33 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.876 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -74.44 -36.28 63.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.989 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -70.32 -29.59 66.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.876 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 6.1 mt -65.25 -18.03 64.98 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.915 0.388 . . . . 0.0 111.219 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 12.1 mtt180 -92.29 -6.05 51.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.42 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 8.1 mm -107.84 -12.47 10.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.69 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.43 128.12 66.98 Favored Pre-proline 0 C--O 1.233 0.192 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.78 179.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -56.8 143.45 90.68 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.557 2.171 . . . . 0.0 112.43 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -61.72 -25.7 67.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.846 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' TRP . . . . . 0.449 ' O ' ' HD1' ' A' ' 221' ' ' TYR . 4.5 m-90 -69.94 -22.29 63.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.949 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -81.48 -38.04 26.99 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.04 0.448 . . . . 0.0 109.81 179.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -71.47 -30.72 66.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.585 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.46 -1.8 35.44 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.05 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.449 ' HD1' ' O ' ' A' ' 217' ' ' TRP . 0.7 OUTLIER -99.94 10.64 40.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.712 179.609 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.21 129.83 52.21 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.088 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -64.17 -48.95 4.17 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.703 2.269 . . . . 0.0 113.016 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 24.7 m . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.108 -0.948 . . . . 0.0 111.324 -179.839 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 mmt . . . . . 0 N--CA 1.485 1.291 0 CA-C-O 120.75 0.309 . . . . 0.0 110.855 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.36 67.0 6.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.007 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.72 148.32 42.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.869 0.366 . . . . 0.0 111.13 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.57 -26.8 64.65 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.307 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.2 mt -64.73 -47.53 77.94 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.978 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.68 -46.52 90.03 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.685 179.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.34 -45.54 93.07 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.023 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.435 ' HB1' ' O ' ' A' ' 150' ' ' ALA . . . -60.51 -43.3 97.24 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.015 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -62.62 -51.02 68.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.671 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.95 -40.21 88.2 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.702 179.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.47 -45.95 90.18 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.4 178.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.91 -42.98 99.57 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.018 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 93.0 t -64.69 -42.64 95.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-O 120.732 0.301 . . . . 0.0 110.579 179.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.69 -40.11 95.98 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.564 179.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.6 m -69.08 -32.67 72.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.907 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -68.03 -42.69 80.21 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.982 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -85.02 -9.43 58.03 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.534 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -66.04 119.17 59.3 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.771 0.319 . . . . 0.0 110.884 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.31 -8.21 18.41 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.802 2.334 . . . . 0.0 112.489 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 96.6 m -82.43 44.84 0.91 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.034 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -94.78 54.66 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.94 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.408 ' O ' ' HB ' ' A' ' 25' ' ' VAL . 0.3 OUTLIER -62.87 -51.19 73.25 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.464 -179.57 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.609 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 51.2 Cg_exo -57.18 -31.8 91.62 Favored 'Trans proline' 0 C--N 1.361 1.203 0 C-N-CA 122.192 1.928 . . . . 0.0 113.018 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.86 -13.31 60.54 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.458 ' HB ' ' HD3' ' A' ' 26' ' ' PRO . 3.3 t -64.98 -53.9 38.58 Favored Pre-proline 0 CA--C 1.543 0.712 0 CA-C-O 119.613 -0.232 . . . . 0.0 111.314 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.609 ' HD2' ' O ' ' A' ' 23' ' ' PRO . 23.6 Cg_exo -65.77 -21.92 57.57 Favored 'Trans proline' 0 C--N 1.361 1.191 0 C-N-CA 121.919 1.746 . . . . 0.0 112.346 178.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -63.85 -24.67 67.84 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.392 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -66.12 -31.94 73.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.009 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.1 mp -86.6 -22.74 26.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.161 0.505 . . . . 0.0 110.487 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -75.07 -20.05 59.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.339 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -82.18 -20.86 36.99 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.782 0.325 . . . . 0.0 110.779 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.47 -36.46 17.65 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.011 0.434 . . . . 0.0 110.288 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -92.32 4.45 77.11 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.054 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -93.45 52.2 2.4 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.647 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.58 126.06 30.32 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.536 -0.172 . . . . 0.0 110.536 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 17.9 mtp180 62.23 32.72 17.09 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.577 0.548 . . . . 0.0 110.933 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -102.36 -168.73 26.8 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.55 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.4 88.45 29.88 Favored Pre-proline 0 C--O 1.234 0.277 0 CA-C-O 120.559 0.218 . . . . 0.0 111.109 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.75 -33.95 96.17 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.684 2.256 . . . . 0.0 112.49 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.2 mt -62.17 -45.34 93.86 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.55 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -73.63 -39.84 64.23 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.026 -179.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.88 -42.67 97.43 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.832 0.349 . . . . 0.0 110.632 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.29 -51.55 59.97 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.835 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.29 -42.3 86.29 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.482 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -63.9 -42.85 97.33 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.49 0.186 . . . . 0.0 110.815 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.98 -42.08 94.86 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.706 179.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 91.0 mt -65.43 -42.55 93.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.231 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.44 -50.08 75.02 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.483 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.491 ' O ' HG22 ' A' ' 53' ' ' VAL . . . -59.2 -45.91 94.62 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.749 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -69.17 -37.71 78.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.654 0.264 . . . . 0.0 110.947 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -61.64 -43.61 99.04 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 121.086 -0.578 . . . . 0.0 111.821 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.57 -43.26 99.19 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.698 0.285 . . . . 0.0 110.674 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.491 HG22 ' O ' ' A' ' 49' ' ' GLY . 91.4 t -63.54 -43.94 98.49 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.043 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -65.76 -34.55 78.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.435 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -76.52 -43.33 39.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.703 0.287 . . . . 0.0 110.806 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.15 -28.87 69.12 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.907 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.05 -18.27 27.64 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.897 0.38 . . . . 0.0 109.976 178.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -74.91 -32.02 57.35 Favored Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.998 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.21 -56.25 37.26 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 179.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -72.84 -13.71 26.69 Favored 'Trans proline' 0 C--N 1.361 1.189 0 C-N-CA 122.266 1.977 . . . . 0.0 112.735 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.66 -23.59 63.19 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.328 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -65.8 -41.68 91.61 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.957 0.408 . . . . 0.0 110.539 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -88.63 -21.53 23.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.765 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.65 -18.19 45.44 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.427 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.59 -32.29 80.84 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 121.253 -0.499 . . . . 0.0 112.566 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -71.97 -31.6 64.26 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.91 179.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.6 mt -84.69 -23.76 29.26 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.723 0.297 . . . . 0.0 110.226 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.18 -19.4 64.78 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.92 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -58.66 -21.89 55.38 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.266 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -127.84 146.41 50.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.33 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 61.95 57.46 2.11 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 123.375 0.422 . . . . 0.0 111.716 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -89.17 -28.39 20.05 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.79 0.328 . . . . 0.0 111.238 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -69.68 -20.06 63.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.545 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -63.26 -32.58 74.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.51 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.4 mp -81.76 -21.79 37.63 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.674 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.01 -28.47 35.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.555 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . 0.415 ' O ' HG23 ' A' ' 81' ' ' VAL . 26.7 mtp85 -63.5 -39.02 93.33 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.994 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 3.8 t -60.69 -37.9 77.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.437 179.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -64.55 -39.45 96.82 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.858 -0.687 . . . . 0.0 111.604 179.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.412 ' O ' HG22 ' A' ' 84' ' ' VAL . . . -64.54 -42.94 97.22 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.896 -0.669 . . . . 0.0 111.596 179.11 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.415 HG23 ' O ' ' A' ' 77' ' ' ARG . 57.9 t -59.04 -42.95 87.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-O 120.806 0.336 . . . . 0.0 110.569 178.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 87.8 t -63.36 -38.74 82.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.414 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.3 mt -61.29 -42.3 98.42 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.527 179.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.412 HG22 ' O ' ' A' ' 80' ' ' GLY . 31.6 t -65.56 -43.53 94.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 120.941 0.4 . . . . 0.0 110.088 178.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.69 -40.38 96.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.604 179.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.33 -37.08 85.99 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.64 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -61.08 -42.21 99.71 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.699 178.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.46 -34.54 78.17 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.862 0.363 . . . . 0.0 110.605 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -70.0 -42.6 72.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.703 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.94 -24.22 63.32 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.938 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.71 -11.38 58.21 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.35 178.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.55 10.82 57.67 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.645 -0.788 . . . . 0.0 113.058 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.3 tp -77.92 125.06 28.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 117.04 0.42 . . . . 0.0 110.583 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.457 ' H ' ' HE ' ' A' ' 94' ' ' ARG . 0.3 OUTLIER -72.25 142.32 84.51 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.007 179.657 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -67.51 145.19 69.84 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.255 1.97 . . . . 0.0 112.153 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -85.39 137.34 33.0 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.796 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 4.8 m-90 59.28 41.08 20.54 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.378 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -157.71 73.15 0.23 Allowed Glycine 0 N--CA 1.451 -0.327 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.114 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 9.4 p -100.97 146.44 9.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.874 0.369 . . . . 0.0 110.824 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.63 40.53 0.85 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.119 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.5 mt 59.36 -106.19 0.28 Allowed 'General case' 0 N--CA 1.467 0.392 0 O-C-N 123.56 0.537 . . . . 0.0 111.134 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -130.11 161.16 31.68 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -80.31 95.05 6.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.983 0.42 . . . . 0.0 111.053 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -134.61 173.33 11.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.431 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -80.25 71.39 2.8 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.455 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -117.23 16.1 14.89 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.409 0.151 . . . . 0.0 111.409 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.413 ' O ' ' HD2' ' A' ' 110' ' ' PRO . 0.6 OUTLIER 59.52 70.98 0.6 Allowed 'General case' 0 N--CA 1.466 0.325 0 O-C-N 123.427 0.454 . . . . 0.0 111.385 -179.813 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.51 0.32 50.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.897 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.8 -51.77 73.48 Favored Pre-proline 0 CA--C 1.541 0.607 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.413 ' HD2' ' O ' ' A' ' 107' ' ' THR . 46.3 Cg_exo -58.29 -25.61 73.31 Favored 'Trans proline' 0 C--N 1.363 1.295 0 C-N-CA 122.241 1.96 . . . . 0.0 112.927 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.8 mt -68.46 -34.18 75.5 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.716 0.293 . . . . 0.0 110.588 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -66.85 -36.33 90.95 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.705 -0.76 . . . . 0.0 111.373 179.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -75.2 -35.43 61.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.707 0.289 . . . . 0.0 110.629 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -65.37 -47.04 77.76 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.001 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.8 mp -64.63 -39.08 93.07 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.539 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.425 ' O ' ' HB2' ' A' ' 120' ' ' LEU . 0.6 OUTLIER -69.49 -31.59 69.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.397 179.209 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -74.64 -44.18 26.94 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.909 -0.662 . . . . 0.0 111.487 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.21 -42.94 87.3 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.945 0.402 . . . . 0.0 110.819 178.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 3.0 m -73.2 -27.68 61.76 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.142 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.425 ' HB2' ' O ' ' A' ' 116' ' ' LEU . 0.3 OUTLIER -76.4 -37.09 57.62 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.74 0.305 . . . . 0.0 110.96 179.642 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -73.27 -37.85 66.14 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.843 0.354 . . . . 0.0 111.226 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.95 -19.48 37.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.017 0.436 . . . . 0.0 110.738 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -92.04 95.62 2.06 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.701 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 4.8 t-105 -80.34 130.98 35.55 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.026 0.441 . . . . 0.0 111.31 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.2 119.88 78.67 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.083 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.84 -15.98 48.7 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.98 2.454 . . . . 0.0 112.909 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 8.0 m -62.74 -26.79 68.87 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.783 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.4 mt -86.67 -0.83 7.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.785 0.326 . . . . 0.0 111.004 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -59.65 -65.04 3.69 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 121.174 -0.536 . . . . 0.0 112.738 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.4 -38.56 73.51 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.618 2.212 . . . . 0.0 112.194 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 61.6 mt -60.93 -41.61 89.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.164 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.6 mt -63.18 -33.32 75.23 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-O 120.687 0.279 . . . . 0.0 110.848 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -61.24 -38.07 95.05 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 121.118 -0.563 . . . . 0.0 111.967 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.53 -36.19 73.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.123 0.487 . . . . 0.0 109.967 178.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 45.6 mm -67.17 -42.41 88.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.337 179.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.67 -36.91 82.22 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.32 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 38.4 m -64.5 -38.34 90.68 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.252 178.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 7.8 mt -70.06 -30.83 68.18 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.618 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.1 m -79.99 -22.4 42.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.086 0.469 . . . . 0.0 110.551 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.18 -30.27 64.8 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.914 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 20.5 m -100.25 4.98 10.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.009 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 141.54 -92.6 0.18 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.46 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.98 -123.54 7.02 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.543 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 130.8 159.67 9.7 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.571 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 11.1 p -77.36 -23.41 14.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.684 0.278 . . . . 0.0 111.33 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -58.35 -37.52 87.81 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.745 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -68.62 -41.67 79.18 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.691 0.281 . . . . 0.0 110.423 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.416 ' O ' HG13 ' A' ' 152' ' ' ILE . 0.3 OUTLIER -60.86 -46.28 91.2 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.605 179.233 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.83 -40.63 95.5 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.729 179.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.435 ' O ' ' HB1' ' A' ' 8' ' ' ALA . . . -62.43 -41.18 98.52 Favored 'General case' 0 C--O 1.226 -0.168 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.771 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.4 ' O ' HD13 ' A' ' 155' ' ' LEU . 1.3 m-85 -60.61 -44.91 95.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.091 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.416 HG13 ' O ' ' A' ' 148' ' ' LEU . 23.9 mt -64.5 -44.06 96.91 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 CA-C-O 120.95 0.405 . . . . 0.0 110.341 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.92 -35.89 82.6 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.569 179.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . 0.435 ' O ' ' HD2' ' A' ' 158' ' ' PRO . . . -60.56 -46.08 95.08 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.143 179.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.4 HD13 ' O ' ' A' ' 151' ' ' TYR . 0.4 OUTLIER -69.38 -29.88 67.75 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.059 0.457 . . . . 0.0 110.754 178.651 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -63.43 -35.21 79.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.589 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.543 ' O ' HG23 ' A' ' 161' ' ' VAL . 95.1 t -55.38 -63.7 2.83 Favored Pre-proline 0 CA--C 1.543 0.685 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.462 ' CD ' ' HB ' ' A' ' 157' ' ' VAL . 19.1 Cg_endo -60.88 -36.38 83.83 Favored 'Trans proline' 0 C--N 1.359 1.109 0 C-N-CA 121.906 1.737 . . . . 0.0 112.384 179.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -58.08 -45.28 87.42 Favored 'General case' 0 N--CA 1.462 0.158 0 O-C-N 123.169 0.293 . . . . 0.0 111.19 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -70.47 -36.67 74.02 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.718 -0.219 . . . . 0.0 110.873 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 157' ' ' VAL . 96.5 t -64.91 -45.28 95.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-O 120.731 0.3 . . . . 0.0 110.692 179.096 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 68.9 t -65.8 -39.4 84.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.49 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -61.07 -34.82 75.5 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.28 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.8 -42.79 39.26 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.188 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -71.95 -19.23 61.93 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.374 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.09 -19.16 61.13 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.414 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -64.19 -43.05 96.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.765 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 2.6 mtp180 -73.03 -31.98 64.79 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.992 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 11.8 mt -72.83 -26.32 23.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.787 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.42 -30.92 71.95 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.968 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -70.89 -38.98 65.06 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.813 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -74.22 -24.07 59.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.63 0.252 . . . . 0.0 110.84 179.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 3.2 tp -59.71 -37.61 79.35 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.785 178.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 41.8 mtp180 -76.59 -21.86 55.02 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.816 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 -84.87 -32.19 23.34 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.943 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -65.16 -33.81 76.89 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.642 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 70.76 -98.77 0.71 Allowed Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.8 -0.714 . . . . 0.0 113.029 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -104.74 -6.01 20.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.558 0.218 . . . . 0.0 111.232 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 50.2 mm -64.58 -41.54 92.55 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 CA-C-O 120.671 0.272 . . . . 0.0 110.819 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' SER . . . . . 0.498 ' O ' ' HG3' ' A' ' 184' ' ' GLU . 0.0 OUTLIER -61.65 -33.77 74.53 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.12 179.831 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . 0.46 ' HA ' ' OE2' ' A' ' 184' ' ' GLU . 11.7 m80 -66.64 -32.28 73.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.245 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.454 ' O ' ' HB2' ' A' ' 186' ' ' LEU . 4.9 m-85 -68.7 -41.43 79.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.75 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 1.6 t -68.47 -20.09 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 120.927 0.394 . . . . 0.0 111.023 179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . 0.498 ' HG3' ' O ' ' A' ' 180' ' ' SER . 41.9 mt-10 -76.42 -47.15 24.1 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.502 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 6.1 t -77.11 -37.5 26.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.232 -179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.511 ' O ' HG22 ' A' ' 190' ' ' VAL . 0.6 OUTLIER -58.84 -48.91 79.69 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.616 -0.266 . . . . 0.0 111.431 -179.744 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -63.74 -33.52 75.83 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.873 0.368 . . . . 0.0 110.941 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.423 ' O ' HG22 ' A' ' 192' ' ' VAL . . . -65.95 -44.91 90.78 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.797 -0.715 . . . . 0.0 111.849 179.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 84.0 t -60.68 -43.98 96.13 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-O 120.484 0.183 . . . . 0.0 110.676 179.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.511 HG22 ' O ' ' A' ' 186' ' ' LEU . 48.2 t -60.82 -47.7 92.13 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.099 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.027 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -61.42 -42.62 99.04 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.236 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 188' ' ' GLY . 71.9 t -65.59 -44.21 93.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.7 tp -58.54 -45.97 87.78 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.654 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.438 HG21 ' O ' ' A' ' 190' ' ' VAL . 78.8 t -63.21 -40.04 87.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.502 179.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -59.44 -45.05 96.15 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.304 179.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 22.4 t -71.57 -38.81 68.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-O 120.755 0.312 . . . . 0.0 110.675 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.99 -23.95 63.24 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.376 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.46 -41.73 16.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.746 -0.206 . . . . 0.0 110.895 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 22.5 t80 -68.55 -56.28 8.85 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.645 0.259 . . . . 0.0 111.37 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.41 -10.08 59.55 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.895 0.379 . . . . 0.0 111.306 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -91.05 -55.53 1.84 Allowed Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.262 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 18.8 m 68.37 -70.31 0.13 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.049 0.54 . . . . 0.0 111.528 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' PHE . . . . . 0.419 ' C ' ' H ' ' A' ' 205' ' ' ALA . 73.0 m-85 -97.63 160.86 14.06 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 -179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 23.6 m 74.24 -40.33 0.45 Allowed 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 122.781 0.433 . . . . 0.0 111.173 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . 0.419 ' H ' ' C ' ' A' ' 203' ' ' PHE . . . -75.57 -36.1 60.45 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.145 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.438 ' O ' ' HB2' ' A' ' 210' ' ' PHE . 0.4 OUTLIER -60.46 -44.79 95.51 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.364 179.906 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -71.65 -38.74 70.68 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.755 0.312 . . . . 0.0 111.181 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 62.1 m -64.34 -43.03 95.9 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.946 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -74.7 -30.91 61.71 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.237 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . 0.438 ' HB2' ' O ' ' A' ' 206' ' ' LEU . 0.1 OUTLIER -63.56 -24.53 67.84 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.257 -179.947 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.2 -22.25 65.74 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.884 0.373 . . . . 0.0 110.539 179.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.37 -7.05 51.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.917 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 2.5 mt -102.7 3.82 10.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.949 0.404 . . . . 0.0 110.901 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.88 117.84 61.43 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.785 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -72.16 120.83 7.05 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.25 1.967 . . . . 0.0 112.183 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . 0.543 ' HA ' ' OE1' ' A' ' 219' ' ' GLN . 1.9 mt-10 -65.01 -26.35 68.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.467 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 1.3 m-90 -72.67 -24.11 60.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.958 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.1 -33.27 24.38 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . 0.543 ' OE1' ' HA ' ' A' ' 216' ' ' GLU . 68.4 mt-30 -67.0 -30.3 70.37 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.363 179.075 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -78.77 -11.05 59.97 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.768 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -89.18 -13.02 39.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.58 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 13.3 mt -95.06 116.47 66.39 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.19 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -60.5 -49.83 8.13 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.7 2.267 . . . . 0.0 112.749 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.247 0.922 0 CA-C-O 118.249 -0.881 . . . . 0.0 110.76 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.4 mtt . . . . . 0 N--CA 1.485 1.292 0 CA-C-O 120.759 0.314 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.65 57.5 2.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.502 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.12 -6.78 34.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.203 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.47 -37.54 87.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.475 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.2 -45.19 70.52 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.495 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.64 -47.05 87.14 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.667 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.74 -42.8 99.45 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.635 178.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.17 -48.38 78.62 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.888 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.434 ' O ' HG21 ' A' ' 13' ' ' VAL . 5.5 m-85 -55.95 -46.45 78.55 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.617 178.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.81 -44.4 96.27 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.815 0.341 . . . . 0.0 110.525 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.39 -39.75 94.25 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.677 178.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.09 -41.13 99.36 Favored Glycine 0 C--N 1.334 0.429 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.065 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.434 HG21 ' O ' ' A' ' 9' ' ' PHE . 98.0 t -65.03 -36.43 77.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 178.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.1 tp -63.77 -43.17 97.17 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.791 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -35.05 79.06 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.793 0.33 . . . . 0.0 110.844 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.13 -28.84 63.52 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.889 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.35 -13.21 50.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.046 0.451 . . . . 0.0 110.632 178.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 61.6 m -85.82 135.86 37.33 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.364 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.63 -14.71 36.89 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.474 2.116 . . . . 0.0 113.027 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 6.3 t -90.16 132.9 35.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.352 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.1 t 61.46 65.28 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 O-C-N 123.724 0.64 . . . . 0.0 111.03 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.6 tp -109.78 105.34 57.07 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.896 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.473 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 28.1 Cg_exo -63.05 -15.34 47.29 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.989 2.459 . . . . 0.0 112.81 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.2 tp -77.95 -15.38 59.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.148 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.485 ' HB ' ' HD3' ' A' ' 26' ' ' PRO . 8.6 t -72.12 -52.35 7.43 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 116.684 -0.234 . . . . 0.0 111.327 179.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.485 ' HD3' ' HB ' ' A' ' 25' ' ' VAL . 22.9 Cg_exo -65.36 -38.68 25.38 Favored 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 122.029 1.82 . . . . 0.0 112.59 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.1 p -65.85 -33.57 76.16 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.707 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -62.56 -36.05 81.43 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.877 0.37 . . . . 0.0 110.769 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.46 -42.62 18.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.573 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -57.8 -36.36 72.09 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.51 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -71.32 -33.08 69.33 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.804 0.335 . . . . 0.0 110.884 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -79.75 -22.6 43.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.487 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -78.0 -24.87 63.24 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.199 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 110.29 43.46 1.08 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.715 -0.755 . . . . 0.0 113.004 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.42 96.36 9.06 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.702 0.286 . . . . 0.0 111.181 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.14 122.06 40.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.639 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 170.87 -158.21 29.66 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 111.673 -0.571 . . . . 0.0 111.673 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 2.2 mmt180 -103.67 118.78 56.61 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.845 0.322 . . . . 0.0 110.75 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.06 -27.0 42.62 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.65 2.233 . . . . 0.0 112.79 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.07 -34.89 77.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.13 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -71.41 -38.22 71.45 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.795 0.331 . . . . 0.0 110.289 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -64.88 -43.77 91.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.283 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.81 -41.01 88.22 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.658 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.58 -46.78 86.22 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.109 179.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -67.3 -36.28 81.18 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.871 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -65.18 -42.9 93.2 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.732 -0.213 . . . . 0.0 110.573 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 70.6 mt -60.42 -46.11 95.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.332 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.22 -42.44 93.44 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.472 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -60.44 -48.24 87.17 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 121.216 -0.516 . . . . 0.0 112.344 178.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.08 -34.85 75.78 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.734 0.302 . . . . 0.0 110.338 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -61.81 -46.44 94.15 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 178.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.58 -42.12 96.05 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 120.769 0.318 . . . . 0.0 110.463 178.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.6 t -62.69 -45.2 99.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.704 179.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -62.96 -33.41 75.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.466 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.96 -42.29 21.48 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 121.115 -0.234 . . . . 0.0 110.878 179.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.36 -37.1 85.97 Favored 'General case' 0 C--O 1.226 -0.168 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.08 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.39 -19.93 24.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.815 0.341 . . . . 0.0 110.86 179.101 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.22 -36.2 70.84 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.953 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.88 -57.63 22.94 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -67.95 -13.68 39.02 Favored 'Trans proline' 0 C--N 1.359 1.108 0 C-N-CA 122.583 2.189 . . . . 0.0 113.063 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -58.29 -20.58 43.95 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.698 0.285 . . . . 0.0 111.536 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 11.6 p -66.63 -47.82 71.39 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.148 0.499 . . . . 0.0 110.27 178.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.5 mt -81.63 -19.22 42.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.621 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.24 -18.21 59.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.524 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -69.94 -36.38 73.3 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.875 -0.679 . . . . 0.0 111.919 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.82 -25.71 64.19 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.806 -0.711 . . . . 0.0 111.711 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 mt -76.23 -20.54 57.34 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.633 0.254 . . . . 0.0 110.703 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 28.9 mt -63.83 -19.66 65.2 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.028 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -70.19 -17.67 63.16 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.775 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -95.52 39.84 1.12 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.558 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 73.4 160.87 0.24 Allowed 'General case' 0 N--CA 1.472 0.644 0 O-C-N 123.953 0.783 . . . . 0.0 111.149 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' A' ' 72' ' ' ARG . 3.1 ptt180 -139.22 12.05 2.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.38 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -69.4 -35.93 76.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.492 -179.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.19 -24.6 64.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.579 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.7 tp -82.56 -28.75 30.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.929 0.395 . . . . 0.0 110.798 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -79.85 -28.53 40.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.994 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -62.72 -34.84 78.01 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.277 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 18.7 t -59.78 -37.87 73.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.568 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -66.44 -33.56 85.15 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.983 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.475 ' O ' HG21 ' A' ' 84' ' ' VAL . . . -66.41 -43.82 91.74 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.851 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.0 t -62.24 -39.9 85.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-O 121.039 0.447 . . . . 0.0 110.373 179.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.5 t -64.64 -41.64 92.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.715 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.0 -40.85 90.62 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.603 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.475 HG21 ' O ' ' A' ' 80' ' ' GLY . 61.5 t -63.82 -43.98 98.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.207 178.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.81 -40.41 95.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.804 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -60.22 -43.66 95.81 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 178.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -65.38 -39.25 95.72 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.733 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . 0.417 ' O ' ' HB2' ' A' ' 91' ' ' LEU . 1.0 OUTLIER -62.68 -40.63 97.73 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.711 0.291 . . . . 0.0 111.024 179.368 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -72.3 -32.69 66.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.878 0.371 . . . . 0.0 110.665 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -73.45 -17.46 61.24 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.706 179.028 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.417 ' HB2' ' O ' ' A' ' 88' ' ' LEU . 5.5 mt -67.08 -10.05 45.87 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.478 178.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.6 13.91 64.36 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.675 -0.774 . . . . 0.0 113.209 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 24.5 mt -88.22 122.89 32.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.837 0.351 . . . . 0.0 110.578 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.09 112.56 63.05 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.912 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -62.34 -55.27 1.01 Allowed 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.634 2.223 . . . . 0.0 112.446 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.92 118.31 14.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.067 0.46 . . . . 0.0 110.708 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 4.8 p90 -95.86 -4.78 43.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.713 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -89.21 45.9 3.19 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.805 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 9.7 p -108.86 -22.59 4.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.031 0.443 . . . . 0.0 110.792 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.4 -76.22 0.59 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.03 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.2 mt 58.5 -108.53 0.41 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.862 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 2.8 ttp85 58.07 -146.44 0.54 Allowed 'General case' 0 CA--C 1.532 0.283 0 O-C-N 123.386 0.429 . . . . 0.0 110.959 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -121.91 -59.64 1.65 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.826 0.346 . . . . 0.0 110.44 179.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -136.14 122.07 20.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.568 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -163.56 -70.63 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.894 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 58.97 29.48 19.01 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.079 0.466 . . . . 0.0 111.486 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.34 54.98 3.1 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.246 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.54 -11.99 50.03 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.333 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.417 ' N ' ' HD2' ' A' ' 110' ' ' PRO . 10.6 ttp180 -62.81 -54.73 44.65 Favored Pre-proline 0 CA--C 1.539 0.527 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.417 ' HD2' ' N ' ' A' ' 109' ' ' ARG . 28.0 Cg_endo -63.0 -38.21 48.11 Favored 'Trans proline' 0 C--N 1.361 1.195 0 C-N-CA 121.93 1.754 . . . . 0.0 112.489 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.72 -42.46 70.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.865 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -63.66 -41.83 98.92 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.927 -0.654 . . . . 0.0 111.961 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.02 -36.86 80.64 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.906 0.384 . . . . 0.0 110.607 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -67.06 -44.59 79.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.992 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.04 -38.9 86.68 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.978 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.9 -37.33 85.82 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.97 0.414 . . . . 0.0 110.399 179.151 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -74.11 -36.49 51.2 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 121.002 -0.618 . . . . 0.0 111.75 179.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -55.25 -41.89 72.74 Favored 'General case' 0 N--CA 1.461 0.106 0 C-N-CA 122.362 0.265 . . . . 0.0 111.153 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.38 -46.41 86.6 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.828 179.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.07 -35.24 80.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.259 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -72.96 -29.74 63.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.994 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.2 mt -81.91 -27.4 33.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.667 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -78.1 138.38 21.23 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.05 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -82.86 -7.18 59.68 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 121.041 -0.264 . . . . 0.0 111.707 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.5 m 58.5 85.66 0.18 Allowed Pre-proline 0 C--O 1.233 0.187 0 O-C-N 123.508 0.505 . . . . 0.0 111.128 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -59.13 -17.77 40.42 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 123.063 2.509 . . . . 0.0 113.156 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 83.9 m -65.26 -43.21 92.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.071 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 11.6 pt -104.29 5.47 10.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.358 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -55.92 -67.35 2.26 Favored Glycine 0 CA--C 1.52 0.362 0 CA-C-N 116.122 -0.49 . . . . 0.0 113.112 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -62.5 -33.71 77.9 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.502 2.135 . . . . 0.0 112.101 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 26.9 mt -61.94 -40.09 85.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.031 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 6.3 mt -64.05 -29.32 70.47 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.682 0.277 . . . . 0.0 110.95 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -67.13 -30.16 75.39 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.902 -0.666 . . . . 0.0 111.778 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -79.74 -36.19 37.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.942 0.401 . . . . 0.0 110.355 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 45.3 mm -67.26 -30.93 50.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.711 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.61 -43.86 89.72 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.804 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.13 -24.77 62.34 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.077 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -76.21 -38.06 56.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.217 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.5 m -68.54 -18.03 64.28 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.942 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.27 -38.54 88.05 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.828 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 4.1 m -102.24 -22.59 4.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.017 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -129.37 78.79 0.38 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 121.018 -0.61 . . . . 0.0 112.063 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -111.18 121.36 5.77 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.533 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -156.16 141.6 8.12 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.178 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 6.3 t -66.84 -27.8 40.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-O 120.882 0.372 . . . . 0.0 110.875 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -62.38 -28.56 71.26 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.584 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -68.33 -52.82 29.11 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.706 0.289 . . . . 0.0 110.599 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 20.1 mt -62.53 -37.25 85.37 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.757 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.01 -44.38 89.4 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.479 179.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.88 -39.27 93.81 Favored 'General case' 0 C--O 1.225 -0.23 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.787 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -60.43 -47.54 85.65 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.069 179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.427 HD13 HG21 ' A' ' 152' ' ' ILE . 48.5 mm -64.16 -44.86 97.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.455 179.37 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.27 -34.83 79.29 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.89 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -61.0 -41.22 99.36 Favored Glycine 0 C--O 1.225 -0.415 0 CA-C-N 115.976 -0.557 . . . . 0.0 112.386 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.43 ' O ' ' HD2' ' A' ' 158' ' ' PRO . 0.0 OUTLIER -82.69 -27.69 31.08 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.831 0.348 . . . . 0.0 110.915 178.77 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -62.57 -38.9 91.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.855 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.508 ' HB ' ' HD3' ' A' ' 158' ' ' PRO . 6.9 t -57.44 -57.63 23.83 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-O 119.322 -0.37 . . . . 0.0 111.791 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.508 ' HD3' ' HB ' ' A' ' 157' ' ' VAL . 38.0 Cg_exo -58.44 -40.67 72.74 Favored 'Trans proline' 0 C--N 1.361 1.229 0 C-N-CA 122.024 1.816 . . . . 0.0 112.244 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.65 -45.29 92.45 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.151 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -66.34 -41.07 90.11 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.684 -0.234 . . . . 0.0 110.73 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.439 HG22 ' O ' ' A' ' 157' ' ' VAL . 98.0 t -63.51 -46.57 94.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.716 179.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 158' ' ' PRO . 78.9 t -64.73 -43.69 96.52 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.718 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -60.88 -33.56 73.29 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.649 0.261 . . . . 0.0 111.658 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.2 tp -79.51 -45.89 18.45 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.096 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -68.3 -19.39 64.68 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.125 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -65.51 -18.92 65.68 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.029 179.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -59.99 -40.56 89.6 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.005 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 1.2 mmt85 -87.6 -32.97 19.04 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.89 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 46.9 mm -67.1 -31.64 54.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.004 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.93 -28.49 67.66 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.579 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -70.69 -37.23 67.28 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.296 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -86.84 -34.07 19.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.555 0.217 . . . . 0.0 110.816 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.87 -22.98 63.04 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.375 179.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -53.15 61.18 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-O 121.009 0.433 . . . . 0.0 110.167 178.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 7.3 mtm180 -78.57 -31.25 47.24 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.66 178.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -62.41 -41.07 98.4 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.494 179.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -42.52 -31.58 1.07 Allowed Glycine 0 C--N 1.34 0.765 0 O-C-N 123.91 0.756 . . . . 0.0 114.081 178.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 4.5 ttp180 -61.36 -56.46 20.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.105 0.479 . . . . 0.0 110.331 179.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -75.07 -27.75 20.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.011 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 19.5 m -71.27 -16.55 62.48 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.764 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -56.13 -37.35 69.33 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.764 0.316 . . . . 0.0 111.498 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -73.26 -24.56 60.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.118 0.485 . . . . 0.0 110.82 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 4.9 t -82.22 -21.7 9.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.249 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -70.06 -43.47 71.11 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.389 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 2.9 t -69.68 -41.92 80.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.81 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 4.6 mt -58.98 -48.67 80.74 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.084 179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -63.48 -39.67 95.07 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.644 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.518 ' O ' HG23 ' A' ' 192' ' ' VAL . . . -62.91 -45.12 96.33 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.064 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 54.2 t -60.51 -47.54 92.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-O 120.645 0.259 . . . . 0.0 110.629 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . . . . . . . . . 84.7 t -61.42 -44.06 97.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.95 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -57.0 -46.78 82.04 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.005 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 188' ' ' GLY . 45.0 t -67.05 -42.37 88.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.403 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.78 -42.64 89.46 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.037 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 58.6 t -61.8 -43.85 97.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 178.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -61.86 -41.27 99.62 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.107 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 61.2 t -68.63 -42.64 83.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.481 0.182 . . . . 0.0 110.814 179.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.27 -25.96 68.28 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.795 0.331 . . . . 0.0 111.403 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.68 -43.61 18.28 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.774 0.321 . . . . 0.0 110.385 178.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -71.2 -48.41 51.71 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.099 -0.501 . . . . 0.0 112.089 -179.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 69.3 p -84.2 -9.14 58.79 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.908 0.385 . . . . 0.0 111.314 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -87.09 -53.87 2.73 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.907 -0.664 . . . . 0.0 112.094 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 52.74 45.96 27.67 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.94 0.4 . . . . 0.0 111.634 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -151.05 -174.05 4.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.934 0.397 . . . . 0.0 110.911 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.26 10.46 10.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.67 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -58.63 -33.15 69.72 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.156 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.13 -37.63 45.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.816 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.1 -35.78 74.4 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.609 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 5.9 m -69.09 -35.12 76.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.269 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -71.74 -29.35 64.43 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.955 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -69.43 -21.83 63.71 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.198 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.95 -11.2 51.28 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.9 0.381 . . . . 0.0 110.625 179.035 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 17.4 mtt180 -91.23 -14.11 31.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.127 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 6.8 pt -102.35 -6.72 9.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.371 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 1.3 p -87.36 118.21 69.6 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.606 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -70.54 149.08 61.33 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.379 2.053 . . . . 0.0 112.491 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -63.34 -22.13 66.69 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.977 0.418 . . . . 0.0 111.335 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -66.51 -18.7 65.51 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.407 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.2 -22.61 55.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.973 0.416 . . . . 0.0 110.249 179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -84.31 -30.25 25.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.163 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.55 -2.19 58.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.856 179.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -94.18 2.53 55.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.071 0.462 . . . . 0.0 110.648 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.61 129.54 38.07 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.188 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.17 -46.49 32.55 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.804 2.336 . . . . 0.0 112.524 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.202 -0.904 . . . . 0.0 111.003 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.9 mtm . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.828 0.347 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.64 72.76 3.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.264 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 15.0 mt -90.45 48.28 1.53 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.032 0.444 . . . . 0.0 111.115 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.3 -22.01 58.03 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.137 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.84 -38.84 89.94 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.645 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.27 -34.65 78.13 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.873 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.72 -49.27 66.59 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.697 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.7 -25.07 64.59 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.196 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.47 ' O ' HG22 ' A' ' 13' ' ' VAL . 0.3 OUTLIER -74.39 -50.83 17.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.068 179.823 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.9 mt -64.64 -34.65 78.79 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.424 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.81 -43.44 96.27 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.518 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.49 -42.85 98.83 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.744 178.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.47 HG22 ' O ' ' A' ' 9' ' ' PHE . 59.1 t -64.87 -41.91 93.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.932 0.396 . . . . 0.0 110.078 179.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.1 mt -63.12 -39.57 95.06 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.844 179.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 28.7 m -65.97 -36.35 83.1 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.991 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -73.47 -31.28 63.69 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.75 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.2 mt -83.88 -14.66 50.56 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.06 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 38.4 m -61.43 146.68 89.06 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.776 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.48 -20.23 48.12 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.788 2.326 . . . . 0.0 113.081 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.459 ' O ' ' HZ2' ' A' ' 124' ' ' TRP . 39.6 m -75.69 -38.81 58.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.427 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 1.2 t 55.6 -155.71 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 O-C-N 123.294 0.371 . . . . 0.0 110.025 -178.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.42 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 0.2 OUTLIER -173.62 -56.79 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.309 0 CA-C-O 119.328 -0.368 . . . . 0.0 111.326 179.606 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . 0.42 ' HD2' ' N ' ' A' ' 22' ' ' LEU . 21.5 Cg_endo -61.19 -15.19 38.27 Favored 'Trans proline' 0 C--N 1.364 1.388 0 C-N-CA 122.647 2.231 . . . . 0.0 113.787 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.3 tp -55.44 -46.75 76.71 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 123.207 0.317 . . . . 0.0 111.838 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -67.51 -55.44 14.76 Favored Pre-proline 0 CA--C 1.542 0.663 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -51.23 -44.19 44.42 Favored 'Trans proline' 0 C--N 1.362 1.282 0 C-N-CA 122.418 2.079 . . . . 0.0 113.469 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.1 p -64.15 -37.66 88.25 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.69 0.281 . . . . 0.0 111.566 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 12.2 m-30 -73.19 -35.96 66.47 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.741 0.305 . . . . 0.0 110.686 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -70.34 -32.12 69.7 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.895 0.379 . . . . 0.0 110.137 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -61.04 -46.62 89.98 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.047 178.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -64.77 -34.89 79.41 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.723 178.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.21 -38.15 81.63 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.647 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.85 -33.25 55.75 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.104 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.01 31.49 64.28 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.656 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -133.9 131.58 39.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.698 0.285 . . . . 0.0 111.062 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 4.1 mtp180 -88.4 67.87 8.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.839 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -74.94 150.82 41.62 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.812 -0.708 . . . . 0.0 111.844 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -69.95 115.27 32.07 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.715 0.258 . . . . 0.0 111.062 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -60.83 -20.46 66.47 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 123.042 2.495 . . . . 0.0 112.889 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.84 -34.9 76.8 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.225 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -68.9 -42.06 77.39 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.013 0.435 . . . . 0.0 110.406 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.92 -42.04 86.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.301 179.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.85 -44.69 92.39 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.041 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.04 -46.7 88.66 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.91 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -62.52 -39.45 93.59 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.861 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -67.08 -40.9 87.06 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.949 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 71.8 mt -60.84 -45.99 97.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-O 120.778 0.323 . . . . 0.0 110.317 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.91 -46.95 73.27 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.529 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.518 ' O ' HG22 ' A' ' 53' ' ' VAL . . . -58.54 -49.78 73.54 Favored Glycine 0 C--N 1.334 0.439 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.913 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.52 -35.35 77.36 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.703 0.252 . . . . 0.0 110.844 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -60.28 -48.41 86.26 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.509 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.79 -46.0 92.2 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.523 0.201 . . . . 0.0 110.922 178.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.518 HG22 ' O ' ' A' ' 49' ' ' GLY . 85.6 t -61.76 -44.06 98.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.186 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -62.72 -38.64 91.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.355 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -74.63 -40.36 61.55 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 120.634 0.254 . . . . 0.0 110.727 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.4 mt -64.41 -28.16 69.49 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.527 179.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.6 -19.91 24.36 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.469 178.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.59 -34.86 62.92 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 121.147 -0.549 . . . . 0.0 112.095 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.56 -56.16 37.94 Favored Pre-proline 0 CA--C 1.542 0.667 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 179.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.98 -13.81 29.06 Favored 'Trans proline' 0 C--N 1.36 1.154 0 C-N-CA 122.229 1.953 . . . . 0.0 112.961 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.59 -32.28 62.92 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 123.052 0.22 . . . . 0.0 111.379 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.28 -40.04 92.63 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.912 0.387 . . . . 0.0 110.73 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.2 mt -88.75 -19.4 26.11 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.705 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.9 tp -68.31 -17.36 64.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.779 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.27 -30.31 70.71 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.6 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.63 -22.11 73.24 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.588 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 tp -73.74 -19.86 60.67 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.689 0.281 . . . . 0.0 110.401 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.9 -22.85 60.29 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.158 179.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -76.01 -36.3 59.21 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.98 0.419 . . . . 0.0 110.416 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -122.3 70.64 0.98 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.915 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -61.4 125.96 25.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.374 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 18.3 mtm180 -78.88 100.64 7.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.435 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -69.56 -18.0 63.61 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.075 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.435 ' O ' HG21 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -61.45 -28.38 69.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.989 179.485 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 20.5 mt -67.68 -29.6 68.92 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.73 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -74.29 -32.22 62.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.45 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 9.6 ttt-85 -67.38 -39.65 85.65 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.487 179.464 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.435 HG21 ' O ' ' A' ' 74' ' ' THR . 18.1 t -59.98 -39.74 81.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.483 179.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.43 -39.9 98.25 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.862 -0.685 . . . . 0.0 111.672 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -64.43 -42.71 97.49 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.726 179.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 99.1 t -58.89 -44.41 90.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-O 120.825 0.345 . . . . 0.0 110.649 178.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 79.1 t -65.51 -40.66 88.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.488 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.55 -42.37 96.41 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.919 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 72.8 t -62.55 -46.22 96.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-O 120.774 0.321 . . . . 0.0 110.233 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.87 -40.77 94.19 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.675 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -65.32 -45.56 83.8 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.329 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -61.53 -39.38 97.26 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.202 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.8 mp -62.16 -42.51 99.33 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.693 0.282 . . . . 0.0 110.802 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -72.92 -31.99 65.02 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.979 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.31 -28.42 67.15 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.817 0.341 . . . . 0.0 110.881 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.67 -21.67 66.1 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.259 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.02 1.93 90.19 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.422 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.0 mt -97.21 160.1 14.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.999 0.399 . . . . 0.0 111.088 -179.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 3.1 mtp180 -98.58 119.04 62.31 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.303 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -69.77 -72.92 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.408 2.072 . . . . 0.0 112.921 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 71.7 mmt-85 -134.64 -178.67 5.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.91 0.386 . . . . 0.0 110.657 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -85.05 76.23 10.28 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.566 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -98.17 57.55 1.04 Allowed Glycine 0 N--CA 1.453 -0.195 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.446 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.1 m -93.92 41.19 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.984 0.421 . . . . 0.0 111.646 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.86 3.12 41.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.146 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.2 mp -107.46 135.75 48.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.622 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.41 123.26 32.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.898 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -115.07 132.68 56.52 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.712 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.75 155.02 46.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.5 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 113.95 154.72 11.26 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.528 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -110.92 -13.36 14.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.826 0.346 . . . . 0.0 111.148 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -92.28 52.38 1.93 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.271 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.62 -20.88 56.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.649 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.48 -56.94 7.51 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -64.15 -33.34 61.33 Favored 'Trans proline' 0 C--N 1.36 1.171 0 C-N-CA 121.99 1.793 . . . . 0.0 112.411 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 17.3 mt -75.23 -22.31 58.0 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.939 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -64.91 -35.77 92.3 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.955 -0.641 . . . . 0.0 111.899 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.56 -32.91 71.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.982 0.42 . . . . 0.0 110.712 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -80.83 -39.8 25.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.739 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.94 -47.47 71.58 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.636 -0.257 . . . . 0.0 110.464 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 1.2 mp -65.75 -31.68 72.79 Favored 'General case' 0 CA--C 1.523 -0.076 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -70.63 -43.63 59.73 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.609 178.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.42 -45.49 87.33 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.638 0.256 . . . . 0.0 110.871 179.187 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 3.2 m -64.18 -41.12 97.23 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.621 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.05 -35.43 80.52 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.604 179.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.77 -39.69 94.04 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.75 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.24 -10.14 59.23 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.881 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -108.31 -0.49 33.18 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.851 179.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . 0.459 ' HZ2' ' O ' ' A' ' 20' ' ' CYS . 0.2 OUTLIER -94.17 -5.76 46.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.758 0.313 . . . . 0.0 110.8 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.13 -50.03 89.93 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.628 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.5 -25.1 79.86 Favored 'Trans proline' 0 C--N 1.361 1.232 0 C-N-CA 121.999 1.8 . . . . 0.0 112.176 178.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -70.15 -40.83 74.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.279 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.5 pt -96.09 4.82 8.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.832 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -57.14 -58.92 12.07 Favored Glycine 0 CA--C 1.52 0.363 0 CA-C-N 115.845 -0.616 . . . . 0.0 113.152 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.2 -25.59 78.69 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 122.635 2.223 . . . . 0.0 112.283 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 37.9 mm -80.21 -35.54 15.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.011 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 5.1 tp -61.64 -24.99 67.08 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.154 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -63.14 -34.6 90.4 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.119 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -81.77 -22.37 37.24 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.005 0.431 . . . . 0.0 110.721 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 52.3 mt -80.28 -33.16 13.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.193 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.56 -28.35 67.72 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.236 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -70.78 -20.19 62.63 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-O 120.828 0.347 . . . . 0.0 110.681 179.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 89.6 mt -80.22 -18.24 50.06 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.952 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -82.79 -17.34 44.49 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.946 0.403 . . . . 0.0 110.696 179.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -82.28 -22.62 35.63 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.191 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 2.4 m -99.48 4.07 10.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.261 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 148.33 98.03 0.19 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.682 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -82.25 80.31 1.79 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.608 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -100.59 142.45 15.84 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.745 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 6.6 m -74.67 -18.7 16.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-O 120.774 0.321 . . . . 0.0 111.448 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -65.0 -30.38 77.86 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 121.026 -0.606 . . . . 0.0 112.531 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.47 -44.11 83.63 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-O 120.779 0.323 . . . . 0.0 110.392 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . 0.447 ' O ' HG13 ' A' ' 152' ' ' ILE . 0.8 OUTLIER -62.09 -43.36 99.0 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.549 179.247 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.07 -42.21 89.71 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.927 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.28 -37.81 88.71 Favored 'General case' 0 CA--C 1.524 -0.05 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.532 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -61.09 -48.28 82.43 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.886 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 148' ' ' LEU . 42.0 mt -63.73 -45.01 98.49 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.566 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 4.7 tp -64.82 -38.59 91.5 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.621 0.248 . . . . 0.0 110.915 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -59.52 -42.38 97.63 Favored Glycine 0 C--N 1.334 0.428 0 CA-C-N 116.031 -0.532 . . . . 0.0 112.424 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.473 ' O ' ' HD2' ' A' ' 158' ' ' PRO . 0.4 OUTLIER -80.95 -25.05 37.68 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.836 0.318 . . . . 0.0 111.179 178.963 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -62.93 -38.82 92.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.652 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.504 ' HB ' ' HD3' ' A' ' 158' ' ' PRO . 4.8 t -57.58 -56.72 31.31 Favored Pre-proline 0 CA--C 1.545 0.771 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.504 ' HD3' ' HB ' ' A' ' 157' ' ' VAL . 33.4 Cg_exo -61.04 -35.43 87.21 Favored 'Trans proline' 0 C--N 1.36 1.141 0 C-N-CA 122.131 1.887 . . . . 0.0 112.236 178.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . 0.492 ' O ' ' HB1' ' A' ' 163' ' ' ALA . 4.9 t80 -61.73 -42.93 99.61 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.846 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -65.67 -38.15 88.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.627 0.251 . . . . 0.0 110.491 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.46 HG21 ' O ' ' A' ' 157' ' ' VAL . 91.7 t -60.82 -49.86 82.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.047 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 158' ' ' PRO . 11.8 m -72.64 -36.31 53.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 120.931 -0.308 . . . . 0.0 111.539 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.551 ' O ' ' HB2' ' A' ' 167' ' ' ASP . . . -57.79 -35.87 71.39 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 5.8 tp -80.05 -45.65 17.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.7 0.286 . . . . 0.0 111.048 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -65.36 -44.11 88.7 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.897 -179.213 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.472 ' O ' ' HB2' ' A' ' 170' ' ' LYS . . . -71.83 -19.15 62.02 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.388 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . 0.551 ' HB2' ' O ' ' A' ' 163' ' ' ALA . 14.1 t70 -76.63 -40.85 48.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.145 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 10.9 mmt-85 -69.55 -43.32 73.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.254 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 4.6 pt -76.32 -18.91 15.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 166' ' ' ALA . 0.0 OUTLIER -60.1 -33.42 72.08 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.697 -0.229 . . . . 0.0 111.56 -179.676 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -63.79 -38.53 96.3 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.586 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -86.66 -38.77 16.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.625 0.25 . . . . 0.0 111.26 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -65.16 -16.81 63.91 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.663 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.43 -52.56 65.1 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 120.806 0.336 . . . . 0.0 110.632 178.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.92 -30.52 14.72 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.619 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -84.79 4.97 30.45 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -81.15 33.58 2.44 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 121.146 -0.55 . . . . 0.0 113.348 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . 0.401 ' O ' ' HB2' ' A' ' 181' ' ' HIS . 0.4 OUTLIER -80.29 -38.79 30.08 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.916 0.389 . . . . 0.0 110.718 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 19.5 mm -73.27 -30.27 30.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.847 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.08 -16.95 64.65 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.375 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . 0.401 ' HB2' ' O ' ' A' ' 178' ' ' ARG . 3.3 m80 -61.89 -38.38 88.1 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.086 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -75.66 -27.6 58.41 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 121.031 0.443 . . . . 0.0 110.477 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 3.2 t -75.88 -18.54 15.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.47 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -83.4 -27.72 29.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.601 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.485 ' O ' HG23 ' A' ' 189' ' ' VAL . 51.2 t -63.13 -47.79 90.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.547 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.441 ' O ' HG22 ' A' ' 190' ' ' VAL . 1.0 OUTLIER -62.04 -40.66 96.48 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.796 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -62.49 -38.2 88.95 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.506 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.515 ' O ' HG21 ' A' ' 192' ' ' VAL . . . -68.67 -42.88 78.51 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.035 179.202 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 185' ' ' VAL . 88.7 t -61.84 -49.66 83.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-O 120.763 0.316 . . . . 0.0 110.671 179.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.441 HG22 ' O ' ' A' ' 186' ' ' LEU . 50.4 t -63.35 -35.77 73.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.706 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.56 -46.83 83.46 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.804 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . 0.515 HG21 ' O ' ' A' ' 188' ' ' GLY . 22.5 t -62.53 -42.29 95.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.345 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 23.5 mt -64.2 -44.57 91.56 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.788 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 69.0 t -63.77 -40.37 88.82 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.366 179.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -57.82 -45.52 93.43 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.159 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 32.4 t -70.72 -40.09 76.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.682 0.277 . . . . 0.0 110.606 179.293 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.16 -39.04 93.52 Favored 'General case' 0 C--O 1.225 -0.205 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.044 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.4 mp -72.83 -30.74 64.27 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.497 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -59.12 -54.56 45.57 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.99 0.424 . . . . 0.0 111.055 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -89.19 -7.16 56.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.967 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -83.15 -4.56 89.71 Favored Glycine 0 N--CA 1.452 -0.256 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.712 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.64 68.64 0.1 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.674 0.39 . . . . 0.0 111.59 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -165.23 -73.05 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.398 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 6.8 t -158.22 12.19 0.18 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.104 0.478 . . . . 0.0 111.302 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -84.16 -16.01 45.06 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.191 -179.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . 0.472 ' O ' ' HB2' ' A' ' 210' ' ' PHE . 3.6 mt -74.89 -30.09 61.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.203 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.72 -34.87 76.35 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.169 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.19 -40.24 93.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.312 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -87.13 -26.6 23.54 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.25 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . 0.472 ' HB2' ' O ' ' A' ' 206' ' ' LEU . 0.2 OUTLIER -66.62 -21.16 66.12 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.142 179.764 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.43 -27.54 69.18 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.981 0.42 . . . . 0.0 110.782 179.163 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 5.4 mmm180 -92.3 -4.47 53.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.666 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 10.4 mm -103.55 -11.07 9.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.014 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.75 118.09 31.51 Favored Pre-proline 0 C--O 1.233 0.218 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.155 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -61.67 155.74 51.93 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.815 2.343 . . . . 0.0 112.476 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.94 -27.55 68.31 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.447 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' TRP . . . . . 0.441 ' O ' ' HB2' ' A' ' 221' ' ' TYR . 0.2 OUTLIER -68.73 -28.28 66.69 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.765 179.546 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.22 -29.24 26.71 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -67.71 -38.02 83.06 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.163 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 42.4 mtp180 -84.3 -3.59 58.33 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.058 179.375 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . 0.441 ' HB2' ' O ' ' A' ' 217' ' ' TRP . 0.3 OUTLIER -109.24 7.31 25.27 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.831 0.348 . . . . 0.0 110.757 179.759 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -87.09 118.41 69.98 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.394 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -70.13 143.47 49.14 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.415 2.076 . . . . 0.0 112.659 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.318 -0.849 . . . . 0.0 111.201 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 ttt . . . . . 0 N--CA 1.485 1.288 0 CA-C-O 120.83 0.348 . . . . 0.0 110.739 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.445 ' HB2' ' OG ' ' A' ' 4' ' ' SER . 0.0 OUTLIER -87.57 -31.95 19.6 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.812 179.786 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 62.61 24.99 14.88 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 123.838 0.711 . . . . 0.0 111.771 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . 0.445 ' OG ' ' HB2' ' A' ' 2' ' ' SER . 0.0 OUTLIER -75.45 -24.35 57.0 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.965 0.412 . . . . 0.0 111.028 179.702 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.6 mp -81.36 -42.87 19.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.383 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.39 -29.83 69.44 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.936 0.398 . . . . 0.0 110.532 179.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.65 -52.19 28.01 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.312 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.69 -27.85 69.53 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.995 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -69.66 -49.23 55.57 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.526 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.407 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 0.2 OUTLIER -65.26 -37.32 86.84 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.482 179.404 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.67 -46.1 80.38 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.764 0.316 . . . . 0.0 110.992 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -65.41 -43.32 95.1 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.323 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -66.92 -31.79 55.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 120.77 0.319 . . . . 0.0 111.005 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.407 ' HB2' ' O ' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -67.43 -50.51 59.06 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.154 179.703 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 3.7 m -67.87 -24.83 65.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.76 0.314 . . . . 0.0 110.776 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -72.66 -41.12 65.77 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.215 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.432 ' O ' HD12 ' A' ' 213' ' ' ILE . 11.7 mt -86.8 -7.86 57.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.107 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.64 130.02 91.82 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.404 178.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -71.15 -8.03 22.64 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.497 2.131 . . . . 0.0 112.829 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.8 m -66.85 150.46 49.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.06 0.457 . . . . 0.0 111.054 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -71.51 94.98 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.418 -179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -143.63 -54.37 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.376 179.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -66.25 -18.47 55.78 Favored 'Trans proline' 0 C--N 1.361 1.192 0 C-N-CA 122.256 1.971 . . . . 0.0 112.42 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.3 mt -88.02 -13.15 42.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.303 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.43 ' HB ' ' HD3' ' A' ' 26' ' ' PRO . 20.8 t -57.34 -50.1 90.09 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.627 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.43 ' HD3' ' HB ' ' A' ' 25' ' ' VAL . 52.0 Cg_exo -55.97 -40.63 83.85 Favored 'Trans proline' 0 C--N 1.363 1.318 0 C-N-CA 122.237 1.958 . . . . 0.0 112.907 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.75 -36.84 78.87 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.795 0.331 . . . . 0.0 111.406 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -77.46 -41.01 41.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.265 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.54 -22.75 66.16 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.012 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -64.94 -59.24 4.4 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 178.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -60.79 -33.22 72.65 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.099 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.2 mt -71.91 -16.38 62.11 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.879 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -93.7 -0.72 66.44 Favored Glycine 0 N--CA 1.452 -0.287 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 178.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 66.67 -109.31 2.84 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 121.403 -0.427 . . . . 0.0 112.704 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -119.13 10.58 12.13 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.011 0.434 . . . . 0.0 110.659 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -131.21 40.91 3.4 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.887 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -100.15 99.77 2.09 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.214 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.81 129.47 29.81 Favored Pre-proline 0 C--N 1.326 -0.414 0 O-C-N 122.804 -0.233 . . . . 0.0 110.85 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -65.18 -23.43 60.05 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.817 2.344 . . . . 0.0 112.84 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -66.02 -44.48 84.6 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.081 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -72.17 -33.36 67.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.226 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.423 ' O ' ' HB2' ' A' ' 46' ' ' PHE . 8.0 t-20 -65.23 -50.25 66.57 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.319 178.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.81 -39.7 94.86 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.879 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.38 -50.48 71.39 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.974 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -66.19 -36.82 84.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.069 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.446 ' O ' ' HB2' ' A' ' 50' ' ' PHE . 0.2 OUTLIER -63.51 -49.83 72.0 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.239 179.462 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 tt -65.97 -28.73 44.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-O 120.728 0.299 . . . . 0.0 110.895 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.75 -55.46 5.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.701 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.486 ' O ' HG21 ' A' ' 53' ' ' VAL . . . -57.54 -44.55 93.77 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.152 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.446 ' HB2' ' O ' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -70.92 -32.4 69.3 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 110.503 -0.184 . . . . 0.0 110.503 179.532 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -63.16 -48.62 78.18 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.517 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.28 -43.21 92.55 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.743 0.306 . . . . 0.0 110.752 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.486 HG21 ' O ' ' A' ' 49' ' ' GLY . 98.9 t -66.22 -43.3 91.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.029 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.7 -28.73 69.28 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.396 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -84.35 -45.07 13.16 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.526 0.203 . . . . 0.0 110.849 179.335 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.93 -39.16 93.52 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.198 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.33 -18.18 27.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.733 0.302 . . . . 0.0 110.381 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.95 -33.0 73.91 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 121.189 -0.529 . . . . 0.0 112.255 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.577 ' O ' HG23 ' A' ' 62' ' ' THR . 1.1 mm? -64.52 -57.69 16.21 Favored Pre-proline 0 CA--C 1.537 0.481 0 CA-C-O 119.453 -0.308 . . . . 0.0 111.509 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -67.86 -13.39 38.37 Favored 'Trans proline' 0 C--N 1.36 1.169 0 C-N-CA 122.064 1.842 . . . . 0.0 112.623 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -55.7 -27.46 50.4 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.619 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.577 HG23 ' O ' ' A' ' 59' ' ' LEU . 8.6 t -66.32 -32.74 74.32 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.929 0.395 . . . . 0.0 110.64 179.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.86 -20.42 24.64 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.855 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.5 mt -64.88 -17.42 64.28 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.2 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -63.32 -30.14 76.65 Favored Glycine 0 C--N 1.334 0.442 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.474 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.08 -24.88 70.32 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 121.02 -0.61 . . . . 0.0 111.686 178.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 tp -85.11 -20.87 29.67 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.689 0.28 . . . . 0.0 110.569 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.7 -19.58 64.03 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.977 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -64.22 -25.13 67.93 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.799 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -108.42 118.38 36.62 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -77.83 109.08 11.55 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.102 0.477 . . . . 0.0 110.92 -179.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.4 mmm180 -78.89 90.21 4.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.332 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -68.76 -18.28 64.18 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.821 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 1.8 t -67.94 -26.21 65.85 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.163 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.1 tp -69.24 -35.84 76.56 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.924 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.79 -34.69 78.75 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.378 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -69.73 -43.35 72.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.433 179.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 99.4 t -64.74 -45.24 95.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.187 179.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.73 -40.1 97.61 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.961 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -64.49 -38.64 96.03 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.796 178.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 40.9 t -62.12 -41.78 92.57 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-O 120.699 0.285 . . . . 0.0 110.579 179.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 67.9 t -60.5 -41.74 88.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.666 179.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.5 mt -64.32 -41.73 96.66 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.549 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 93.6 t -66.98 -41.6 87.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.285 178.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.74 -41.16 97.29 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.708 179.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -61.95 -41.21 97.73 Favored 'General case' 0 CA--C 1.523 -0.091 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 178.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -65.12 -40.6 97.0 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.852 -0.689 . . . . 0.0 111.812 178.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 53.8 mt -62.16 -38.23 88.23 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.808 0.337 . . . . 0.0 110.854 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -77.12 -30.42 55.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.659 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 8.9 mtp -72.3 -19.6 61.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.869 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.89 -7.06 25.11 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.132 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.79 19.16 48.97 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.913 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.77 130.51 43.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.808 0.304 . . . . 0.0 110.63 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.49 146.19 88.54 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.19 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -63.02 111.95 1.54 Allowed 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.774 2.316 . . . . 0.0 112.378 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 6.9 mtm180 -96.63 89.35 4.94 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.878 0.37 . . . . 0.0 110.809 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 4.3 t-105 -135.65 98.45 3.93 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.085 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 72.96 -140.01 28.08 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.701 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -116.19 152.23 17.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.617 0.246 . . . . 0.0 110.509 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.49 -19.1 65.28 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.44 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 mt -78.27 -7.57 57.35 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.117 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 22.9 mtt180 -129.77 36.73 4.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.026 0.441 . . . . 0.0 110.426 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -76.2 114.71 15.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.536 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -113.95 125.34 53.92 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.844 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 154.02 119.95 0.74 Allowed Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.688 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -112.0 139.24 47.67 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.741 0.271 . . . . 0.0 110.49 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.434 ' O ' ' HD2' ' A' ' 110' ' ' PRO . 0.2 OUTLIER 58.62 73.0 0.49 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.237 0.542 . . . . 0.0 110.852 -179.41 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.98 -1.63 33.01 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.213 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.9 ttp180 -62.03 -56.57 30.4 Favored Pre-proline 0 CA--C 1.54 0.583 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.434 ' HD2' ' O ' ' A' ' 107' ' ' THR . 38.5 Cg_endo -66.79 -26.97 44.59 Favored 'Trans proline' 0 C--N 1.361 1.199 0 C-N-CA 121.865 1.71 . . . . 0.0 112.049 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.2 mt -70.73 -33.37 70.77 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.625 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -64.41 -41.53 98.02 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.435 178.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -73.96 -36.36 64.59 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 120.724 0.297 . . . . 0.0 110.442 178.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -66.19 -43.89 85.51 Favored 'General case' 0 C--N 1.334 -0.094 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.907 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.39 -34.37 78.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.984 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.17 -30.45 68.68 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.989 0.423 . . . . 0.0 110.093 179.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -80.83 -42.04 10.17 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 178.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.07 -42.9 95.54 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.621 0.248 . . . . 0.0 111.116 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 10.1 p -67.15 -38.56 85.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.049 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.82 -28.14 65.46 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.773 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -81.65 -34.41 30.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.833 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.84 -38.05 47.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.011 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -77.74 117.54 4.77 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.751 -0.737 . . . . 0.0 111.662 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . 0.528 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 77.8 m95 -67.59 143.3 56.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.704 0.288 . . . . 0.0 111.167 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.65 102.79 5.64 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.354 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.528 ' HD3' ' O ' ' A' ' 124' ' ' TRP . 57.3 Cg_endo -75.06 -16.85 19.85 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.705 2.27 . . . . 0.0 112.869 -179.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . 0.4 ' O ' HD11 ' A' ' 131' ' ' ILE . 0.8 OUTLIER -65.28 -48.02 74.63 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.112 -179.951 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.8 pt -101.56 5.42 10.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.535 -179.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -58.91 -67.3 2.25 Favored Glycine 0 CA--C 1.52 0.362 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.933 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -62.26 -29.63 80.42 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.36 2.04 . . . . 0.0 112.286 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.4 HD11 ' O ' ' A' ' 127' ' ' CYS . 65.3 mt -66.73 -54.41 25.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.135 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 15.1 mt -73.73 -31.22 63.25 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.095 -179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -63.69 -36.47 93.38 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.216 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.04 -43.23 71.68 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.836 0.351 . . . . 0.0 111.008 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 23.2 mm -71.92 -29.85 34.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.194 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.47 -46.95 83.09 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.016 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.0 -22.69 67.03 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.868 0.366 . . . . 0.0 111.591 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.54 ' O ' HG11 ' A' ' 141' ' ' VAL . 2.6 tp -86.13 -35.68 20.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.697 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 25.6 p -82.21 -20.01 38.61 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.354 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -82.84 -8.49 59.57 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.439 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . 0.54 HG11 ' O ' ' A' ' 138' ' ' LEU . 1.4 p -88.42 -8.0 10.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-O 121.163 0.506 . . . . 0.0 110.945 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -145.57 -64.28 0.02 OUTLIER Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.571 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 144.43 57.31 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.187 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -82.74 62.08 4.66 Favored Glycine 0 N--CA 1.453 -0.173 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.734 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 9.5 m -70.26 -25.51 27.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.833 0.349 . . . . 0.0 111.28 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -63.61 -30.69 78.38 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.252 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -67.35 -42.49 83.42 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.822 0.344 . . . . 0.0 110.233 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.99 -40.95 97.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.58 179.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.438 ' O ' HG13 ' A' ' 152' ' ' ILE . 0.6 OUTLIER -68.3 -42.1 79.94 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.452 179.233 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -66.31 -29.82 70.11 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.638 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -64.63 -57.78 8.14 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.053 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 149' ' ' LEU . 0.9 OUTLIER -63.26 -42.75 97.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.377 -179.377 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.08 -32.97 72.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.745 -0.207 . . . . 0.0 110.74 179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -60.42 -41.11 98.42 Favored Glycine 0 C--O 1.223 -0.547 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.001 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 29.6 tp -80.29 -29.0 38.21 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.693 0.282 . . . . 0.0 110.8 178.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.3 -39.36 79.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.425 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.532 ' O ' HG21 ' A' ' 161' ' ' VAL . 49.8 t -57.28 -63.81 3.3 Favored Pre-proline 0 CA--C 1.542 0.671 0 O-C-N 123.253 0.345 . . . . 0.0 111.817 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.506 ' CD ' ' HB ' ' A' ' 157' ' ' VAL . 20.7 Cg_endo -60.43 -33.56 93.98 Favored 'Trans proline' 0 C--N 1.362 1.272 0 C-N-CA 122.188 1.926 . . . . 0.0 112.637 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.35 -44.74 95.27 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.631 -0.258 . . . . 0.0 110.938 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -69.36 -35.08 75.51 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.758 0.314 . . . . 0.0 110.358 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.532 HG21 ' O ' ' A' ' 157' ' ' VAL . 89.4 t -62.21 -47.34 93.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.214 178.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 158' ' ' PRO . 58.2 t -67.04 -41.97 87.91 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.609 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -57.37 -39.37 75.86 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.511 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -77.49 -40.96 41.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.206 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -70.3 -19.77 63.07 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.658 0.266 . . . . 0.0 111.159 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.59 -26.47 68.7 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.145 178.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -66.91 -38.31 85.99 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.551 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 6.1 mtp180 -65.83 -34.16 77.51 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.728 178.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 6.6 mt -75.3 -28.06 20.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.787 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.97 -36.76 77.83 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.197 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -61.38 -49.64 75.18 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.348 179.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 52.6 m95 -72.26 -26.26 61.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.808 0.337 . . . . 0.0 111.156 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.83 -23.75 61.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.958 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 14.8 mtp85 -75.82 -17.93 59.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.026 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.08 -43.83 95.22 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.063 0.459 . . . . 0.0 110.47 178.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -108.57 -76.55 0.61 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.116 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 98.51 -25.61 27.21 Favored Glycine 0 C--N 1.329 0.163 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.424 178.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 26.6 mtp180 -84.13 -10.56 57.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.966 0.412 . . . . 0.0 110.983 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 1.6 pt -76.84 -18.86 14.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.214 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.02 -22.27 65.56 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.432 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . 0.521 ' O ' HG21 ' A' ' 185' ' ' VAL . 0.1 OUTLIER -84.18 -23.0 30.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.935 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -72.83 -42.62 63.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.867 0.365 . . . . 0.0 110.66 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 4.4 m -71.5 -19.14 20.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.073 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -80.33 -37.56 32.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.608 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . 0.521 HG21 ' O ' ' A' ' 181' ' ' HIS . 91.6 t -68.98 -41.73 81.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.739 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 1.7 mp -61.25 -38.98 88.63 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.752 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -66.7 -36.28 82.12 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.16 178.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -66.35 -36.43 91.63 Favored Glycine 0 C--N 1.333 0.366 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.85 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 98.7 t -61.81 -52.86 55.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.846 0.355 . . . . 0.0 110.695 179.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.434 ' O ' HG21 ' A' ' 194' ' ' VAL . 4.0 t -63.4 -31.2 51.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.977 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.34 -54.26 46.08 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.203 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . 0.413 ' O ' HG22 ' A' ' 196' ' ' VAL . 35.0 m -68.29 -30.66 48.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.822 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.77 -50.75 69.82 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.19 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . 0.434 HG21 ' O ' ' A' ' 190' ' ' VAL . 58.8 t -66.46 -37.99 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.124 0 CA-C-O 120.883 0.373 . . . . 0.0 110.215 179.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -59.55 -47.21 92.04 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.441 178.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.413 HG22 ' O ' ' A' ' 192' ' ' VAL . 91.4 t -72.08 -36.81 58.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.619 0.247 . . . . 0.0 111.022 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.32 -31.74 73.02 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.699 0.285 . . . . 0.0 111.211 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.33 -33.91 21.97 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.68 -0.236 . . . . 0.0 111.296 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -77.23 -47.22 20.76 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.4 -35.29 17.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.677 0.275 . . . . 0.0 111.627 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -83.55 -63.64 1.69 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.405 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' THR . . . . . 0.417 ' O ' ' HB2' ' A' ' 205' ' ' ALA . 0.2 OUTLIER 54.3 -148.29 0.47 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 122.403 0.281 . . . . 0.0 110.819 -179.878 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 48.55 -111.07 0.41 Allowed 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 179.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.44 30.94 6.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.829 0.347 . . . . 0.0 110.975 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . 0.417 ' HB2' ' O ' ' A' ' 202' ' ' THR . . . -69.71 -14.4 62.78 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.386 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.1 mt -77.58 -16.12 58.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.956 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -64.84 -36.03 83.04 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.198 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 75.6 p -62.59 -36.96 84.36 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.122 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . 0.463 ' O ' HG12 ' A' ' 213' ' ' ILE . 1.6 m-85 -87.04 -22.71 25.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.057 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.02 -16.29 61.32 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.542 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.49 -29.63 69.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.847 0.356 . . . . 0.0 110.731 179.271 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.88 -6.3 48.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.997 0.427 . . . . 0.0 110.355 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . 0.463 HG12 ' O ' ' A' ' 209' ' ' PHE . 11.1 mm -93.56 -3.68 10.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.743 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.46 116.98 29.91 Favored Pre-proline 0 CA--C 1.529 0.16 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.411 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -69.3 122.24 9.04 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.564 2.176 . . . . 0.0 112.994 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -74.04 -22.7 59.45 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.794 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -70.15 -24.54 63.18 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.955 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.402 HD23 ' HG ' ' A' ' 10' ' ' LEU . 1.8 mm? -76.13 -30.55 58.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.279 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -74.15 -23.15 59.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.059 179.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 5.2 mmm180 -87.09 -1.04 57.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.827 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -94.78 2.53 55.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.031 0.444 . . . . 0.0 110.843 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.61 136.66 30.95 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.583 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -63.27 100.99 0.28 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.871 2.38 . . . . 0.0 112.651 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.195 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.103 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 mmt . . . . . 0 N--CA 1.485 1.285 0 CA-C-O 120.473 0.178 . . . . 0.0 110.569 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 58.91 -147.58 0.49 Allowed 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.422 -179.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.549 ' O ' ' HB3' ' A' ' 7' ' ' ALA . 0.3 OUTLIER -102.01 9.07 40.72 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.944 0.402 . . . . 0.0 110.43 179.333 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.89 -42.59 60.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.107 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.69 -42.25 64.44 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.793 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.54 -45.28 91.26 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.542 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.549 ' HB3' ' O ' ' A' ' 3' ' ' LEU . . . -59.41 -40.59 87.16 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.61 178.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 150' ' ' ALA . . . -61.02 -48.61 80.99 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.717 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -57.43 -46.82 83.14 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.776 179.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.0 mp -61.7 -45.8 92.43 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.509 178.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.25 -42.37 90.97 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.534 178.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.86 -44.28 98.26 Favored Glycine 0 C--N 1.334 0.417 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.887 178.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 74.4 t -63.5 -41.94 94.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-O 120.781 0.324 . . . . 0.0 110.517 179.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.94 -45.12 90.62 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.813 0.34 . . . . 0.0 110.522 179.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 9.9 m -64.42 -35.15 79.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.868 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -73.65 -34.13 64.82 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.327 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.6 mt -79.15 -14.86 58.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.979 0.419 . . . . 0.0 110.757 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 1.4 t -86.37 126.9 63.13 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.873 178.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 30.8 Cg_exo -61.56 -14.84 37.75 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.784 2.323 . . . . 0.0 112.654 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 6.0 t -81.23 66.92 6.97 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.142 0.496 . . . . 0.0 110.633 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.1 m -89.98 161.53 2.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.864 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.65 -55.73 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.517 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -66.58 -22.52 50.93 Favored 'Trans proline' 0 C--N 1.361 1.202 0 C-N-CA 122.289 1.993 . . . . 0.0 112.89 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -74.17 -13.6 60.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.59 179.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.431 ' N ' ' HD2' ' A' ' 26' ' ' PRO . 73.7 t -74.51 -56.58 2.33 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-O 119.675 -0.202 . . . . 0.0 111.399 179.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.431 ' HD2' ' N ' ' A' ' 25' ' ' VAL . 17.1 Cg_endo -57.54 -23.43 56.39 Favored 'Trans proline' 0 C--N 1.362 1.254 0 C-N-CA 122.614 2.209 . . . . 0.0 113.449 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.04 -24.86 66.51 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.721 0.296 . . . . 0.0 111.416 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -76.84 -38.07 54.45 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.907 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -82.94 -22.47 33.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.448 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -53.61 -28.7 34.05 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.438 178.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -62.35 -33.53 74.89 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 120.83 0.348 . . . . 0.0 110.854 178.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 21.9 mt -86.45 -22.99 26.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.622 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -93.94 3.27 70.27 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.999 -0.619 . . . . 0.0 111.683 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -81.59 65.7 3.97 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 121.399 -0.429 . . . . 0.0 112.505 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -89.62 -19.87 24.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.939 0.4 . . . . 0.0 111.188 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 9.4 mmm180 -109.51 -97.16 0.39 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.024 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 165.17 -176.38 40.87 Favored Glycine 0 N--CA 1.448 -0.5 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 4.9 ttm105 57.26 72.87 0.86 Allowed Pre-proline 0 N--CA 1.469 0.49 0 C-N-CA 122.575 0.35 . . . . 0.0 111.343 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.11 -23.99 39.15 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.487 2.125 . . . . 0.0 112.502 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.6 mt -66.26 -34.98 79.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.977 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -73.32 -37.57 66.11 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.03 -36.59 84.88 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.99 178.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.44 -47.19 82.9 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.331 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -56.01 -42.32 76.25 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.162 178.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.47 -37.66 77.38 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.6 0.238 . . . . 0.0 110.947 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -65.05 -48.34 74.15 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.324 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 13.3 pt -68.29 -27.91 38.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.678 0.275 . . . . 0.0 110.92 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.47 -51.35 29.76 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.484 ' O ' HG21 ' A' ' 53' ' ' VAL . . . -61.66 -43.85 98.71 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.081 179.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -67.32 -35.64 79.84 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.632 0.253 . . . . 0.0 110.609 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -63.08 -42.72 99.48 Favored Glycine 0 C--N 1.334 0.428 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.39 -44.88 92.71 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.672 0.273 . . . . 0.0 110.667 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.484 HG21 ' O ' ' A' ' 49' ' ' GLY . 26.5 t -65.49 -41.94 92.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.98 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.86 -34.68 78.95 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.917 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -76.56 -43.54 38.51 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.592 179.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.2 tp -61.12 -33.01 72.69 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.973 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 3.8 mt -89.73 -18.4 26.44 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.083 178.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -72.01 -32.04 63.75 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.334 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.18 -54.55 32.3 Favored Pre-proline 0 CA--C 1.543 0.69 0 N-CA-C 111.698 0.258 . . . . 0.0 111.698 179.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -67.46 -13.6 39.7 Favored 'Trans proline' 0 C--N 1.361 1.223 0 C-N-CA 122.559 2.172 . . . . 0.0 112.528 179.189 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -57.69 -20.87 37.07 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.387 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.3 p -62.04 -35.9 79.99 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.227 0.537 . . . . 0.0 110.45 178.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.4 -19.54 26.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.682 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 70.6 mt -75.38 -17.42 60.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.993 -179.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.61 -31.18 78.98 Favored Glycine 0 C--N 1.334 0.422 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.912 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -77.23 -29.61 56.14 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.146 179.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 tp -76.88 -25.07 52.63 Favored 'General case' 0 N--CA 1.461 0.094 0 CA-C-O 120.784 0.326 . . . . 0.0 110.817 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.62 -19.25 65.2 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.945 179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -71.29 -17.46 62.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.566 178.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.84 161.86 17.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.419 179.295 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 9.1 m-70 -82.26 77.27 9.08 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.043 0.449 . . . . 0.0 111.36 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.2 mmp_? -96.7 49.15 1.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.829 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -73.01 -22.16 60.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.865 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -65.26 -24.64 67.37 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.329 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.19 -23.16 44.04 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.734 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.96 -30.32 26.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.056 179.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.5 mmt-85 -60.27 -27.65 67.44 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.493 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.3 t -63.47 -26.46 40.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-O 120.964 0.411 . . . . 0.0 110.519 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -65.0 -34.81 90.87 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.919 -0.658 . . . . 0.0 111.824 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -66.93 -39.45 93.31 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.417 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.8 t -61.57 -40.35 86.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-O 120.875 0.369 . . . . 0.0 110.59 179.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 80.5 t -63.35 -39.68 86.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.386 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.98 -40.1 96.71 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.796 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 53.1 t -63.59 -44.09 98.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.222 179.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.58 -41.1 93.95 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.593 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -65.57 -42.94 91.24 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.331 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -61.98 -38.29 95.81 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.247 179.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.0 -38.47 91.05 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.813 0.339 . . . . 0.0 110.831 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -73.74 -30.14 62.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.345 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 6.7 mtp -71.11 -27.1 63.35 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.538 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 65.0 mt -63.82 -16.23 60.75 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.26 178.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.37 16.08 74.81 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.751 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.4 mp -77.4 137.85 38.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.918 0.39 . . . . 0.0 110.505 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 15.6 mtp180 -107.82 115.31 59.09 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.889 -178.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -63.31 124.51 13.97 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.632 2.221 . . . . 0.0 112.114 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.78 132.11 37.25 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.814 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -137.26 -67.99 0.48 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.603 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -112.45 -175.58 19.65 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.235 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.7 t -75.79 96.9 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.005 0.431 . . . . 0.0 110.795 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -98.39 99.21 10.38 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.841 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.85 31.33 6.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.208 0.528 . . . . 0.0 110.522 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.9 ptp180 -132.31 157.41 44.51 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.938 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -101.42 -9.48 21.06 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.895 0.379 . . . . 0.0 111.264 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 14.1 mp0 -127.61 -80.23 0.59 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.483 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 80.21 -61.6 4.36 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.606 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -128.46 -174.98 3.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.728 0.299 . . . . 0.0 110.454 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.34 105.45 8.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.404 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.74 -40.23 19.08 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.61 -56.53 34.69 Favored Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -60.91 -28.27 86.09 Favored 'Trans proline' 0 C--N 1.36 1.165 0 C-N-CA 122.32 2.014 . . . . 0.0 112.503 179.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.8 tp -69.09 -28.73 66.77 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.772 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -63.01 -33.79 88.21 Favored Glycine 0 C--N 1.336 0.572 0 C-N-CA 120.93 -0.652 . . . . 0.0 111.714 178.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -77.71 -34.17 52.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.94 0.4 . . . . 0.0 110.544 178.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -70.56 -38.35 74.12 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.708 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.29 -27.42 62.45 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.503 179.16 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.08 -44.88 94.46 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.305 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . 0.438 ' O ' ' HB1' ' A' ' 121' ' ' ALA . . . -71.65 -27.78 70.42 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.556 178.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.06 -48.45 65.55 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.674 0.273 . . . . 0.0 110.809 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 3.5 p -69.02 -31.88 71.0 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.866 0.365 . . . . 0.0 110.981 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -74.11 -39.88 63.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.778 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . 0.438 ' HB1' ' O ' ' A' ' 117' ' ' GLY . . . -65.16 -24.0 67.27 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.935 0.398 . . . . 0.0 110.962 178.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 43.5 mt -80.73 -18.36 48.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.477 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -95.78 81.23 0.81 Allowed Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 3.3 m0 -66.56 -82.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.729 0.3 . . . . 0.0 111.324 -179.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -144.57 65.84 13.12 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.575 179.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -74.76 -57.4 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.006 1.804 . . . . 0.0 112.492 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -86.06 -16.94 36.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.051 0.453 . . . . 0.0 110.466 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.2 mt -92.14 2.43 8.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.421 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -57.14 -60.68 8.59 Favored Glycine 0 CA--C 1.521 0.413 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.426 178.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -59.45 -35.03 97.13 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.459 2.106 . . . . 0.0 112.141 178.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ILE . . . . . 0.495 ' O ' HG13 ' A' ' 135' ' ' ILE . 19.1 mt -68.42 -49.18 68.44 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.956 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 tp -63.92 -34.48 78.05 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.755 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -61.17 -39.96 97.89 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.854 -0.689 . . . . 0.0 111.599 178.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -71.38 -30.95 66.73 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.82 0.343 . . . . 0.0 110.683 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ILE . . . . . 0.495 HG13 ' O ' ' A' ' 131' ' ' ILE . 79.7 mt -72.06 -31.87 41.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.642 179.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 7.7 mt -60.37 -35.8 76.55 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.908 179.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.5 -22.59 63.59 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.809 178.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.5 tp -81.65 -27.35 34.14 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.382 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.583 ' HA ' ' O ' ' A' ' 143' ' ' GLY . 0.3 OUTLIER -76.3 -17.36 59.47 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.631 179.401 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -71.82 -17.99 62.12 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.358 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 8.1 t -73.89 -28.8 24.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.984 0.421 . . . . 0.0 110.712 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 129.36 64.77 0.11 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.148 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.583 ' O ' ' HA ' ' A' ' 139' ' ' THR . . . 113.13 -152.25 18.04 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.16 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 115.73 20.45 5.36 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.378 -0.915 . . . . 0.0 112.729 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 11.7 p -66.12 -25.54 36.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 CA-C-O 120.961 0.41 . . . . 0.0 110.976 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -62.43 -30.32 75.98 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.093 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -67.4 -42.6 83.03 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.605 0.24 . . . . 0.0 110.503 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.8 tp -61.96 -43.75 98.19 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.512 179.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.519 ' O ' HG13 ' A' ' 152' ' ' ILE . 1.6 mp -67.95 -41.45 82.47 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.648 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.475 ' O ' ' HB3' ' A' ' 8' ' ' ALA . . . -64.52 -35.14 80.0 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.477 178.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -61.05 -54.66 42.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.421 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.519 HG13 ' O ' ' A' ' 149' ' ' LEU . 0.5 OUTLIER -63.8 -42.67 96.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.874 -179.778 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -64.44 -40.76 96.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.169 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -59.36 -41.51 96.99 Favored Glycine 0 C--N 1.334 0.429 0 CA-C-N 116.207 -0.451 . . . . 0.0 112.758 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 7.0 mt -80.59 -26.67 37.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.814 0.34 . . . . 0.0 111.016 178.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -62.7 -37.35 86.13 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.314 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.484 ' HB ' ' CD ' ' A' ' 158' ' ' PRO . 96.5 t -54.8 -63.66 2.69 Favored Pre-proline 0 CA--C 1.541 0.601 0 O-C-N 123.382 0.426 . . . . 0.0 111.642 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' PRO . . . . . 0.484 ' CD ' ' HB ' ' A' ' 157' ' ' VAL . 28.7 Cg_endo -62.65 -36.64 62.57 Favored 'Trans proline' 0 C--N 1.358 1.077 0 C-N-CA 121.765 1.643 . . . . 0.0 112.578 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -58.92 -48.27 82.07 Favored 'General case' 0 N--CA 1.462 0.134 0 O-C-N 123.017 0.198 . . . . 0.0 111.37 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -65.8 -39.28 90.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.958 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 92.9 t -63.61 -44.26 98.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.188 178.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.415 ' O ' ' HB1' ' A' ' 166' ' ' ALA . 71.8 t -66.17 -44.91 91.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.284 178.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -58.02 -35.55 71.42 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.885 0.374 . . . . 0.0 111.377 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.7 mt -69.12 -45.83 69.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.011 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.13 -34.47 68.59 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.926 0.393 . . . . 0.0 110.624 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ALA . . . . . 0.451 ' O ' ' HB2' ' A' ' 170' ' ' LYS . . . -69.93 -19.06 63.4 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.999 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -67.0 -26.34 66.74 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.372 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 1.1 tpt85 -79.19 -46.6 17.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.06 0.457 . . . . 0.0 110.668 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.423 HG12 ' HA ' ' A' ' 166' ' ' ALA . 20.7 pt -75.03 -18.77 16.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.288 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.456 ' O ' ' HG3' ' A' ' 174' ' ' ARG . 0.2 OUTLIER -57.44 -44.27 84.58 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.057 179.751 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -68.29 -25.36 74.69 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.672 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 1.3 m-90 -86.9 -41.08 14.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.658 0.266 . . . . 0.0 111.201 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.82 -16.63 62.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.581 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.456 ' HG3' ' O ' ' A' ' 170' ' ' LYS . 0.0 OUTLIER -52.44 -54.69 28.96 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.764 0.316 . . . . 0.0 111.342 179.197 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 14.8 mtm180 -94.12 -16.36 23.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.567 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -92.21 1.37 57.26 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.72 0.295 . . . . 0.0 111.635 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -85.09 55.43 4.96 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.599 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.5 -53.02 3.45 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.981 0.419 . . . . 0.0 110.41 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 7.3 pt -74.26 -22.18 17.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.339 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' SER . . . . . 0.421 ' O ' ' HG3' ' A' ' 184' ' ' GLU . 0.3 OUTLIER -66.51 -18.71 65.51 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.467 179.975 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' HIS . . . . . 0.433 ' HA ' ' OE2' ' A' ' 184' ' ' GLU . 0.0 OUTLIER -63.85 -32.6 74.17 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.03 179.918 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -80.23 -25.31 39.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.93 0.395 . . . . 0.0 110.62 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 11.9 t -74.67 -25.34 18.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.44 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' GLU . . . . . 0.433 ' OE2' ' HA ' ' A' ' 181' ' ' HIS . 32.7 mt-10 -74.41 -29.68 61.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.649 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 11.4 t -69.62 -48.89 63.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.688 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.468 ' O ' HG21 ' A' ' 190' ' ' VAL . 2.7 mt -59.33 -43.18 92.77 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.841 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -68.9 -40.76 78.96 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.704 179.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.404 ' O ' HG22 ' A' ' 192' ' ' VAL . . . -62.69 -41.61 99.8 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.265 179.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 54.4 t -61.49 -52.41 61.44 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.103 0 CA-C-O 120.43 0.157 . . . . 0.0 110.803 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' VAL . . . . . 0.468 HG21 ' O ' ' A' ' 186' ' ' LEU . 54.8 t -58.16 -39.62 73.91 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.92 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 1.8 mt -61.71 -47.39 85.5 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.173 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' VAL . . . . . 0.404 HG22 ' O ' ' A' ' 188' ' ' GLY . 60.3 t -70.74 -35.89 62.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.657 0.265 . . . . 0.0 110.598 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.4 tp -59.83 -51.79 68.23 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.131 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 31.7 m -67.08 -29.61 46.71 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.585 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -65.36 -49.65 59.94 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.703 178.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 46.2 t -67.09 -37.74 79.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 O-C-N 122.744 -0.268 . . . . 0.0 110.328 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.53 -31.12 72.2 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.776 179.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -76.05 -29.78 58.15 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.075 0.464 . . . . 0.0 110.424 178.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -78.31 -41.17 34.51 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.602 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 66.9 p -86.24 -39.84 16.16 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -91.08 -4.74 68.6 Favored Glycine 0 C--N 1.329 0.174 0 C-N-CA 121.223 -0.513 . . . . 0.0 112.707 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.1 -142.44 0.56 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 122.69 0.396 . . . . 0.0 110.962 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -83.8 -11.41 57.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.769 0.319 . . . . 0.0 110.959 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.81 -43.23 80.15 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.46 179.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -74.55 -30.36 61.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.838 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 5.8 tp -73.17 -33.62 65.55 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.719 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -63.27 -41.38 99.01 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.786 0.327 . . . . 0.0 111.033 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 4.3 p -73.56 -25.36 60.34 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.076 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -87.44 -27.12 22.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.272 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -80.97 -15.64 55.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.494 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.17 -35.05 71.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.243 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.26 -6.37 55.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.245 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 4.6 mt -106.94 7.44 9.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.124 0.488 . . . . 0.0 110.801 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 2.3 p -61.49 122.33 69.98 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.865 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -60.16 145.9 97.47 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.367 2.044 . . . . 0.0 112.311 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -63.8 -21.16 66.29 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.329 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -73.2 -26.44 61.15 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.75 0.309 . . . . 0.0 110.913 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.21 -30.3 17.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.376 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.97 -22.79 63.12 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.518 179.129 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 1.2 ttp180 -85.32 -16.15 40.95 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.729 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -102.21 13.4 34.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.033 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.92 120.38 69.35 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.681 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -77.81 69.58 7.33 Favored 'Trans proline' 0 CA--C 1.53 0.306 0 C-N-CA 122.645 2.23 . . . . 0.0 112.502 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.93 0 CA-C-O 118.154 -0.927 . . . . 0.0 111.381 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.619 0.247 . . . . 0.0 110.365 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.55 102.18 9.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.902 0.382 . . . . 0.0 111.064 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.29 -18.79 61.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.916 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.31 -27.62 69.45 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.992 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.41 -48.26 82.52 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.778 0.323 . . . . 0.0 110.59 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.36 -45.69 92.05 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.774 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.403 ' HB1' ' HA ' ' A' ' 151' ' ' TYR . . . -64.19 -33.58 76.12 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.964 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.454 ' O ' HG23 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -66.69 -52.38 45.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.247 179.527 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.8 mp -61.33 -38.02 85.39 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.104 178.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.81 -43.03 99.88 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.468 178.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.3 -41.91 98.57 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 121.054 -0.593 . . . . 0.0 111.994 178.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 9' ' ' PHE . 48.2 t -64.59 -38.57 82.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.125 0.488 . . . . 0.0 109.839 178.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 60.1 mt -63.81 -41.17 97.94 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.5 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.6 m -65.46 -33.22 75.43 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.697 0.284 . . . . 0.0 110.877 179.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -69.35 -36.79 77.23 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.023 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.6 mp -90.5 -4.37 56.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.953 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.1 t -79.08 124.01 84.75 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.363 179.214 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.422 ' HG3' HD13 ' A' ' 213' ' ' ILE . 37.9 Cg_endo -67.44 -8.63 22.72 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.691 2.261 . . . . 0.0 112.709 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.422 ' SG ' ' HZ ' ' A' ' 210' ' ' PHE . 1.0 OUTLIER -88.11 -14.48 38.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.954 179.756 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.6 t -116.98 -79.74 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.188 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.423 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 15.0 mt 51.15 82.61 0.24 Allowed Pre-proline 0 N--CA 1.466 0.351 0 O-C-N 123.709 0.631 . . . . 0.0 111.699 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -55.23 -24.08 40.08 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.99 2.46 . . . . 0.0 113.273 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.4 tp -64.36 -26.2 68.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.717 -0.22 . . . . 0.0 111.133 178.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.442 ' HB ' ' CD ' ' A' ' 26' ' ' PRO . 71.4 t -67.48 -61.14 4.81 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.162 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.442 ' CD ' ' HB ' ' A' ' 25' ' ' VAL . 19.3 Cg_endo -59.11 -35.19 98.49 Favored 'Trans proline' 0 C--N 1.361 1.185 0 C-N-CA 122.032 1.821 . . . . 0.0 112.559 178.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 20.2 m -64.9 -36.54 84.68 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.714 0.292 . . . . 0.0 111.002 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.446 ' O ' ' HB2' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -66.53 -28.51 68.6 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.566 179.562 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 7.9 mt -85.06 -36.22 21.35 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.075 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -63.28 -44.05 96.18 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.549 178.647 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -73.63 -21.6 60.25 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.763 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.446 ' HB2' ' O ' ' A' ' 28' ' ' TYR . 2.1 tp -75.94 -18.85 59.18 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.4 179.266 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -89.59 -4.38 73.29 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.946 -0.645 . . . . 0.0 111.66 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.99 -59.46 4.94 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 121.161 -0.543 . . . . 0.0 112.666 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . 57.74 -113.28 0.72 Allowed 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 122.753 0.421 . . . . 0.0 111.024 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.11 -36.92 1.14 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.935 0.397 . . . . 0.0 110.725 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.11 18.08 11.85 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.094 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -111.77 96.96 35.53 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.514 0.197 . . . . 0.0 110.624 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -69.32 -32.04 21.21 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.507 2.138 . . . . 0.0 112.932 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.62 -44.37 90.75 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.132 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -73.79 -36.03 64.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.818 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -65.42 -42.24 92.71 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.165 178.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.49 -51.91 56.66 Favored 'General case' 0 C--O 1.227 -0.126 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.627 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.33 -42.0 73.19 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.244 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -64.07 -44.69 91.65 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.861 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.46 -40.41 89.39 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.62 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 55.5 mt -60.71 -48.57 88.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.573 179.116 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.65 -45.83 81.48 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.905 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.587 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -59.84 -48.45 85.99 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.407 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.03 -41.75 90.52 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.55 0.214 . . . . 0.0 110.998 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -61.74 -44.26 98.13 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.078 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.12 -46.04 90.96 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.658 0.266 . . . . 0.0 111.11 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 49' ' ' GLY . 46.1 t -65.25 -42.23 93.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.098 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -64.29 -28.29 69.62 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.531 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -84.95 -46.61 11.08 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.896 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.87 -39.21 93.19 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.09 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.448 ' HB2' ' O ' ' A' ' 53' ' ' VAL . 1.0 OUTLIER -85.82 -19.07 31.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.487 179.386 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.421 ' O ' ' HB2' ' A' ' 61' ' ' PHE . . . -74.69 -26.69 66.73 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.203 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.68 -56.41 33.04 Favored Pre-proline 0 CA--C 1.54 0.59 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -65.65 -13.78 41.51 Favored 'Trans proline' 0 C--N 1.362 1.281 0 C-N-CA 122.305 2.004 . . . . 0.0 113.155 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.421 ' HB2' ' O ' ' A' ' 58' ' ' GLY . 8.2 m-30 -61.44 -17.94 56.63 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.651 0.262 . . . . 0.0 111.422 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 21.8 p -71.89 -41.34 68.08 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.135 0.493 . . . . 0.0 110.195 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.3 mt -88.48 -21.63 24.09 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.888 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.86 -17.9 64.06 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.901 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -63.43 -24.52 67.7 Favored Glycine 0 C--N 1.335 0.477 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.934 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.49 -21.82 76.64 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.149 179.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.69 -20.67 46.01 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.833 0.349 . . . . 0.0 110.631 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.457 HD13 ' HA ' ' A' ' 68' ' ' LEU . 1.4 mm? -64.32 -19.26 65.32 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.995 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -69.73 -17.62 63.46 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.814 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -97.27 -133.36 0.22 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.906 179.006 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -151.03 126.26 9.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.909 0.385 . . . . 0.0 110.841 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -134.59 37.71 3.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.598 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -66.88 -18.09 65.21 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.411 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.46 -18.06 65.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.398 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.4 mp -74.15 -22.86 59.25 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.624 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.19 -24.11 51.44 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.502 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.451 ' O ' HG23 ' A' ' 81' ' ' VAL . 0.2 OUTLIER -71.79 -33.56 68.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.888 179.798 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.486 ' O ' HG23 ' A' ' 82' ' ' VAL . 41.9 t -62.52 -36.76 76.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.729 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.67 -36.8 93.8 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.068 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.449 ' O ' HG23 ' A' ' 84' ' ' VAL . . . -66.34 -41.59 94.46 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.873 -0.679 . . . . 0.0 111.764 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 77' ' ' ARG . 21.5 t -60.49 -43.88 95.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 120.83 0.348 . . . . 0.0 110.714 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 78' ' ' VAL . 47.1 t -63.91 -41.07 91.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.601 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.87 -43.16 99.55 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.771 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 80' ' ' GLY . 92.7 t -62.97 -44.95 99.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-O 120.832 0.349 . . . . 0.0 110.429 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.78 -41.46 97.74 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.72 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -66.52 -40.17 89.04 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.667 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -61.34 -39.52 97.35 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.997 -0.621 . . . . 0.0 111.893 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.5 -40.93 98.37 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.829 0.347 . . . . 0.0 110.698 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -71.72 -31.45 66.73 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.548 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 5.2 mtt -67.12 -27.59 67.46 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.473 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.74 -9.58 51.46 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.024 178.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.56 11.27 83.32 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.849 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.34 145.15 25.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.926 0.393 . . . . 0.0 110.842 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.324 -0.501 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.613 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.228 0 CA-C-O 120.889 0.376 . . . . 0.0 111.011 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.3 -13.66 43.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.299 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.46 ' N ' ' HD2' ' A' ' 110' ' ' PRO . 0.0 OUTLIER -66.85 -52.54 32.08 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.933 179.845 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' A' ' 109' ' ' ARG . 36.6 Cg_endo -65.18 -15.56 50.79 Favored 'Trans proline' 0 C--N 1.363 1.325 0 C-N-CA 122.069 1.846 . . . . 0.0 112.797 179.488 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.416 ' O ' ' HB2' ' A' ' 115' ' ' LEU . 0.5 OUTLIER -67.65 -39.64 84.58 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.682 179.857 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -69.28 -31.88 71.91 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.628 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -71.42 -46.16 60.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.888 0.375 . . . . 0.0 110.775 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -67.98 -39.16 83.34 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.063 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.416 ' HB2' ' O ' ' A' ' 111' ' ' LEU . 0.7 OUTLIER -65.23 -40.2 93.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.79 179.474 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.59 -33.62 76.36 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.705 0.288 . . . . 0.0 110.522 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -66.52 -48.85 60.15 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.21 178.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.44 -29.84 70.56 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.753 0.311 . . . . 0.0 110.713 178.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 52.7 m -61.89 -44.81 96.04 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.811 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.2 mt -69.87 -21.43 63.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.384 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -85.22 -40.86 16.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.484 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.1 mp -85.83 -33.06 21.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.741 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -80.55 92.24 1.41 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.392 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -81.69 132.87 35.31 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.894 0.378 . . . . 0.0 110.913 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.0 113.14 45.96 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.789 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -63.68 -22.37 69.95 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.827 2.351 . . . . 0.0 112.963 -179.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -70.45 -25.69 63.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.244 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.5 mm -103.1 2.37 10.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.111 0.482 . . . . 0.0 110.406 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -61.53 -59.64 9.51 Favored Glycine 0 CA--C 1.521 0.44 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.611 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -57.4 -34.78 98.51 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 122.72 2.28 . . . . 0.0 112.323 178.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 16.0 mm -67.83 -43.45 86.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.808 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.39 -37.37 66.01 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.465 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -61.38 -31.17 76.37 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 121.075 -0.583 . . . . 0.0 112.197 178.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.74 -21.91 62.48 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.908 0.385 . . . . 0.0 110.927 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 38.4 mm -79.58 -30.34 13.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.681 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.07 -39.26 94.2 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.574 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.11 -23.76 67.24 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.105 178.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.76 -33.5 19.92 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.743 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 23.6 p -80.3 -17.16 52.9 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.357 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -75.94 -29.23 58.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.98 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 21.8 m -100.15 2.91 10.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.266 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -173.43 -90.07 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.478 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 151.3 -152.58 24.34 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.431 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 167.52 63.01 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.264 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' VAL . . . . . 0.405 ' H ' HG23 ' A' ' 145' ' ' VAL . 1.7 t -62.25 -49.17 85.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.87 0.367 . . . . 0.0 110.672 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -65.82 -28.98 74.13 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.937 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.42 -44.06 83.97 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.809 0.338 . . . . 0.0 110.453 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.93 -42.37 99.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.384 179.03 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 34.4 mt -66.26 -39.25 89.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.385 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -61.58 -38.81 88.91 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.561 178.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.403 ' HA ' ' HB1' ' A' ' 8' ' ' ALA . 0.2 OUTLIER -62.52 -47.59 83.24 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.654 179.23 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 17.6 mt -64.87 -46.9 90.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.382 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.43 ' O ' HG23 ' A' ' 157' ' ' VAL . 0.2 OUTLIER -62.09 -37.7 86.05 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.951 179.28 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -60.13 -38.84 95.0 Favored Glycine 0 C--O 1.224 -0.518 0 C-N-CA 121.273 -0.489 . . . . 0.0 112.058 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.403 HD13 ' HA ' ' A' ' 155' ' ' LEU . 0.9 OUTLIER -79.98 -26.31 40.0 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.678 0.275 . . . . 0.0 110.971 178.627 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -64.48 -37.46 87.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.153 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.515 ' O ' HG23 ' A' ' 161' ' ' VAL . 59.4 t -55.33 -62.73 3.91 Favored Pre-proline 0 CA--C 1.541 0.633 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.824 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.494 ' CD ' ' HB ' ' A' ' 157' ' ' VAL . 17.9 Cg_endo -59.68 -36.59 91.58 Favored 'Trans proline' 0 C--N 1.36 1.157 0 C-N-CA 122.123 1.882 . . . . 0.0 112.339 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.08 -44.82 96.78 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.271 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -66.11 -40.47 90.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.635 0.255 . . . . 0.0 110.708 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 157' ' ' VAL . 48.3 t -63.88 -45.43 97.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.499 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 60.9 t -65.07 -40.24 88.29 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.606 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -58.8 -41.7 87.36 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.547 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.97 -39.23 63.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.238 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -70.9 -27.65 63.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.739 0.304 . . . . 0.0 110.8 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -64.46 -18.75 65.05 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.532 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -62.77 -46.65 87.05 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.758 0.313 . . . . 0.0 111.044 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -78.24 -34.0 49.43 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.742 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 58.1 mt -69.74 -23.1 25.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.921 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -59.69 -39.1 83.41 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.913 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -71.54 -23.8 77.59 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.674 179.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 60.2 t-105 -81.64 -37.89 26.81 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.423 0.154 . . . . 0.0 111.133 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.59 -38.04 59.23 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -87.47 -15.67 36.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.495 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.16 -27.59 18.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.466 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -53.47 -65.78 0.5 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.758 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 131.3 -124.47 4.11 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.806 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 2.7 mtt180 -100.26 0.6 40.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.675 0.274 . . . . 0.0 111.357 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 7.9 mt -66.81 -33.8 65.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.965 0.412 . . . . 0.0 110.844 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.47 -20.22 66.05 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.315 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 37.7 m170 -84.01 -21.45 31.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.83 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -73.1 -45.91 54.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.524 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 3.6 m -73.54 -19.57 18.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.186 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -65.11 -50.79 64.69 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.708 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.462 ' O ' HG23 ' A' ' 189' ' ' VAL . 2.4 m -81.82 -28.08 9.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.506 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.41 ' O ' HG23 ' A' ' 190' ' ' VAL . 1.2 tp -58.59 -50.72 72.8 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.19 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -62.21 -35.34 78.59 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.785 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.432 ' O ' HG23 ' A' ' 192' ' ' VAL . . . -65.28 -42.33 96.26 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.193 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 185' ' ' VAL . 94.8 t -62.55 -47.56 92.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 120.76 0.314 . . . . 0.0 110.724 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 186' ' ' LEU . 39.5 t -62.18 -39.42 83.89 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.891 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.98 -46.52 87.9 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.841 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 188' ' ' GLY . 55.8 t -66.51 -40.55 86.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.422 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.403 ' O ' ' HB2' ' A' ' 197' ' ' LEU . 4.3 mt -60.98 -46.57 90.19 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.961 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 87.5 t -66.93 -41.1 87.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.801 0.334 . . . . 0.0 110.262 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -62.44 -43.46 99.01 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.742 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 3.6 p -72.93 -32.36 39.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 116.8 0.3 . . . . 0.0 111.279 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.53 HD23 HD11 ' A' ' 206' ' ' LEU . 0.5 OUTLIER -74.85 -22.46 58.67 Favored 'General case' 0 C--N 1.334 -0.078 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.122 179.84 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.2 mp -84.76 -38.92 19.05 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.379 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -67.17 -47.75 70.03 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.127 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 81.3 p -84.42 -20.27 32.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.255 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -78.39 -48.78 7.16 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.245 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 57.3 -133.42 1.28 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.653 0.263 . . . . 0.0 111.501 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -81.25 84.11 6.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.916 0.388 . . . . 0.0 111.153 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.765 HG23 ' H ' ' A' ' 206' ' ' LEU . 13.7 t -150.75 -161.61 1.37 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.651 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -59.71 -14.38 13.96 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 122.643 0.377 . . . . 0.0 111.795 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.765 ' H ' HG23 ' A' ' 204' ' ' THR . 0.5 OUTLIER -67.03 -33.11 74.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.619 179.544 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -71.44 -28.69 64.14 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.996 0.427 . . . . 0.0 110.262 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.0 -21.21 31.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.781 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -66.97 -21.65 65.96 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.906 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 210' ' ' PHE . . . . . 0.57 ' HA ' HD12 ' A' ' 213' ' ' ILE . 1.0 OUTLIER -67.2 -19.13 65.51 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.884 179.216 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 3.0 mt -86.21 -10.86 53.88 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.719 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.96 -21.86 36.98 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.98 0.419 . . . . 0.0 110.42 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 213' ' ' ILE . . . . . 0.57 HD12 ' HA ' ' A' ' 210' ' ' PHE . 2.9 mt -87.5 -24.79 6.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.401 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.23 120.37 79.19 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.371 179.215 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.39 130.51 24.01 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.449 2.099 . . . . 0.0 112.718 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -68.94 -19.59 64.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.241 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 9.5 m95 -69.57 -18.58 63.65 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.332 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.69 -32.19 16.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.849 0.357 . . . . 0.0 110.28 179.098 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -74.49 -34.53 63.1 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.621 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 . . . . . 0 N--CA 1.463 0.182 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.871 179.419 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.457 -0.08 0 CA-C-O 120.876 0.369 . . . . 0.0 111.06 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.07 20.28 9.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.181 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.67 -34.0 76.9 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.126 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 16.9 mt -73.97 -47.83 34.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.544 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.03 -40.91 91.0 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.762 178.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.89 -48.39 76.86 Favored 'General case' 0 CA--C 1.523 -0.079 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.706 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.649 ' HB1' ' HA ' ' A' ' 151' ' ' TYR . . . -58.74 -36.45 74.35 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.161 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.406 ' O ' HG23 ' A' ' 13' ' ' VAL . 41.3 t80 -69.27 -52.04 31.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.336 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.74 -38.28 81.31 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.478 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.06 -44.62 97.11 Favored 'General case' 0 C--N 1.334 -0.077 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.801 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.08 -44.23 96.45 Favored Glycine 0 C--N 1.335 0.515 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.185 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 9' ' ' PHE . 11.8 t -70.11 -35.21 62.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.909 0.385 . . . . 0.0 110.327 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.16 -42.85 96.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.77 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.8 m -66.7 -33.28 75.28 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.816 0.341 . . . . 0.0 110.711 179.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -75.13 -32.52 61.37 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.502 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -94.59 -1.28 53.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.649 0.261 . . . . 0.0 111.31 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.4 p -62.67 143.94 96.36 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.355 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.06 -8.07 18.99 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.543 2.162 . . . . 0.0 112.812 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.415 ' O ' ' HB ' ' A' ' 21' ' ' VAL . 0.1 OUTLIER -63.63 -47.37 81.62 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.957 179.65 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.415 ' HB ' ' O ' ' A' ' 20' ' ' CYS . 96.1 t 71.11 137.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 O-C-N 123.769 0.668 . . . . 0.0 110.945 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -105.17 128.77 25.98 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.553 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -65.04 -18.51 62.13 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.631 2.22 . . . . 0.0 112.469 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.1 mt -74.27 -12.51 60.57 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.248 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.497 ' HB ' ' HD3' ' A' ' 26' ' ' PRO . 55.1 t -75.71 -60.21 1.09 Allowed Pre-proline 0 CA--C 1.542 0.661 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.497 ' HD3' ' HB ' ' A' ' 25' ' ' VAL . 60.4 Cg_endo -73.31 -34.1 6.39 Favored 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 121.836 1.69 . . . . 0.0 113.511 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.2 m -71.03 -18.18 62.59 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.21 -21.09 66.3 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.762 0.315 . . . . 0.0 111.199 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 6.0 mt -82.12 -52.84 6.6 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.833 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -62.41 -28.69 69.97 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.475 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -60.73 -43.24 98.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.766 178.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.412 ' HA ' HD22 ' A' ' 32' ' ' LEU . 0.6 OUTLIER -74.07 -22.16 59.63 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.997 -179.753 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -86.59 -9.57 74.99 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.245 178.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -108.49 -46.61 0.97 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 121.407 -0.425 . . . . 0.0 112.11 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -117.62 124.67 49.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.806 0.336 . . . . 0.0 110.503 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -77.63 86.84 3.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.099 0.476 . . . . 0.0 110.956 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -138.01 171.95 23.11 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.896 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.403 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 14.4 mtt180 -96.61 124.86 49.19 Favored Pre-proline 0 C--N 1.324 -0.528 0 C-N-CA 121.162 -0.215 . . . . 0.0 110.834 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 38' ' ' ARG . 50.0 Cg_exo -55.81 -30.57 77.09 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.905 2.404 . . . . 0.0 112.782 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.6 mp -63.98 -39.21 93.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.0 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.91 -37.14 67.34 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.224 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -65.04 -43.84 91.01 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.085 178.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.55 -49.42 73.51 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.647 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.76 -45.0 78.19 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.024 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -65.5 -45.28 84.19 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.21 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -62.65 -42.38 99.57 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.157 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 28.4 mm -65.29 -43.05 95.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.566 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.55 -44.01 97.41 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.283 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.404 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -61.64 -44.5 97.86 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.064 178.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -68.91 -36.69 78.3 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.606 0.241 . . . . 0.0 110.625 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -62.94 -42.42 99.68 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.46 178.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.87 -43.94 97.82 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.595 0.236 . . . . 0.0 110.578 178.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 49' ' ' GLY . 93.8 t -63.88 -43.37 97.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.726 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -63.6 -36.25 83.2 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.234 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -76.52 -44.48 34.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.017 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.08 -30.87 71.93 Favored 'General case' 0 C--O 1.226 -0.153 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.976 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -89.34 -20.51 23.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.791 0.329 . . . . 0.0 110.484 178.857 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -72.2 -31.2 64.09 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 121.191 -0.528 . . . . 0.0 112.507 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.2 mp -62.59 -57.21 23.54 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 111.452 0.168 . . . . 0.0 111.452 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -73.97 -13.6 23.89 Favored 'Trans proline' 0 C--N 1.359 1.116 0 C-N-CA 122.019 1.813 . . . . 0.0 112.454 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.413 ' HA ' HD12 ' A' ' 64' ' ' LEU . 0.1 OUTLIER -56.81 -31.5 64.76 Favored 'General case' 0 N--CA 1.464 0.24 0 O-C-N 123.14 0.275 . . . . 0.0 111.334 179.805 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -64.35 -32.09 73.56 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.805 0.336 . . . . 0.0 110.867 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.82 -23.51 25.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.038 0.447 . . . . 0.0 110.148 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.413 HD12 ' HA ' ' A' ' 61' ' ' PHE . 14.7 mt -69.33 -17.96 63.76 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.963 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -59.87 -29.51 67.79 Favored Glycine 0 C--N 1.336 0.573 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.076 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.69 -29.5 61.28 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.908 178.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.3 mt -83.56 -21.39 32.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.904 0.383 . . . . 0.0 110.555 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.37 -19.25 65.86 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.446 179.176 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.87 -17.88 65.11 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.952 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -94.5 -110.14 0.12 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -162.19 148.65 13.38 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.683 0.278 . . . . 0.0 110.882 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.1 mmt-85 -124.24 53.32 1.43 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.939 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -75.88 -18.13 59.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.881 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -66.74 -26.94 67.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.003 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -76.94 -22.29 53.52 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.918 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.72 -32.39 72.15 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.038 0.447 . . . . 0.0 110.372 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.533 ' O ' HG23 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -73.19 -36.7 66.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.722 179.598 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.485 ' O ' HG23 ' A' ' 82' ' ' VAL . 20.8 t -58.3 -44.88 89.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.87 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.64 -39.76 97.01 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.923 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.538 ' O ' HG23 ' A' ' 84' ' ' VAL . . . -65.94 -38.63 94.37 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.079 -0.581 . . . . 0.0 111.924 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 77' ' ' ARG . 95.0 t -62.31 -42.86 97.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-O 120.777 0.322 . . . . 0.0 110.779 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 78' ' ' VAL . 47.0 t -62.74 -38.6 82.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.536 179.531 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 11.5 mt -64.57 -43.15 94.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.696 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 80' ' ' GLY . 42.9 t -66.41 -39.13 83.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.285 178.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.61 -43.1 99.49 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.657 178.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -67.03 -36.75 82.77 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.453 179.192 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -64.64 -39.97 97.16 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.712 178.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.9 mt -64.46 -36.76 85.22 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.728 0.299 . . . . 0.0 110.783 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -75.73 -31.5 59.63 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.474 179.148 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 2.8 tpt -69.14 -25.34 64.33 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.615 179.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.2 mt -69.06 -11.01 60.4 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.041 178.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.99 23.77 54.47 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.682 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.29 115.15 14.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.722 0.296 . . . . 0.0 110.761 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.387 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.589 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.415 ' C ' ' HD2' ' A' ' 110' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.797 0.332 . . . . 0.0 111.592 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.32 -33.69 67.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.021 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.431 ' HB2' ' HD3' ' A' ' 110' ' ' PRO . 30.8 mmt-85 -73.23 -52.94 5.07 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.034 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.431 ' HD3' ' HB2' ' A' ' 109' ' ' ARG . 35.6 Cg_exo -58.87 -29.06 89.1 Favored 'Trans proline' 0 C--N 1.362 1.277 0 C-N-CA 122.194 1.929 . . . . 0.0 112.604 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.74 -26.95 60.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.027 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -68.24 -32.95 76.95 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.777 -0.725 . . . . 0.0 111.487 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.69 -32.58 71.26 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.937 0.398 . . . . 0.0 110.585 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -71.36 -35.07 71.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.889 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.65 -33.55 72.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.577 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.25 -22.06 63.87 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.521 179.307 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -83.5 -34.36 19.91 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.527 178.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -69.28 -42.39 75.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.773 0.321 . . . . 0.0 111.222 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 6.1 p -65.91 -39.31 90.46 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.445 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.68 -21.92 63.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.865 0.364 . . . . 0.0 110.805 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -84.0 -36.34 23.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.798 179.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 53.2 mt -81.11 -39.37 25.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.36 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -81.56 -19.41 66.21 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.581 -0.819 . . . . 0.0 111.827 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 15.0 m95 63.41 -170.44 0.18 Allowed 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 123.027 0.531 . . . . 0.0 111.234 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.91 107.75 11.64 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.762 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -57.63 -23.15 55.67 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.041 2.494 . . . . 0.0 112.946 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 4.2 m -68.5 -20.21 64.57 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.027 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.418 ' HA ' HD12 ' A' ' 131' ' ' ILE . 6.4 mt -102.62 5.21 10.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.039 0.447 . . . . 0.0 110.079 179.355 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -57.15 -63.74 5.04 Favored Glycine 0 C--N 1.334 0.418 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.546 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -58.67 -37.13 95.74 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.426 2.084 . . . . 0.0 112.171 178.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.418 HD12 ' HA ' ' A' ' 128' ' ' ILE . 15.7 mt -64.71 -44.36 96.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.844 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.447 ' O ' HG22 ' A' ' 135' ' ' ILE . 3.2 tp -67.54 -42.53 82.54 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.285 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -61.56 -42.86 99.84 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.871 -0.68 . . . . 0.0 111.862 178.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -68.39 -34.3 75.8 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.764 0.316 . . . . 0.0 110.996 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.447 HG22 ' O ' ' A' ' 132' ' ' LEU . 0.0 OUTLIER -72.07 -26.21 24.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.099 179.875 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.2 -35.23 79.18 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.935 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.01 -22.43 66.93 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.811 178.513 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.2 tp -80.41 -42.83 22.04 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.222 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 142' ' ' GLY . 0.8 OUTLIER -69.59 -16.46 63.41 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.124 179.583 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.43 -26.44 61.84 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.737 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 2.0 t -98.26 -19.22 6.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.776 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.449 ' O ' ' HA ' ' A' ' 139' ' ' THR . . . 153.47 -125.43 1.76 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.154 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 125.68 -152.23 17.91 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.264 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 173.58 169.25 35.71 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.138 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 3.6 m -75.18 -23.33 17.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.683 0.278 . . . . 0.0 111.378 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -62.38 -30.59 76.67 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.625 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.46 -49.36 71.74 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.678 0.275 . . . . 0.0 110.795 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.0 mp -63.52 -42.52 98.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.602 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.1 mt -62.08 -40.61 96.38 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.08 179.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.22 -44.04 97.47 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.852 0.358 . . . . 0.0 110.47 178.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.649 ' HA ' ' HB1' ' A' ' 8' ' ' ALA . 14.3 m-85 -65.11 -38.45 90.71 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.023 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 23.1 mm -62.59 -46.62 95.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.16 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.51 -38.23 90.28 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.61 0.243 . . . . 0.0 110.769 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -59.28 -39.28 94.44 Favored Glycine 0 C--N 1.335 0.503 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.423 179.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.49 ' O ' ' HD2' ' A' ' 158' ' ' PRO . 0.4 OUTLIER -84.24 -21.76 31.05 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.763 0.316 . . . . 0.0 110.787 178.978 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -62.1 -43.27 99.2 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.445 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.513 ' HB ' ' HD3' ' A' ' 158' ' ' PRO . 0.3 OUTLIER -54.78 -57.03 21.13 Favored Pre-proline 0 N--CA 1.472 0.647 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.513 ' HD3' ' HB ' ' A' ' 157' ' ' VAL . 38.1 Cg_exo -62.33 -40.37 40.74 Favored 'Trans proline' 0 C--N 1.359 1.106 0 C-N-CA 122.256 1.97 . . . . 0.0 112.681 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.7 -44.22 93.76 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.402 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.69 -44.19 82.39 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.058 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 157' ' ' VAL . 95.2 t -61.26 -44.72 98.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.62 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 55.4 t -66.36 -46.37 87.12 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.162 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.87 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -54.33 -38.18 65.7 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.737 0.303 . . . . 0.0 111.801 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.3 mt -75.31 -47.19 28.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.616 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -70.2 -25.7 63.54 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.449 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.578 ' O ' ' HB2' ' A' ' 170' ' ' LYS . . . -64.6 -25.85 68.15 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.129 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -77.58 -42.3 35.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.843 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.57 -46.11 89.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.11 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 3.7 pt -75.66 -20.55 15.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.676 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.578 ' HB2' ' O ' ' A' ' 166' ' ' ALA . 0.2 OUTLIER -62.01 -41.35 97.97 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.916 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -64.95 -38.81 95.94 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.01 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -75.62 -30.23 59.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.6 0.238 . . . . 0.0 111.113 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.405 ' HG ' ' HB3' ' A' ' 180' ' ' SER . 0.2 OUTLIER -60.46 -32.68 71.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.088 179.077 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.77 -17.47 38.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.921 0.391 . . . . 0.0 110.818 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 67.5 mtm-85 -91.23 -24.49 19.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.91 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -59.36 -48.96 79.64 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.208 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 133.04 -130.95 5.93 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.587 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -99.37 -3.23 34.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.846 0.355 . . . . 0.0 111.159 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 4.1 mt -69.51 -32.19 51.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.248 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' SER . . . . . 0.405 ' HB3' ' HG ' ' A' ' 173' ' ' LEU . 0.1 OUTLIER -62.41 -26.87 68.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.295 179.501 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 15.0 t60 -71.31 -29.7 65.34 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.742 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.434 ' O ' ' HB2' ' A' ' 186' ' ' LEU . 0.9 OUTLIER -68.58 -32.7 72.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.812 -179.929 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 2.9 t -76.6 -22.43 15.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.565 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.69 -46.4 25.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.562 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.505 ' O ' HG23 ' A' ' 189' ' ' VAL . 16.9 m -75.05 -26.37 19.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.744 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.553 ' O ' HG23 ' A' ' 190' ' ' VAL . 2.2 tp -60.32 -47.3 86.63 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.073 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -63.81 -33.81 76.51 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.867 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.444 ' O ' HG23 ' A' ' 192' ' ' VAL . . . -67.94 -42.93 84.43 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.086 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 185' ' ' VAL . 87.0 t -60.91 -44.35 97.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-O 120.776 0.322 . . . . 0.0 110.767 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 186' ' ' LEU . 24.4 t -62.91 -42.22 95.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.903 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 1.1 mt -59.84 -42.72 94.22 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.732 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 188' ' ' GLY . 65.4 t -67.59 -43.82 86.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.2 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.3 tp -58.44 -45.67 88.05 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.917 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 70.4 t -62.61 -42.39 95.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.675 0.274 . . . . 0.0 110.546 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -62.18 -40.72 99.34 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.328 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 98.4 t -75.21 -41.13 44.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.543 0.211 . . . . 0.0 111.055 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.46 ' O ' ' HA3' ' A' ' 201' ' ' GLY . 1.8 mp -65.48 -23.62 66.95 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.155 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.54 -46.22 11.8 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.696 -0.229 . . . . 0.0 110.789 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -69.47 -49.38 55.37 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.932 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.69 -13.1 52.42 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.926 0.393 . . . . 0.0 111.108 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' A' ' 197' ' ' LEU . . . -88.66 -63.27 1.35 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.466 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 50.87 48.55 22.75 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.986 0.422 . . . . 0.0 111.548 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -119.84 150.44 40.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.931 0.396 . . . . 0.0 111.552 -179.245 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.412 ' H ' HG22 ' A' ' 204' ' ' THR . 0.1 OUTLIER -74.71 -36.17 62.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.369 -179.678 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -59.8 -27.09 66.28 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.918 0.389 . . . . 0.0 111.426 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 19.5 mt -67.25 -38.52 85.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.234 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -74.75 -29.26 61.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.258 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.31 -41.29 81.07 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.552 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -70.12 -27.39 64.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.768 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -72.56 -24.11 61.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.678 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.0 mp -81.2 -22.44 38.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.568 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.42 -7.5 58.44 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.69 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 27.9 mm -82.09 -14.99 12.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.114 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 1.7 m -65.98 118.19 49.86 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.429 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -57.7 128.73 30.31 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.305 2.003 . . . . 0.0 111.956 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -63.86 -17.03 62.75 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.247 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 7.8 m0 -70.08 -21.7 63.12 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.893 179.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 1.1 mt -89.08 -31.41 18.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.333 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -79.53 -24.81 41.95 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.316 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 1.9 mtt-85 . . . . . 0 N--CA 1.462 0.148 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.812 179.309 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.1 m . . . . . 0 CA--C 1.528 0.133 0 CA-C-O 121.079 0.466 . . . . 0.0 110.519 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -130.9 19.62 5.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.961 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.08 -34.39 76.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.055 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.06 -43.93 77.48 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.868 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.38 -42.42 98.68 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.751 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.51 -45.57 92.38 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.018 178.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.33 -33.69 76.3 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.929 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.409 ' O ' HG23 ' A' ' 13' ' ' VAL . 0.3 OUTLIER -69.19 -49.03 60.31 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.742 179.928 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.9 mt -58.71 -42.03 87.72 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.528 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.28 -41.74 99.03 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.267 178.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.46 -43.98 97.4 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 121.206 -0.521 . . . . 0.0 112.261 179.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 9' ' ' PHE . 98.2 t -62.71 -42.67 97.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.794 0.331 . . . . 0.0 110.192 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 14.1 mt -63.93 -42.09 97.46 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.465 179.062 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.5 m -65.95 -41.37 91.35 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.773 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -62.75 -39.35 93.85 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.984 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 87.2 mt -80.59 -13.48 59.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.038 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.468 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 4.1 p -83.79 137.54 41.0 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.592 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.488 ' HD3' HD13 ' A' ' 213' ' ' ILE . 23.2 Cg_exo -65.36 -8.56 19.2 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.64 2.226 . . . . 0.0 112.46 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 64.2 m -65.35 -24.43 67.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.174 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.1 t -111.2 18.2 7.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.393 0.616 . . . . 0.0 110.269 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.434 ' HB2' ' O ' ' A' ' 19' ' ' PRO . 0.5 OUTLIER -72.1 -48.23 10.65 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.406 179.051 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -59.37 -15.11 27.98 Favored 'Trans proline' 0 C--N 1.362 1.283 0 C-N-CA 122.337 2.024 . . . . 0.0 112.734 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.51 -12.81 60.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.316 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.409 ' HB ' ' CD ' ' A' ' 26' ' ' PRO . 92.7 t -77.41 -57.92 1.01 Allowed Pre-proline 0 CA--C 1.54 0.574 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.122 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.409 ' CD ' ' HB ' ' A' ' 25' ' ' VAL . 30.5 Cg_endo -63.43 -30.37 72.22 Favored 'Trans proline' 0 C--N 1.361 1.215 0 C-N-CA 122.21 1.94 . . . . 0.0 112.747 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.2 p -66.42 -32.11 73.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.603 -0.272 . . . . 0.0 110.933 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -65.28 -39.72 92.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.323 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.4 mt -67.47 -37.03 82.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.244 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -67.79 -38.62 83.59 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.949 178.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.596 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 6.5 m-85 -69.26 -38.76 78.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.366 178.518 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.3 mt -66.46 -34.71 78.54 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.512 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.2 4.34 86.26 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.934 -0.65 . . . . 0.0 111.825 178.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -91.4 56.31 3.15 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 121.319 -0.467 . . . . 0.0 112.265 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . 62.99 -101.06 0.09 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.072 0.549 . . . . 0.0 111.654 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 6.2 mtt85 -90.75 60.57 4.52 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.193 0.52 . . . . 0.0 111.036 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.596 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -103.28 75.91 0.29 Allowed Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.249 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 10.8 mtt180 -83.98 137.09 40.67 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-O 120.504 0.193 . . . . 0.0 110.924 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.655 ' HB3' ' HB1' ' A' ' 163' ' ' ALA . 44.0 Cg_exo -56.7 -47.03 25.57 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.956 2.438 . . . . 0.0 112.714 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.9 mp -62.24 -38.85 90.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.167 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -70.57 -39.06 74.11 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.393 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -64.89 -45.75 84.66 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.223 178.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.98 -35.95 81.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.836 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.5 tp -67.48 -48.1 68.12 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.714 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -66.73 -28.09 68.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.463 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.482 ' O ' ' HB2' ' A' ' 50' ' ' PHE . 0.2 OUTLIER -64.18 -50.71 67.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.558 178.815 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 38.2 mt -65.09 -39.08 84.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.865 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -68.81 -52.08 33.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.128 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -58.85 -43.45 96.61 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.17 178.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.482 ' HB2' ' O ' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -68.9 -36.8 78.47 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.542 0.21 . . . . 0.0 110.64 179.473 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -61.36 -45.71 95.88 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.541 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.43 -44.4 95.83 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.881 0.372 . . . . 0.0 110.78 179.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 95.9 t -65.91 -45.13 92.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.034 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -63.43 -30.26 71.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.271 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -78.4 -44.74 24.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.756 0.312 . . . . 0.0 110.682 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.33 -30.97 71.49 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.65 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.08 -18.48 27.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.866 0.365 . . . . 0.0 110.287 178.643 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.515 ' O ' ' HB2' ' A' ' 61' ' ' PHE . . . -75.03 -29.44 60.68 Favored Glycine 0 C--N 1.331 0.276 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.13 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.92 -55.61 43.0 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-O 119.872 -0.108 . . . . 0.0 111.166 178.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -69.83 -12.86 33.61 Favored 'Trans proline' 0 C--N 1.358 1.047 0 C-N-CA 122.186 1.924 . . . . 0.0 112.626 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.515 ' HB2' ' O ' ' A' ' 58' ' ' GLY . 0.1 OUTLIER -50.18 -34.26 21.97 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 179.926 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.22 -40.3 93.48 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.087 0.47 . . . . 0.0 110.871 179.088 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.61 -19.64 32.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.635 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.56 -18.37 62.25 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.91 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -64.05 -32.19 83.35 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 121.01 -0.614 . . . . 0.0 111.757 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -81.22 -22.9 59.92 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.794 179.044 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.421 HD13 ' HA ' ' A' ' 67' ' ' LEU . 1.1 mm? -82.5 -20.52 36.59 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.642 0.258 . . . . 0.0 110.921 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.3 tp -67.01 -22.54 65.9 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.898 179.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -70.4 -38.45 74.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.861 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -123.1 62.96 1.0 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.139 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -78.36 153.11 31.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.804 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.1 mtp180 -109.1 130.09 55.48 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.111 -179.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLN . . . . . 0.452 ' O ' ' HG3' ' A' ' 77' ' ' ARG . 67.8 mt-30 -73.69 -21.86 60.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.859 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.13 -25.87 68.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.294 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -80.55 -30.25 37.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.723 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.06 -21.9 49.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.911 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.452 ' HG3' ' O ' ' A' ' 73' ' ' GLN . 88.0 mtt-85 -69.58 -23.09 63.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.201 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.474 ' O ' HG23 ' A' ' 82' ' ' VAL . 21.8 t -63.47 -36.37 76.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.878 0.37 . . . . 0.0 110.405 179.483 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -65.53 -35.43 91.24 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.712 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.435 ' O ' HG23 ' A' ' 84' ' ' VAL . . . -66.36 -38.48 93.66 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.324 178.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 77' ' ' ARG . 58.4 t -59.95 -43.71 92.92 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-O 120.907 0.384 . . . . 0.0 110.1 178.595 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 78' ' ' VAL . 33.0 t -61.98 -39.66 84.48 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.448 179.063 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.07 -43.72 97.77 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.519 179.048 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 80' ' ' GLY . 97.2 t -62.95 -43.28 98.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-O 121.003 0.43 . . . . 0.0 110.05 178.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.5 mp -62.88 -40.42 97.49 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.467 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -63.47 -41.74 98.6 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -59.57 -40.32 96.18 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.7 178.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.451 ' HA ' HD12 ' A' ' 91' ' ' LEU . 10.8 mt -65.61 -37.22 85.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.753 0.311 . . . . 0.0 110.7 179.086 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -72.01 -36.05 69.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.912 0.387 . . . . 0.0 110.644 179.22 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 46.6 mmm -70.27 -22.03 62.91 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.86 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.451 HD12 ' HA ' ' A' ' 88' ' ' LEU . 4.1 mt -70.52 -2.99 15.77 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.084 178.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.67 10.71 66.98 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.916 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 17.3 mt -78.16 122.22 25.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.938 0.369 . . . . 0.0 110.569 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 . . . . . 0 C--N 1.326 -0.455 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.785 -179.361 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.919 0.39 . . . . 0.0 111.097 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.6 -20.56 50.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.975 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.414 ' N ' ' HD2' ' A' ' 110' ' ' PRO . 0.9 OUTLIER -77.89 -56.42 1.09 Allowed Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.665 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.414 ' HD2' ' N ' ' A' ' 109' ' ' ARG . 28.6 Cg_endo -62.35 -35.26 74.06 Favored 'Trans proline' 0 C--N 1.362 1.248 0 C-N-CA 122.012 1.808 . . . . 0.0 112.198 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -81.46 -21.85 38.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.085 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -68.4 -41.2 85.98 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.772 -0.728 . . . . 0.0 111.369 178.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -72.3 -33.9 67.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.741 0.305 . . . . 0.0 110.521 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.76 -36.17 72.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.076 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.1 tp -67.29 -48.46 67.57 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.711 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 12.0 mt -67.41 -29.54 69.06 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.448 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -72.68 -48.69 21.37 Favored Glycine 0 N--CA 1.451 -0.361 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 178.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.73 -36.33 80.67 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.75 0.31 . . . . 0.0 110.738 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 90.7 m -64.73 -43.24 94.03 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.884 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.76 -29.65 68.09 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.806 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -77.5 -31.66 53.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.004 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -79.16 -24.83 43.0 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.04 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -86.88 160.39 32.38 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.75 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -96.8 120.93 38.04 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 122.429 -0.454 . . . . 0.0 111.0 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.443 ' O ' HG22 ' A' ' 128' ' ' ILE . 0.2 OUTLIER -80.93 114.06 45.49 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.849 179.71 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -59.87 -16.94 41.02 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.763 2.308 . . . . 0.0 112.985 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 11.1 t -77.04 -26.55 53.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.753 0.311 . . . . 0.0 110.903 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.443 HG22 ' O ' ' A' ' 125' ' ' THR . 1.4 tp -99.98 -4.72 9.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.124 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -56.57 -64.38 4.45 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 115.942 -0.572 . . . . 0.0 113.159 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -58.13 -37.95 93.47 Favored 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 122.459 2.106 . . . . 0.0 112.413 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.497 ' O ' HG13 ' A' ' 135' ' ' ILE . 69.2 mt -61.94 -46.07 97.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.865 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.78 -39.97 95.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.001 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -62.94 -36.6 93.65 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.78 178.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -68.32 -39.9 81.83 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.576 0.227 . . . . 0.0 111.061 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.497 HG13 ' O ' ' A' ' 131' ' ' ILE . 70.4 mt -63.06 -32.97 58.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.075 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.37 -34.8 79.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.111 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -84.88 -22.07 29.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.904 178.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.9 -29.67 58.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.986 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -81.62 -16.22 52.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.04 0.448 . . . . 0.0 110.712 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -77.93 -28.6 49.7 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.666 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 7.3 m -102.6 4.87 10.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.986 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -169.68 97.73 0.13 Allowed Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.182 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -85.42 81.25 1.75 Allowed Glycine 0 CA--C 1.517 0.187 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.685 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -124.57 106.6 0.94 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.509 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -69.2 -23.77 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 121.011 0.434 . . . . 0.0 111.06 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -65.77 -30.36 77.07 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.139 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.26 -43.36 86.68 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.788 0.328 . . . . 0.0 110.62 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.57 -40.24 92.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.9 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.69 -42.04 87.09 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.335 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.82 -32.75 74.36 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.447 179.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -63.32 -49.88 72.22 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.741 179.034 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 10.2 mt -61.02 -44.35 98.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.989 0.423 . . . . 0.0 110.535 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.3 -34.04 74.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.409 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -59.92 -36.93 91.74 Favored Glycine 0 C--N 1.334 0.471 0 C-N-CA 121.267 -0.492 . . . . 0.0 112.105 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.538 ' C ' ' HD2' ' A' ' 158' ' ' PRO . 5.5 mt -86.36 -22.6 26.57 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 120.842 0.354 . . . . 0.0 110.97 178.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -61.21 -49.55 76.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.052 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.782 HG13 ' HD3' ' A' ' 158' ' ' PRO . 0.3 OUTLIER -54.6 -51.59 77.24 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.331 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.782 ' HD3' HG13 ' A' ' 157' ' ' VAL . 43.4 Cg_exo -58.96 -40.78 68.2 Favored 'Trans proline' 0 C--N 1.36 1.147 0 C-N-CA 122.138 1.892 . . . . 0.0 112.346 178.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -60.6 -40.38 91.59 Favored 'General case' 0 CA--C 1.522 -0.1 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.336 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -65.65 -43.38 89.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.794 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 157' ' ' VAL . 40.1 t -63.37 -44.04 98.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.809 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 158' ' ' PRO . 84.9 t -67.73 -49.11 72.82 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.906 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.655 ' HB1' ' HB3' ' A' ' 39' ' ' PRO . . . -57.98 -32.26 67.71 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.644 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.4 -48.79 54.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.301 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -71.27 -33.65 69.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.702 0.287 . . . . 0.0 110.82 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.615 ' HA ' HG22 ' A' ' 169' ' ' ILE . . . -68.97 -21.03 64.2 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.019 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -72.31 -35.63 68.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.169 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 13.4 mmm180 -84.82 -42.71 14.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.23 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.615 HG22 ' HA ' ' A' ' 166' ' ' ALA . 3.3 tt -68.41 -19.99 24.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.277 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.43 ' HB2' ' O ' ' A' ' 166' ' ' ALA . 0.8 OUTLIER -57.46 -36.4 71.38 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.313 179.59 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -70.0 -30.28 70.13 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.579 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 1.4 m95 -86.82 -47.41 9.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.76 0.314 . . . . 0.0 111.469 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 4.7 mt -66.89 -16.49 64.35 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.701 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.43 ' HB2' ' O ' ' A' ' 170' ' ' LYS . 9.9 ttt-85 -56.79 -53.25 60.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.998 0.428 . . . . 0.0 110.984 178.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 8.1 mtm180 -93.77 -16.39 24.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.348 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -94.19 4.7 53.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.71 0.29 . . . . 0.0 111.554 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -83.13 9.5 60.58 Favored Glycine 0 CA--C 1.517 0.183 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.681 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 22.2 mtt180 -67.79 -38.65 83.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.943 0.401 . . . . 0.0 110.611 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -81.39 -29.5 10.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.467 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.95 -16.74 64.2 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.108 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' HIS . . . . . 0.468 ' O ' HG23 ' A' ' 185' ' ' VAL . 0.3 OUTLIER -57.27 -31.99 66.16 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.225 179.701 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.32 -44.2 88.61 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.045 0.45 . . . . 0.0 110.412 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 2.2 t -72.17 -19.67 19.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.781 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.79 -44.82 31.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.133 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 181' ' ' HIS . 46.7 t -67.64 -41.24 85.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.549 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.455 ' O ' HG23 ' A' ' 190' ' ' VAL . 0.3 OUTLIER -60.9 -47.9 84.26 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.739 179.504 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -62.35 -36.45 82.26 Favored 'General case' 0 N--CA 1.457 -0.092 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.384 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.46 ' O ' HG23 ' A' ' 192' ' ' VAL . . . -64.0 -46.5 91.2 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.98 -0.629 . . . . 0.0 111.951 178.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 86.8 t -62.18 -48.95 86.06 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 CA-C-O 120.555 0.217 . . . . 0.0 110.616 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 186' ' ' LEU . 76.6 t -59.3 -38.33 74.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.898 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 2.7 tp -62.22 -46.07 90.49 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.778 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 188' ' ' GLY . 61.7 t -66.19 -38.38 81.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.256 179.205 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 9.0 mt -59.05 -54.24 49.35 Favored 'General case' 0 C--N 1.334 -0.094 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.308 179.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 32.6 m -68.56 -29.74 44.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.861 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -66.65 -47.08 70.66 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.449 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 6.1 p -72.17 -31.33 39.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-O 120.722 0.296 . . . . 0.0 110.79 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 197' ' ' LEU . 11.9 mt -67.52 -38.09 83.75 Favored 'General case' 0 N--CA 1.458 -0.069 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.238 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.77 -33.36 60.19 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 121.024 -0.27 . . . . 0.0 110.747 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -66.5 -47.16 73.89 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.792 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 10.1 t -81.76 -11.11 59.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.212 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -87.79 -51.77 3.15 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.557 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 53.87 37.83 27.38 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.037 0.446 . . . . 0.0 111.229 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -139.72 -167.58 2.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.692 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.48 56.21 1.37 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.686 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -82.37 -19.5 39.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.009 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 8.8 tp -70.65 -32.92 70.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.807 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -70.22 -40.79 74.31 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.017 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.8 -32.07 71.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.97 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 209' ' ' PHE . . . . . 0.443 ' O ' HG13 ' A' ' 213' ' ' ILE . 5.9 m-85 -80.84 -43.91 19.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.025 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -61.9 -32.7 73.11 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.458 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.77 -18.08 65.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.752 0.31 . . . . 0.0 111.188 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.48 -24.39 18.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.844 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 213' ' ' ILE . . . . . 0.488 HD13 ' HD3' ' A' ' 19' ' ' PRO . 1.9 mt -92.4 -19.05 7.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.276 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 88.3 m -70.48 120.01 76.02 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.716 179.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -72.17 151.26 54.87 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.4 2.066 . . . . 0.0 112.076 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.06 -16.27 63.65 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.35 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 15.0 m95 -70.13 -25.46 63.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.16 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 1.3 mp -82.68 -23.47 34.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.961 0.41 . . . . 0.0 110.311 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 59.6 mt-30 -78.17 -21.98 49.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.393 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 36.5 mmt-85 . . . . . 0 C--N 1.332 -0.176 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.954 179.541 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.845 0.355 . . . . 0.0 110.994 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.7 mt -73.66 -21.95 60.12 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.499 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.88 -30.47 69.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.648 179.298 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -74.39 -44.1 53.56 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.666 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -58.32 -46.52 86.0 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.726 179.085 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.85 -47.94 78.72 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.932 179.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.605 ' HB1' ' HA3' ' A' ' 154' ' ' GLY . . . -58.58 -40.61 83.65 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.295 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.84 -49.78 64.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.498 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 14.2 tp -57.5 -43.91 84.57 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.609 178.692 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.76 -45.88 91.98 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.062 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.8 -45.0 96.51 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.244 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 67.9 t -68.09 -39.42 81.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.521 0.2 . . . . 0.0 110.606 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.486 ' O ' ' HB2' ' A' ' 18' ' ' SER . 0.2 OUTLIER -61.16 -46.57 89.96 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.871 179.516 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 43.2 m -64.35 -36.12 83.09 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.728 0.299 . . . . 0.0 111.167 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -72.18 -38.39 69.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.746 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.48 -11.66 59.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.847 0.356 . . . . 0.0 111.115 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.486 ' HB2' ' O ' ' A' ' 14' ' ' LEU . 0.2 OUTLIER -87.05 134.08 37.62 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.387 179.239 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.94 -7.96 22.05 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.653 2.236 . . . . 0.0 112.537 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -106.28 147.27 29.35 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.481 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.531 HG22 HG21 ' A' ' 125' ' ' THR . 6.5 t 60.65 65.69 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-O 121.384 0.612 . . . . 0.0 110.874 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 30.5 mt -109.07 116.68 55.06 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.285 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.11 -24.31 44.89 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.767 2.311 . . . . 0.0 112.688 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.81 -19.27 65.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.471 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 54.1 t -64.99 -60.15 8.65 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.291 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.92 -24.91 77.92 Favored 'Trans proline' 0 C--N 1.361 1.196 0 C-N-CA 121.985 1.79 . . . . 0.0 112.547 178.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.7 m -65.2 -39.83 93.35 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.844 0.354 . . . . 0.0 110.815 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -69.02 -31.24 69.91 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.739 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.83 -41.48 44.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.369 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -59.48 -41.95 90.97 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.041 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -73.99 -28.7 61.59 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.806 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.68 -28.9 64.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.267 179.241 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.452 ' O ' ' HD3' ' A' ' 110' ' ' PRO . . . -74.1 -32.18 58.79 Favored Glycine 0 N--CA 1.448 -0.567 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.066 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.69 83.86 1.52 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.328 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -124.5 -68.34 0.86 Allowed 'General case' 0 C--N 1.328 -0.341 0 O-C-N 122.923 -0.163 . . . . 0.0 111.246 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 18.8 mtt180 57.93 38.68 27.0 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.271 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -104.15 61.55 0.42 Allowed Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.359 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 58.38 82.82 0.23 Allowed Pre-proline 0 N--CA 1.468 0.451 0 C-N-CA 122.894 0.478 . . . . 0.0 111.522 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -57.36 -30.11 86.66 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.861 2.374 . . . . 0.0 112.586 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.9 -38.32 90.45 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.34 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -77.13 -37.12 54.72 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.499 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 19.9 t30 -65.59 -36.06 82.66 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.222 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.566 ' O ' HG12 ' A' ' 47' ' ' ILE . . . -61.61 -54.83 37.68 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.615 178.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 74.2 mt -56.23 -39.75 73.02 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.2 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -63.95 -45.89 87.16 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.826 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -63.91 -42.73 97.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.948 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.566 HG12 ' O ' ' A' ' 43' ' ' ALA . 48.8 mm -64.89 -41.08 91.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.656 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.3 tp -65.28 -45.98 82.29 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 179.136 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.535 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -60.74 -42.94 99.62 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.755 179.129 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.18 -40.83 86.62 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.619 0.247 . . . . 0.0 110.959 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -62.06 -39.38 97.53 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.86 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.9 -47.92 73.2 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.459 0.171 . . . . 0.0 110.88 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 49' ' ' GLY . 57.8 t -61.87 -40.23 86.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.033 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.33 -45.86 78.85 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.323 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -68.18 -38.54 82.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.4 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.54 -32.95 74.62 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.12 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.29 -18.75 26.35 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.977 0.418 . . . . 0.0 110.802 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -79.24 -25.3 59.63 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 121.127 -0.558 . . . . 0.0 112.299 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.88 -56.41 29.11 Favored Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 111.464 0.172 . . . . 0.0 111.464 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -70.13 -14.03 34.44 Favored 'Trans proline' 0 C--N 1.362 1.253 0 C-N-CA 122.023 1.815 . . . . 0.0 112.646 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -63.76 -19.74 65.21 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.318 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.0 m -63.53 -45.14 91.95 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.012 0.434 . . . . 0.0 110.651 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.72 -21.18 24.0 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.102 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.93 -18.05 58.53 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.785 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -63.25 -26.31 69.23 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.067 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -78.75 -24.53 62.18 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.89 -0.672 . . . . 0.0 111.769 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 54.9 mt -87.35 -20.73 26.33 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.69 0.281 . . . . 0.0 110.652 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.5 -19.32 64.66 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.647 179.031 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -65.3 -17.45 64.52 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.837 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -84.33 179.07 7.53 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.268 0.556 . . . . 0.0 110.353 178.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -80.23 72.36 7.05 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.299 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' A' ' 72' ' ' ARG . 8.0 mtt180 -114.26 25.3 11.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.386 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -78.38 -18.19 55.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.985 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.35 -20.21 65.96 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.469 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.4 -28.32 67.83 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.662 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.1 -23.53 28.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.428 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -64.66 -29.21 70.21 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.157 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.1 t -63.73 -21.41 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.625 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -66.58 -29.61 75.05 Favored Glycine 0 C--N 1.336 0.546 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.715 179.079 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.503 ' O ' HG23 ' A' ' 84' ' ' VAL . . . -74.23 -38.69 45.94 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.51 -0.852 . . . . 0.0 111.169 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.9 t -59.13 -48.87 85.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-O 120.825 0.345 . . . . 0.0 111.05 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.2 m -69.07 -31.35 49.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.107 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.495 HD13 ' HA2' ' A' ' 195' ' ' GLY . 0.4 OUTLIER -64.72 -43.13 94.4 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.673 179.103 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 80' ' ' GLY . 74.1 t -65.54 -40.09 87.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.21 179.108 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.89 -41.02 95.21 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.636 179.089 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -66.25 -37.7 86.12 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.4 179.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -65.25 -39.65 96.16 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.713 178.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.53 -39.92 95.67 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.738 0.304 . . . . 0.0 110.654 179.038 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -71.62 -32.03 67.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.554 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.87 -19.81 61.23 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.903 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.48 -3.5 8.71 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.375 178.327 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 108.49 6.43 31.14 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.681 -0.771 . . . . 0.0 113.147 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.96 121.06 12.04 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 117.083 0.441 . . . . 0.0 110.499 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 6.9 mtt180 . . . . . 0 C--N 1.324 -0.522 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.663 -179.583 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.132 0 CA-C-O 120.926 0.393 . . . . 0.0 111.452 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.74 -2.48 58.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.062 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.464 ' N ' ' HD2' ' A' ' 110' ' ' PRO . 0.9 OUTLIER -64.39 -53.19 48.02 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.351 -179.745 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 109' ' ' ARG . 15.8 Cg_endo -57.88 -36.27 98.3 Favored 'Trans proline' 0 C--N 1.362 1.242 0 C-N-CA 122.171 1.914 . . . . 0.0 112.617 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -75.07 -31.11 61.16 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.34 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -74.48 -25.8 69.41 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 178.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -64.31 -36.77 85.19 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.802 0.334 . . . . 0.0 110.887 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.17 -40.71 71.1 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.652 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.9 tp -68.79 -36.08 77.82 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.349 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.14 -22.13 61.36 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.201 0.525 . . . . 0.0 110.22 178.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -80.27 -44.31 8.91 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.79 -40.07 96.2 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.522 0.201 . . . . 0.0 111.17 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.4 p -65.31 -38.94 91.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.967 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.69 -24.79 61.88 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.654 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -80.21 -35.02 36.87 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.952 0.406 . . . . 0.0 110.371 179.032 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 72.5 mt -78.46 -26.14 46.05 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.314 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -76.71 160.35 50.45 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.768 178.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 14.9 p90 -112.62 154.38 26.13 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.978 0.418 . . . . 0.0 110.86 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.574 ' HB ' ' SG ' ' A' ' 127' ' ' CYS . 0.8 OUTLIER -109.32 104.39 55.04 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.519 179.424 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.97 -18.26 56.44 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.115 2.543 . . . . 0.0 113.203 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' CYS . . . . . 0.574 ' SG ' ' HB ' ' A' ' 125' ' ' THR . 0.8 OUTLIER -64.88 -37.45 87.68 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.14 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 pt -103.45 4.79 10.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.24 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -58.89 -68.59 1.61 Allowed Glycine 0 C--N 1.334 0.472 0 CA-C-N 116.046 -0.525 . . . . 0.0 112.756 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.51 -31.61 92.63 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.348 2.032 . . . . 0.0 111.878 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.401 ' O ' HG12 ' A' ' 135' ' ' ILE . 60.6 mt -63.69 -55.83 20.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.888 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.43 -34.7 77.76 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.708 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -61.88 -36.2 92.45 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.226 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -75.61 -36.7 60.19 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.833 0.349 . . . . 0.0 111.086 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.401 HG12 ' O ' ' A' ' 131' ' ' ILE . 46.7 mm -70.48 -35.33 61.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.971 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.97 -30.17 70.74 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.118 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.88 -26.97 64.44 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.941 0.4 . . . . 0.0 110.75 178.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 8.7 mt -84.52 -38.75 19.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.893 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 16.0 p -70.11 -16.3 63.09 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.473 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -75.86 -29.48 58.57 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.791 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 2.1 t -96.81 -32.77 4.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.592 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -150.15 90.76 0.14 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.318 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -162.92 -97.59 0.12 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.601 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 111.56 -179.77 19.84 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.49 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 6.2 t -75.0 -31.11 24.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 120.67 0.271 . . . . 0.0 111.0 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -60.44 -32.67 78.35 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.669 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.87 -40.87 83.55 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.853 0.358 . . . . 0.0 110.426 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.417 ' O ' HG13 ' A' ' 152' ' ' ILE . 17.0 mt -62.35 -42.52 99.46 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.486 179.26 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 30.7 mt -65.77 -39.82 91.41 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.508 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.18 -40.11 96.58 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.385 178.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -61.49 -44.8 96.43 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.026 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.417 HG13 ' O ' ' A' ' 148' ' ' LEU . 53.9 mt -64.39 -49.0 82.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.633 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.427 ' O ' HG23 ' A' ' 157' ' ' VAL . 0.1 OUTLIER -66.55 -34.57 78.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.928 -179.941 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 154' ' ' GLY . . . . . 0.605 ' HA3' ' HB1' ' A' ' 8' ' ' ALA . . . -60.55 -44.82 97.34 Favored Glycine 0 C--O 1.223 -0.546 0 C-N-CA 121.176 -0.535 . . . . 0.0 112.189 179.088 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.45 -28.17 61.81 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.166 0.508 . . . . 0.0 110.561 178.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -64.4 -35.34 80.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.438 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.495 ' O ' HG23 ' A' ' 161' ' ' VAL . 96.7 t -55.38 -62.79 3.83 Favored Pre-proline 0 CA--C 1.542 0.643 0 O-C-N 123.272 0.358 . . . . 0.0 111.595 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.478 ' CD ' ' HB ' ' A' ' 157' ' ' VAL . 18.0 Cg_endo -60.15 -36.09 89.96 Favored 'Trans proline' 0 C--N 1.359 1.127 0 C-N-CA 122.04 1.827 . . . . 0.0 112.225 179.11 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -59.66 -46.44 89.02 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-O 120.739 0.304 . . . . 0.0 110.944 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -63.57 -39.41 94.32 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.942 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 157' ' ' VAL . 52.8 t -61.27 -43.59 96.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-O 120.927 0.394 . . . . 0.0 110.321 179.077 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 158' ' ' PRO . 61.0 t -68.36 -38.58 79.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.647 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -58.56 -35.6 72.62 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.779 0.323 . . . . 0.0 111.313 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 17.1 mt -78.96 -42.63 26.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.194 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.78 -19.24 62.04 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.224 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.556 ' HA ' HD12 ' A' ' 169' ' ' ILE . . . -66.01 -19.85 65.99 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.158 179.127 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -64.29 -39.76 94.58 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.782 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 16.5 mtt180 -69.16 -24.17 64.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.649 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.556 HD12 ' HA ' ' A' ' 166' ' ' ALA . 26.4 mt -83.38 -22.42 8.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.427 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -62.76 -38.17 89.49 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.749 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -75.85 -36.23 42.7 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.664 -0.779 . . . . 0.0 111.882 179.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 1.8 m95 -73.92 -26.95 60.79 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.525 0.194 . . . . 0.0 111.525 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 2.3 tp -57.49 -36.53 71.62 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.709 0.29 . . . . 0.0 111.367 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 1.1 mtp-105 -87.07 -20.45 27.11 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.136 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -83.78 -34.13 24.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.921 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.421 ' HB1' ' HB ' ' A' ' 179' ' ' ILE . . . -62.55 -65.19 0.72 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.793 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 79.78 -64.85 3.81 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.969 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 9.4 mtm180 -81.18 -40.14 24.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.722 0.296 . . . . 0.0 111.285 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.421 ' HB ' ' HB1' ' A' ' 176' ' ' ALA . 14.3 mm -69.04 -31.4 50.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.051 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -63.33 -26.64 68.86 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.048 0.452 . . . . 0.0 111.092 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -84.8 -22.01 29.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.128 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -75.63 -28.79 58.96 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.825 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 17.4 t -65.54 -25.37 36.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.703 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -82.41 -37.98 24.72 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.768 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.8 t -70.99 -46.3 68.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.891 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 5.2 tp -62.32 -52.67 62.72 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.282 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -64.42 -35.09 79.79 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.02 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.425 ' O ' HG23 ' A' ' 192' ' ' VAL . . . -62.41 -49.96 69.17 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.21 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 96.4 t -62.0 -46.99 95.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 120.479 0.181 . . . . 0.0 110.783 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.471 ' O ' HG23 ' A' ' 194' ' ' VAL . 85.9 t -59.33 -43.15 89.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.878 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 5.4 tp -58.43 -48.85 79.34 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.756 0.312 . . . . 0.0 111.228 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.531 ' O ' HG23 ' A' ' 196' ' ' VAL . 41.4 t -66.06 -40.85 88.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.465 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 193' ' ' LEU . . . . . 0.448 ' O ' ' HB2' ' A' ' 197' ' ' LEU . 2.2 tp -58.77 -50.08 75.28 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.681 179.189 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 190' ' ' VAL . 87.7 t -61.1 -39.75 83.41 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.434 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.495 ' HA2' HD13 ' A' ' 83' ' ' LEU . . . -57.86 -48.03 84.87 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.611 179.255 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 192' ' ' VAL . 4.2 t -73.87 -34.89 41.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.726 0.298 . . . . 0.0 110.517 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 197' ' ' LEU . . . . . 0.539 ' O ' ' HA3' ' A' ' 201' ' ' GLY . 0.5 OUTLIER -63.1 -28.31 69.99 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.714 179.236 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.652 HD23 HD11 ' A' ' 206' ' ' LEU . 65.0 mt -80.38 -42.54 22.65 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.818 178.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -70.79 -57.6 4.48 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 68.2 p -81.46 -9.26 59.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.803 0.335 . . . . 0.0 111.727 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' GLY . . . . . 0.693 ' HA2' ' HB3' ' A' ' 205' ' ' ALA . . . -84.67 -54.21 3.0 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.436 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 28.5 m 67.23 -72.2 0.09 Allowed 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 122.845 0.458 . . . . 0.0 111.521 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -163.84 -50.19 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.523 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.91 -46.2 90.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.35 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 205' ' ' ALA . . . . . 0.693 ' HB3' ' HA2' ' A' ' 201' ' ' GLY . . . -84.8 -19.52 32.41 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.738 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.652 HD11 HD23 ' A' ' 198' ' ' LEU . 1.1 mt -77.27 -36.86 54.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.889 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.98 -39.59 95.16 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.625 -0.261 . . . . 0.0 110.949 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.52 -37.82 73.67 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.342 178.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -87.04 -24.52 24.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.167 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -67.65 -17.19 64.51 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.978 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.0 mt -61.35 -30.84 70.77 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 121.019 0.437 . . . . 0.0 110.722 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 3.2 mtt180 -92.91 -3.61 54.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.711 179.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 37.0 mm -103.21 -20.16 5.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.941 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.56 119.7 45.9 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.047 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.46 151.63 65.17 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.304 2.003 . . . . 0.0 112.254 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -64.61 -22.42 66.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.191 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 8.0 m-90 -63.55 -24.8 67.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.303 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 16.0 mt -89.53 -27.22 20.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.94 0.4 . . . . 0.0 110.399 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.04 -35.43 31.84 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.363 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 1.4 mtp180 . . . . . 0 C--N 1.331 -0.221 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.03 179.502 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.544 0.211 . . . . 0.0 110.943 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 8.2 mt -76.17 -20.94 57.08 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.505 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.75 -26.21 64.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.687 179.323 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.8 mt -77.4 -46.1 23.78 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.562 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -60.51 -39.81 89.13 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.796 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.76 -46.02 89.97 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.737 178.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.97 -35.12 79.11 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.769 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.474 ' O ' HG23 ' A' ' 13' ' ' VAL . 1.2 m-85 -65.56 -51.74 57.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.18 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.43 -39.02 82.18 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.29 178.499 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.23 -44.17 97.7 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.425 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.81 -42.9 99.8 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 120.888 -0.672 . . . . 0.0 111.835 178.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 9' ' ' PHE . 49.1 t -65.61 -41.31 90.38 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-O 120.719 0.295 . . . . 0.0 110.307 179.202 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.4 tp -63.99 -41.72 97.41 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.456 179.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 18.9 m -64.34 -35.78 81.98 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.726 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -72.04 -36.08 69.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.988 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.8 -4.86 59.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.811 0.339 . . . . 0.0 111.077 179.324 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.0 t -68.89 119.87 72.37 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.805 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.573 ' HD3' HG21 ' A' ' 213' ' ' ILE . 39.3 Cg_endo -67.3 -8.07 20.89 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.84 2.36 . . . . 0.0 112.697 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 2.2 t -73.38 -25.31 60.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.841 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.4 m -130.82 5.78 2.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.666 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.411 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 0.3 OUTLIER -70.77 -53.72 8.82 Favored Pre-proline 0 CA--C 1.538 0.504 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 179.896 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.411 ' HD2' ' N ' ' A' ' 22' ' ' LEU . 46.0 Cg_endo -68.97 -14.71 39.1 Favored 'Trans proline' 0 C--N 1.361 1.201 0 C-N-CA 121.888 1.725 . . . . 0.0 112.432 179.457 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.1 mp -81.28 -16.13 53.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.459 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.466 ' N ' ' HD2' ' A' ' 26' ' ' PRO . 95.0 t -62.86 -55.2 40.31 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-O 119.725 -0.179 . . . . 0.0 111.289 178.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.602 ' HA ' HD12 ' A' ' 29' ' ' LEU . 14.4 Cg_endo -58.05 -33.06 96.87 Favored 'Trans proline' 0 C--N 1.362 1.246 0 C-N-CA 122.275 1.984 . . . . 0.0 112.505 178.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.54 -36.64 65.69 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.791 0.329 . . . . 0.0 110.943 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.0 -28.5 68.3 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.021 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.602 HD12 ' HA ' ' A' ' 26' ' ' PRO . 8.3 mt -63.06 -37.52 87.51 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.718 179.276 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.58 -35.52 67.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.065 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -66.75 -37.14 84.05 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.336 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.63 -15.18 60.83 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.23 178.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -67.65 -24.96 74.08 Favored Glycine 0 C--N 1.332 0.346 0 N-CA-C 111.77 -0.532 . . . . 0.0 111.77 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.53 -16.35 80.1 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.985 -0.626 . . . . 0.0 111.54 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -126.9 51.39 1.87 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.975 0.417 . . . . 0.0 109.988 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.7 70.79 1.4 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.39 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -146.48 84.95 0.18 Allowed Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.548 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.2 mtp180 66.4 91.25 0.08 OUTLIER Pre-proline 0 N--CA 1.467 0.416 0 C-N-CA 122.922 0.489 . . . . 0.0 111.16 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -64.09 -30.24 65.67 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.434 2.089 . . . . 0.0 112.466 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.4 mp -62.55 -40.83 98.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.279 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -72.47 -37.35 68.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.615 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -67.57 -43.8 79.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.393 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.05 -50.68 67.44 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.769 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.74 -42.68 75.75 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.219 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -63.85 -41.31 97.84 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.876 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.28 -41.47 94.15 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.37 179.08 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 54.6 mt -62.96 -42.43 96.6 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.943 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.31 -44.07 92.74 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.468 179.242 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.514 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -59.27 -43.71 97.04 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.862 -0.685 . . . . 0.0 111.693 178.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.02 -37.24 81.16 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.76 0.314 . . . . 0.0 110.242 179.181 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -63.17 -41.93 99.55 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 178.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.42 -45.99 87.38 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 120.509 0.195 . . . . 0.0 110.635 178.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 49' ' ' GLY . 24.7 t -63.41 -43.02 98.29 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.837 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -66.04 -28.2 68.67 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.426 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -82.82 -47.39 11.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.561 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.59 -35.71 80.4 Favored 'General case' 0 C--O 1.227 -0.109 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.85 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.42 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 0.9 OUTLIER -89.52 -18.35 26.82 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.792 0.33 . . . . 0.0 110.497 178.488 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.28 -35.68 83.12 Favored Glycine 0 C--N 1.33 0.204 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.41 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.406 ' CB ' ' HD3' ' A' ' 60' ' ' PRO . 0.5 OUTLIER -63.23 -55.63 34.65 Favored Pre-proline 0 CA--C 1.543 0.687 0 N-CA-C 111.49 0.182 . . . . 0.0 111.49 179.197 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.42 ' HD2' ' C ' ' A' ' 57' ' ' LEU . 13.6 Cg_exo -70.47 -13.96 33.4 Favored 'Trans proline' 0 C--N 1.361 1.185 0 C-N-CA 122.517 2.144 . . . . 0.0 112.629 179.369 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.63 -25.74 64.92 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.119 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.5 -34.72 76.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.032 0.444 . . . . 0.0 110.403 178.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.57 -19.81 25.84 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.618 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.402 ' HA ' HD12 ' A' ' 67' ' ' LEU . 0.3 OUTLIER -67.25 -17.78 64.94 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.863 179.874 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.32 -27.5 65.57 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.947 -0.644 . . . . 0.0 111.901 179.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -78.38 -22.06 68.46 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.582 179.016 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.402 HD12 ' HA ' ' A' ' 64' ' ' LEU . 13.9 mt -87.12 -20.56 26.89 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.646 0.26 . . . . 0.0 110.415 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.86 -19.42 62.6 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.916 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -60.45 -26.0 66.42 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.758 178.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -97.59 125.18 42.17 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -74.59 98.74 3.45 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.026 0.441 . . . . 0.0 111.419 -179.18 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -87.1 64.79 8.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.984 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -67.45 -19.79 65.41 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.135 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.0 t -69.99 -17.76 63.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.3 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.53 -22.51 30.13 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.883 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.44 -22.4 38.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.862 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.61 -27.14 66.65 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.92 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.495 ' O ' HG23 ' A' ' 82' ' ' VAL . 3.3 t -63.0 -32.47 56.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.798 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -64.31 -34.98 91.37 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.033 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.446 ' O ' HG23 ' A' ' 84' ' ' VAL . . . -66.72 -38.9 93.49 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.666 179.286 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.9 t -62.53 -41.22 91.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-O 120.766 0.317 . . . . 0.0 110.462 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 78' ' ' VAL . 40.5 t -63.8 -40.54 89.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.383 179.208 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.1 -42.72 99.65 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.718 179.233 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 80' ' ' GLY . 94.5 t -64.02 -43.52 97.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.392 179.141 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.86 -43.33 98.53 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.952 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -66.15 -43.53 86.72 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.743 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -62.83 -40.14 98.87 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.148 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.2 -36.45 83.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.724 0.297 . . . . 0.0 110.613 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -74.74 -30.09 61.38 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.283 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 28.5 mmt -67.07 -27.94 67.78 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.29 178.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.4 mp -66.96 -10.51 50.07 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.265 178.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.41 20.22 59.02 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.85 -0.69 . . . . 0.0 113.259 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -78.42 124.14 27.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.93 0.365 . . . . 0.0 110.594 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.679 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.169 0 CA-C-O 121.084 0.469 . . . . 0.0 111.054 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.25 -12.55 59.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.15 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.419 ' CB ' ' HD3' ' A' ' 110' ' ' PRO . 0.0 OUTLIER -74.26 -58.46 1.93 Allowed Pre-proline 0 CA--C 1.539 0.53 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -179.571 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.419 ' HD3' ' CB ' ' A' ' 109' ' ' ARG . 23.8 Cg_exo -64.8 -40.21 22.8 Favored 'Trans proline' 0 C--N 1.358 1.047 0 C-N-CA 122.055 1.837 . . . . 0.0 112.34 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -74.17 -30.6 62.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.642 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' A' ' 116' ' ' LEU . . . -64.8 -40.71 97.55 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.909 -0.662 . . . . 0.0 111.974 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.51 -30.51 69.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.866 0.365 . . . . 0.0 110.919 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -80.5 -45.49 17.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.009 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.5 mt -65.66 -43.47 89.25 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.894 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.474 ' HB2' ' O ' ' A' ' 112' ' ' GLY . 1.9 mt -71.03 -22.87 62.09 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.944 0.402 . . . . 0.0 110.181 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -78.07 -46.13 9.6 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.22 -38.72 77.37 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.654 0.264 . . . . 0.0 111.304 178.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.3 p -68.55 -35.77 77.87 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.935 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.27 -33.1 61.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.478 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -71.27 -47.2 58.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.671 179.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.77 -24.01 60.89 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.834 179.228 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -78.88 89.03 1.16 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.944 -0.646 . . . . 0.0 111.73 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -59.3 126.29 27.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.082 0.468 . . . . 0.0 111.714 -179.317 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.52 ' O ' HG22 ' A' ' 128' ' ' ILE . 1.1 p -73.6 134.87 78.74 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.216 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -64.13 -19.27 65.91 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.757 2.305 . . . . 0.0 113.116 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 3.9 m -73.13 -14.95 61.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.089 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.52 HG22 ' O ' ' A' ' 125' ' ' THR . 3.7 tp -97.2 -3.95 9.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.363 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -51.79 -59.52 8.54 Favored Glycine 0 C--N 1.336 0.57 0 CA-C-N 115.894 -0.593 . . . . 0.0 113.091 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -56.73 -41.48 75.23 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.473 2.115 . . . . 0.0 112.236 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.459 ' O ' HG13 ' A' ' 135' ' ' ILE . 25.1 mm -65.48 -47.34 87.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.003 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.07 -44.12 97.36 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.535 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -58.74 -38.5 92.08 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.837 178.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.48 -40.58 89.41 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.86 0.362 . . . . 0.0 110.665 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.459 HG13 ' O ' ' A' ' 131' ' ' ILE . 78.6 mt -65.4 -37.44 80.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.213 179.189 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LEU . . . . . 0.46 ' HA ' ' OG1' ' A' ' 139' ' ' THR . 0.3 OUTLIER -64.1 -31.42 72.61 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.983 179.49 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.2 m -65.46 -30.88 71.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.994 0.426 . . . . 0.0 110.741 178.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 18.4 mt -83.39 -37.16 23.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.992 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.46 ' OG1' ' HA ' ' A' ' 136' ' ' LEU . 0.6 OUTLIER -72.3 -20.35 61.52 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.948 179.848 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -68.56 -27.52 66.15 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.549 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 2.0 t -94.13 -29.4 4.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.246 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 146.92 -95.16 0.17 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.552 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 100.33 -66.62 0.55 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.342 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 113.32 163.65 15.51 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.703 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 12.3 p -68.14 -25.59 32.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-O 120.801 0.334 . . . . 0.0 111.227 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -59.9 -34.29 82.33 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 121.161 -0.543 . . . . 0.0 112.708 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.99 -43.2 88.48 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.815 0.341 . . . . 0.0 110.424 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.52 -45.36 91.0 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.504 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.67 -40.36 95.28 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.979 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -61.15 -41.2 96.32 Favored 'General case' 0 C--O 1.226 -0.154 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.778 179.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -63.86 -43.54 95.81 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.985 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 59.4 mt -62.67 -50.84 78.16 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.733 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 71.6 mt -68.24 -32.71 73.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.463 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -60.69 -44.71 97.57 Favored Glycine 0 C--O 1.225 -0.415 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.355 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.69 -21.66 44.38 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.716 0.293 . . . . 0.0 110.954 178.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -65.89 -37.23 85.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.484 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.437 ' HB ' ' CD ' ' A' ' 158' ' ' PRO . 90.8 t -57.73 -59.15 13.95 Favored Pre-proline 0 CA--C 1.541 0.606 0 CA-C-O 119.518 -0.277 . . . . 0.0 111.685 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.437 ' CD ' ' HB ' ' A' ' 157' ' ' VAL . 15.5 Cg_endo -59.26 -36.69 94.41 Favored 'Trans proline' 0 C--N 1.361 1.192 0 C-N-CA 122.142 1.895 . . . . 0.0 112.178 178.466 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -63.95 -38.15 90.02 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 120.548 0.213 . . . . 0.0 110.972 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.59 -49.31 69.29 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.47 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 13.5 m -66.71 -32.67 59.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.06 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 3.9 t -67.73 -43.18 86.67 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 178.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -60.09 -34.02 72.88 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.96 178.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 11.2 tp -75.78 -45.39 36.48 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.827 179.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -69.15 -19.15 64.01 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.083 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.64 -19.07 64.57 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.984 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.49 -40.42 94.49 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.468 179.166 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 2.0 ttt85 -69.12 -36.24 77.29 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.438 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 18.0 mt -70.66 -30.16 41.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.377 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -60.97 -36.91 80.64 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.442 179.053 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -81.5 -34.37 25.72 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.6 -0.809 . . . . 0.0 111.61 178.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 27.8 t-105 -70.09 -25.84 63.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.893 -0.153 . . . . 0.0 111.393 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.38 -37.53 65.11 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.726 0.298 . . . . 0.0 111.522 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 2.6 mpp_? -87.08 -19.86 27.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.368 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 3.8 mtt85 -86.21 -37.03 19.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.547 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.527 ' HB1' ' HB ' ' A' ' 179' ' ' ILE . . . -59.08 -70.1 0.17 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.836 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 69.51 -83.3 0.27 Allowed Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.983 -0.627 . . . . 0.0 113.212 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.13 -40.38 82.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.546 0.212 . . . . 0.0 111.228 -179.283 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.556 ' O ' HG23 ' A' ' 183' ' ' VAL . 22.6 mt -59.44 -46.14 93.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.811 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.06 -41.44 96.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.085 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -66.07 -32.49 73.99 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.259 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -70.27 -42.98 71.41 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.784 0.326 . . . . 0.0 110.834 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 179' ' ' ILE . 15.0 t -70.77 -19.97 21.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.828 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -67.56 -51.78 46.55 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.604 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.481 ' O ' HG23 ' A' ' 189' ' ' VAL . 5.3 t -75.37 -31.83 24.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.061 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.452 ' O ' HG23 ' A' ' 190' ' ' VAL . 0.6 OUTLIER -58.2 -47.91 81.96 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.912 179.78 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -63.08 -33.67 75.95 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.746 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.413 ' O ' HG23 ' A' ' 192' ' ' VAL . . . -66.84 -45.74 80.89 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.41 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 185' ' ' VAL . 46.4 t -61.94 -47.6 92.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 120.736 0.303 . . . . 0.0 110.937 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 186' ' ' LEU . 43.4 t -62.79 -40.98 90.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.774 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 3.7 mt -58.23 -45.96 86.77 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.321 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 188' ' ' GLY . 81.8 t -64.4 -42.38 95.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-O 120.771 0.32 . . . . 0.0 110.537 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.59 -44.07 91.81 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.066 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 190' ' ' VAL . 78.2 t -64.2 -38.84 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.097 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -58.39 -44.04 95.43 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.233 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 61.8 t -73.56 -40.01 54.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-O 120.763 0.316 . . . . 0.0 110.681 179.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.39 -34.91 79.27 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.112 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.51 -41.11 48.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.071 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.7 -41.6 95.89 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.08 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 1.3 m -83.99 -13.76 52.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.982 0.42 . . . . 0.0 110.469 179.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -85.59 -49.32 4.4 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.55 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 4.7 m 70.57 -65.22 0.34 Allowed 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 122.946 0.498 . . . . 0.0 111.511 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -154.19 161.31 41.92 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 5.8 m 73.72 -41.42 0.49 Allowed 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 122.98 0.512 . . . . 0.0 111.663 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -60.98 -36.52 79.65 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.028 0.442 . . . . 0.0 110.862 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.06 -23.39 38.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.901 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -75.21 -50.09 17.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.171 -179.169 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 1.7 m -61.57 -33.71 74.33 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.876 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -74.44 -36.28 63.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.989 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -70.32 -29.59 66.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.876 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 6.1 mt -65.25 -18.03 64.98 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.915 0.388 . . . . 0.0 111.219 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 12.1 mtt180 -92.29 -6.05 51.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.42 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' ILE . . . . . 0.573 HG21 ' HD3' ' A' ' 19' ' ' PRO . 8.1 mm -107.84 -12.47 10.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.69 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.43 128.12 66.98 Favored Pre-proline 0 C--O 1.233 0.192 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.78 179.2 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -56.8 143.45 90.68 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.557 2.171 . . . . 0.0 112.43 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -61.72 -25.7 67.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.846 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 -69.94 -22.29 63.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.949 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -81.48 -38.04 26.99 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.04 0.448 . . . . 0.0 109.81 179.185 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -71.47 -30.72 66.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.585 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.332 -0.191 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.05 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.225 0 CA-C-O 120.797 0.332 . . . . 0.0 111.007 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.72 148.32 42.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.869 0.366 . . . . 0.0 111.13 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.57 -26.8 64.65 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.307 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.2 mt -64.73 -47.53 77.94 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.978 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.68 -46.52 90.03 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.685 179.17 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.34 -45.54 93.07 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.023 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.51 -43.3 97.24 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.015 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.413 ' O ' HG23 ' A' ' 13' ' ' VAL . 1.0 OUTLIER -62.62 -51.02 68.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.671 179.566 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.95 -40.21 88.2 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.702 179.127 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.47 -45.95 90.18 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.4 178.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.91 -42.98 99.57 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.018 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 9' ' ' PHE . 93.0 t -64.69 -42.64 95.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-O 120.732 0.301 . . . . 0.0 110.579 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.69 -40.11 95.98 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.564 179.249 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.6 m -69.08 -32.67 72.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.907 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -68.03 -42.69 80.21 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.982 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -85.02 -9.43 58.03 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.534 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -66.04 119.17 59.3 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.771 0.319 . . . . 0.0 110.884 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.31 -8.21 18.41 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.802 2.334 . . . . 0.0 112.489 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 96.6 m -82.43 44.84 0.91 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.034 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -94.78 54.66 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.94 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.549 HD11 HD21 ' A' ' 83' ' ' LEU . 0.3 OUTLIER -62.87 -51.19 73.25 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.464 -179.57 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.615 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 51.2 Cg_exo -57.18 -31.8 91.62 Favored 'Trans proline' 0 C--N 1.361 1.203 0 C-N-CA 122.192 1.928 . . . . 0.0 113.018 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.86 -13.31 60.54 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.492 ' HB ' ' HD3' ' A' ' 26' ' ' PRO . 3.3 t -64.98 -53.9 38.58 Favored Pre-proline 0 CA--C 1.543 0.712 0 CA-C-O 119.613 -0.232 . . . . 0.0 111.314 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.615 ' HD2' ' O ' ' A' ' 23' ' ' PRO . 23.6 Cg_exo -65.77 -21.92 57.57 Favored 'Trans proline' 0 C--N 1.361 1.191 0 C-N-CA 121.919 1.746 . . . . 0.0 112.346 178.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -63.85 -24.67 67.84 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.392 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -66.12 -31.94 73.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.009 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.1 mp -86.6 -22.74 26.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.161 0.505 . . . . 0.0 110.487 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -75.07 -20.05 59.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.339 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -82.18 -20.86 36.99 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.782 0.325 . . . . 0.0 110.779 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.618 ' HG ' HD21 ' A' ' 173' ' ' LEU . 0.4 OUTLIER -87.47 -36.46 17.65 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.011 0.434 . . . . 0.0 110.288 179.442 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -92.32 4.45 77.11 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.054 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -93.45 52.2 2.4 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.647 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.58 126.06 30.32 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.536 -0.172 . . . . 0.0 110.536 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 17.9 mtp180 62.23 32.72 17.09 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.577 0.548 . . . . 0.0 110.933 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -102.36 -168.73 26.8 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.55 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.4 88.45 29.88 Favored Pre-proline 0 C--O 1.234 0.277 0 CA-C-O 120.559 0.218 . . . . 0.0 111.109 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.75 -33.95 96.17 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.684 2.256 . . . . 0.0 112.49 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.2 mt -62.17 -45.34 93.86 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.55 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -73.63 -39.84 64.23 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.026 -179.508 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.88 -42.67 97.43 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.832 0.349 . . . . 0.0 110.632 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.29 -51.55 59.97 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.835 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.29 -42.3 86.29 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.482 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -63.9 -42.85 97.33 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.49 0.186 . . . . 0.0 110.815 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.98 -42.08 94.86 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.706 179.168 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 91.0 mt -65.43 -42.55 93.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.231 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.44 -50.08 75.02 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.483 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.457 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -59.2 -45.91 94.62 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.749 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -69.17 -37.71 78.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.654 0.264 . . . . 0.0 110.947 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -61.64 -43.61 99.04 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 121.086 -0.578 . . . . 0.0 111.821 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.57 -43.26 99.19 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.698 0.285 . . . . 0.0 110.674 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 49' ' ' GLY . 91.4 t -63.54 -43.94 98.49 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.043 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -65.76 -34.55 78.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.435 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -76.52 -43.33 39.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.703 0.287 . . . . 0.0 110.806 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.15 -28.87 69.12 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.907 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.05 -18.27 27.64 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.897 0.38 . . . . 0.0 109.976 178.349 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -74.91 -32.02 57.35 Favored Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.998 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.21 -56.25 37.26 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 179.262 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -72.84 -13.71 26.69 Favored 'Trans proline' 0 C--N 1.361 1.189 0 C-N-CA 122.266 1.977 . . . . 0.0 112.735 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.66 -23.59 63.19 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.328 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -65.8 -41.68 91.61 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.957 0.408 . . . . 0.0 110.539 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -88.63 -21.53 23.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.765 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.65 -18.19 45.44 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.427 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.59 -32.29 80.84 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 121.253 -0.499 . . . . 0.0 112.566 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -71.97 -31.6 64.26 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.91 179.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.6 mt -84.69 -23.76 29.26 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.723 0.297 . . . . 0.0 110.226 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.18 -19.4 64.78 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.92 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -58.66 -21.89 55.38 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.266 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -127.84 146.41 50.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.33 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 61.95 57.46 2.11 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 123.375 0.422 . . . . 0.0 111.716 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -89.17 -28.39 20.05 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.79 0.328 . . . . 0.0 111.238 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -69.68 -20.06 63.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.545 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -63.26 -32.58 74.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.51 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.4 mp -81.76 -21.79 37.63 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.674 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.01 -28.47 35.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.555 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.449 ' O ' HG23 ' A' ' 81' ' ' VAL . 26.7 mtp85 -63.5 -39.02 93.33 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.994 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.463 ' O ' HG23 ' A' ' 82' ' ' VAL . 3.8 t -60.69 -37.9 77.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.437 179.355 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -64.55 -39.45 96.82 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.858 -0.687 . . . . 0.0 111.604 179.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.49 ' O ' HG23 ' A' ' 84' ' ' VAL . . . -64.54 -42.94 97.22 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.896 -0.669 . . . . 0.0 111.596 179.11 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 77' ' ' ARG . 57.9 t -59.04 -42.95 87.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-O 120.806 0.336 . . . . 0.0 110.569 178.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.573 HG21 ' HA2' ' A' ' 123' ' ' GLY . 87.8 t -63.36 -38.74 82.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.414 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.549 HD21 HD11 ' A' ' 22' ' ' LEU . 8.3 mt -61.29 -42.3 98.42 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.527 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 80' ' ' GLY . 31.6 t -65.56 -43.53 94.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 120.941 0.4 . . . . 0.0 110.088 178.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.69 -40.38 96.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.604 179.181 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.33 -37.08 85.99 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.64 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -61.08 -42.21 99.71 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.699 178.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.46 -34.54 78.17 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.862 0.363 . . . . 0.0 110.605 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -70.0 -42.6 72.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.703 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.94 -24.22 63.32 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.938 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.71 -11.38 58.21 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.35 178.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.55 10.82 57.67 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.645 -0.788 . . . . 0.0 113.058 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.3 tp -77.92 125.06 28.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 117.04 0.42 . . . . 0.0 110.583 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.528 ' H ' ' HE ' ' A' ' 94' ' ' ARG . 0.3 OUTLIER . . . . . 0 C--N 1.326 -0.417 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.007 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.43 ' O ' ' HD2' ' A' ' 110' ' ' PRO . 0.6 OUTLIER . . . . . 0 N--CA 1.466 0.325 0 CA-C-O 121.046 0.451 . . . . 0.0 111.385 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.51 0.32 50.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.897 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.8 -51.77 73.48 Favored Pre-proline 0 CA--C 1.541 0.607 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.43 ' HD2' ' O ' ' A' ' 107' ' ' THR . 46.3 Cg_exo -58.29 -25.61 73.31 Favored 'Trans proline' 0 C--N 1.363 1.295 0 C-N-CA 122.241 1.96 . . . . 0.0 112.927 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.8 mt -68.46 -34.18 75.5 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.716 0.293 . . . . 0.0 110.588 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -66.85 -36.33 90.95 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.705 -0.76 . . . . 0.0 111.373 179.012 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -75.2 -35.43 61.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.707 0.289 . . . . 0.0 110.629 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -65.37 -47.04 77.76 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.001 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.8 mp -64.63 -39.08 93.07 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.539 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.427 ' O ' ' HB2' ' A' ' 120' ' ' LEU . 0.6 OUTLIER -69.49 -31.59 69.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.397 179.209 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -74.64 -44.18 26.94 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.909 -0.662 . . . . 0.0 111.487 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.21 -42.94 87.3 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.945 0.402 . . . . 0.0 110.819 178.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 3.0 m -73.2 -27.68 61.76 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.142 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.427 ' HB2' ' O ' ' A' ' 116' ' ' LEU . 0.3 OUTLIER -76.4 -37.09 57.62 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.74 0.305 . . . . 0.0 110.96 179.642 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -73.27 -37.85 66.14 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.843 0.354 . . . . 0.0 111.226 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.95 -19.48 37.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.017 0.436 . . . . 0.0 110.738 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLY . . . . . 0.573 ' HA2' HG21 ' A' ' 82' ' ' VAL . . . -92.04 95.62 2.06 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.701 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 4.8 t-105 -80.34 130.98 35.55 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.026 0.441 . . . . 0.0 111.31 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.2 119.88 78.67 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.083 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.84 -15.98 48.7 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.98 2.454 . . . . 0.0 112.909 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 8.0 m -62.74 -26.79 68.87 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.783 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.422 ' H ' HG13 ' A' ' 128' ' ' ILE . 1.4 mt -86.67 -0.83 7.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.785 0.326 . . . . 0.0 111.004 -179.628 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -59.65 -65.04 3.69 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 121.174 -0.536 . . . . 0.0 112.738 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.4 -38.56 73.51 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.618 2.212 . . . . 0.0 112.194 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 61.6 mt -60.93 -41.61 89.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.164 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.6 mt -63.18 -33.32 75.23 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-O 120.687 0.279 . . . . 0.0 110.848 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -61.24 -38.07 95.05 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 121.118 -0.563 . . . . 0.0 111.967 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.53 -36.19 73.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.123 0.487 . . . . 0.0 109.967 178.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 45.6 mm -67.17 -42.41 88.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.337 179.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.67 -36.91 82.22 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.32 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 38.4 m -64.5 -38.34 90.68 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.252 178.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 7.8 mt -70.06 -30.83 68.18 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.618 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.1 m -79.99 -22.4 42.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.086 0.469 . . . . 0.0 110.551 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.18 -30.27 64.8 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.914 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 20.5 m -100.25 4.98 10.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.009 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 141.54 -92.6 0.18 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.46 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.98 -123.54 7.02 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.543 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 130.8 159.67 9.7 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.571 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 11.1 p -77.36 -23.41 14.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.684 0.278 . . . . 0.0 111.33 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -58.35 -37.52 87.81 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.745 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -68.62 -41.67 79.18 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.691 0.281 . . . . 0.0 110.423 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.409 ' O ' HG13 ' A' ' 152' ' ' ILE . 0.3 OUTLIER -60.86 -46.28 91.2 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.605 179.233 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.83 -40.63 95.5 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.729 179.297 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.43 -41.18 98.52 Favored 'General case' 0 C--O 1.226 -0.168 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.771 179.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -60.61 -44.91 95.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.091 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 148' ' ' LEU . 23.9 mt -64.5 -44.06 96.91 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 CA-C-O 120.95 0.405 . . . . 0.0 110.341 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.92 -35.89 82.6 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.569 179.438 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' GLY . . . . . 0.463 ' O ' ' HD2' ' A' ' 158' ' ' PRO . . . -60.56 -46.08 95.08 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.143 179.017 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.38 -29.88 67.75 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.059 0.457 . . . . 0.0 110.754 178.651 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -63.43 -35.21 79.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.589 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.536 ' O ' HG23 ' A' ' 161' ' ' VAL . 95.1 t -55.38 -63.7 2.83 Favored Pre-proline 0 CA--C 1.543 0.685 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.473 ' CD ' ' HB ' ' A' ' 157' ' ' VAL . 19.1 Cg_endo -60.88 -36.38 83.83 Favored 'Trans proline' 0 C--N 1.359 1.109 0 C-N-CA 121.906 1.737 . . . . 0.0 112.384 179.241 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -58.08 -45.28 87.42 Favored 'General case' 0 N--CA 1.462 0.158 0 O-C-N 123.169 0.293 . . . . 0.0 111.19 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -70.47 -36.67 74.02 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.718 -0.219 . . . . 0.0 110.873 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 157' ' ' VAL . 96.5 t -64.91 -45.28 95.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-O 120.731 0.3 . . . . 0.0 110.692 179.096 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 68.9 t -65.8 -39.4 84.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.49 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -61.07 -34.82 75.5 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.28 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.8 -42.79 39.26 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.188 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -71.95 -19.23 61.93 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.374 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.09 -19.16 61.13 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.414 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -64.19 -43.05 96.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.765 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 2.6 mtp180 -73.03 -31.98 64.79 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.992 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 11.8 mt -72.83 -26.32 23.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.787 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.42 -30.92 71.95 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.968 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -70.89 -38.98 65.06 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.813 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -74.22 -24.07 59.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.63 0.252 . . . . 0.0 110.84 179.326 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.618 HD21 ' HG ' ' A' ' 32' ' ' LEU . 3.2 tp -59.71 -37.61 79.35 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.785 178.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 41.8 mtp180 -76.59 -21.86 55.02 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.816 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 -84.87 -32.19 23.34 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.943 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.473 ' HB1' ' HB ' ' A' ' 179' ' ' ILE . . . -65.16 -33.81 76.89 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.642 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 70.76 -98.77 0.71 Allowed Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.8 -0.714 . . . . 0.0 113.029 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -104.74 -6.01 20.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.558 0.218 . . . . 0.0 111.232 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.473 ' HB ' ' HB1' ' A' ' 176' ' ' ALA . 50.2 mm -64.58 -41.54 92.55 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 CA-C-O 120.671 0.272 . . . . 0.0 110.819 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' SER . . . . . 0.492 ' O ' ' HG3' ' A' ' 184' ' ' GLU . 0.0 OUTLIER -61.65 -33.77 74.53 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.12 179.831 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 181' ' ' HIS . . . . . 0.465 ' HA ' ' OE2' ' A' ' 184' ' ' GLU . 11.7 m80 -66.64 -32.28 73.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.245 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' TYR . . . . . 0.454 ' O ' ' HB2' ' A' ' 186' ' ' LEU . 4.9 m-85 -68.7 -41.43 79.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.75 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.434 HG23 ' H ' ' A' ' 183' ' ' VAL . 1.6 t -68.47 -20.09 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 120.927 0.394 . . . . 0.0 111.023 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' GLU . . . . . 0.492 ' HG3' ' O ' ' A' ' 180' ' ' SER . 41.9 mt-10 -76.42 -47.15 24.1 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.502 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.443 ' O ' HG23 ' A' ' 189' ' ' VAL . 6.1 t -77.11 -37.5 26.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.232 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.51 ' O ' HG23 ' A' ' 190' ' ' VAL . 0.6 OUTLIER -58.84 -48.91 79.69 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.616 -0.266 . . . . 0.0 111.431 -179.744 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -63.74 -33.52 75.83 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.873 0.368 . . . . 0.0 110.941 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -65.95 -44.91 90.78 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.797 -0.715 . . . . 0.0 111.849 179.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 185' ' ' VAL . 84.0 t -60.68 -43.98 96.13 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-O 120.484 0.183 . . . . 0.0 110.676 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 186' ' ' LEU . 48.2 t -60.82 -47.7 92.13 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.099 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.027 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 191' ' ' LEU . . . . . 0.479 HD12 ' HG ' ' A' ' 22' ' ' LEU . 0.7 OUTLIER -61.42 -42.62 99.04 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.236 -179.984 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.478 ' O ' HG23 ' A' ' 196' ' ' VAL . 71.9 t -65.59 -44.21 93.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.7 tp -58.54 -45.97 87.78 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.654 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.456 HG11 ' CE1' ' A' ' 209' ' ' PHE . 78.8 t -63.21 -40.04 87.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.502 179.18 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.45 ' HA3' HD22 ' A' ' 83' ' ' LEU . . . -59.44 -45.05 96.15 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.304 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 192' ' ' VAL . 22.4 t -71.57 -38.81 68.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-O 120.755 0.312 . . . . 0.0 110.675 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.99 -23.95 63.24 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.376 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.46 -41.73 16.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.746 -0.206 . . . . 0.0 110.895 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 199' ' ' PHE . . . . . 0.406 ' CE1' ' HA ' ' A' ' 77' ' ' ARG . 22.5 t80 -68.55 -56.28 8.85 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.645 0.259 . . . . 0.0 111.37 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.41 -10.08 59.55 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.895 0.379 . . . . 0.0 111.306 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -91.05 -55.53 1.84 Allowed Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.262 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 18.8 m 68.37 -70.31 0.13 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.049 0.54 . . . . 0.0 111.528 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -97.63 160.86 14.06 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 23.6 m 74.24 -40.33 0.45 Allowed 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 122.781 0.433 . . . . 0.0 111.173 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -75.57 -36.1 60.45 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.145 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.446 ' O ' ' HB2' ' A' ' 210' ' ' PHE . 0.4 OUTLIER -60.46 -44.79 95.51 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.364 179.906 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -71.65 -38.74 70.68 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.755 0.312 . . . . 0.0 111.181 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 62.1 m -64.34 -43.03 95.9 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.946 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' PHE . . . . . 0.456 ' CE1' HG11 ' A' ' 194' ' ' VAL . 2.3 t80 -74.7 -30.91 61.71 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.237 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 210' ' ' PHE . . . . . 0.446 ' HB2' ' O ' ' A' ' 206' ' ' LEU . 0.1 OUTLIER -63.56 -24.53 67.84 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.257 -179.947 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.2 -22.25 65.74 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.884 0.373 . . . . 0.0 110.539 179.134 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.37 -7.05 51.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.917 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 2.5 mt -102.7 3.82 10.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.949 0.404 . . . . 0.0 110.901 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.88 117.84 61.43 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.785 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -72.16 120.83 7.05 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.25 1.967 . . . . 0.0 112.183 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' GLU . . . . . 0.551 ' HA ' ' OE1' ' A' ' 219' ' ' GLN . 1.9 mt-10 -65.01 -26.35 68.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.467 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 1.3 m-90 -72.67 -24.11 60.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.958 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.1 -33.27 24.38 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 219' ' ' GLN . . . . . 0.551 ' OE1' ' HA ' ' A' ' 216' ' ' GLU . 68.4 mt-30 -67.0 -30.3 70.37 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.363 179.075 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.332 -0.178 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.768 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.118 0 CA-C-O 120.861 0.362 . . . . 0.0 111.502 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.12 -6.78 34.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.203 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.47 -37.54 87.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.475 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.2 -45.19 70.52 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.495 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.64 -47.05 87.14 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.667 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.74 -42.8 99.45 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.635 178.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.445 ' HB1' ' HA ' ' A' ' 151' ' ' TYR . . . -63.17 -48.38 78.62 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.888 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.45 ' O ' HG23 ' A' ' 13' ' ' VAL . 5.5 m-85 -55.95 -46.45 78.55 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.617 178.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.81 -44.4 96.27 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.815 0.341 . . . . 0.0 110.525 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.39 -39.75 94.25 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.677 178.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.09 -41.13 99.36 Favored Glycine 0 C--N 1.334 0.429 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.065 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 9' ' ' PHE . 98.0 t -65.03 -36.43 77.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 178.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.1 tp -63.77 -43.17 97.17 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.791 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -35.05 79.06 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.793 0.33 . . . . 0.0 110.844 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.13 -28.84 63.52 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.889 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.35 -13.21 50.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.046 0.451 . . . . 0.0 110.632 178.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 61.6 m -85.82 135.86 37.33 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.364 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.63 -14.71 36.89 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.474 2.116 . . . . 0.0 113.027 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 6.3 t -90.16 132.9 35.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.352 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.1 t 61.46 65.28 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 O-C-N 123.724 0.64 . . . . 0.0 111.03 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.6 tp -109.78 105.34 57.07 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.896 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.476 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 28.1 Cg_exo -63.05 -15.34 47.29 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.989 2.459 . . . . 0.0 112.81 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.2 tp -77.95 -15.38 59.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.148 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.526 ' HB ' ' HD3' ' A' ' 26' ' ' PRO . 8.6 t -72.12 -52.35 7.43 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 116.684 -0.234 . . . . 0.0 111.327 179.315 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.526 ' HD3' ' HB ' ' A' ' 25' ' ' VAL . 22.9 Cg_exo -65.36 -38.68 25.38 Favored 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 122.029 1.82 . . . . 0.0 112.59 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.1 p -65.85 -33.57 76.16 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.707 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -62.56 -36.05 81.43 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.877 0.37 . . . . 0.0 110.769 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.46 -42.62 18.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.573 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -57.8 -36.36 72.09 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.51 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -71.32 -33.08 69.33 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.804 0.335 . . . . 0.0 110.884 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -79.75 -22.6 43.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.487 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -78.0 -24.87 63.24 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.199 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 110.29 43.46 1.08 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.715 -0.755 . . . . 0.0 113.004 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.42 96.36 9.06 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.702 0.286 . . . . 0.0 111.181 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.14 122.06 40.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.639 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 170.87 -158.21 29.66 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 111.673 -0.571 . . . . 0.0 111.673 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 2.2 mmt180 -103.67 118.78 56.61 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.845 0.322 . . . . 0.0 110.75 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.06 -27.0 42.62 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.65 2.233 . . . . 0.0 112.79 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.07 -34.89 77.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.13 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -71.41 -38.22 71.45 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.795 0.331 . . . . 0.0 110.289 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -64.88 -43.77 91.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.283 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.81 -41.01 88.22 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.658 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.445 HD22 ' HA ' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -58.58 -46.78 86.22 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.109 179.616 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -67.3 -36.28 81.18 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.871 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -65.18 -42.9 93.2 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.732 -0.213 . . . . 0.0 110.573 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 70.6 mt -60.42 -46.11 95.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.332 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.22 -42.44 93.44 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.472 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -60.44 -48.24 87.17 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 121.216 -0.516 . . . . 0.0 112.344 178.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.08 -34.85 75.78 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.734 0.302 . . . . 0.0 110.338 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -61.81 -46.44 94.15 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 178.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.58 -42.12 96.05 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 120.769 0.318 . . . . 0.0 110.463 178.424 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.6 t -62.69 -45.2 99.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.704 179.316 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -62.96 -33.41 75.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.466 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.96 -42.29 21.48 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 121.115 -0.234 . . . . 0.0 110.878 179.48 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.36 -37.1 85.97 Favored 'General case' 0 C--O 1.226 -0.168 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.08 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.39 -19.93 24.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.815 0.341 . . . . 0.0 110.86 179.101 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.22 -36.2 70.84 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.953 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.88 -57.63 22.94 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -67.95 -13.68 39.02 Favored 'Trans proline' 0 C--N 1.359 1.108 0 C-N-CA 122.583 2.189 . . . . 0.0 113.063 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -58.29 -20.58 43.95 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.698 0.285 . . . . 0.0 111.536 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 11.6 p -66.63 -47.82 71.39 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.148 0.499 . . . . 0.0 110.27 178.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.5 mt -81.63 -19.22 42.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.621 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.24 -18.21 59.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.524 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -69.94 -36.38 73.3 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.875 -0.679 . . . . 0.0 111.919 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.82 -25.71 64.19 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.806 -0.711 . . . . 0.0 111.711 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 mt -76.23 -20.54 57.34 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.633 0.254 . . . . 0.0 110.703 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 28.9 mt -63.83 -19.66 65.2 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.028 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -70.19 -17.67 63.16 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.775 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -95.52 39.84 1.12 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.558 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 73.4 160.87 0.24 Allowed 'General case' 0 N--CA 1.472 0.644 0 O-C-N 123.953 0.783 . . . . 0.0 111.149 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 72' ' ' ARG . 3.1 ptt180 -139.22 12.05 2.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.38 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -69.4 -35.93 76.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.492 -179.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.19 -24.6 64.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.579 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.41 HD12 ' HA ' ' A' ' 75' ' ' LEU . 4.7 tp -82.56 -28.75 30.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.929 0.395 . . . . 0.0 110.798 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -79.85 -28.53 40.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.994 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -62.72 -34.84 78.01 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.277 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 18.7 t -59.78 -37.87 73.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.568 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -66.44 -33.56 85.15 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.983 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.479 ' O ' HG23 ' A' ' 84' ' ' VAL . . . -66.41 -43.82 91.74 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.851 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.0 t -62.24 -39.9 85.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-O 121.039 0.447 . . . . 0.0 110.373 179.124 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.5 t -64.64 -41.64 92.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.715 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.0 -40.85 90.62 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.603 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 80' ' ' GLY . 61.5 t -63.82 -43.98 98.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.207 178.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.81 -40.41 95.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.804 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -60.22 -43.66 95.81 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 178.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -65.38 -39.25 95.72 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.733 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LEU . . . . . 0.804 ' HA ' HD12 ' A' ' 91' ' ' LEU . 1.0 OUTLIER -62.68 -40.63 97.73 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.711 0.291 . . . . 0.0 111.024 179.368 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -72.3 -32.69 66.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.878 0.371 . . . . 0.0 110.665 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -73.45 -17.46 61.24 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.706 179.028 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.804 HD12 ' HA ' ' A' ' 88' ' ' LEU . 5.5 mt -67.08 -10.05 45.87 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.478 178.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.6 13.91 64.36 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.675 -0.774 . . . . 0.0 113.209 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 24.5 mt -88.22 122.89 32.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.837 0.351 . . . . 0.0 110.578 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.369 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.912 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.23 0 CA-C-O 120.95 0.405 . . . . 0.0 111.246 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.54 -11.99 50.03 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.333 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.425 ' N ' ' HD2' ' A' ' 110' ' ' PRO . 10.6 ttp180 -62.81 -54.73 44.65 Favored Pre-proline 0 CA--C 1.539 0.527 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 109' ' ' ARG . 28.0 Cg_endo -63.0 -38.21 48.11 Favored 'Trans proline' 0 C--N 1.361 1.195 0 C-N-CA 121.93 1.754 . . . . 0.0 112.489 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.72 -42.46 70.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.865 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -63.66 -41.83 98.92 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.927 -0.654 . . . . 0.0 111.961 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.02 -36.86 80.64 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.906 0.384 . . . . 0.0 110.607 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -67.06 -44.59 79.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.992 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.04 -38.9 86.68 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.978 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.9 -37.33 85.82 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.97 0.414 . . . . 0.0 110.399 179.151 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -74.11 -36.49 51.2 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 121.002 -0.618 . . . . 0.0 111.75 179.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -55.25 -41.89 72.74 Favored 'General case' 0 N--CA 1.461 0.106 0 C-N-CA 122.362 0.265 . . . . 0.0 111.153 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.38 -46.41 86.6 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.828 179.192 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.07 -35.24 80.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.259 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -72.96 -29.74 63.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.994 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.2 mt -81.91 -27.4 33.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.667 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -78.1 138.38 21.23 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.05 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -82.86 -7.18 59.68 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 121.041 -0.264 . . . . 0.0 111.707 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.5 m 58.5 85.66 0.18 Allowed Pre-proline 0 C--O 1.233 0.187 0 O-C-N 123.508 0.505 . . . . 0.0 111.128 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -59.13 -17.77 40.42 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 123.063 2.509 . . . . 0.0 113.156 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 83.9 m -65.26 -43.21 92.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.071 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 11.6 pt -104.29 5.47 10.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.358 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -55.92 -67.35 2.26 Favored Glycine 0 CA--C 1.52 0.362 0 CA-C-N 116.122 -0.49 . . . . 0.0 113.112 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -62.5 -33.71 77.9 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.502 2.135 . . . . 0.0 112.101 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 26.9 mt -61.94 -40.09 85.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.031 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 6.3 mt -64.05 -29.32 70.47 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.682 0.277 . . . . 0.0 110.95 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -67.13 -30.16 75.39 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.902 -0.666 . . . . 0.0 111.778 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -79.74 -36.19 37.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.942 0.401 . . . . 0.0 110.355 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 45.3 mm -67.26 -30.93 50.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.711 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.61 -43.86 89.72 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.804 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.13 -24.77 62.34 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.077 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -76.21 -38.06 56.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.217 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.5 m -68.54 -18.03 64.28 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.942 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.27 -38.54 88.05 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.828 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 4.1 m -102.24 -22.59 4.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.017 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -129.37 78.79 0.38 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 121.018 -0.61 . . . . 0.0 112.063 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -111.18 121.36 5.77 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.533 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -156.16 141.6 8.12 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.178 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 6.3 t -66.84 -27.8 40.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-O 120.882 0.372 . . . . 0.0 110.875 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -62.38 -28.56 71.26 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.584 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -68.33 -52.82 29.11 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.706 0.289 . . . . 0.0 110.599 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 20.1 mt -62.53 -37.25 85.37 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.757 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.01 -44.38 89.4 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.479 179.184 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.88 -39.27 93.81 Favored 'General case' 0 C--O 1.225 -0.23 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.787 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.445 ' HA ' ' HB1' ' A' ' 8' ' ' ALA . 2.8 m-85 -60.43 -47.54 85.65 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.069 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 48.5 mm -64.16 -44.86 97.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.455 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.27 -34.83 79.29 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.89 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -61.0 -41.22 99.36 Favored Glycine 0 C--O 1.225 -0.415 0 CA-C-N 115.976 -0.557 . . . . 0.0 112.386 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.424 ' O ' ' HD2' ' A' ' 158' ' ' PRO . 0.0 OUTLIER -82.69 -27.69 31.08 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.831 0.348 . . . . 0.0 110.915 178.77 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -62.57 -38.9 91.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.855 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.556 ' HB ' ' HD3' ' A' ' 158' ' ' PRO . 6.9 t -57.44 -57.63 23.83 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-O 119.322 -0.37 . . . . 0.0 111.791 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.556 ' HD3' ' HB ' ' A' ' 157' ' ' VAL . 38.0 Cg_exo -58.44 -40.67 72.74 Favored 'Trans proline' 0 C--N 1.361 1.229 0 C-N-CA 122.024 1.816 . . . . 0.0 112.244 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.65 -45.29 92.45 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.151 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -66.34 -41.07 90.11 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.684 -0.234 . . . . 0.0 110.73 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 157' ' ' VAL . 98.0 t -63.51 -46.57 94.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.716 179.315 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 158' ' ' PRO . 78.9 t -64.73 -43.69 96.52 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.718 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -60.88 -33.56 73.29 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.649 0.261 . . . . 0.0 111.658 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.2 tp -79.51 -45.89 18.45 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.096 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -68.3 -19.39 64.68 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.125 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -65.51 -18.92 65.68 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.029 179.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -59.99 -40.56 89.6 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.005 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 1.2 mmt85 -87.6 -32.97 19.04 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.89 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 46.9 mm -67.1 -31.64 54.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.004 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.93 -28.49 67.66 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.579 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -70.69 -37.23 67.28 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.296 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -86.84 -34.07 19.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.555 0.217 . . . . 0.0 110.816 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.566 ' HA ' ' HB3' ' A' ' 176' ' ' ALA . 0.2 OUTLIER -59.87 -22.98 63.04 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.375 179.301 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -53.15 61.18 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-O 121.009 0.433 . . . . 0.0 110.167 178.445 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 7.3 mtm180 -78.57 -31.25 47.24 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.66 178.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.566 ' HB3' ' HA ' ' A' ' 173' ' ' LEU . . . -62.41 -41.07 98.4 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.494 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -42.52 -31.58 1.07 Allowed Glycine 0 C--N 1.34 0.765 0 O-C-N 123.91 0.756 . . . . 0.0 114.081 178.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 4.5 ttp180 -61.36 -56.46 20.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.105 0.479 . . . . 0.0 110.331 179.026 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -75.07 -27.75 20.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.011 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 19.5 m -71.27 -16.55 62.48 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.764 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -56.13 -37.35 69.33 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.764 0.316 . . . . 0.0 111.498 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -73.26 -24.56 60.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.118 0.485 . . . . 0.0 110.82 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 4.9 t -82.22 -21.7 9.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.249 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -70.06 -43.47 71.11 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.389 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 2.9 t -69.68 -41.92 80.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.81 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.416 ' O ' HG23 ' A' ' 190' ' ' VAL . 4.6 mt -58.98 -48.67 80.74 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.084 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -63.48 -39.67 95.07 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.644 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.509 ' O ' HG23 ' A' ' 192' ' ' VAL . . . -62.91 -45.12 96.33 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.064 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 54.2 t -60.51 -47.54 92.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-O 120.645 0.259 . . . . 0.0 110.629 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.419 ' O ' HG23 ' A' ' 194' ' ' VAL . 84.7 t -61.42 -44.06 97.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.95 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -57.0 -46.78 82.04 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.005 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.533 ' O ' HG23 ' A' ' 196' ' ' VAL . 45.0 t -67.05 -42.37 88.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.403 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.78 -42.64 89.46 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.037 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 194' ' ' VAL . . . . . 0.616 HG13 HD11 ' A' ' 206' ' ' LEU . 58.6 t -61.8 -43.85 97.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 178.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -61.86 -41.27 99.62 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.107 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 192' ' ' VAL . 61.2 t -68.63 -42.64 83.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.481 0.182 . . . . 0.0 110.814 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.27 -25.96 68.28 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.795 0.331 . . . . 0.0 111.403 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.68 -43.61 18.28 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.774 0.321 . . . . 0.0 110.385 178.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -71.2 -48.41 51.71 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.099 -0.501 . . . . 0.0 112.089 -179.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 69.3 p -84.2 -9.14 58.79 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.908 0.385 . . . . 0.0 111.314 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -87.09 -53.87 2.73 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.907 -0.664 . . . . 0.0 112.094 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 52.74 45.96 27.67 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.94 0.4 . . . . 0.0 111.634 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -151.05 -174.05 4.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.934 0.397 . . . . 0.0 110.911 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.26 10.46 10.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.67 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -58.63 -33.15 69.72 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.156 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.616 HD11 HG13 ' A' ' 194' ' ' VAL . 0.4 OUTLIER -78.13 -37.63 45.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.816 179.656 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.1 -35.78 74.4 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.609 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 5.9 m -69.09 -35.12 76.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.269 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -71.74 -29.35 64.43 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.955 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -69.43 -21.83 63.71 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.198 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.95 -11.2 51.28 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.9 0.381 . . . . 0.0 110.625 179.035 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 17.4 mtt180 -91.23 -14.11 31.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.127 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 6.8 pt -102.35 -6.72 9.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.371 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 1.3 p -87.36 118.21 69.6 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.606 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 215' ' ' PRO . . . . . 0.43 ' HG2' HD23 ' A' ' 218' ' ' LEU . 47.2 Cg_endo -70.54 149.08 61.33 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.379 2.053 . . . . 0.0 112.491 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -63.34 -22.13 66.69 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.977 0.418 . . . . 0.0 111.335 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -66.51 -18.7 65.51 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.407 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.43 HD23 ' HG2' ' A' ' 215' ' ' PRO . 0.5 OUTLIER -76.2 -22.61 55.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.973 0.416 . . . . 0.0 110.249 179.539 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -84.31 -30.25 25.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.163 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 220' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.856 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.529 0.153 0 CA-C-O 120.89 0.376 . . . . 0.0 111.264 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 15.0 mt -90.45 48.28 1.53 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.032 0.444 . . . . 0.0 111.115 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.3 -22.01 58.03 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.137 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.84 -38.84 89.94 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.645 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.27 -34.65 78.13 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.873 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.72 -49.27 66.59 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.697 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.7 -25.07 64.59 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.196 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.45 ' O ' HG23 ' A' ' 13' ' ' VAL . 0.3 OUTLIER -74.39 -50.83 17.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.068 179.823 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.42 HD21 ' HB3' ' A' ' 217' ' ' TRP . 7.9 mt -64.64 -34.65 78.79 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.424 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.81 -43.44 96.27 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.518 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.49 -42.85 98.83 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.744 178.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 9' ' ' PHE . 59.1 t -64.87 -41.91 93.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.932 0.396 . . . . 0.0 110.078 179.103 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.1 mt -63.12 -39.57 95.06 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.844 179.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 28.7 m -65.97 -36.35 83.1 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.991 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -73.47 -31.28 63.69 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.75 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.2 mt -83.88 -14.66 50.56 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.06 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 38.4 m -61.43 146.68 89.06 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.776 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.48 -20.23 48.12 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.788 2.326 . . . . 0.0 113.081 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.459 ' O ' ' HZ2' ' A' ' 124' ' ' TRP . 39.6 m -75.69 -38.81 58.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.427 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.612 HG12 ' H ' ' A' ' 22' ' ' LEU . 1.2 t 55.6 -155.71 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 O-C-N 123.294 0.371 . . . . 0.0 110.025 -178.357 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.612 ' H ' HG12 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -173.62 -56.79 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.309 0 CA-C-O 119.328 -0.368 . . . . 0.0 111.326 179.606 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 22' ' ' LEU . 21.5 Cg_endo -61.19 -15.19 38.27 Favored 'Trans proline' 0 C--N 1.364 1.388 0 C-N-CA 122.647 2.231 . . . . 0.0 113.787 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.3 tp -55.44 -46.75 76.71 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 123.207 0.317 . . . . 0.0 111.838 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -67.51 -55.44 14.76 Favored Pre-proline 0 CA--C 1.542 0.663 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -51.23 -44.19 44.42 Favored 'Trans proline' 0 C--N 1.362 1.282 0 C-N-CA 122.418 2.079 . . . . 0.0 113.469 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.1 p -64.15 -37.66 88.25 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.69 0.281 . . . . 0.0 111.566 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 12.2 m-30 -73.19 -35.96 66.47 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.741 0.305 . . . . 0.0 110.686 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.628 HD21 HD22 ' A' ' 116' ' ' LEU . 1.8 mm? -70.34 -32.12 69.7 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.895 0.379 . . . . 0.0 110.137 179.107 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -61.04 -46.62 89.98 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.047 178.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -64.77 -34.89 79.41 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.723 178.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.21 -38.15 81.63 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.647 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.85 -33.25 55.75 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.104 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.01 31.49 64.28 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.656 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -133.9 131.58 39.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.698 0.285 . . . . 0.0 111.062 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 4.1 mtp180 -88.4 67.87 8.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.839 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -74.94 150.82 41.62 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.812 -0.708 . . . . 0.0 111.844 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -69.95 115.27 32.07 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.715 0.258 . . . . 0.0 111.062 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -60.83 -20.46 66.47 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 123.042 2.495 . . . . 0.0 112.889 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.84 -34.9 76.8 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.225 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -68.9 -42.06 77.39 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.013 0.435 . . . . 0.0 110.406 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.92 -42.04 86.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.301 179.053 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.85 -44.69 92.39 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.041 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.04 -46.7 88.66 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.91 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -62.52 -39.45 93.59 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.861 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -67.08 -40.9 87.06 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.949 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 71.8 mt -60.84 -45.99 97.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-O 120.778 0.323 . . . . 0.0 110.317 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.91 -46.95 73.27 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.529 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.455 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -58.54 -49.78 73.54 Favored Glycine 0 C--N 1.334 0.439 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.913 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.52 -35.35 77.36 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.703 0.252 . . . . 0.0 110.844 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -60.28 -48.41 86.26 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.509 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.79 -46.0 92.2 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.523 0.201 . . . . 0.0 110.922 178.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 49' ' ' GLY . 85.6 t -61.76 -44.06 98.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.186 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -62.72 -38.64 91.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.355 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -74.63 -40.36 61.55 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 120.634 0.254 . . . . 0.0 110.727 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.4 mt -64.41 -28.16 69.49 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.527 179.228 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.6 -19.91 24.36 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.469 178.395 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.59 -34.86 62.92 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 121.147 -0.549 . . . . 0.0 112.095 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.56 -56.16 37.94 Favored Pre-proline 0 CA--C 1.542 0.667 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 179.188 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.98 -13.81 29.06 Favored 'Trans proline' 0 C--N 1.36 1.154 0 C-N-CA 122.229 1.953 . . . . 0.0 112.961 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.59 -32.28 62.92 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 123.052 0.22 . . . . 0.0 111.379 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.28 -40.04 92.63 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.912 0.387 . . . . 0.0 110.73 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.2 mt -88.75 -19.4 26.11 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.705 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.9 tp -68.31 -17.36 64.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.779 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.27 -30.31 70.71 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.6 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.63 -22.11 73.24 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.588 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 tp -73.74 -19.86 60.67 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.689 0.281 . . . . 0.0 110.401 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.9 -22.85 60.29 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.158 179.43 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -76.01 -36.3 59.21 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.98 0.419 . . . . 0.0 110.416 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -122.3 70.64 0.98 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.915 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -61.4 125.96 25.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.374 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 18.3 mtm180 -78.88 100.64 7.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.435 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -69.56 -18.0 63.61 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.075 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.485 ' O ' HG23 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -61.45 -28.38 69.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.989 179.485 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 20.5 mt -67.68 -29.6 68.92 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.73 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -74.29 -32.22 62.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.45 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ARG . . . . . 0.405 ' O ' HG23 ' A' ' 81' ' ' VAL . 9.6 ttt-85 -67.38 -39.65 85.65 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.487 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 74' ' ' THR . 18.1 t -59.98 -39.74 81.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.483 179.236 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.43 -39.9 98.25 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.862 -0.685 . . . . 0.0 111.672 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -64.43 -42.71 97.49 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.726 179.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 77' ' ' ARG . 99.1 t -58.89 -44.41 90.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-O 120.825 0.345 . . . . 0.0 110.649 178.858 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 79.1 t -65.51 -40.66 88.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.488 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.55 -42.37 96.41 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.919 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 72.8 t -62.55 -46.22 96.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-O 120.774 0.321 . . . . 0.0 110.233 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.87 -40.77 94.19 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.675 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -65.32 -45.56 83.8 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.329 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -61.53 -39.38 97.26 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.202 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.8 mp -62.16 -42.51 99.33 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.693 0.282 . . . . 0.0 110.802 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -72.92 -31.99 65.02 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.979 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.31 -28.42 67.15 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.817 0.341 . . . . 0.0 110.881 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.67 -21.67 66.1 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.259 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.02 1.93 90.19 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.422 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.0 mt -97.21 160.1 14.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.999 0.399 . . . . 0.0 111.088 -179.011 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 3.1 mtp180 . . . . . 0 C--N 1.327 -0.39 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.303 179.432 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.806 0.336 . . . . 0.0 111.271 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.62 -20.88 56.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.649 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.48 -56.94 7.51 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -64.15 -33.34 61.33 Favored 'Trans proline' 0 C--N 1.36 1.171 0 C-N-CA 121.99 1.793 . . . . 0.0 112.411 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 17.3 mt -75.23 -22.31 58.0 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.939 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -64.91 -35.77 92.3 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.955 -0.641 . . . . 0.0 111.899 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.56 -32.91 71.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.982 0.42 . . . . 0.0 110.712 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -80.83 -39.8 25.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.739 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.94 -47.47 71.58 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.636 -0.257 . . . . 0.0 110.464 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.628 HD22 HD21 ' A' ' 29' ' ' LEU . 1.2 mp -65.75 -31.68 72.79 Favored 'General case' 0 CA--C 1.523 -0.076 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.107 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -70.63 -43.63 59.73 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.609 178.82 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.42 -45.49 87.33 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.638 0.256 . . . . 0.0 110.871 179.187 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 3.2 m -64.18 -41.12 97.23 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.621 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.05 -35.43 80.52 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.604 179.17 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.77 -39.69 94.04 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.75 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.24 -10.14 59.23 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.881 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -108.31 -0.49 33.18 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.851 179.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' TRP . . . . . 0.459 ' HZ2' ' O ' ' A' ' 20' ' ' CYS . 0.2 OUTLIER -94.17 -5.76 46.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.758 0.313 . . . . 0.0 110.8 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.13 -50.03 89.93 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.628 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.5 -25.1 79.86 Favored 'Trans proline' 0 C--N 1.361 1.232 0 C-N-CA 121.999 1.8 . . . . 0.0 112.176 178.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -70.15 -40.83 74.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.279 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.5 pt -96.09 4.82 8.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.832 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -57.14 -58.92 12.07 Favored Glycine 0 CA--C 1.52 0.363 0 CA-C-N 115.845 -0.616 . . . . 0.0 113.152 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.2 -25.59 78.69 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 122.635 2.223 . . . . 0.0 112.283 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 37.9 mm -80.21 -35.54 15.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.011 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 5.1 tp -61.64 -24.99 67.08 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.154 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -63.14 -34.6 90.4 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.119 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -81.77 -22.37 37.24 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.005 0.431 . . . . 0.0 110.721 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 52.3 mt -80.28 -33.16 13.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.193 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.56 -28.35 67.72 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.236 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -70.78 -20.19 62.63 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-O 120.828 0.347 . . . . 0.0 110.681 179.119 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 89.6 mt -80.22 -18.24 50.06 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.952 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -82.79 -17.34 44.49 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.946 0.403 . . . . 0.0 110.696 179.209 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -82.28 -22.62 35.63 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.191 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 2.4 m -99.48 4.07 10.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.261 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 148.33 98.03 0.19 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.682 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -82.25 80.31 1.79 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.608 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -100.59 142.45 15.84 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.745 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 6.6 m -74.67 -18.7 16.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-O 120.774 0.321 . . . . 0.0 111.448 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -65.0 -30.38 77.86 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 121.026 -0.606 . . . . 0.0 112.531 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.47 -44.11 83.63 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-O 120.779 0.323 . . . . 0.0 110.392 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' LEU . . . . . 0.446 ' O ' HG13 ' A' ' 152' ' ' ILE . 0.8 OUTLIER -62.09 -43.36 99.0 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.549 179.247 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.07 -42.21 89.71 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.927 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.28 -37.81 88.71 Favored 'General case' 0 CA--C 1.524 -0.05 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.532 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -61.09 -48.28 82.43 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.886 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 148' ' ' LEU . 42.0 mt -63.73 -45.01 98.49 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.566 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 4.7 tp -64.82 -38.59 91.5 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.621 0.248 . . . . 0.0 110.915 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -59.52 -42.38 97.63 Favored Glycine 0 C--N 1.334 0.428 0 CA-C-N 116.031 -0.532 . . . . 0.0 112.424 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.467 ' O ' ' HD2' ' A' ' 158' ' ' PRO . 0.4 OUTLIER -80.95 -25.05 37.68 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.836 0.318 . . . . 0.0 111.179 178.963 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -62.93 -38.82 92.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.652 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.549 ' HB ' ' HD3' ' A' ' 158' ' ' PRO . 4.8 t -57.58 -56.72 31.31 Favored Pre-proline 0 CA--C 1.545 0.771 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.549 ' HD3' ' HB ' ' A' ' 157' ' ' VAL . 33.4 Cg_exo -61.04 -35.43 87.21 Favored 'Trans proline' 0 C--N 1.36 1.141 0 C-N-CA 122.131 1.887 . . . . 0.0 112.236 178.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -61.73 -42.93 99.61 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.846 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -65.67 -38.15 88.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.627 0.251 . . . . 0.0 110.491 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 157' ' ' VAL . 91.7 t -60.82 -49.86 82.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.047 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.466 HG22 ' O ' ' A' ' 158' ' ' PRO . 11.8 m -72.64 -36.31 53.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 120.931 -0.308 . . . . 0.0 111.539 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.565 ' O ' ' HB2' ' A' ' 167' ' ' ASP . . . -57.79 -35.87 71.39 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 5.8 tp -80.05 -45.65 17.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.7 0.286 . . . . 0.0 111.048 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -65.36 -44.11 88.7 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.897 -179.213 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 170' ' ' LYS . . . -71.83 -19.15 62.02 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.388 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ASP . . . . . 0.565 ' HB2' ' O ' ' A' ' 163' ' ' ALA . 14.1 t70 -76.63 -40.85 48.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.145 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 10.9 mmt-85 -69.55 -43.32 73.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.254 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 4.6 pt -76.32 -18.91 15.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 166' ' ' ALA . 0.0 OUTLIER -60.1 -33.42 72.08 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.697 -0.229 . . . . 0.0 111.56 -179.676 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -63.79 -38.53 96.3 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.586 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -86.66 -38.77 16.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.625 0.25 . . . . 0.0 111.26 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -65.16 -16.81 63.91 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.663 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.43 -52.56 65.1 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 120.806 0.336 . . . . 0.0 110.632 178.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.92 -30.52 14.72 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.619 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -84.79 4.97 30.45 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -81.15 33.58 2.44 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 121.146 -0.55 . . . . 0.0 113.348 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' ARG . . . . . 0.408 ' O ' ' HB2' ' A' ' 181' ' ' HIS . 0.4 OUTLIER -80.29 -38.79 30.08 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.916 0.389 . . . . 0.0 110.718 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 19.5 mm -73.27 -30.27 30.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.847 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.08 -16.95 64.65 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.375 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' HIS . . . . . 0.408 ' HB2' ' O ' ' A' ' 178' ' ' ARG . 3.3 m80 -61.89 -38.38 88.1 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.086 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -75.66 -27.6 58.41 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 121.031 0.443 . . . . 0.0 110.477 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 3.2 t -75.88 -18.54 15.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.47 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -83.4 -27.72 29.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.601 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.506 ' O ' HG23 ' A' ' 189' ' ' VAL . 51.2 t -63.13 -47.79 90.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.547 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.468 ' O ' HG23 ' A' ' 190' ' ' VAL . 1.0 OUTLIER -62.04 -40.66 96.48 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.796 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -62.49 -38.2 88.95 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.506 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.52 ' O ' HG23 ' A' ' 192' ' ' VAL . . . -68.67 -42.88 78.51 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.035 179.202 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 185' ' ' VAL . 88.7 t -61.84 -49.66 83.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-O 120.763 0.316 . . . . 0.0 110.671 179.369 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 186' ' ' LEU . 50.4 t -63.35 -35.77 73.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.706 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.56 -46.83 83.46 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.804 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 188' ' ' GLY . 22.5 t -62.53 -42.29 95.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.345 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 23.5 mt -64.2 -44.57 91.56 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.788 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 69.0 t -63.77 -40.37 88.82 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.366 179.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -57.82 -45.52 93.43 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.159 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 192' ' ' VAL . 32.4 t -70.72 -40.09 76.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.682 0.277 . . . . 0.0 110.606 179.293 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.16 -39.04 93.52 Favored 'General case' 0 C--O 1.225 -0.205 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.044 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.455 HD11 HD21 ' A' ' 206' ' ' LEU . 1.4 mp -72.83 -30.74 64.27 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.497 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -59.12 -54.56 45.57 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.99 0.424 . . . . 0.0 111.055 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -89.19 -7.16 56.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.967 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -83.15 -4.56 89.71 Favored Glycine 0 N--CA 1.452 -0.256 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.712 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.64 68.64 0.1 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.674 0.39 . . . . 0.0 111.59 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -165.23 -73.05 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.398 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 6.8 t -158.22 12.19 0.18 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.104 0.478 . . . . 0.0 111.302 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -84.16 -16.01 45.06 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.191 -179.082 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.477 ' O ' ' HB2' ' A' ' 210' ' ' PHE . 3.6 mt -74.89 -30.09 61.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.203 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.72 -34.87 76.35 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.169 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.19 -40.24 93.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.312 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -87.13 -26.6 23.54 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.25 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' PHE . . . . . 0.477 ' HB2' ' O ' ' A' ' 206' ' ' LEU . 0.2 OUTLIER -66.62 -21.16 66.12 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.142 179.764 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.43 -27.54 69.18 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.981 0.42 . . . . 0.0 110.782 179.163 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 5.4 mmm180 -92.3 -4.47 53.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.666 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 10.4 mm -103.55 -11.07 9.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.014 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' THR . . . . . 0.407 ' HA ' ' HD3' ' A' ' 215' ' ' PRO . 0.2 OUTLIER -60.75 118.09 31.51 Favored Pre-proline 0 C--O 1.233 0.218 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.155 179.774 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 215' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 214' ' ' THR . 33.9 Cg_exo -61.67 155.74 51.93 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.815 2.343 . . . . 0.0 112.476 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.94 -27.55 68.31 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.447 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 217' ' ' TRP . . . . . 0.42 ' HB3' HD21 ' A' ' 10' ' ' LEU . 0.2 OUTLIER -68.73 -28.28 66.69 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.765 179.546 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.22 -29.24 26.71 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -67.71 -38.02 83.06 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.163 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 42.4 mtp180 . . . . . 0 C--N 1.332 -0.155 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.058 179.375 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' SER . . . . . 0.449 ' HB2' ' OG ' ' A' ' 4' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.141 0 CA-C-O 120.494 0.188 . . . . 0.0 110.812 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 62.61 24.99 14.88 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 123.838 0.711 . . . . 0.0 111.771 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' SER . . . . . 0.449 ' OG ' ' HB2' ' A' ' 2' ' ' SER . 0.0 OUTLIER -75.45 -24.35 57.0 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.965 0.412 . . . . 0.0 111.028 179.702 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.6 mp -81.36 -42.87 19.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.383 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.39 -29.83 69.44 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.936 0.398 . . . . 0.0 110.532 179.165 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.65 -52.19 28.01 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.312 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.69 -27.85 69.53 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.995 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -69.66 -49.23 55.57 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.526 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.658 ' HG ' HD21 ' A' ' 218' ' ' LEU . 0.2 OUTLIER -65.26 -37.32 86.84 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.482 179.404 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.67 -46.1 80.38 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.764 0.316 . . . . 0.0 110.992 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -65.41 -43.32 95.1 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.323 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -66.92 -31.79 55.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 120.77 0.319 . . . . 0.0 111.005 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.409 ' HB2' ' O ' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -67.43 -50.51 59.06 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.154 179.703 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.804 ' HB2' HD13 ' A' ' 155' ' ' LEU . 3.7 m -67.87 -24.83 65.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.76 0.314 . . . . 0.0 110.776 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -72.66 -41.12 65.77 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.215 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 11.7 mt -86.8 -7.86 57.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.107 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.64 130.02 91.82 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.404 178.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -71.15 -8.03 22.64 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.497 2.131 . . . . 0.0 112.829 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.8 m -66.85 150.46 49.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.06 0.457 . . . . 0.0 111.054 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.425 HG23 ' H ' ' A' ' 21' ' ' VAL . 0.2 OUTLIER -71.51 94.98 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.418 -179.578 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.44 ' H ' ' CD ' ' A' ' 23' ' ' PRO . 0.1 OUTLIER -143.63 -54.37 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.376 179.586 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PRO . . . . . 0.44 ' CD ' ' H ' ' A' ' 22' ' ' LEU . 23.2 Cg_exo -66.25 -18.47 55.78 Favored 'Trans proline' 0 C--N 1.361 1.192 0 C-N-CA 122.256 1.971 . . . . 0.0 112.42 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.3 mt -88.02 -13.15 42.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.303 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.472 ' HB ' ' HD3' ' A' ' 26' ' ' PRO . 20.8 t -57.34 -50.1 90.09 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.627 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.472 ' HD3' ' HB ' ' A' ' 25' ' ' VAL . 52.0 Cg_exo -55.97 -40.63 83.85 Favored 'Trans proline' 0 C--N 1.363 1.318 0 C-N-CA 122.237 1.958 . . . . 0.0 112.907 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.75 -36.84 78.87 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.795 0.331 . . . . 0.0 111.406 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -77.46 -41.01 41.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.265 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.54 -22.75 66.16 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.012 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -64.94 -59.24 4.4 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 178.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -60.79 -33.22 72.65 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.099 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.2 mt -71.91 -16.38 62.11 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.879 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -93.7 -0.72 66.44 Favored Glycine 0 N--CA 1.452 -0.287 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 178.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 66.67 -109.31 2.84 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 121.403 -0.427 . . . . 0.0 112.704 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -119.13 10.58 12.13 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.011 0.434 . . . . 0.0 110.659 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -131.21 40.91 3.4 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.887 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -100.15 99.77 2.09 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.214 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.81 129.47 29.81 Favored Pre-proline 0 C--N 1.326 -0.414 0 O-C-N 122.804 -0.233 . . . . 0.0 110.85 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -65.18 -23.43 60.05 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.817 2.344 . . . . 0.0 112.84 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -66.02 -44.48 84.6 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.081 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -72.17 -33.36 67.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.226 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.43 ' O ' ' HB2' ' A' ' 46' ' ' PHE . 16.0 t30 -65.23 -50.25 66.57 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.319 178.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.81 -39.7 94.86 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.879 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.38 -50.48 71.39 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.974 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -66.19 -36.82 84.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.069 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.46 ' O ' ' HB2' ' A' ' 50' ' ' PHE . 0.2 OUTLIER -63.51 -49.83 72.0 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.239 179.462 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 tt -65.97 -28.73 44.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-O 120.728 0.299 . . . . 0.0 110.895 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.75 -55.46 5.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.701 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.423 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -57.54 -44.55 93.77 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.152 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.46 ' HB2' ' O ' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -70.92 -32.4 69.3 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 110.503 -0.184 . . . . 0.0 110.503 179.532 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -63.16 -48.62 78.18 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.517 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.28 -43.21 92.55 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.743 0.306 . . . . 0.0 110.752 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 49' ' ' GLY . 98.9 t -66.22 -43.3 91.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.029 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.7 -28.73 69.28 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.396 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -84.35 -45.07 13.16 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.526 0.203 . . . . 0.0 110.849 179.335 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.93 -39.16 93.52 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.198 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.33 -18.18 27.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.733 0.302 . . . . 0.0 110.381 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.95 -33.0 73.91 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 121.189 -0.529 . . . . 0.0 112.255 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.548 ' O ' HG22 ' A' ' 62' ' ' THR . 1.1 mm? -64.52 -57.69 16.21 Favored Pre-proline 0 CA--C 1.537 0.481 0 CA-C-O 119.453 -0.308 . . . . 0.0 111.509 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -67.86 -13.39 38.37 Favored 'Trans proline' 0 C--N 1.36 1.169 0 C-N-CA 122.064 1.842 . . . . 0.0 112.623 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.47 ' HA ' HD12 ' A' ' 64' ' ' LEU . 0.1 OUTLIER -55.7 -27.46 50.4 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.619 179.831 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.548 HG22 ' O ' ' A' ' 59' ' ' LEU . 8.6 t -66.32 -32.74 74.32 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.929 0.395 . . . . 0.0 110.64 179.014 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.86 -20.42 24.64 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.855 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.47 HD12 ' HA ' ' A' ' 61' ' ' PHE . 1.5 mt -64.88 -17.42 64.28 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.2 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -63.32 -30.14 76.65 Favored Glycine 0 C--N 1.334 0.442 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.474 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.08 -24.88 70.32 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 121.02 -0.61 . . . . 0.0 111.686 178.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 tp -85.11 -20.87 29.67 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.689 0.28 . . . . 0.0 110.569 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.7 -19.58 64.03 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.977 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -64.22 -25.13 67.93 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.799 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -108.42 118.38 36.62 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -77.83 109.08 11.55 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.102 0.477 . . . . 0.0 110.92 -179.241 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.4 mmm180 -78.89 90.21 4.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.332 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -68.76 -18.28 64.18 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.821 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.416 ' O ' HG23 ' A' ' 78' ' ' VAL . 1.8 t -67.94 -26.21 65.85 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.163 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.1 tp -69.24 -35.84 76.56 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.924 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.79 -34.69 78.75 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.378 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -69.73 -43.35 72.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.433 179.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.44 ' O ' HG23 ' A' ' 82' ' ' VAL . 99.4 t -64.74 -45.24 95.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.187 179.241 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.73 -40.1 97.61 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.961 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.435 ' O ' HG23 ' A' ' 84' ' ' VAL . . . -64.49 -38.64 96.03 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.796 178.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 40.9 t -62.12 -41.78 92.57 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-O 120.699 0.285 . . . . 0.0 110.579 179.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 78' ' ' VAL . 67.9 t -60.5 -41.74 88.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.666 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.439 HD13 ' HA2' ' A' ' 195' ' ' GLY . 8.5 mt -64.32 -41.73 96.66 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.549 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 80' ' ' GLY . 93.6 t -66.98 -41.6 87.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.285 178.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.74 -41.16 97.29 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.708 179.131 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -61.95 -41.21 97.73 Favored 'General case' 0 CA--C 1.523 -0.091 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 178.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.516 ' HA3' HG12 ' A' ' 192' ' ' VAL . . . -65.12 -40.6 97.0 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.852 -0.689 . . . . 0.0 111.812 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 53.8 mt -62.16 -38.23 88.23 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.808 0.337 . . . . 0.0 110.854 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -77.12 -30.42 55.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.659 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 8.9 mtp -72.3 -19.6 61.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.869 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.89 -7.06 25.11 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.132 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.79 19.16 48.97 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.913 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.77 130.51 43.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.808 0.304 . . . . 0.0 110.63 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.379 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.19 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.43 ' O ' ' HD2' ' A' ' 110' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.462 0.173 0 CA-C-O 121.237 0.542 . . . . 0.0 110.852 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.98 -1.63 33.01 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.213 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.9 ttp180 -62.03 -56.57 30.4 Favored Pre-proline 0 CA--C 1.54 0.583 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.43 ' HD2' ' O ' ' A' ' 107' ' ' THR . 38.5 Cg_endo -66.79 -26.97 44.59 Favored 'Trans proline' 0 C--N 1.361 1.199 0 C-N-CA 121.865 1.71 . . . . 0.0 112.049 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.2 mt -70.73 -33.37 70.77 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.625 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -64.41 -41.53 98.02 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.435 178.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -73.96 -36.36 64.59 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 120.724 0.297 . . . . 0.0 110.442 178.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -66.19 -43.89 85.51 Favored 'General case' 0 C--N 1.334 -0.094 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.907 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.39 -34.37 78.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.984 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.17 -30.45 68.68 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.989 0.423 . . . . 0.0 110.093 179.031 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -80.83 -42.04 10.17 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 178.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.07 -42.9 95.54 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.621 0.248 . . . . 0.0 111.116 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 10.1 p -67.15 -38.56 85.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.049 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.82 -28.14 65.46 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.773 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -81.65 -34.41 30.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.833 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.84 -38.05 47.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.011 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -77.74 117.54 4.77 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.751 -0.737 . . . . 0.0 111.662 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' TRP . . . . . 0.542 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 77.8 m95 -67.59 143.3 56.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.704 0.288 . . . . 0.0 111.167 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.65 102.79 5.64 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.354 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.542 ' HD3' ' O ' ' A' ' 124' ' ' TRP . 57.3 Cg_endo -75.06 -16.85 19.85 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.705 2.27 . . . . 0.0 112.869 -179.429 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -65.28 -48.02 74.63 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.112 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.431 HD12 HD12 ' A' ' 132' ' ' LEU . 4.8 pt -101.56 5.42 10.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.535 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -58.91 -67.3 2.25 Favored Glycine 0 CA--C 1.52 0.362 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.933 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -62.26 -29.63 80.42 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.36 2.04 . . . . 0.0 112.286 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 65.3 mt -66.73 -54.41 25.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.135 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.431 HD12 HD12 ' A' ' 128' ' ' ILE . 15.1 mt -73.73 -31.22 63.25 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.095 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -63.69 -36.47 93.38 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.216 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.04 -43.23 71.68 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.836 0.351 . . . . 0.0 111.008 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 23.2 mm -71.92 -29.85 34.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.194 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.47 -46.95 83.09 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.016 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.0 -22.69 67.03 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.868 0.366 . . . . 0.0 111.591 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LEU . . . . . 0.513 ' O ' HG12 ' A' ' 141' ' ' VAL . 2.6 tp -86.13 -35.68 20.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.697 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 25.6 p -82.21 -20.01 38.61 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.354 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -82.84 -8.49 59.57 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.439 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' VAL . . . . . 0.513 HG12 ' O ' ' A' ' 138' ' ' LEU . 1.4 p -88.42 -8.0 10.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-O 121.163 0.506 . . . . 0.0 110.945 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -145.57 -64.28 0.02 OUTLIER Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.571 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 144.43 57.31 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.187 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -82.74 62.08 4.66 Favored Glycine 0 N--CA 1.453 -0.173 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.734 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 9.5 m -70.26 -25.51 27.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.833 0.349 . . . . 0.0 111.28 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -63.61 -30.69 78.38 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.252 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -67.35 -42.49 83.42 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.822 0.344 . . . . 0.0 110.233 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.99 -40.95 97.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.58 179.415 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.445 ' O ' HG13 ' A' ' 152' ' ' ILE . 0.6 OUTLIER -68.3 -42.1 79.94 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.452 179.233 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -66.31 -29.82 70.11 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.638 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -64.63 -57.78 8.14 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.053 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.445 HG13 ' O ' ' A' ' 149' ' ' LEU . 0.9 OUTLIER -63.26 -42.75 97.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.377 -179.377 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.451 ' O ' HG23 ' A' ' 157' ' ' VAL . 0.4 OUTLIER -69.08 -32.97 72.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.745 -0.207 . . . . 0.0 110.74 179.605 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -60.42 -41.11 98.42 Favored Glycine 0 C--O 1.223 -0.547 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.001 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.804 HD13 ' HB2' ' A' ' 15' ' ' SER . 29.6 tp -80.29 -29.0 38.21 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.693 0.282 . . . . 0.0 110.8 178.409 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.3 -39.36 79.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.425 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.528 ' O ' HG23 ' A' ' 161' ' ' VAL . 49.8 t -57.28 -63.81 3.3 Favored Pre-proline 0 CA--C 1.542 0.671 0 O-C-N 123.253 0.345 . . . . 0.0 111.817 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.525 ' CD ' ' HB ' ' A' ' 157' ' ' VAL . 20.7 Cg_endo -60.43 -33.56 93.98 Favored 'Trans proline' 0 C--N 1.362 1.272 0 C-N-CA 122.188 1.926 . . . . 0.0 112.637 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.35 -44.74 95.27 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.631 -0.258 . . . . 0.0 110.938 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -69.36 -35.08 75.51 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.758 0.314 . . . . 0.0 110.358 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 157' ' ' VAL . 89.4 t -62.21 -47.34 93.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.214 178.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 158' ' ' PRO . 58.2 t -67.04 -41.97 87.91 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.609 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -57.37 -39.37 75.86 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.511 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -77.49 -40.96 41.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.206 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -70.3 -19.77 63.07 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.658 0.266 . . . . 0.0 111.159 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.606 ' HA ' HD12 ' A' ' 169' ' ' ILE . . . -63.59 -26.47 68.7 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.145 178.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -66.91 -38.31 85.99 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.551 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 6.1 mtp180 -65.83 -34.16 77.51 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.728 178.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.606 HD12 ' HA ' ' A' ' 166' ' ' ALA . 6.6 mt -75.3 -28.06 20.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.787 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.97 -36.76 77.83 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.197 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -61.38 -49.64 75.18 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.348 179.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' TRP . . . . . 0.406 ' O ' ' HB2' ' A' ' 175' ' ' ARG . 52.6 m95 -72.26 -26.26 61.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.808 0.337 . . . . 0.0 111.156 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.83 -23.75 61.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.958 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 14.8 mtp85 -75.82 -17.93 59.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.026 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ARG . . . . . 0.406 ' HB2' ' O ' ' A' ' 172' ' ' TRP . 0.0 OUTLIER -60.08 -43.83 95.22 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.063 0.459 . . . . 0.0 110.47 178.876 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -108.57 -76.55 0.61 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.116 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 98.51 -25.61 27.21 Favored Glycine 0 C--N 1.329 0.163 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.424 178.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 26.6 mtp180 -84.13 -10.56 57.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.966 0.412 . . . . 0.0 110.983 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 1.6 pt -76.84 -18.86 14.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.214 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.02 -22.27 65.56 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.432 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' HIS . . . . . 0.501 ' O ' HG23 ' A' ' 185' ' ' VAL . 0.1 OUTLIER -84.18 -23.0 30.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.935 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -72.83 -42.62 63.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.867 0.365 . . . . 0.0 110.66 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.421 HG22 ' H ' ' A' ' 183' ' ' VAL . 4.4 m -71.5 -19.14 20.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.073 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -80.33 -37.56 32.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.608 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 181' ' ' HIS . 91.6 t -68.98 -41.73 81.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.739 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.435 ' O ' HG23 ' A' ' 190' ' ' VAL . 1.7 mp -61.25 -38.98 88.63 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.752 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -66.7 -36.28 82.12 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.16 178.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -66.35 -36.43 91.63 Favored Glycine 0 C--N 1.333 0.366 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.85 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 185' ' ' VAL . 98.7 t -61.81 -52.86 55.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.846 0.355 . . . . 0.0 110.695 179.031 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 186' ' ' LEU . 4.0 t -63.4 -31.2 51.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.977 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.34 -54.26 46.08 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.203 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' VAL . . . . . 0.516 HG12 ' HA3' ' A' ' 87' ' ' GLY . 35.0 m -68.29 -30.66 48.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.822 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.77 -50.75 69.82 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.19 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 58.8 t -66.46 -37.99 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.124 0 CA-C-O 120.883 0.373 . . . . 0.0 110.215 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' GLY . . . . . 0.439 ' HA2' HD13 ' A' ' 83' ' ' LEU . . . -59.55 -47.21 92.04 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.441 178.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 192' ' ' VAL . 91.4 t -72.08 -36.81 58.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.619 0.247 . . . . 0.0 111.022 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.32 -31.74 73.02 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.699 0.285 . . . . 0.0 111.211 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.33 -33.91 21.97 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.68 -0.236 . . . . 0.0 111.296 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -77.23 -47.22 20.76 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.4 -35.29 17.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.677 0.275 . . . . 0.0 111.627 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -83.55 -63.64 1.69 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.405 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 54.3 -148.29 0.47 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 122.403 0.281 . . . . 0.0 110.819 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 48.55 -111.07 0.41 Allowed 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 179.052 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.44 30.94 6.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.829 0.347 . . . . 0.0 110.975 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -69.71 -14.4 62.78 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.386 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.1 mt -77.58 -16.12 58.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.956 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -64.84 -36.03 83.04 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.198 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 75.6 p -62.59 -36.96 84.36 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.122 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' PHE . . . . . 0.472 ' O ' HG12 ' A' ' 213' ' ' ILE . 1.6 m-85 -87.04 -22.71 25.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.057 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.02 -16.29 61.32 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.542 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.49 -29.63 69.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.847 0.356 . . . . 0.0 110.731 179.271 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.88 -6.3 48.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.997 0.427 . . . . 0.0 110.355 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 213' ' ' ILE . . . . . 0.472 HG12 ' O ' ' A' ' 209' ' ' PHE . 11.1 mm -93.56 -3.68 10.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.743 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 214' ' ' THR . . . . . 0.409 ' HA ' ' HD3' ' A' ' 215' ' ' PRO . 0.2 OUTLIER -63.46 116.98 29.91 Favored Pre-proline 0 CA--C 1.529 0.16 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.411 179.163 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 215' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 214' ' ' THR . 16.3 Cg_exo -69.3 122.24 9.04 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.564 2.176 . . . . 0.0 112.994 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -74.04 -22.7 59.45 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.794 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -70.15 -24.54 63.18 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.955 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.658 HD21 ' HG ' ' A' ' 10' ' ' LEU . 1.8 mm? -76.13 -30.55 58.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.279 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -74.15 -23.15 59.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.059 179.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 5.2 mmm180 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.827 179.427 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.462 0.147 0 CA-C-O 120.608 0.242 . . . . 0.0 110.422 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -102.01 9.07 40.72 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.944 0.402 . . . . 0.0 110.43 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.89 -42.59 60.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.107 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.69 -42.25 64.44 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.793 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.54 -45.28 91.26 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.542 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.41 -40.59 87.16 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.61 178.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.523 ' HB2' ' HB1' ' A' ' 150' ' ' ALA . . . -61.02 -48.61 80.99 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.717 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -57.43 -46.82 83.14 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.776 179.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.0 mp -61.7 -45.8 92.43 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.509 178.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.25 -42.37 90.97 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.534 178.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.86 -44.28 98.26 Favored Glycine 0 C--N 1.334 0.417 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.887 178.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 74.4 t -63.5 -41.94 94.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-O 120.781 0.324 . . . . 0.0 110.517 179.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.94 -45.12 90.62 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.813 0.34 . . . . 0.0 110.522 179.25 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.541 ' HB2' HD21 ' A' ' 155' ' ' LEU . 9.9 m -64.42 -35.15 79.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.868 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -73.65 -34.13 64.82 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.327 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.6 mt -79.15 -14.86 58.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.979 0.419 . . . . 0.0 110.757 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.402 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 1.4 t -86.37 126.9 63.13 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.873 178.529 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 18' ' ' SER . 30.8 Cg_exo -61.56 -14.84 37.75 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.784 2.323 . . . . 0.0 112.654 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 6.0 t -81.23 66.92 6.97 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.142 0.496 . . . . 0.0 110.633 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.1 m -89.98 161.53 2.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.864 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.65 -55.73 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.517 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -66.58 -22.52 50.93 Favored 'Trans proline' 0 C--N 1.361 1.202 0 C-N-CA 122.289 1.993 . . . . 0.0 112.89 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -74.17 -13.6 60.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.59 179.188 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.433 ' N ' ' HD2' ' A' ' 26' ' ' PRO . 73.7 t -74.51 -56.58 2.33 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-O 119.675 -0.202 . . . . 0.0 111.399 179.316 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 25' ' ' VAL . 17.1 Cg_endo -57.54 -23.43 56.39 Favored 'Trans proline' 0 C--N 1.362 1.254 0 C-N-CA 122.614 2.209 . . . . 0.0 113.449 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.04 -24.86 66.51 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.721 0.296 . . . . 0.0 111.416 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -76.84 -38.07 54.45 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.907 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -82.94 -22.47 33.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.448 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -53.61 -28.7 34.05 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.438 178.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -62.35 -33.53 74.89 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 120.83 0.348 . . . . 0.0 110.854 178.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 21.9 mt -86.45 -22.99 26.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.622 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -93.94 3.27 70.27 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.999 -0.619 . . . . 0.0 111.683 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -81.59 65.7 3.97 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 121.399 -0.429 . . . . 0.0 112.505 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.405 ' HB2' ' HB3' ' A' ' 109' ' ' ARG . . . -89.62 -19.87 24.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.939 0.4 . . . . 0.0 111.188 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 9.4 mmm180 -109.51 -97.16 0.39 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.024 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 165.17 -176.38 40.87 Favored Glycine 0 N--CA 1.448 -0.5 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 4.9 ttm105 57.26 72.87 0.86 Allowed Pre-proline 0 N--CA 1.469 0.49 0 C-N-CA 122.575 0.35 . . . . 0.0 111.343 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.11 -23.99 39.15 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.487 2.125 . . . . 0.0 112.502 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.6 mt -66.26 -34.98 79.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.977 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -73.32 -37.57 66.11 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.03 -36.59 84.88 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.99 178.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.44 -47.19 82.9 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.331 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -56.01 -42.32 76.25 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.162 178.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.47 -37.66 77.38 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.6 0.238 . . . . 0.0 110.947 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -65.05 -48.34 74.15 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.324 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 13.3 pt -68.29 -27.91 38.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.678 0.275 . . . . 0.0 110.92 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.47 -51.35 29.76 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.484 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -61.66 -43.85 98.71 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.081 179.123 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -67.32 -35.64 79.84 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.632 0.253 . . . . 0.0 110.609 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -63.08 -42.72 99.48 Favored Glycine 0 C--N 1.334 0.428 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.39 -44.88 92.71 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.672 0.273 . . . . 0.0 110.667 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 49' ' ' GLY . 26.5 t -65.49 -41.94 92.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.98 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.86 -34.68 78.95 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.917 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -76.56 -43.54 38.51 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.592 179.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.2 tp -61.12 -33.01 72.69 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.973 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.414 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 3.8 mt -89.73 -18.4 26.44 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.083 178.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -72.01 -32.04 63.75 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.334 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.18 -54.55 32.3 Favored Pre-proline 0 CA--C 1.543 0.69 0 N-CA-C 111.698 0.258 . . . . 0.0 111.698 179.157 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.414 ' HD2' ' C ' ' A' ' 57' ' ' LEU . 17.2 Cg_exo -67.46 -13.6 39.7 Favored 'Trans proline' 0 C--N 1.361 1.223 0 C-N-CA 122.559 2.172 . . . . 0.0 112.528 179.189 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.493 ' HA ' HD12 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -57.69 -20.87 37.07 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.387 179.728 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.3 p -62.04 -35.9 79.99 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.227 0.537 . . . . 0.0 110.45 178.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.4 -19.54 26.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.682 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.493 HD12 ' HA ' ' A' ' 61' ' ' PHE . 70.6 mt -75.38 -17.42 60.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.993 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.61 -31.18 78.98 Favored Glycine 0 C--N 1.334 0.422 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.912 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -77.23 -29.61 56.14 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.146 179.07 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 tp -76.88 -25.07 52.63 Favored 'General case' 0 N--CA 1.461 0.094 0 CA-C-O 120.784 0.326 . . . . 0.0 110.817 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.406 HD13 ' HA ' ' A' ' 68' ' ' LEU . 0.5 OUTLIER -67.62 -19.25 65.2 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.945 179.902 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -71.29 -17.46 62.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.566 178.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.84 161.86 17.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.419 179.295 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 9.1 m-70 -82.26 77.27 9.08 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.043 0.449 . . . . 0.0 111.36 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.2 mmp_? -96.7 49.15 1.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.829 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -73.01 -22.16 60.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.865 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -65.26 -24.64 67.37 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.329 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.19 -23.16 44.04 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.734 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.96 -30.32 26.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.056 179.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.5 mmt-85 -60.27 -27.65 67.44 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.493 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.3 t -63.47 -26.46 40.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-O 120.964 0.411 . . . . 0.0 110.519 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -65.0 -34.81 90.87 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.919 -0.658 . . . . 0.0 111.824 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.477 ' O ' HG23 ' A' ' 84' ' ' VAL . . . -66.93 -39.45 93.31 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.417 179.206 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.8 t -61.57 -40.35 86.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-O 120.875 0.369 . . . . 0.0 110.59 179.115 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 80.5 t -63.35 -39.68 86.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.386 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.98 -40.1 96.71 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.796 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 80' ' ' GLY . 53.1 t -63.59 -44.09 98.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.222 179.05 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.58 -41.1 93.95 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.593 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -65.57 -42.94 91.24 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.331 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -61.98 -38.29 95.81 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.247 179.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.0 -38.47 91.05 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.813 0.339 . . . . 0.0 110.831 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -73.74 -30.14 62.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.345 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 6.7 mtp -71.11 -27.1 63.35 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.538 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 65.0 mt -63.82 -16.23 60.75 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.26 178.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.37 16.08 74.81 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.751 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.4 mp -77.4 137.85 38.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.918 0.39 . . . . 0.0 110.505 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 15.6 mtp180 . . . . . 0 C--N 1.325 -0.475 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.889 -178.939 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.4 ' HB ' ' HD2' ' A' ' 110' ' ' PRO . 0.2 OUTLIER . . . . . 0 CA--C 1.532 0.252 0 CA-C-O 120.794 0.331 . . . . 0.0 111.404 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.74 -40.23 19.08 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.405 ' HB3' ' HB2' ' A' ' 35' ' ' ALA . 0.0 OUTLIER -58.61 -56.53 34.69 Favored Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.634 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 110' ' ' PRO . . . . . 0.405 ' HD3' ' CB ' ' A' ' 109' ' ' ARG . 31.4 Cg_exo -60.91 -28.27 86.09 Favored 'Trans proline' 0 C--N 1.36 1.165 0 C-N-CA 122.32 2.014 . . . . 0.0 112.503 179.159 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.8 tp -69.09 -28.73 66.77 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.772 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -63.01 -33.79 88.21 Favored Glycine 0 C--N 1.336 0.572 0 C-N-CA 120.93 -0.652 . . . . 0.0 111.714 178.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -77.71 -34.17 52.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.94 0.4 . . . . 0.0 110.544 178.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -70.56 -38.35 74.12 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.708 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.29 -27.42 62.45 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.503 179.16 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.08 -44.88 94.46 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.305 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -71.65 -27.78 70.42 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.556 178.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.06 -48.45 65.55 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.674 0.273 . . . . 0.0 110.809 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 3.5 p -69.02 -31.88 71.0 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.866 0.365 . . . . 0.0 110.981 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -74.11 -39.88 63.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.778 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.16 -24.0 67.27 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.935 0.398 . . . . 0.0 110.962 178.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 43.5 mt -80.73 -18.36 48.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.477 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -95.78 81.23 0.81 Allowed Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 3.3 m0 -66.56 -82.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.729 0.3 . . . . 0.0 111.324 -179.118 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.497 HG22 ' HB ' ' A' ' 128' ' ' ILE . 0.7 OUTLIER -144.57 65.84 13.12 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.575 179.326 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -74.76 -57.4 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.006 1.804 . . . . 0.0 112.492 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -86.06 -16.94 36.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.051 0.453 . . . . 0.0 110.466 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.497 ' HB ' HG22 ' A' ' 125' ' ' THR . 1.2 mt -92.14 2.43 8.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.421 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.4 ' N ' ' HD2' ' A' ' 130' ' ' PRO . . . -57.14 -60.68 8.59 Favored Glycine 0 CA--C 1.521 0.413 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.426 178.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' PRO . . . . . 0.4 ' HD2' ' N ' ' A' ' 129' ' ' GLY . 19.0 Cg_endo -59.45 -35.03 97.13 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.459 2.106 . . . . 0.0 112.141 178.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ILE . . . . . 0.494 ' O ' HG13 ' A' ' 135' ' ' ILE . 19.1 mt -68.42 -49.18 68.44 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.956 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 tp -63.92 -34.48 78.05 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.755 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -61.17 -39.96 97.89 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.854 -0.689 . . . . 0.0 111.599 178.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -71.38 -30.95 66.73 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.82 0.343 . . . . 0.0 110.683 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ILE . . . . . 0.494 HG13 ' O ' ' A' ' 131' ' ' ILE . 79.7 mt -72.06 -31.87 41.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.642 179.237 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 7.7 mt -60.37 -35.8 76.55 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.908 179.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.5 -22.59 63.59 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.809 178.595 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.5 tp -81.65 -27.35 34.14 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.382 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.59 ' HA ' ' O ' ' A' ' 143' ' ' GLY . 0.3 OUTLIER -76.3 -17.36 59.47 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.631 179.401 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -71.82 -17.99 62.12 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.358 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 8.1 t -73.89 -28.8 24.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.984 0.421 . . . . 0.0 110.712 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 129.36 64.77 0.11 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.148 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.59 ' O ' ' HA ' ' A' ' 139' ' ' THR . . . 113.13 -152.25 18.04 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.16 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 115.73 20.45 5.36 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.378 -0.915 . . . . 0.0 112.729 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 11.7 p -66.12 -25.54 36.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 CA-C-O 120.961 0.41 . . . . 0.0 110.976 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -62.43 -30.32 75.98 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.093 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -67.4 -42.6 83.03 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.605 0.24 . . . . 0.0 110.503 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.8 tp -61.96 -43.75 98.19 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.512 179.395 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.522 ' O ' HG13 ' A' ' 152' ' ' ILE . 1.6 mp -67.95 -41.45 82.47 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.648 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.523 ' HB1' ' HB2' ' A' ' 8' ' ' ALA . . . -64.52 -35.14 80.0 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.477 178.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -61.05 -54.66 42.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.421 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.522 HG13 ' O ' ' A' ' 149' ' ' LEU . 0.5 OUTLIER -63.8 -42.67 96.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.874 -179.778 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 153' ' ' LEU . . . . . 0.431 ' O ' HG23 ' A' ' 157' ' ' VAL . 0.0 OUTLIER -64.44 -40.76 96.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.169 179.352 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -59.36 -41.51 96.99 Favored Glycine 0 C--N 1.334 0.429 0 CA-C-N 116.207 -0.451 . . . . 0.0 112.758 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.541 HD21 ' HB2' ' A' ' 15' ' ' SER . 7.0 mt -80.59 -26.67 37.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.814 0.34 . . . . 0.0 111.016 178.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -62.7 -37.35 86.13 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.314 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.499 ' HB ' ' CD ' ' A' ' 158' ' ' PRO . 96.5 t -54.8 -63.66 2.69 Favored Pre-proline 0 CA--C 1.541 0.601 0 O-C-N 123.382 0.426 . . . . 0.0 111.642 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' PRO . . . . . 0.499 ' CD ' ' HB ' ' A' ' 157' ' ' VAL . 28.7 Cg_endo -62.65 -36.64 62.57 Favored 'Trans proline' 0 C--N 1.358 1.077 0 C-N-CA 121.765 1.643 . . . . 0.0 112.578 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -58.92 -48.27 82.07 Favored 'General case' 0 N--CA 1.462 0.134 0 O-C-N 123.017 0.198 . . . . 0.0 111.37 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -65.8 -39.28 90.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.958 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 157' ' ' VAL . 92.9 t -63.61 -44.26 98.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.188 178.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 71.8 t -66.17 -44.91 91.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.284 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -58.02 -35.55 71.42 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.885 0.374 . . . . 0.0 111.377 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.7 mt -69.12 -45.83 69.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.011 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.13 -34.47 68.59 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.926 0.393 . . . . 0.0 110.624 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 170' ' ' LYS . . . -69.93 -19.06 63.4 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.999 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -67.0 -26.34 66.74 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.372 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 1.1 tpt85 -79.19 -46.6 17.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.06 0.457 . . . . 0.0 110.668 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.438 HG12 ' HA ' ' A' ' 166' ' ' ALA . 20.7 pt -75.03 -18.77 16.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.288 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.468 ' O ' ' HG3' ' A' ' 174' ' ' ARG . 0.2 OUTLIER -57.44 -44.27 84.58 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.057 179.751 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -68.29 -25.36 74.69 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.672 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 1.3 m-90 -86.9 -41.08 14.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.658 0.266 . . . . 0.0 111.201 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.82 -16.63 62.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.581 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.468 ' HG3' ' O ' ' A' ' 170' ' ' LYS . 0.0 OUTLIER -52.44 -54.69 28.96 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.764 0.316 . . . . 0.0 111.342 179.197 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 14.8 mtm180 -94.12 -16.36 23.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.567 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -92.21 1.37 57.26 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.72 0.295 . . . . 0.0 111.635 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -85.09 55.43 4.96 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.599 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.5 -53.02 3.45 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.981 0.419 . . . . 0.0 110.41 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' ILE . . . . . 0.429 HG12 ' H ' ' A' ' 179' ' ' ILE . 7.3 pt -74.26 -22.18 17.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.339 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' SER . . . . . 0.415 ' O ' ' HG3' ' A' ' 184' ' ' GLU . 0.3 OUTLIER -66.51 -18.71 65.51 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.467 179.975 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 181' ' ' HIS . . . . . 0.441 ' HA ' ' OE2' ' A' ' 184' ' ' GLU . 0.0 OUTLIER -63.85 -32.6 74.17 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.03 179.918 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -80.23 -25.31 39.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.93 0.395 . . . . 0.0 110.62 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 11.9 t -74.67 -25.34 18.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.44 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' GLU . . . . . 0.441 ' OE2' ' HA ' ' A' ' 181' ' ' HIS . 32.7 mt-10 -74.41 -29.68 61.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.649 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 11.4 t -69.62 -48.89 63.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.688 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' LEU . . . . . 0.448 ' O ' HG23 ' A' ' 190' ' ' VAL . 2.7 mt -59.33 -43.18 92.77 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.841 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -68.9 -40.76 78.96 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.704 179.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -62.69 -41.61 99.8 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.265 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 54.4 t -61.49 -52.41 61.44 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.103 0 CA-C-O 120.43 0.157 . . . . 0.0 110.803 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 186' ' ' LEU . 54.8 t -58.16 -39.62 73.91 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.92 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 1.8 mt -61.71 -47.39 85.5 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.173 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 60.3 t -70.74 -35.89 62.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.657 0.265 . . . . 0.0 110.598 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.4 tp -59.83 -51.79 68.23 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.131 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 31.7 m -67.08 -29.61 46.71 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.585 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -65.36 -49.65 59.94 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.703 178.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 46.2 t -67.09 -37.74 79.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 O-C-N 122.744 -0.268 . . . . 0.0 110.328 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.53 -31.12 72.2 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.776 179.32 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.464 HD13 HD13 ' A' ' 206' ' ' LEU . 0.5 OUTLIER -76.05 -29.78 58.15 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.075 0.464 . . . . 0.0 110.424 178.813 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -78.31 -41.17 34.51 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.602 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 66.9 p -86.24 -39.84 16.16 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -91.08 -4.74 68.6 Favored Glycine 0 C--N 1.329 0.174 0 C-N-CA 121.223 -0.513 . . . . 0.0 112.707 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.1 -142.44 0.56 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 122.69 0.396 . . . . 0.0 110.962 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -83.8 -11.41 57.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.769 0.319 . . . . 0.0 110.959 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.81 -43.23 80.15 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.46 179.141 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -74.55 -30.36 61.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.838 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' LEU . . . . . 0.464 HD13 HD13 ' A' ' 198' ' ' LEU . 5.8 tp -73.17 -33.62 65.55 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.719 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -63.27 -41.38 99.01 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.786 0.327 . . . . 0.0 111.033 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 4.3 p -73.56 -25.36 60.34 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.076 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -87.44 -27.12 22.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.272 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -80.97 -15.64 55.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.494 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.17 -35.05 71.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.243 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.26 -6.37 55.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.245 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 4.6 mt -106.94 7.44 9.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.124 0.488 . . . . 0.0 110.801 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 2.3 p -61.49 122.33 69.98 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.865 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -60.16 145.9 97.47 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.367 2.044 . . . . 0.0 112.311 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -63.8 -21.16 66.29 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.329 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -73.2 -26.44 61.15 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.75 0.309 . . . . 0.0 110.913 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.21 -30.3 17.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.376 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.97 -22.79 63.12 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.518 179.129 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 1.2 ttp180 . . . . . 0 C--N 1.332 -0.189 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.729 179.132 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.1 mtp . . . . . 0 N--CA 1.487 1.422 0 CA-C-O 121.012 0.434 . . . . 0.0 110.561 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.58 137.31 36.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.365 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.55 102.18 9.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.902 0.382 . . . . 0.0 111.064 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.29 -18.79 61.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.916 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.31 -27.62 69.45 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.992 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.41 -48.26 82.52 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.778 0.323 . . . . 0.0 110.59 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.36 -45.69 92.05 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.774 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.403 ' HB1' ' HA ' ' A' ' 151' ' ' TYR . . . -64.19 -33.58 76.12 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.964 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.454 ' O ' HG23 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -66.69 -52.38 45.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.247 179.527 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.8 mp -61.33 -38.02 85.39 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.104 178.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.81 -43.03 99.88 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.468 178.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.3 -41.91 98.57 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 121.054 -0.593 . . . . 0.0 111.994 178.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 9' ' ' PHE . 48.2 t -64.59 -38.57 82.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.125 0.488 . . . . 0.0 109.839 178.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 60.1 mt -63.81 -41.17 97.94 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.5 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.6 m -65.46 -33.22 75.43 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.697 0.284 . . . . 0.0 110.877 179.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -69.35 -36.79 77.23 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.023 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.6 mp -90.5 -4.37 56.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.953 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.1 t -79.08 124.01 84.75 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.363 179.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.422 ' HG3' HD13 ' A' ' 213' ' ' ILE . 37.9 Cg_endo -67.44 -8.63 22.72 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.691 2.261 . . . . 0.0 112.709 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.422 ' SG ' ' HZ ' ' A' ' 210' ' ' PHE . 1.0 OUTLIER -88.11 -14.48 38.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.954 179.756 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.6 t -116.98 -79.74 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.188 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.423 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 15.0 mt 51.15 82.61 0.24 Allowed Pre-proline 0 N--CA 1.466 0.351 0 O-C-N 123.709 0.631 . . . . 0.0 111.699 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -55.23 -24.08 40.08 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.99 2.46 . . . . 0.0 113.273 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.4 tp -64.36 -26.2 68.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.717 -0.22 . . . . 0.0 111.133 178.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.442 ' HB ' ' CD ' ' A' ' 26' ' ' PRO . 71.4 t -67.48 -61.14 4.81 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.162 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.442 ' CD ' ' HB ' ' A' ' 25' ' ' VAL . 19.3 Cg_endo -59.11 -35.19 98.49 Favored 'Trans proline' 0 C--N 1.361 1.185 0 C-N-CA 122.032 1.821 . . . . 0.0 112.559 178.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 20.2 m -64.9 -36.54 84.68 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.714 0.292 . . . . 0.0 111.002 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.446 ' O ' ' HB2' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -66.53 -28.51 68.6 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.566 179.562 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 7.9 mt -85.06 -36.22 21.35 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.075 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -63.28 -44.05 96.18 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.549 178.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -73.63 -21.6 60.25 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.763 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.446 ' HB2' ' O ' ' A' ' 28' ' ' TYR . 2.1 tp -75.94 -18.85 59.18 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.4 179.266 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -89.59 -4.38 73.29 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.946 -0.645 . . . . 0.0 111.66 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.99 -59.46 4.94 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 121.161 -0.543 . . . . 0.0 112.666 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . 57.74 -113.28 0.72 Allowed 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 122.753 0.421 . . . . 0.0 111.024 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.11 -36.92 1.14 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.935 0.397 . . . . 0.0 110.725 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.11 18.08 11.85 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.094 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -111.77 96.96 35.53 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.514 0.197 . . . . 0.0 110.624 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -69.32 -32.04 21.21 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.507 2.138 . . . . 0.0 112.932 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.62 -44.37 90.75 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.132 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -73.79 -36.03 64.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.818 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -65.42 -42.24 92.71 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.165 178.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.49 -51.91 56.66 Favored 'General case' 0 C--O 1.227 -0.126 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.627 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.33 -42.0 73.19 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.244 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -64.07 -44.69 91.65 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.861 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.46 -40.41 89.39 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.62 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 55.5 mt -60.71 -48.57 88.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.573 179.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.65 -45.83 81.48 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.905 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.587 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -59.84 -48.45 85.99 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.407 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.03 -41.75 90.52 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.55 0.214 . . . . 0.0 110.998 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -61.74 -44.26 98.13 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.078 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.12 -46.04 90.96 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.658 0.266 . . . . 0.0 111.11 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 49' ' ' GLY . 46.1 t -65.25 -42.23 93.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.098 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -64.29 -28.29 69.62 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.531 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -84.95 -46.61 11.08 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.896 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.87 -39.21 93.19 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.09 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.448 ' HB2' ' O ' ' A' ' 53' ' ' VAL . 1.0 OUTLIER -85.82 -19.07 31.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.487 179.386 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.421 ' O ' ' HB2' ' A' ' 61' ' ' PHE . . . -74.69 -26.69 66.73 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.203 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.68 -56.41 33.04 Favored Pre-proline 0 CA--C 1.54 0.59 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -65.65 -13.78 41.51 Favored 'Trans proline' 0 C--N 1.362 1.281 0 C-N-CA 122.305 2.004 . . . . 0.0 113.155 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.421 ' HB2' ' O ' ' A' ' 58' ' ' GLY . 8.2 m-30 -61.44 -17.94 56.63 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.651 0.262 . . . . 0.0 111.422 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 21.8 p -71.89 -41.34 68.08 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.135 0.493 . . . . 0.0 110.195 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.3 mt -88.48 -21.63 24.09 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.888 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.86 -17.9 64.06 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.901 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -63.43 -24.52 67.7 Favored Glycine 0 C--N 1.335 0.477 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.934 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.49 -21.82 76.64 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.149 179.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.69 -20.67 46.01 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.833 0.349 . . . . 0.0 110.631 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.457 HD13 ' HA ' ' A' ' 68' ' ' LEU . 1.4 mm? -64.32 -19.26 65.32 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.995 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -69.73 -17.62 63.46 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.814 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -97.27 -133.36 0.22 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.906 179.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -151.03 126.26 9.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.909 0.385 . . . . 0.0 110.841 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -134.59 37.71 3.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.598 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -66.88 -18.09 65.21 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.411 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.46 -18.06 65.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.398 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.4 mp -74.15 -22.86 59.25 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.624 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.19 -24.11 51.44 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.502 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.451 ' O ' HG23 ' A' ' 81' ' ' VAL . 0.2 OUTLIER -71.79 -33.56 68.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.888 179.798 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.486 ' O ' HG23 ' A' ' 82' ' ' VAL . 41.9 t -62.52 -36.76 76.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.729 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.67 -36.8 93.8 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.068 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.449 ' O ' HG23 ' A' ' 84' ' ' VAL . . . -66.34 -41.59 94.46 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.873 -0.679 . . . . 0.0 111.764 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 77' ' ' ARG . 21.5 t -60.49 -43.88 95.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 120.83 0.348 . . . . 0.0 110.714 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 78' ' ' VAL . 47.1 t -63.91 -41.07 91.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.601 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.87 -43.16 99.55 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.771 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 80' ' ' GLY . 92.7 t -62.97 -44.95 99.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-O 120.832 0.349 . . . . 0.0 110.429 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.78 -41.46 97.74 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.72 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -66.52 -40.17 89.04 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.667 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -61.34 -39.52 97.35 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.997 -0.621 . . . . 0.0 111.893 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.5 -40.93 98.37 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.829 0.347 . . . . 0.0 110.698 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -71.72 -31.45 66.73 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.548 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 5.2 mtt -67.12 -27.59 67.46 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.473 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.74 -9.58 51.46 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.024 178.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.56 11.27 83.32 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.849 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.34 145.15 25.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.926 0.393 . . . . 0.0 110.842 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -106.75 140.82 21.73 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.613 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.29 -36.07 22.18 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.705 2.27 . . . . 0.0 112.671 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.7 ttp85 -98.81 104.93 17.01 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.445 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 3.3 m95 -83.03 63.51 7.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.295 0.569 . . . . 0.0 111.061 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -168.75 55.42 0.21 Allowed Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.447 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.0 t -81.88 122.77 37.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.88 0.372 . . . . 0.0 111.139 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.12 175.77 8.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.943 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.4 mt -109.03 175.59 5.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.255 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 102' ' ' ARG . 0.0 OUTLIER 60.79 55.27 3.29 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.453 0.644 . . . . 0.0 110.596 -179.209 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -99.28 178.51 4.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.02 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -111.75 156.48 21.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.676 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -167.71 -69.33 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.021 -0.609 . . . . 0.0 111.936 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 62.28 -93.58 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 122.883 0.473 . . . . 0.0 111.484 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.62 62.78 7.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.889 0.376 . . . . 0.0 111.011 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.3 -13.66 43.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.299 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.46 ' N ' ' HD2' ' A' ' 110' ' ' PRO . 0.0 OUTLIER -66.85 -52.54 32.08 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.933 179.845 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' A' ' 109' ' ' ARG . 36.6 Cg_endo -65.18 -15.56 50.79 Favored 'Trans proline' 0 C--N 1.363 1.325 0 C-N-CA 122.069 1.846 . . . . 0.0 112.797 179.488 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.416 ' O ' ' HB2' ' A' ' 115' ' ' LEU . 0.5 OUTLIER -67.65 -39.64 84.58 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.682 179.857 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -69.28 -31.88 71.91 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.628 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -71.42 -46.16 60.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.888 0.375 . . . . 0.0 110.775 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -67.98 -39.16 83.34 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.063 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.416 ' HB2' ' O ' ' A' ' 111' ' ' LEU . 0.7 OUTLIER -65.23 -40.2 93.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.79 179.474 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.59 -33.62 76.36 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.705 0.288 . . . . 0.0 110.522 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -66.52 -48.85 60.15 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.21 178.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.44 -29.84 70.56 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.753 0.311 . . . . 0.0 110.713 178.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 52.7 m -61.89 -44.81 96.04 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.811 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.2 mt -69.87 -21.43 63.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.384 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -85.22 -40.86 16.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.484 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.1 mp -85.83 -33.06 21.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.741 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -80.55 92.24 1.41 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.392 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -81.69 132.87 35.31 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.894 0.378 . . . . 0.0 110.913 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.0 113.14 45.96 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.789 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -63.68 -22.37 69.95 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.827 2.351 . . . . 0.0 112.963 -179.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -70.45 -25.69 63.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.244 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.5 mm -103.1 2.37 10.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.111 0.482 . . . . 0.0 110.406 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -61.53 -59.64 9.51 Favored Glycine 0 CA--C 1.521 0.44 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.611 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -57.4 -34.78 98.51 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 122.72 2.28 . . . . 0.0 112.323 178.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 16.0 mm -67.83 -43.45 86.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.808 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.39 -37.37 66.01 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.465 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -61.38 -31.17 76.37 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 121.075 -0.583 . . . . 0.0 112.197 178.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.74 -21.91 62.48 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.908 0.385 . . . . 0.0 110.927 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 38.4 mm -79.58 -30.34 13.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.681 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.07 -39.26 94.2 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.574 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.11 -23.76 67.24 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.105 178.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.76 -33.5 19.92 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.743 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 23.6 p -80.3 -17.16 52.9 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.357 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -75.94 -29.23 58.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.98 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 21.8 m -100.15 2.91 10.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.266 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -173.43 -90.07 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.478 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 151.3 -152.58 24.34 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.431 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 167.52 63.01 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.264 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' VAL . . . . . 0.405 ' H ' HG23 ' A' ' 145' ' ' VAL . 1.7 t -62.25 -49.17 85.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.87 0.367 . . . . 0.0 110.672 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -65.82 -28.98 74.13 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.937 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.42 -44.06 83.97 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.809 0.338 . . . . 0.0 110.453 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.93 -42.37 99.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.384 179.03 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 34.4 mt -66.26 -39.25 89.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.385 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -61.58 -38.81 88.91 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.561 178.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.403 ' HA ' ' HB1' ' A' ' 8' ' ' ALA . 0.2 OUTLIER -62.52 -47.59 83.24 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.654 179.23 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 17.6 mt -64.87 -46.9 90.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.382 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.43 ' O ' HG23 ' A' ' 157' ' ' VAL . 0.2 OUTLIER -62.09 -37.7 86.05 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.951 179.28 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -60.13 -38.84 95.0 Favored Glycine 0 C--O 1.224 -0.518 0 C-N-CA 121.273 -0.489 . . . . 0.0 112.058 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.403 HD13 ' HA ' ' A' ' 155' ' ' LEU . 0.9 OUTLIER -79.98 -26.31 40.0 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.678 0.275 . . . . 0.0 110.971 178.627 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -64.48 -37.46 87.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.153 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.515 ' O ' HG23 ' A' ' 161' ' ' VAL . 59.4 t -55.33 -62.73 3.91 Favored Pre-proline 0 CA--C 1.541 0.633 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.824 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.494 ' CD ' ' HB ' ' A' ' 157' ' ' VAL . 17.9 Cg_endo -59.68 -36.59 91.58 Favored 'Trans proline' 0 C--N 1.36 1.157 0 C-N-CA 122.123 1.882 . . . . 0.0 112.339 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.08 -44.82 96.78 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.271 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -66.11 -40.47 90.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.635 0.255 . . . . 0.0 110.708 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 157' ' ' VAL . 48.3 t -63.88 -45.43 97.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.499 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 60.9 t -65.07 -40.24 88.29 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.606 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -58.8 -41.7 87.36 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.547 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.97 -39.23 63.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.238 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -70.9 -27.65 63.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.739 0.304 . . . . 0.0 110.8 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -64.46 -18.75 65.05 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.532 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -62.77 -46.65 87.05 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.758 0.313 . . . . 0.0 111.044 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -78.24 -34.0 49.43 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.742 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 58.1 mt -69.74 -23.1 25.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.921 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -59.69 -39.1 83.41 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.913 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -71.54 -23.8 77.59 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.674 179.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 60.2 t-105 -81.64 -37.89 26.81 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.423 0.154 . . . . 0.0 111.133 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.59 -38.04 59.23 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -87.47 -15.67 36.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.495 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.16 -27.59 18.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.466 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -53.47 -65.78 0.5 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.758 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 131.3 -124.47 4.11 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.806 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 2.7 mtt180 -100.26 0.6 40.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.675 0.274 . . . . 0.0 111.357 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 7.9 mt -66.81 -33.8 65.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.965 0.412 . . . . 0.0 110.844 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.47 -20.22 66.05 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.315 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 37.7 m170 -84.01 -21.45 31.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.83 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -73.1 -45.91 54.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.524 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 3.6 m -73.54 -19.57 18.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.186 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -65.11 -50.79 64.69 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.708 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.462 ' O ' HG23 ' A' ' 189' ' ' VAL . 2.4 m -81.82 -28.08 9.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.506 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.41 ' O ' HG23 ' A' ' 190' ' ' VAL . 1.2 tp -58.59 -50.72 72.8 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.19 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -62.21 -35.34 78.59 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.785 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.432 ' O ' HG23 ' A' ' 192' ' ' VAL . . . -65.28 -42.33 96.26 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.193 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 185' ' ' VAL . 94.8 t -62.55 -47.56 92.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 120.76 0.314 . . . . 0.0 110.724 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 186' ' ' LEU . 39.5 t -62.18 -39.42 83.89 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.891 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.98 -46.52 87.9 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.841 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 188' ' ' GLY . 55.8 t -66.51 -40.55 86.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.422 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.403 ' O ' ' HB2' ' A' ' 197' ' ' LEU . 4.3 mt -60.98 -46.57 90.19 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.961 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 87.5 t -66.93 -41.1 87.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.801 0.334 . . . . 0.0 110.262 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -62.44 -43.46 99.01 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.742 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 3.6 p -72.93 -32.36 39.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 116.8 0.3 . . . . 0.0 111.279 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.53 HD23 HD11 ' A' ' 206' ' ' LEU . 0.5 OUTLIER -74.85 -22.46 58.67 Favored 'General case' 0 C--N 1.334 -0.078 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.122 179.84 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.2 mp -84.76 -38.92 19.05 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.379 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -67.17 -47.75 70.03 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.127 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 81.3 p -84.42 -20.27 32.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.255 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -78.39 -48.78 7.16 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.245 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 57.3 -133.42 1.28 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.653 0.263 . . . . 0.0 111.501 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -81.25 84.11 6.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.916 0.388 . . . . 0.0 111.153 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.765 HG23 ' H ' ' A' ' 206' ' ' LEU . 13.7 t -150.75 -161.61 1.37 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.651 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -59.71 -14.38 13.96 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 122.643 0.377 . . . . 0.0 111.795 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.765 ' H ' HG23 ' A' ' 204' ' ' THR . 0.5 OUTLIER -67.03 -33.11 74.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.619 179.544 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -71.44 -28.69 64.14 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.996 0.427 . . . . 0.0 110.262 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.0 -21.21 31.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.781 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -66.97 -21.65 65.96 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.906 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' PHE . . . . . 0.57 ' HA ' HD12 ' A' ' 213' ' ' ILE . 1.0 OUTLIER -67.2 -19.13 65.51 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.884 179.216 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 3.0 mt -86.21 -10.86 53.88 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.719 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.96 -21.86 36.98 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.98 0.419 . . . . 0.0 110.42 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' ILE . . . . . 0.57 HD12 ' HA ' ' A' ' 210' ' ' PHE . 2.9 mt -87.5 -24.79 6.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.401 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.23 120.37 79.19 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.371 179.215 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.39 130.51 24.01 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.449 2.099 . . . . 0.0 112.718 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -68.94 -19.59 64.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.241 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 9.5 m95 -69.57 -18.58 63.65 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.332 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.69 -32.19 16.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.849 0.357 . . . . 0.0 110.28 179.098 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -74.49 -34.53 63.1 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.621 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -75.91 -8.76 57.69 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.871 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -94.15 11.18 30.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.317 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.23 124.96 56.29 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.434 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -69.46 -32.46 19.76 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.59 2.193 . . . . 0.0 112.493 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.907 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.4 mtm . . . . . 0 N--CA 1.484 1.253 0 CA-C-O 120.696 0.284 . . . . 0.0 110.638 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -116.07 179.87 3.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.876 0.369 . . . . 0.0 111.06 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.07 20.28 9.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.181 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.67 -34.0 76.9 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.126 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 16.9 mt -73.97 -47.83 34.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.544 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.03 -40.91 91.0 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.762 178.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.89 -48.39 76.86 Favored 'General case' 0 CA--C 1.523 -0.079 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.706 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.649 ' HB1' ' HA ' ' A' ' 151' ' ' TYR . . . -58.74 -36.45 74.35 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.161 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.406 ' O ' HG23 ' A' ' 13' ' ' VAL . 41.3 t80 -69.27 -52.04 31.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.336 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.74 -38.28 81.31 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.478 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.06 -44.62 97.11 Favored 'General case' 0 C--N 1.334 -0.077 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.801 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.08 -44.23 96.45 Favored Glycine 0 C--N 1.335 0.515 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.185 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 9' ' ' PHE . 11.8 t -70.11 -35.21 62.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.909 0.385 . . . . 0.0 110.327 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.16 -42.85 96.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.77 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.8 m -66.7 -33.28 75.28 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.816 0.341 . . . . 0.0 110.711 179.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -75.13 -32.52 61.37 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.502 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -94.59 -1.28 53.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.649 0.261 . . . . 0.0 111.31 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.4 p -62.67 143.94 96.36 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.355 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.06 -8.07 18.99 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.543 2.162 . . . . 0.0 112.812 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.415 ' O ' ' HB ' ' A' ' 21' ' ' VAL . 0.1 OUTLIER -63.63 -47.37 81.62 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.957 179.65 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.415 ' HB ' ' O ' ' A' ' 20' ' ' CYS . 96.1 t 71.11 137.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 O-C-N 123.769 0.668 . . . . 0.0 110.945 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -105.17 128.77 25.98 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.553 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -65.04 -18.51 62.13 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.631 2.22 . . . . 0.0 112.469 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.1 mt -74.27 -12.51 60.57 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.248 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.497 ' HB ' ' HD3' ' A' ' 26' ' ' PRO . 55.1 t -75.71 -60.21 1.09 Allowed Pre-proline 0 CA--C 1.542 0.661 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.497 ' HD3' ' HB ' ' A' ' 25' ' ' VAL . 60.4 Cg_endo -73.31 -34.1 6.39 Favored 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 121.836 1.69 . . . . 0.0 113.511 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.2 m -71.03 -18.18 62.59 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.21 -21.09 66.3 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.762 0.315 . . . . 0.0 111.199 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 6.0 mt -82.12 -52.84 6.6 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.833 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -62.41 -28.69 69.97 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.475 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -60.73 -43.24 98.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.766 178.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.412 ' HA ' HD22 ' A' ' 32' ' ' LEU . 0.6 OUTLIER -74.07 -22.16 59.63 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.997 -179.753 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -86.59 -9.57 74.99 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.245 178.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -108.49 -46.61 0.97 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 121.407 -0.425 . . . . 0.0 112.11 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -117.62 124.67 49.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.806 0.336 . . . . 0.0 110.503 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -77.63 86.84 3.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.099 0.476 . . . . 0.0 110.956 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -138.01 171.95 23.11 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.896 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.403 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 14.4 mtt180 -96.61 124.86 49.19 Favored Pre-proline 0 C--N 1.324 -0.528 0 C-N-CA 121.162 -0.215 . . . . 0.0 110.834 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 38' ' ' ARG . 50.0 Cg_exo -55.81 -30.57 77.09 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.905 2.404 . . . . 0.0 112.782 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.6 mp -63.98 -39.21 93.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.0 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.91 -37.14 67.34 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.224 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -65.04 -43.84 91.01 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.085 178.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.55 -49.42 73.51 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.647 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.76 -45.0 78.19 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.024 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -65.5 -45.28 84.19 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.21 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -62.65 -42.38 99.57 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.157 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 28.4 mm -65.29 -43.05 95.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.566 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.55 -44.01 97.41 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.283 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.404 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -61.64 -44.5 97.86 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.064 178.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -68.91 -36.69 78.3 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.606 0.241 . . . . 0.0 110.625 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -62.94 -42.42 99.68 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.46 178.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.87 -43.94 97.82 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.595 0.236 . . . . 0.0 110.578 178.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 49' ' ' GLY . 93.8 t -63.88 -43.37 97.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.726 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -63.6 -36.25 83.2 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.234 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -76.52 -44.48 34.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.017 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.08 -30.87 71.93 Favored 'General case' 0 C--O 1.226 -0.153 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.976 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -89.34 -20.51 23.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.791 0.329 . . . . 0.0 110.484 178.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -72.2 -31.2 64.09 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 121.191 -0.528 . . . . 0.0 112.507 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.2 mp -62.59 -57.21 23.54 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 111.452 0.168 . . . . 0.0 111.452 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -73.97 -13.6 23.89 Favored 'Trans proline' 0 C--N 1.359 1.116 0 C-N-CA 122.019 1.813 . . . . 0.0 112.454 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.413 ' HA ' HD12 ' A' ' 64' ' ' LEU . 0.1 OUTLIER -56.81 -31.5 64.76 Favored 'General case' 0 N--CA 1.464 0.24 0 O-C-N 123.14 0.275 . . . . 0.0 111.334 179.805 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -64.35 -32.09 73.56 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.805 0.336 . . . . 0.0 110.867 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.82 -23.51 25.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.038 0.447 . . . . 0.0 110.148 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.413 HD12 ' HA ' ' A' ' 61' ' ' PHE . 14.7 mt -69.33 -17.96 63.76 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.963 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -59.87 -29.51 67.79 Favored Glycine 0 C--N 1.336 0.573 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.076 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.69 -29.5 61.28 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.908 178.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.3 mt -83.56 -21.39 32.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.904 0.383 . . . . 0.0 110.555 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.37 -19.25 65.86 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.446 179.176 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.87 -17.88 65.11 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.952 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -94.5 -110.14 0.12 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -162.19 148.65 13.38 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.683 0.278 . . . . 0.0 110.882 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.1 mmt-85 -124.24 53.32 1.43 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.939 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -75.88 -18.13 59.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.881 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -66.74 -26.94 67.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.003 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -76.94 -22.29 53.52 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.918 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.72 -32.39 72.15 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.038 0.447 . . . . 0.0 110.372 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.533 ' O ' HG23 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -73.19 -36.7 66.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.722 179.598 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.485 ' O ' HG23 ' A' ' 82' ' ' VAL . 20.8 t -58.3 -44.88 89.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.87 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.64 -39.76 97.01 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.923 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.538 ' O ' HG23 ' A' ' 84' ' ' VAL . . . -65.94 -38.63 94.37 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.079 -0.581 . . . . 0.0 111.924 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 77' ' ' ARG . 95.0 t -62.31 -42.86 97.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-O 120.777 0.322 . . . . 0.0 110.779 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 78' ' ' VAL . 47.0 t -62.74 -38.6 82.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.536 179.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 11.5 mt -64.57 -43.15 94.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.696 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 80' ' ' GLY . 42.9 t -66.41 -39.13 83.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.285 178.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.61 -43.1 99.49 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.657 178.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -67.03 -36.75 82.77 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.453 179.192 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -64.64 -39.97 97.16 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.712 178.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.9 mt -64.46 -36.76 85.22 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.728 0.299 . . . . 0.0 110.783 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -75.73 -31.5 59.63 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.474 179.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 2.8 tpt -69.14 -25.34 64.33 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.615 179.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.2 mt -69.06 -11.01 60.4 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.041 178.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.99 23.77 54.47 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.682 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.29 115.15 14.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.722 0.296 . . . . 0.0 110.761 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.01 138.47 87.5 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.589 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.4 164.5 33.95 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.494 2.129 . . . . 0.0 112.333 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -88.78 159.45 17.75 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.541 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 59.2 m95 62.63 34.43 14.98 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.35 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -143.86 47.11 0.8 Allowed Glycine 0 C--N 1.33 0.222 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.796 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.9 t -108.52 -37.13 3.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.91 0.386 . . . . 0.0 111.097 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.57 -24.16 24.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.858 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.96 133.91 38.07 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.098 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.07 -177.52 3.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.903 0.383 . . . . 0.0 110.8 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -100.1 77.08 1.96 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.171 0.51 . . . . 0.0 110.549 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -89.25 136.87 32.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.779 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 162.82 -165.4 36.33 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.875 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -115.96 -19.19 10.48 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.005 0.431 . . . . 0.0 110.841 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.415 ' C ' ' HD2' ' A' ' 110' ' ' PRO . 0.0 OUTLIER -90.79 13.7 15.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.592 -179.712 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.32 -33.69 67.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.021 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.431 ' HB2' ' HD3' ' A' ' 110' ' ' PRO . 30.8 mmt-85 -73.23 -52.94 5.07 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.034 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.431 ' HD3' ' HB2' ' A' ' 109' ' ' ARG . 35.6 Cg_exo -58.87 -29.06 89.1 Favored 'Trans proline' 0 C--N 1.362 1.277 0 C-N-CA 122.194 1.929 . . . . 0.0 112.604 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.74 -26.95 60.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.027 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -68.24 -32.95 76.95 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.777 -0.725 . . . . 0.0 111.487 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.69 -32.58 71.26 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.937 0.398 . . . . 0.0 110.585 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -71.36 -35.07 71.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.889 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.65 -33.55 72.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.577 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.25 -22.06 63.87 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.521 179.307 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -83.5 -34.36 19.91 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.527 178.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -69.28 -42.39 75.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.773 0.321 . . . . 0.0 111.222 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 6.1 p -65.91 -39.31 90.46 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.445 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.68 -21.92 63.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.865 0.364 . . . . 0.0 110.805 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -84.0 -36.34 23.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.798 179.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 53.2 mt -81.11 -39.37 25.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.36 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -81.56 -19.41 66.21 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.581 -0.819 . . . . 0.0 111.827 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 15.0 m95 63.41 -170.44 0.18 Allowed 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 123.027 0.531 . . . . 0.0 111.234 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.91 107.75 11.64 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.762 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -57.63 -23.15 55.67 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.041 2.494 . . . . 0.0 112.946 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 4.2 m -68.5 -20.21 64.57 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.027 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.418 ' HA ' HD12 ' A' ' 131' ' ' ILE . 6.4 mt -102.62 5.21 10.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.039 0.447 . . . . 0.0 110.079 179.355 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -57.15 -63.74 5.04 Favored Glycine 0 C--N 1.334 0.418 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.546 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -58.67 -37.13 95.74 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.426 2.084 . . . . 0.0 112.171 178.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.418 HD12 ' HA ' ' A' ' 128' ' ' ILE . 15.7 mt -64.71 -44.36 96.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.844 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.447 ' O ' HG22 ' A' ' 135' ' ' ILE . 3.2 tp -67.54 -42.53 82.54 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.285 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -61.56 -42.86 99.84 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.871 -0.68 . . . . 0.0 111.862 178.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -68.39 -34.3 75.8 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.764 0.316 . . . . 0.0 110.996 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.447 HG22 ' O ' ' A' ' 132' ' ' LEU . 0.0 OUTLIER -72.07 -26.21 24.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.099 179.875 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.2 -35.23 79.18 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.935 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.01 -22.43 66.93 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.811 178.513 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.2 tp -80.41 -42.83 22.04 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.222 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 142' ' ' GLY . 0.8 OUTLIER -69.59 -16.46 63.41 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.124 179.583 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.43 -26.44 61.84 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.737 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 2.0 t -98.26 -19.22 6.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.776 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.449 ' O ' ' HA ' ' A' ' 139' ' ' THR . . . 153.47 -125.43 1.76 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.154 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 125.68 -152.23 17.91 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.264 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 173.58 169.25 35.71 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.138 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 3.6 m -75.18 -23.33 17.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.683 0.278 . . . . 0.0 111.378 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -62.38 -30.59 76.67 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.625 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.46 -49.36 71.74 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.678 0.275 . . . . 0.0 110.795 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.0 mp -63.52 -42.52 98.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.602 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.1 mt -62.08 -40.61 96.38 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.08 179.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.22 -44.04 97.47 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.852 0.358 . . . . 0.0 110.47 178.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.649 ' HA ' ' HB1' ' A' ' 8' ' ' ALA . 14.3 m-85 -65.11 -38.45 90.71 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.023 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 23.1 mm -62.59 -46.62 95.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.16 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.51 -38.23 90.28 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.61 0.243 . . . . 0.0 110.769 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -59.28 -39.28 94.44 Favored Glycine 0 C--N 1.335 0.503 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.423 179.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.49 ' O ' ' HD2' ' A' ' 158' ' ' PRO . 0.4 OUTLIER -84.24 -21.76 31.05 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.763 0.316 . . . . 0.0 110.787 178.978 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -62.1 -43.27 99.2 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.445 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.513 ' HB ' ' HD3' ' A' ' 158' ' ' PRO . 0.3 OUTLIER -54.78 -57.03 21.13 Favored Pre-proline 0 N--CA 1.472 0.647 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.513 ' HD3' ' HB ' ' A' ' 157' ' ' VAL . 38.1 Cg_exo -62.33 -40.37 40.74 Favored 'Trans proline' 0 C--N 1.359 1.106 0 C-N-CA 122.256 1.97 . . . . 0.0 112.681 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.7 -44.22 93.76 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.402 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.69 -44.19 82.39 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.058 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 157' ' ' VAL . 95.2 t -61.26 -44.72 98.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.62 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 55.4 t -66.36 -46.37 87.12 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.162 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.87 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -54.33 -38.18 65.7 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.737 0.303 . . . . 0.0 111.801 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.3 mt -75.31 -47.19 28.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.616 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -70.2 -25.7 63.54 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.449 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.578 ' O ' ' HB2' ' A' ' 170' ' ' LYS . . . -64.6 -25.85 68.15 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.129 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -77.58 -42.3 35.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.843 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.57 -46.11 89.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.11 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 3.7 pt -75.66 -20.55 15.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.676 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.578 ' HB2' ' O ' ' A' ' 166' ' ' ALA . 0.2 OUTLIER -62.01 -41.35 97.97 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.916 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -64.95 -38.81 95.94 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.01 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -75.62 -30.23 59.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.6 0.238 . . . . 0.0 111.113 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.405 ' HG ' ' HB3' ' A' ' 180' ' ' SER . 0.2 OUTLIER -60.46 -32.68 71.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.088 179.077 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.77 -17.47 38.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.921 0.391 . . . . 0.0 110.818 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 67.5 mtm-85 -91.23 -24.49 19.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.91 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -59.36 -48.96 79.64 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.208 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 133.04 -130.95 5.93 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.587 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -99.37 -3.23 34.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.846 0.355 . . . . 0.0 111.159 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 4.1 mt -69.51 -32.19 51.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.248 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.405 ' HB3' ' HG ' ' A' ' 173' ' ' LEU . 0.1 OUTLIER -62.41 -26.87 68.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.295 179.501 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 15.0 t60 -71.31 -29.7 65.34 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.742 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.434 ' O ' ' HB2' ' A' ' 186' ' ' LEU . 0.9 OUTLIER -68.58 -32.7 72.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.812 -179.929 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 2.9 t -76.6 -22.43 15.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.565 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.69 -46.4 25.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.562 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.505 ' O ' HG23 ' A' ' 189' ' ' VAL . 16.9 m -75.05 -26.37 19.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.744 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.553 ' O ' HG23 ' A' ' 190' ' ' VAL . 2.2 tp -60.32 -47.3 86.63 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.073 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -63.81 -33.81 76.51 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.867 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.444 ' O ' HG23 ' A' ' 192' ' ' VAL . . . -67.94 -42.93 84.43 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.086 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 185' ' ' VAL . 87.0 t -60.91 -44.35 97.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-O 120.776 0.322 . . . . 0.0 110.767 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 186' ' ' LEU . 24.4 t -62.91 -42.22 95.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.903 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 1.1 mt -59.84 -42.72 94.22 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.732 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 188' ' ' GLY . 65.4 t -67.59 -43.82 86.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.2 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.3 tp -58.44 -45.67 88.05 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.917 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 70.4 t -62.61 -42.39 95.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.675 0.274 . . . . 0.0 110.546 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -62.18 -40.72 99.34 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.328 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 98.4 t -75.21 -41.13 44.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.543 0.211 . . . . 0.0 111.055 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.46 ' O ' ' HA3' ' A' ' 201' ' ' GLY . 1.8 mp -65.48 -23.62 66.95 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.155 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.54 -46.22 11.8 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.696 -0.229 . . . . 0.0 110.789 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -69.47 -49.38 55.37 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.932 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.69 -13.1 52.42 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.926 0.393 . . . . 0.0 111.108 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' A' ' 197' ' ' LEU . . . -88.66 -63.27 1.35 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.466 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 50.87 48.55 22.75 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.986 0.422 . . . . 0.0 111.548 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -119.84 150.44 40.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.931 0.396 . . . . 0.0 111.552 -179.245 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.412 ' H ' HG22 ' A' ' 204' ' ' THR . 0.1 OUTLIER -74.71 -36.17 62.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.369 -179.678 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -59.8 -27.09 66.28 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.918 0.389 . . . . 0.0 111.426 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 19.5 mt -67.25 -38.52 85.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.234 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -74.75 -29.26 61.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.258 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.31 -41.29 81.07 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.552 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -70.12 -27.39 64.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.768 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -72.56 -24.11 61.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.678 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.0 mp -81.2 -22.44 38.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.568 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.42 -7.5 58.44 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.69 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 27.9 mm -82.09 -14.99 12.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.114 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 1.7 m -65.98 118.19 49.86 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.429 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -57.7 128.73 30.31 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.305 2.003 . . . . 0.0 111.956 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -63.86 -17.03 62.75 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.247 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 7.8 m0 -70.08 -21.7 63.12 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.893 179.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 1.1 mt -89.08 -31.41 18.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.333 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -79.53 -24.81 41.95 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.316 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 1.9 mtt-85 -79.04 -0.88 33.14 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.812 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -89.33 13.68 12.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.996 0.427 . . . . 0.0 110.918 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.447 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 0.5 OUTLIER -65.82 141.44 97.69 Favored Pre-proline 0 C--O 1.234 0.277 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.583 179.194 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -79.61 52.97 4.52 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.305 2.003 . . . . 0.0 112.6 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 5.5 m . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.247 -0.882 . . . . 0.0 111.538 -179.837 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.6 mmm . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 121.108 0.48 . . . . 0.0 110.536 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.1 m -80.97 60.02 4.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.519 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -130.9 19.62 5.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.961 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.08 -34.39 76.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.055 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.06 -43.93 77.48 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.868 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.38 -42.42 98.68 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.751 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.51 -45.57 92.38 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.018 178.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.33 -33.69 76.3 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.929 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.409 ' O ' HG23 ' A' ' 13' ' ' VAL . 0.3 OUTLIER -69.19 -49.03 60.31 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.742 179.928 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.9 mt -58.71 -42.03 87.72 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.528 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.28 -41.74 99.03 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.267 178.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.46 -43.98 97.4 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 121.206 -0.521 . . . . 0.0 112.261 179.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 9' ' ' PHE . 98.2 t -62.71 -42.67 97.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.794 0.331 . . . . 0.0 110.192 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 14.1 mt -63.93 -42.09 97.46 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.465 179.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.5 m -65.95 -41.37 91.35 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.773 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -62.75 -39.35 93.85 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.984 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 87.2 mt -80.59 -13.48 59.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.038 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.468 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 4.1 p -83.79 137.54 41.0 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.592 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.488 ' HD3' HD13 ' A' ' 213' ' ' ILE . 23.2 Cg_exo -65.36 -8.56 19.2 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.64 2.226 . . . . 0.0 112.46 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 64.2 m -65.35 -24.43 67.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.174 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.1 t -111.2 18.2 7.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.393 0.616 . . . . 0.0 110.269 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.434 ' HB2' ' O ' ' A' ' 19' ' ' PRO . 0.5 OUTLIER -72.1 -48.23 10.65 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.406 179.051 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -59.37 -15.11 27.98 Favored 'Trans proline' 0 C--N 1.362 1.283 0 C-N-CA 122.337 2.024 . . . . 0.0 112.734 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.51 -12.81 60.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.316 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.409 ' HB ' ' CD ' ' A' ' 26' ' ' PRO . 92.7 t -77.41 -57.92 1.01 Allowed Pre-proline 0 CA--C 1.54 0.574 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.122 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.409 ' CD ' ' HB ' ' A' ' 25' ' ' VAL . 30.5 Cg_endo -63.43 -30.37 72.22 Favored 'Trans proline' 0 C--N 1.361 1.215 0 C-N-CA 122.21 1.94 . . . . 0.0 112.747 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.2 p -66.42 -32.11 73.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.603 -0.272 . . . . 0.0 110.933 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -65.28 -39.72 92.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.323 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.4 mt -67.47 -37.03 82.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.244 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -67.79 -38.62 83.59 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.949 178.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.596 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 6.5 m-85 -69.26 -38.76 78.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.366 178.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.3 mt -66.46 -34.71 78.54 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.512 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.2 4.34 86.26 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.934 -0.65 . . . . 0.0 111.825 178.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -91.4 56.31 3.15 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 121.319 -0.467 . . . . 0.0 112.265 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . 62.99 -101.06 0.09 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.072 0.549 . . . . 0.0 111.654 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 6.2 mtt85 -90.75 60.57 4.52 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.193 0.52 . . . . 0.0 111.036 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.596 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -103.28 75.91 0.29 Allowed Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.249 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 10.8 mtt180 -83.98 137.09 40.67 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-O 120.504 0.193 . . . . 0.0 110.924 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.655 ' HB3' ' HB1' ' A' ' 163' ' ' ALA . 44.0 Cg_exo -56.7 -47.03 25.57 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.956 2.438 . . . . 0.0 112.714 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.9 mp -62.24 -38.85 90.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.167 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -70.57 -39.06 74.11 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.393 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -64.89 -45.75 84.66 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.223 178.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.98 -35.95 81.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.836 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.5 tp -67.48 -48.1 68.12 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.714 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -66.73 -28.09 68.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.463 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.482 ' O ' ' HB2' ' A' ' 50' ' ' PHE . 0.2 OUTLIER -64.18 -50.71 67.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.558 178.815 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 38.2 mt -65.09 -39.08 84.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.865 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -68.81 -52.08 33.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.128 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -58.85 -43.45 96.61 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.17 178.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.482 ' HB2' ' O ' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -68.9 -36.8 78.47 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.542 0.21 . . . . 0.0 110.64 179.473 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -61.36 -45.71 95.88 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.541 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.43 -44.4 95.83 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.881 0.372 . . . . 0.0 110.78 179.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 95.9 t -65.91 -45.13 92.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.034 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -63.43 -30.26 71.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.271 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -78.4 -44.74 24.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.756 0.312 . . . . 0.0 110.682 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.33 -30.97 71.49 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.65 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.08 -18.48 27.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.866 0.365 . . . . 0.0 110.287 178.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.515 ' O ' ' HB2' ' A' ' 61' ' ' PHE . . . -75.03 -29.44 60.68 Favored Glycine 0 C--N 1.331 0.276 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.13 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.92 -55.61 43.0 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-O 119.872 -0.108 . . . . 0.0 111.166 178.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -69.83 -12.86 33.61 Favored 'Trans proline' 0 C--N 1.358 1.047 0 C-N-CA 122.186 1.924 . . . . 0.0 112.626 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.515 ' HB2' ' O ' ' A' ' 58' ' ' GLY . 0.1 OUTLIER -50.18 -34.26 21.97 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 179.926 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.22 -40.3 93.48 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.087 0.47 . . . . 0.0 110.871 179.088 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.61 -19.64 32.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.635 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.56 -18.37 62.25 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.91 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -64.05 -32.19 83.35 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 121.01 -0.614 . . . . 0.0 111.757 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -81.22 -22.9 59.92 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.794 179.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.421 HD13 ' HA ' ' A' ' 67' ' ' LEU . 1.1 mm? -82.5 -20.52 36.59 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.642 0.258 . . . . 0.0 110.921 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.3 tp -67.01 -22.54 65.9 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.898 179.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -70.4 -38.45 74.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.861 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -123.1 62.96 1.0 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.139 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -78.36 153.11 31.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.804 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.1 mtp180 -109.1 130.09 55.48 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.111 -179.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLN . . . . . 0.452 ' O ' ' HG3' ' A' ' 77' ' ' ARG . 67.8 mt-30 -73.69 -21.86 60.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.859 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.13 -25.87 68.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.294 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -80.55 -30.25 37.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.723 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.06 -21.9 49.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.911 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.452 ' HG3' ' O ' ' A' ' 73' ' ' GLN . 88.0 mtt-85 -69.58 -23.09 63.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.201 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.474 ' O ' HG23 ' A' ' 82' ' ' VAL . 21.8 t -63.47 -36.37 76.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.878 0.37 . . . . 0.0 110.405 179.483 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -65.53 -35.43 91.24 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.712 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.435 ' O ' HG23 ' A' ' 84' ' ' VAL . . . -66.36 -38.48 93.66 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.324 178.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 77' ' ' ARG . 58.4 t -59.95 -43.71 92.92 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-O 120.907 0.384 . . . . 0.0 110.1 178.595 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 78' ' ' VAL . 33.0 t -61.98 -39.66 84.48 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.448 179.063 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.07 -43.72 97.77 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.519 179.048 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 80' ' ' GLY . 97.2 t -62.95 -43.28 98.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-O 121.003 0.43 . . . . 0.0 110.05 178.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.5 mp -62.88 -40.42 97.49 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.467 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -63.47 -41.74 98.6 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -59.57 -40.32 96.18 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.7 178.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.451 ' HA ' HD12 ' A' ' 91' ' ' LEU . 10.8 mt -65.61 -37.22 85.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.753 0.311 . . . . 0.0 110.7 179.086 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -72.01 -36.05 69.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.912 0.387 . . . . 0.0 110.644 179.22 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 46.6 mmm -70.27 -22.03 62.91 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.86 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.451 HD12 ' HA ' ' A' ' 88' ' ' LEU . 4.1 mt -70.52 -2.99 15.77 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.084 178.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.67 10.71 66.98 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.916 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 17.3 mt -78.16 122.22 25.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.938 0.369 . . . . 0.0 110.569 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 -117.43 135.47 23.22 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.785 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -69.92 104.64 1.38 Allowed 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 122.712 2.275 . . . . 0.0 112.587 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -80.02 -22.88 41.93 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.808 179.554 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 10.8 t-105 -131.03 121.83 25.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.725 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 179.3 -131.08 1.62 Allowed Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.891 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -96.96 93.01 3.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.961 0.41 . . . . 0.0 111.083 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.5 52.69 2.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.355 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.64 78.39 1.13 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.192 0.52 . . . . 0.0 110.527 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.58 173.33 11.84 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.618 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -92.21 -6.23 50.97 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.019 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLU . . . . . 0.453 ' HB3' ' H ' ' A' ' 105' ' ' GLY . 4.3 mt-10 61.84 -157.59 0.33 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.297 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.453 ' H ' ' HB3' ' A' ' 104' ' ' GLU . . . 91.44 -132.92 11.52 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.255 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -124.54 15.36 8.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.926 0.393 . . . . 0.0 110.838 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.18 2.37 52.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.097 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.6 -20.56 50.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.975 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.414 ' N ' ' HD2' ' A' ' 110' ' ' PRO . 0.9 OUTLIER -77.89 -56.42 1.09 Allowed Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.665 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.414 ' HD2' ' N ' ' A' ' 109' ' ' ARG . 28.6 Cg_endo -62.35 -35.26 74.06 Favored 'Trans proline' 0 C--N 1.362 1.248 0 C-N-CA 122.012 1.808 . . . . 0.0 112.198 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -81.46 -21.85 38.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.085 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -68.4 -41.2 85.98 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.772 -0.728 . . . . 0.0 111.369 178.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -72.3 -33.9 67.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.741 0.305 . . . . 0.0 110.521 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.76 -36.17 72.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.076 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.1 tp -67.29 -48.46 67.57 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.711 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 12.0 mt -67.41 -29.54 69.06 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.448 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -72.68 -48.69 21.37 Favored Glycine 0 N--CA 1.451 -0.361 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 178.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.73 -36.33 80.67 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.75 0.31 . . . . 0.0 110.738 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 90.7 m -64.73 -43.24 94.03 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.884 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.76 -29.65 68.09 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.806 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -77.5 -31.66 53.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.004 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -79.16 -24.83 43.0 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.04 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -86.88 160.39 32.38 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.75 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -96.8 120.93 38.04 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 122.429 -0.454 . . . . 0.0 111.0 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.443 ' O ' HG22 ' A' ' 128' ' ' ILE . 0.2 OUTLIER -80.93 114.06 45.49 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.849 179.71 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -59.87 -16.94 41.02 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.763 2.308 . . . . 0.0 112.985 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 11.1 t -77.04 -26.55 53.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.753 0.311 . . . . 0.0 110.903 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.443 HG22 ' O ' ' A' ' 125' ' ' THR . 1.4 tp -99.98 -4.72 9.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.124 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -56.57 -64.38 4.45 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 115.942 -0.572 . . . . 0.0 113.159 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -58.13 -37.95 93.47 Favored 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 122.459 2.106 . . . . 0.0 112.413 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.497 ' O ' HG13 ' A' ' 135' ' ' ILE . 69.2 mt -61.94 -46.07 97.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.865 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.78 -39.97 95.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.001 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -62.94 -36.6 93.65 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.78 178.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -68.32 -39.9 81.83 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.576 0.227 . . . . 0.0 111.061 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.497 HG13 ' O ' ' A' ' 131' ' ' ILE . 70.4 mt -63.06 -32.97 58.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.075 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.37 -34.8 79.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.111 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -84.88 -22.07 29.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.904 178.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.9 -29.67 58.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.986 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -81.62 -16.22 52.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.04 0.448 . . . . 0.0 110.712 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -77.93 -28.6 49.7 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.666 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 7.3 m -102.6 4.87 10.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.986 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -169.68 97.73 0.13 Allowed Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.182 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -85.42 81.25 1.75 Allowed Glycine 0 CA--C 1.517 0.187 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.685 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -124.57 106.6 0.94 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.509 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -69.2 -23.77 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 121.011 0.434 . . . . 0.0 111.06 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -65.77 -30.36 77.07 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.139 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.26 -43.36 86.68 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.788 0.328 . . . . 0.0 110.62 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.57 -40.24 92.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.9 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.69 -42.04 87.09 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.335 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.82 -32.75 74.36 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.447 179.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -63.32 -49.88 72.22 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.741 179.034 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 10.2 mt -61.02 -44.35 98.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.989 0.423 . . . . 0.0 110.535 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.3 -34.04 74.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.409 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -59.92 -36.93 91.74 Favored Glycine 0 C--N 1.334 0.471 0 C-N-CA 121.267 -0.492 . . . . 0.0 112.105 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.538 ' C ' ' HD2' ' A' ' 158' ' ' PRO . 5.5 mt -86.36 -22.6 26.57 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 120.842 0.354 . . . . 0.0 110.97 178.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -61.21 -49.55 76.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.052 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.782 HG13 ' HD3' ' A' ' 158' ' ' PRO . 0.3 OUTLIER -54.6 -51.59 77.24 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.331 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.782 ' HD3' HG13 ' A' ' 157' ' ' VAL . 43.4 Cg_exo -58.96 -40.78 68.2 Favored 'Trans proline' 0 C--N 1.36 1.147 0 C-N-CA 122.138 1.892 . . . . 0.0 112.346 178.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -60.6 -40.38 91.59 Favored 'General case' 0 CA--C 1.522 -0.1 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.336 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -65.65 -43.38 89.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.794 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 157' ' ' VAL . 40.1 t -63.37 -44.04 98.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.809 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 158' ' ' PRO . 84.9 t -67.73 -49.11 72.82 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.906 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.655 ' HB1' ' HB3' ' A' ' 39' ' ' PRO . . . -57.98 -32.26 67.71 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.644 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.4 -48.79 54.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.301 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -71.27 -33.65 69.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.702 0.287 . . . . 0.0 110.82 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.615 ' HA ' HG22 ' A' ' 169' ' ' ILE . . . -68.97 -21.03 64.2 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.019 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -72.31 -35.63 68.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.169 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 13.4 mmm180 -84.82 -42.71 14.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.23 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.615 HG22 ' HA ' ' A' ' 166' ' ' ALA . 3.3 tt -68.41 -19.99 24.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.277 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.43 ' HB2' ' O ' ' A' ' 166' ' ' ALA . 0.8 OUTLIER -57.46 -36.4 71.38 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.313 179.59 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -70.0 -30.28 70.13 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.579 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 1.4 m95 -86.82 -47.41 9.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.76 0.314 . . . . 0.0 111.469 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 4.7 mt -66.89 -16.49 64.35 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.701 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.43 ' HB2' ' O ' ' A' ' 170' ' ' LYS . 9.9 ttt-85 -56.79 -53.25 60.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.998 0.428 . . . . 0.0 110.984 178.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 8.1 mtm180 -93.77 -16.39 24.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.348 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -94.19 4.7 53.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.71 0.29 . . . . 0.0 111.554 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -83.13 9.5 60.58 Favored Glycine 0 CA--C 1.517 0.183 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.681 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 22.2 mtt180 -67.79 -38.65 83.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.943 0.401 . . . . 0.0 110.611 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -81.39 -29.5 10.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.467 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.95 -16.74 64.2 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.108 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' HIS . . . . . 0.468 ' O ' HG23 ' A' ' 185' ' ' VAL . 0.3 OUTLIER -57.27 -31.99 66.16 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.225 179.701 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.32 -44.2 88.61 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.045 0.45 . . . . 0.0 110.412 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 2.2 t -72.17 -19.67 19.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.781 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.79 -44.82 31.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.133 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 181' ' ' HIS . 46.7 t -67.64 -41.24 85.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.549 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.455 ' O ' HG23 ' A' ' 190' ' ' VAL . 0.3 OUTLIER -60.9 -47.9 84.26 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.739 179.504 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -62.35 -36.45 82.26 Favored 'General case' 0 N--CA 1.457 -0.092 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.384 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.46 ' O ' HG23 ' A' ' 192' ' ' VAL . . . -64.0 -46.5 91.2 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.98 -0.629 . . . . 0.0 111.951 178.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 86.8 t -62.18 -48.95 86.06 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 CA-C-O 120.555 0.217 . . . . 0.0 110.616 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 186' ' ' LEU . 76.6 t -59.3 -38.33 74.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.898 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 2.7 tp -62.22 -46.07 90.49 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.778 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 188' ' ' GLY . 61.7 t -66.19 -38.38 81.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.256 179.205 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 9.0 mt -59.05 -54.24 49.35 Favored 'General case' 0 C--N 1.334 -0.094 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.308 179.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 32.6 m -68.56 -29.74 44.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.861 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -66.65 -47.08 70.66 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.449 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 6.1 p -72.17 -31.33 39.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-O 120.722 0.296 . . . . 0.0 110.79 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 197' ' ' LEU . 11.9 mt -67.52 -38.09 83.75 Favored 'General case' 0 N--CA 1.458 -0.069 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.238 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.77 -33.36 60.19 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 121.024 -0.27 . . . . 0.0 110.747 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -66.5 -47.16 73.89 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.792 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 10.1 t -81.76 -11.11 59.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.212 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -87.79 -51.77 3.15 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.557 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 53.87 37.83 27.38 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.037 0.446 . . . . 0.0 111.229 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -139.72 -167.58 2.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.692 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.48 56.21 1.37 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.686 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -82.37 -19.5 39.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.009 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 8.8 tp -70.65 -32.92 70.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.807 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -70.22 -40.79 74.31 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.017 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.8 -32.07 71.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.97 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 209' ' ' PHE . . . . . 0.443 ' O ' HG13 ' A' ' 213' ' ' ILE . 5.9 m-85 -80.84 -43.91 19.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.025 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -61.9 -32.7 73.11 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.458 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.77 -18.08 65.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.752 0.31 . . . . 0.0 111.188 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.48 -24.39 18.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.844 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 213' ' ' ILE . . . . . 0.488 HD13 ' HD3' ' A' ' 19' ' ' PRO . 1.9 mt -92.4 -19.05 7.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.276 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 88.3 m -70.48 120.01 76.02 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.716 179.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -72.17 151.26 54.87 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.4 2.066 . . . . 0.0 112.076 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.06 -16.27 63.65 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.35 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 15.0 m95 -70.13 -25.46 63.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.16 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 1.3 mp -82.68 -23.47 34.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.961 0.41 . . . . 0.0 110.311 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 59.6 mt-30 -78.17 -21.98 49.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.393 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 36.5 mmt-85 -81.4 -2.88 51.07 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.954 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -94.36 -9.07 36.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.995 0.426 . . . . 0.0 110.762 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 1.3 mt -95.09 135.66 23.31 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.689 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -70.07 77.29 1.19 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.68 2.253 . . . . 0.0 112.745 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 2.5 m . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.277 -0.868 . . . . 0.0 111.061 -179.966 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.485 1.298 0 CA-C-O 120.852 0.358 . . . . 0.0 110.738 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -114.61 23.93 12.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.994 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.7 mt -73.66 -21.95 60.12 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.499 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.88 -30.47 69.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.648 179.298 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -74.39 -44.1 53.56 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.666 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -58.32 -46.52 86.0 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.726 179.085 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.85 -47.94 78.72 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.932 179.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.605 ' HB1' ' HA3' ' A' ' 154' ' ' GLY . . . -58.58 -40.61 83.65 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.295 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.84 -49.78 64.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.498 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 14.2 tp -57.5 -43.91 84.57 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.609 178.692 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.76 -45.88 91.98 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.062 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.8 -45.0 96.51 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.244 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 67.9 t -68.09 -39.42 81.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.521 0.2 . . . . 0.0 110.606 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.486 ' O ' ' HB2' ' A' ' 18' ' ' SER . 0.2 OUTLIER -61.16 -46.57 89.96 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.871 179.516 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 43.2 m -64.35 -36.12 83.09 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.728 0.299 . . . . 0.0 111.167 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -72.18 -38.39 69.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.746 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.48 -11.66 59.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.847 0.356 . . . . 0.0 111.115 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.486 ' HB2' ' O ' ' A' ' 14' ' ' LEU . 0.2 OUTLIER -87.05 134.08 37.62 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.387 179.239 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.94 -7.96 22.05 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.653 2.236 . . . . 0.0 112.537 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -106.28 147.27 29.35 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.481 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.531 HG22 HG21 ' A' ' 125' ' ' THR . 6.5 t 60.65 65.69 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-O 121.384 0.612 . . . . 0.0 110.874 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 30.5 mt -109.07 116.68 55.06 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.285 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.11 -24.31 44.89 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.767 2.311 . . . . 0.0 112.688 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.81 -19.27 65.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.471 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 54.1 t -64.99 -60.15 8.65 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.291 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.92 -24.91 77.92 Favored 'Trans proline' 0 C--N 1.361 1.196 0 C-N-CA 121.985 1.79 . . . . 0.0 112.547 178.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.7 m -65.2 -39.83 93.35 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.844 0.354 . . . . 0.0 110.815 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -69.02 -31.24 69.91 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.739 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.83 -41.48 44.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.369 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -59.48 -41.95 90.97 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.041 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -73.99 -28.7 61.59 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.806 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.68 -28.9 64.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.267 179.241 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.452 ' O ' ' HD3' ' A' ' 110' ' ' PRO . . . -74.1 -32.18 58.79 Favored Glycine 0 N--CA 1.448 -0.567 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.066 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.69 83.86 1.52 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.328 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -124.5 -68.34 0.86 Allowed 'General case' 0 C--N 1.328 -0.341 0 O-C-N 122.923 -0.163 . . . . 0.0 111.246 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 18.8 mtt180 57.93 38.68 27.0 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.271 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -104.15 61.55 0.42 Allowed Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.359 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 58.38 82.82 0.23 Allowed Pre-proline 0 N--CA 1.468 0.451 0 C-N-CA 122.894 0.478 . . . . 0.0 111.522 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -57.36 -30.11 86.66 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.861 2.374 . . . . 0.0 112.586 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.9 -38.32 90.45 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.34 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -77.13 -37.12 54.72 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.499 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 19.9 t30 -65.59 -36.06 82.66 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.222 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.566 ' O ' HG12 ' A' ' 47' ' ' ILE . . . -61.61 -54.83 37.68 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.615 178.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 74.2 mt -56.23 -39.75 73.02 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.2 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -63.95 -45.89 87.16 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.826 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -63.91 -42.73 97.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.948 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.566 HG12 ' O ' ' A' ' 43' ' ' ALA . 48.8 mm -64.89 -41.08 91.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.656 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.3 tp -65.28 -45.98 82.29 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 179.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.535 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -60.74 -42.94 99.62 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.755 179.129 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.18 -40.83 86.62 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.619 0.247 . . . . 0.0 110.959 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -62.06 -39.38 97.53 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.86 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.9 -47.92 73.2 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.459 0.171 . . . . 0.0 110.88 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 49' ' ' GLY . 57.8 t -61.87 -40.23 86.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.033 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.33 -45.86 78.85 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.323 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -68.18 -38.54 82.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.4 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.54 -32.95 74.62 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.12 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.29 -18.75 26.35 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.977 0.418 . . . . 0.0 110.802 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -79.24 -25.3 59.63 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 121.127 -0.558 . . . . 0.0 112.299 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.88 -56.41 29.11 Favored Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 111.464 0.172 . . . . 0.0 111.464 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -70.13 -14.03 34.44 Favored 'Trans proline' 0 C--N 1.362 1.253 0 C-N-CA 122.023 1.815 . . . . 0.0 112.646 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -63.76 -19.74 65.21 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.318 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.0 m -63.53 -45.14 91.95 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.012 0.434 . . . . 0.0 110.651 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.72 -21.18 24.0 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.102 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.93 -18.05 58.53 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.785 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -63.25 -26.31 69.23 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.067 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -78.75 -24.53 62.18 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.89 -0.672 . . . . 0.0 111.769 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 54.9 mt -87.35 -20.73 26.33 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.69 0.281 . . . . 0.0 110.652 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.5 -19.32 64.66 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.647 179.031 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -65.3 -17.45 64.52 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.837 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -84.33 179.07 7.53 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.268 0.556 . . . . 0.0 110.353 178.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -80.23 72.36 7.05 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.299 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' A' ' 72' ' ' ARG . 8.0 mtt180 -114.26 25.3 11.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.386 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -78.38 -18.19 55.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.985 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.35 -20.21 65.96 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.469 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.4 -28.32 67.83 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.662 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.1 -23.53 28.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.428 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -64.66 -29.21 70.21 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.157 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.1 t -63.73 -21.41 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.625 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -66.58 -29.61 75.05 Favored Glycine 0 C--N 1.336 0.546 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.715 179.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.503 ' O ' HG23 ' A' ' 84' ' ' VAL . . . -74.23 -38.69 45.94 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.51 -0.852 . . . . 0.0 111.169 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.9 t -59.13 -48.87 85.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-O 120.825 0.345 . . . . 0.0 111.05 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.2 m -69.07 -31.35 49.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.107 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.495 HD13 ' HA2' ' A' ' 195' ' ' GLY . 0.4 OUTLIER -64.72 -43.13 94.4 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.673 179.103 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 80' ' ' GLY . 74.1 t -65.54 -40.09 87.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.21 179.108 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.89 -41.02 95.21 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.636 179.089 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -66.25 -37.7 86.12 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.4 179.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -65.25 -39.65 96.16 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.713 178.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.53 -39.92 95.67 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.738 0.304 . . . . 0.0 110.654 179.038 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -71.62 -32.03 67.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.554 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.87 -19.81 61.23 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.903 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.48 -3.5 8.71 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.375 178.327 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 108.49 6.43 31.14 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.681 -0.771 . . . . 0.0 113.147 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.96 121.06 12.04 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 117.083 0.441 . . . . 0.0 110.499 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 6.9 mtt180 -125.69 143.09 43.94 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.663 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -77.05 -178.33 4.5 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.353 2.036 . . . . 0.0 112.047 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 77.5 mtt-85 -85.79 -46.3 10.79 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.98 0.419 . . . . 0.0 111.376 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -122.97 164.74 17.94 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.61 -179.195 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -173.1 -106.73 0.2 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.374 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.4 p -121.78 -44.32 2.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.899 0.38 . . . . 0.0 110.813 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.92 84.26 4.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.313 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.38 68.66 8.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.865 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 17.7 mtt180 70.71 -72.15 0.12 Allowed 'General case' 0 N--CA 1.471 0.624 0 O-C-N 123.819 0.699 . . . . 0.0 111.205 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -102.98 166.22 10.57 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.22 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 62.15 54.64 2.63 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 123.562 0.539 . . . . 0.0 110.896 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -85.62 124.4 6.8 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.855 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -109.34 161.37 15.34 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.909 0.385 . . . . 0.0 111.121 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.01 90.1 5.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.452 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.74 -2.48 58.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.062 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.464 ' N ' ' HD2' ' A' ' 110' ' ' PRO . 0.9 OUTLIER -64.39 -53.19 48.02 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.351 -179.745 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 109' ' ' ARG . 15.8 Cg_endo -57.88 -36.27 98.3 Favored 'Trans proline' 0 C--N 1.362 1.242 0 C-N-CA 122.171 1.914 . . . . 0.0 112.617 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -75.07 -31.11 61.16 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.34 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -74.48 -25.8 69.41 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 178.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -64.31 -36.77 85.19 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.802 0.334 . . . . 0.0 110.887 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.17 -40.71 71.1 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.652 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.9 tp -68.79 -36.08 77.82 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.349 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.14 -22.13 61.36 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.201 0.525 . . . . 0.0 110.22 178.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -80.27 -44.31 8.91 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.79 -40.07 96.2 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.522 0.201 . . . . 0.0 111.17 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.4 p -65.31 -38.94 91.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.967 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.69 -24.79 61.88 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.654 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -80.21 -35.02 36.87 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.952 0.406 . . . . 0.0 110.371 179.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 72.5 mt -78.46 -26.14 46.05 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.314 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -76.71 160.35 50.45 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.768 178.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 14.9 p90 -112.62 154.38 26.13 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.978 0.418 . . . . 0.0 110.86 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.574 ' HB ' ' SG ' ' A' ' 127' ' ' CYS . 0.8 OUTLIER -109.32 104.39 55.04 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.519 179.424 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.97 -18.26 56.44 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.115 2.543 . . . . 0.0 113.203 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' CYS . . . . . 0.574 ' SG ' ' HB ' ' A' ' 125' ' ' THR . 0.8 OUTLIER -64.88 -37.45 87.68 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.14 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 pt -103.45 4.79 10.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.24 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -58.89 -68.59 1.61 Allowed Glycine 0 C--N 1.334 0.472 0 CA-C-N 116.046 -0.525 . . . . 0.0 112.756 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.51 -31.61 92.63 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.348 2.032 . . . . 0.0 111.878 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.401 ' O ' HG12 ' A' ' 135' ' ' ILE . 60.6 mt -63.69 -55.83 20.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.888 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.43 -34.7 77.76 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.708 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -61.88 -36.2 92.45 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.226 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -75.61 -36.7 60.19 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.833 0.349 . . . . 0.0 111.086 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.401 HG12 ' O ' ' A' ' 131' ' ' ILE . 46.7 mm -70.48 -35.33 61.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.971 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.97 -30.17 70.74 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.118 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.88 -26.97 64.44 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.941 0.4 . . . . 0.0 110.75 178.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 8.7 mt -84.52 -38.75 19.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.893 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 16.0 p -70.11 -16.3 63.09 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.473 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -75.86 -29.48 58.57 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.791 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 2.1 t -96.81 -32.77 4.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.592 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -150.15 90.76 0.14 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.318 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -162.92 -97.59 0.12 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.601 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 111.56 -179.77 19.84 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.49 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 6.2 t -75.0 -31.11 24.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 120.67 0.271 . . . . 0.0 111.0 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -60.44 -32.67 78.35 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.669 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.87 -40.87 83.55 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.853 0.358 . . . . 0.0 110.426 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.417 ' O ' HG13 ' A' ' 152' ' ' ILE . 17.0 mt -62.35 -42.52 99.46 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.486 179.26 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 30.7 mt -65.77 -39.82 91.41 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.508 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.18 -40.11 96.58 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.385 178.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -61.49 -44.8 96.43 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.026 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.417 HG13 ' O ' ' A' ' 148' ' ' LEU . 53.9 mt -64.39 -49.0 82.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.633 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.427 ' O ' HG23 ' A' ' 157' ' ' VAL . 0.1 OUTLIER -66.55 -34.57 78.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.928 -179.941 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.605 ' HA3' ' HB1' ' A' ' 8' ' ' ALA . . . -60.55 -44.82 97.34 Favored Glycine 0 C--O 1.223 -0.546 0 C-N-CA 121.176 -0.535 . . . . 0.0 112.189 179.088 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.45 -28.17 61.81 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.166 0.508 . . . . 0.0 110.561 178.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -64.4 -35.34 80.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.438 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.495 ' O ' HG23 ' A' ' 161' ' ' VAL . 96.7 t -55.38 -62.79 3.83 Favored Pre-proline 0 CA--C 1.542 0.643 0 O-C-N 123.272 0.358 . . . . 0.0 111.595 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.478 ' CD ' ' HB ' ' A' ' 157' ' ' VAL . 18.0 Cg_endo -60.15 -36.09 89.96 Favored 'Trans proline' 0 C--N 1.359 1.127 0 C-N-CA 122.04 1.827 . . . . 0.0 112.225 179.11 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -59.66 -46.44 89.02 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-O 120.739 0.304 . . . . 0.0 110.944 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -63.57 -39.41 94.32 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.942 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 157' ' ' VAL . 52.8 t -61.27 -43.59 96.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-O 120.927 0.394 . . . . 0.0 110.321 179.077 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 158' ' ' PRO . 61.0 t -68.36 -38.58 79.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.647 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -58.56 -35.6 72.62 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.779 0.323 . . . . 0.0 111.313 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 17.1 mt -78.96 -42.63 26.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.194 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.78 -19.24 62.04 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.224 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.556 ' HA ' HD12 ' A' ' 169' ' ' ILE . . . -66.01 -19.85 65.99 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.158 179.127 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -64.29 -39.76 94.58 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.782 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 16.5 mtt180 -69.16 -24.17 64.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.649 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.556 HD12 ' HA ' ' A' ' 166' ' ' ALA . 26.4 mt -83.38 -22.42 8.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.427 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -62.76 -38.17 89.49 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.749 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -75.85 -36.23 42.7 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.664 -0.779 . . . . 0.0 111.882 179.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 1.8 m95 -73.92 -26.95 60.79 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.525 0.194 . . . . 0.0 111.525 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 2.3 tp -57.49 -36.53 71.62 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.709 0.29 . . . . 0.0 111.367 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 1.1 mtp-105 -87.07 -20.45 27.11 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.136 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -83.78 -34.13 24.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.921 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.421 ' HB1' ' HB ' ' A' ' 179' ' ' ILE . . . -62.55 -65.19 0.72 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.793 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 79.78 -64.85 3.81 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.969 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 9.4 mtm180 -81.18 -40.14 24.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.722 0.296 . . . . 0.0 111.285 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.421 ' HB ' ' HB1' ' A' ' 176' ' ' ALA . 14.3 mm -69.04 -31.4 50.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.051 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -63.33 -26.64 68.86 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.048 0.452 . . . . 0.0 111.092 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -84.8 -22.01 29.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.128 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -75.63 -28.79 58.96 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.825 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 17.4 t -65.54 -25.37 36.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.703 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -82.41 -37.98 24.72 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.768 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.8 t -70.99 -46.3 68.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.891 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 5.2 tp -62.32 -52.67 62.72 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.282 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -64.42 -35.09 79.79 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.02 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.425 ' O ' HG23 ' A' ' 192' ' ' VAL . . . -62.41 -49.96 69.17 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.21 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 96.4 t -62.0 -46.99 95.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 120.479 0.181 . . . . 0.0 110.783 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.471 ' O ' HG23 ' A' ' 194' ' ' VAL . 85.9 t -59.33 -43.15 89.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.878 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 5.4 tp -58.43 -48.85 79.34 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.756 0.312 . . . . 0.0 111.228 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.531 ' O ' HG23 ' A' ' 196' ' ' VAL . 41.4 t -66.06 -40.85 88.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.465 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' LEU . . . . . 0.448 ' O ' ' HB2' ' A' ' 197' ' ' LEU . 2.2 tp -58.77 -50.08 75.28 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.681 179.189 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 190' ' ' VAL . 87.7 t -61.1 -39.75 83.41 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.434 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.495 ' HA2' HD13 ' A' ' 83' ' ' LEU . . . -57.86 -48.03 84.87 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.611 179.255 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 192' ' ' VAL . 4.2 t -73.87 -34.89 41.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.726 0.298 . . . . 0.0 110.517 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' LEU . . . . . 0.539 ' O ' ' HA3' ' A' ' 201' ' ' GLY . 0.5 OUTLIER -63.1 -28.31 69.99 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.714 179.236 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.652 HD23 HD11 ' A' ' 206' ' ' LEU . 65.0 mt -80.38 -42.54 22.65 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.818 178.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -70.79 -57.6 4.48 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 68.2 p -81.46 -9.26 59.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.803 0.335 . . . . 0.0 111.727 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' GLY . . . . . 0.693 ' HA2' ' HB3' ' A' ' 205' ' ' ALA . . . -84.67 -54.21 3.0 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.436 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 28.5 m 67.23 -72.2 0.09 Allowed 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 122.845 0.458 . . . . 0.0 111.521 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -163.84 -50.19 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.523 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.91 -46.2 90.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.35 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 205' ' ' ALA . . . . . 0.693 ' HB3' ' HA2' ' A' ' 201' ' ' GLY . . . -84.8 -19.52 32.41 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.738 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.652 HD11 HD23 ' A' ' 198' ' ' LEU . 1.1 mt -77.27 -36.86 54.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.889 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.98 -39.59 95.16 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.625 -0.261 . . . . 0.0 110.949 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.52 -37.82 73.67 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.342 178.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -87.04 -24.52 24.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.167 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -67.65 -17.19 64.51 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.978 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.0 mt -61.35 -30.84 70.77 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 121.019 0.437 . . . . 0.0 110.722 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 3.2 mtt180 -92.91 -3.61 54.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.711 179.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 37.0 mm -103.21 -20.16 5.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.941 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.56 119.7 45.9 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.047 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.46 151.63 65.17 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.304 2.003 . . . . 0.0 112.254 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -64.61 -22.42 66.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.191 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 8.0 m-90 -63.55 -24.8 67.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.303 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 16.0 mt -89.53 -27.22 20.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.94 0.4 . . . . 0.0 110.399 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.04 -35.43 31.84 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.363 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 1.4 mtp180 -74.66 -7.26 52.68 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.03 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -87.92 -9.56 53.28 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.991 0.424 . . . . 0.0 110.301 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' LEU . . . . . 0.424 ' HA ' ' HD3' ' A' ' 223' ' ' PRO . 23.7 mt -89.51 129.19 48.06 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.29 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 223' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 222' ' ' LEU . 32.3 Cg_exo -57.63 -38.57 93.02 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.836 2.358 . . . . 0.0 112.626 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.024 -0.989 . . . . 0.0 110.599 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 121.099 0.476 . . . . 0.0 110.84 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.97 155.72 18.51 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.943 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 8.2 mt -76.17 -20.94 57.08 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.505 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.75 -26.21 64.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.687 179.323 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.8 mt -77.4 -46.1 23.78 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.562 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -60.51 -39.81 89.13 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.796 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.76 -46.02 89.97 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.737 178.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.97 -35.12 79.11 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.769 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.474 ' O ' HG23 ' A' ' 13' ' ' VAL . 1.2 m-85 -65.56 -51.74 57.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.18 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.43 -39.02 82.18 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.29 178.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.23 -44.17 97.7 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.425 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.81 -42.9 99.8 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 120.888 -0.672 . . . . 0.0 111.835 178.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 9' ' ' PHE . 49.1 t -65.61 -41.31 90.38 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-O 120.719 0.295 . . . . 0.0 110.307 179.202 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.4 tp -63.99 -41.72 97.41 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.456 179.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 18.9 m -64.34 -35.78 81.98 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.726 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -72.04 -36.08 69.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.988 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.8 -4.86 59.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.811 0.339 . . . . 0.0 111.077 179.324 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.0 t -68.89 119.87 72.37 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.805 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.573 ' HD3' HG21 ' A' ' 213' ' ' ILE . 39.3 Cg_endo -67.3 -8.07 20.89 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.84 2.36 . . . . 0.0 112.697 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 2.2 t -73.38 -25.31 60.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.841 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.4 m -130.82 5.78 2.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.666 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.411 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 0.3 OUTLIER -70.77 -53.72 8.82 Favored Pre-proline 0 CA--C 1.538 0.504 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 179.896 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.411 ' HD2' ' N ' ' A' ' 22' ' ' LEU . 46.0 Cg_endo -68.97 -14.71 39.1 Favored 'Trans proline' 0 C--N 1.361 1.201 0 C-N-CA 121.888 1.725 . . . . 0.0 112.432 179.457 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.1 mp -81.28 -16.13 53.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.459 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.466 ' N ' ' HD2' ' A' ' 26' ' ' PRO . 95.0 t -62.86 -55.2 40.31 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-O 119.725 -0.179 . . . . 0.0 111.289 178.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.602 ' HA ' HD12 ' A' ' 29' ' ' LEU . 14.4 Cg_endo -58.05 -33.06 96.87 Favored 'Trans proline' 0 C--N 1.362 1.246 0 C-N-CA 122.275 1.984 . . . . 0.0 112.505 178.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.54 -36.64 65.69 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.791 0.329 . . . . 0.0 110.943 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.0 -28.5 68.3 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.021 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.602 HD12 ' HA ' ' A' ' 26' ' ' PRO . 8.3 mt -63.06 -37.52 87.51 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.718 179.276 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.58 -35.52 67.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.065 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -66.75 -37.14 84.05 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.336 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.63 -15.18 60.83 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.23 178.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -67.65 -24.96 74.08 Favored Glycine 0 C--N 1.332 0.346 0 N-CA-C 111.77 -0.532 . . . . 0.0 111.77 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.53 -16.35 80.1 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.985 -0.626 . . . . 0.0 111.54 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -126.9 51.39 1.87 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.975 0.417 . . . . 0.0 109.988 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.7 70.79 1.4 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.39 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -146.48 84.95 0.18 Allowed Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.548 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.2 mtp180 66.4 91.25 0.08 OUTLIER Pre-proline 0 N--CA 1.467 0.416 0 C-N-CA 122.922 0.489 . . . . 0.0 111.16 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -64.09 -30.24 65.67 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.434 2.089 . . . . 0.0 112.466 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.4 mp -62.55 -40.83 98.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.279 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -72.47 -37.35 68.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.615 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -67.57 -43.8 79.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.393 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.05 -50.68 67.44 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.769 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.74 -42.68 75.75 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.219 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -63.85 -41.31 97.84 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.876 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.28 -41.47 94.15 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.37 179.08 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 54.6 mt -62.96 -42.43 96.6 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.943 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.31 -44.07 92.74 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.468 179.242 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.514 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -59.27 -43.71 97.04 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.862 -0.685 . . . . 0.0 111.693 178.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.02 -37.24 81.16 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.76 0.314 . . . . 0.0 110.242 179.181 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -63.17 -41.93 99.55 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 178.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.42 -45.99 87.38 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 120.509 0.195 . . . . 0.0 110.635 178.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 49' ' ' GLY . 24.7 t -63.41 -43.02 98.29 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.837 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -66.04 -28.2 68.67 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.426 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -82.82 -47.39 11.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.561 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.59 -35.71 80.4 Favored 'General case' 0 C--O 1.227 -0.109 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.85 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.42 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 0.9 OUTLIER -89.52 -18.35 26.82 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.792 0.33 . . . . 0.0 110.497 178.488 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.28 -35.68 83.12 Favored Glycine 0 C--N 1.33 0.204 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.41 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.406 ' CB ' ' HD3' ' A' ' 60' ' ' PRO . 0.5 OUTLIER -63.23 -55.63 34.65 Favored Pre-proline 0 CA--C 1.543 0.687 0 N-CA-C 111.49 0.182 . . . . 0.0 111.49 179.197 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.42 ' HD2' ' C ' ' A' ' 57' ' ' LEU . 13.6 Cg_exo -70.47 -13.96 33.4 Favored 'Trans proline' 0 C--N 1.361 1.185 0 C-N-CA 122.517 2.144 . . . . 0.0 112.629 179.369 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.63 -25.74 64.92 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.119 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.5 -34.72 76.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.032 0.444 . . . . 0.0 110.403 178.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.57 -19.81 25.84 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.618 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.402 ' HA ' HD12 ' A' ' 67' ' ' LEU . 0.3 OUTLIER -67.25 -17.78 64.94 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.863 179.874 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.32 -27.5 65.57 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.947 -0.644 . . . . 0.0 111.901 179.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -78.38 -22.06 68.46 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.582 179.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.402 HD12 ' HA ' ' A' ' 64' ' ' LEU . 13.9 mt -87.12 -20.56 26.89 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.646 0.26 . . . . 0.0 110.415 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.86 -19.42 62.6 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.916 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -60.45 -26.0 66.42 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.758 178.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -97.59 125.18 42.17 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -74.59 98.74 3.45 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.026 0.441 . . . . 0.0 111.419 -179.18 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -87.1 64.79 8.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.984 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -67.45 -19.79 65.41 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.135 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.0 t -69.99 -17.76 63.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.3 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.53 -22.51 30.13 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.883 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.44 -22.4 38.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.862 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.61 -27.14 66.65 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.92 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.495 ' O ' HG23 ' A' ' 82' ' ' VAL . 3.3 t -63.0 -32.47 56.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.798 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -64.31 -34.98 91.37 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.033 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.446 ' O ' HG23 ' A' ' 84' ' ' VAL . . . -66.72 -38.9 93.49 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.666 179.286 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.9 t -62.53 -41.22 91.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-O 120.766 0.317 . . . . 0.0 110.462 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 78' ' ' VAL . 40.5 t -63.8 -40.54 89.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.383 179.208 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.1 -42.72 99.65 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.718 179.233 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 80' ' ' GLY . 94.5 t -64.02 -43.52 97.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.392 179.141 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.86 -43.33 98.53 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.952 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -66.15 -43.53 86.72 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.743 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -62.83 -40.14 98.87 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.148 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.2 -36.45 83.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.724 0.297 . . . . 0.0 110.613 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -74.74 -30.09 61.38 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.283 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 28.5 mmt -67.07 -27.94 67.78 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.29 178.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.4 mp -66.96 -10.51 50.07 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.265 178.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.41 20.22 59.02 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.85 -0.69 . . . . 0.0 113.259 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -78.42 124.14 27.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.93 0.365 . . . . 0.0 110.594 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.461 ' NH2' ' HA ' ' A' ' 96' ' ' ARG . 0.2 OUTLIER -128.24 122.07 21.86 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.679 -179.494 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -73.68 104.95 1.91 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.329 2.019 . . . . 0.0 112.417 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ARG . . . . . 0.461 ' HA ' ' NH2' ' A' ' 94' ' ' ARG . 76.2 mtp180 -77.88 -20.46 52.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.455 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 8.6 m95 65.83 -90.44 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 O-C-N 123.746 0.654 . . . . 0.0 111.922 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.99 71.31 1.32 Allowed Glycine 0 C--N 1.329 0.19 0 C-N-CA 120.791 -0.719 . . . . 0.0 111.997 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.73 -89.64 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.84 0.352 . . . . 0.0 111.329 -179.479 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.87 150.61 20.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.752 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.1 tp -85.4 79.13 9.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.947 0.403 . . . . 0.0 110.546 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 49.1 mtp180 -127.58 179.4 5.52 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.549 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -117.68 121.99 42.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.922 0.392 . . . . 0.0 110.872 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -96.04 75.59 3.06 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.341 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -86.87 70.03 2.98 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.676 -0.773 . . . . 0.0 111.843 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -120.56 153.78 36.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.913 0.387 . . . . 0.0 111.113 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.43 71.39 10.71 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.054 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.25 -12.55 59.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.15 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.419 ' CB ' ' HD3' ' A' ' 110' ' ' PRO . 0.0 OUTLIER -74.26 -58.46 1.93 Allowed Pre-proline 0 CA--C 1.539 0.53 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -179.571 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.419 ' HD3' ' CB ' ' A' ' 109' ' ' ARG . 23.8 Cg_exo -64.8 -40.21 22.8 Favored 'Trans proline' 0 C--N 1.358 1.047 0 C-N-CA 122.055 1.837 . . . . 0.0 112.34 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -74.17 -30.6 62.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.642 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' A' ' 116' ' ' LEU . . . -64.8 -40.71 97.55 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.909 -0.662 . . . . 0.0 111.974 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.51 -30.51 69.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.866 0.365 . . . . 0.0 110.919 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -80.5 -45.49 17.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.009 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.5 mt -65.66 -43.47 89.25 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.894 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.474 ' HB2' ' O ' ' A' ' 112' ' ' GLY . 1.9 mt -71.03 -22.87 62.09 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.944 0.402 . . . . 0.0 110.181 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -78.07 -46.13 9.6 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.22 -38.72 77.37 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.654 0.264 . . . . 0.0 111.304 178.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.3 p -68.55 -35.77 77.87 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.935 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.27 -33.1 61.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.478 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -71.27 -47.2 58.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.671 179.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.77 -24.01 60.89 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.834 179.228 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -78.88 89.03 1.16 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.944 -0.646 . . . . 0.0 111.73 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -59.3 126.29 27.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.082 0.468 . . . . 0.0 111.714 -179.317 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.52 ' O ' HG22 ' A' ' 128' ' ' ILE . 1.1 p -73.6 134.87 78.74 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.216 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -64.13 -19.27 65.91 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.757 2.305 . . . . 0.0 113.116 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 3.9 m -73.13 -14.95 61.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.089 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.52 HG22 ' O ' ' A' ' 125' ' ' THR . 3.7 tp -97.2 -3.95 9.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.363 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -51.79 -59.52 8.54 Favored Glycine 0 C--N 1.336 0.57 0 CA-C-N 115.894 -0.593 . . . . 0.0 113.091 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -56.73 -41.48 75.23 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.473 2.115 . . . . 0.0 112.236 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.459 ' O ' HG13 ' A' ' 135' ' ' ILE . 25.1 mm -65.48 -47.34 87.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.003 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.07 -44.12 97.36 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.535 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -58.74 -38.5 92.08 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.837 178.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.48 -40.58 89.41 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.86 0.362 . . . . 0.0 110.665 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.459 HG13 ' O ' ' A' ' 131' ' ' ILE . 78.6 mt -65.4 -37.44 80.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.213 179.189 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LEU . . . . . 0.46 ' HA ' ' OG1' ' A' ' 139' ' ' THR . 0.3 OUTLIER -64.1 -31.42 72.61 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.983 179.49 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.2 m -65.46 -30.88 71.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.994 0.426 . . . . 0.0 110.741 178.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 18.4 mt -83.39 -37.16 23.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.992 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.46 ' OG1' ' HA ' ' A' ' 136' ' ' LEU . 0.6 OUTLIER -72.3 -20.35 61.52 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.948 179.848 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -68.56 -27.52 66.15 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.549 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 2.0 t -94.13 -29.4 4.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.246 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 146.92 -95.16 0.17 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.552 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 100.33 -66.62 0.55 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.342 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 113.32 163.65 15.51 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.703 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 12.3 p -68.14 -25.59 32.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-O 120.801 0.334 . . . . 0.0 111.227 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -59.9 -34.29 82.33 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 121.161 -0.543 . . . . 0.0 112.708 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.99 -43.2 88.48 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.815 0.341 . . . . 0.0 110.424 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.52 -45.36 91.0 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.504 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.67 -40.36 95.28 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.979 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -61.15 -41.2 96.32 Favored 'General case' 0 C--O 1.226 -0.154 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.778 179.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -63.86 -43.54 95.81 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.985 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 59.4 mt -62.67 -50.84 78.16 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.733 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 71.6 mt -68.24 -32.71 73.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.463 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -60.69 -44.71 97.57 Favored Glycine 0 C--O 1.225 -0.415 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.355 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.69 -21.66 44.38 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.716 0.293 . . . . 0.0 110.954 178.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -65.89 -37.23 85.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.484 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.437 ' HB ' ' CD ' ' A' ' 158' ' ' PRO . 90.8 t -57.73 -59.15 13.95 Favored Pre-proline 0 CA--C 1.541 0.606 0 CA-C-O 119.518 -0.277 . . . . 0.0 111.685 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.437 ' CD ' ' HB ' ' A' ' 157' ' ' VAL . 15.5 Cg_endo -59.26 -36.69 94.41 Favored 'Trans proline' 0 C--N 1.361 1.192 0 C-N-CA 122.142 1.895 . . . . 0.0 112.178 178.466 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -63.95 -38.15 90.02 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 120.548 0.213 . . . . 0.0 110.972 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.59 -49.31 69.29 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.47 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 13.5 m -66.71 -32.67 59.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.06 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 3.9 t -67.73 -43.18 86.67 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 178.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -60.09 -34.02 72.88 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.96 178.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 11.2 tp -75.78 -45.39 36.48 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.827 179.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -69.15 -19.15 64.01 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.083 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.64 -19.07 64.57 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.984 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.49 -40.42 94.49 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.468 179.166 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 2.0 ttt85 -69.12 -36.24 77.29 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.438 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 18.0 mt -70.66 -30.16 41.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.377 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -60.97 -36.91 80.64 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.442 179.053 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -81.5 -34.37 25.72 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.6 -0.809 . . . . 0.0 111.61 178.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 27.8 t-105 -70.09 -25.84 63.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.893 -0.153 . . . . 0.0 111.393 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.38 -37.53 65.11 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.726 0.298 . . . . 0.0 111.522 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 2.6 mpp_? -87.08 -19.86 27.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.368 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 3.8 mtt85 -86.21 -37.03 19.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.547 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.527 ' HB1' ' HB ' ' A' ' 179' ' ' ILE . . . -59.08 -70.1 0.17 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.836 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 69.51 -83.3 0.27 Allowed Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.983 -0.627 . . . . 0.0 113.212 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.13 -40.38 82.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.546 0.212 . . . . 0.0 111.228 -179.283 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.556 ' O ' HG23 ' A' ' 183' ' ' VAL . 22.6 mt -59.44 -46.14 93.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.811 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.06 -41.44 96.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.085 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -66.07 -32.49 73.99 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.259 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -70.27 -42.98 71.41 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.784 0.326 . . . . 0.0 110.834 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 179' ' ' ILE . 15.0 t -70.77 -19.97 21.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.828 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -67.56 -51.78 46.55 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.604 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.481 ' O ' HG23 ' A' ' 189' ' ' VAL . 5.3 t -75.37 -31.83 24.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.061 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.452 ' O ' HG23 ' A' ' 190' ' ' VAL . 0.6 OUTLIER -58.2 -47.91 81.96 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.912 179.78 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -63.08 -33.67 75.95 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.746 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.413 ' O ' HG23 ' A' ' 192' ' ' VAL . . . -66.84 -45.74 80.89 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.41 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 185' ' ' VAL . 46.4 t -61.94 -47.6 92.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 120.736 0.303 . . . . 0.0 110.937 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 186' ' ' LEU . 43.4 t -62.79 -40.98 90.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.774 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 3.7 mt -58.23 -45.96 86.77 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.321 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 188' ' ' GLY . 81.8 t -64.4 -42.38 95.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-O 120.771 0.32 . . . . 0.0 110.537 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.59 -44.07 91.81 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.066 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 190' ' ' VAL . 78.2 t -64.2 -38.84 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.097 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -58.39 -44.04 95.43 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.233 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 61.8 t -73.56 -40.01 54.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-O 120.763 0.316 . . . . 0.0 110.681 179.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.39 -34.91 79.27 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.112 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.51 -41.11 48.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.071 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.7 -41.6 95.89 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.08 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 1.3 m -83.99 -13.76 52.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.982 0.42 . . . . 0.0 110.469 179.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -85.59 -49.32 4.4 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.55 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 4.7 m 70.57 -65.22 0.34 Allowed 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 122.946 0.498 . . . . 0.0 111.511 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -154.19 161.31 41.92 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 5.8 m 73.72 -41.42 0.49 Allowed 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 122.98 0.512 . . . . 0.0 111.663 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -60.98 -36.52 79.65 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.028 0.442 . . . . 0.0 110.862 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.06 -23.39 38.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.901 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -75.21 -50.09 17.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.171 -179.169 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 1.7 m -61.57 -33.71 74.33 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.876 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -74.44 -36.28 63.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.989 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -70.32 -29.59 66.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.876 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 6.1 mt -65.25 -18.03 64.98 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.915 0.388 . . . . 0.0 111.219 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 12.1 mtt180 -92.29 -6.05 51.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.42 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' ILE . . . . . 0.573 HG21 ' HD3' ' A' ' 19' ' ' PRO . 8.1 mm -107.84 -12.47 10.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.69 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.43 128.12 66.98 Favored Pre-proline 0 C--O 1.233 0.192 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.78 179.2 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -56.8 143.45 90.68 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.557 2.171 . . . . 0.0 112.43 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -61.72 -25.7 67.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.846 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' TRP . . . . . 0.446 ' O ' ' HD1' ' A' ' 221' ' ' TYR . 4.5 m-90 -69.94 -22.29 63.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.949 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -81.48 -38.04 26.99 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.04 0.448 . . . . 0.0 109.81 179.185 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -71.47 -30.72 66.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.585 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.46 -1.8 35.44 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.05 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.446 ' HD1' ' O ' ' A' ' 217' ' ' TRP . 0.7 OUTLIER -99.94 10.64 40.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.712 179.609 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.21 129.83 52.21 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.088 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -64.17 -48.95 4.17 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.703 2.269 . . . . 0.0 113.016 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 24.7 m . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.108 -0.948 . . . . 0.0 111.324 -179.839 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 mmt . . . . . 0 N--CA 1.485 1.291 0 CA-C-O 120.75 0.309 . . . . 0.0 110.855 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.36 67.0 6.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.007 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.72 148.32 42.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.869 0.366 . . . . 0.0 111.13 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.57 -26.8 64.65 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.307 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.2 mt -64.73 -47.53 77.94 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.978 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.68 -46.52 90.03 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.685 179.17 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.34 -45.54 93.07 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.023 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.51 -43.3 97.24 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.015 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.413 ' O ' HG23 ' A' ' 13' ' ' VAL . 1.0 OUTLIER -62.62 -51.02 68.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.671 179.566 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.95 -40.21 88.2 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.702 179.127 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.47 -45.95 90.18 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.4 178.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.91 -42.98 99.57 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.018 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 9' ' ' PHE . 93.0 t -64.69 -42.64 95.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-O 120.732 0.301 . . . . 0.0 110.579 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.69 -40.11 95.98 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.564 179.249 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.6 m -69.08 -32.67 72.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.907 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -68.03 -42.69 80.21 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.982 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -85.02 -9.43 58.03 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.534 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -66.04 119.17 59.3 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.771 0.319 . . . . 0.0 110.884 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.31 -8.21 18.41 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.802 2.334 . . . . 0.0 112.489 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 96.6 m -82.43 44.84 0.91 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.034 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -94.78 54.66 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.94 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.549 HD11 HD21 ' A' ' 83' ' ' LEU . 0.3 OUTLIER -62.87 -51.19 73.25 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.464 -179.57 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.615 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 51.2 Cg_exo -57.18 -31.8 91.62 Favored 'Trans proline' 0 C--N 1.361 1.203 0 C-N-CA 122.192 1.928 . . . . 0.0 113.018 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.86 -13.31 60.54 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.492 ' HB ' ' HD3' ' A' ' 26' ' ' PRO . 3.3 t -64.98 -53.9 38.58 Favored Pre-proline 0 CA--C 1.543 0.712 0 CA-C-O 119.613 -0.232 . . . . 0.0 111.314 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.615 ' HD2' ' O ' ' A' ' 23' ' ' PRO . 23.6 Cg_exo -65.77 -21.92 57.57 Favored 'Trans proline' 0 C--N 1.361 1.191 0 C-N-CA 121.919 1.746 . . . . 0.0 112.346 178.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -63.85 -24.67 67.84 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.392 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -66.12 -31.94 73.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.009 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.1 mp -86.6 -22.74 26.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.161 0.505 . . . . 0.0 110.487 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -75.07 -20.05 59.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.339 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -82.18 -20.86 36.99 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.782 0.325 . . . . 0.0 110.779 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.618 ' HG ' HD21 ' A' ' 173' ' ' LEU . 0.4 OUTLIER -87.47 -36.46 17.65 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.011 0.434 . . . . 0.0 110.288 179.442 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -92.32 4.45 77.11 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.054 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -93.45 52.2 2.4 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.647 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.58 126.06 30.32 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.536 -0.172 . . . . 0.0 110.536 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 17.9 mtp180 62.23 32.72 17.09 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.577 0.548 . . . . 0.0 110.933 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -102.36 -168.73 26.8 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.55 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.4 88.45 29.88 Favored Pre-proline 0 C--O 1.234 0.277 0 CA-C-O 120.559 0.218 . . . . 0.0 111.109 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.75 -33.95 96.17 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.684 2.256 . . . . 0.0 112.49 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.2 mt -62.17 -45.34 93.86 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.55 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -73.63 -39.84 64.23 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.026 -179.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.88 -42.67 97.43 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.832 0.349 . . . . 0.0 110.632 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.29 -51.55 59.97 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.835 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.29 -42.3 86.29 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.482 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -63.9 -42.85 97.33 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.49 0.186 . . . . 0.0 110.815 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.98 -42.08 94.86 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.706 179.168 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 91.0 mt -65.43 -42.55 93.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.231 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.44 -50.08 75.02 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.483 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.457 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -59.2 -45.91 94.62 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.749 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -69.17 -37.71 78.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.654 0.264 . . . . 0.0 110.947 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -61.64 -43.61 99.04 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 121.086 -0.578 . . . . 0.0 111.821 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.57 -43.26 99.19 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.698 0.285 . . . . 0.0 110.674 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 49' ' ' GLY . 91.4 t -63.54 -43.94 98.49 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.043 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -65.76 -34.55 78.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.435 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -76.52 -43.33 39.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.703 0.287 . . . . 0.0 110.806 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.15 -28.87 69.12 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.907 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.05 -18.27 27.64 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.897 0.38 . . . . 0.0 109.976 178.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -74.91 -32.02 57.35 Favored Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.998 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.21 -56.25 37.26 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 179.262 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -72.84 -13.71 26.69 Favored 'Trans proline' 0 C--N 1.361 1.189 0 C-N-CA 122.266 1.977 . . . . 0.0 112.735 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.66 -23.59 63.19 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.328 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -65.8 -41.68 91.61 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.957 0.408 . . . . 0.0 110.539 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -88.63 -21.53 23.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.765 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.65 -18.19 45.44 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.427 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.59 -32.29 80.84 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 121.253 -0.499 . . . . 0.0 112.566 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -71.97 -31.6 64.26 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.91 179.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.6 mt -84.69 -23.76 29.26 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.723 0.297 . . . . 0.0 110.226 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.18 -19.4 64.78 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.92 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -58.66 -21.89 55.38 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.266 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -127.84 146.41 50.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.33 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 61.95 57.46 2.11 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 123.375 0.422 . . . . 0.0 111.716 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -89.17 -28.39 20.05 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.79 0.328 . . . . 0.0 111.238 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -69.68 -20.06 63.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.545 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -63.26 -32.58 74.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.51 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.4 mp -81.76 -21.79 37.63 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.674 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.01 -28.47 35.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.555 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.449 ' O ' HG23 ' A' ' 81' ' ' VAL . 26.7 mtp85 -63.5 -39.02 93.33 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.994 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.463 ' O ' HG23 ' A' ' 82' ' ' VAL . 3.8 t -60.69 -37.9 77.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.437 179.355 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -64.55 -39.45 96.82 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.858 -0.687 . . . . 0.0 111.604 179.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.49 ' O ' HG23 ' A' ' 84' ' ' VAL . . . -64.54 -42.94 97.22 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.896 -0.669 . . . . 0.0 111.596 179.11 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 77' ' ' ARG . 57.9 t -59.04 -42.95 87.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-O 120.806 0.336 . . . . 0.0 110.569 178.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.573 HG21 ' HA2' ' A' ' 123' ' ' GLY . 87.8 t -63.36 -38.74 82.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.414 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.549 HD21 HD11 ' A' ' 22' ' ' LEU . 8.3 mt -61.29 -42.3 98.42 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.527 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 80' ' ' GLY . 31.6 t -65.56 -43.53 94.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 120.941 0.4 . . . . 0.0 110.088 178.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.69 -40.38 96.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.604 179.181 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.33 -37.08 85.99 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.64 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -61.08 -42.21 99.71 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.699 178.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.46 -34.54 78.17 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.862 0.363 . . . . 0.0 110.605 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -70.0 -42.6 72.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.703 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.94 -24.22 63.32 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.938 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.71 -11.38 58.21 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.35 178.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.55 10.82 57.67 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.645 -0.788 . . . . 0.0 113.058 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.3 tp -77.92 125.06 28.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 117.04 0.42 . . . . 0.0 110.583 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.528 ' H ' ' HE ' ' A' ' 94' ' ' ARG . 0.3 OUTLIER -72.25 142.32 84.51 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.007 179.657 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -67.51 145.19 69.84 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.255 1.97 . . . . 0.0 112.153 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -85.39 137.34 33.0 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.796 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 4.8 m-90 59.28 41.08 20.54 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.378 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -157.71 73.15 0.23 Allowed Glycine 0 N--CA 1.451 -0.327 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.114 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 9.4 p -100.97 146.44 9.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.874 0.369 . . . . 0.0 110.824 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.63 40.53 0.85 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.119 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.5 mt 59.36 -106.19 0.28 Allowed 'General case' 0 N--CA 1.467 0.392 0 O-C-N 123.56 0.537 . . . . 0.0 111.134 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -130.11 161.16 31.68 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -80.31 95.05 6.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.983 0.42 . . . . 0.0 111.053 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -134.61 173.33 11.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.431 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -80.25 71.39 2.8 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.455 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -117.23 16.1 14.89 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.409 0.151 . . . . 0.0 111.409 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.43 ' O ' ' HD2' ' A' ' 110' ' ' PRO . 0.6 OUTLIER 59.52 70.98 0.6 Allowed 'General case' 0 N--CA 1.466 0.325 0 O-C-N 123.427 0.454 . . . . 0.0 111.385 -179.813 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.51 0.32 50.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.897 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.8 -51.77 73.48 Favored Pre-proline 0 CA--C 1.541 0.607 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.43 ' HD2' ' O ' ' A' ' 107' ' ' THR . 46.3 Cg_exo -58.29 -25.61 73.31 Favored 'Trans proline' 0 C--N 1.363 1.295 0 C-N-CA 122.241 1.96 . . . . 0.0 112.927 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.8 mt -68.46 -34.18 75.5 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.716 0.293 . . . . 0.0 110.588 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -66.85 -36.33 90.95 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.705 -0.76 . . . . 0.0 111.373 179.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -75.2 -35.43 61.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.707 0.289 . . . . 0.0 110.629 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -65.37 -47.04 77.76 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.001 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.8 mp -64.63 -39.08 93.07 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.539 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.427 ' O ' ' HB2' ' A' ' 120' ' ' LEU . 0.6 OUTLIER -69.49 -31.59 69.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.397 179.209 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -74.64 -44.18 26.94 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.909 -0.662 . . . . 0.0 111.487 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.21 -42.94 87.3 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.945 0.402 . . . . 0.0 110.819 178.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 3.0 m -73.2 -27.68 61.76 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.142 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.427 ' HB2' ' O ' ' A' ' 116' ' ' LEU . 0.3 OUTLIER -76.4 -37.09 57.62 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.74 0.305 . . . . 0.0 110.96 179.642 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -73.27 -37.85 66.14 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.843 0.354 . . . . 0.0 111.226 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.95 -19.48 37.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.017 0.436 . . . . 0.0 110.738 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.573 ' HA2' HG21 ' A' ' 82' ' ' VAL . . . -92.04 95.62 2.06 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.701 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 4.8 t-105 -80.34 130.98 35.55 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.026 0.441 . . . . 0.0 111.31 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.2 119.88 78.67 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.083 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.84 -15.98 48.7 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.98 2.454 . . . . 0.0 112.909 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 8.0 m -62.74 -26.79 68.87 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.783 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.422 ' H ' HG13 ' A' ' 128' ' ' ILE . 1.4 mt -86.67 -0.83 7.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.785 0.326 . . . . 0.0 111.004 -179.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -59.65 -65.04 3.69 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 121.174 -0.536 . . . . 0.0 112.738 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.4 -38.56 73.51 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.618 2.212 . . . . 0.0 112.194 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 61.6 mt -60.93 -41.61 89.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.164 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.6 mt -63.18 -33.32 75.23 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-O 120.687 0.279 . . . . 0.0 110.848 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -61.24 -38.07 95.05 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 121.118 -0.563 . . . . 0.0 111.967 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.53 -36.19 73.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.123 0.487 . . . . 0.0 109.967 178.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 45.6 mm -67.17 -42.41 88.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.337 179.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.67 -36.91 82.22 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.32 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 38.4 m -64.5 -38.34 90.68 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.252 178.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 7.8 mt -70.06 -30.83 68.18 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.618 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.1 m -79.99 -22.4 42.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.086 0.469 . . . . 0.0 110.551 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.18 -30.27 64.8 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.914 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 20.5 m -100.25 4.98 10.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.009 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 141.54 -92.6 0.18 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.46 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.98 -123.54 7.02 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.543 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 130.8 159.67 9.7 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.571 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 11.1 p -77.36 -23.41 14.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.684 0.278 . . . . 0.0 111.33 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -58.35 -37.52 87.81 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.745 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -68.62 -41.67 79.18 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.691 0.281 . . . . 0.0 110.423 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.409 ' O ' HG13 ' A' ' 152' ' ' ILE . 0.3 OUTLIER -60.86 -46.28 91.2 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.605 179.233 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.83 -40.63 95.5 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.729 179.297 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.43 -41.18 98.52 Favored 'General case' 0 C--O 1.226 -0.168 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.771 179.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -60.61 -44.91 95.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.091 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 148' ' ' LEU . 23.9 mt -64.5 -44.06 96.91 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 CA-C-O 120.95 0.405 . . . . 0.0 110.341 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.92 -35.89 82.6 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.569 179.438 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.463 ' O ' ' HD2' ' A' ' 158' ' ' PRO . . . -60.56 -46.08 95.08 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.143 179.017 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.38 -29.88 67.75 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.059 0.457 . . . . 0.0 110.754 178.651 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -63.43 -35.21 79.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.589 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.536 ' O ' HG23 ' A' ' 161' ' ' VAL . 95.1 t -55.38 -63.7 2.83 Favored Pre-proline 0 CA--C 1.543 0.685 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.473 ' CD ' ' HB ' ' A' ' 157' ' ' VAL . 19.1 Cg_endo -60.88 -36.38 83.83 Favored 'Trans proline' 0 C--N 1.359 1.109 0 C-N-CA 121.906 1.737 . . . . 0.0 112.384 179.241 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -58.08 -45.28 87.42 Favored 'General case' 0 N--CA 1.462 0.158 0 O-C-N 123.169 0.293 . . . . 0.0 111.19 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -70.47 -36.67 74.02 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.718 -0.219 . . . . 0.0 110.873 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 157' ' ' VAL . 96.5 t -64.91 -45.28 95.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-O 120.731 0.3 . . . . 0.0 110.692 179.096 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 68.9 t -65.8 -39.4 84.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.49 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -61.07 -34.82 75.5 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.28 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.8 -42.79 39.26 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.188 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -71.95 -19.23 61.93 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.374 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.09 -19.16 61.13 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.414 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -64.19 -43.05 96.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.765 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 2.6 mtp180 -73.03 -31.98 64.79 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.992 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 11.8 mt -72.83 -26.32 23.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.787 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.42 -30.92 71.95 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.968 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -70.89 -38.98 65.06 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.813 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -74.22 -24.07 59.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.63 0.252 . . . . 0.0 110.84 179.326 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.618 HD21 ' HG ' ' A' ' 32' ' ' LEU . 3.2 tp -59.71 -37.61 79.35 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.785 178.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 41.8 mtp180 -76.59 -21.86 55.02 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.816 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 -84.87 -32.19 23.34 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.943 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.473 ' HB1' ' HB ' ' A' ' 179' ' ' ILE . . . -65.16 -33.81 76.89 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.642 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 70.76 -98.77 0.71 Allowed Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.8 -0.714 . . . . 0.0 113.029 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -104.74 -6.01 20.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.558 0.218 . . . . 0.0 111.232 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.473 ' HB ' ' HB1' ' A' ' 176' ' ' ALA . 50.2 mm -64.58 -41.54 92.55 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 CA-C-O 120.671 0.272 . . . . 0.0 110.819 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.492 ' O ' ' HG3' ' A' ' 184' ' ' GLU . 0.0 OUTLIER -61.65 -33.77 74.53 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.12 179.831 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 181' ' ' HIS . . . . . 0.465 ' HA ' ' OE2' ' A' ' 184' ' ' GLU . 11.7 m80 -66.64 -32.28 73.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.245 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.454 ' O ' ' HB2' ' A' ' 186' ' ' LEU . 4.9 m-85 -68.7 -41.43 79.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.75 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.434 HG23 ' H ' ' A' ' 183' ' ' VAL . 1.6 t -68.47 -20.09 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 120.927 0.394 . . . . 0.0 111.023 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' GLU . . . . . 0.492 ' HG3' ' O ' ' A' ' 180' ' ' SER . 41.9 mt-10 -76.42 -47.15 24.1 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.502 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.443 ' O ' HG23 ' A' ' 189' ' ' VAL . 6.1 t -77.11 -37.5 26.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.232 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.51 ' O ' HG23 ' A' ' 190' ' ' VAL . 0.6 OUTLIER -58.84 -48.91 79.69 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.616 -0.266 . . . . 0.0 111.431 -179.744 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -63.74 -33.52 75.83 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.873 0.368 . . . . 0.0 110.941 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -65.95 -44.91 90.78 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.797 -0.715 . . . . 0.0 111.849 179.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 185' ' ' VAL . 84.0 t -60.68 -43.98 96.13 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-O 120.484 0.183 . . . . 0.0 110.676 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 186' ' ' LEU . 48.2 t -60.82 -47.7 92.13 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.099 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.027 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 191' ' ' LEU . . . . . 0.479 HD12 ' HG ' ' A' ' 22' ' ' LEU . 0.7 OUTLIER -61.42 -42.62 99.04 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.236 -179.984 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.478 ' O ' HG23 ' A' ' 196' ' ' VAL . 71.9 t -65.59 -44.21 93.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.7 tp -58.54 -45.97 87.78 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.654 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.456 HG11 ' CE1' ' A' ' 209' ' ' PHE . 78.8 t -63.21 -40.04 87.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.502 179.18 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.45 ' HA3' HD22 ' A' ' 83' ' ' LEU . . . -59.44 -45.05 96.15 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.304 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 192' ' ' VAL . 22.4 t -71.57 -38.81 68.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-O 120.755 0.312 . . . . 0.0 110.675 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.99 -23.95 63.24 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.376 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.46 -41.73 16.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.746 -0.206 . . . . 0.0 110.895 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' PHE . . . . . 0.406 ' CE1' ' HA ' ' A' ' 77' ' ' ARG . 22.5 t80 -68.55 -56.28 8.85 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.645 0.259 . . . . 0.0 111.37 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.41 -10.08 59.55 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.895 0.379 . . . . 0.0 111.306 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -91.05 -55.53 1.84 Allowed Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.262 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 18.8 m 68.37 -70.31 0.13 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.049 0.54 . . . . 0.0 111.528 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -97.63 160.86 14.06 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 23.6 m 74.24 -40.33 0.45 Allowed 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 122.781 0.433 . . . . 0.0 111.173 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -75.57 -36.1 60.45 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.145 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.446 ' O ' ' HB2' ' A' ' 210' ' ' PHE . 0.4 OUTLIER -60.46 -44.79 95.51 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.364 179.906 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -71.65 -38.74 70.68 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.755 0.312 . . . . 0.0 111.181 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 62.1 m -64.34 -43.03 95.9 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.946 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' PHE . . . . . 0.456 ' CE1' HG11 ' A' ' 194' ' ' VAL . 2.3 t80 -74.7 -30.91 61.71 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.237 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 210' ' ' PHE . . . . . 0.446 ' HB2' ' O ' ' A' ' 206' ' ' LEU . 0.1 OUTLIER -63.56 -24.53 67.84 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.257 -179.947 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.2 -22.25 65.74 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.884 0.373 . . . . 0.0 110.539 179.134 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.37 -7.05 51.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.917 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 2.5 mt -102.7 3.82 10.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.949 0.404 . . . . 0.0 110.901 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.88 117.84 61.43 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.785 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -72.16 120.83 7.05 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.25 1.967 . . . . 0.0 112.183 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' GLU . . . . . 0.551 ' HA ' ' OE1' ' A' ' 219' ' ' GLN . 1.9 mt-10 -65.01 -26.35 68.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.467 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 1.3 m-90 -72.67 -24.11 60.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.958 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.1 -33.27 24.38 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 219' ' ' GLN . . . . . 0.551 ' OE1' ' HA ' ' A' ' 216' ' ' GLU . 68.4 mt-30 -67.0 -30.3 70.37 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.363 179.075 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -78.77 -11.05 59.97 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.768 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -89.18 -13.02 39.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.58 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 13.3 mt -95.06 116.47 66.39 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.19 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -60.5 -49.83 8.13 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.7 2.267 . . . . 0.0 112.749 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.247 0.922 0 CA-C-O 118.249 -0.881 . . . . 0.0 110.76 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.4 mtt . . . . . 0 N--CA 1.485 1.292 0 CA-C-O 120.759 0.314 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.65 57.5 2.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.502 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.12 -6.78 34.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.203 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.47 -37.54 87.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.475 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.2 -45.19 70.52 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.495 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.64 -47.05 87.14 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.667 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.74 -42.8 99.45 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.635 178.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.445 ' HB1' ' HA ' ' A' ' 151' ' ' TYR . . . -63.17 -48.38 78.62 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.888 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.45 ' O ' HG23 ' A' ' 13' ' ' VAL . 5.5 m-85 -55.95 -46.45 78.55 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.617 178.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.81 -44.4 96.27 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.815 0.341 . . . . 0.0 110.525 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.39 -39.75 94.25 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.677 178.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.09 -41.13 99.36 Favored Glycine 0 C--N 1.334 0.429 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.065 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 9' ' ' PHE . 98.0 t -65.03 -36.43 77.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 178.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.1 tp -63.77 -43.17 97.17 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.791 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -35.05 79.06 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.793 0.33 . . . . 0.0 110.844 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.13 -28.84 63.52 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.889 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.35 -13.21 50.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.046 0.451 . . . . 0.0 110.632 178.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 61.6 m -85.82 135.86 37.33 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.364 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.63 -14.71 36.89 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.474 2.116 . . . . 0.0 113.027 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 6.3 t -90.16 132.9 35.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.352 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.1 t 61.46 65.28 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 O-C-N 123.724 0.64 . . . . 0.0 111.03 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.6 tp -109.78 105.34 57.07 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.896 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.476 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 28.1 Cg_exo -63.05 -15.34 47.29 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.989 2.459 . . . . 0.0 112.81 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.2 tp -77.95 -15.38 59.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.148 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.526 ' HB ' ' HD3' ' A' ' 26' ' ' PRO . 8.6 t -72.12 -52.35 7.43 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 116.684 -0.234 . . . . 0.0 111.327 179.315 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.526 ' HD3' ' HB ' ' A' ' 25' ' ' VAL . 22.9 Cg_exo -65.36 -38.68 25.38 Favored 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 122.029 1.82 . . . . 0.0 112.59 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.1 p -65.85 -33.57 76.16 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.707 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -62.56 -36.05 81.43 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.877 0.37 . . . . 0.0 110.769 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.46 -42.62 18.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.573 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -57.8 -36.36 72.09 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.51 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -71.32 -33.08 69.33 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.804 0.335 . . . . 0.0 110.884 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -79.75 -22.6 43.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.487 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -78.0 -24.87 63.24 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.199 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 110.29 43.46 1.08 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.715 -0.755 . . . . 0.0 113.004 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.42 96.36 9.06 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.702 0.286 . . . . 0.0 111.181 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.14 122.06 40.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.639 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 170.87 -158.21 29.66 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 111.673 -0.571 . . . . 0.0 111.673 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 2.2 mmt180 -103.67 118.78 56.61 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.845 0.322 . . . . 0.0 110.75 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.06 -27.0 42.62 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.65 2.233 . . . . 0.0 112.79 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.07 -34.89 77.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.13 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -71.41 -38.22 71.45 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.795 0.331 . . . . 0.0 110.289 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -64.88 -43.77 91.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.283 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.81 -41.01 88.22 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.658 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.445 HD22 ' HA ' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -58.58 -46.78 86.22 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.109 179.616 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -67.3 -36.28 81.18 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.871 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -65.18 -42.9 93.2 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.732 -0.213 . . . . 0.0 110.573 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 70.6 mt -60.42 -46.11 95.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.332 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.22 -42.44 93.44 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.472 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -60.44 -48.24 87.17 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 121.216 -0.516 . . . . 0.0 112.344 178.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.08 -34.85 75.78 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.734 0.302 . . . . 0.0 110.338 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -61.81 -46.44 94.15 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 178.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.58 -42.12 96.05 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 120.769 0.318 . . . . 0.0 110.463 178.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.6 t -62.69 -45.2 99.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.704 179.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -62.96 -33.41 75.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.466 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.96 -42.29 21.48 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 121.115 -0.234 . . . . 0.0 110.878 179.48 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.36 -37.1 85.97 Favored 'General case' 0 C--O 1.226 -0.168 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.08 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.39 -19.93 24.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.815 0.341 . . . . 0.0 110.86 179.101 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.22 -36.2 70.84 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.953 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.88 -57.63 22.94 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -67.95 -13.68 39.02 Favored 'Trans proline' 0 C--N 1.359 1.108 0 C-N-CA 122.583 2.189 . . . . 0.0 113.063 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -58.29 -20.58 43.95 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.698 0.285 . . . . 0.0 111.536 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 11.6 p -66.63 -47.82 71.39 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.148 0.499 . . . . 0.0 110.27 178.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.5 mt -81.63 -19.22 42.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.621 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.24 -18.21 59.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.524 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -69.94 -36.38 73.3 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.875 -0.679 . . . . 0.0 111.919 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.82 -25.71 64.19 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.806 -0.711 . . . . 0.0 111.711 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 mt -76.23 -20.54 57.34 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.633 0.254 . . . . 0.0 110.703 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 28.9 mt -63.83 -19.66 65.2 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.028 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -70.19 -17.67 63.16 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.775 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -95.52 39.84 1.12 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.558 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 73.4 160.87 0.24 Allowed 'General case' 0 N--CA 1.472 0.644 0 O-C-N 123.953 0.783 . . . . 0.0 111.149 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 72' ' ' ARG . 3.1 ptt180 -139.22 12.05 2.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.38 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -69.4 -35.93 76.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.492 -179.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.19 -24.6 64.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.579 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.41 HD12 ' HA ' ' A' ' 75' ' ' LEU . 4.7 tp -82.56 -28.75 30.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.929 0.395 . . . . 0.0 110.798 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -79.85 -28.53 40.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.994 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -62.72 -34.84 78.01 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.277 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 18.7 t -59.78 -37.87 73.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.568 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -66.44 -33.56 85.15 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.983 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.479 ' O ' HG23 ' A' ' 84' ' ' VAL . . . -66.41 -43.82 91.74 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.851 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.0 t -62.24 -39.9 85.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-O 121.039 0.447 . . . . 0.0 110.373 179.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.5 t -64.64 -41.64 92.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.715 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.0 -40.85 90.62 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.603 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 80' ' ' GLY . 61.5 t -63.82 -43.98 98.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.207 178.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.81 -40.41 95.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.804 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -60.22 -43.66 95.81 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 178.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -65.38 -39.25 95.72 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.733 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LEU . . . . . 0.804 ' HA ' HD12 ' A' ' 91' ' ' LEU . 1.0 OUTLIER -62.68 -40.63 97.73 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.711 0.291 . . . . 0.0 111.024 179.368 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -72.3 -32.69 66.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.878 0.371 . . . . 0.0 110.665 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -73.45 -17.46 61.24 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.706 179.028 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.804 HD12 ' HA ' ' A' ' 88' ' ' LEU . 5.5 mt -67.08 -10.05 45.87 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.478 178.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.6 13.91 64.36 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.675 -0.774 . . . . 0.0 113.209 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 24.5 mt -88.22 122.89 32.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.837 0.351 . . . . 0.0 110.578 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.09 112.56 63.05 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.912 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -62.34 -55.27 1.01 Allowed 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.634 2.223 . . . . 0.0 112.446 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.92 118.31 14.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.067 0.46 . . . . 0.0 110.708 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 4.8 p90 -95.86 -4.78 43.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.713 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -89.21 45.9 3.19 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.805 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 9.7 p -108.86 -22.59 4.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.031 0.443 . . . . 0.0 110.792 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.4 -76.22 0.59 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.03 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.2 mt 58.5 -108.53 0.41 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.862 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 2.8 ttp85 58.07 -146.44 0.54 Allowed 'General case' 0 CA--C 1.532 0.283 0 O-C-N 123.386 0.429 . . . . 0.0 110.959 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -121.91 -59.64 1.65 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.826 0.346 . . . . 0.0 110.44 179.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -136.14 122.07 20.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.568 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -163.56 -70.63 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.894 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 58.97 29.48 19.01 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.079 0.466 . . . . 0.0 111.486 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.34 54.98 3.1 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.246 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.54 -11.99 50.03 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.333 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.425 ' N ' ' HD2' ' A' ' 110' ' ' PRO . 10.6 ttp180 -62.81 -54.73 44.65 Favored Pre-proline 0 CA--C 1.539 0.527 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 109' ' ' ARG . 28.0 Cg_endo -63.0 -38.21 48.11 Favored 'Trans proline' 0 C--N 1.361 1.195 0 C-N-CA 121.93 1.754 . . . . 0.0 112.489 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.72 -42.46 70.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.865 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -63.66 -41.83 98.92 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.927 -0.654 . . . . 0.0 111.961 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.02 -36.86 80.64 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.906 0.384 . . . . 0.0 110.607 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -67.06 -44.59 79.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.992 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.04 -38.9 86.68 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.978 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.9 -37.33 85.82 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.97 0.414 . . . . 0.0 110.399 179.151 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -74.11 -36.49 51.2 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 121.002 -0.618 . . . . 0.0 111.75 179.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -55.25 -41.89 72.74 Favored 'General case' 0 N--CA 1.461 0.106 0 C-N-CA 122.362 0.265 . . . . 0.0 111.153 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.38 -46.41 86.6 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.828 179.192 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.07 -35.24 80.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.259 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -72.96 -29.74 63.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.994 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.2 mt -81.91 -27.4 33.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.667 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -78.1 138.38 21.23 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.05 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -82.86 -7.18 59.68 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 121.041 -0.264 . . . . 0.0 111.707 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.5 m 58.5 85.66 0.18 Allowed Pre-proline 0 C--O 1.233 0.187 0 O-C-N 123.508 0.505 . . . . 0.0 111.128 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -59.13 -17.77 40.42 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 123.063 2.509 . . . . 0.0 113.156 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 83.9 m -65.26 -43.21 92.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.071 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 11.6 pt -104.29 5.47 10.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.358 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -55.92 -67.35 2.26 Favored Glycine 0 CA--C 1.52 0.362 0 CA-C-N 116.122 -0.49 . . . . 0.0 113.112 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -62.5 -33.71 77.9 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.502 2.135 . . . . 0.0 112.101 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 26.9 mt -61.94 -40.09 85.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.031 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 6.3 mt -64.05 -29.32 70.47 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.682 0.277 . . . . 0.0 110.95 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -67.13 -30.16 75.39 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.902 -0.666 . . . . 0.0 111.778 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -79.74 -36.19 37.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.942 0.401 . . . . 0.0 110.355 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 45.3 mm -67.26 -30.93 50.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.711 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.61 -43.86 89.72 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.804 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.13 -24.77 62.34 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.077 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -76.21 -38.06 56.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.217 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.5 m -68.54 -18.03 64.28 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.942 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.27 -38.54 88.05 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.828 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 4.1 m -102.24 -22.59 4.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.017 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -129.37 78.79 0.38 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 121.018 -0.61 . . . . 0.0 112.063 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -111.18 121.36 5.77 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.533 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -156.16 141.6 8.12 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.178 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 6.3 t -66.84 -27.8 40.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-O 120.882 0.372 . . . . 0.0 110.875 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -62.38 -28.56 71.26 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.584 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -68.33 -52.82 29.11 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.706 0.289 . . . . 0.0 110.599 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 20.1 mt -62.53 -37.25 85.37 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.757 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.01 -44.38 89.4 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.479 179.184 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.88 -39.27 93.81 Favored 'General case' 0 C--O 1.225 -0.23 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.787 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.445 ' HA ' ' HB1' ' A' ' 8' ' ' ALA . 2.8 m-85 -60.43 -47.54 85.65 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.069 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 48.5 mm -64.16 -44.86 97.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.455 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.27 -34.83 79.29 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.89 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -61.0 -41.22 99.36 Favored Glycine 0 C--O 1.225 -0.415 0 CA-C-N 115.976 -0.557 . . . . 0.0 112.386 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.424 ' O ' ' HD2' ' A' ' 158' ' ' PRO . 0.0 OUTLIER -82.69 -27.69 31.08 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.831 0.348 . . . . 0.0 110.915 178.77 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -62.57 -38.9 91.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.855 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.556 ' HB ' ' HD3' ' A' ' 158' ' ' PRO . 6.9 t -57.44 -57.63 23.83 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-O 119.322 -0.37 . . . . 0.0 111.791 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.556 ' HD3' ' HB ' ' A' ' 157' ' ' VAL . 38.0 Cg_exo -58.44 -40.67 72.74 Favored 'Trans proline' 0 C--N 1.361 1.229 0 C-N-CA 122.024 1.816 . . . . 0.0 112.244 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.65 -45.29 92.45 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.151 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -66.34 -41.07 90.11 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.684 -0.234 . . . . 0.0 110.73 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 157' ' ' VAL . 98.0 t -63.51 -46.57 94.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.716 179.315 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 158' ' ' PRO . 78.9 t -64.73 -43.69 96.52 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.718 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -60.88 -33.56 73.29 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.649 0.261 . . . . 0.0 111.658 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.2 tp -79.51 -45.89 18.45 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.096 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -68.3 -19.39 64.68 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.125 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -65.51 -18.92 65.68 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.029 179.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -59.99 -40.56 89.6 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.005 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 1.2 mmt85 -87.6 -32.97 19.04 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.89 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 46.9 mm -67.1 -31.64 54.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.004 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.93 -28.49 67.66 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.579 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -70.69 -37.23 67.28 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.296 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -86.84 -34.07 19.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.555 0.217 . . . . 0.0 110.816 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.566 ' HA ' ' HB3' ' A' ' 176' ' ' ALA . 0.2 OUTLIER -59.87 -22.98 63.04 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.375 179.301 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -53.15 61.18 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-O 121.009 0.433 . . . . 0.0 110.167 178.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 7.3 mtm180 -78.57 -31.25 47.24 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.66 178.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.566 ' HB3' ' HA ' ' A' ' 173' ' ' LEU . . . -62.41 -41.07 98.4 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.494 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -42.52 -31.58 1.07 Allowed Glycine 0 C--N 1.34 0.765 0 O-C-N 123.91 0.756 . . . . 0.0 114.081 178.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 4.5 ttp180 -61.36 -56.46 20.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.105 0.479 . . . . 0.0 110.331 179.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -75.07 -27.75 20.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.011 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 19.5 m -71.27 -16.55 62.48 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.764 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -56.13 -37.35 69.33 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.764 0.316 . . . . 0.0 111.498 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -73.26 -24.56 60.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.118 0.485 . . . . 0.0 110.82 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 4.9 t -82.22 -21.7 9.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.249 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -70.06 -43.47 71.11 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.389 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 2.9 t -69.68 -41.92 80.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.81 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.416 ' O ' HG23 ' A' ' 190' ' ' VAL . 4.6 mt -58.98 -48.67 80.74 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.084 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -63.48 -39.67 95.07 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.644 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.509 ' O ' HG23 ' A' ' 192' ' ' VAL . . . -62.91 -45.12 96.33 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.064 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 54.2 t -60.51 -47.54 92.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-O 120.645 0.259 . . . . 0.0 110.629 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.419 ' O ' HG23 ' A' ' 194' ' ' VAL . 84.7 t -61.42 -44.06 97.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.95 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -57.0 -46.78 82.04 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.005 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.533 ' O ' HG23 ' A' ' 196' ' ' VAL . 45.0 t -67.05 -42.37 88.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.403 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.78 -42.64 89.46 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.037 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 194' ' ' VAL . . . . . 0.616 HG13 HD11 ' A' ' 206' ' ' LEU . 58.6 t -61.8 -43.85 97.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 178.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -61.86 -41.27 99.62 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.107 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 192' ' ' VAL . 61.2 t -68.63 -42.64 83.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.481 0.182 . . . . 0.0 110.814 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.27 -25.96 68.28 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.795 0.331 . . . . 0.0 111.403 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.68 -43.61 18.28 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.774 0.321 . . . . 0.0 110.385 178.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -71.2 -48.41 51.71 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.099 -0.501 . . . . 0.0 112.089 -179.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 69.3 p -84.2 -9.14 58.79 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.908 0.385 . . . . 0.0 111.314 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -87.09 -53.87 2.73 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.907 -0.664 . . . . 0.0 112.094 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 52.74 45.96 27.67 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.94 0.4 . . . . 0.0 111.634 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -151.05 -174.05 4.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.934 0.397 . . . . 0.0 110.911 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.26 10.46 10.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.67 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -58.63 -33.15 69.72 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.156 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.616 HD11 HG13 ' A' ' 194' ' ' VAL . 0.4 OUTLIER -78.13 -37.63 45.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.816 179.656 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.1 -35.78 74.4 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.609 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 5.9 m -69.09 -35.12 76.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.269 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -71.74 -29.35 64.43 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.955 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -69.43 -21.83 63.71 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.198 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.95 -11.2 51.28 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.9 0.381 . . . . 0.0 110.625 179.035 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 17.4 mtt180 -91.23 -14.11 31.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.127 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 6.8 pt -102.35 -6.72 9.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.371 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 1.3 p -87.36 118.21 69.6 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.606 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.43 ' HG2' HD23 ' A' ' 218' ' ' LEU . 47.2 Cg_endo -70.54 149.08 61.33 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.379 2.053 . . . . 0.0 112.491 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -63.34 -22.13 66.69 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.977 0.418 . . . . 0.0 111.335 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -66.51 -18.7 65.51 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.407 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.43 HD23 ' HG2' ' A' ' 215' ' ' PRO . 0.5 OUTLIER -76.2 -22.61 55.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.973 0.416 . . . . 0.0 110.249 179.539 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -84.31 -30.25 25.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.163 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 220' ' ' ARG . 0.0 OUTLIER -87.55 -2.19 58.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.856 179.519 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -94.18 2.53 55.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.071 0.462 . . . . 0.0 110.648 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.61 129.54 38.07 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.188 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.17 -46.49 32.55 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.804 2.336 . . . . 0.0 112.524 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.202 -0.904 . . . . 0.0 111.003 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.9 mtm . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.828 0.347 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.64 72.76 3.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.264 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 15.0 mt -90.45 48.28 1.53 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.032 0.444 . . . . 0.0 111.115 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.3 -22.01 58.03 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.137 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.84 -38.84 89.94 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.645 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.27 -34.65 78.13 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.873 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.72 -49.27 66.59 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.697 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.7 -25.07 64.59 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.196 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.45 ' O ' HG23 ' A' ' 13' ' ' VAL . 0.3 OUTLIER -74.39 -50.83 17.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.068 179.823 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.42 HD21 ' HB3' ' A' ' 217' ' ' TRP . 7.9 mt -64.64 -34.65 78.79 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.424 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.81 -43.44 96.27 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.518 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.49 -42.85 98.83 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.744 178.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 9' ' ' PHE . 59.1 t -64.87 -41.91 93.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.932 0.396 . . . . 0.0 110.078 179.103 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.1 mt -63.12 -39.57 95.06 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.844 179.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 28.7 m -65.97 -36.35 83.1 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.991 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -73.47 -31.28 63.69 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.75 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.2 mt -83.88 -14.66 50.56 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.06 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 38.4 m -61.43 146.68 89.06 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.776 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.48 -20.23 48.12 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.788 2.326 . . . . 0.0 113.081 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.459 ' O ' ' HZ2' ' A' ' 124' ' ' TRP . 39.6 m -75.69 -38.81 58.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.427 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.612 HG12 ' H ' ' A' ' 22' ' ' LEU . 1.2 t 55.6 -155.71 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 O-C-N 123.294 0.371 . . . . 0.0 110.025 -178.357 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.612 ' H ' HG12 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -173.62 -56.79 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.309 0 CA-C-O 119.328 -0.368 . . . . 0.0 111.326 179.606 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 22' ' ' LEU . 21.5 Cg_endo -61.19 -15.19 38.27 Favored 'Trans proline' 0 C--N 1.364 1.388 0 C-N-CA 122.647 2.231 . . . . 0.0 113.787 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.3 tp -55.44 -46.75 76.71 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 123.207 0.317 . . . . 0.0 111.838 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -67.51 -55.44 14.76 Favored Pre-proline 0 CA--C 1.542 0.663 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -51.23 -44.19 44.42 Favored 'Trans proline' 0 C--N 1.362 1.282 0 C-N-CA 122.418 2.079 . . . . 0.0 113.469 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.1 p -64.15 -37.66 88.25 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.69 0.281 . . . . 0.0 111.566 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 12.2 m-30 -73.19 -35.96 66.47 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.741 0.305 . . . . 0.0 110.686 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.628 HD21 HD22 ' A' ' 116' ' ' LEU . 1.8 mm? -70.34 -32.12 69.7 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.895 0.379 . . . . 0.0 110.137 179.107 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -61.04 -46.62 89.98 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.047 178.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -64.77 -34.89 79.41 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.723 178.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.21 -38.15 81.63 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.647 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.85 -33.25 55.75 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.104 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.01 31.49 64.28 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.656 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -133.9 131.58 39.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.698 0.285 . . . . 0.0 111.062 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 4.1 mtp180 -88.4 67.87 8.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.839 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -74.94 150.82 41.62 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.812 -0.708 . . . . 0.0 111.844 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -69.95 115.27 32.07 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.715 0.258 . . . . 0.0 111.062 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -60.83 -20.46 66.47 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 123.042 2.495 . . . . 0.0 112.889 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.84 -34.9 76.8 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.225 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -68.9 -42.06 77.39 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.013 0.435 . . . . 0.0 110.406 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.92 -42.04 86.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.301 179.053 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.85 -44.69 92.39 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.041 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.04 -46.7 88.66 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.91 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -62.52 -39.45 93.59 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.861 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -67.08 -40.9 87.06 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.949 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 71.8 mt -60.84 -45.99 97.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-O 120.778 0.323 . . . . 0.0 110.317 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.91 -46.95 73.27 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.529 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.455 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -58.54 -49.78 73.54 Favored Glycine 0 C--N 1.334 0.439 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.913 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.52 -35.35 77.36 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.703 0.252 . . . . 0.0 110.844 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -60.28 -48.41 86.26 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.509 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.79 -46.0 92.2 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.523 0.201 . . . . 0.0 110.922 178.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 49' ' ' GLY . 85.6 t -61.76 -44.06 98.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.186 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -62.72 -38.64 91.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.355 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -74.63 -40.36 61.55 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 120.634 0.254 . . . . 0.0 110.727 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.4 mt -64.41 -28.16 69.49 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.527 179.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.6 -19.91 24.36 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.469 178.395 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.59 -34.86 62.92 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 121.147 -0.549 . . . . 0.0 112.095 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.56 -56.16 37.94 Favored Pre-proline 0 CA--C 1.542 0.667 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 179.188 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.98 -13.81 29.06 Favored 'Trans proline' 0 C--N 1.36 1.154 0 C-N-CA 122.229 1.953 . . . . 0.0 112.961 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.59 -32.28 62.92 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 123.052 0.22 . . . . 0.0 111.379 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.28 -40.04 92.63 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.912 0.387 . . . . 0.0 110.73 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.2 mt -88.75 -19.4 26.11 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.705 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.9 tp -68.31 -17.36 64.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.779 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.27 -30.31 70.71 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.6 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.63 -22.11 73.24 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.588 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 tp -73.74 -19.86 60.67 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.689 0.281 . . . . 0.0 110.401 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.9 -22.85 60.29 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.158 179.43 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -76.01 -36.3 59.21 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.98 0.419 . . . . 0.0 110.416 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -122.3 70.64 0.98 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.915 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -61.4 125.96 25.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.374 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 18.3 mtm180 -78.88 100.64 7.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.435 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -69.56 -18.0 63.61 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.075 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.485 ' O ' HG23 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -61.45 -28.38 69.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.989 179.485 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 20.5 mt -67.68 -29.6 68.92 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.73 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -74.29 -32.22 62.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.45 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ARG . . . . . 0.405 ' O ' HG23 ' A' ' 81' ' ' VAL . 9.6 ttt-85 -67.38 -39.65 85.65 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.487 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 74' ' ' THR . 18.1 t -59.98 -39.74 81.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.483 179.236 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.43 -39.9 98.25 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.862 -0.685 . . . . 0.0 111.672 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -64.43 -42.71 97.49 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.726 179.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 77' ' ' ARG . 99.1 t -58.89 -44.41 90.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-O 120.825 0.345 . . . . 0.0 110.649 178.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 79.1 t -65.51 -40.66 88.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.488 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.55 -42.37 96.41 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.919 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 72.8 t -62.55 -46.22 96.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-O 120.774 0.321 . . . . 0.0 110.233 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.87 -40.77 94.19 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.675 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -65.32 -45.56 83.8 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.329 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -61.53 -39.38 97.26 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.202 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.8 mp -62.16 -42.51 99.33 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.693 0.282 . . . . 0.0 110.802 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -72.92 -31.99 65.02 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.979 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.31 -28.42 67.15 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.817 0.341 . . . . 0.0 110.881 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.67 -21.67 66.1 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.259 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.02 1.93 90.19 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.422 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.0 mt -97.21 160.1 14.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.999 0.399 . . . . 0.0 111.088 -179.011 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 3.1 mtp180 -98.58 119.04 62.31 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.303 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -69.77 -72.92 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.408 2.072 . . . . 0.0 112.921 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 71.7 mmt-85 -134.64 -178.67 5.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.91 0.386 . . . . 0.0 110.657 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -85.05 76.23 10.28 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.566 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -98.17 57.55 1.04 Allowed Glycine 0 N--CA 1.453 -0.195 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.446 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.1 m -93.92 41.19 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.984 0.421 . . . . 0.0 111.646 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.86 3.12 41.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.146 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.2 mp -107.46 135.75 48.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.622 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.41 123.26 32.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.898 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -115.07 132.68 56.52 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.712 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.75 155.02 46.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.5 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 113.95 154.72 11.26 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.528 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -110.92 -13.36 14.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.826 0.346 . . . . 0.0 111.148 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -92.28 52.38 1.93 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.271 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.62 -20.88 56.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.649 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.48 -56.94 7.51 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -64.15 -33.34 61.33 Favored 'Trans proline' 0 C--N 1.36 1.171 0 C-N-CA 121.99 1.793 . . . . 0.0 112.411 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 17.3 mt -75.23 -22.31 58.0 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.939 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -64.91 -35.77 92.3 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.955 -0.641 . . . . 0.0 111.899 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.56 -32.91 71.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.982 0.42 . . . . 0.0 110.712 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -80.83 -39.8 25.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.739 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.94 -47.47 71.58 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.636 -0.257 . . . . 0.0 110.464 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.628 HD22 HD21 ' A' ' 29' ' ' LEU . 1.2 mp -65.75 -31.68 72.79 Favored 'General case' 0 CA--C 1.523 -0.076 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.107 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -70.63 -43.63 59.73 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.609 178.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.42 -45.49 87.33 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.638 0.256 . . . . 0.0 110.871 179.187 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 3.2 m -64.18 -41.12 97.23 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.621 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.05 -35.43 80.52 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.604 179.17 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.77 -39.69 94.04 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.75 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.24 -10.14 59.23 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.881 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -108.31 -0.49 33.18 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.851 179.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' TRP . . . . . 0.459 ' HZ2' ' O ' ' A' ' 20' ' ' CYS . 0.2 OUTLIER -94.17 -5.76 46.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.758 0.313 . . . . 0.0 110.8 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.13 -50.03 89.93 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.628 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.5 -25.1 79.86 Favored 'Trans proline' 0 C--N 1.361 1.232 0 C-N-CA 121.999 1.8 . . . . 0.0 112.176 178.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -70.15 -40.83 74.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.279 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.5 pt -96.09 4.82 8.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.832 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -57.14 -58.92 12.07 Favored Glycine 0 CA--C 1.52 0.363 0 CA-C-N 115.845 -0.616 . . . . 0.0 113.152 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.2 -25.59 78.69 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 122.635 2.223 . . . . 0.0 112.283 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 37.9 mm -80.21 -35.54 15.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.011 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 5.1 tp -61.64 -24.99 67.08 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.154 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -63.14 -34.6 90.4 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.119 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -81.77 -22.37 37.24 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.005 0.431 . . . . 0.0 110.721 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 52.3 mt -80.28 -33.16 13.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.193 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.56 -28.35 67.72 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.236 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -70.78 -20.19 62.63 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-O 120.828 0.347 . . . . 0.0 110.681 179.119 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 89.6 mt -80.22 -18.24 50.06 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.952 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -82.79 -17.34 44.49 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.946 0.403 . . . . 0.0 110.696 179.209 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -82.28 -22.62 35.63 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.191 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 2.4 m -99.48 4.07 10.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.261 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 148.33 98.03 0.19 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.682 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -82.25 80.31 1.79 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.608 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -100.59 142.45 15.84 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.745 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 6.6 m -74.67 -18.7 16.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-O 120.774 0.321 . . . . 0.0 111.448 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -65.0 -30.38 77.86 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 121.026 -0.606 . . . . 0.0 112.531 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.47 -44.11 83.63 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-O 120.779 0.323 . . . . 0.0 110.392 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' LEU . . . . . 0.446 ' O ' HG13 ' A' ' 152' ' ' ILE . 0.8 OUTLIER -62.09 -43.36 99.0 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.549 179.247 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.07 -42.21 89.71 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.927 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.28 -37.81 88.71 Favored 'General case' 0 CA--C 1.524 -0.05 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.532 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -61.09 -48.28 82.43 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.886 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 148' ' ' LEU . 42.0 mt -63.73 -45.01 98.49 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.566 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 4.7 tp -64.82 -38.59 91.5 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.621 0.248 . . . . 0.0 110.915 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -59.52 -42.38 97.63 Favored Glycine 0 C--N 1.334 0.428 0 CA-C-N 116.031 -0.532 . . . . 0.0 112.424 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.467 ' O ' ' HD2' ' A' ' 158' ' ' PRO . 0.4 OUTLIER -80.95 -25.05 37.68 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.836 0.318 . . . . 0.0 111.179 178.963 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -62.93 -38.82 92.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.652 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.549 ' HB ' ' HD3' ' A' ' 158' ' ' PRO . 4.8 t -57.58 -56.72 31.31 Favored Pre-proline 0 CA--C 1.545 0.771 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.549 ' HD3' ' HB ' ' A' ' 157' ' ' VAL . 33.4 Cg_exo -61.04 -35.43 87.21 Favored 'Trans proline' 0 C--N 1.36 1.141 0 C-N-CA 122.131 1.887 . . . . 0.0 112.236 178.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -61.73 -42.93 99.61 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.846 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -65.67 -38.15 88.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.627 0.251 . . . . 0.0 110.491 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 157' ' ' VAL . 91.7 t -60.82 -49.86 82.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.047 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.466 HG22 ' O ' ' A' ' 158' ' ' PRO . 11.8 m -72.64 -36.31 53.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 120.931 -0.308 . . . . 0.0 111.539 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.565 ' O ' ' HB2' ' A' ' 167' ' ' ASP . . . -57.79 -35.87 71.39 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 5.8 tp -80.05 -45.65 17.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.7 0.286 . . . . 0.0 111.048 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -65.36 -44.11 88.7 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.897 -179.213 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 170' ' ' LYS . . . -71.83 -19.15 62.02 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.388 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ASP . . . . . 0.565 ' HB2' ' O ' ' A' ' 163' ' ' ALA . 14.1 t70 -76.63 -40.85 48.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.145 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 10.9 mmt-85 -69.55 -43.32 73.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.254 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 4.6 pt -76.32 -18.91 15.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 166' ' ' ALA . 0.0 OUTLIER -60.1 -33.42 72.08 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.697 -0.229 . . . . 0.0 111.56 -179.676 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -63.79 -38.53 96.3 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.586 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -86.66 -38.77 16.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.625 0.25 . . . . 0.0 111.26 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -65.16 -16.81 63.91 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.663 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.43 -52.56 65.1 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 120.806 0.336 . . . . 0.0 110.632 178.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.92 -30.52 14.72 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.619 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -84.79 4.97 30.45 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -81.15 33.58 2.44 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 121.146 -0.55 . . . . 0.0 113.348 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ARG . . . . . 0.408 ' O ' ' HB2' ' A' ' 181' ' ' HIS . 0.4 OUTLIER -80.29 -38.79 30.08 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.916 0.389 . . . . 0.0 110.718 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 19.5 mm -73.27 -30.27 30.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.847 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.08 -16.95 64.65 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.375 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' HIS . . . . . 0.408 ' HB2' ' O ' ' A' ' 178' ' ' ARG . 3.3 m80 -61.89 -38.38 88.1 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.086 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -75.66 -27.6 58.41 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 121.031 0.443 . . . . 0.0 110.477 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 3.2 t -75.88 -18.54 15.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.47 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -83.4 -27.72 29.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.601 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.506 ' O ' HG23 ' A' ' 189' ' ' VAL . 51.2 t -63.13 -47.79 90.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.547 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.468 ' O ' HG23 ' A' ' 190' ' ' VAL . 1.0 OUTLIER -62.04 -40.66 96.48 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.796 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -62.49 -38.2 88.95 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.506 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.52 ' O ' HG23 ' A' ' 192' ' ' VAL . . . -68.67 -42.88 78.51 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.035 179.202 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 185' ' ' VAL . 88.7 t -61.84 -49.66 83.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-O 120.763 0.316 . . . . 0.0 110.671 179.369 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 186' ' ' LEU . 50.4 t -63.35 -35.77 73.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.706 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.56 -46.83 83.46 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.804 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 188' ' ' GLY . 22.5 t -62.53 -42.29 95.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.345 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 23.5 mt -64.2 -44.57 91.56 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.788 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 69.0 t -63.77 -40.37 88.82 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.366 179.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -57.82 -45.52 93.43 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.159 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 192' ' ' VAL . 32.4 t -70.72 -40.09 76.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.682 0.277 . . . . 0.0 110.606 179.293 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.16 -39.04 93.52 Favored 'General case' 0 C--O 1.225 -0.205 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.044 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.455 HD11 HD21 ' A' ' 206' ' ' LEU . 1.4 mp -72.83 -30.74 64.27 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.497 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -59.12 -54.56 45.57 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.99 0.424 . . . . 0.0 111.055 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -89.19 -7.16 56.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.967 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -83.15 -4.56 89.71 Favored Glycine 0 N--CA 1.452 -0.256 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.712 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.64 68.64 0.1 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.674 0.39 . . . . 0.0 111.59 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -165.23 -73.05 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.398 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 6.8 t -158.22 12.19 0.18 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.104 0.478 . . . . 0.0 111.302 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -84.16 -16.01 45.06 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.191 -179.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.477 ' O ' ' HB2' ' A' ' 210' ' ' PHE . 3.6 mt -74.89 -30.09 61.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.203 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.72 -34.87 76.35 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.169 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.19 -40.24 93.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.312 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -87.13 -26.6 23.54 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.25 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' PHE . . . . . 0.477 ' HB2' ' O ' ' A' ' 206' ' ' LEU . 0.2 OUTLIER -66.62 -21.16 66.12 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.142 179.764 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.43 -27.54 69.18 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.981 0.42 . . . . 0.0 110.782 179.163 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 5.4 mmm180 -92.3 -4.47 53.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.666 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 10.4 mm -103.55 -11.07 9.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.014 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' THR . . . . . 0.407 ' HA ' ' HD3' ' A' ' 215' ' ' PRO . 0.2 OUTLIER -60.75 118.09 31.51 Favored Pre-proline 0 C--O 1.233 0.218 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.155 179.774 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 214' ' ' THR . 33.9 Cg_exo -61.67 155.74 51.93 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.815 2.343 . . . . 0.0 112.476 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.94 -27.55 68.31 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.447 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 217' ' ' TRP . . . . . 0.454 ' O ' ' HB2' ' A' ' 221' ' ' TYR . 0.2 OUTLIER -68.73 -28.28 66.69 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.765 179.546 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.22 -29.24 26.71 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -67.71 -38.02 83.06 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.163 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 42.4 mtp180 -84.3 -3.59 58.33 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.058 179.375 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' TYR . . . . . 0.454 ' HB2' ' O ' ' A' ' 217' ' ' TRP . 0.3 OUTLIER -109.24 7.31 25.27 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.831 0.348 . . . . 0.0 110.757 179.759 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -87.09 118.41 69.98 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.394 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -70.13 143.47 49.14 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.415 2.076 . . . . 0.0 112.659 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.318 -0.849 . . . . 0.0 111.201 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 ttt . . . . . 0 N--CA 1.485 1.288 0 CA-C-O 120.83 0.348 . . . . 0.0 110.739 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.449 ' HB2' ' OG ' ' A' ' 4' ' ' SER . 0.0 OUTLIER -87.57 -31.95 19.6 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.812 179.786 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 62.61 24.99 14.88 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 123.838 0.711 . . . . 0.0 111.771 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . 0.449 ' OG ' ' HB2' ' A' ' 2' ' ' SER . 0.0 OUTLIER -75.45 -24.35 57.0 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.965 0.412 . . . . 0.0 111.028 179.702 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.6 mp -81.36 -42.87 19.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.383 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.39 -29.83 69.44 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.936 0.398 . . . . 0.0 110.532 179.165 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.65 -52.19 28.01 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.312 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.69 -27.85 69.53 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.995 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -69.66 -49.23 55.57 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.526 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.658 ' HG ' HD21 ' A' ' 218' ' ' LEU . 0.2 OUTLIER -65.26 -37.32 86.84 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.482 179.404 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.67 -46.1 80.38 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.764 0.316 . . . . 0.0 110.992 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -65.41 -43.32 95.1 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.323 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -66.92 -31.79 55.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 120.77 0.319 . . . . 0.0 111.005 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.409 ' HB2' ' O ' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -67.43 -50.51 59.06 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.154 179.703 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.804 ' HB2' HD13 ' A' ' 155' ' ' LEU . 3.7 m -67.87 -24.83 65.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.76 0.314 . . . . 0.0 110.776 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -72.66 -41.12 65.77 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.215 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 11.7 mt -86.8 -7.86 57.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.107 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.64 130.02 91.82 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.404 178.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -71.15 -8.03 22.64 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.497 2.131 . . . . 0.0 112.829 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.8 m -66.85 150.46 49.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.06 0.457 . . . . 0.0 111.054 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.425 HG23 ' H ' ' A' ' 21' ' ' VAL . 0.2 OUTLIER -71.51 94.98 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.418 -179.578 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.44 ' H ' ' CD ' ' A' ' 23' ' ' PRO . 0.1 OUTLIER -143.63 -54.37 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.376 179.586 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PRO . . . . . 0.44 ' CD ' ' H ' ' A' ' 22' ' ' LEU . 23.2 Cg_exo -66.25 -18.47 55.78 Favored 'Trans proline' 0 C--N 1.361 1.192 0 C-N-CA 122.256 1.971 . . . . 0.0 112.42 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.3 mt -88.02 -13.15 42.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.303 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.472 ' HB ' ' HD3' ' A' ' 26' ' ' PRO . 20.8 t -57.34 -50.1 90.09 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.627 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.472 ' HD3' ' HB ' ' A' ' 25' ' ' VAL . 52.0 Cg_exo -55.97 -40.63 83.85 Favored 'Trans proline' 0 C--N 1.363 1.318 0 C-N-CA 122.237 1.958 . . . . 0.0 112.907 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.75 -36.84 78.87 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.795 0.331 . . . . 0.0 111.406 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -77.46 -41.01 41.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.265 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.54 -22.75 66.16 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.012 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -64.94 -59.24 4.4 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 178.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -60.79 -33.22 72.65 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.099 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.2 mt -71.91 -16.38 62.11 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.879 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -93.7 -0.72 66.44 Favored Glycine 0 N--CA 1.452 -0.287 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 178.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 66.67 -109.31 2.84 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 121.403 -0.427 . . . . 0.0 112.704 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -119.13 10.58 12.13 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.011 0.434 . . . . 0.0 110.659 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -131.21 40.91 3.4 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.887 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -100.15 99.77 2.09 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.214 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.81 129.47 29.81 Favored Pre-proline 0 C--N 1.326 -0.414 0 O-C-N 122.804 -0.233 . . . . 0.0 110.85 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -65.18 -23.43 60.05 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.817 2.344 . . . . 0.0 112.84 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -66.02 -44.48 84.6 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.081 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -72.17 -33.36 67.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.226 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.43 ' O ' ' HB2' ' A' ' 46' ' ' PHE . 16.0 t30 -65.23 -50.25 66.57 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.319 178.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.81 -39.7 94.86 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.879 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.38 -50.48 71.39 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.974 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -66.19 -36.82 84.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.069 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.46 ' O ' ' HB2' ' A' ' 50' ' ' PHE . 0.2 OUTLIER -63.51 -49.83 72.0 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.239 179.462 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 tt -65.97 -28.73 44.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-O 120.728 0.299 . . . . 0.0 110.895 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.75 -55.46 5.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.701 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.423 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -57.54 -44.55 93.77 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.152 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.46 ' HB2' ' O ' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -70.92 -32.4 69.3 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 110.503 -0.184 . . . . 0.0 110.503 179.532 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -63.16 -48.62 78.18 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.517 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.28 -43.21 92.55 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.743 0.306 . . . . 0.0 110.752 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 49' ' ' GLY . 98.9 t -66.22 -43.3 91.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.029 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.7 -28.73 69.28 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.396 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -84.35 -45.07 13.16 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.526 0.203 . . . . 0.0 110.849 179.335 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.93 -39.16 93.52 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.198 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.33 -18.18 27.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.733 0.302 . . . . 0.0 110.381 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.95 -33.0 73.91 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 121.189 -0.529 . . . . 0.0 112.255 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.548 ' O ' HG22 ' A' ' 62' ' ' THR . 1.1 mm? -64.52 -57.69 16.21 Favored Pre-proline 0 CA--C 1.537 0.481 0 CA-C-O 119.453 -0.308 . . . . 0.0 111.509 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -67.86 -13.39 38.37 Favored 'Trans proline' 0 C--N 1.36 1.169 0 C-N-CA 122.064 1.842 . . . . 0.0 112.623 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.47 ' HA ' HD12 ' A' ' 64' ' ' LEU . 0.1 OUTLIER -55.7 -27.46 50.4 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.619 179.831 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.548 HG22 ' O ' ' A' ' 59' ' ' LEU . 8.6 t -66.32 -32.74 74.32 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.929 0.395 . . . . 0.0 110.64 179.014 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.86 -20.42 24.64 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.855 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.47 HD12 ' HA ' ' A' ' 61' ' ' PHE . 1.5 mt -64.88 -17.42 64.28 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.2 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -63.32 -30.14 76.65 Favored Glycine 0 C--N 1.334 0.442 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.474 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.08 -24.88 70.32 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 121.02 -0.61 . . . . 0.0 111.686 178.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 tp -85.11 -20.87 29.67 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.689 0.28 . . . . 0.0 110.569 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.7 -19.58 64.03 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.977 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -64.22 -25.13 67.93 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.799 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -108.42 118.38 36.62 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -77.83 109.08 11.55 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.102 0.477 . . . . 0.0 110.92 -179.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.4 mmm180 -78.89 90.21 4.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.332 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -68.76 -18.28 64.18 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.821 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.416 ' O ' HG23 ' A' ' 78' ' ' VAL . 1.8 t -67.94 -26.21 65.85 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.163 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.1 tp -69.24 -35.84 76.56 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.924 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.79 -34.69 78.75 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.378 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -69.73 -43.35 72.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.433 179.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.44 ' O ' HG23 ' A' ' 82' ' ' VAL . 99.4 t -64.74 -45.24 95.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.187 179.241 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.73 -40.1 97.61 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.961 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.435 ' O ' HG23 ' A' ' 84' ' ' VAL . . . -64.49 -38.64 96.03 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.796 178.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 40.9 t -62.12 -41.78 92.57 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-O 120.699 0.285 . . . . 0.0 110.579 179.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 78' ' ' VAL . 67.9 t -60.5 -41.74 88.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.666 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.439 HD13 ' HA2' ' A' ' 195' ' ' GLY . 8.5 mt -64.32 -41.73 96.66 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.549 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 80' ' ' GLY . 93.6 t -66.98 -41.6 87.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.285 178.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.74 -41.16 97.29 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.708 179.131 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -61.95 -41.21 97.73 Favored 'General case' 0 CA--C 1.523 -0.091 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 178.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.516 ' HA3' HG12 ' A' ' 192' ' ' VAL . . . -65.12 -40.6 97.0 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.852 -0.689 . . . . 0.0 111.812 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 53.8 mt -62.16 -38.23 88.23 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.808 0.337 . . . . 0.0 110.854 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -77.12 -30.42 55.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.659 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 8.9 mtp -72.3 -19.6 61.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.869 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.89 -7.06 25.11 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.132 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.79 19.16 48.97 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.913 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.77 130.51 43.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.808 0.304 . . . . 0.0 110.63 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.49 146.19 88.54 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.19 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -63.02 111.95 1.54 Allowed 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.774 2.316 . . . . 0.0 112.378 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 6.9 mtm180 -96.63 89.35 4.94 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.878 0.37 . . . . 0.0 110.809 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 4.3 t-105 -135.65 98.45 3.93 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.085 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 72.96 -140.01 28.08 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.701 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -116.19 152.23 17.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.617 0.246 . . . . 0.0 110.509 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.49 -19.1 65.28 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.44 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 mt -78.27 -7.57 57.35 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.117 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 22.9 mtt180 -129.77 36.73 4.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.026 0.441 . . . . 0.0 110.426 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -76.2 114.71 15.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.536 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -113.95 125.34 53.92 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.844 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 154.02 119.95 0.74 Allowed Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.688 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -112.0 139.24 47.67 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.741 0.271 . . . . 0.0 110.49 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.43 ' O ' ' HD2' ' A' ' 110' ' ' PRO . 0.2 OUTLIER 58.62 73.0 0.49 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.237 0.542 . . . . 0.0 110.852 -179.41 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.98 -1.63 33.01 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.213 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.9 ttp180 -62.03 -56.57 30.4 Favored Pre-proline 0 CA--C 1.54 0.583 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.43 ' HD2' ' O ' ' A' ' 107' ' ' THR . 38.5 Cg_endo -66.79 -26.97 44.59 Favored 'Trans proline' 0 C--N 1.361 1.199 0 C-N-CA 121.865 1.71 . . . . 0.0 112.049 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.2 mt -70.73 -33.37 70.77 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.625 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -64.41 -41.53 98.02 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.435 178.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -73.96 -36.36 64.59 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 120.724 0.297 . . . . 0.0 110.442 178.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -66.19 -43.89 85.51 Favored 'General case' 0 C--N 1.334 -0.094 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.907 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.39 -34.37 78.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.984 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.17 -30.45 68.68 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.989 0.423 . . . . 0.0 110.093 179.031 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -80.83 -42.04 10.17 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 178.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.07 -42.9 95.54 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.621 0.248 . . . . 0.0 111.116 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 10.1 p -67.15 -38.56 85.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.049 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.82 -28.14 65.46 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.773 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -81.65 -34.41 30.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.833 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.84 -38.05 47.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.011 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -77.74 117.54 4.77 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.751 -0.737 . . . . 0.0 111.662 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' TRP . . . . . 0.542 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 77.8 m95 -67.59 143.3 56.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.704 0.288 . . . . 0.0 111.167 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.65 102.79 5.64 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.354 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.542 ' HD3' ' O ' ' A' ' 124' ' ' TRP . 57.3 Cg_endo -75.06 -16.85 19.85 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.705 2.27 . . . . 0.0 112.869 -179.429 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -65.28 -48.02 74.63 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.112 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.431 HD12 HD12 ' A' ' 132' ' ' LEU . 4.8 pt -101.56 5.42 10.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.535 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -58.91 -67.3 2.25 Favored Glycine 0 CA--C 1.52 0.362 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.933 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -62.26 -29.63 80.42 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.36 2.04 . . . . 0.0 112.286 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 65.3 mt -66.73 -54.41 25.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.135 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.431 HD12 HD12 ' A' ' 128' ' ' ILE . 15.1 mt -73.73 -31.22 63.25 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.095 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -63.69 -36.47 93.38 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.216 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.04 -43.23 71.68 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.836 0.351 . . . . 0.0 111.008 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 23.2 mm -71.92 -29.85 34.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.194 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.47 -46.95 83.09 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.016 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.0 -22.69 67.03 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.868 0.366 . . . . 0.0 111.591 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LEU . . . . . 0.513 ' O ' HG12 ' A' ' 141' ' ' VAL . 2.6 tp -86.13 -35.68 20.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.697 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 25.6 p -82.21 -20.01 38.61 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.354 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -82.84 -8.49 59.57 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.439 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' VAL . . . . . 0.513 HG12 ' O ' ' A' ' 138' ' ' LEU . 1.4 p -88.42 -8.0 10.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-O 121.163 0.506 . . . . 0.0 110.945 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -145.57 -64.28 0.02 OUTLIER Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.571 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 144.43 57.31 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.187 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -82.74 62.08 4.66 Favored Glycine 0 N--CA 1.453 -0.173 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.734 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 9.5 m -70.26 -25.51 27.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.833 0.349 . . . . 0.0 111.28 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -63.61 -30.69 78.38 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.252 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -67.35 -42.49 83.42 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.822 0.344 . . . . 0.0 110.233 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.99 -40.95 97.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.58 179.415 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.445 ' O ' HG13 ' A' ' 152' ' ' ILE . 0.6 OUTLIER -68.3 -42.1 79.94 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.452 179.233 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -66.31 -29.82 70.11 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.638 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -64.63 -57.78 8.14 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.053 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.445 HG13 ' O ' ' A' ' 149' ' ' LEU . 0.9 OUTLIER -63.26 -42.75 97.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.377 -179.377 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.451 ' O ' HG23 ' A' ' 157' ' ' VAL . 0.4 OUTLIER -69.08 -32.97 72.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.745 -0.207 . . . . 0.0 110.74 179.605 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -60.42 -41.11 98.42 Favored Glycine 0 C--O 1.223 -0.547 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.001 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.804 HD13 ' HB2' ' A' ' 15' ' ' SER . 29.6 tp -80.29 -29.0 38.21 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.693 0.282 . . . . 0.0 110.8 178.409 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.3 -39.36 79.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.425 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.528 ' O ' HG23 ' A' ' 161' ' ' VAL . 49.8 t -57.28 -63.81 3.3 Favored Pre-proline 0 CA--C 1.542 0.671 0 O-C-N 123.253 0.345 . . . . 0.0 111.817 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.525 ' CD ' ' HB ' ' A' ' 157' ' ' VAL . 20.7 Cg_endo -60.43 -33.56 93.98 Favored 'Trans proline' 0 C--N 1.362 1.272 0 C-N-CA 122.188 1.926 . . . . 0.0 112.637 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.35 -44.74 95.27 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.631 -0.258 . . . . 0.0 110.938 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -69.36 -35.08 75.51 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.758 0.314 . . . . 0.0 110.358 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 157' ' ' VAL . 89.4 t -62.21 -47.34 93.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.214 178.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 158' ' ' PRO . 58.2 t -67.04 -41.97 87.91 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.609 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -57.37 -39.37 75.86 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.511 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -77.49 -40.96 41.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.206 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -70.3 -19.77 63.07 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.658 0.266 . . . . 0.0 111.159 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.606 ' HA ' HD12 ' A' ' 169' ' ' ILE . . . -63.59 -26.47 68.7 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.145 178.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -66.91 -38.31 85.99 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.551 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 6.1 mtp180 -65.83 -34.16 77.51 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.728 178.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.606 HD12 ' HA ' ' A' ' 166' ' ' ALA . 6.6 mt -75.3 -28.06 20.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.787 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.97 -36.76 77.83 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.197 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -61.38 -49.64 75.18 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.348 179.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' TRP . . . . . 0.406 ' O ' ' HB2' ' A' ' 175' ' ' ARG . 52.6 m95 -72.26 -26.26 61.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.808 0.337 . . . . 0.0 111.156 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.83 -23.75 61.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.958 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 14.8 mtp85 -75.82 -17.93 59.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.026 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ARG . . . . . 0.406 ' HB2' ' O ' ' A' ' 172' ' ' TRP . 0.0 OUTLIER -60.08 -43.83 95.22 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.063 0.459 . . . . 0.0 110.47 178.876 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -108.57 -76.55 0.61 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.116 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 98.51 -25.61 27.21 Favored Glycine 0 C--N 1.329 0.163 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.424 178.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 26.6 mtp180 -84.13 -10.56 57.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.966 0.412 . . . . 0.0 110.983 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 1.6 pt -76.84 -18.86 14.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.214 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.02 -22.27 65.56 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.432 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' HIS . . . . . 0.501 ' O ' HG23 ' A' ' 185' ' ' VAL . 0.1 OUTLIER -84.18 -23.0 30.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.935 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -72.83 -42.62 63.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.867 0.365 . . . . 0.0 110.66 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.421 HG22 ' H ' ' A' ' 183' ' ' VAL . 4.4 m -71.5 -19.14 20.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.073 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -80.33 -37.56 32.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.608 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 181' ' ' HIS . 91.6 t -68.98 -41.73 81.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.739 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.435 ' O ' HG23 ' A' ' 190' ' ' VAL . 1.7 mp -61.25 -38.98 88.63 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.752 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -66.7 -36.28 82.12 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.16 178.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -66.35 -36.43 91.63 Favored Glycine 0 C--N 1.333 0.366 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.85 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 185' ' ' VAL . 98.7 t -61.81 -52.86 55.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.846 0.355 . . . . 0.0 110.695 179.031 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 186' ' ' LEU . 4.0 t -63.4 -31.2 51.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.977 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.34 -54.26 46.08 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.203 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' VAL . . . . . 0.516 HG12 ' HA3' ' A' ' 87' ' ' GLY . 35.0 m -68.29 -30.66 48.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.822 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.77 -50.75 69.82 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.19 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 58.8 t -66.46 -37.99 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.124 0 CA-C-O 120.883 0.373 . . . . 0.0 110.215 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' GLY . . . . . 0.439 ' HA2' HD13 ' A' ' 83' ' ' LEU . . . -59.55 -47.21 92.04 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.441 178.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 192' ' ' VAL . 91.4 t -72.08 -36.81 58.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.619 0.247 . . . . 0.0 111.022 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.32 -31.74 73.02 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.699 0.285 . . . . 0.0 111.211 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.33 -33.91 21.97 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.68 -0.236 . . . . 0.0 111.296 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -77.23 -47.22 20.76 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.4 -35.29 17.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.677 0.275 . . . . 0.0 111.627 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -83.55 -63.64 1.69 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.405 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 54.3 -148.29 0.47 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 122.403 0.281 . . . . 0.0 110.819 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 48.55 -111.07 0.41 Allowed 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 179.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.44 30.94 6.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.829 0.347 . . . . 0.0 110.975 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -69.71 -14.4 62.78 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.386 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.1 mt -77.58 -16.12 58.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.956 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -64.84 -36.03 83.04 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.198 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 75.6 p -62.59 -36.96 84.36 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.122 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' PHE . . . . . 0.472 ' O ' HG12 ' A' ' 213' ' ' ILE . 1.6 m-85 -87.04 -22.71 25.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.057 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.02 -16.29 61.32 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.542 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.49 -29.63 69.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.847 0.356 . . . . 0.0 110.731 179.271 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.88 -6.3 48.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.997 0.427 . . . . 0.0 110.355 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 213' ' ' ILE . . . . . 0.472 HG12 ' O ' ' A' ' 209' ' ' PHE . 11.1 mm -93.56 -3.68 10.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.743 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 214' ' ' THR . . . . . 0.409 ' HA ' ' HD3' ' A' ' 215' ' ' PRO . 0.2 OUTLIER -63.46 116.98 29.91 Favored Pre-proline 0 CA--C 1.529 0.16 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.411 179.163 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 215' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 214' ' ' THR . 16.3 Cg_exo -69.3 122.24 9.04 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.564 2.176 . . . . 0.0 112.994 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -74.04 -22.7 59.45 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.794 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -70.15 -24.54 63.18 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.955 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.658 HD21 ' HG ' ' A' ' 10' ' ' LEU . 1.8 mm? -76.13 -30.55 58.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.279 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -74.15 -23.15 59.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.059 179.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 5.2 mmm180 -87.09 -1.04 57.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.827 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -94.78 2.53 55.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.031 0.444 . . . . 0.0 110.843 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.61 136.66 30.95 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.583 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -63.27 100.99 0.28 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.871 2.38 . . . . 0.0 112.651 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.195 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.103 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 mmt . . . . . 0 N--CA 1.485 1.285 0 CA-C-O 120.473 0.178 . . . . 0.0 110.569 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 58.91 -147.58 0.49 Allowed 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.422 -179.446 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -102.01 9.07 40.72 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.944 0.402 . . . . 0.0 110.43 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.89 -42.59 60.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.107 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.69 -42.25 64.44 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.793 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.54 -45.28 91.26 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.542 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.41 -40.59 87.16 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.61 178.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.523 ' HB2' ' HB1' ' A' ' 150' ' ' ALA . . . -61.02 -48.61 80.99 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.717 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -57.43 -46.82 83.14 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.776 179.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.0 mp -61.7 -45.8 92.43 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.509 178.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.25 -42.37 90.97 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.534 178.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.86 -44.28 98.26 Favored Glycine 0 C--N 1.334 0.417 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.887 178.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 74.4 t -63.5 -41.94 94.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-O 120.781 0.324 . . . . 0.0 110.517 179.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.94 -45.12 90.62 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.813 0.34 . . . . 0.0 110.522 179.25 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.541 ' HB2' HD21 ' A' ' 155' ' ' LEU . 9.9 m -64.42 -35.15 79.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.868 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -73.65 -34.13 64.82 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.327 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.6 mt -79.15 -14.86 58.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.979 0.419 . . . . 0.0 110.757 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.402 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 1.4 t -86.37 126.9 63.13 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.873 178.529 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 18' ' ' SER . 30.8 Cg_exo -61.56 -14.84 37.75 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.784 2.323 . . . . 0.0 112.654 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 6.0 t -81.23 66.92 6.97 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.142 0.496 . . . . 0.0 110.633 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.1 m -89.98 161.53 2.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.864 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.65 -55.73 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.517 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -66.58 -22.52 50.93 Favored 'Trans proline' 0 C--N 1.361 1.202 0 C-N-CA 122.289 1.993 . . . . 0.0 112.89 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -74.17 -13.6 60.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.59 179.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.433 ' N ' ' HD2' ' A' ' 26' ' ' PRO . 73.7 t -74.51 -56.58 2.33 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-O 119.675 -0.202 . . . . 0.0 111.399 179.316 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 25' ' ' VAL . 17.1 Cg_endo -57.54 -23.43 56.39 Favored 'Trans proline' 0 C--N 1.362 1.254 0 C-N-CA 122.614 2.209 . . . . 0.0 113.449 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.04 -24.86 66.51 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.721 0.296 . . . . 0.0 111.416 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -76.84 -38.07 54.45 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.907 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -82.94 -22.47 33.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.448 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -53.61 -28.7 34.05 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.438 178.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -62.35 -33.53 74.89 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 120.83 0.348 . . . . 0.0 110.854 178.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 21.9 mt -86.45 -22.99 26.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.622 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -93.94 3.27 70.27 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.999 -0.619 . . . . 0.0 111.683 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -81.59 65.7 3.97 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 121.399 -0.429 . . . . 0.0 112.505 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.405 ' HB2' ' HB3' ' A' ' 109' ' ' ARG . . . -89.62 -19.87 24.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.939 0.4 . . . . 0.0 111.188 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 9.4 mmm180 -109.51 -97.16 0.39 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.024 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 165.17 -176.38 40.87 Favored Glycine 0 N--CA 1.448 -0.5 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 4.9 ttm105 57.26 72.87 0.86 Allowed Pre-proline 0 N--CA 1.469 0.49 0 C-N-CA 122.575 0.35 . . . . 0.0 111.343 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.11 -23.99 39.15 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.487 2.125 . . . . 0.0 112.502 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.6 mt -66.26 -34.98 79.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.977 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -73.32 -37.57 66.11 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.03 -36.59 84.88 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.99 178.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.44 -47.19 82.9 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.331 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -56.01 -42.32 76.25 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.162 178.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.47 -37.66 77.38 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.6 0.238 . . . . 0.0 110.947 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -65.05 -48.34 74.15 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.324 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 13.3 pt -68.29 -27.91 38.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.678 0.275 . . . . 0.0 110.92 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.47 -51.35 29.76 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.484 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -61.66 -43.85 98.71 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.081 179.123 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -67.32 -35.64 79.84 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.632 0.253 . . . . 0.0 110.609 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -63.08 -42.72 99.48 Favored Glycine 0 C--N 1.334 0.428 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.39 -44.88 92.71 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.672 0.273 . . . . 0.0 110.667 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 49' ' ' GLY . 26.5 t -65.49 -41.94 92.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.98 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.86 -34.68 78.95 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.917 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -76.56 -43.54 38.51 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.592 179.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.2 tp -61.12 -33.01 72.69 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.973 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.414 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 3.8 mt -89.73 -18.4 26.44 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.083 178.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -72.01 -32.04 63.75 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.334 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.18 -54.55 32.3 Favored Pre-proline 0 CA--C 1.543 0.69 0 N-CA-C 111.698 0.258 . . . . 0.0 111.698 179.157 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.414 ' HD2' ' C ' ' A' ' 57' ' ' LEU . 17.2 Cg_exo -67.46 -13.6 39.7 Favored 'Trans proline' 0 C--N 1.361 1.223 0 C-N-CA 122.559 2.172 . . . . 0.0 112.528 179.189 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.493 ' HA ' HD12 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -57.69 -20.87 37.07 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.387 179.728 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.3 p -62.04 -35.9 79.99 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.227 0.537 . . . . 0.0 110.45 178.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.4 -19.54 26.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.682 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.493 HD12 ' HA ' ' A' ' 61' ' ' PHE . 70.6 mt -75.38 -17.42 60.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.993 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.61 -31.18 78.98 Favored Glycine 0 C--N 1.334 0.422 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.912 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -77.23 -29.61 56.14 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.146 179.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 tp -76.88 -25.07 52.63 Favored 'General case' 0 N--CA 1.461 0.094 0 CA-C-O 120.784 0.326 . . . . 0.0 110.817 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.406 HD13 ' HA ' ' A' ' 68' ' ' LEU . 0.5 OUTLIER -67.62 -19.25 65.2 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.945 179.902 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -71.29 -17.46 62.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.566 178.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.84 161.86 17.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.419 179.295 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 9.1 m-70 -82.26 77.27 9.08 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.043 0.449 . . . . 0.0 111.36 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.2 mmp_? -96.7 49.15 1.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.829 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -73.01 -22.16 60.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.865 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -65.26 -24.64 67.37 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.329 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.19 -23.16 44.04 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.734 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.96 -30.32 26.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.056 179.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.5 mmt-85 -60.27 -27.65 67.44 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.493 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.3 t -63.47 -26.46 40.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-O 120.964 0.411 . . . . 0.0 110.519 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -65.0 -34.81 90.87 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.919 -0.658 . . . . 0.0 111.824 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.477 ' O ' HG23 ' A' ' 84' ' ' VAL . . . -66.93 -39.45 93.31 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.417 179.206 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.8 t -61.57 -40.35 86.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-O 120.875 0.369 . . . . 0.0 110.59 179.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 80.5 t -63.35 -39.68 86.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.386 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.98 -40.1 96.71 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.796 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 80' ' ' GLY . 53.1 t -63.59 -44.09 98.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.222 179.05 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.58 -41.1 93.95 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.593 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -65.57 -42.94 91.24 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.331 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -61.98 -38.29 95.81 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.247 179.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.0 -38.47 91.05 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.813 0.339 . . . . 0.0 110.831 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -73.74 -30.14 62.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.345 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 6.7 mtp -71.11 -27.1 63.35 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.538 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 65.0 mt -63.82 -16.23 60.75 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.26 178.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.37 16.08 74.81 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.751 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.4 mp -77.4 137.85 38.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.918 0.39 . . . . 0.0 110.505 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 15.6 mtp180 -107.82 115.31 59.09 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.889 -178.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -63.31 124.51 13.97 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.632 2.221 . . . . 0.0 112.114 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.78 132.11 37.25 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.814 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -137.26 -67.99 0.48 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.603 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -112.45 -175.58 19.65 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.235 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.7 t -75.79 96.9 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.005 0.431 . . . . 0.0 110.795 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -98.39 99.21 10.38 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.841 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.85 31.33 6.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.208 0.528 . . . . 0.0 110.522 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.9 ptp180 -132.31 157.41 44.51 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.938 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -101.42 -9.48 21.06 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.895 0.379 . . . . 0.0 111.264 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 14.1 mp0 -127.61 -80.23 0.59 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.483 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 80.21 -61.6 4.36 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.606 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -128.46 -174.98 3.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.728 0.299 . . . . 0.0 110.454 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.4 ' HB ' ' HD2' ' A' ' 110' ' ' PRO . 0.2 OUTLIER -77.34 105.45 8.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.404 -179.833 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.74 -40.23 19.08 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.405 ' HB3' ' HB2' ' A' ' 35' ' ' ALA . 0.0 OUTLIER -58.61 -56.53 34.69 Favored Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.634 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.405 ' HD3' ' CB ' ' A' ' 109' ' ' ARG . 31.4 Cg_exo -60.91 -28.27 86.09 Favored 'Trans proline' 0 C--N 1.36 1.165 0 C-N-CA 122.32 2.014 . . . . 0.0 112.503 179.159 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.8 tp -69.09 -28.73 66.77 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.772 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -63.01 -33.79 88.21 Favored Glycine 0 C--N 1.336 0.572 0 C-N-CA 120.93 -0.652 . . . . 0.0 111.714 178.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -77.71 -34.17 52.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.94 0.4 . . . . 0.0 110.544 178.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -70.56 -38.35 74.12 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.708 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.29 -27.42 62.45 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.503 179.16 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.08 -44.88 94.46 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.305 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -71.65 -27.78 70.42 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.556 178.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.06 -48.45 65.55 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.674 0.273 . . . . 0.0 110.809 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 3.5 p -69.02 -31.88 71.0 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.866 0.365 . . . . 0.0 110.981 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -74.11 -39.88 63.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.778 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.16 -24.0 67.27 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.935 0.398 . . . . 0.0 110.962 178.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 43.5 mt -80.73 -18.36 48.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.477 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -95.78 81.23 0.81 Allowed Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 3.3 m0 -66.56 -82.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.729 0.3 . . . . 0.0 111.324 -179.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.497 HG22 ' HB ' ' A' ' 128' ' ' ILE . 0.7 OUTLIER -144.57 65.84 13.12 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.575 179.326 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -74.76 -57.4 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.006 1.804 . . . . 0.0 112.492 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -86.06 -16.94 36.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.051 0.453 . . . . 0.0 110.466 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.497 ' HB ' HG22 ' A' ' 125' ' ' THR . 1.2 mt -92.14 2.43 8.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.421 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.4 ' N ' ' HD2' ' A' ' 130' ' ' PRO . . . -57.14 -60.68 8.59 Favored Glycine 0 CA--C 1.521 0.413 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.426 178.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' PRO . . . . . 0.4 ' HD2' ' N ' ' A' ' 129' ' ' GLY . 19.0 Cg_endo -59.45 -35.03 97.13 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.459 2.106 . . . . 0.0 112.141 178.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ILE . . . . . 0.494 ' O ' HG13 ' A' ' 135' ' ' ILE . 19.1 mt -68.42 -49.18 68.44 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.956 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 tp -63.92 -34.48 78.05 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.755 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -61.17 -39.96 97.89 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.854 -0.689 . . . . 0.0 111.599 178.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -71.38 -30.95 66.73 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.82 0.343 . . . . 0.0 110.683 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ILE . . . . . 0.494 HG13 ' O ' ' A' ' 131' ' ' ILE . 79.7 mt -72.06 -31.87 41.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.642 179.237 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 7.7 mt -60.37 -35.8 76.55 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.908 179.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.5 -22.59 63.59 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.809 178.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.5 tp -81.65 -27.35 34.14 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.382 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.59 ' HA ' ' O ' ' A' ' 143' ' ' GLY . 0.3 OUTLIER -76.3 -17.36 59.47 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.631 179.401 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -71.82 -17.99 62.12 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.358 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 8.1 t -73.89 -28.8 24.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.984 0.421 . . . . 0.0 110.712 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 129.36 64.77 0.11 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.148 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.59 ' O ' ' HA ' ' A' ' 139' ' ' THR . . . 113.13 -152.25 18.04 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.16 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 115.73 20.45 5.36 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.378 -0.915 . . . . 0.0 112.729 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 11.7 p -66.12 -25.54 36.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 CA-C-O 120.961 0.41 . . . . 0.0 110.976 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -62.43 -30.32 75.98 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.093 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -67.4 -42.6 83.03 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.605 0.24 . . . . 0.0 110.503 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.8 tp -61.96 -43.75 98.19 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.512 179.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.522 ' O ' HG13 ' A' ' 152' ' ' ILE . 1.6 mp -67.95 -41.45 82.47 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.648 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.523 ' HB1' ' HB2' ' A' ' 8' ' ' ALA . . . -64.52 -35.14 80.0 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.477 178.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -61.05 -54.66 42.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.421 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.522 HG13 ' O ' ' A' ' 149' ' ' LEU . 0.5 OUTLIER -63.8 -42.67 96.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.874 -179.778 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 153' ' ' LEU . . . . . 0.431 ' O ' HG23 ' A' ' 157' ' ' VAL . 0.0 OUTLIER -64.44 -40.76 96.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.169 179.352 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -59.36 -41.51 96.99 Favored Glycine 0 C--N 1.334 0.429 0 CA-C-N 116.207 -0.451 . . . . 0.0 112.758 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.541 HD21 ' HB2' ' A' ' 15' ' ' SER . 7.0 mt -80.59 -26.67 37.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.814 0.34 . . . . 0.0 111.016 178.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -62.7 -37.35 86.13 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.314 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.499 ' HB ' ' CD ' ' A' ' 158' ' ' PRO . 96.5 t -54.8 -63.66 2.69 Favored Pre-proline 0 CA--C 1.541 0.601 0 O-C-N 123.382 0.426 . . . . 0.0 111.642 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' PRO . . . . . 0.499 ' CD ' ' HB ' ' A' ' 157' ' ' VAL . 28.7 Cg_endo -62.65 -36.64 62.57 Favored 'Trans proline' 0 C--N 1.358 1.077 0 C-N-CA 121.765 1.643 . . . . 0.0 112.578 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -58.92 -48.27 82.07 Favored 'General case' 0 N--CA 1.462 0.134 0 O-C-N 123.017 0.198 . . . . 0.0 111.37 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -65.8 -39.28 90.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.958 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 157' ' ' VAL . 92.9 t -63.61 -44.26 98.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.188 178.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 71.8 t -66.17 -44.91 91.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.284 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -58.02 -35.55 71.42 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.885 0.374 . . . . 0.0 111.377 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.7 mt -69.12 -45.83 69.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.011 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.13 -34.47 68.59 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.926 0.393 . . . . 0.0 110.624 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 170' ' ' LYS . . . -69.93 -19.06 63.4 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.999 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -67.0 -26.34 66.74 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.372 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 1.1 tpt85 -79.19 -46.6 17.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.06 0.457 . . . . 0.0 110.668 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.438 HG12 ' HA ' ' A' ' 166' ' ' ALA . 20.7 pt -75.03 -18.77 16.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.288 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.468 ' O ' ' HG3' ' A' ' 174' ' ' ARG . 0.2 OUTLIER -57.44 -44.27 84.58 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.057 179.751 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -68.29 -25.36 74.69 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.672 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 1.3 m-90 -86.9 -41.08 14.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.658 0.266 . . . . 0.0 111.201 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.82 -16.63 62.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.581 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.468 ' HG3' ' O ' ' A' ' 170' ' ' LYS . 0.0 OUTLIER -52.44 -54.69 28.96 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.764 0.316 . . . . 0.0 111.342 179.197 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 14.8 mtm180 -94.12 -16.36 23.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.567 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -92.21 1.37 57.26 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.72 0.295 . . . . 0.0 111.635 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -85.09 55.43 4.96 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.599 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.5 -53.02 3.45 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.981 0.419 . . . . 0.0 110.41 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ILE . . . . . 0.429 HG12 ' H ' ' A' ' 179' ' ' ILE . 7.3 pt -74.26 -22.18 17.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.339 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.415 ' O ' ' HG3' ' A' ' 184' ' ' GLU . 0.3 OUTLIER -66.51 -18.71 65.51 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.467 179.975 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 181' ' ' HIS . . . . . 0.441 ' HA ' ' OE2' ' A' ' 184' ' ' GLU . 0.0 OUTLIER -63.85 -32.6 74.17 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.03 179.918 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -80.23 -25.31 39.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.93 0.395 . . . . 0.0 110.62 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 11.9 t -74.67 -25.34 18.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.44 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' GLU . . . . . 0.441 ' OE2' ' HA ' ' A' ' 181' ' ' HIS . 32.7 mt-10 -74.41 -29.68 61.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.649 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 11.4 t -69.62 -48.89 63.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.688 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.448 ' O ' HG23 ' A' ' 190' ' ' VAL . 2.7 mt -59.33 -43.18 92.77 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.841 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -68.9 -40.76 78.96 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.704 179.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -62.69 -41.61 99.8 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.265 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 54.4 t -61.49 -52.41 61.44 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.103 0 CA-C-O 120.43 0.157 . . . . 0.0 110.803 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 186' ' ' LEU . 54.8 t -58.16 -39.62 73.91 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.92 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 1.8 mt -61.71 -47.39 85.5 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.173 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 60.3 t -70.74 -35.89 62.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.657 0.265 . . . . 0.0 110.598 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.4 tp -59.83 -51.79 68.23 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.131 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 31.7 m -67.08 -29.61 46.71 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.585 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -65.36 -49.65 59.94 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.703 178.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 46.2 t -67.09 -37.74 79.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 O-C-N 122.744 -0.268 . . . . 0.0 110.328 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.53 -31.12 72.2 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.776 179.32 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.464 HD13 HD13 ' A' ' 206' ' ' LEU . 0.5 OUTLIER -76.05 -29.78 58.15 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.075 0.464 . . . . 0.0 110.424 178.813 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -78.31 -41.17 34.51 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.602 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 66.9 p -86.24 -39.84 16.16 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -91.08 -4.74 68.6 Favored Glycine 0 C--N 1.329 0.174 0 C-N-CA 121.223 -0.513 . . . . 0.0 112.707 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.1 -142.44 0.56 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 122.69 0.396 . . . . 0.0 110.962 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -83.8 -11.41 57.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.769 0.319 . . . . 0.0 110.959 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.81 -43.23 80.15 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.46 179.141 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -74.55 -30.36 61.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.838 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' LEU . . . . . 0.464 HD13 HD13 ' A' ' 198' ' ' LEU . 5.8 tp -73.17 -33.62 65.55 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.719 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -63.27 -41.38 99.01 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.786 0.327 . . . . 0.0 111.033 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 4.3 p -73.56 -25.36 60.34 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.076 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -87.44 -27.12 22.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.272 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -80.97 -15.64 55.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.494 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.17 -35.05 71.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.243 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.26 -6.37 55.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.245 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 4.6 mt -106.94 7.44 9.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.124 0.488 . . . . 0.0 110.801 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 2.3 p -61.49 122.33 69.98 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.865 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -60.16 145.9 97.47 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.367 2.044 . . . . 0.0 112.311 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -63.8 -21.16 66.29 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.329 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -73.2 -26.44 61.15 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.75 0.309 . . . . 0.0 110.913 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.21 -30.3 17.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.376 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.97 -22.79 63.12 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.518 179.129 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 1.2 ttp180 -85.32 -16.15 40.95 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.729 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -102.21 13.4 34.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.033 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.92 120.38 69.35 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.681 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -77.81 69.58 7.33 Favored 'Trans proline' 0 CA--C 1.53 0.306 0 C-N-CA 122.645 2.23 . . . . 0.0 112.502 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.93 0 CA-C-O 118.154 -0.927 . . . . 0.0 111.381 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.619 0.247 . . . . 0.0 110.365 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.55 102.18 9.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.902 0.382 . . . . 0.0 111.064 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.29 -18.79 61.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.916 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.31 -27.62 69.45 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.992 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.41 -48.26 82.52 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.778 0.323 . . . . 0.0 110.59 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.36 -45.69 92.05 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.774 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.403 ' HB1' ' HA ' ' A' ' 151' ' ' TYR . . . -64.19 -33.58 76.12 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.964 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.454 ' O ' HG23 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -66.69 -52.38 45.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.247 179.527 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.8 mp -61.33 -38.02 85.39 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.104 178.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.81 -43.03 99.88 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.468 178.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.3 -41.91 98.57 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 121.054 -0.593 . . . . 0.0 111.994 178.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 9' ' ' PHE . 48.2 t -64.59 -38.57 82.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.125 0.488 . . . . 0.0 109.839 178.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 60.1 mt -63.81 -41.17 97.94 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.5 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.6 m -65.46 -33.22 75.43 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.697 0.284 . . . . 0.0 110.877 179.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -69.35 -36.79 77.23 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.023 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.6 mp -90.5 -4.37 56.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.953 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.1 t -79.08 124.01 84.75 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.363 179.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.422 ' HG3' HD13 ' A' ' 213' ' ' ILE . 37.9 Cg_endo -67.44 -8.63 22.72 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.691 2.261 . . . . 0.0 112.709 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.422 ' SG ' ' HZ ' ' A' ' 210' ' ' PHE . 1.0 OUTLIER -88.11 -14.48 38.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.954 179.756 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.6 t -116.98 -79.74 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.188 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.423 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 15.0 mt 51.15 82.61 0.24 Allowed Pre-proline 0 N--CA 1.466 0.351 0 O-C-N 123.709 0.631 . . . . 0.0 111.699 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -55.23 -24.08 40.08 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.99 2.46 . . . . 0.0 113.273 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.4 tp -64.36 -26.2 68.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.717 -0.22 . . . . 0.0 111.133 178.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.442 ' HB ' ' CD ' ' A' ' 26' ' ' PRO . 71.4 t -67.48 -61.14 4.81 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.162 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.442 ' CD ' ' HB ' ' A' ' 25' ' ' VAL . 19.3 Cg_endo -59.11 -35.19 98.49 Favored 'Trans proline' 0 C--N 1.361 1.185 0 C-N-CA 122.032 1.821 . . . . 0.0 112.559 178.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 20.2 m -64.9 -36.54 84.68 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.714 0.292 . . . . 0.0 111.002 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.446 ' O ' ' HB2' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -66.53 -28.51 68.6 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.566 179.562 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 7.9 mt -85.06 -36.22 21.35 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.075 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -63.28 -44.05 96.18 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.549 178.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -73.63 -21.6 60.25 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.763 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.446 ' HB2' ' O ' ' A' ' 28' ' ' TYR . 2.1 tp -75.94 -18.85 59.18 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.4 179.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -89.59 -4.38 73.29 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.946 -0.645 . . . . 0.0 111.66 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.99 -59.46 4.94 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 121.161 -0.543 . . . . 0.0 112.666 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . 57.74 -113.28 0.72 Allowed 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 122.753 0.421 . . . . 0.0 111.024 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.11 -36.92 1.14 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.935 0.397 . . . . 0.0 110.725 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.11 18.08 11.85 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.094 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -111.77 96.96 35.53 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.514 0.197 . . . . 0.0 110.624 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -69.32 -32.04 21.21 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.507 2.138 . . . . 0.0 112.932 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.62 -44.37 90.75 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.132 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -73.79 -36.03 64.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.818 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -65.42 -42.24 92.71 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.165 178.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.49 -51.91 56.66 Favored 'General case' 0 C--O 1.227 -0.126 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.627 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.33 -42.0 73.19 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.244 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -64.07 -44.69 91.65 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.861 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.46 -40.41 89.39 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.62 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 55.5 mt -60.71 -48.57 88.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.573 179.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.65 -45.83 81.48 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.905 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.587 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -59.84 -48.45 85.99 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.407 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.03 -41.75 90.52 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.55 0.214 . . . . 0.0 110.998 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -61.74 -44.26 98.13 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.078 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.12 -46.04 90.96 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.658 0.266 . . . . 0.0 111.11 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 49' ' ' GLY . 46.1 t -65.25 -42.23 93.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.098 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -64.29 -28.29 69.62 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.531 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -84.95 -46.61 11.08 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.896 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.87 -39.21 93.19 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.09 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.448 ' HB2' ' O ' ' A' ' 53' ' ' VAL . 1.0 OUTLIER -85.82 -19.07 31.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.487 179.386 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.421 ' O ' ' HB2' ' A' ' 61' ' ' PHE . . . -74.69 -26.69 66.73 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.203 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.68 -56.41 33.04 Favored Pre-proline 0 CA--C 1.54 0.59 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -65.65 -13.78 41.51 Favored 'Trans proline' 0 C--N 1.362 1.281 0 C-N-CA 122.305 2.004 . . . . 0.0 113.155 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.421 ' HB2' ' O ' ' A' ' 58' ' ' GLY . 8.2 m-30 -61.44 -17.94 56.63 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.651 0.262 . . . . 0.0 111.422 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 21.8 p -71.89 -41.34 68.08 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.135 0.493 . . . . 0.0 110.195 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.3 mt -88.48 -21.63 24.09 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.888 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.86 -17.9 64.06 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.901 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -63.43 -24.52 67.7 Favored Glycine 0 C--N 1.335 0.477 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.934 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.49 -21.82 76.64 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.149 179.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.69 -20.67 46.01 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.833 0.349 . . . . 0.0 110.631 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.457 ' HA ' HD13 ' A' ' 68' ' ' LEU . 1.4 mm? -64.32 -19.26 65.32 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.995 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -69.73 -17.62 63.46 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.814 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -97.27 -133.36 0.22 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.906 179.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -151.03 126.26 9.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.909 0.385 . . . . 0.0 110.841 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -134.59 37.71 3.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.598 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -66.88 -18.09 65.21 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.411 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.46 -18.06 65.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.398 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.4 mp -74.15 -22.86 59.25 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.624 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.19 -24.11 51.44 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.502 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.451 ' O ' HG23 ' A' ' 81' ' ' VAL . 0.2 OUTLIER -71.79 -33.56 68.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.888 179.798 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.486 ' O ' HG23 ' A' ' 82' ' ' VAL . 41.9 t -62.52 -36.76 76.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.729 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.67 -36.8 93.8 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.068 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.449 ' O ' HG23 ' A' ' 84' ' ' VAL . . . -66.34 -41.59 94.46 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.873 -0.679 . . . . 0.0 111.764 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 77' ' ' ARG . 21.5 t -60.49 -43.88 95.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 120.83 0.348 . . . . 0.0 110.714 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 78' ' ' VAL . 47.1 t -63.91 -41.07 91.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.601 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.87 -43.16 99.55 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.771 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 80' ' ' GLY . 92.7 t -62.97 -44.95 99.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-O 120.832 0.349 . . . . 0.0 110.429 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.78 -41.46 97.74 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.72 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -66.52 -40.17 89.04 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.667 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -61.34 -39.52 97.35 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.997 -0.621 . . . . 0.0 111.893 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.5 -40.93 98.37 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.829 0.347 . . . . 0.0 110.698 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -71.72 -31.45 66.73 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.548 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 5.2 mtt -67.12 -27.59 67.46 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.473 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.74 -9.58 51.46 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.024 178.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.56 11.27 83.32 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.849 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.34 145.15 25.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.926 0.393 . . . . 0.0 110.842 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.324 -0.501 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.613 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.228 0 CA-C-O 120.889 0.376 . . . . 0.0 111.011 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.3 -13.66 43.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.299 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.46 ' N ' ' HD2' ' A' ' 110' ' ' PRO . 0.0 OUTLIER -66.85 -52.54 32.08 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.933 179.845 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' A' ' 109' ' ' ARG . 36.6 Cg_endo -65.18 -15.56 50.79 Favored 'Trans proline' 0 C--N 1.363 1.325 0 C-N-CA 122.069 1.846 . . . . 0.0 112.797 179.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.416 ' O ' ' HB2' ' A' ' 115' ' ' LEU . 0.5 OUTLIER -67.65 -39.64 84.58 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.682 179.857 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -69.28 -31.88 71.91 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.628 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -71.42 -46.16 60.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.888 0.375 . . . . 0.0 110.775 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -67.98 -39.16 83.34 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.063 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.416 ' HB2' ' O ' ' A' ' 111' ' ' LEU . 0.7 OUTLIER -65.23 -40.2 93.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.79 179.474 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.59 -33.62 76.36 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.705 0.288 . . . . 0.0 110.522 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -66.52 -48.85 60.15 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.21 178.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.44 -29.84 70.56 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.753 0.311 . . . . 0.0 110.713 178.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 52.7 m -61.89 -44.81 96.04 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.811 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.2 mt -69.87 -21.43 63.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.384 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -85.22 -40.86 16.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.484 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.1 mp -85.83 -33.06 21.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.741 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -80.55 92.24 1.41 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.392 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -81.69 132.87 35.31 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.894 0.378 . . . . 0.0 110.913 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.0 113.14 45.96 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.789 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -63.68 -22.37 69.95 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.827 2.351 . . . . 0.0 112.963 -179.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -70.45 -25.69 63.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.244 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.5 mm -103.1 2.37 10.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.111 0.482 . . . . 0.0 110.406 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -61.53 -59.64 9.51 Favored Glycine 0 CA--C 1.521 0.44 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.611 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -57.4 -34.78 98.51 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 122.72 2.28 . . . . 0.0 112.323 178.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 16.0 mm -67.83 -43.45 86.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.808 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.39 -37.37 66.01 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.465 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -61.38 -31.17 76.37 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 121.075 -0.583 . . . . 0.0 112.197 178.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.74 -21.91 62.48 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.908 0.385 . . . . 0.0 110.927 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 38.4 mm -79.58 -30.34 13.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.681 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.07 -39.26 94.2 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.574 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.11 -23.76 67.24 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.105 178.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.76 -33.5 19.92 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.743 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 23.6 p -80.3 -17.16 52.9 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.357 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -75.94 -29.23 58.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.98 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 21.8 m -100.15 2.91 10.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.266 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -173.43 -90.07 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.478 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 151.3 -152.58 24.34 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.431 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 167.52 63.01 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.264 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . 0.405 ' H ' HG23 ' A' ' 145' ' ' VAL . 1.7 t -62.25 -49.17 85.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.87 0.367 . . . . 0.0 110.672 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -65.82 -28.98 74.13 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.937 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.42 -44.06 83.97 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.809 0.338 . . . . 0.0 110.453 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.93 -42.37 99.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.384 179.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 34.4 mt -66.26 -39.25 89.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.385 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -61.58 -38.81 88.91 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.561 178.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.403 ' HA ' ' HB1' ' A' ' 8' ' ' ALA . 0.2 OUTLIER -62.52 -47.59 83.24 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.654 179.23 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 17.6 mt -64.87 -46.9 90.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.382 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.43 ' O ' HG23 ' A' ' 157' ' ' VAL . 0.2 OUTLIER -62.09 -37.7 86.05 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.951 179.28 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -60.13 -38.84 95.0 Favored Glycine 0 C--O 1.224 -0.518 0 C-N-CA 121.273 -0.489 . . . . 0.0 112.058 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.403 HD13 ' HA ' ' A' ' 155' ' ' LEU . 0.9 OUTLIER -79.98 -26.31 40.0 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.678 0.275 . . . . 0.0 110.971 178.627 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -64.48 -37.46 87.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.153 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.515 ' O ' HG23 ' A' ' 161' ' ' VAL . 59.4 t -55.33 -62.73 3.91 Favored Pre-proline 0 CA--C 1.541 0.633 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.824 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.494 ' CD ' ' HB ' ' A' ' 157' ' ' VAL . 17.9 Cg_endo -59.68 -36.59 91.58 Favored 'Trans proline' 0 C--N 1.36 1.157 0 C-N-CA 122.123 1.882 . . . . 0.0 112.339 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.08 -44.82 96.78 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.271 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -66.11 -40.47 90.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.635 0.255 . . . . 0.0 110.708 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 157' ' ' VAL . 48.3 t -63.88 -45.43 97.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.499 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 60.9 t -65.07 -40.24 88.29 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.606 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -58.8 -41.7 87.36 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.547 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.97 -39.23 63.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.238 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -70.9 -27.65 63.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.739 0.304 . . . . 0.0 110.8 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -64.46 -18.75 65.05 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.532 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -62.77 -46.65 87.05 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.758 0.313 . . . . 0.0 111.044 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -78.24 -34.0 49.43 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.742 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 58.1 mt -69.74 -23.1 25.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.921 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -59.69 -39.1 83.41 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.913 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -71.54 -23.8 77.59 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.674 179.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 60.2 t-105 -81.64 -37.89 26.81 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.423 0.154 . . . . 0.0 111.133 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.59 -38.04 59.23 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -87.47 -15.67 36.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.495 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.16 -27.59 18.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.466 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -53.47 -65.78 0.5 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.758 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 131.3 -124.47 4.11 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.806 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 2.7 mtt180 -100.26 0.6 40.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.675 0.274 . . . . 0.0 111.357 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 7.9 mt -66.81 -33.8 65.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.965 0.412 . . . . 0.0 110.844 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.47 -20.22 66.05 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.315 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 37.7 m170 -84.01 -21.45 31.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.83 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -73.1 -45.91 54.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.524 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 3.6 m -73.54 -19.57 18.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.186 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -65.11 -50.79 64.69 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.708 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.462 ' O ' HG23 ' A' ' 189' ' ' VAL . 2.4 m -81.82 -28.08 9.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.506 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.41 ' O ' HG23 ' A' ' 190' ' ' VAL . 1.2 tp -58.59 -50.72 72.8 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.19 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -62.21 -35.34 78.59 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.785 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.432 ' O ' HG23 ' A' ' 192' ' ' VAL . . . -65.28 -42.33 96.26 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.193 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 185' ' ' VAL . 94.8 t -62.55 -47.56 92.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 120.76 0.314 . . . . 0.0 110.724 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 186' ' ' LEU . 39.5 t -62.18 -39.42 83.89 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.891 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.98 -46.52 87.9 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.841 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 188' ' ' GLY . 55.8 t -66.51 -40.55 86.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.422 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.403 ' O ' ' HB2' ' A' ' 197' ' ' LEU . 4.3 mt -60.98 -46.57 90.19 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.961 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 87.5 t -66.93 -41.1 87.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.801 0.334 . . . . 0.0 110.262 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -62.44 -43.46 99.01 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.742 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 3.6 p -72.93 -32.36 39.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 116.8 0.3 . . . . 0.0 111.279 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.53 HD23 HD11 ' A' ' 206' ' ' LEU . 0.5 OUTLIER -74.85 -22.46 58.67 Favored 'General case' 0 C--N 1.334 -0.078 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.122 179.84 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.2 mp -84.76 -38.92 19.05 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.379 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -67.17 -47.75 70.03 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.127 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 81.3 p -84.42 -20.27 32.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.255 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -78.39 -48.78 7.16 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.245 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 57.3 -133.42 1.28 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.653 0.263 . . . . 0.0 111.501 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -81.25 84.11 6.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.916 0.388 . . . . 0.0 111.153 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.765 HG23 ' H ' ' A' ' 206' ' ' LEU . 13.7 t -150.75 -161.61 1.37 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.651 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -59.71 -14.38 13.96 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 122.643 0.377 . . . . 0.0 111.795 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.765 ' H ' HG23 ' A' ' 204' ' ' THR . 0.5 OUTLIER -67.03 -33.11 74.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.619 179.544 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -71.44 -28.69 64.14 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.996 0.427 . . . . 0.0 110.262 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.0 -21.21 31.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.781 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -66.97 -21.65 65.96 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.906 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . 0.57 ' HA ' HD12 ' A' ' 213' ' ' ILE . 1.0 OUTLIER -67.2 -19.13 65.51 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.884 179.216 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 3.0 mt -86.21 -10.86 53.88 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.719 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.96 -21.86 36.98 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.98 0.419 . . . . 0.0 110.42 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . 0.57 HD12 ' HA ' ' A' ' 210' ' ' PHE . 2.9 mt -87.5 -24.79 6.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.401 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.23 120.37 79.19 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.371 179.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.39 130.51 24.01 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.449 2.099 . . . . 0.0 112.718 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -68.94 -19.59 64.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.241 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 9.5 m95 -69.57 -18.58 63.65 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.332 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.69 -32.19 16.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.849 0.357 . . . . 0.0 110.28 179.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -74.49 -34.53 63.1 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.621 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 . . . . . 0 N--CA 1.463 0.182 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.871 179.419 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.457 -0.08 0 CA-C-O 120.876 0.369 . . . . 0.0 111.06 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.07 20.28 9.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.181 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.67 -34.0 76.9 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.126 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 16.9 mt -73.97 -47.83 34.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.544 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.03 -40.91 91.0 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.762 178.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.89 -48.39 76.86 Favored 'General case' 0 CA--C 1.523 -0.079 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.706 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.649 ' HB1' ' HA ' ' A' ' 151' ' ' TYR . . . -58.74 -36.45 74.35 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.161 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.406 ' O ' HG23 ' A' ' 13' ' ' VAL . 41.3 t80 -69.27 -52.04 31.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.336 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.74 -38.28 81.31 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.478 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.06 -44.62 97.11 Favored 'General case' 0 C--N 1.334 -0.077 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.801 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.08 -44.23 96.45 Favored Glycine 0 C--N 1.335 0.515 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.185 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 9' ' ' PHE . 11.8 t -70.11 -35.21 62.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.909 0.385 . . . . 0.0 110.327 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.16 -42.85 96.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.77 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.8 m -66.7 -33.28 75.28 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.816 0.341 . . . . 0.0 110.711 179.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -75.13 -32.52 61.37 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.502 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -94.59 -1.28 53.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.649 0.261 . . . . 0.0 111.31 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.4 p -62.67 143.94 96.36 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.355 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.06 -8.07 18.99 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.543 2.162 . . . . 0.0 112.812 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.415 ' O ' ' HB ' ' A' ' 21' ' ' VAL . 0.1 OUTLIER -63.63 -47.37 81.62 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.957 179.65 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.415 ' HB ' ' O ' ' A' ' 20' ' ' CYS . 96.1 t 71.11 137.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 O-C-N 123.769 0.668 . . . . 0.0 110.945 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -105.17 128.77 25.98 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.553 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -65.04 -18.51 62.13 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.631 2.22 . . . . 0.0 112.469 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.1 mt -74.27 -12.51 60.57 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.248 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.497 ' HB ' ' HD3' ' A' ' 26' ' ' PRO . 55.1 t -75.71 -60.21 1.09 Allowed Pre-proline 0 CA--C 1.542 0.661 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.497 ' HD3' ' HB ' ' A' ' 25' ' ' VAL . 60.4 Cg_endo -73.31 -34.1 6.39 Favored 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 121.836 1.69 . . . . 0.0 113.511 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.2 m -71.03 -18.18 62.59 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.21 -21.09 66.3 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.762 0.315 . . . . 0.0 111.199 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 6.0 mt -82.12 -52.84 6.6 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.833 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -62.41 -28.69 69.97 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.475 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -60.73 -43.24 98.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.766 178.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.412 ' HA ' HD22 ' A' ' 32' ' ' LEU . 0.6 OUTLIER -74.07 -22.16 59.63 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.997 -179.753 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -86.59 -9.57 74.99 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.245 178.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -108.49 -46.61 0.97 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 121.407 -0.425 . . . . 0.0 112.11 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -117.62 124.67 49.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.806 0.336 . . . . 0.0 110.503 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -77.63 86.84 3.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.099 0.476 . . . . 0.0 110.956 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -138.01 171.95 23.11 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.896 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.403 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 14.4 mtt180 -96.61 124.86 49.19 Favored Pre-proline 0 C--N 1.324 -0.528 0 C-N-CA 121.162 -0.215 . . . . 0.0 110.834 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 38' ' ' ARG . 50.0 Cg_exo -55.81 -30.57 77.09 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.905 2.404 . . . . 0.0 112.782 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.6 mp -63.98 -39.21 93.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.0 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.91 -37.14 67.34 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.224 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -65.04 -43.84 91.01 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.085 178.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.55 -49.42 73.51 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.647 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.76 -45.0 78.19 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.024 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -65.5 -45.28 84.19 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.21 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -62.65 -42.38 99.57 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.157 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 28.4 mm -65.29 -43.05 95.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.566 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.55 -44.01 97.41 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.283 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.404 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -61.64 -44.5 97.86 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.064 178.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -68.91 -36.69 78.3 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.606 0.241 . . . . 0.0 110.625 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -62.94 -42.42 99.68 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.46 178.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.87 -43.94 97.82 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.595 0.236 . . . . 0.0 110.578 178.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 49' ' ' GLY . 93.8 t -63.88 -43.37 97.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.726 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -63.6 -36.25 83.2 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.234 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -76.52 -44.48 34.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.017 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.08 -30.87 71.93 Favored 'General case' 0 C--O 1.226 -0.153 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.976 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -89.34 -20.51 23.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.791 0.329 . . . . 0.0 110.484 178.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -72.2 -31.2 64.09 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 121.191 -0.528 . . . . 0.0 112.507 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.2 mp -62.59 -57.21 23.54 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 111.452 0.168 . . . . 0.0 111.452 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -73.97 -13.6 23.89 Favored 'Trans proline' 0 C--N 1.359 1.116 0 C-N-CA 122.019 1.813 . . . . 0.0 112.454 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.413 ' HA ' HD12 ' A' ' 64' ' ' LEU . 0.1 OUTLIER -56.81 -31.5 64.76 Favored 'General case' 0 N--CA 1.464 0.24 0 O-C-N 123.14 0.275 . . . . 0.0 111.334 179.805 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -64.35 -32.09 73.56 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.805 0.336 . . . . 0.0 110.867 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.82 -23.51 25.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.038 0.447 . . . . 0.0 110.148 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.413 HD12 ' HA ' ' A' ' 61' ' ' PHE . 14.7 mt -69.33 -17.96 63.76 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.963 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -59.87 -29.51 67.79 Favored Glycine 0 C--N 1.336 0.573 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.076 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.69 -29.5 61.28 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.908 178.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.3 mt -83.56 -21.39 32.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.904 0.383 . . . . 0.0 110.555 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.37 -19.25 65.86 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.446 179.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.87 -17.88 65.11 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.952 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -94.5 -110.14 0.12 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -162.19 148.65 13.38 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.683 0.278 . . . . 0.0 110.882 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.1 mmt-85 -124.24 53.32 1.43 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.939 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -75.88 -18.13 59.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.881 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -66.74 -26.94 67.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.003 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -76.94 -22.29 53.52 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.918 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.72 -32.39 72.15 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.038 0.447 . . . . 0.0 110.372 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.533 ' O ' HG23 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -73.19 -36.7 66.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.722 179.598 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.485 ' O ' HG23 ' A' ' 82' ' ' VAL . 20.8 t -58.3 -44.88 89.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.87 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.64 -39.76 97.01 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.923 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.538 ' O ' HG23 ' A' ' 84' ' ' VAL . . . -65.94 -38.63 94.37 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.079 -0.581 . . . . 0.0 111.924 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 77' ' ' ARG . 95.0 t -62.31 -42.86 97.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-O 120.777 0.322 . . . . 0.0 110.779 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 78' ' ' VAL . 47.0 t -62.74 -38.6 82.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.536 179.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 11.5 mt -64.57 -43.15 94.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.696 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 80' ' ' GLY . 42.9 t -66.41 -39.13 83.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.285 178.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.61 -43.1 99.49 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.657 178.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -67.03 -36.75 82.77 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.453 179.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -64.64 -39.97 97.16 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.712 178.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.9 mt -64.46 -36.76 85.22 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.728 0.299 . . . . 0.0 110.783 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -75.73 -31.5 59.63 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.474 179.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 2.8 tpt -69.14 -25.34 64.33 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.615 179.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.2 mt -69.06 -11.01 60.4 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.041 178.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.99 23.77 54.47 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.682 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.29 115.15 14.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.722 0.296 . . . . 0.0 110.761 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.387 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.589 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.415 ' C ' ' HD2' ' A' ' 110' ' ' PRO . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.797 0.332 . . . . 0.0 111.592 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.32 -33.69 67.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.021 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.431 ' HB2' ' HD3' ' A' ' 110' ' ' PRO . 30.8 mmt-85 -73.23 -52.94 5.07 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.034 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.431 ' HD3' ' HB2' ' A' ' 109' ' ' ARG . 35.6 Cg_exo -58.87 -29.06 89.1 Favored 'Trans proline' 0 C--N 1.362 1.277 0 C-N-CA 122.194 1.929 . . . . 0.0 112.604 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.74 -26.95 60.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.027 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -68.24 -32.95 76.95 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.777 -0.725 . . . . 0.0 111.487 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.69 -32.58 71.26 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.937 0.398 . . . . 0.0 110.585 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -71.36 -35.07 71.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.889 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.65 -33.55 72.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.577 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.25 -22.06 63.87 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.521 179.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -83.5 -34.36 19.91 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.527 178.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -69.28 -42.39 75.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.773 0.321 . . . . 0.0 111.222 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 6.1 p -65.91 -39.31 90.46 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.445 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.68 -21.92 63.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.865 0.364 . . . . 0.0 110.805 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -84.0 -36.34 23.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.798 179.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 53.2 mt -81.11 -39.37 25.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.36 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -81.56 -19.41 66.21 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.581 -0.819 . . . . 0.0 111.827 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 15.0 m95 63.41 -170.44 0.18 Allowed 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 123.027 0.531 . . . . 0.0 111.234 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.91 107.75 11.64 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.762 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -57.63 -23.15 55.67 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.041 2.494 . . . . 0.0 112.946 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 4.2 m -68.5 -20.21 64.57 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.027 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.418 ' HA ' HD12 ' A' ' 131' ' ' ILE . 6.4 mt -102.62 5.21 10.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.039 0.447 . . . . 0.0 110.079 179.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -57.15 -63.74 5.04 Favored Glycine 0 C--N 1.334 0.418 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.546 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -58.67 -37.13 95.74 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.426 2.084 . . . . 0.0 112.171 178.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.418 HD12 ' HA ' ' A' ' 128' ' ' ILE . 15.7 mt -64.71 -44.36 96.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.844 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.447 ' O ' HG22 ' A' ' 135' ' ' ILE . 3.2 tp -67.54 -42.53 82.54 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.285 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -61.56 -42.86 99.84 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.871 -0.68 . . . . 0.0 111.862 178.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -68.39 -34.3 75.8 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.764 0.316 . . . . 0.0 110.996 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.447 HG22 ' O ' ' A' ' 132' ' ' LEU . 0.0 OUTLIER -72.07 -26.21 24.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.099 179.875 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.2 -35.23 79.18 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.935 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.01 -22.43 66.93 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.811 178.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.2 tp -80.41 -42.83 22.04 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.222 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 142' ' ' GLY . 0.8 OUTLIER -69.59 -16.46 63.41 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.124 179.583 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.43 -26.44 61.84 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.737 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 2.0 t -98.26 -19.22 6.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.776 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.449 ' O ' ' HA ' ' A' ' 139' ' ' THR . . . 153.47 -125.43 1.76 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.154 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 125.68 -152.23 17.91 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.264 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 173.58 169.25 35.71 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.138 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 3.6 m -75.18 -23.33 17.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.683 0.278 . . . . 0.0 111.378 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -62.38 -30.59 76.67 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.625 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.46 -49.36 71.74 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.678 0.275 . . . . 0.0 110.795 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.0 mp -63.52 -42.52 98.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.602 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.1 mt -62.08 -40.61 96.38 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.08 179.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.22 -44.04 97.47 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.852 0.358 . . . . 0.0 110.47 178.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.649 ' HA ' ' HB1' ' A' ' 8' ' ' ALA . 14.3 m-85 -65.11 -38.45 90.71 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.023 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 23.1 mm -62.59 -46.62 95.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.16 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.51 -38.23 90.28 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.61 0.243 . . . . 0.0 110.769 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -59.28 -39.28 94.44 Favored Glycine 0 C--N 1.335 0.503 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.423 179.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.49 ' O ' ' HD2' ' A' ' 158' ' ' PRO . 0.4 OUTLIER -84.24 -21.76 31.05 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.763 0.316 . . . . 0.0 110.787 178.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -62.1 -43.27 99.2 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.445 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.513 ' HB ' ' HD3' ' A' ' 158' ' ' PRO . 0.3 OUTLIER -54.78 -57.03 21.13 Favored Pre-proline 0 N--CA 1.472 0.647 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.513 ' HD3' ' HB ' ' A' ' 157' ' ' VAL . 38.1 Cg_exo -62.33 -40.37 40.74 Favored 'Trans proline' 0 C--N 1.359 1.106 0 C-N-CA 122.256 1.97 . . . . 0.0 112.681 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.7 -44.22 93.76 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.402 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.69 -44.19 82.39 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.058 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 157' ' ' VAL . 95.2 t -61.26 -44.72 98.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.62 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 55.4 t -66.36 -46.37 87.12 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.162 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.87 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -54.33 -38.18 65.7 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.737 0.303 . . . . 0.0 111.801 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.3 mt -75.31 -47.19 28.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.616 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -70.2 -25.7 63.54 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.449 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.578 ' O ' ' HB2' ' A' ' 170' ' ' LYS . . . -64.6 -25.85 68.15 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.129 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -77.58 -42.3 35.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.843 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.57 -46.11 89.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.11 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 3.7 pt -75.66 -20.55 15.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.676 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.578 ' HB2' ' O ' ' A' ' 166' ' ' ALA . 0.2 OUTLIER -62.01 -41.35 97.97 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.916 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -64.95 -38.81 95.94 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.01 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -75.62 -30.23 59.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.6 0.238 . . . . 0.0 111.113 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.405 ' HG ' ' HB3' ' A' ' 180' ' ' SER . 0.2 OUTLIER -60.46 -32.68 71.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.088 179.077 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.77 -17.47 38.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.921 0.391 . . . . 0.0 110.818 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 67.5 mtm-85 -91.23 -24.49 19.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.91 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -59.36 -48.96 79.64 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.208 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 133.04 -130.95 5.93 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.587 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -99.37 -3.23 34.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.846 0.355 . . . . 0.0 111.159 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 4.1 mt -69.51 -32.19 51.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.248 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . 0.405 ' HB3' ' HG ' ' A' ' 173' ' ' LEU . 0.1 OUTLIER -62.41 -26.87 68.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.295 179.501 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 15.0 t60 -71.31 -29.7 65.34 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.742 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.434 ' O ' ' HB2' ' A' ' 186' ' ' LEU . 0.9 OUTLIER -68.58 -32.7 72.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.812 -179.929 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 2.9 t -76.6 -22.43 15.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.565 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.69 -46.4 25.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.562 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.505 ' O ' HG23 ' A' ' 189' ' ' VAL . 16.9 m -75.05 -26.37 19.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.744 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.553 ' O ' HG23 ' A' ' 190' ' ' VAL . 2.2 tp -60.32 -47.3 86.63 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.073 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -63.81 -33.81 76.51 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.867 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.444 ' O ' HG23 ' A' ' 192' ' ' VAL . . . -67.94 -42.93 84.43 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.086 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 185' ' ' VAL . 87.0 t -60.91 -44.35 97.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-O 120.776 0.322 . . . . 0.0 110.767 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 186' ' ' LEU . 24.4 t -62.91 -42.22 95.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.903 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 1.1 mt -59.84 -42.72 94.22 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.732 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 188' ' ' GLY . 65.4 t -67.59 -43.82 86.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.2 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.3 tp -58.44 -45.67 88.05 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.917 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 70.4 t -62.61 -42.39 95.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.675 0.274 . . . . 0.0 110.546 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -62.18 -40.72 99.34 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.328 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 98.4 t -75.21 -41.13 44.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.543 0.211 . . . . 0.0 111.055 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.46 ' O ' ' HA3' ' A' ' 201' ' ' GLY . 1.8 mp -65.48 -23.62 66.95 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.155 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.54 -46.22 11.8 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.696 -0.229 . . . . 0.0 110.789 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -69.47 -49.38 55.37 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.932 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.69 -13.1 52.42 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.926 0.393 . . . . 0.0 111.108 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' A' ' 197' ' ' LEU . . . -88.66 -63.27 1.35 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.466 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 50.87 48.55 22.75 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.986 0.422 . . . . 0.0 111.548 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -119.84 150.44 40.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.931 0.396 . . . . 0.0 111.552 -179.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.412 ' H ' HG22 ' A' ' 204' ' ' THR . 0.1 OUTLIER -74.71 -36.17 62.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.369 -179.678 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -59.8 -27.09 66.28 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.918 0.389 . . . . 0.0 111.426 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 19.5 mt -67.25 -38.52 85.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.234 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -74.75 -29.26 61.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.258 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.31 -41.29 81.07 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.552 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -70.12 -27.39 64.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.768 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -72.56 -24.11 61.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.678 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.0 mp -81.2 -22.44 38.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.568 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.42 -7.5 58.44 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.69 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 27.9 mm -82.09 -14.99 12.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.114 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 1.7 m -65.98 118.19 49.86 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.429 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -57.7 128.73 30.31 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.305 2.003 . . . . 0.0 111.956 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -63.86 -17.03 62.75 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.247 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 7.8 m0 -70.08 -21.7 63.12 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.893 179.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 1.1 mt -89.08 -31.41 18.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.333 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -79.53 -24.81 41.95 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.316 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 1.9 mtt-85 . . . . . 0 N--CA 1.462 0.148 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.812 179.309 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.1 m . . . . . 0 CA--C 1.528 0.133 0 CA-C-O 121.079 0.466 . . . . 0.0 110.519 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -130.9 19.62 5.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.961 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.08 -34.39 76.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.055 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.06 -43.93 77.48 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.868 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.38 -42.42 98.68 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.751 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.51 -45.57 92.38 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.018 178.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.33 -33.69 76.3 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.929 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.409 ' O ' HG23 ' A' ' 13' ' ' VAL . 0.3 OUTLIER -69.19 -49.03 60.31 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.742 179.928 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.9 mt -58.71 -42.03 87.72 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.528 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.28 -41.74 99.03 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.267 178.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.46 -43.98 97.4 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 121.206 -0.521 . . . . 0.0 112.261 179.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 9' ' ' PHE . 98.2 t -62.71 -42.67 97.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.794 0.331 . . . . 0.0 110.192 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 14.1 mt -63.93 -42.09 97.46 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.465 179.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.5 m -65.95 -41.37 91.35 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.773 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -62.75 -39.35 93.85 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.984 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 87.2 mt -80.59 -13.48 59.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.038 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.468 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 4.1 p -83.79 137.54 41.0 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.592 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.488 ' HD3' HD13 ' A' ' 213' ' ' ILE . 23.2 Cg_exo -65.36 -8.56 19.2 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.64 2.226 . . . . 0.0 112.46 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 64.2 m -65.35 -24.43 67.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.174 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.1 t -111.2 18.2 7.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.393 0.616 . . . . 0.0 110.269 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.434 ' HB2' ' O ' ' A' ' 19' ' ' PRO . 0.5 OUTLIER -72.1 -48.23 10.65 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.406 179.051 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -59.37 -15.11 27.98 Favored 'Trans proline' 0 C--N 1.362 1.283 0 C-N-CA 122.337 2.024 . . . . 0.0 112.734 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.51 -12.81 60.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.316 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.409 ' HB ' ' CD ' ' A' ' 26' ' ' PRO . 92.7 t -77.41 -57.92 1.01 Allowed Pre-proline 0 CA--C 1.54 0.574 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.122 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.409 ' CD ' ' HB ' ' A' ' 25' ' ' VAL . 30.5 Cg_endo -63.43 -30.37 72.22 Favored 'Trans proline' 0 C--N 1.361 1.215 0 C-N-CA 122.21 1.94 . . . . 0.0 112.747 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.2 p -66.42 -32.11 73.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.603 -0.272 . . . . 0.0 110.933 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -65.28 -39.72 92.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.323 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.4 mt -67.47 -37.03 82.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.244 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -67.79 -38.62 83.59 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.949 178.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.596 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 6.5 m-85 -69.26 -38.76 78.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.366 178.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.3 mt -66.46 -34.71 78.54 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.512 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.2 4.34 86.26 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.934 -0.65 . . . . 0.0 111.825 178.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -91.4 56.31 3.15 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 121.319 -0.467 . . . . 0.0 112.265 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . 62.99 -101.06 0.09 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.072 0.549 . . . . 0.0 111.654 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 6.2 mtt85 -90.75 60.57 4.52 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.193 0.52 . . . . 0.0 111.036 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.596 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -103.28 75.91 0.29 Allowed Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.249 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 10.8 mtt180 -83.98 137.09 40.67 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-O 120.504 0.193 . . . . 0.0 110.924 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.655 ' HB3' ' HB1' ' A' ' 163' ' ' ALA . 44.0 Cg_exo -56.7 -47.03 25.57 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.956 2.438 . . . . 0.0 112.714 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.9 mp -62.24 -38.85 90.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.167 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -70.57 -39.06 74.11 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.393 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -64.89 -45.75 84.66 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.223 178.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.98 -35.95 81.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.836 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.5 tp -67.48 -48.1 68.12 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.714 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -66.73 -28.09 68.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.463 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.482 ' O ' ' HB2' ' A' ' 50' ' ' PHE . 0.2 OUTLIER -64.18 -50.71 67.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.558 178.815 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 38.2 mt -65.09 -39.08 84.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.865 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -68.81 -52.08 33.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.128 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -58.85 -43.45 96.61 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.17 178.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.482 ' HB2' ' O ' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -68.9 -36.8 78.47 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.542 0.21 . . . . 0.0 110.64 179.473 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -61.36 -45.71 95.88 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.541 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.43 -44.4 95.83 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.881 0.372 . . . . 0.0 110.78 179.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 95.9 t -65.91 -45.13 92.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.034 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -63.43 -30.26 71.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.271 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -78.4 -44.74 24.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.756 0.312 . . . . 0.0 110.682 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.33 -30.97 71.49 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.65 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.08 -18.48 27.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.866 0.365 . . . . 0.0 110.287 178.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.515 ' O ' ' HB2' ' A' ' 61' ' ' PHE . . . -75.03 -29.44 60.68 Favored Glycine 0 C--N 1.331 0.276 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.13 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.92 -55.61 43.0 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-O 119.872 -0.108 . . . . 0.0 111.166 178.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -69.83 -12.86 33.61 Favored 'Trans proline' 0 C--N 1.358 1.047 0 C-N-CA 122.186 1.924 . . . . 0.0 112.626 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.515 ' HB2' ' O ' ' A' ' 58' ' ' GLY . 0.1 OUTLIER -50.18 -34.26 21.97 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 179.926 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.22 -40.3 93.48 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.087 0.47 . . . . 0.0 110.871 179.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.61 -19.64 32.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.635 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.56 -18.37 62.25 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.91 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -64.05 -32.19 83.35 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 121.01 -0.614 . . . . 0.0 111.757 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -81.22 -22.9 59.92 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.794 179.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.421 HD13 ' HA ' ' A' ' 67' ' ' LEU . 1.1 mm? -82.5 -20.52 36.59 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.642 0.258 . . . . 0.0 110.921 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.3 tp -67.01 -22.54 65.9 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.898 179.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -70.4 -38.45 74.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.861 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -123.1 62.96 1.0 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.139 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -78.36 153.11 31.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.804 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.1 mtp180 -109.1 130.09 55.48 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.111 -179.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . 0.452 ' O ' ' HG3' ' A' ' 77' ' ' ARG . 67.8 mt-30 -73.69 -21.86 60.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.859 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.13 -25.87 68.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.294 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -80.55 -30.25 37.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.723 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.06 -21.9 49.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.911 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.452 ' HG3' ' O ' ' A' ' 73' ' ' GLN . 88.0 mtt-85 -69.58 -23.09 63.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.201 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.474 ' O ' HG23 ' A' ' 82' ' ' VAL . 21.8 t -63.47 -36.37 76.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.878 0.37 . . . . 0.0 110.405 179.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -65.53 -35.43 91.24 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.712 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.435 ' O ' HG23 ' A' ' 84' ' ' VAL . . . -66.36 -38.48 93.66 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.324 178.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 77' ' ' ARG . 58.4 t -59.95 -43.71 92.92 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-O 120.907 0.384 . . . . 0.0 110.1 178.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 78' ' ' VAL . 33.0 t -61.98 -39.66 84.48 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.448 179.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.07 -43.72 97.77 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.519 179.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 80' ' ' GLY . 97.2 t -62.95 -43.28 98.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-O 121.003 0.43 . . . . 0.0 110.05 178.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.5 mp -62.88 -40.42 97.49 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.467 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -63.47 -41.74 98.6 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -59.57 -40.32 96.18 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.7 178.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.451 ' HA ' HD12 ' A' ' 91' ' ' LEU . 10.8 mt -65.61 -37.22 85.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.753 0.311 . . . . 0.0 110.7 179.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -72.01 -36.05 69.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.912 0.387 . . . . 0.0 110.644 179.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 46.6 mmm -70.27 -22.03 62.91 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.86 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.451 HD12 ' HA ' ' A' ' 88' ' ' LEU . 4.1 mt -70.52 -2.99 15.77 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.084 178.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.67 10.71 66.98 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.916 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 17.3 mt -78.16 122.22 25.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.938 0.369 . . . . 0.0 110.569 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 . . . . . 0 C--N 1.326 -0.455 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.785 -179.361 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.919 0.39 . . . . 0.0 111.097 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.6 -20.56 50.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.975 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.414 ' N ' ' HD2' ' A' ' 110' ' ' PRO . 0.9 OUTLIER -77.89 -56.42 1.09 Allowed Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.665 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.414 ' HD2' ' N ' ' A' ' 109' ' ' ARG . 28.6 Cg_endo -62.35 -35.26 74.06 Favored 'Trans proline' 0 C--N 1.362 1.248 0 C-N-CA 122.012 1.808 . . . . 0.0 112.198 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -81.46 -21.85 38.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.085 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -68.4 -41.2 85.98 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.772 -0.728 . . . . 0.0 111.369 178.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -72.3 -33.9 67.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.741 0.305 . . . . 0.0 110.521 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.76 -36.17 72.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.076 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.1 tp -67.29 -48.46 67.57 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.711 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 12.0 mt -67.41 -29.54 69.06 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.448 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -72.68 -48.69 21.37 Favored Glycine 0 N--CA 1.451 -0.361 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 178.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.73 -36.33 80.67 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.75 0.31 . . . . 0.0 110.738 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 90.7 m -64.73 -43.24 94.03 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.884 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.76 -29.65 68.09 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.806 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -77.5 -31.66 53.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.004 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -79.16 -24.83 43.0 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.04 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -86.88 160.39 32.38 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.75 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -96.8 120.93 38.04 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 122.429 -0.454 . . . . 0.0 111.0 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.443 ' O ' HG22 ' A' ' 128' ' ' ILE . 0.2 OUTLIER -80.93 114.06 45.49 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.849 179.71 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -59.87 -16.94 41.02 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.763 2.308 . . . . 0.0 112.985 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 11.1 t -77.04 -26.55 53.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.753 0.311 . . . . 0.0 110.903 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.443 HG22 ' O ' ' A' ' 125' ' ' THR . 1.4 tp -99.98 -4.72 9.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.124 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -56.57 -64.38 4.45 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 115.942 -0.572 . . . . 0.0 113.159 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -58.13 -37.95 93.47 Favored 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 122.459 2.106 . . . . 0.0 112.413 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.497 ' O ' HG13 ' A' ' 135' ' ' ILE . 69.2 mt -61.94 -46.07 97.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.865 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.78 -39.97 95.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.001 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -62.94 -36.6 93.65 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.78 178.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -68.32 -39.9 81.83 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.576 0.227 . . . . 0.0 111.061 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.497 HG13 ' O ' ' A' ' 131' ' ' ILE . 70.4 mt -63.06 -32.97 58.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.075 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.37 -34.8 79.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.111 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -84.88 -22.07 29.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.904 178.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.9 -29.67 58.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.986 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -81.62 -16.22 52.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.04 0.448 . . . . 0.0 110.712 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -77.93 -28.6 49.7 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.666 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 7.3 m -102.6 4.87 10.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.986 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -169.68 97.73 0.13 Allowed Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.182 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -85.42 81.25 1.75 Allowed Glycine 0 CA--C 1.517 0.187 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.685 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -124.57 106.6 0.94 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.509 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -69.2 -23.77 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 121.011 0.434 . . . . 0.0 111.06 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -65.77 -30.36 77.07 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.139 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.26 -43.36 86.68 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.788 0.328 . . . . 0.0 110.62 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.57 -40.24 92.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.9 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.69 -42.04 87.09 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.335 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.82 -32.75 74.36 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.447 179.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -63.32 -49.88 72.22 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.741 179.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 10.2 mt -61.02 -44.35 98.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.989 0.423 . . . . 0.0 110.535 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.3 -34.04 74.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.409 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -59.92 -36.93 91.74 Favored Glycine 0 C--N 1.334 0.471 0 C-N-CA 121.267 -0.492 . . . . 0.0 112.105 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.538 ' C ' ' HD2' ' A' ' 158' ' ' PRO . 5.5 mt -86.36 -22.6 26.57 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 120.842 0.354 . . . . 0.0 110.97 178.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -61.21 -49.55 76.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.052 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.782 HG13 ' HD3' ' A' ' 158' ' ' PRO . 0.3 OUTLIER -54.6 -51.59 77.24 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.331 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.782 ' HD3' HG13 ' A' ' 157' ' ' VAL . 43.4 Cg_exo -58.96 -40.78 68.2 Favored 'Trans proline' 0 C--N 1.36 1.147 0 C-N-CA 122.138 1.892 . . . . 0.0 112.346 178.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -60.6 -40.38 91.59 Favored 'General case' 0 CA--C 1.522 -0.1 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.336 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -65.65 -43.38 89.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.794 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 157' ' ' VAL . 40.1 t -63.37 -44.04 98.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.809 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 158' ' ' PRO . 84.9 t -67.73 -49.11 72.82 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.906 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.655 ' HB1' ' HB3' ' A' ' 39' ' ' PRO . . . -57.98 -32.26 67.71 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.644 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.4 -48.79 54.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.301 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -71.27 -33.65 69.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.702 0.287 . . . . 0.0 110.82 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.615 ' HA ' HG22 ' A' ' 169' ' ' ILE . . . -68.97 -21.03 64.2 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.019 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -72.31 -35.63 68.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.169 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 13.4 mmm180 -84.82 -42.71 14.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.23 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.615 HG22 ' HA ' ' A' ' 166' ' ' ALA . 3.3 tt -68.41 -19.99 24.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.277 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.43 ' HB2' ' O ' ' A' ' 166' ' ' ALA . 0.8 OUTLIER -57.46 -36.4 71.38 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.313 179.59 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -70.0 -30.28 70.13 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.579 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 1.4 m95 -86.82 -47.41 9.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.76 0.314 . . . . 0.0 111.469 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 4.7 mt -66.89 -16.49 64.35 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.701 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.43 ' HB2' ' O ' ' A' ' 170' ' ' LYS . 9.9 ttt-85 -56.79 -53.25 60.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.998 0.428 . . . . 0.0 110.984 178.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 8.1 mtm180 -93.77 -16.39 24.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.348 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -94.19 4.7 53.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.71 0.29 . . . . 0.0 111.554 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -83.13 9.5 60.58 Favored Glycine 0 CA--C 1.517 0.183 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.681 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 22.2 mtt180 -67.79 -38.65 83.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.943 0.401 . . . . 0.0 110.611 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -81.39 -29.5 10.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.467 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.95 -16.74 64.2 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.108 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' HIS . . . . . 0.468 ' O ' HG23 ' A' ' 185' ' ' VAL . 0.3 OUTLIER -57.27 -31.99 66.16 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.225 179.701 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.32 -44.2 88.61 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.045 0.45 . . . . 0.0 110.412 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 2.2 t -72.17 -19.67 19.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.781 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.79 -44.82 31.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.133 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 181' ' ' HIS . 46.7 t -67.64 -41.24 85.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.549 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.455 ' O ' HG23 ' A' ' 190' ' ' VAL . 0.3 OUTLIER -60.9 -47.9 84.26 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.739 179.504 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -62.35 -36.45 82.26 Favored 'General case' 0 N--CA 1.457 -0.092 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.384 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.46 ' O ' HG23 ' A' ' 192' ' ' VAL . . . -64.0 -46.5 91.2 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.98 -0.629 . . . . 0.0 111.951 178.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 86.8 t -62.18 -48.95 86.06 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 CA-C-O 120.555 0.217 . . . . 0.0 110.616 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 186' ' ' LEU . 76.6 t -59.3 -38.33 74.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.898 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 2.7 tp -62.22 -46.07 90.49 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.778 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 188' ' ' GLY . 61.7 t -66.19 -38.38 81.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.256 179.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 9.0 mt -59.05 -54.24 49.35 Favored 'General case' 0 C--N 1.334 -0.094 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.308 179.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 32.6 m -68.56 -29.74 44.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.861 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -66.65 -47.08 70.66 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.449 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 6.1 p -72.17 -31.33 39.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-O 120.722 0.296 . . . . 0.0 110.79 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 197' ' ' LEU . 11.9 mt -67.52 -38.09 83.75 Favored 'General case' 0 N--CA 1.458 -0.069 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.238 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.77 -33.36 60.19 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 121.024 -0.27 . . . . 0.0 110.747 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -66.5 -47.16 73.89 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.792 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 10.1 t -81.76 -11.11 59.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.212 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -87.79 -51.77 3.15 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.557 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 53.87 37.83 27.38 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.037 0.446 . . . . 0.0 111.229 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -139.72 -167.58 2.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.692 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.48 56.21 1.37 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.686 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -82.37 -19.5 39.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.009 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 8.8 tp -70.65 -32.92 70.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.807 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -70.22 -40.79 74.31 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.017 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.8 -32.07 71.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.97 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . 0.443 ' O ' HG13 ' A' ' 213' ' ' ILE . 5.9 m-85 -80.84 -43.91 19.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.025 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -61.9 -32.7 73.11 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.458 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.77 -18.08 65.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.752 0.31 . . . . 0.0 111.188 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.48 -24.39 18.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.844 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . 0.488 HD13 ' HD3' ' A' ' 19' ' ' PRO . 1.9 mt -92.4 -19.05 7.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.276 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 88.3 m -70.48 120.01 76.02 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.716 179.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -72.17 151.26 54.87 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.4 2.066 . . . . 0.0 112.076 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.06 -16.27 63.65 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.35 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 15.0 m95 -70.13 -25.46 63.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.16 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 1.3 mp -82.68 -23.47 34.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.961 0.41 . . . . 0.0 110.311 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 59.6 mt-30 -78.17 -21.98 49.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.393 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 36.5 mmt-85 . . . . . 0 C--N 1.332 -0.176 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.954 179.541 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.845 0.355 . . . . 0.0 110.994 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.7 mt -73.66 -21.95 60.12 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.499 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.88 -30.47 69.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.648 179.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -74.39 -44.1 53.56 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.666 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -58.32 -46.52 86.0 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.726 179.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.85 -47.94 78.72 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.932 179.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.605 ' HB1' ' HA3' ' A' ' 154' ' ' GLY . . . -58.58 -40.61 83.65 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.295 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.84 -49.78 64.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.498 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 14.2 tp -57.5 -43.91 84.57 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.609 178.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.76 -45.88 91.98 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.062 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.8 -45.0 96.51 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.244 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 67.9 t -68.09 -39.42 81.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.521 0.2 . . . . 0.0 110.606 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.486 ' O ' ' HB2' ' A' ' 18' ' ' SER . 0.2 OUTLIER -61.16 -46.57 89.96 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.871 179.516 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 43.2 m -64.35 -36.12 83.09 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.728 0.299 . . . . 0.0 111.167 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -72.18 -38.39 69.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.746 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.48 -11.66 59.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.847 0.356 . . . . 0.0 111.115 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.486 ' HB2' ' O ' ' A' ' 14' ' ' LEU . 0.2 OUTLIER -87.05 134.08 37.62 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.387 179.239 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.94 -7.96 22.05 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.653 2.236 . . . . 0.0 112.537 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -106.28 147.27 29.35 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.481 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.531 HG22 HG21 ' A' ' 125' ' ' THR . 6.5 t 60.65 65.69 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-O 121.384 0.612 . . . . 0.0 110.874 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 30.5 mt -109.07 116.68 55.06 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.285 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.11 -24.31 44.89 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.767 2.311 . . . . 0.0 112.688 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.81 -19.27 65.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.471 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 54.1 t -64.99 -60.15 8.65 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.291 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.92 -24.91 77.92 Favored 'Trans proline' 0 C--N 1.361 1.196 0 C-N-CA 121.985 1.79 . . . . 0.0 112.547 178.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.7 m -65.2 -39.83 93.35 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.844 0.354 . . . . 0.0 110.815 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -69.02 -31.24 69.91 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.739 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.83 -41.48 44.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.369 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -59.48 -41.95 90.97 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.041 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -73.99 -28.7 61.59 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.806 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.68 -28.9 64.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.267 179.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.452 ' O ' ' HD3' ' A' ' 110' ' ' PRO . . . -74.1 -32.18 58.79 Favored Glycine 0 N--CA 1.448 -0.567 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.066 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.69 83.86 1.52 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.328 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -124.5 -68.34 0.86 Allowed 'General case' 0 C--N 1.328 -0.341 0 O-C-N 122.923 -0.163 . . . . 0.0 111.246 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 18.8 mtt180 57.93 38.68 27.0 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.271 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -104.15 61.55 0.42 Allowed Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.359 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 58.38 82.82 0.23 Allowed Pre-proline 0 N--CA 1.468 0.451 0 C-N-CA 122.894 0.478 . . . . 0.0 111.522 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -57.36 -30.11 86.66 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.861 2.374 . . . . 0.0 112.586 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.9 -38.32 90.45 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.34 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -77.13 -37.12 54.72 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.499 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 19.9 t30 -65.59 -36.06 82.66 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.222 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.566 ' O ' HG12 ' A' ' 47' ' ' ILE . . . -61.61 -54.83 37.68 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.615 178.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 74.2 mt -56.23 -39.75 73.02 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.2 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -63.95 -45.89 87.16 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.826 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -63.91 -42.73 97.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.948 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.566 HG12 ' O ' ' A' ' 43' ' ' ALA . 48.8 mm -64.89 -41.08 91.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.656 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.3 tp -65.28 -45.98 82.29 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 179.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.535 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -60.74 -42.94 99.62 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.755 179.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.18 -40.83 86.62 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.619 0.247 . . . . 0.0 110.959 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -62.06 -39.38 97.53 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.86 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.9 -47.92 73.2 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.459 0.171 . . . . 0.0 110.88 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 49' ' ' GLY . 57.8 t -61.87 -40.23 86.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.033 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.33 -45.86 78.85 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.323 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -68.18 -38.54 82.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.4 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.54 -32.95 74.62 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.12 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.29 -18.75 26.35 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.977 0.418 . . . . 0.0 110.802 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -79.24 -25.3 59.63 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 121.127 -0.558 . . . . 0.0 112.299 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.88 -56.41 29.11 Favored Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 111.464 0.172 . . . . 0.0 111.464 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -70.13 -14.03 34.44 Favored 'Trans proline' 0 C--N 1.362 1.253 0 C-N-CA 122.023 1.815 . . . . 0.0 112.646 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -63.76 -19.74 65.21 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.318 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.0 m -63.53 -45.14 91.95 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.012 0.434 . . . . 0.0 110.651 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.72 -21.18 24.0 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.102 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.93 -18.05 58.53 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.785 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -63.25 -26.31 69.23 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.067 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -78.75 -24.53 62.18 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.89 -0.672 . . . . 0.0 111.769 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 54.9 mt -87.35 -20.73 26.33 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.69 0.281 . . . . 0.0 110.652 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.5 -19.32 64.66 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.647 179.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -65.3 -17.45 64.52 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.837 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -84.33 179.07 7.53 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.268 0.556 . . . . 0.0 110.353 178.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -80.23 72.36 7.05 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.299 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' A' ' 72' ' ' ARG . 8.0 mtt180 -114.26 25.3 11.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.386 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -78.38 -18.19 55.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.985 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.35 -20.21 65.96 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.469 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.4 -28.32 67.83 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.662 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.1 -23.53 28.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.428 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -64.66 -29.21 70.21 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.157 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.1 t -63.73 -21.41 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.625 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -66.58 -29.61 75.05 Favored Glycine 0 C--N 1.336 0.546 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.715 179.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.503 ' O ' HG23 ' A' ' 84' ' ' VAL . . . -74.23 -38.69 45.94 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.51 -0.852 . . . . 0.0 111.169 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.9 t -59.13 -48.87 85.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-O 120.825 0.345 . . . . 0.0 111.05 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.2 m -69.07 -31.35 49.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.107 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.495 HD13 ' HA2' ' A' ' 195' ' ' GLY . 0.4 OUTLIER -64.72 -43.13 94.4 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.673 179.103 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 80' ' ' GLY . 74.1 t -65.54 -40.09 87.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.21 179.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.89 -41.02 95.21 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.636 179.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -66.25 -37.7 86.12 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.4 179.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -65.25 -39.65 96.16 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.713 178.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.53 -39.92 95.67 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.738 0.304 . . . . 0.0 110.654 179.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -71.62 -32.03 67.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.554 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.87 -19.81 61.23 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.903 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.48 -3.5 8.71 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.375 178.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 108.49 6.43 31.14 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.681 -0.771 . . . . 0.0 113.147 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.96 121.06 12.04 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 117.083 0.441 . . . . 0.0 110.499 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 6.9 mtt180 . . . . . 0 C--N 1.324 -0.522 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.663 -179.583 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.132 0 CA-C-O 120.926 0.393 . . . . 0.0 111.452 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.74 -2.48 58.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.062 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.464 ' N ' ' HD2' ' A' ' 110' ' ' PRO . 0.9 OUTLIER -64.39 -53.19 48.02 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.351 -179.745 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 109' ' ' ARG . 15.8 Cg_endo -57.88 -36.27 98.3 Favored 'Trans proline' 0 C--N 1.362 1.242 0 C-N-CA 122.171 1.914 . . . . 0.0 112.617 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -75.07 -31.11 61.16 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.34 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -74.48 -25.8 69.41 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 178.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -64.31 -36.77 85.19 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.802 0.334 . . . . 0.0 110.887 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.17 -40.71 71.1 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.652 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.9 tp -68.79 -36.08 77.82 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.349 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.14 -22.13 61.36 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.201 0.525 . . . . 0.0 110.22 178.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -80.27 -44.31 8.91 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.79 -40.07 96.2 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.522 0.201 . . . . 0.0 111.17 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.4 p -65.31 -38.94 91.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.967 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.69 -24.79 61.88 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.654 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -80.21 -35.02 36.87 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.952 0.406 . . . . 0.0 110.371 179.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 72.5 mt -78.46 -26.14 46.05 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.314 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -76.71 160.35 50.45 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.768 178.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 14.9 p90 -112.62 154.38 26.13 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.978 0.418 . . . . 0.0 110.86 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.574 ' HB ' ' SG ' ' A' ' 127' ' ' CYS . 0.8 OUTLIER -109.32 104.39 55.04 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.519 179.424 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.97 -18.26 56.44 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.115 2.543 . . . . 0.0 113.203 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . 0.574 ' SG ' ' HB ' ' A' ' 125' ' ' THR . 0.8 OUTLIER -64.88 -37.45 87.68 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.14 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 pt -103.45 4.79 10.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.24 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -58.89 -68.59 1.61 Allowed Glycine 0 C--N 1.334 0.472 0 CA-C-N 116.046 -0.525 . . . . 0.0 112.756 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.51 -31.61 92.63 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.348 2.032 . . . . 0.0 111.878 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.401 ' O ' HG12 ' A' ' 135' ' ' ILE . 60.6 mt -63.69 -55.83 20.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.888 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.43 -34.7 77.76 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.708 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -61.88 -36.2 92.45 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.226 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -75.61 -36.7 60.19 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.833 0.349 . . . . 0.0 111.086 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.401 HG12 ' O ' ' A' ' 131' ' ' ILE . 46.7 mm -70.48 -35.33 61.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.971 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.97 -30.17 70.74 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.118 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.88 -26.97 64.44 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.941 0.4 . . . . 0.0 110.75 178.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 8.7 mt -84.52 -38.75 19.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.893 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 16.0 p -70.11 -16.3 63.09 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.473 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -75.86 -29.48 58.57 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.791 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 2.1 t -96.81 -32.77 4.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.592 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -150.15 90.76 0.14 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.318 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -162.92 -97.59 0.12 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.601 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 111.56 -179.77 19.84 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.49 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 6.2 t -75.0 -31.11 24.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 120.67 0.271 . . . . 0.0 111.0 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -60.44 -32.67 78.35 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.669 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.87 -40.87 83.55 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.853 0.358 . . . . 0.0 110.426 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.417 ' O ' HG13 ' A' ' 152' ' ' ILE . 17.0 mt -62.35 -42.52 99.46 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.486 179.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 30.7 mt -65.77 -39.82 91.41 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.508 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.18 -40.11 96.58 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.385 178.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -61.49 -44.8 96.43 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.026 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.417 HG13 ' O ' ' A' ' 148' ' ' LEU . 53.9 mt -64.39 -49.0 82.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.633 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.427 ' O ' HG23 ' A' ' 157' ' ' VAL . 0.1 OUTLIER -66.55 -34.57 78.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.928 -179.941 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . 0.605 ' HA3' ' HB1' ' A' ' 8' ' ' ALA . . . -60.55 -44.82 97.34 Favored Glycine 0 C--O 1.223 -0.546 0 C-N-CA 121.176 -0.535 . . . . 0.0 112.189 179.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.45 -28.17 61.81 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.166 0.508 . . . . 0.0 110.561 178.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -64.4 -35.34 80.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.438 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.495 ' O ' HG23 ' A' ' 161' ' ' VAL . 96.7 t -55.38 -62.79 3.83 Favored Pre-proline 0 CA--C 1.542 0.643 0 O-C-N 123.272 0.358 . . . . 0.0 111.595 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.478 ' CD ' ' HB ' ' A' ' 157' ' ' VAL . 18.0 Cg_endo -60.15 -36.09 89.96 Favored 'Trans proline' 0 C--N 1.359 1.127 0 C-N-CA 122.04 1.827 . . . . 0.0 112.225 179.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -59.66 -46.44 89.02 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-O 120.739 0.304 . . . . 0.0 110.944 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -63.57 -39.41 94.32 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.942 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 157' ' ' VAL . 52.8 t -61.27 -43.59 96.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-O 120.927 0.394 . . . . 0.0 110.321 179.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 158' ' ' PRO . 61.0 t -68.36 -38.58 79.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.647 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -58.56 -35.6 72.62 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.779 0.323 . . . . 0.0 111.313 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 17.1 mt -78.96 -42.63 26.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.194 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.78 -19.24 62.04 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.224 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.556 ' HA ' HD12 ' A' ' 169' ' ' ILE . . . -66.01 -19.85 65.99 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.158 179.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -64.29 -39.76 94.58 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.782 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 16.5 mtt180 -69.16 -24.17 64.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.649 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.556 HD12 ' HA ' ' A' ' 166' ' ' ALA . 26.4 mt -83.38 -22.42 8.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.427 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -62.76 -38.17 89.49 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.749 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -75.85 -36.23 42.7 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.664 -0.779 . . . . 0.0 111.882 179.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 1.8 m95 -73.92 -26.95 60.79 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.525 0.194 . . . . 0.0 111.525 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 2.3 tp -57.49 -36.53 71.62 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.709 0.29 . . . . 0.0 111.367 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 1.1 mtp-105 -87.07 -20.45 27.11 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.136 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -83.78 -34.13 24.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.921 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.421 ' HB1' ' HB ' ' A' ' 179' ' ' ILE . . . -62.55 -65.19 0.72 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.793 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 79.78 -64.85 3.81 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.969 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 9.4 mtm180 -81.18 -40.14 24.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.722 0.296 . . . . 0.0 111.285 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.421 ' HB ' ' HB1' ' A' ' 176' ' ' ALA . 14.3 mm -69.04 -31.4 50.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.051 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -63.33 -26.64 68.86 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.048 0.452 . . . . 0.0 111.092 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -84.8 -22.01 29.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.128 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -75.63 -28.79 58.96 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.825 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 17.4 t -65.54 -25.37 36.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.703 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -82.41 -37.98 24.72 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.768 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.8 t -70.99 -46.3 68.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.891 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 5.2 tp -62.32 -52.67 62.72 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.282 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -64.42 -35.09 79.79 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.02 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.425 ' O ' HG23 ' A' ' 192' ' ' VAL . . . -62.41 -49.96 69.17 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.21 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 96.4 t -62.0 -46.99 95.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 120.479 0.181 . . . . 0.0 110.783 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.471 ' O ' HG23 ' A' ' 194' ' ' VAL . 85.9 t -59.33 -43.15 89.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.878 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 5.4 tp -58.43 -48.85 79.34 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.756 0.312 . . . . 0.0 111.228 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.531 ' O ' HG23 ' A' ' 196' ' ' VAL . 41.4 t -66.06 -40.85 88.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.465 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . 0.448 ' O ' ' HB2' ' A' ' 197' ' ' LEU . 2.2 tp -58.77 -50.08 75.28 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.681 179.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 190' ' ' VAL . 87.7 t -61.1 -39.75 83.41 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.434 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.495 ' HA2' HD13 ' A' ' 83' ' ' LEU . . . -57.86 -48.03 84.87 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.611 179.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 192' ' ' VAL . 4.2 t -73.87 -34.89 41.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.726 0.298 . . . . 0.0 110.517 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . 0.539 ' O ' ' HA3' ' A' ' 201' ' ' GLY . 0.5 OUTLIER -63.1 -28.31 69.99 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.714 179.236 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.652 HD23 HD11 ' A' ' 206' ' ' LEU . 65.0 mt -80.38 -42.54 22.65 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.818 178.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -70.79 -57.6 4.48 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 68.2 p -81.46 -9.26 59.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.803 0.335 . . . . 0.0 111.727 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . 0.693 ' HA2' ' HB3' ' A' ' 205' ' ' ALA . . . -84.67 -54.21 3.0 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.436 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 28.5 m 67.23 -72.2 0.09 Allowed 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 122.845 0.458 . . . . 0.0 111.521 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -163.84 -50.19 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.523 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.91 -46.2 90.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.35 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . 0.693 ' HB3' ' HA2' ' A' ' 201' ' ' GLY . . . -84.8 -19.52 32.41 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.738 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.652 HD11 HD23 ' A' ' 198' ' ' LEU . 1.1 mt -77.27 -36.86 54.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.889 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.98 -39.59 95.16 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.625 -0.261 . . . . 0.0 110.949 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.52 -37.82 73.67 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.342 178.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -87.04 -24.52 24.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.167 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -67.65 -17.19 64.51 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.978 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.0 mt -61.35 -30.84 70.77 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 121.019 0.437 . . . . 0.0 110.722 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 3.2 mtt180 -92.91 -3.61 54.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.711 179.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 37.0 mm -103.21 -20.16 5.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.941 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.56 119.7 45.9 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.047 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.46 151.63 65.17 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.304 2.003 . . . . 0.0 112.254 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -64.61 -22.42 66.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.191 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 8.0 m-90 -63.55 -24.8 67.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.303 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 16.0 mt -89.53 -27.22 20.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.94 0.4 . . . . 0.0 110.399 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.04 -35.43 31.84 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.363 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 1.4 mtp180 . . . . . 0 C--N 1.331 -0.221 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.03 179.502 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.544 0.211 . . . . 0.0 110.943 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 8.2 mt -76.17 -20.94 57.08 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.505 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.75 -26.21 64.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.687 179.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.8 mt -77.4 -46.1 23.78 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.562 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -60.51 -39.81 89.13 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.796 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.76 -46.02 89.97 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.737 178.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.97 -35.12 79.11 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.769 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.474 ' O ' HG23 ' A' ' 13' ' ' VAL . 1.2 m-85 -65.56 -51.74 57.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.18 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.43 -39.02 82.18 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.29 178.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.23 -44.17 97.7 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.425 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.81 -42.9 99.8 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 120.888 -0.672 . . . . 0.0 111.835 178.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 9' ' ' PHE . 49.1 t -65.61 -41.31 90.38 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-O 120.719 0.295 . . . . 0.0 110.307 179.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.4 tp -63.99 -41.72 97.41 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.456 179.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 18.9 m -64.34 -35.78 81.98 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.726 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -72.04 -36.08 69.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.988 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.8 -4.86 59.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.811 0.339 . . . . 0.0 111.077 179.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.0 t -68.89 119.87 72.37 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.805 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.573 ' HD3' HG21 ' A' ' 213' ' ' ILE . 39.3 Cg_endo -67.3 -8.07 20.89 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.84 2.36 . . . . 0.0 112.697 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 2.2 t -73.38 -25.31 60.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.841 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.4 m -130.82 5.78 2.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.666 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.411 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 0.3 OUTLIER -70.77 -53.72 8.82 Favored Pre-proline 0 CA--C 1.538 0.504 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 179.896 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.411 ' HD2' ' N ' ' A' ' 22' ' ' LEU . 46.0 Cg_endo -68.97 -14.71 39.1 Favored 'Trans proline' 0 C--N 1.361 1.201 0 C-N-CA 121.888 1.725 . . . . 0.0 112.432 179.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.1 mp -81.28 -16.13 53.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.459 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.466 ' N ' ' HD2' ' A' ' 26' ' ' PRO . 95.0 t -62.86 -55.2 40.31 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-O 119.725 -0.179 . . . . 0.0 111.289 178.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.602 ' HA ' HD12 ' A' ' 29' ' ' LEU . 14.4 Cg_endo -58.05 -33.06 96.87 Favored 'Trans proline' 0 C--N 1.362 1.246 0 C-N-CA 122.275 1.984 . . . . 0.0 112.505 178.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.54 -36.64 65.69 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.791 0.329 . . . . 0.0 110.943 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.0 -28.5 68.3 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.021 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.602 HD12 ' HA ' ' A' ' 26' ' ' PRO . 8.3 mt -63.06 -37.52 87.51 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.718 179.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.58 -35.52 67.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.065 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -66.75 -37.14 84.05 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.336 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.63 -15.18 60.83 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.23 178.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -67.65 -24.96 74.08 Favored Glycine 0 C--N 1.332 0.346 0 N-CA-C 111.77 -0.532 . . . . 0.0 111.77 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.53 -16.35 80.1 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.985 -0.626 . . . . 0.0 111.54 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -126.9 51.39 1.87 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.975 0.417 . . . . 0.0 109.988 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.7 70.79 1.4 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.39 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -146.48 84.95 0.18 Allowed Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.548 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.2 mtp180 66.4 91.25 0.08 OUTLIER Pre-proline 0 N--CA 1.467 0.416 0 C-N-CA 122.922 0.489 . . . . 0.0 111.16 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -64.09 -30.24 65.67 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.434 2.089 . . . . 0.0 112.466 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.4 mp -62.55 -40.83 98.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.279 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -72.47 -37.35 68.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.615 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -67.57 -43.8 79.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.393 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.05 -50.68 67.44 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.769 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.74 -42.68 75.75 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.219 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -63.85 -41.31 97.84 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.876 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.28 -41.47 94.15 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.37 179.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 54.6 mt -62.96 -42.43 96.6 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.943 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.31 -44.07 92.74 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.468 179.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.514 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -59.27 -43.71 97.04 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.862 -0.685 . . . . 0.0 111.693 178.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.02 -37.24 81.16 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.76 0.314 . . . . 0.0 110.242 179.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -63.17 -41.93 99.55 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 178.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.42 -45.99 87.38 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 120.509 0.195 . . . . 0.0 110.635 178.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 49' ' ' GLY . 24.7 t -63.41 -43.02 98.29 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.837 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -66.04 -28.2 68.67 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.426 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -82.82 -47.39 11.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.561 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.59 -35.71 80.4 Favored 'General case' 0 C--O 1.227 -0.109 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.85 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.42 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 0.9 OUTLIER -89.52 -18.35 26.82 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.792 0.33 . . . . 0.0 110.497 178.488 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.28 -35.68 83.12 Favored Glycine 0 C--N 1.33 0.204 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.41 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.406 ' CB ' ' HD3' ' A' ' 60' ' ' PRO . 0.5 OUTLIER -63.23 -55.63 34.65 Favored Pre-proline 0 CA--C 1.543 0.687 0 N-CA-C 111.49 0.182 . . . . 0.0 111.49 179.197 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.42 ' HD2' ' C ' ' A' ' 57' ' ' LEU . 13.6 Cg_exo -70.47 -13.96 33.4 Favored 'Trans proline' 0 C--N 1.361 1.185 0 C-N-CA 122.517 2.144 . . . . 0.0 112.629 179.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.63 -25.74 64.92 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.119 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.5 -34.72 76.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.032 0.444 . . . . 0.0 110.403 178.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.57 -19.81 25.84 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.618 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.402 ' HA ' HD12 ' A' ' 67' ' ' LEU . 0.3 OUTLIER -67.25 -17.78 64.94 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.863 179.874 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.32 -27.5 65.57 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.947 -0.644 . . . . 0.0 111.901 179.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -78.38 -22.06 68.46 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.582 179.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.402 HD12 ' HA ' ' A' ' 64' ' ' LEU . 13.9 mt -87.12 -20.56 26.89 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.646 0.26 . . . . 0.0 110.415 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.86 -19.42 62.6 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.916 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -60.45 -26.0 66.42 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.758 178.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -97.59 125.18 42.17 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -74.59 98.74 3.45 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.026 0.441 . . . . 0.0 111.419 -179.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -87.1 64.79 8.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.984 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -67.45 -19.79 65.41 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.135 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.0 t -69.99 -17.76 63.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.3 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.53 -22.51 30.13 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.883 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.44 -22.4 38.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.862 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.61 -27.14 66.65 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.92 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.495 ' O ' HG23 ' A' ' 82' ' ' VAL . 3.3 t -63.0 -32.47 56.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.798 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -64.31 -34.98 91.37 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.033 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.446 ' O ' HG23 ' A' ' 84' ' ' VAL . . . -66.72 -38.9 93.49 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.666 179.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.9 t -62.53 -41.22 91.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-O 120.766 0.317 . . . . 0.0 110.462 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 78' ' ' VAL . 40.5 t -63.8 -40.54 89.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.383 179.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.1 -42.72 99.65 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.718 179.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 80' ' ' GLY . 94.5 t -64.02 -43.52 97.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.392 179.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.86 -43.33 98.53 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.952 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -66.15 -43.53 86.72 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.743 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -62.83 -40.14 98.87 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.148 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.2 -36.45 83.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.724 0.297 . . . . 0.0 110.613 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -74.74 -30.09 61.38 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.283 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 28.5 mmt -67.07 -27.94 67.78 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.29 178.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.4 mp -66.96 -10.51 50.07 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.265 178.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.41 20.22 59.02 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.85 -0.69 . . . . 0.0 113.259 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -78.42 124.14 27.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.93 0.365 . . . . 0.0 110.594 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.679 -179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.169 0 CA-C-O 121.084 0.469 . . . . 0.0 111.054 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.25 -12.55 59.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.15 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.419 ' CB ' ' HD3' ' A' ' 110' ' ' PRO . 0.0 OUTLIER -74.26 -58.46 1.93 Allowed Pre-proline 0 CA--C 1.539 0.53 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -179.571 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.419 ' HD3' ' CB ' ' A' ' 109' ' ' ARG . 23.8 Cg_exo -64.8 -40.21 22.8 Favored 'Trans proline' 0 C--N 1.358 1.047 0 C-N-CA 122.055 1.837 . . . . 0.0 112.34 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -74.17 -30.6 62.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.642 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' A' ' 116' ' ' LEU . . . -64.8 -40.71 97.55 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.909 -0.662 . . . . 0.0 111.974 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.51 -30.51 69.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.866 0.365 . . . . 0.0 110.919 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -80.5 -45.49 17.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.009 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.5 mt -65.66 -43.47 89.25 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.894 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.474 ' HB2' ' O ' ' A' ' 112' ' ' GLY . 1.9 mt -71.03 -22.87 62.09 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.944 0.402 . . . . 0.0 110.181 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -78.07 -46.13 9.6 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.22 -38.72 77.37 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.654 0.264 . . . . 0.0 111.304 178.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.3 p -68.55 -35.77 77.87 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.935 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.27 -33.1 61.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.478 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -71.27 -47.2 58.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.671 179.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.77 -24.01 60.89 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.834 179.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -78.88 89.03 1.16 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.944 -0.646 . . . . 0.0 111.73 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -59.3 126.29 27.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.082 0.468 . . . . 0.0 111.714 -179.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.52 ' O ' HG22 ' A' ' 128' ' ' ILE . 1.1 p -73.6 134.87 78.74 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.216 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -64.13 -19.27 65.91 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.757 2.305 . . . . 0.0 113.116 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 3.9 m -73.13 -14.95 61.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.089 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.52 HG22 ' O ' ' A' ' 125' ' ' THR . 3.7 tp -97.2 -3.95 9.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.363 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -51.79 -59.52 8.54 Favored Glycine 0 C--N 1.336 0.57 0 CA-C-N 115.894 -0.593 . . . . 0.0 113.091 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -56.73 -41.48 75.23 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.473 2.115 . . . . 0.0 112.236 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.459 ' O ' HG13 ' A' ' 135' ' ' ILE . 25.1 mm -65.48 -47.34 87.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.003 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.07 -44.12 97.36 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.535 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -58.74 -38.5 92.08 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.837 178.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.48 -40.58 89.41 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.86 0.362 . . . . 0.0 110.665 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.459 HG13 ' O ' ' A' ' 131' ' ' ILE . 78.6 mt -65.4 -37.44 80.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.213 179.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . 0.46 ' HA ' ' OG1' ' A' ' 139' ' ' THR . 0.3 OUTLIER -64.1 -31.42 72.61 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.983 179.49 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.2 m -65.46 -30.88 71.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.994 0.426 . . . . 0.0 110.741 178.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 18.4 mt -83.39 -37.16 23.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.992 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.46 ' OG1' ' HA ' ' A' ' 136' ' ' LEU . 0.6 OUTLIER -72.3 -20.35 61.52 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.948 179.848 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -68.56 -27.52 66.15 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.549 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 2.0 t -94.13 -29.4 4.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.246 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 146.92 -95.16 0.17 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.552 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 100.33 -66.62 0.55 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.342 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 113.32 163.65 15.51 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.703 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 12.3 p -68.14 -25.59 32.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-O 120.801 0.334 . . . . 0.0 111.227 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -59.9 -34.29 82.33 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 121.161 -0.543 . . . . 0.0 112.708 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.99 -43.2 88.48 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.815 0.341 . . . . 0.0 110.424 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.52 -45.36 91.0 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.504 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.67 -40.36 95.28 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.979 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -61.15 -41.2 96.32 Favored 'General case' 0 C--O 1.226 -0.154 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.778 179.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -63.86 -43.54 95.81 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.985 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 59.4 mt -62.67 -50.84 78.16 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.733 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 71.6 mt -68.24 -32.71 73.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.463 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -60.69 -44.71 97.57 Favored Glycine 0 C--O 1.225 -0.415 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.355 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.69 -21.66 44.38 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.716 0.293 . . . . 0.0 110.954 178.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -65.89 -37.23 85.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.484 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.437 ' HB ' ' CD ' ' A' ' 158' ' ' PRO . 90.8 t -57.73 -59.15 13.95 Favored Pre-proline 0 CA--C 1.541 0.606 0 CA-C-O 119.518 -0.277 . . . . 0.0 111.685 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.437 ' CD ' ' HB ' ' A' ' 157' ' ' VAL . 15.5 Cg_endo -59.26 -36.69 94.41 Favored 'Trans proline' 0 C--N 1.361 1.192 0 C-N-CA 122.142 1.895 . . . . 0.0 112.178 178.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -63.95 -38.15 90.02 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 120.548 0.213 . . . . 0.0 110.972 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.59 -49.31 69.29 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.47 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 13.5 m -66.71 -32.67 59.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.06 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 3.9 t -67.73 -43.18 86.67 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 178.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -60.09 -34.02 72.88 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.96 178.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 11.2 tp -75.78 -45.39 36.48 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.827 179.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -69.15 -19.15 64.01 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.083 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.64 -19.07 64.57 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.984 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.49 -40.42 94.49 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.468 179.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 2.0 ttt85 -69.12 -36.24 77.29 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.438 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 18.0 mt -70.66 -30.16 41.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.377 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -60.97 -36.91 80.64 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.442 179.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -81.5 -34.37 25.72 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.6 -0.809 . . . . 0.0 111.61 178.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 27.8 t-105 -70.09 -25.84 63.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.893 -0.153 . . . . 0.0 111.393 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.38 -37.53 65.11 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.726 0.298 . . . . 0.0 111.522 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 2.6 mpp_? -87.08 -19.86 27.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.368 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 3.8 mtt85 -86.21 -37.03 19.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.547 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.527 ' HB1' ' HB ' ' A' ' 179' ' ' ILE . . . -59.08 -70.1 0.17 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.836 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 69.51 -83.3 0.27 Allowed Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.983 -0.627 . . . . 0.0 113.212 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.13 -40.38 82.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.546 0.212 . . . . 0.0 111.228 -179.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.556 ' O ' HG23 ' A' ' 183' ' ' VAL . 22.6 mt -59.44 -46.14 93.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.811 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.06 -41.44 96.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.085 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -66.07 -32.49 73.99 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.259 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -70.27 -42.98 71.41 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.784 0.326 . . . . 0.0 110.834 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 179' ' ' ILE . 15.0 t -70.77 -19.97 21.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.828 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -67.56 -51.78 46.55 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.604 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.481 ' O ' HG23 ' A' ' 189' ' ' VAL . 5.3 t -75.37 -31.83 24.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.061 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.452 ' O ' HG23 ' A' ' 190' ' ' VAL . 0.6 OUTLIER -58.2 -47.91 81.96 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.912 179.78 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -63.08 -33.67 75.95 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.746 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.413 ' O ' HG23 ' A' ' 192' ' ' VAL . . . -66.84 -45.74 80.89 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.41 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 185' ' ' VAL . 46.4 t -61.94 -47.6 92.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 120.736 0.303 . . . . 0.0 110.937 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 186' ' ' LEU . 43.4 t -62.79 -40.98 90.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.774 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 3.7 mt -58.23 -45.96 86.77 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.321 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 188' ' ' GLY . 81.8 t -64.4 -42.38 95.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-O 120.771 0.32 . . . . 0.0 110.537 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.59 -44.07 91.81 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.066 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 190' ' ' VAL . 78.2 t -64.2 -38.84 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.097 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -58.39 -44.04 95.43 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.233 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 61.8 t -73.56 -40.01 54.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-O 120.763 0.316 . . . . 0.0 110.681 179.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.39 -34.91 79.27 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.112 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.51 -41.11 48.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.071 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.7 -41.6 95.89 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.08 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 1.3 m -83.99 -13.76 52.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.982 0.42 . . . . 0.0 110.469 179.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -85.59 -49.32 4.4 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.55 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 4.7 m 70.57 -65.22 0.34 Allowed 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 122.946 0.498 . . . . 0.0 111.511 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -154.19 161.31 41.92 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 5.8 m 73.72 -41.42 0.49 Allowed 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 122.98 0.512 . . . . 0.0 111.663 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -60.98 -36.52 79.65 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.028 0.442 . . . . 0.0 110.862 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.06 -23.39 38.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.901 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -75.21 -50.09 17.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.171 -179.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 1.7 m -61.57 -33.71 74.33 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.876 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -74.44 -36.28 63.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.989 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -70.32 -29.59 66.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.876 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 6.1 mt -65.25 -18.03 64.98 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.915 0.388 . . . . 0.0 111.219 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 12.1 mtt180 -92.29 -6.05 51.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.42 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . 0.573 HG21 ' HD3' ' A' ' 19' ' ' PRO . 8.1 mm -107.84 -12.47 10.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.69 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.43 128.12 66.98 Favored Pre-proline 0 C--O 1.233 0.192 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.78 179.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -56.8 143.45 90.68 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.557 2.171 . . . . 0.0 112.43 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -61.72 -25.7 67.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.846 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 4.5 m-90 -69.94 -22.29 63.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.949 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -81.48 -38.04 26.99 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.04 0.448 . . . . 0.0 109.81 179.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -71.47 -30.72 66.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.585 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.332 -0.191 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.05 179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.233 0.225 0 CA-C-O 120.797 0.332 . . . . 0.0 111.007 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.72 148.32 42.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.869 0.366 . . . . 0.0 111.13 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.57 -26.8 64.65 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.307 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.2 mt -64.73 -47.53 77.94 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.978 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.68 -46.52 90.03 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.685 179.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.34 -45.54 93.07 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.023 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.51 -43.3 97.24 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.015 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.413 ' O ' HG23 ' A' ' 13' ' ' VAL . 1.0 OUTLIER -62.62 -51.02 68.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.671 179.566 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.95 -40.21 88.2 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.702 179.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.47 -45.95 90.18 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.4 178.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.91 -42.98 99.57 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.018 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 9' ' ' PHE . 93.0 t -64.69 -42.64 95.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-O 120.732 0.301 . . . . 0.0 110.579 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.69 -40.11 95.98 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.564 179.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.6 m -69.08 -32.67 72.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.907 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -68.03 -42.69 80.21 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.982 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -85.02 -9.43 58.03 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.534 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -66.04 119.17 59.3 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.771 0.319 . . . . 0.0 110.884 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.31 -8.21 18.41 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.802 2.334 . . . . 0.0 112.489 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 96.6 m -82.43 44.84 0.91 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.034 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -94.78 54.66 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.94 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.549 HD11 HD21 ' A' ' 83' ' ' LEU . 0.3 OUTLIER -62.87 -51.19 73.25 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.464 -179.57 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.615 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 51.2 Cg_exo -57.18 -31.8 91.62 Favored 'Trans proline' 0 C--N 1.361 1.203 0 C-N-CA 122.192 1.928 . . . . 0.0 113.018 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.86 -13.31 60.54 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.492 ' HB ' ' HD3' ' A' ' 26' ' ' PRO . 3.3 t -64.98 -53.9 38.58 Favored Pre-proline 0 CA--C 1.543 0.712 0 CA-C-O 119.613 -0.232 . . . . 0.0 111.314 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.615 ' HD2' ' O ' ' A' ' 23' ' ' PRO . 23.6 Cg_exo -65.77 -21.92 57.57 Favored 'Trans proline' 0 C--N 1.361 1.191 0 C-N-CA 121.919 1.746 . . . . 0.0 112.346 178.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -63.85 -24.67 67.84 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.392 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -66.12 -31.94 73.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.009 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.1 mp -86.6 -22.74 26.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.161 0.505 . . . . 0.0 110.487 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -75.07 -20.05 59.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.339 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -82.18 -20.86 36.99 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.782 0.325 . . . . 0.0 110.779 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.618 ' HG ' HD21 ' A' ' 173' ' ' LEU . 0.4 OUTLIER -87.47 -36.46 17.65 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.011 0.434 . . . . 0.0 110.288 179.442 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -92.32 4.45 77.11 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.054 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -93.45 52.2 2.4 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.647 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.58 126.06 30.32 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.536 -0.172 . . . . 0.0 110.536 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 17.9 mtp180 62.23 32.72 17.09 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.577 0.548 . . . . 0.0 110.933 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -102.36 -168.73 26.8 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.55 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.4 88.45 29.88 Favored Pre-proline 0 C--O 1.234 0.277 0 CA-C-O 120.559 0.218 . . . . 0.0 111.109 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.75 -33.95 96.17 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.684 2.256 . . . . 0.0 112.49 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.2 mt -62.17 -45.34 93.86 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.55 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -73.63 -39.84 64.23 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.026 -179.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.88 -42.67 97.43 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.832 0.349 . . . . 0.0 110.632 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.29 -51.55 59.97 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.835 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.29 -42.3 86.29 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.482 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -63.9 -42.85 97.33 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.49 0.186 . . . . 0.0 110.815 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.98 -42.08 94.86 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.706 179.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 91.0 mt -65.43 -42.55 93.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.231 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.44 -50.08 75.02 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.483 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.457 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -59.2 -45.91 94.62 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.749 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -69.17 -37.71 78.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.654 0.264 . . . . 0.0 110.947 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -61.64 -43.61 99.04 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 121.086 -0.578 . . . . 0.0 111.821 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.57 -43.26 99.19 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.698 0.285 . . . . 0.0 110.674 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 49' ' ' GLY . 91.4 t -63.54 -43.94 98.49 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.043 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -65.76 -34.55 78.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.435 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -76.52 -43.33 39.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.703 0.287 . . . . 0.0 110.806 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.15 -28.87 69.12 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.907 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.05 -18.27 27.64 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.897 0.38 . . . . 0.0 109.976 178.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -74.91 -32.02 57.35 Favored Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.998 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.21 -56.25 37.26 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 179.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -72.84 -13.71 26.69 Favored 'Trans proline' 0 C--N 1.361 1.189 0 C-N-CA 122.266 1.977 . . . . 0.0 112.735 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.66 -23.59 63.19 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.328 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -65.8 -41.68 91.61 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.957 0.408 . . . . 0.0 110.539 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -88.63 -21.53 23.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.765 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.65 -18.19 45.44 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.427 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.59 -32.29 80.84 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 121.253 -0.499 . . . . 0.0 112.566 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -71.97 -31.6 64.26 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.91 179.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.6 mt -84.69 -23.76 29.26 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.723 0.297 . . . . 0.0 110.226 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.18 -19.4 64.78 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.92 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -58.66 -21.89 55.38 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.266 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -127.84 146.41 50.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.33 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 61.95 57.46 2.11 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 123.375 0.422 . . . . 0.0 111.716 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -89.17 -28.39 20.05 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.79 0.328 . . . . 0.0 111.238 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -69.68 -20.06 63.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.545 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -63.26 -32.58 74.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.51 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.4 mp -81.76 -21.79 37.63 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.674 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.01 -28.47 35.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.555 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.449 ' O ' HG23 ' A' ' 81' ' ' VAL . 26.7 mtp85 -63.5 -39.02 93.33 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.994 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.463 ' O ' HG23 ' A' ' 82' ' ' VAL . 3.8 t -60.69 -37.9 77.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.437 179.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -64.55 -39.45 96.82 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.858 -0.687 . . . . 0.0 111.604 179.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.49 ' O ' HG23 ' A' ' 84' ' ' VAL . . . -64.54 -42.94 97.22 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.896 -0.669 . . . . 0.0 111.596 179.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 77' ' ' ARG . 57.9 t -59.04 -42.95 87.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-O 120.806 0.336 . . . . 0.0 110.569 178.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.573 HG21 ' HA2' ' A' ' 123' ' ' GLY . 87.8 t -63.36 -38.74 82.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.414 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.549 HD21 HD11 ' A' ' 22' ' ' LEU . 8.3 mt -61.29 -42.3 98.42 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.527 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 80' ' ' GLY . 31.6 t -65.56 -43.53 94.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 120.941 0.4 . . . . 0.0 110.088 178.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.69 -40.38 96.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.604 179.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.33 -37.08 85.99 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.64 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -61.08 -42.21 99.71 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.699 178.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.46 -34.54 78.17 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.862 0.363 . . . . 0.0 110.605 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -70.0 -42.6 72.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.703 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.94 -24.22 63.32 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.938 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.71 -11.38 58.21 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.35 178.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.55 10.82 57.67 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.645 -0.788 . . . . 0.0 113.058 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.3 tp -77.92 125.06 28.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 117.04 0.42 . . . . 0.0 110.583 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.528 ' H ' ' HE ' ' A' ' 94' ' ' ARG . 0.3 OUTLIER . . . . . 0 C--N 1.326 -0.417 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.007 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.43 ' O ' ' HD2' ' A' ' 110' ' ' PRO . 0.6 OUTLIER . . . . . 0 N--CA 1.466 0.325 0 CA-C-O 121.046 0.451 . . . . 0.0 111.385 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.51 0.32 50.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.897 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.8 -51.77 73.48 Favored Pre-proline 0 CA--C 1.541 0.607 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.43 ' HD2' ' O ' ' A' ' 107' ' ' THR . 46.3 Cg_exo -58.29 -25.61 73.31 Favored 'Trans proline' 0 C--N 1.363 1.295 0 C-N-CA 122.241 1.96 . . . . 0.0 112.927 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.8 mt -68.46 -34.18 75.5 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.716 0.293 . . . . 0.0 110.588 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -66.85 -36.33 90.95 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.705 -0.76 . . . . 0.0 111.373 179.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -75.2 -35.43 61.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.707 0.289 . . . . 0.0 110.629 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -65.37 -47.04 77.76 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.001 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.8 mp -64.63 -39.08 93.07 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.539 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.427 ' O ' ' HB2' ' A' ' 120' ' ' LEU . 0.6 OUTLIER -69.49 -31.59 69.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.397 179.209 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -74.64 -44.18 26.94 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.909 -0.662 . . . . 0.0 111.487 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.21 -42.94 87.3 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.945 0.402 . . . . 0.0 110.819 178.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 3.0 m -73.2 -27.68 61.76 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.142 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.427 ' HB2' ' O ' ' A' ' 116' ' ' LEU . 0.3 OUTLIER -76.4 -37.09 57.62 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.74 0.305 . . . . 0.0 110.96 179.642 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -73.27 -37.85 66.14 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.843 0.354 . . . . 0.0 111.226 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.95 -19.48 37.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.017 0.436 . . . . 0.0 110.738 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . 0.573 ' HA2' HG21 ' A' ' 82' ' ' VAL . . . -92.04 95.62 2.06 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.701 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 4.8 t-105 -80.34 130.98 35.55 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.026 0.441 . . . . 0.0 111.31 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.2 119.88 78.67 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.083 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.84 -15.98 48.7 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.98 2.454 . . . . 0.0 112.909 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 8.0 m -62.74 -26.79 68.87 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.783 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.422 ' H ' HG13 ' A' ' 128' ' ' ILE . 1.4 mt -86.67 -0.83 7.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.785 0.326 . . . . 0.0 111.004 -179.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -59.65 -65.04 3.69 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 121.174 -0.536 . . . . 0.0 112.738 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.4 -38.56 73.51 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.618 2.212 . . . . 0.0 112.194 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 61.6 mt -60.93 -41.61 89.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.164 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.6 mt -63.18 -33.32 75.23 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-O 120.687 0.279 . . . . 0.0 110.848 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -61.24 -38.07 95.05 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 121.118 -0.563 . . . . 0.0 111.967 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.53 -36.19 73.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.123 0.487 . . . . 0.0 109.967 178.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 45.6 mm -67.17 -42.41 88.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.337 179.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.67 -36.91 82.22 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.32 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 38.4 m -64.5 -38.34 90.68 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.252 178.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 7.8 mt -70.06 -30.83 68.18 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.618 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.1 m -79.99 -22.4 42.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.086 0.469 . . . . 0.0 110.551 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.18 -30.27 64.8 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.914 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 20.5 m -100.25 4.98 10.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.009 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 141.54 -92.6 0.18 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.46 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.98 -123.54 7.02 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.543 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 130.8 159.67 9.7 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.571 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 11.1 p -77.36 -23.41 14.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.684 0.278 . . . . 0.0 111.33 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -58.35 -37.52 87.81 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.745 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -68.62 -41.67 79.18 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.691 0.281 . . . . 0.0 110.423 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.409 ' O ' HG13 ' A' ' 152' ' ' ILE . 0.3 OUTLIER -60.86 -46.28 91.2 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.605 179.233 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.83 -40.63 95.5 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.729 179.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.43 -41.18 98.52 Favored 'General case' 0 C--O 1.226 -0.168 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.771 179.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -60.61 -44.91 95.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.091 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 148' ' ' LEU . 23.9 mt -64.5 -44.06 96.91 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 CA-C-O 120.95 0.405 . . . . 0.0 110.341 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.92 -35.89 82.6 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.569 179.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . 0.463 ' O ' ' HD2' ' A' ' 158' ' ' PRO . . . -60.56 -46.08 95.08 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.143 179.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.38 -29.88 67.75 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.059 0.457 . . . . 0.0 110.754 178.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -63.43 -35.21 79.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.589 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.536 ' O ' HG23 ' A' ' 161' ' ' VAL . 95.1 t -55.38 -63.7 2.83 Favored Pre-proline 0 CA--C 1.543 0.685 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.473 ' CD ' ' HB ' ' A' ' 157' ' ' VAL . 19.1 Cg_endo -60.88 -36.38 83.83 Favored 'Trans proline' 0 C--N 1.359 1.109 0 C-N-CA 121.906 1.737 . . . . 0.0 112.384 179.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -58.08 -45.28 87.42 Favored 'General case' 0 N--CA 1.462 0.158 0 O-C-N 123.169 0.293 . . . . 0.0 111.19 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -70.47 -36.67 74.02 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.718 -0.219 . . . . 0.0 110.873 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 157' ' ' VAL . 96.5 t -64.91 -45.28 95.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-O 120.731 0.3 . . . . 0.0 110.692 179.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 68.9 t -65.8 -39.4 84.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.49 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -61.07 -34.82 75.5 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.28 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.8 -42.79 39.26 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.188 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -71.95 -19.23 61.93 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.374 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.09 -19.16 61.13 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.414 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -64.19 -43.05 96.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.765 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 2.6 mtp180 -73.03 -31.98 64.79 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.992 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 11.8 mt -72.83 -26.32 23.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.787 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.42 -30.92 71.95 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.968 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -70.89 -38.98 65.06 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.813 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -74.22 -24.07 59.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.63 0.252 . . . . 0.0 110.84 179.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.618 HD21 ' HG ' ' A' ' 32' ' ' LEU . 3.2 tp -59.71 -37.61 79.35 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.785 178.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 41.8 mtp180 -76.59 -21.86 55.02 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.816 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 -84.87 -32.19 23.34 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.943 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.473 ' HB1' ' HB ' ' A' ' 179' ' ' ILE . . . -65.16 -33.81 76.89 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.642 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 70.76 -98.77 0.71 Allowed Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.8 -0.714 . . . . 0.0 113.029 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -104.74 -6.01 20.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.558 0.218 . . . . 0.0 111.232 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.473 ' HB ' ' HB1' ' A' ' 176' ' ' ALA . 50.2 mm -64.58 -41.54 92.55 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 CA-C-O 120.671 0.272 . . . . 0.0 110.819 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . 0.492 ' O ' ' HG3' ' A' ' 184' ' ' GLU . 0.0 OUTLIER -61.65 -33.77 74.53 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.12 179.831 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' HIS . . . . . 0.465 ' HA ' ' OE2' ' A' ' 184' ' ' GLU . 11.7 m80 -66.64 -32.28 73.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.245 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . 0.454 ' O ' ' HB2' ' A' ' 186' ' ' LEU . 4.9 m-85 -68.7 -41.43 79.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.75 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.434 HG23 ' H ' ' A' ' 183' ' ' VAL . 1.6 t -68.47 -20.09 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 120.927 0.394 . . . . 0.0 111.023 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . 0.492 ' HG3' ' O ' ' A' ' 180' ' ' SER . 41.9 mt-10 -76.42 -47.15 24.1 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.502 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.443 ' O ' HG23 ' A' ' 189' ' ' VAL . 6.1 t -77.11 -37.5 26.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.232 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.51 ' O ' HG23 ' A' ' 190' ' ' VAL . 0.6 OUTLIER -58.84 -48.91 79.69 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.616 -0.266 . . . . 0.0 111.431 -179.744 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -63.74 -33.52 75.83 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.873 0.368 . . . . 0.0 110.941 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -65.95 -44.91 90.78 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.797 -0.715 . . . . 0.0 111.849 179.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 185' ' ' VAL . 84.0 t -60.68 -43.98 96.13 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-O 120.484 0.183 . . . . 0.0 110.676 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 186' ' ' LEU . 48.2 t -60.82 -47.7 92.13 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.099 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.027 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . 0.479 HD12 ' HG ' ' A' ' 22' ' ' LEU . 0.7 OUTLIER -61.42 -42.62 99.04 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.236 -179.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.478 ' O ' HG23 ' A' ' 196' ' ' VAL . 71.9 t -65.59 -44.21 93.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.7 tp -58.54 -45.97 87.78 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.654 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.456 HG11 ' CE1' ' A' ' 209' ' ' PHE . 78.8 t -63.21 -40.04 87.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.502 179.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.45 ' HA3' HD22 ' A' ' 83' ' ' LEU . . . -59.44 -45.05 96.15 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.304 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 192' ' ' VAL . 22.4 t -71.57 -38.81 68.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-O 120.755 0.312 . . . . 0.0 110.675 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.99 -23.95 63.24 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.376 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.46 -41.73 16.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.746 -0.206 . . . . 0.0 110.895 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . 0.406 ' CE1' ' HA ' ' A' ' 77' ' ' ARG . 22.5 t80 -68.55 -56.28 8.85 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.645 0.259 . . . . 0.0 111.37 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.41 -10.08 59.55 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.895 0.379 . . . . 0.0 111.306 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -91.05 -55.53 1.84 Allowed Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.262 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 18.8 m 68.37 -70.31 0.13 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.049 0.54 . . . . 0.0 111.528 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -97.63 160.86 14.06 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 23.6 m 74.24 -40.33 0.45 Allowed 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 122.781 0.433 . . . . 0.0 111.173 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -75.57 -36.1 60.45 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.145 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.446 ' O ' ' HB2' ' A' ' 210' ' ' PHE . 0.4 OUTLIER -60.46 -44.79 95.51 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.364 179.906 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -71.65 -38.74 70.68 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.755 0.312 . . . . 0.0 111.181 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 62.1 m -64.34 -43.03 95.9 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.946 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . 0.456 ' CE1' HG11 ' A' ' 194' ' ' VAL . 2.3 t80 -74.7 -30.91 61.71 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.237 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . 0.446 ' HB2' ' O ' ' A' ' 206' ' ' LEU . 0.1 OUTLIER -63.56 -24.53 67.84 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.257 -179.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.2 -22.25 65.74 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.884 0.373 . . . . 0.0 110.539 179.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.37 -7.05 51.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.917 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 2.5 mt -102.7 3.82 10.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.949 0.404 . . . . 0.0 110.901 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.88 117.84 61.43 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.785 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -72.16 120.83 7.05 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.25 1.967 . . . . 0.0 112.183 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . 0.551 ' HA ' ' OE1' ' A' ' 219' ' ' GLN . 1.9 mt-10 -65.01 -26.35 68.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.467 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 1.3 m-90 -72.67 -24.11 60.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.958 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.1 -33.27 24.38 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . 0.551 ' OE1' ' HA ' ' A' ' 216' ' ' GLU . 68.4 mt-30 -67.0 -30.3 70.37 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.363 179.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.332 -0.178 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.768 179.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.118 0 CA-C-O 120.861 0.362 . . . . 0.0 111.502 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.12 -6.78 34.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.203 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.47 -37.54 87.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.475 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.2 -45.19 70.52 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.495 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.64 -47.05 87.14 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.667 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.74 -42.8 99.45 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.635 178.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.445 ' HB1' ' HA ' ' A' ' 151' ' ' TYR . . . -63.17 -48.38 78.62 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.888 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.45 ' O ' HG23 ' A' ' 13' ' ' VAL . 5.5 m-85 -55.95 -46.45 78.55 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.617 178.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.81 -44.4 96.27 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.815 0.341 . . . . 0.0 110.525 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.39 -39.75 94.25 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.677 178.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.09 -41.13 99.36 Favored Glycine 0 C--N 1.334 0.429 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.065 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 9' ' ' PHE . 98.0 t -65.03 -36.43 77.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 178.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.1 tp -63.77 -43.17 97.17 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.791 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -35.05 79.06 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.793 0.33 . . . . 0.0 110.844 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.13 -28.84 63.52 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.889 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.35 -13.21 50.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.046 0.451 . . . . 0.0 110.632 178.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 61.6 m -85.82 135.86 37.33 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.364 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.63 -14.71 36.89 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.474 2.116 . . . . 0.0 113.027 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 6.3 t -90.16 132.9 35.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.352 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.1 t 61.46 65.28 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 O-C-N 123.724 0.64 . . . . 0.0 111.03 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.6 tp -109.78 105.34 57.07 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.896 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.476 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 28.1 Cg_exo -63.05 -15.34 47.29 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.989 2.459 . . . . 0.0 112.81 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.2 tp -77.95 -15.38 59.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.148 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.526 ' HB ' ' HD3' ' A' ' 26' ' ' PRO . 8.6 t -72.12 -52.35 7.43 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 116.684 -0.234 . . . . 0.0 111.327 179.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.526 ' HD3' ' HB ' ' A' ' 25' ' ' VAL . 22.9 Cg_exo -65.36 -38.68 25.38 Favored 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 122.029 1.82 . . . . 0.0 112.59 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.1 p -65.85 -33.57 76.16 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.707 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -62.56 -36.05 81.43 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.877 0.37 . . . . 0.0 110.769 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.46 -42.62 18.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.573 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -57.8 -36.36 72.09 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.51 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -71.32 -33.08 69.33 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.804 0.335 . . . . 0.0 110.884 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -79.75 -22.6 43.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.487 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -78.0 -24.87 63.24 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.199 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 110.29 43.46 1.08 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.715 -0.755 . . . . 0.0 113.004 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.42 96.36 9.06 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.702 0.286 . . . . 0.0 111.181 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.14 122.06 40.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.639 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 170.87 -158.21 29.66 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 111.673 -0.571 . . . . 0.0 111.673 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 2.2 mmt180 -103.67 118.78 56.61 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.845 0.322 . . . . 0.0 110.75 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.06 -27.0 42.62 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.65 2.233 . . . . 0.0 112.79 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.07 -34.89 77.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.13 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -71.41 -38.22 71.45 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.795 0.331 . . . . 0.0 110.289 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -64.88 -43.77 91.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.283 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.81 -41.01 88.22 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.658 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.445 HD22 ' HA ' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -58.58 -46.78 86.22 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.109 179.616 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -67.3 -36.28 81.18 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.871 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -65.18 -42.9 93.2 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.732 -0.213 . . . . 0.0 110.573 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 70.6 mt -60.42 -46.11 95.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.332 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.22 -42.44 93.44 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.472 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -60.44 -48.24 87.17 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 121.216 -0.516 . . . . 0.0 112.344 178.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.08 -34.85 75.78 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.734 0.302 . . . . 0.0 110.338 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -61.81 -46.44 94.15 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 178.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.58 -42.12 96.05 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 120.769 0.318 . . . . 0.0 110.463 178.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.6 t -62.69 -45.2 99.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.704 179.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -62.96 -33.41 75.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.466 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.96 -42.29 21.48 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 121.115 -0.234 . . . . 0.0 110.878 179.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.36 -37.1 85.97 Favored 'General case' 0 C--O 1.226 -0.168 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.08 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.39 -19.93 24.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.815 0.341 . . . . 0.0 110.86 179.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.22 -36.2 70.84 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.953 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.88 -57.63 22.94 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -67.95 -13.68 39.02 Favored 'Trans proline' 0 C--N 1.359 1.108 0 C-N-CA 122.583 2.189 . . . . 0.0 113.063 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -58.29 -20.58 43.95 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.698 0.285 . . . . 0.0 111.536 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 11.6 p -66.63 -47.82 71.39 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.148 0.499 . . . . 0.0 110.27 178.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.5 mt -81.63 -19.22 42.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.621 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.24 -18.21 59.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.524 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -69.94 -36.38 73.3 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.875 -0.679 . . . . 0.0 111.919 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.82 -25.71 64.19 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.806 -0.711 . . . . 0.0 111.711 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 mt -76.23 -20.54 57.34 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.633 0.254 . . . . 0.0 110.703 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 28.9 mt -63.83 -19.66 65.2 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.028 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -70.19 -17.67 63.16 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.775 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -95.52 39.84 1.12 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.558 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 73.4 160.87 0.24 Allowed 'General case' 0 N--CA 1.472 0.644 0 O-C-N 123.953 0.783 . . . . 0.0 111.149 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 72' ' ' ARG . 3.1 ptt180 -139.22 12.05 2.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.38 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -69.4 -35.93 76.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.492 -179.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.19 -24.6 64.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.579 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.41 HD12 ' HA ' ' A' ' 75' ' ' LEU . 4.7 tp -82.56 -28.75 30.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.929 0.395 . . . . 0.0 110.798 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -79.85 -28.53 40.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.994 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -62.72 -34.84 78.01 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.277 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 18.7 t -59.78 -37.87 73.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.568 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -66.44 -33.56 85.15 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.983 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.479 ' O ' HG23 ' A' ' 84' ' ' VAL . . . -66.41 -43.82 91.74 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.851 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.0 t -62.24 -39.9 85.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-O 121.039 0.447 . . . . 0.0 110.373 179.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.5 t -64.64 -41.64 92.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.715 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.0 -40.85 90.62 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.603 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 80' ' ' GLY . 61.5 t -63.82 -43.98 98.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.207 178.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.81 -40.41 95.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.804 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -60.22 -43.66 95.81 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 178.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -65.38 -39.25 95.72 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.733 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . 0.804 ' HA ' HD12 ' A' ' 91' ' ' LEU . 1.0 OUTLIER -62.68 -40.63 97.73 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.711 0.291 . . . . 0.0 111.024 179.368 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -72.3 -32.69 66.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.878 0.371 . . . . 0.0 110.665 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -73.45 -17.46 61.24 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.706 179.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.804 HD12 ' HA ' ' A' ' 88' ' ' LEU . 5.5 mt -67.08 -10.05 45.87 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.478 178.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.6 13.91 64.36 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.675 -0.774 . . . . 0.0 113.209 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 24.5 mt -88.22 122.89 32.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.837 0.351 . . . . 0.0 110.578 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.369 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.912 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.23 0 CA-C-O 120.95 0.405 . . . . 0.0 111.246 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.54 -11.99 50.03 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.333 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.425 ' N ' ' HD2' ' A' ' 110' ' ' PRO . 10.6 ttp180 -62.81 -54.73 44.65 Favored Pre-proline 0 CA--C 1.539 0.527 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 109' ' ' ARG . 28.0 Cg_endo -63.0 -38.21 48.11 Favored 'Trans proline' 0 C--N 1.361 1.195 0 C-N-CA 121.93 1.754 . . . . 0.0 112.489 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.72 -42.46 70.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.865 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -63.66 -41.83 98.92 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.927 -0.654 . . . . 0.0 111.961 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.02 -36.86 80.64 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.906 0.384 . . . . 0.0 110.607 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -67.06 -44.59 79.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.992 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.04 -38.9 86.68 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.978 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.9 -37.33 85.82 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.97 0.414 . . . . 0.0 110.399 179.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -74.11 -36.49 51.2 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 121.002 -0.618 . . . . 0.0 111.75 179.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -55.25 -41.89 72.74 Favored 'General case' 0 N--CA 1.461 0.106 0 C-N-CA 122.362 0.265 . . . . 0.0 111.153 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.38 -46.41 86.6 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.828 179.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.07 -35.24 80.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.259 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -72.96 -29.74 63.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.994 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.2 mt -81.91 -27.4 33.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.667 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -78.1 138.38 21.23 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.05 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -82.86 -7.18 59.68 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 121.041 -0.264 . . . . 0.0 111.707 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.5 m 58.5 85.66 0.18 Allowed Pre-proline 0 C--O 1.233 0.187 0 O-C-N 123.508 0.505 . . . . 0.0 111.128 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -59.13 -17.77 40.42 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 123.063 2.509 . . . . 0.0 113.156 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 83.9 m -65.26 -43.21 92.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.071 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 11.6 pt -104.29 5.47 10.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.358 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -55.92 -67.35 2.26 Favored Glycine 0 CA--C 1.52 0.362 0 CA-C-N 116.122 -0.49 . . . . 0.0 113.112 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -62.5 -33.71 77.9 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.502 2.135 . . . . 0.0 112.101 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 26.9 mt -61.94 -40.09 85.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.031 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 6.3 mt -64.05 -29.32 70.47 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.682 0.277 . . . . 0.0 110.95 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -67.13 -30.16 75.39 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.902 -0.666 . . . . 0.0 111.778 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -79.74 -36.19 37.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.942 0.401 . . . . 0.0 110.355 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 45.3 mm -67.26 -30.93 50.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.711 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.61 -43.86 89.72 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.804 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.13 -24.77 62.34 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.077 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -76.21 -38.06 56.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.217 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.5 m -68.54 -18.03 64.28 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.942 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.27 -38.54 88.05 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.828 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 4.1 m -102.24 -22.59 4.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.017 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -129.37 78.79 0.38 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 121.018 -0.61 . . . . 0.0 112.063 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -111.18 121.36 5.77 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.533 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -156.16 141.6 8.12 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.178 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 6.3 t -66.84 -27.8 40.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-O 120.882 0.372 . . . . 0.0 110.875 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -62.38 -28.56 71.26 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.584 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -68.33 -52.82 29.11 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.706 0.289 . . . . 0.0 110.599 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 20.1 mt -62.53 -37.25 85.37 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.757 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.01 -44.38 89.4 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.479 179.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.88 -39.27 93.81 Favored 'General case' 0 C--O 1.225 -0.23 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.787 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.445 ' HA ' ' HB1' ' A' ' 8' ' ' ALA . 2.8 m-85 -60.43 -47.54 85.65 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.069 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 48.5 mm -64.16 -44.86 97.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.455 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.27 -34.83 79.29 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.89 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -61.0 -41.22 99.36 Favored Glycine 0 C--O 1.225 -0.415 0 CA-C-N 115.976 -0.557 . . . . 0.0 112.386 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.424 ' O ' ' HD2' ' A' ' 158' ' ' PRO . 0.0 OUTLIER -82.69 -27.69 31.08 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.831 0.348 . . . . 0.0 110.915 178.77 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -62.57 -38.9 91.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.855 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.556 ' HB ' ' HD3' ' A' ' 158' ' ' PRO . 6.9 t -57.44 -57.63 23.83 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-O 119.322 -0.37 . . . . 0.0 111.791 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.556 ' HD3' ' HB ' ' A' ' 157' ' ' VAL . 38.0 Cg_exo -58.44 -40.67 72.74 Favored 'Trans proline' 0 C--N 1.361 1.229 0 C-N-CA 122.024 1.816 . . . . 0.0 112.244 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.65 -45.29 92.45 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.151 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -66.34 -41.07 90.11 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.684 -0.234 . . . . 0.0 110.73 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 157' ' ' VAL . 98.0 t -63.51 -46.57 94.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.716 179.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 158' ' ' PRO . 78.9 t -64.73 -43.69 96.52 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.718 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -60.88 -33.56 73.29 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.649 0.261 . . . . 0.0 111.658 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.2 tp -79.51 -45.89 18.45 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.096 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -68.3 -19.39 64.68 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.125 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -65.51 -18.92 65.68 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.029 179.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -59.99 -40.56 89.6 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.005 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 1.2 mmt85 -87.6 -32.97 19.04 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.89 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 46.9 mm -67.1 -31.64 54.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.004 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.93 -28.49 67.66 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.579 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -70.69 -37.23 67.28 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.296 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -86.84 -34.07 19.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.555 0.217 . . . . 0.0 110.816 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.566 ' HA ' ' HB3' ' A' ' 176' ' ' ALA . 0.2 OUTLIER -59.87 -22.98 63.04 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.375 179.301 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -53.15 61.18 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-O 121.009 0.433 . . . . 0.0 110.167 178.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 7.3 mtm180 -78.57 -31.25 47.24 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.66 178.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.566 ' HB3' ' HA ' ' A' ' 173' ' ' LEU . . . -62.41 -41.07 98.4 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.494 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -42.52 -31.58 1.07 Allowed Glycine 0 C--N 1.34 0.765 0 O-C-N 123.91 0.756 . . . . 0.0 114.081 178.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 4.5 ttp180 -61.36 -56.46 20.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.105 0.479 . . . . 0.0 110.331 179.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -75.07 -27.75 20.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.011 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 19.5 m -71.27 -16.55 62.48 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.764 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -56.13 -37.35 69.33 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.764 0.316 . . . . 0.0 111.498 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -73.26 -24.56 60.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.118 0.485 . . . . 0.0 110.82 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 4.9 t -82.22 -21.7 9.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.249 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -70.06 -43.47 71.11 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.389 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 2.9 t -69.68 -41.92 80.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.81 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.416 ' O ' HG23 ' A' ' 190' ' ' VAL . 4.6 mt -58.98 -48.67 80.74 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.084 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -63.48 -39.67 95.07 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.644 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.509 ' O ' HG23 ' A' ' 192' ' ' VAL . . . -62.91 -45.12 96.33 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.064 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 54.2 t -60.51 -47.54 92.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-O 120.645 0.259 . . . . 0.0 110.629 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.419 ' O ' HG23 ' A' ' 194' ' ' VAL . 84.7 t -61.42 -44.06 97.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.95 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -57.0 -46.78 82.04 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.005 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.533 ' O ' HG23 ' A' ' 196' ' ' VAL . 45.0 t -67.05 -42.37 88.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.403 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.78 -42.64 89.46 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.037 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . 0.616 HG13 HD11 ' A' ' 206' ' ' LEU . 58.6 t -61.8 -43.85 97.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 178.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -61.86 -41.27 99.62 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.107 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 192' ' ' VAL . 61.2 t -68.63 -42.64 83.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.481 0.182 . . . . 0.0 110.814 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.27 -25.96 68.28 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.795 0.331 . . . . 0.0 111.403 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.68 -43.61 18.28 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.774 0.321 . . . . 0.0 110.385 178.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -71.2 -48.41 51.71 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.099 -0.501 . . . . 0.0 112.089 -179.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 69.3 p -84.2 -9.14 58.79 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.908 0.385 . . . . 0.0 111.314 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -87.09 -53.87 2.73 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.907 -0.664 . . . . 0.0 112.094 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 52.74 45.96 27.67 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.94 0.4 . . . . 0.0 111.634 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -151.05 -174.05 4.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.934 0.397 . . . . 0.0 110.911 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.26 10.46 10.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.67 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -58.63 -33.15 69.72 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.156 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.616 HD11 HG13 ' A' ' 194' ' ' VAL . 0.4 OUTLIER -78.13 -37.63 45.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.816 179.656 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.1 -35.78 74.4 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.609 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 5.9 m -69.09 -35.12 76.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.269 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -71.74 -29.35 64.43 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.955 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -69.43 -21.83 63.71 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.198 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.95 -11.2 51.28 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.9 0.381 . . . . 0.0 110.625 179.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 17.4 mtt180 -91.23 -14.11 31.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.127 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 6.8 pt -102.35 -6.72 9.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.371 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 1.3 p -87.36 118.21 69.6 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.606 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . 0.43 ' HG2' HD23 ' A' ' 218' ' ' LEU . 47.2 Cg_endo -70.54 149.08 61.33 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.379 2.053 . . . . 0.0 112.491 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -63.34 -22.13 66.69 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.977 0.418 . . . . 0.0 111.335 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -66.51 -18.7 65.51 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.407 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.43 HD23 ' HG2' ' A' ' 215' ' ' PRO . 0.5 OUTLIER -76.2 -22.61 55.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.973 0.416 . . . . 0.0 110.249 179.539 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -84.31 -30.25 25.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.163 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 220' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.856 179.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.529 0.153 0 CA-C-O 120.89 0.376 . . . . 0.0 111.264 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 15.0 mt -90.45 48.28 1.53 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.032 0.444 . . . . 0.0 111.115 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.3 -22.01 58.03 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.137 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.84 -38.84 89.94 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.645 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.27 -34.65 78.13 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.873 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.72 -49.27 66.59 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.697 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.7 -25.07 64.59 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.196 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.45 ' O ' HG23 ' A' ' 13' ' ' VAL . 0.3 OUTLIER -74.39 -50.83 17.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.068 179.823 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.42 HD21 ' HB3' ' A' ' 217' ' ' TRP . 7.9 mt -64.64 -34.65 78.79 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.424 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.81 -43.44 96.27 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.518 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.49 -42.85 98.83 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.744 178.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 9' ' ' PHE . 59.1 t -64.87 -41.91 93.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.932 0.396 . . . . 0.0 110.078 179.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.1 mt -63.12 -39.57 95.06 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.844 179.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 28.7 m -65.97 -36.35 83.1 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.991 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -73.47 -31.28 63.69 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.75 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.2 mt -83.88 -14.66 50.56 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.06 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 38.4 m -61.43 146.68 89.06 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.776 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.48 -20.23 48.12 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.788 2.326 . . . . 0.0 113.081 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.459 ' O ' ' HZ2' ' A' ' 124' ' ' TRP . 39.6 m -75.69 -38.81 58.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.427 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.612 HG12 ' H ' ' A' ' 22' ' ' LEU . 1.2 t 55.6 -155.71 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 O-C-N 123.294 0.371 . . . . 0.0 110.025 -178.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.612 ' H ' HG12 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -173.62 -56.79 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.309 0 CA-C-O 119.328 -0.368 . . . . 0.0 111.326 179.606 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 22' ' ' LEU . 21.5 Cg_endo -61.19 -15.19 38.27 Favored 'Trans proline' 0 C--N 1.364 1.388 0 C-N-CA 122.647 2.231 . . . . 0.0 113.787 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.3 tp -55.44 -46.75 76.71 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 123.207 0.317 . . . . 0.0 111.838 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -67.51 -55.44 14.76 Favored Pre-proline 0 CA--C 1.542 0.663 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -51.23 -44.19 44.42 Favored 'Trans proline' 0 C--N 1.362 1.282 0 C-N-CA 122.418 2.079 . . . . 0.0 113.469 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.1 p -64.15 -37.66 88.25 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.69 0.281 . . . . 0.0 111.566 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 12.2 m-30 -73.19 -35.96 66.47 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.741 0.305 . . . . 0.0 110.686 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.628 HD21 HD22 ' A' ' 116' ' ' LEU . 1.8 mm? -70.34 -32.12 69.7 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.895 0.379 . . . . 0.0 110.137 179.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -61.04 -46.62 89.98 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.047 178.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -64.77 -34.89 79.41 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.723 178.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.21 -38.15 81.63 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.647 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.85 -33.25 55.75 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.104 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.01 31.49 64.28 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.656 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -133.9 131.58 39.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.698 0.285 . . . . 0.0 111.062 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 4.1 mtp180 -88.4 67.87 8.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.839 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -74.94 150.82 41.62 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.812 -0.708 . . . . 0.0 111.844 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -69.95 115.27 32.07 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.715 0.258 . . . . 0.0 111.062 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -60.83 -20.46 66.47 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 123.042 2.495 . . . . 0.0 112.889 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.84 -34.9 76.8 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.225 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -68.9 -42.06 77.39 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.013 0.435 . . . . 0.0 110.406 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.92 -42.04 86.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.301 179.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.85 -44.69 92.39 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.041 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.04 -46.7 88.66 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.91 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -62.52 -39.45 93.59 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.861 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -67.08 -40.9 87.06 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.949 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 71.8 mt -60.84 -45.99 97.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-O 120.778 0.323 . . . . 0.0 110.317 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.91 -46.95 73.27 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.529 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.455 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -58.54 -49.78 73.54 Favored Glycine 0 C--N 1.334 0.439 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.913 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.52 -35.35 77.36 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.703 0.252 . . . . 0.0 110.844 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -60.28 -48.41 86.26 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.509 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.79 -46.0 92.2 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.523 0.201 . . . . 0.0 110.922 178.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 49' ' ' GLY . 85.6 t -61.76 -44.06 98.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.186 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -62.72 -38.64 91.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.355 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -74.63 -40.36 61.55 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 120.634 0.254 . . . . 0.0 110.727 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.4 mt -64.41 -28.16 69.49 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.527 179.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.6 -19.91 24.36 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.469 178.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.59 -34.86 62.92 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 121.147 -0.549 . . . . 0.0 112.095 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.56 -56.16 37.94 Favored Pre-proline 0 CA--C 1.542 0.667 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 179.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.98 -13.81 29.06 Favored 'Trans proline' 0 C--N 1.36 1.154 0 C-N-CA 122.229 1.953 . . . . 0.0 112.961 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.59 -32.28 62.92 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 123.052 0.22 . . . . 0.0 111.379 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.28 -40.04 92.63 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.912 0.387 . . . . 0.0 110.73 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.2 mt -88.75 -19.4 26.11 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.705 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.9 tp -68.31 -17.36 64.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.779 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.27 -30.31 70.71 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.6 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.63 -22.11 73.24 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.588 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 tp -73.74 -19.86 60.67 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.689 0.281 . . . . 0.0 110.401 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.9 -22.85 60.29 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.158 179.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -76.01 -36.3 59.21 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.98 0.419 . . . . 0.0 110.416 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -122.3 70.64 0.98 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.915 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -61.4 125.96 25.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.374 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 18.3 mtm180 -78.88 100.64 7.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.435 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -69.56 -18.0 63.61 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.075 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.485 ' O ' HG23 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -61.45 -28.38 69.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.989 179.485 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 20.5 mt -67.68 -29.6 68.92 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.73 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -74.29 -32.22 62.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.45 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . 0.405 ' O ' HG23 ' A' ' 81' ' ' VAL . 9.6 ttt-85 -67.38 -39.65 85.65 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.487 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 74' ' ' THR . 18.1 t -59.98 -39.74 81.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.483 179.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.43 -39.9 98.25 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.862 -0.685 . . . . 0.0 111.672 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -64.43 -42.71 97.49 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.726 179.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 77' ' ' ARG . 99.1 t -58.89 -44.41 90.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-O 120.825 0.345 . . . . 0.0 110.649 178.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 79.1 t -65.51 -40.66 88.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.488 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.55 -42.37 96.41 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.919 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 72.8 t -62.55 -46.22 96.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-O 120.774 0.321 . . . . 0.0 110.233 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.87 -40.77 94.19 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.675 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -65.32 -45.56 83.8 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.329 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -61.53 -39.38 97.26 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.202 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.8 mp -62.16 -42.51 99.33 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.693 0.282 . . . . 0.0 110.802 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -72.92 -31.99 65.02 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.979 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.31 -28.42 67.15 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.817 0.341 . . . . 0.0 110.881 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.67 -21.67 66.1 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.259 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.02 1.93 90.19 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.422 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.0 mt -97.21 160.1 14.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.999 0.399 . . . . 0.0 111.088 -179.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 3.1 mtp180 . . . . . 0 C--N 1.327 -0.39 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.303 179.432 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.806 0.336 . . . . 0.0 111.271 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.62 -20.88 56.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.649 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.48 -56.94 7.51 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -64.15 -33.34 61.33 Favored 'Trans proline' 0 C--N 1.36 1.171 0 C-N-CA 121.99 1.793 . . . . 0.0 112.411 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 17.3 mt -75.23 -22.31 58.0 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.939 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -64.91 -35.77 92.3 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.955 -0.641 . . . . 0.0 111.899 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.56 -32.91 71.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.982 0.42 . . . . 0.0 110.712 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -80.83 -39.8 25.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.739 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.94 -47.47 71.58 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.636 -0.257 . . . . 0.0 110.464 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.628 HD22 HD21 ' A' ' 29' ' ' LEU . 1.2 mp -65.75 -31.68 72.79 Favored 'General case' 0 CA--C 1.523 -0.076 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -70.63 -43.63 59.73 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.609 178.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.42 -45.49 87.33 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.638 0.256 . . . . 0.0 110.871 179.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 3.2 m -64.18 -41.12 97.23 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.621 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.05 -35.43 80.52 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.604 179.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.77 -39.69 94.04 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.75 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.24 -10.14 59.23 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.881 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -108.31 -0.49 33.18 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.851 179.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . 0.459 ' HZ2' ' O ' ' A' ' 20' ' ' CYS . 0.2 OUTLIER -94.17 -5.76 46.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.758 0.313 . . . . 0.0 110.8 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.13 -50.03 89.93 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.628 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.5 -25.1 79.86 Favored 'Trans proline' 0 C--N 1.361 1.232 0 C-N-CA 121.999 1.8 . . . . 0.0 112.176 178.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -70.15 -40.83 74.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.279 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.5 pt -96.09 4.82 8.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.832 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -57.14 -58.92 12.07 Favored Glycine 0 CA--C 1.52 0.363 0 CA-C-N 115.845 -0.616 . . . . 0.0 113.152 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.2 -25.59 78.69 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 122.635 2.223 . . . . 0.0 112.283 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 37.9 mm -80.21 -35.54 15.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.011 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 5.1 tp -61.64 -24.99 67.08 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.154 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -63.14 -34.6 90.4 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.119 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -81.77 -22.37 37.24 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.005 0.431 . . . . 0.0 110.721 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 52.3 mt -80.28 -33.16 13.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.193 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.56 -28.35 67.72 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.236 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -70.78 -20.19 62.63 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-O 120.828 0.347 . . . . 0.0 110.681 179.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 89.6 mt -80.22 -18.24 50.06 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.952 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -82.79 -17.34 44.49 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.946 0.403 . . . . 0.0 110.696 179.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -82.28 -22.62 35.63 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.191 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 2.4 m -99.48 4.07 10.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.261 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 148.33 98.03 0.19 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.682 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -82.25 80.31 1.79 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.608 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -100.59 142.45 15.84 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.745 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 6.6 m -74.67 -18.7 16.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-O 120.774 0.321 . . . . 0.0 111.448 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -65.0 -30.38 77.86 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 121.026 -0.606 . . . . 0.0 112.531 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.47 -44.11 83.63 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-O 120.779 0.323 . . . . 0.0 110.392 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . 0.446 ' O ' HG13 ' A' ' 152' ' ' ILE . 0.8 OUTLIER -62.09 -43.36 99.0 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.549 179.247 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.07 -42.21 89.71 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.927 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.28 -37.81 88.71 Favored 'General case' 0 CA--C 1.524 -0.05 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.532 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -61.09 -48.28 82.43 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.886 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 148' ' ' LEU . 42.0 mt -63.73 -45.01 98.49 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.566 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 4.7 tp -64.82 -38.59 91.5 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.621 0.248 . . . . 0.0 110.915 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -59.52 -42.38 97.63 Favored Glycine 0 C--N 1.334 0.428 0 CA-C-N 116.031 -0.532 . . . . 0.0 112.424 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.467 ' O ' ' HD2' ' A' ' 158' ' ' PRO . 0.4 OUTLIER -80.95 -25.05 37.68 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.836 0.318 . . . . 0.0 111.179 178.963 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -62.93 -38.82 92.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.652 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.549 ' HB ' ' HD3' ' A' ' 158' ' ' PRO . 4.8 t -57.58 -56.72 31.31 Favored Pre-proline 0 CA--C 1.545 0.771 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.549 ' HD3' ' HB ' ' A' ' 157' ' ' VAL . 33.4 Cg_exo -61.04 -35.43 87.21 Favored 'Trans proline' 0 C--N 1.36 1.141 0 C-N-CA 122.131 1.887 . . . . 0.0 112.236 178.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -61.73 -42.93 99.61 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.846 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -65.67 -38.15 88.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.627 0.251 . . . . 0.0 110.491 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 157' ' ' VAL . 91.7 t -60.82 -49.86 82.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.047 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.466 HG22 ' O ' ' A' ' 158' ' ' PRO . 11.8 m -72.64 -36.31 53.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 120.931 -0.308 . . . . 0.0 111.539 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.565 ' O ' ' HB2' ' A' ' 167' ' ' ASP . . . -57.79 -35.87 71.39 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 5.8 tp -80.05 -45.65 17.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.7 0.286 . . . . 0.0 111.048 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -65.36 -44.11 88.7 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.897 -179.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 170' ' ' LYS . . . -71.83 -19.15 62.02 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.388 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . 0.565 ' HB2' ' O ' ' A' ' 163' ' ' ALA . 14.1 t70 -76.63 -40.85 48.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.145 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 10.9 mmt-85 -69.55 -43.32 73.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.254 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 4.6 pt -76.32 -18.91 15.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 166' ' ' ALA . 0.0 OUTLIER -60.1 -33.42 72.08 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.697 -0.229 . . . . 0.0 111.56 -179.676 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -63.79 -38.53 96.3 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.586 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -86.66 -38.77 16.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.625 0.25 . . . . 0.0 111.26 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -65.16 -16.81 63.91 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.663 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.43 -52.56 65.1 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 120.806 0.336 . . . . 0.0 110.632 178.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.92 -30.52 14.72 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.619 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -84.79 4.97 30.45 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -81.15 33.58 2.44 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 121.146 -0.55 . . . . 0.0 113.348 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . 0.408 ' O ' ' HB2' ' A' ' 181' ' ' HIS . 0.4 OUTLIER -80.29 -38.79 30.08 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.916 0.389 . . . . 0.0 110.718 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 19.5 mm -73.27 -30.27 30.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.847 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.08 -16.95 64.65 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.375 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' HIS . . . . . 0.408 ' HB2' ' O ' ' A' ' 178' ' ' ARG . 3.3 m80 -61.89 -38.38 88.1 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.086 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -75.66 -27.6 58.41 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 121.031 0.443 . . . . 0.0 110.477 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 3.2 t -75.88 -18.54 15.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.47 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -83.4 -27.72 29.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.601 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.506 ' O ' HG23 ' A' ' 189' ' ' VAL . 51.2 t -63.13 -47.79 90.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.547 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.468 ' O ' HG23 ' A' ' 190' ' ' VAL . 1.0 OUTLIER -62.04 -40.66 96.48 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.796 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -62.49 -38.2 88.95 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.506 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.52 ' O ' HG23 ' A' ' 192' ' ' VAL . . . -68.67 -42.88 78.51 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.035 179.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 185' ' ' VAL . 88.7 t -61.84 -49.66 83.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-O 120.763 0.316 . . . . 0.0 110.671 179.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 186' ' ' LEU . 50.4 t -63.35 -35.77 73.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.706 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.56 -46.83 83.46 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.804 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 188' ' ' GLY . 22.5 t -62.53 -42.29 95.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.345 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 23.5 mt -64.2 -44.57 91.56 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.788 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 69.0 t -63.77 -40.37 88.82 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.366 179.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -57.82 -45.52 93.43 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.159 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 192' ' ' VAL . 32.4 t -70.72 -40.09 76.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.682 0.277 . . . . 0.0 110.606 179.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.16 -39.04 93.52 Favored 'General case' 0 C--O 1.225 -0.205 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.044 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.455 HD11 HD21 ' A' ' 206' ' ' LEU . 1.4 mp -72.83 -30.74 64.27 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.497 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -59.12 -54.56 45.57 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.99 0.424 . . . . 0.0 111.055 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -89.19 -7.16 56.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.967 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -83.15 -4.56 89.71 Favored Glycine 0 N--CA 1.452 -0.256 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.712 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.64 68.64 0.1 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.674 0.39 . . . . 0.0 111.59 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -165.23 -73.05 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.398 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 6.8 t -158.22 12.19 0.18 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.104 0.478 . . . . 0.0 111.302 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -84.16 -16.01 45.06 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.191 -179.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.477 ' O ' ' HB2' ' A' ' 210' ' ' PHE . 3.6 mt -74.89 -30.09 61.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.203 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.72 -34.87 76.35 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.169 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.19 -40.24 93.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.312 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -87.13 -26.6 23.54 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.25 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . 0.477 ' HB2' ' O ' ' A' ' 206' ' ' LEU . 0.2 OUTLIER -66.62 -21.16 66.12 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.142 179.764 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.43 -27.54 69.18 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.981 0.42 . . . . 0.0 110.782 179.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 5.4 mmm180 -92.3 -4.47 53.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.666 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 10.4 mm -103.55 -11.07 9.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.014 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . 0.407 ' HA ' ' HD3' ' A' ' 215' ' ' PRO . 0.2 OUTLIER -60.75 118.09 31.51 Favored Pre-proline 0 C--O 1.233 0.218 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.155 179.774 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 214' ' ' THR . 33.9 Cg_exo -61.67 155.74 51.93 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.815 2.343 . . . . 0.0 112.476 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.94 -27.55 68.31 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.447 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' TRP . . . . . 0.42 ' HB3' HD21 ' A' ' 10' ' ' LEU . 0.2 OUTLIER -68.73 -28.28 66.69 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.765 179.546 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.22 -29.24 26.71 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -67.71 -38.02 83.06 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.163 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 42.4 mtp180 . . . . . 0 C--N 1.332 -0.155 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.058 179.375 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . 0.449 ' HB2' ' OG ' ' A' ' 4' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.141 0 CA-C-O 120.494 0.188 . . . . 0.0 110.812 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 62.61 24.99 14.88 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 123.838 0.711 . . . . 0.0 111.771 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . 0.449 ' OG ' ' HB2' ' A' ' 2' ' ' SER . 0.0 OUTLIER -75.45 -24.35 57.0 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.965 0.412 . . . . 0.0 111.028 179.702 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.6 mp -81.36 -42.87 19.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.383 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.39 -29.83 69.44 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.936 0.398 . . . . 0.0 110.532 179.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.65 -52.19 28.01 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.312 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.69 -27.85 69.53 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.995 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -69.66 -49.23 55.57 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.526 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.658 ' HG ' HD21 ' A' ' 218' ' ' LEU . 0.2 OUTLIER -65.26 -37.32 86.84 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.482 179.404 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.67 -46.1 80.38 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.764 0.316 . . . . 0.0 110.992 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -65.41 -43.32 95.1 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.323 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -66.92 -31.79 55.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 120.77 0.319 . . . . 0.0 111.005 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.409 ' HB2' ' O ' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -67.43 -50.51 59.06 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.154 179.703 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.804 ' HB2' HD13 ' A' ' 155' ' ' LEU . 3.7 m -67.87 -24.83 65.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.76 0.314 . . . . 0.0 110.776 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -72.66 -41.12 65.77 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.215 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 11.7 mt -86.8 -7.86 57.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.107 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.64 130.02 91.82 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.404 178.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -71.15 -8.03 22.64 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.497 2.131 . . . . 0.0 112.829 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.8 m -66.85 150.46 49.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.06 0.457 . . . . 0.0 111.054 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.425 HG23 ' H ' ' A' ' 21' ' ' VAL . 0.2 OUTLIER -71.51 94.98 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.418 -179.578 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.44 ' H ' ' CD ' ' A' ' 23' ' ' PRO . 0.1 OUTLIER -143.63 -54.37 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.376 179.586 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . 0.44 ' CD ' ' H ' ' A' ' 22' ' ' LEU . 23.2 Cg_exo -66.25 -18.47 55.78 Favored 'Trans proline' 0 C--N 1.361 1.192 0 C-N-CA 122.256 1.971 . . . . 0.0 112.42 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.3 mt -88.02 -13.15 42.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.303 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.472 ' HB ' ' HD3' ' A' ' 26' ' ' PRO . 20.8 t -57.34 -50.1 90.09 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.627 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.472 ' HD3' ' HB ' ' A' ' 25' ' ' VAL . 52.0 Cg_exo -55.97 -40.63 83.85 Favored 'Trans proline' 0 C--N 1.363 1.318 0 C-N-CA 122.237 1.958 . . . . 0.0 112.907 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.75 -36.84 78.87 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.795 0.331 . . . . 0.0 111.406 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -77.46 -41.01 41.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.265 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.54 -22.75 66.16 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.012 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -64.94 -59.24 4.4 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 178.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -60.79 -33.22 72.65 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.099 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.2 mt -71.91 -16.38 62.11 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.879 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -93.7 -0.72 66.44 Favored Glycine 0 N--CA 1.452 -0.287 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 178.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 66.67 -109.31 2.84 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 121.403 -0.427 . . . . 0.0 112.704 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -119.13 10.58 12.13 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.011 0.434 . . . . 0.0 110.659 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -131.21 40.91 3.4 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.887 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -100.15 99.77 2.09 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.214 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.81 129.47 29.81 Favored Pre-proline 0 C--N 1.326 -0.414 0 O-C-N 122.804 -0.233 . . . . 0.0 110.85 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -65.18 -23.43 60.05 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.817 2.344 . . . . 0.0 112.84 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -66.02 -44.48 84.6 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.081 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -72.17 -33.36 67.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.226 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.43 ' O ' ' HB2' ' A' ' 46' ' ' PHE . 8.0 t-20 -65.23 -50.25 66.57 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.319 178.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.81 -39.7 94.86 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.879 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.38 -50.48 71.39 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.974 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -66.19 -36.82 84.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.069 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.46 ' O ' ' HB2' ' A' ' 50' ' ' PHE . 0.2 OUTLIER -63.51 -49.83 72.0 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.239 179.462 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 tt -65.97 -28.73 44.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-O 120.728 0.299 . . . . 0.0 110.895 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.75 -55.46 5.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.701 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.423 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -57.54 -44.55 93.77 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.152 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.46 ' HB2' ' O ' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -70.92 -32.4 69.3 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 110.503 -0.184 . . . . 0.0 110.503 179.532 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -63.16 -48.62 78.18 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.517 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.28 -43.21 92.55 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.743 0.306 . . . . 0.0 110.752 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 49' ' ' GLY . 98.9 t -66.22 -43.3 91.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.029 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.7 -28.73 69.28 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.396 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -84.35 -45.07 13.16 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.526 0.203 . . . . 0.0 110.849 179.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.93 -39.16 93.52 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.198 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.33 -18.18 27.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.733 0.302 . . . . 0.0 110.381 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.95 -33.0 73.91 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 121.189 -0.529 . . . . 0.0 112.255 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.548 ' O ' HG22 ' A' ' 62' ' ' THR . 1.1 mm? -64.52 -57.69 16.21 Favored Pre-proline 0 CA--C 1.537 0.481 0 CA-C-O 119.453 -0.308 . . . . 0.0 111.509 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -67.86 -13.39 38.37 Favored 'Trans proline' 0 C--N 1.36 1.169 0 C-N-CA 122.064 1.842 . . . . 0.0 112.623 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.47 ' HA ' HD12 ' A' ' 64' ' ' LEU . 0.1 OUTLIER -55.7 -27.46 50.4 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.619 179.831 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.548 HG22 ' O ' ' A' ' 59' ' ' LEU . 8.6 t -66.32 -32.74 74.32 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.929 0.395 . . . . 0.0 110.64 179.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.86 -20.42 24.64 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.855 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.47 HD12 ' HA ' ' A' ' 61' ' ' PHE . 1.5 mt -64.88 -17.42 64.28 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.2 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -63.32 -30.14 76.65 Favored Glycine 0 C--N 1.334 0.442 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.474 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.08 -24.88 70.32 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 121.02 -0.61 . . . . 0.0 111.686 178.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 tp -85.11 -20.87 29.67 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.689 0.28 . . . . 0.0 110.569 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.7 -19.58 64.03 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.977 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -64.22 -25.13 67.93 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.799 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -108.42 118.38 36.62 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -77.83 109.08 11.55 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.102 0.477 . . . . 0.0 110.92 -179.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.4 mmm180 -78.89 90.21 4.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.332 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -68.76 -18.28 64.18 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.821 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.416 ' O ' HG23 ' A' ' 78' ' ' VAL . 1.8 t -67.94 -26.21 65.85 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.163 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.1 tp -69.24 -35.84 76.56 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.924 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.79 -34.69 78.75 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.378 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -69.73 -43.35 72.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.433 179.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.44 ' O ' HG23 ' A' ' 82' ' ' VAL . 99.4 t -64.74 -45.24 95.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.187 179.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.73 -40.1 97.61 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.961 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.435 ' O ' HG23 ' A' ' 84' ' ' VAL . . . -64.49 -38.64 96.03 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.796 178.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 40.9 t -62.12 -41.78 92.57 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-O 120.699 0.285 . . . . 0.0 110.579 179.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 78' ' ' VAL . 67.9 t -60.5 -41.74 88.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.666 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.439 HD13 ' HA2' ' A' ' 195' ' ' GLY . 8.5 mt -64.32 -41.73 96.66 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.549 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 80' ' ' GLY . 93.6 t -66.98 -41.6 87.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.285 178.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.74 -41.16 97.29 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.708 179.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -61.95 -41.21 97.73 Favored 'General case' 0 CA--C 1.523 -0.091 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 178.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.516 ' HA3' HG12 ' A' ' 192' ' ' VAL . . . -65.12 -40.6 97.0 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.852 -0.689 . . . . 0.0 111.812 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 53.8 mt -62.16 -38.23 88.23 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.808 0.337 . . . . 0.0 110.854 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -77.12 -30.42 55.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.659 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 8.9 mtp -72.3 -19.6 61.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.869 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.89 -7.06 25.11 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.132 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.79 19.16 48.97 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.913 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.77 130.51 43.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.808 0.304 . . . . 0.0 110.63 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.379 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.19 -179.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.43 ' O ' ' HD2' ' A' ' 110' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.462 0.173 0 CA-C-O 121.237 0.542 . . . . 0.0 110.852 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.98 -1.63 33.01 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.213 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.9 ttp180 -62.03 -56.57 30.4 Favored Pre-proline 0 CA--C 1.54 0.583 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.43 ' HD2' ' O ' ' A' ' 107' ' ' THR . 38.5 Cg_endo -66.79 -26.97 44.59 Favored 'Trans proline' 0 C--N 1.361 1.199 0 C-N-CA 121.865 1.71 . . . . 0.0 112.049 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.2 mt -70.73 -33.37 70.77 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.625 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -64.41 -41.53 98.02 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.435 178.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -73.96 -36.36 64.59 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 120.724 0.297 . . . . 0.0 110.442 178.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -66.19 -43.89 85.51 Favored 'General case' 0 C--N 1.334 -0.094 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.907 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.39 -34.37 78.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.984 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.17 -30.45 68.68 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.989 0.423 . . . . 0.0 110.093 179.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -80.83 -42.04 10.17 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 178.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.07 -42.9 95.54 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.621 0.248 . . . . 0.0 111.116 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 10.1 p -67.15 -38.56 85.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.049 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.82 -28.14 65.46 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.773 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -81.65 -34.41 30.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.833 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.84 -38.05 47.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.011 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -77.74 117.54 4.77 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.751 -0.737 . . . . 0.0 111.662 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . 0.542 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 77.8 m95 -67.59 143.3 56.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.704 0.288 . . . . 0.0 111.167 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.65 102.79 5.64 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.354 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.542 ' HD3' ' O ' ' A' ' 124' ' ' TRP . 57.3 Cg_endo -75.06 -16.85 19.85 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.705 2.27 . . . . 0.0 112.869 -179.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -65.28 -48.02 74.63 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.112 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.431 HD12 HD12 ' A' ' 132' ' ' LEU . 4.8 pt -101.56 5.42 10.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.535 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -58.91 -67.3 2.25 Favored Glycine 0 CA--C 1.52 0.362 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.933 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -62.26 -29.63 80.42 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.36 2.04 . . . . 0.0 112.286 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 65.3 mt -66.73 -54.41 25.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.135 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.431 HD12 HD12 ' A' ' 128' ' ' ILE . 15.1 mt -73.73 -31.22 63.25 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.095 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -63.69 -36.47 93.38 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.216 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.04 -43.23 71.68 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.836 0.351 . . . . 0.0 111.008 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 23.2 mm -71.92 -29.85 34.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.194 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.47 -46.95 83.09 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.016 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.0 -22.69 67.03 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.868 0.366 . . . . 0.0 111.591 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . 0.513 ' O ' HG12 ' A' ' 141' ' ' VAL . 2.6 tp -86.13 -35.68 20.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.697 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 25.6 p -82.21 -20.01 38.61 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.354 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -82.84 -8.49 59.57 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.439 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . 0.513 HG12 ' O ' ' A' ' 138' ' ' LEU . 1.4 p -88.42 -8.0 10.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-O 121.163 0.506 . . . . 0.0 110.945 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -145.57 -64.28 0.02 OUTLIER Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.571 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 144.43 57.31 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.187 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -82.74 62.08 4.66 Favored Glycine 0 N--CA 1.453 -0.173 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.734 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 9.5 m -70.26 -25.51 27.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.833 0.349 . . . . 0.0 111.28 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -63.61 -30.69 78.38 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.252 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -67.35 -42.49 83.42 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.822 0.344 . . . . 0.0 110.233 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.99 -40.95 97.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.58 179.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.445 ' O ' HG13 ' A' ' 152' ' ' ILE . 0.6 OUTLIER -68.3 -42.1 79.94 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.452 179.233 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -66.31 -29.82 70.11 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.638 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -64.63 -57.78 8.14 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.053 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.445 HG13 ' O ' ' A' ' 149' ' ' LEU . 0.9 OUTLIER -63.26 -42.75 97.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.377 -179.377 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.451 ' O ' HG23 ' A' ' 157' ' ' VAL . 0.4 OUTLIER -69.08 -32.97 72.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.745 -0.207 . . . . 0.0 110.74 179.605 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -60.42 -41.11 98.42 Favored Glycine 0 C--O 1.223 -0.547 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.001 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.804 HD13 ' HB2' ' A' ' 15' ' ' SER . 29.6 tp -80.29 -29.0 38.21 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.693 0.282 . . . . 0.0 110.8 178.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.3 -39.36 79.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.425 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.528 ' O ' HG23 ' A' ' 161' ' ' VAL . 49.8 t -57.28 -63.81 3.3 Favored Pre-proline 0 CA--C 1.542 0.671 0 O-C-N 123.253 0.345 . . . . 0.0 111.817 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.525 ' CD ' ' HB ' ' A' ' 157' ' ' VAL . 20.7 Cg_endo -60.43 -33.56 93.98 Favored 'Trans proline' 0 C--N 1.362 1.272 0 C-N-CA 122.188 1.926 . . . . 0.0 112.637 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.35 -44.74 95.27 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.631 -0.258 . . . . 0.0 110.938 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -69.36 -35.08 75.51 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.758 0.314 . . . . 0.0 110.358 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 157' ' ' VAL . 89.4 t -62.21 -47.34 93.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.214 178.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 158' ' ' PRO . 58.2 t -67.04 -41.97 87.91 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.609 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -57.37 -39.37 75.86 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.511 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -77.49 -40.96 41.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.206 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -70.3 -19.77 63.07 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.658 0.266 . . . . 0.0 111.159 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.606 ' HA ' HD12 ' A' ' 169' ' ' ILE . . . -63.59 -26.47 68.7 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.145 178.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -66.91 -38.31 85.99 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.551 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 6.1 mtp180 -65.83 -34.16 77.51 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.728 178.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.606 HD12 ' HA ' ' A' ' 166' ' ' ALA . 6.6 mt -75.3 -28.06 20.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.787 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.97 -36.76 77.83 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.197 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -61.38 -49.64 75.18 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.348 179.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . 0.406 ' O ' ' HB2' ' A' ' 175' ' ' ARG . 52.6 m95 -72.26 -26.26 61.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.808 0.337 . . . . 0.0 111.156 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.83 -23.75 61.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.958 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 14.8 mtp85 -75.82 -17.93 59.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.026 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . 0.406 ' HB2' ' O ' ' A' ' 172' ' ' TRP . 0.0 OUTLIER -60.08 -43.83 95.22 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.063 0.459 . . . . 0.0 110.47 178.876 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -108.57 -76.55 0.61 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.116 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 98.51 -25.61 27.21 Favored Glycine 0 C--N 1.329 0.163 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.424 178.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 26.6 mtp180 -84.13 -10.56 57.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.966 0.412 . . . . 0.0 110.983 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 1.6 pt -76.84 -18.86 14.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.214 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.02 -22.27 65.56 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.432 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' HIS . . . . . 0.501 ' O ' HG23 ' A' ' 185' ' ' VAL . 0.1 OUTLIER -84.18 -23.0 30.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.935 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -72.83 -42.62 63.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.867 0.365 . . . . 0.0 110.66 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.421 HG22 ' H ' ' A' ' 183' ' ' VAL . 4.4 m -71.5 -19.14 20.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.073 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -80.33 -37.56 32.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.608 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 181' ' ' HIS . 91.6 t -68.98 -41.73 81.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.739 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.435 ' O ' HG23 ' A' ' 190' ' ' VAL . 1.7 mp -61.25 -38.98 88.63 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.752 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -66.7 -36.28 82.12 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.16 178.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -66.35 -36.43 91.63 Favored Glycine 0 C--N 1.333 0.366 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.85 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 185' ' ' VAL . 98.7 t -61.81 -52.86 55.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.846 0.355 . . . . 0.0 110.695 179.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 186' ' ' LEU . 4.0 t -63.4 -31.2 51.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.977 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.34 -54.26 46.08 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.203 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . 0.516 HG12 ' HA3' ' A' ' 87' ' ' GLY . 35.0 m -68.29 -30.66 48.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.822 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.77 -50.75 69.82 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.19 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 58.8 t -66.46 -37.99 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.124 0 CA-C-O 120.883 0.373 . . . . 0.0 110.215 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . 0.439 ' HA2' HD13 ' A' ' 83' ' ' LEU . . . -59.55 -47.21 92.04 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.441 178.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 192' ' ' VAL . 91.4 t -72.08 -36.81 58.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.619 0.247 . . . . 0.0 111.022 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.32 -31.74 73.02 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.699 0.285 . . . . 0.0 111.211 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.33 -33.91 21.97 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.68 -0.236 . . . . 0.0 111.296 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -77.23 -47.22 20.76 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.4 -35.29 17.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.677 0.275 . . . . 0.0 111.627 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -83.55 -63.64 1.69 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.405 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 54.3 -148.29 0.47 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 122.403 0.281 . . . . 0.0 110.819 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 48.55 -111.07 0.41 Allowed 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 179.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.44 30.94 6.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.829 0.347 . . . . 0.0 110.975 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -69.71 -14.4 62.78 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.386 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.1 mt -77.58 -16.12 58.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.956 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -64.84 -36.03 83.04 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.198 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 75.6 p -62.59 -36.96 84.36 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.122 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . 0.472 ' O ' HG12 ' A' ' 213' ' ' ILE . 1.6 m-85 -87.04 -22.71 25.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.057 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.02 -16.29 61.32 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.542 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.49 -29.63 69.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.847 0.356 . . . . 0.0 110.731 179.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.88 -6.3 48.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.997 0.427 . . . . 0.0 110.355 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . 0.472 HG12 ' O ' ' A' ' 209' ' ' PHE . 11.1 mm -93.56 -3.68 10.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.743 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . 0.409 ' HA ' ' HD3' ' A' ' 215' ' ' PRO . 0.2 OUTLIER -63.46 116.98 29.91 Favored Pre-proline 0 CA--C 1.529 0.16 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.411 179.163 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 214' ' ' THR . 16.3 Cg_exo -69.3 122.24 9.04 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.564 2.176 . . . . 0.0 112.994 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -74.04 -22.7 59.45 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.794 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -70.15 -24.54 63.18 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.955 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.658 HD21 ' HG ' ' A' ' 10' ' ' LEU . 1.8 mm? -76.13 -30.55 58.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.279 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -74.15 -23.15 59.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.059 179.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 5.2 mmm180 . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.827 179.427 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.462 0.147 0 CA-C-O 120.608 0.242 . . . . 0.0 110.422 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -102.01 9.07 40.72 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.944 0.402 . . . . 0.0 110.43 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.89 -42.59 60.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.107 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.69 -42.25 64.44 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.793 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.54 -45.28 91.26 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.542 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.41 -40.59 87.16 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.61 178.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.523 ' HB2' ' HB1' ' A' ' 150' ' ' ALA . . . -61.02 -48.61 80.99 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.717 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -57.43 -46.82 83.14 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.776 179.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.0 mp -61.7 -45.8 92.43 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.509 178.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.25 -42.37 90.97 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.534 178.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.86 -44.28 98.26 Favored Glycine 0 C--N 1.334 0.417 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.887 178.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 74.4 t -63.5 -41.94 94.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-O 120.781 0.324 . . . . 0.0 110.517 179.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.94 -45.12 90.62 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.813 0.34 . . . . 0.0 110.522 179.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.541 ' HB2' HD21 ' A' ' 155' ' ' LEU . 9.9 m -64.42 -35.15 79.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.868 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -73.65 -34.13 64.82 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.327 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.6 mt -79.15 -14.86 58.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.979 0.419 . . . . 0.0 110.757 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.402 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 1.4 t -86.37 126.9 63.13 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.873 178.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 18' ' ' SER . 30.8 Cg_exo -61.56 -14.84 37.75 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.784 2.323 . . . . 0.0 112.654 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 6.0 t -81.23 66.92 6.97 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.142 0.496 . . . . 0.0 110.633 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.1 m -89.98 161.53 2.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.864 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.65 -55.73 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.517 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -66.58 -22.52 50.93 Favored 'Trans proline' 0 C--N 1.361 1.202 0 C-N-CA 122.289 1.993 . . . . 0.0 112.89 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -74.17 -13.6 60.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.59 179.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.433 ' N ' ' HD2' ' A' ' 26' ' ' PRO . 73.7 t -74.51 -56.58 2.33 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-O 119.675 -0.202 . . . . 0.0 111.399 179.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 25' ' ' VAL . 17.1 Cg_endo -57.54 -23.43 56.39 Favored 'Trans proline' 0 C--N 1.362 1.254 0 C-N-CA 122.614 2.209 . . . . 0.0 113.449 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.04 -24.86 66.51 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.721 0.296 . . . . 0.0 111.416 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -76.84 -38.07 54.45 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.907 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -82.94 -22.47 33.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.448 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -53.61 -28.7 34.05 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.438 178.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -62.35 -33.53 74.89 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 120.83 0.348 . . . . 0.0 110.854 178.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 21.9 mt -86.45 -22.99 26.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.622 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -93.94 3.27 70.27 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.999 -0.619 . . . . 0.0 111.683 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -81.59 65.7 3.97 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 121.399 -0.429 . . . . 0.0 112.505 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.405 ' HB2' ' HB3' ' A' ' 109' ' ' ARG . . . -89.62 -19.87 24.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.939 0.4 . . . . 0.0 111.188 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 9.4 mmm180 -109.51 -97.16 0.39 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.024 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 165.17 -176.38 40.87 Favored Glycine 0 N--CA 1.448 -0.5 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 4.9 ttm105 57.26 72.87 0.86 Allowed Pre-proline 0 N--CA 1.469 0.49 0 C-N-CA 122.575 0.35 . . . . 0.0 111.343 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.11 -23.99 39.15 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.487 2.125 . . . . 0.0 112.502 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.6 mt -66.26 -34.98 79.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.977 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -73.32 -37.57 66.11 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.03 -36.59 84.88 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.99 178.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.44 -47.19 82.9 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.331 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -56.01 -42.32 76.25 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.162 178.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.47 -37.66 77.38 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.6 0.238 . . . . 0.0 110.947 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -65.05 -48.34 74.15 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.324 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 13.3 pt -68.29 -27.91 38.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.678 0.275 . . . . 0.0 110.92 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.47 -51.35 29.76 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.484 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -61.66 -43.85 98.71 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.081 179.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -67.32 -35.64 79.84 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.632 0.253 . . . . 0.0 110.609 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -63.08 -42.72 99.48 Favored Glycine 0 C--N 1.334 0.428 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.39 -44.88 92.71 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.672 0.273 . . . . 0.0 110.667 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 49' ' ' GLY . 26.5 t -65.49 -41.94 92.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.98 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.86 -34.68 78.95 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.917 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -76.56 -43.54 38.51 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.592 179.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.2 tp -61.12 -33.01 72.69 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.973 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.414 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 3.8 mt -89.73 -18.4 26.44 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.083 178.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -72.01 -32.04 63.75 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.334 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.18 -54.55 32.3 Favored Pre-proline 0 CA--C 1.543 0.69 0 N-CA-C 111.698 0.258 . . . . 0.0 111.698 179.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.414 ' HD2' ' C ' ' A' ' 57' ' ' LEU . 17.2 Cg_exo -67.46 -13.6 39.7 Favored 'Trans proline' 0 C--N 1.361 1.223 0 C-N-CA 122.559 2.172 . . . . 0.0 112.528 179.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.493 ' HA ' HD12 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -57.69 -20.87 37.07 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.387 179.728 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.3 p -62.04 -35.9 79.99 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.227 0.537 . . . . 0.0 110.45 178.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.4 -19.54 26.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.682 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.493 HD12 ' HA ' ' A' ' 61' ' ' PHE . 70.6 mt -75.38 -17.42 60.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.993 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.61 -31.18 78.98 Favored Glycine 0 C--N 1.334 0.422 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.912 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -77.23 -29.61 56.14 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.146 179.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 tp -76.88 -25.07 52.63 Favored 'General case' 0 N--CA 1.461 0.094 0 CA-C-O 120.784 0.326 . . . . 0.0 110.817 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.406 HD13 ' HA ' ' A' ' 68' ' ' LEU . 0.5 OUTLIER -67.62 -19.25 65.2 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.945 179.902 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -71.29 -17.46 62.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.566 178.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.84 161.86 17.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.419 179.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 9.1 m-70 -82.26 77.27 9.08 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.043 0.449 . . . . 0.0 111.36 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.2 mmp_? -96.7 49.15 1.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.829 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -73.01 -22.16 60.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.865 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -65.26 -24.64 67.37 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.329 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.19 -23.16 44.04 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.734 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.96 -30.32 26.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.056 179.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.5 mmt-85 -60.27 -27.65 67.44 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.493 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.3 t -63.47 -26.46 40.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-O 120.964 0.411 . . . . 0.0 110.519 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -65.0 -34.81 90.87 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.919 -0.658 . . . . 0.0 111.824 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.477 ' O ' HG23 ' A' ' 84' ' ' VAL . . . -66.93 -39.45 93.31 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.417 179.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.8 t -61.57 -40.35 86.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-O 120.875 0.369 . . . . 0.0 110.59 179.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 80.5 t -63.35 -39.68 86.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.386 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.98 -40.1 96.71 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.796 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 80' ' ' GLY . 53.1 t -63.59 -44.09 98.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.222 179.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.58 -41.1 93.95 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.593 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -65.57 -42.94 91.24 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.331 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -61.98 -38.29 95.81 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.247 179.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.0 -38.47 91.05 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.813 0.339 . . . . 0.0 110.831 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -73.74 -30.14 62.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.345 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 6.7 mtp -71.11 -27.1 63.35 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.538 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 65.0 mt -63.82 -16.23 60.75 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.26 178.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.37 16.08 74.81 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.751 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.4 mp -77.4 137.85 38.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.918 0.39 . . . . 0.0 110.505 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 15.6 mtp180 . . . . . 0 C--N 1.325 -0.475 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.889 -178.939 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.4 ' HB ' ' HD2' ' A' ' 110' ' ' PRO . 0.2 OUTLIER . . . . . 0 CA--C 1.532 0.252 0 CA-C-O 120.794 0.331 . . . . 0.0 111.404 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.74 -40.23 19.08 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.405 ' CB ' ' HD3' ' A' ' 110' ' ' PRO . 0.0 OUTLIER -58.61 -56.53 34.69 Favored Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.634 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' PRO . . . . . 0.405 ' HD3' ' CB ' ' A' ' 109' ' ' ARG . 31.4 Cg_exo -60.91 -28.27 86.09 Favored 'Trans proline' 0 C--N 1.36 1.165 0 C-N-CA 122.32 2.014 . . . . 0.0 112.503 179.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.8 tp -69.09 -28.73 66.77 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.772 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -63.01 -33.79 88.21 Favored Glycine 0 C--N 1.336 0.572 0 C-N-CA 120.93 -0.652 . . . . 0.0 111.714 178.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -77.71 -34.17 52.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.94 0.4 . . . . 0.0 110.544 178.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -70.56 -38.35 74.12 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.708 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.29 -27.42 62.45 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.503 179.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.08 -44.88 94.46 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.305 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -71.65 -27.78 70.42 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.556 178.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.06 -48.45 65.55 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.674 0.273 . . . . 0.0 110.809 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 3.5 p -69.02 -31.88 71.0 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.866 0.365 . . . . 0.0 110.981 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -74.11 -39.88 63.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.778 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.16 -24.0 67.27 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.935 0.398 . . . . 0.0 110.962 178.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 43.5 mt -80.73 -18.36 48.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.477 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -95.78 81.23 0.81 Allowed Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 3.3 m0 -66.56 -82.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.729 0.3 . . . . 0.0 111.324 -179.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.497 HG22 ' HB ' ' A' ' 128' ' ' ILE . 0.7 OUTLIER -144.57 65.84 13.12 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.575 179.326 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -74.76 -57.4 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.006 1.804 . . . . 0.0 112.492 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -86.06 -16.94 36.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.051 0.453 . . . . 0.0 110.466 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.497 ' HB ' HG22 ' A' ' 125' ' ' THR . 1.2 mt -92.14 2.43 8.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.421 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.4 ' N ' ' HD2' ' A' ' 130' ' ' PRO . . . -57.14 -60.68 8.59 Favored Glycine 0 CA--C 1.521 0.413 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.426 178.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' PRO . . . . . 0.4 ' HD2' ' N ' ' A' ' 129' ' ' GLY . 19.0 Cg_endo -59.45 -35.03 97.13 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.459 2.106 . . . . 0.0 112.141 178.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ILE . . . . . 0.494 ' O ' HG13 ' A' ' 135' ' ' ILE . 19.1 mt -68.42 -49.18 68.44 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.956 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 tp -63.92 -34.48 78.05 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.755 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -61.17 -39.96 97.89 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.854 -0.689 . . . . 0.0 111.599 178.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -71.38 -30.95 66.73 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.82 0.343 . . . . 0.0 110.683 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ILE . . . . . 0.494 HG13 ' O ' ' A' ' 131' ' ' ILE . 79.7 mt -72.06 -31.87 41.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.642 179.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 7.7 mt -60.37 -35.8 76.55 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.908 179.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.5 -22.59 63.59 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.809 178.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.5 tp -81.65 -27.35 34.14 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.382 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.59 ' HA ' ' O ' ' A' ' 143' ' ' GLY . 0.3 OUTLIER -76.3 -17.36 59.47 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.631 179.401 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -71.82 -17.99 62.12 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.358 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 8.1 t -73.89 -28.8 24.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.984 0.421 . . . . 0.0 110.712 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 129.36 64.77 0.11 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.148 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.59 ' O ' ' HA ' ' A' ' 139' ' ' THR . . . 113.13 -152.25 18.04 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.16 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 115.73 20.45 5.36 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.378 -0.915 . . . . 0.0 112.729 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 11.7 p -66.12 -25.54 36.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 CA-C-O 120.961 0.41 . . . . 0.0 110.976 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -62.43 -30.32 75.98 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.093 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -67.4 -42.6 83.03 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.605 0.24 . . . . 0.0 110.503 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.8 tp -61.96 -43.75 98.19 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.512 179.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.522 ' O ' HG13 ' A' ' 152' ' ' ILE . 1.6 mp -67.95 -41.45 82.47 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.648 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.523 ' HB1' ' HB2' ' A' ' 8' ' ' ALA . . . -64.52 -35.14 80.0 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.477 178.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -61.05 -54.66 42.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.421 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.522 HG13 ' O ' ' A' ' 149' ' ' LEU . 0.5 OUTLIER -63.8 -42.67 96.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.874 -179.778 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' LEU . . . . . 0.431 ' O ' HG23 ' A' ' 157' ' ' VAL . 0.0 OUTLIER -64.44 -40.76 96.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.169 179.352 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -59.36 -41.51 96.99 Favored Glycine 0 C--N 1.334 0.429 0 CA-C-N 116.207 -0.451 . . . . 0.0 112.758 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.541 HD21 ' HB2' ' A' ' 15' ' ' SER . 7.0 mt -80.59 -26.67 37.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.814 0.34 . . . . 0.0 111.016 178.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -62.7 -37.35 86.13 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.314 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.499 ' HB ' ' CD ' ' A' ' 158' ' ' PRO . 96.5 t -54.8 -63.66 2.69 Favored Pre-proline 0 CA--C 1.541 0.601 0 O-C-N 123.382 0.426 . . . . 0.0 111.642 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' PRO . . . . . 0.499 ' CD ' ' HB ' ' A' ' 157' ' ' VAL . 28.7 Cg_endo -62.65 -36.64 62.57 Favored 'Trans proline' 0 C--N 1.358 1.077 0 C-N-CA 121.765 1.643 . . . . 0.0 112.578 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -58.92 -48.27 82.07 Favored 'General case' 0 N--CA 1.462 0.134 0 O-C-N 123.017 0.198 . . . . 0.0 111.37 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -65.8 -39.28 90.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.958 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 157' ' ' VAL . 92.9 t -63.61 -44.26 98.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.188 178.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 71.8 t -66.17 -44.91 91.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.284 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -58.02 -35.55 71.42 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.885 0.374 . . . . 0.0 111.377 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.7 mt -69.12 -45.83 69.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.011 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.13 -34.47 68.59 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.926 0.393 . . . . 0.0 110.624 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 170' ' ' LYS . . . -69.93 -19.06 63.4 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.999 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -67.0 -26.34 66.74 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.372 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 1.1 tpt85 -79.19 -46.6 17.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.06 0.457 . . . . 0.0 110.668 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.438 HG12 ' HA ' ' A' ' 166' ' ' ALA . 20.7 pt -75.03 -18.77 16.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.288 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.468 ' O ' ' HG3' ' A' ' 174' ' ' ARG . 0.2 OUTLIER -57.44 -44.27 84.58 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.057 179.751 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -68.29 -25.36 74.69 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.672 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 1.3 m-90 -86.9 -41.08 14.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.658 0.266 . . . . 0.0 111.201 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.82 -16.63 62.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.581 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.468 ' HG3' ' O ' ' A' ' 170' ' ' LYS . 0.0 OUTLIER -52.44 -54.69 28.96 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.764 0.316 . . . . 0.0 111.342 179.197 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 14.8 mtm180 -94.12 -16.36 23.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.567 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -92.21 1.37 57.26 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.72 0.295 . . . . 0.0 111.635 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -85.09 55.43 4.96 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.599 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.5 -53.02 3.45 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.981 0.419 . . . . 0.0 110.41 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' ILE . . . . . 0.429 ' H ' HG12 ' A' ' 179' ' ' ILE . 7.3 pt -74.26 -22.18 17.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.339 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' SER . . . . . 0.415 ' O ' ' HG3' ' A' ' 184' ' ' GLU . 0.3 OUTLIER -66.51 -18.71 65.51 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.467 179.975 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' HIS . . . . . 0.441 ' HA ' ' OE2' ' A' ' 184' ' ' GLU . 0.0 OUTLIER -63.85 -32.6 74.17 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.03 179.918 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -80.23 -25.31 39.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.93 0.395 . . . . 0.0 110.62 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 11.9 t -74.67 -25.34 18.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.44 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' GLU . . . . . 0.441 ' OE2' ' HA ' ' A' ' 181' ' ' HIS . 32.7 mt-10 -74.41 -29.68 61.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.649 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 11.4 t -69.62 -48.89 63.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.688 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' LEU . . . . . 0.448 ' O ' HG23 ' A' ' 190' ' ' VAL . 2.7 mt -59.33 -43.18 92.77 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.841 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -68.9 -40.76 78.96 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.704 179.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -62.69 -41.61 99.8 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.265 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 54.4 t -61.49 -52.41 61.44 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.103 0 CA-C-O 120.43 0.157 . . . . 0.0 110.803 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 186' ' ' LEU . 54.8 t -58.16 -39.62 73.91 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.92 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 1.8 mt -61.71 -47.39 85.5 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.173 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 60.3 t -70.74 -35.89 62.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.657 0.265 . . . . 0.0 110.598 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.4 tp -59.83 -51.79 68.23 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.131 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 31.7 m -67.08 -29.61 46.71 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.585 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -65.36 -49.65 59.94 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.703 178.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 46.2 t -67.09 -37.74 79.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 O-C-N 122.744 -0.268 . . . . 0.0 110.328 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.53 -31.12 72.2 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.776 179.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.464 HD13 HD13 ' A' ' 206' ' ' LEU . 0.5 OUTLIER -76.05 -29.78 58.15 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.075 0.464 . . . . 0.0 110.424 178.813 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -78.31 -41.17 34.51 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.602 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 66.9 p -86.24 -39.84 16.16 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -91.08 -4.74 68.6 Favored Glycine 0 C--N 1.329 0.174 0 C-N-CA 121.223 -0.513 . . . . 0.0 112.707 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.1 -142.44 0.56 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 122.69 0.396 . . . . 0.0 110.962 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -83.8 -11.41 57.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.769 0.319 . . . . 0.0 110.959 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.81 -43.23 80.15 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.46 179.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -74.55 -30.36 61.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.838 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' LEU . . . . . 0.464 HD13 HD13 ' A' ' 198' ' ' LEU . 5.8 tp -73.17 -33.62 65.55 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.719 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -63.27 -41.38 99.01 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.786 0.327 . . . . 0.0 111.033 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 4.3 p -73.56 -25.36 60.34 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.076 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -87.44 -27.12 22.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.272 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -80.97 -15.64 55.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.494 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.17 -35.05 71.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.243 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.26 -6.37 55.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.245 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 4.6 mt -106.94 7.44 9.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.124 0.488 . . . . 0.0 110.801 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 2.3 p -61.49 122.33 69.98 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.865 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -60.16 145.9 97.47 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.367 2.044 . . . . 0.0 112.311 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -63.8 -21.16 66.29 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.329 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -73.2 -26.44 61.15 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.75 0.309 . . . . 0.0 110.913 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.21 -30.3 17.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.376 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.97 -22.79 63.12 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.518 179.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 1.2 ttp180 . . . . . 0 C--N 1.332 -0.189 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.729 179.132 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.1 mtp . . . . . 0 N--CA 1.487 1.422 0 CA-C-O 121.012 0.434 . . . . 0.0 110.561 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -97.58 137.31 36.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.365 179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.55 102.18 9.25 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.902 0.382 . . . . 0.0 111.064 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.29 -18.79 61.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.916 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.31 -27.62 69.45 Favored 'General case' 0 C--O 1.226 -0.178 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.992 179.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -60.41 -48.26 82.52 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-O 120.778 0.323 . . . . 0.0 110.59 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.36 -45.69 92.05 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.774 178.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.403 ' HB1' ' HA ' ' A' ' 151' ' ' TYR . . . -64.19 -33.58 76.12 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.964 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.454 ' O ' HG23 ' A' ' 13' ' ' VAL . 0.2 OUTLIER -66.69 -52.38 45.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.247 179.527 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 1.8 mp -61.33 -38.02 85.39 Favored 'General case' 0 C--O 1.231 0.102 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.104 178.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.81 -43.03 99.88 Favored 'General case' 0 C--N 1.333 -0.114 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.468 178.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.3 -41.91 98.57 Favored Glycine 0 C--N 1.335 0.522 0 C-N-CA 121.054 -0.593 . . . . 0.0 111.994 178.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 9' ' ' PHE . 48.2 t -64.59 -38.57 82.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.125 0.488 . . . . 0.0 109.839 178.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 60.1 mt -63.81 -41.17 97.94 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.5 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.6 m -65.46 -33.22 75.43 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.697 0.284 . . . . 0.0 110.877 179.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -69.35 -36.79 77.23 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.023 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.6 mp -90.5 -4.37 56.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.953 179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 8.1 t -79.08 124.01 84.75 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.363 179.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.422 ' HG3' HD13 ' A' ' 213' ' ' ILE . 37.9 Cg_endo -67.44 -8.63 22.72 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.691 2.261 . . . . 0.0 112.709 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.422 ' SG ' ' HZ ' ' A' ' 210' ' ' PHE . 1.0 OUTLIER -88.11 -14.48 38.68 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.954 179.756 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 13.6 t -116.98 -79.74 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.188 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.423 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 15.0 mt 51.15 82.61 0.24 Allowed Pre-proline 0 N--CA 1.466 0.351 0 O-C-N 123.709 0.631 . . . . 0.0 111.699 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -55.23 -24.08 40.08 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.99 2.46 . . . . 0.0 113.273 -179.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.4 tp -64.36 -26.2 68.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.717 -0.22 . . . . 0.0 111.133 178.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.442 ' HB ' ' CD ' ' A' ' 26' ' ' PRO . 71.4 t -67.48 -61.14 4.81 Favored Pre-proline 0 CA--C 1.539 0.557 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.162 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.442 ' CD ' ' HB ' ' A' ' 25' ' ' VAL . 19.3 Cg_endo -59.11 -35.19 98.49 Favored 'Trans proline' 0 C--N 1.361 1.185 0 C-N-CA 122.032 1.821 . . . . 0.0 112.559 178.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 20.2 m -64.9 -36.54 84.68 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-O 120.714 0.292 . . . . 0.0 111.002 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.446 ' O ' ' HB2' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -66.53 -28.51 68.6 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.566 179.562 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 7.9 mt -85.06 -36.22 21.35 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.075 178.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -63.28 -44.05 96.18 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.549 178.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -73.63 -21.6 60.25 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.763 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.446 ' HB2' ' O ' ' A' ' 28' ' ' TYR . 2.1 tp -75.94 -18.85 59.18 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.4 179.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -89.59 -4.38 73.29 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.946 -0.645 . . . . 0.0 111.66 179.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.99 -59.46 4.94 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 121.161 -0.543 . . . . 0.0 112.666 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . 57.74 -113.28 0.72 Allowed 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 122.753 0.421 . . . . 0.0 111.024 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.11 -36.92 1.14 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.935 0.397 . . . . 0.0 110.725 179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.11 18.08 11.85 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.094 -179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -111.77 96.96 35.53 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 120.514 0.197 . . . . 0.0 110.624 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -69.32 -32.04 21.21 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.507 2.138 . . . . 0.0 112.932 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.62 -44.37 90.75 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.132 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -73.79 -36.03 64.99 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.818 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -65.42 -42.24 92.71 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.165 178.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.49 -51.91 56.66 Favored 'General case' 0 C--O 1.227 -0.126 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.627 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -55.33 -42.0 73.19 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.244 179.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -64.07 -44.69 91.65 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.861 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.46 -40.41 89.39 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.62 179.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 55.5 mt -60.71 -48.57 88.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.573 179.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.65 -45.83 81.48 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.905 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.587 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -59.84 -48.45 85.99 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.407 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.03 -41.75 90.52 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.55 0.214 . . . . 0.0 110.998 179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -61.74 -44.26 98.13 Favored Glycine 0 C--N 1.333 0.393 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.078 179.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.12 -46.04 90.96 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.658 0.266 . . . . 0.0 111.11 179.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 49' ' ' GLY . 46.1 t -65.25 -42.23 93.47 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.098 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -64.29 -28.29 69.62 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.531 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 -84.95 -46.61 11.08 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.896 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.87 -39.21 93.19 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.09 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.448 ' HB2' ' O ' ' A' ' 53' ' ' VAL . 1.0 OUTLIER -85.82 -19.07 31.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.487 179.386 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.421 ' O ' ' HB2' ' A' ' 61' ' ' PHE . . . -74.69 -26.69 66.73 Favored Glycine 0 C--N 1.33 0.217 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.203 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.68 -56.41 33.04 Favored Pre-proline 0 CA--C 1.54 0.59 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -65.65 -13.78 41.51 Favored 'Trans proline' 0 C--N 1.362 1.281 0 C-N-CA 122.305 2.004 . . . . 0.0 113.155 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.421 ' HB2' ' O ' ' A' ' 58' ' ' GLY . 8.2 m-30 -61.44 -17.94 56.63 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 120.651 0.262 . . . . 0.0 111.422 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 21.8 p -71.89 -41.34 68.08 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.135 0.493 . . . . 0.0 110.195 178.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.3 mt -88.48 -21.63 24.09 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.888 179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -68.86 -17.9 64.06 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.901 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -63.43 -24.52 67.7 Favored Glycine 0 C--N 1.335 0.477 0 C-N-CA 120.971 -0.633 . . . . 0.0 111.934 179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.49 -21.82 76.64 Favored Glycine 0 C--N 1.334 0.428 0 C-N-CA 121.078 -0.582 . . . . 0.0 112.149 179.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.69 -20.67 46.01 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.833 0.349 . . . . 0.0 110.631 179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.457 ' HA ' HD13 ' A' ' 68' ' ' LEU . 1.4 mm? -64.32 -19.26 65.32 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.995 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -69.73 -17.62 63.46 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.814 179.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -97.27 -133.36 0.22 Allowed 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.906 179.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -151.03 126.26 9.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.909 0.385 . . . . 0.0 110.841 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -134.59 37.71 3.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.598 -179.65 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -66.88 -18.09 65.21 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.411 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.46 -18.06 65.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.398 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.4 mp -74.15 -22.86 59.25 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.624 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -77.19 -24.11 51.44 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.502 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.451 ' O ' HG23 ' A' ' 81' ' ' VAL . 0.2 OUTLIER -71.79 -33.56 68.67 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.888 179.798 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.486 ' O ' HG23 ' A' ' 82' ' ' VAL . 41.9 t -62.52 -36.76 76.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.729 179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.67 -36.8 93.8 Favored Glycine 0 C--N 1.333 0.408 0 C-N-CA 121.007 -0.616 . . . . 0.0 112.068 179.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.449 ' O ' HG23 ' A' ' 84' ' ' VAL . . . -66.34 -41.59 94.46 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.873 -0.679 . . . . 0.0 111.764 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 77' ' ' ARG . 21.5 t -60.49 -43.88 95.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 CA-C-O 120.83 0.348 . . . . 0.0 110.714 179.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.486 HG23 ' O ' ' A' ' 78' ' ' VAL . 47.1 t -63.91 -41.07 91.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.601 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.87 -43.16 99.55 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.771 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 80' ' ' GLY . 92.7 t -62.97 -44.95 99.96 Favored 'Isoleucine or valine' 0 C--O 1.233 0.217 0 CA-C-O 120.832 0.349 . . . . 0.0 110.429 179.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.78 -41.46 97.74 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.72 179.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -66.52 -40.17 89.04 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.667 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -61.34 -39.52 97.35 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.997 -0.621 . . . . 0.0 111.893 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.5 -40.93 98.37 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.829 0.347 . . . . 0.0 110.698 179.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -71.72 -31.45 66.73 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.548 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 5.2 mtt -67.12 -27.59 67.46 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.473 178.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.74 -9.58 51.46 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.024 178.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.56 11.27 83.32 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.849 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.34 145.15 25.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.926 0.393 . . . . 0.0 110.842 -179.563 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -106.75 140.82 21.73 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.613 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -67.29 -36.07 22.18 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.705 2.27 . . . . 0.0 112.671 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.7 ttp85 -98.81 104.93 17.01 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.445 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 3.3 m95 -83.03 63.51 7.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.295 0.569 . . . . 0.0 111.061 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -168.75 55.42 0.21 Allowed Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.447 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.0 t -81.88 122.77 37.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 120.88 0.372 . . . . 0.0 111.139 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.12 175.77 8.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.943 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.4 mt -109.03 175.59 5.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.255 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 102' ' ' ARG . 0.0 OUTLIER 60.79 55.27 3.29 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-O 121.453 0.644 . . . . 0.0 110.596 -179.209 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -99.28 178.51 4.88 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.02 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -111.75 156.48 21.86 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.676 179.503 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -167.71 -69.33 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 121.021 -0.609 . . . . 0.0 111.936 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 62.28 -93.58 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 122.883 0.473 . . . . 0.0 111.484 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -87.62 62.78 7.23 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.889 0.376 . . . . 0.0 111.011 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.3 -13.66 43.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.299 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.46 ' N ' ' HD2' ' A' ' 110' ' ' PRO . 0.0 OUTLIER -66.85 -52.54 32.08 Favored Pre-proline 0 CA--C 1.54 0.59 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.933 179.845 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' A' ' 109' ' ' ARG . 36.6 Cg_endo -65.18 -15.56 50.79 Favored 'Trans proline' 0 C--N 1.363 1.325 0 C-N-CA 122.069 1.846 . . . . 0.0 112.797 179.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.416 ' O ' ' HB2' ' A' ' 115' ' ' LEU . 0.5 OUTLIER -67.65 -39.64 84.58 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.682 179.857 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -69.28 -31.88 71.91 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.628 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -71.42 -46.16 60.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.888 0.375 . . . . 0.0 110.775 179.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -67.98 -39.16 83.34 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.063 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.416 ' HB2' ' O ' ' A' ' 111' ' ' LEU . 0.7 OUTLIER -65.23 -40.2 93.74 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.79 179.474 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.59 -33.62 76.36 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.705 0.288 . . . . 0.0 110.522 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -66.52 -48.85 60.15 Favored Glycine 0 C--N 1.334 0.446 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.21 178.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -65.44 -29.84 70.56 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.753 0.311 . . . . 0.0 110.713 178.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 52.7 m -61.89 -44.81 96.04 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.811 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.2 mt -69.87 -21.43 63.34 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.384 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -85.22 -40.86 16.17 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.484 179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.1 mp -85.83 -33.06 21.42 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.741 -179.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -80.55 92.24 1.41 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.392 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -81.69 132.87 35.31 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.894 0.378 . . . . 0.0 110.913 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -84.0 113.14 45.96 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.789 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -63.68 -22.37 69.95 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.827 2.351 . . . . 0.0 112.963 -179.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -70.45 -25.69 63.3 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.244 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.5 mm -103.1 2.37 10.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.111 0.482 . . . . 0.0 110.406 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -61.53 -59.64 9.51 Favored Glycine 0 CA--C 1.521 0.44 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.611 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -57.4 -34.78 98.51 Favored 'Trans proline' 0 C--N 1.353 0.813 0 C-N-CA 122.72 2.28 . . . . 0.0 112.323 178.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 16.0 mm -67.83 -43.45 86.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.808 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.39 -37.37 66.01 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.465 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -61.38 -31.17 76.37 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 121.075 -0.583 . . . . 0.0 112.197 178.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.74 -21.91 62.48 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.908 0.385 . . . . 0.0 110.927 179.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 38.4 mm -79.58 -30.34 13.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.681 179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.07 -39.26 94.2 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.574 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.11 -23.76 67.24 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.105 178.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -86.76 -33.5 19.92 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.743 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 23.6 p -80.3 -17.16 52.9 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.357 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -75.94 -29.23 58.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.98 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 21.8 m -100.15 2.91 10.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.266 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -173.43 -90.07 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.478 -179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 151.3 -152.58 24.34 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.431 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 167.52 63.01 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.264 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . 0.405 ' H ' HG23 ' A' ' 145' ' ' VAL . 1.7 t -62.25 -49.17 85.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 120.87 0.367 . . . . 0.0 110.672 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -65.82 -28.98 74.13 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.937 178.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.42 -44.06 83.97 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.809 0.338 . . . . 0.0 110.453 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.93 -42.37 99.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.384 179.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 34.4 mt -66.26 -39.25 89.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.385 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -61.58 -38.81 88.91 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.561 178.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.403 ' HA ' ' HB1' ' A' ' 8' ' ' ALA . 0.2 OUTLIER -62.52 -47.59 83.24 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.654 179.23 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 17.6 mt -64.87 -46.9 90.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.382 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.43 ' O ' HG23 ' A' ' 157' ' ' VAL . 0.2 OUTLIER -62.09 -37.7 86.05 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.951 179.28 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -60.13 -38.84 95.0 Favored Glycine 0 C--O 1.224 -0.518 0 C-N-CA 121.273 -0.489 . . . . 0.0 112.058 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.403 HD13 ' HA ' ' A' ' 155' ' ' LEU . 0.9 OUTLIER -79.98 -26.31 40.0 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.678 0.275 . . . . 0.0 110.971 178.627 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -64.48 -37.46 87.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.153 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.515 ' O ' HG23 ' A' ' 161' ' ' VAL . 59.4 t -55.33 -62.73 3.91 Favored Pre-proline 0 CA--C 1.541 0.633 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.824 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.494 ' CD ' ' HB ' ' A' ' 157' ' ' VAL . 17.9 Cg_endo -59.68 -36.59 91.58 Favored 'Trans proline' 0 C--N 1.36 1.157 0 C-N-CA 122.123 1.882 . . . . 0.0 112.339 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.08 -44.82 96.78 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.271 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -66.11 -40.47 90.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.635 0.255 . . . . 0.0 110.708 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 157' ' ' VAL . 48.3 t -63.88 -45.43 97.01 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.499 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 60.9 t -65.07 -40.24 88.29 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.606 179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -58.8 -41.7 87.36 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.547 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.97 -39.23 63.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.238 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -70.9 -27.65 63.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.739 0.304 . . . . 0.0 110.8 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -64.46 -18.75 65.05 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.532 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -62.77 -46.65 87.05 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.758 0.313 . . . . 0.0 111.044 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -78.24 -34.0 49.43 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.742 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 58.1 mt -69.74 -23.1 25.52 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.364 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.921 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -59.69 -39.1 83.41 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.913 179.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -71.54 -23.8 77.59 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.674 179.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 60.2 t-105 -81.64 -37.89 26.81 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.423 0.154 . . . . 0.0 111.133 179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -52.59 -38.04 59.23 Favored 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 15.7 mmm180 -87.47 -15.67 36.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.495 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -91.16 -27.59 18.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.466 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -53.47 -65.78 0.5 Allowed 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.758 179.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 131.3 -124.47 4.11 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.806 179.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 2.7 mtt180 -100.26 0.6 40.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.675 0.274 . . . . 0.0 111.357 -179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 7.9 mt -66.81 -33.8 65.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.965 0.412 . . . . 0.0 110.844 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.47 -20.22 66.05 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.315 179.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 37.7 m170 -84.01 -21.45 31.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.83 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -73.1 -45.91 54.36 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.524 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 3.6 m -73.54 -19.57 18.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.186 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -65.11 -50.79 64.69 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.708 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.462 ' O ' HG23 ' A' ' 189' ' ' VAL . 2.4 m -81.82 -28.08 9.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.506 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.41 ' O ' HG23 ' A' ' 190' ' ' VAL . 1.2 tp -58.59 -50.72 72.8 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.19 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -62.21 -35.34 78.59 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.785 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.432 ' O ' HG23 ' A' ' 192' ' ' VAL . . . -65.28 -42.33 96.26 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.193 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.462 HG23 ' O ' ' A' ' 185' ' ' VAL . 94.8 t -62.55 -47.56 92.41 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-O 120.76 0.314 . . . . 0.0 110.724 179.468 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 186' ' ' LEU . 39.5 t -62.18 -39.42 83.89 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.128 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.891 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.98 -46.52 87.9 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.841 179.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 188' ' ' GLY . 55.8 t -66.51 -40.55 86.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.422 179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.403 ' O ' ' HB2' ' A' ' 197' ' ' LEU . 4.3 mt -60.98 -46.57 90.19 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.961 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 87.5 t -66.93 -41.1 87.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 120.801 0.334 . . . . 0.0 110.262 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -62.44 -43.46 99.01 Favored Glycine 0 C--N 1.332 0.36 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.742 179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 3.6 p -72.93 -32.36 39.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 CA-C-N 116.8 0.3 . . . . 0.0 111.279 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.53 HD23 HD11 ' A' ' 206' ' ' LEU . 0.5 OUTLIER -74.85 -22.46 58.67 Favored 'General case' 0 C--N 1.334 -0.078 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.122 179.84 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.2 mp -84.76 -38.92 19.05 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.379 179.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -67.17 -47.75 70.03 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.127 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 81.3 p -84.42 -20.27 32.11 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.255 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -78.39 -48.78 7.16 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.245 179.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 57.3 -133.42 1.28 Allowed 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.653 0.263 . . . . 0.0 111.501 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -81.25 84.11 6.68 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.916 0.388 . . . . 0.0 111.153 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.765 HG23 ' H ' ' A' ' 206' ' ' LEU . 13.7 t -150.75 -161.61 1.37 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.651 -179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -59.71 -14.38 13.96 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 122.643 0.377 . . . . 0.0 111.795 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.765 ' H ' HG23 ' A' ' 204' ' ' THR . 0.5 OUTLIER -67.03 -33.11 74.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.619 179.544 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -71.44 -28.69 64.14 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.996 0.427 . . . . 0.0 110.262 179.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.0 -21.21 31.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.781 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -66.97 -21.65 65.96 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.906 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . 0.57 ' HA ' HD12 ' A' ' 213' ' ' ILE . 1.0 OUTLIER -67.2 -19.13 65.51 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.884 179.216 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 3.0 mt -86.21 -10.86 53.88 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.719 179.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.96 -21.86 36.98 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.98 0.419 . . . . 0.0 110.42 179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . 0.57 HD12 ' HA ' ' A' ' 210' ' ' PHE . 2.9 mt -87.5 -24.79 6.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.401 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.23 120.37 79.19 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.371 179.215 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.39 130.51 24.01 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.449 2.099 . . . . 0.0 112.718 -179.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -68.94 -19.59 64.19 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.936 -0.575 . . . . 0.0 111.241 -179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 9.5 m95 -69.57 -18.58 63.65 Favored 'General case' 0 CA--C 1.529 0.145 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.332 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.69 -32.19 16.29 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.849 0.357 . . . . 0.0 110.28 179.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -74.49 -34.53 63.1 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.621 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 14.8 ptm180 -75.91 -8.76 57.69 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.871 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -94.15 11.18 30.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.317 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -93.23 124.96 56.29 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.434 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -69.46 -32.46 19.76 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.59 2.193 . . . . 0.0 112.493 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.907 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.4 mtm . . . . . 0 N--CA 1.484 1.253 0 CA-C-O 120.696 0.284 . . . . 0.0 110.638 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -116.07 179.87 3.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.876 0.369 . . . . 0.0 111.06 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -124.07 20.28 9.08 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.181 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.67 -34.0 76.9 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.126 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 16.9 mt -73.97 -47.83 34.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.544 179.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -60.03 -40.91 91.0 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.762 178.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.89 -48.39 76.86 Favored 'General case' 0 CA--C 1.523 -0.079 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.706 178.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.649 ' HB1' ' HA ' ' A' ' 151' ' ' TYR . . . -58.74 -36.45 74.35 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.161 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.406 ' O ' HG23 ' A' ' 13' ' ' VAL . 41.3 t80 -69.27 -52.04 31.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.336 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.74 -38.28 81.31 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.478 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.06 -44.62 97.11 Favored 'General case' 0 C--N 1.334 -0.077 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.801 179.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.08 -44.23 96.45 Favored Glycine 0 C--N 1.335 0.515 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.185 179.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 9' ' ' PHE . 11.8 t -70.11 -35.21 62.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.909 0.385 . . . . 0.0 110.327 179.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.16 -42.85 96.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.77 179.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.8 m -66.7 -33.28 75.28 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 120.816 0.341 . . . . 0.0 110.711 179.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -75.13 -32.52 61.37 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.502 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -94.59 -1.28 53.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.649 0.261 . . . . 0.0 111.31 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.4 p -62.67 143.94 96.36 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.355 179.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.06 -8.07 18.99 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.543 2.162 . . . . 0.0 112.812 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.415 ' O ' ' HB ' ' A' ' 21' ' ' VAL . 0.1 OUTLIER -63.63 -47.37 81.62 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.957 179.65 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.415 ' HB ' ' O ' ' A' ' 20' ' ' CYS . 96.1 t 71.11 137.01 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 O-C-N 123.769 0.668 . . . . 0.0 110.945 -179.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -105.17 128.77 25.98 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.553 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -65.04 -18.51 62.13 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.631 2.22 . . . . 0.0 112.469 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.1 mt -74.27 -12.51 60.57 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.248 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.497 ' HB ' ' HD3' ' A' ' 26' ' ' PRO . 55.1 t -75.71 -60.21 1.09 Allowed Pre-proline 0 CA--C 1.542 0.661 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 -179.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.497 ' HD3' ' HB ' ' A' ' 25' ' ' VAL . 60.4 Cg_endo -73.31 -34.1 6.39 Favored 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 121.836 1.69 . . . . 0.0 113.511 -179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 4.2 m -71.03 -18.18 62.59 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.39 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -66.21 -21.09 66.3 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.762 0.315 . . . . 0.0 111.199 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 6.0 mt -82.12 -52.84 6.6 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.833 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -62.41 -28.69 69.97 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.475 179.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -60.73 -43.24 98.13 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.766 178.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.412 ' HA ' HD22 ' A' ' 32' ' ' LEU . 0.6 OUTLIER -74.07 -22.16 59.63 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.997 -179.753 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -86.59 -9.57 74.99 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.245 178.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -108.49 -46.61 0.97 Allowed Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 121.407 -0.425 . . . . 0.0 112.11 179.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -117.62 124.67 49.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.806 0.336 . . . . 0.0 110.503 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -77.63 86.84 3.93 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.099 0.476 . . . . 0.0 110.956 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -138.01 171.95 23.11 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.896 179.659 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.403 ' HA ' ' HD3' ' A' ' 39' ' ' PRO . 14.4 mtt180 -96.61 124.86 49.19 Favored Pre-proline 0 C--N 1.324 -0.528 0 C-N-CA 121.162 -0.215 . . . . 0.0 110.834 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 38' ' ' ARG . 50.0 Cg_exo -55.81 -30.57 77.09 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 122.905 2.404 . . . . 0.0 112.782 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.6 mp -63.98 -39.21 93.6 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.0 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.91 -37.14 67.34 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.224 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -65.04 -43.84 91.01 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.085 178.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.55 -49.42 73.51 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.647 179.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.76 -45.0 78.19 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.024 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -65.5 -45.28 84.19 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.21 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -62.65 -42.38 99.57 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.157 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 28.4 mm -65.29 -43.05 95.2 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.566 179.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.55 -44.01 97.41 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.283 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.404 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -61.64 -44.5 97.86 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.904 -0.665 . . . . 0.0 112.064 178.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -68.91 -36.69 78.3 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.606 0.241 . . . . 0.0 110.625 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -62.94 -42.42 99.68 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.46 178.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.87 -43.94 97.82 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.595 0.236 . . . . 0.0 110.578 178.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 49' ' ' GLY . 93.8 t -63.88 -43.37 97.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.726 179.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -63.6 -36.25 83.2 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.234 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -76.52 -44.48 34.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.017 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -63.08 -30.87 71.93 Favored 'General case' 0 C--O 1.226 -0.153 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.976 179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -89.34 -20.51 23.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.791 0.329 . . . . 0.0 110.484 178.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -72.2 -31.2 64.09 Favored Glycine 0 C--N 1.333 0.371 0 C-N-CA 121.191 -0.528 . . . . 0.0 112.507 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.2 mp -62.59 -57.21 23.54 Favored Pre-proline 0 CA--C 1.54 0.564 0 N-CA-C 111.452 0.168 . . . . 0.0 111.452 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -73.97 -13.6 23.89 Favored 'Trans proline' 0 C--N 1.359 1.116 0 C-N-CA 122.019 1.813 . . . . 0.0 112.454 179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.413 ' HA ' HD12 ' A' ' 64' ' ' LEU . 0.1 OUTLIER -56.81 -31.5 64.76 Favored 'General case' 0 N--CA 1.464 0.24 0 O-C-N 123.14 0.275 . . . . 0.0 111.334 179.805 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -64.35 -32.09 73.56 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.805 0.336 . . . . 0.0 110.867 179.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -86.82 -23.51 25.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.038 0.447 . . . . 0.0 110.148 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.413 HD12 ' HA ' ' A' ' 61' ' ' PHE . 14.7 mt -69.33 -17.96 63.76 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.963 179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -59.87 -29.51 67.79 Favored Glycine 0 C--N 1.336 0.573 0 C-N-CA 121.033 -0.603 . . . . 0.0 112.076 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -74.69 -29.5 61.28 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.908 178.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.3 mt -83.56 -21.39 32.68 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.904 0.383 . . . . 0.0 110.555 179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.37 -19.25 65.86 Favored 'General case' 0 C--N 1.333 -0.121 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.446 179.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.87 -17.88 65.11 Favored 'General case' 0 C--N 1.333 -0.115 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.952 178.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -94.5 -110.14 0.12 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -162.19 148.65 13.38 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.683 0.278 . . . . 0.0 110.882 179.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.1 mmt-85 -124.24 53.32 1.43 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.939 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -75.88 -18.13 59.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.881 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -66.74 -26.94 67.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.003 179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -76.94 -22.29 53.52 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.918 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.72 -32.39 72.15 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.038 0.447 . . . . 0.0 110.372 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.533 ' O ' HG23 ' A' ' 81' ' ' VAL . 0.1 OUTLIER -73.19 -36.7 66.59 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.722 179.598 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.485 ' O ' HG23 ' A' ' 82' ' ' VAL . 20.8 t -58.3 -44.88 89.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.87 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.64 -39.76 97.01 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.923 179.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.538 ' O ' HG23 ' A' ' 84' ' ' VAL . . . -65.94 -38.63 94.37 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.079 -0.581 . . . . 0.0 111.924 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 77' ' ' ARG . 95.0 t -62.31 -42.86 97.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-O 120.777 0.322 . . . . 0.0 110.779 179.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 78' ' ' VAL . 47.0 t -62.74 -38.6 82.1 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.536 179.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 11.5 mt -64.57 -43.15 94.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.696 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 80' ' ' GLY . 42.9 t -66.41 -39.13 83.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.285 178.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.61 -43.1 99.49 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.657 178.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -67.03 -36.75 82.77 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.453 179.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -64.64 -39.97 97.16 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.895 -0.669 . . . . 0.0 111.712 178.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 4.9 mt -64.46 -36.76 85.22 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.728 0.299 . . . . 0.0 110.783 179.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -75.73 -31.5 59.63 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.474 179.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 2.8 tpt -69.14 -25.34 64.33 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.615 179.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 3.2 mt -69.06 -11.01 60.4 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.041 178.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 82.99 23.77 54.47 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.911 -0.661 . . . . 0.0 112.682 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.29 115.15 14.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.722 0.296 . . . . 0.0 110.761 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.01 138.47 87.5 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.589 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -69.4 164.5 33.95 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.494 2.129 . . . . 0.0 112.333 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -88.78 159.45 17.75 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.541 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 59.2 m95 62.63 34.43 14.98 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.35 -179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -143.86 47.11 0.8 Allowed Glycine 0 C--N 1.33 0.222 0 CA-C-N 115.692 -0.685 . . . . 0.0 111.796 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.9 t -108.52 -37.13 3.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.91 0.386 . . . . 0.0 111.097 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.57 -24.16 24.1 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.858 179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -135.96 133.91 38.07 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.098 -179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.07 -177.52 3.44 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.903 0.383 . . . . 0.0 110.8 -179.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -100.1 77.08 1.96 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.171 0.51 . . . . 0.0 110.549 179.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -89.25 136.87 32.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.779 -179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 162.82 -165.4 36.33 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.875 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -115.96 -19.19 10.48 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.005 0.431 . . . . 0.0 110.841 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.415 ' C ' ' HD2' ' A' ' 110' ' ' PRO . 0.0 OUTLIER -90.79 13.7 15.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.592 -179.712 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.32 -33.69 67.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.021 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.431 ' HB2' ' HD3' ' A' ' 110' ' ' PRO . 30.8 mmt-85 -73.23 -52.94 5.07 Favored Pre-proline 0 CA--C 1.538 0.515 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.034 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.431 ' HD3' ' HB2' ' A' ' 109' ' ' ARG . 35.6 Cg_exo -58.87 -29.06 89.1 Favored 'Trans proline' 0 C--N 1.362 1.277 0 C-N-CA 122.194 1.929 . . . . 0.0 112.604 179.35 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.74 -26.95 60.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.027 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -68.24 -32.95 76.95 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.777 -0.725 . . . . 0.0 111.487 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.69 -32.58 71.26 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.937 0.398 . . . . 0.0 110.585 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 12.1 m-85 -71.36 -35.07 71.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.889 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.65 -33.55 72.77 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.577 179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.25 -22.06 63.87 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.521 179.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -83.5 -34.36 19.91 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.527 178.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -69.28 -42.39 75.59 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.773 0.321 . . . . 0.0 111.222 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 6.1 p -65.91 -39.31 90.46 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.445 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.68 -21.92 63.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.865 0.364 . . . . 0.0 110.805 179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -84.0 -36.34 23.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.798 179.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 53.2 mt -81.11 -39.37 25.74 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.36 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -81.56 -19.41 66.21 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.581 -0.819 . . . . 0.0 111.827 179.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 15.0 m95 63.41 -170.44 0.18 Allowed 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 123.027 0.531 . . . . 0.0 111.234 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -133.91 107.75 11.64 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.762 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -57.63 -23.15 55.67 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.041 2.494 . . . . 0.0 112.946 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 4.2 m -68.5 -20.21 64.57 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.027 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.418 ' HA ' HD12 ' A' ' 131' ' ' ILE . 6.4 mt -102.62 5.21 10.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.039 0.447 . . . . 0.0 110.079 179.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -57.15 -63.74 5.04 Favored Glycine 0 C--N 1.334 0.418 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.546 179.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -58.67 -37.13 95.74 Favored 'Trans proline' 0 C--N 1.351 0.684 0 C-N-CA 122.426 2.084 . . . . 0.0 112.171 178.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.418 HD12 ' HA ' ' A' ' 128' ' ' ILE . 15.7 mt -64.71 -44.36 96.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.844 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.447 ' O ' HG22 ' A' ' 135' ' ' ILE . 3.2 tp -67.54 -42.53 82.54 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.285 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -61.56 -42.86 99.84 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.871 -0.68 . . . . 0.0 111.862 178.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -68.39 -34.3 75.8 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.764 0.316 . . . . 0.0 110.996 179.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.447 HG22 ' O ' ' A' ' 132' ' ' LEU . 0.0 OUTLIER -72.07 -26.21 24.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.099 179.875 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.2 -35.23 79.18 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.935 -179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.01 -22.43 66.93 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.811 178.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.2 tp -80.41 -42.83 22.04 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.222 179.007 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 142' ' ' GLY . 0.8 OUTLIER -69.59 -16.46 63.41 Favored 'General case' 0 N--CA 1.462 0.159 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.124 179.583 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.43 -26.44 61.84 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.737 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 2.0 t -98.26 -19.22 6.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.776 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.449 ' O ' ' HA ' ' A' ' 139' ' ' THR . . . 153.47 -125.43 1.76 Allowed Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 121.001 -0.618 . . . . 0.0 112.154 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 125.68 -152.23 17.91 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.586 -0.816 . . . . 0.0 112.264 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 173.58 169.25 35.71 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.138 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 3.6 m -75.18 -23.33 17.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.683 0.278 . . . . 0.0 111.378 -179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -62.38 -30.59 76.67 Favored Glycine 0 C--N 1.333 0.406 0 C-N-CA 121.038 -0.601 . . . . 0.0 112.625 179.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.46 -49.36 71.74 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.678 0.275 . . . . 0.0 110.795 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 2.0 mp -63.52 -42.52 98.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.602 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.1 mt -62.08 -40.61 96.38 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.08 179.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.22 -44.04 97.47 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.852 0.358 . . . . 0.0 110.47 178.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.649 ' HA ' ' HB1' ' A' ' 8' ' ' ALA . 14.3 m-85 -65.11 -38.45 90.71 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.023 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 23.1 mm -62.59 -46.62 95.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.16 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.51 -38.23 90.28 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 120.61 0.243 . . . . 0.0 110.769 179.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -59.28 -39.28 94.44 Favored Glycine 0 C--N 1.335 0.503 0 CA-C-N 115.966 -0.561 . . . . 0.0 112.423 179.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.49 ' O ' ' HD2' ' A' ' 158' ' ' PRO . 0.4 OUTLIER -84.24 -21.76 31.05 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.763 0.316 . . . . 0.0 110.787 178.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -62.1 -43.27 99.2 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.445 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.513 ' HB ' ' HD3' ' A' ' 158' ' ' PRO . 0.3 OUTLIER -54.78 -57.03 21.13 Favored Pre-proline 0 N--CA 1.472 0.647 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 179.893 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.513 ' HD3' ' HB ' ' A' ' 157' ' ' VAL . 38.1 Cg_exo -62.33 -40.37 40.74 Favored 'Trans proline' 0 C--N 1.359 1.106 0 C-N-CA 122.256 1.97 . . . . 0.0 112.681 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -59.7 -44.22 93.76 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 116.466 -0.334 . . . . 0.0 111.402 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.69 -44.19 82.39 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.685 -0.234 . . . . 0.0 111.058 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 157' ' ' VAL . 95.2 t -61.26 -44.72 98.95 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.62 179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 55.4 t -66.36 -46.37 87.12 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.162 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.87 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -54.33 -38.18 65.7 Favored 'General case' 0 N--CA 1.467 0.406 0 CA-C-O 120.737 0.303 . . . . 0.0 111.801 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.3 mt -75.31 -47.19 28.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.616 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -70.2 -25.7 63.54 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.449 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.578 ' O ' ' HB2' ' A' ' 170' ' ' LYS . . . -64.6 -25.85 68.15 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.129 179.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -77.58 -42.3 35.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.843 179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.57 -46.11 89.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.11 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 3.7 pt -75.66 -20.55 15.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.676 -179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.578 ' HB2' ' O ' ' A' ' 166' ' ' ALA . 0.2 OUTLIER -62.01 -41.35 97.97 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.916 -179.996 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -64.95 -38.81 95.94 Favored Glycine 0 N--CA 1.453 -0.2 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.01 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -75.62 -30.23 59.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.6 0.238 . . . . 0.0 111.113 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.405 ' HG ' ' HB3' ' A' ' 180' ' ' SER . 0.2 OUTLIER -60.46 -32.68 71.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.088 179.077 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -84.77 -17.47 38.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.921 0.391 . . . . 0.0 110.818 179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 67.5 mtm-85 -91.23 -24.49 19.87 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.91 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -59.36 -48.96 79.64 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.208 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 133.04 -130.95 5.93 Favored Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 120.521 -0.847 . . . . 0.0 112.587 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 8.0 ptp180 -99.37 -3.23 34.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.846 0.355 . . . . 0.0 111.159 -179.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 4.1 mt -69.51 -32.19 51.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.248 -179.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.405 ' HB3' ' HG ' ' A' ' 173' ' ' LEU . 0.1 OUTLIER -62.41 -26.87 68.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.295 179.501 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 15.0 t60 -71.31 -29.7 65.34 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.742 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.434 ' O ' ' HB2' ' A' ' 186' ' ' LEU . 0.9 OUTLIER -68.58 -32.7 72.8 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.812 -179.929 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 2.9 t -76.6 -22.43 15.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.565 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -76.69 -46.4 25.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.562 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.505 ' O ' HG23 ' A' ' 189' ' ' VAL . 16.9 m -75.05 -26.37 19.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.744 -179.755 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.553 ' O ' HG23 ' A' ' 190' ' ' VAL . 2.2 tp -60.32 -47.3 86.63 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.622 -0.263 . . . . 0.0 111.073 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -63.81 -33.81 76.51 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.867 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.444 ' O ' HG23 ' A' ' 192' ' ' VAL . . . -67.94 -42.93 84.43 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.086 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 185' ' ' VAL . 87.0 t -60.91 -44.35 97.71 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-O 120.776 0.322 . . . . 0.0 110.767 179.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 186' ' ' LEU . 24.4 t -62.91 -42.22 95.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.903 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 1.1 mt -59.84 -42.72 94.22 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.732 179.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 188' ' ' GLY . 65.4 t -67.59 -43.82 86.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.2 179.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 3.3 tp -58.44 -45.67 88.05 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.917 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 70.4 t -62.61 -42.39 95.78 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.675 0.274 . . . . 0.0 110.546 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -62.18 -40.72 99.34 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.328 179.462 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 98.4 t -75.21 -41.13 44.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.543 0.211 . . . . 0.0 111.055 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.46 ' O ' ' HA3' ' A' ' 201' ' ' GLY . 1.8 mp -65.48 -23.62 66.95 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.601 -0.272 . . . . 0.0 111.155 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.54 -46.22 11.8 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.696 -0.229 . . . . 0.0 110.789 179.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 10.6 t80 -69.47 -49.38 55.37 Favored 'General case' 0 N--CA 1.461 0.122 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.932 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.69 -13.1 52.42 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.926 0.393 . . . . 0.0 111.108 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' A' ' 197' ' ' LEU . . . -88.66 -63.27 1.35 Allowed Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.466 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 50.87 48.55 22.75 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.986 0.422 . . . . 0.0 111.548 -179.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -119.84 150.44 40.44 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.931 0.396 . . . . 0.0 111.552 -179.245 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.412 ' H ' HG22 ' A' ' 204' ' ' THR . 0.1 OUTLIER -74.71 -36.17 62.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.369 -179.678 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -59.8 -27.09 66.28 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 120.918 0.389 . . . . 0.0 111.426 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 19.5 mt -67.25 -38.52 85.29 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.234 179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -74.75 -29.26 61.09 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.258 179.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.31 -41.29 81.07 Favored 'General case' 0 C--N 1.334 -0.107 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.552 179.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -70.12 -27.39 64.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.768 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 2.9 m-30 -72.56 -24.11 61.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.678 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 2.0 mp -81.2 -22.44 38.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.568 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.42 -7.5 58.44 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.69 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 27.9 mm -82.09 -14.99 12.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.114 179.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 1.7 m -65.98 118.19 49.86 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.429 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -57.7 128.73 30.31 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.305 2.003 . . . . 0.0 111.956 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -63.86 -17.03 62.75 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.247 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 7.8 m0 -70.08 -21.7 63.12 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.893 179.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 1.1 mt -89.08 -31.41 18.04 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.333 179.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 45.6 mt-30 -79.53 -24.81 41.95 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.316 179.336 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 1.9 mtt-85 -79.04 -0.88 33.14 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.812 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -89.33 13.68 12.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.996 0.427 . . . . 0.0 110.918 179.664 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.447 ' O ' ' HG ' ' A' ' 222' ' ' LEU . 0.5 OUTLIER -65.82 141.44 97.69 Favored Pre-proline 0 C--O 1.234 0.277 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.583 179.194 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -79.61 52.97 4.52 Favored 'Trans proline' 0 C--N 1.344 0.336 0 C-N-CA 122.305 2.003 . . . . 0.0 112.6 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 5.5 m . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.247 -0.882 . . . . 0.0 111.538 -179.837 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 56.6 mmm . . . . . 0 N--CA 1.489 1.479 0 CA-C-O 121.108 0.48 . . . . 0.0 110.536 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.1 m -80.97 60.02 4.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.519 179.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -130.9 19.62 5.02 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.961 -179.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.08 -34.39 76.33 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.888 -0.597 . . . . 0.0 111.055 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.06 -43.93 77.48 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.868 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.38 -42.42 98.68 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.751 179.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.51 -45.57 92.38 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.018 178.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.33 -33.69 76.3 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.929 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.409 ' O ' HG23 ' A' ' 13' ' ' VAL . 0.3 OUTLIER -69.19 -49.03 60.31 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.742 179.928 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.9 mt -58.71 -42.03 87.72 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.528 179.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.28 -41.74 99.03 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.267 178.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.46 -43.98 97.4 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 121.206 -0.521 . . . . 0.0 112.261 179.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 9' ' ' PHE . 98.2 t -62.71 -42.67 97.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.794 0.331 . . . . 0.0 110.192 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 14.1 mt -63.93 -42.09 97.46 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.465 179.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 16.5 m -65.95 -41.37 91.35 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.773 179.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -62.75 -39.35 93.85 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.984 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 87.2 mt -80.59 -13.48 59.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.038 179.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.468 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 4.1 p -83.79 137.54 41.0 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.493 -0.321 . . . . 0.0 110.592 179.502 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.488 ' HD3' HD13 ' A' ' 213' ' ' ILE . 23.2 Cg_exo -65.36 -8.56 19.2 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.64 2.226 . . . . 0.0 112.46 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 64.2 m -65.35 -24.43 67.25 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.174 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.1 t -111.2 18.2 7.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 121.393 0.616 . . . . 0.0 110.269 179.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.434 ' HB2' ' O ' ' A' ' 19' ' ' PRO . 0.5 OUTLIER -72.1 -48.23 10.65 Favored Pre-proline 0 CA--C 1.536 0.436 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.406 179.051 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -59.37 -15.11 27.98 Favored 'Trans proline' 0 C--N 1.362 1.283 0 C-N-CA 122.337 2.024 . . . . 0.0 112.734 179.018 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.51 -12.81 60.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.316 179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.409 ' HB ' ' CD ' ' A' ' 26' ' ' PRO . 92.7 t -77.41 -57.92 1.01 Allowed Pre-proline 0 CA--C 1.54 0.574 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.122 179.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.409 ' CD ' ' HB ' ' A' ' 25' ' ' VAL . 30.5 Cg_endo -63.43 -30.37 72.22 Favored 'Trans proline' 0 C--N 1.361 1.215 0 C-N-CA 122.21 1.94 . . . . 0.0 112.747 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.2 p -66.42 -32.11 73.29 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.603 -0.272 . . . . 0.0 110.933 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -65.28 -39.72 92.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.323 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.4 mt -67.47 -37.03 82.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.244 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -67.79 -38.62 83.59 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.949 178.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.596 ' O ' ' HA3' ' A' ' 37' ' ' GLY . 6.5 m-85 -69.26 -38.76 78.58 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.366 178.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.3 mt -66.46 -34.71 78.54 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.512 179.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -87.2 4.34 86.26 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.934 -0.65 . . . . 0.0 111.825 178.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -91.4 56.31 3.15 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 121.319 -0.467 . . . . 0.0 112.265 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . 62.99 -101.06 0.09 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.072 0.549 . . . . 0.0 111.654 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 6.2 mtt85 -90.75 60.57 4.52 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.193 0.52 . . . . 0.0 111.036 -179.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.596 ' HA3' ' O ' ' A' ' 31' ' ' TYR . . . -103.28 75.91 0.29 Allowed Glycine 0 N--CA 1.45 -0.374 0 CA-C-N 115.793 -0.639 . . . . 0.0 112.249 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 10.8 mtt180 -83.98 137.09 40.67 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-O 120.504 0.193 . . . . 0.0 110.924 -179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.655 ' HB3' ' HB1' ' A' ' 163' ' ' ALA . 44.0 Cg_exo -56.7 -47.03 25.57 Favored 'Trans proline' 0 C--N 1.35 0.646 0 C-N-CA 122.956 2.438 . . . . 0.0 112.714 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.9 mp -62.24 -38.85 90.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.167 -179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -70.57 -39.06 74.11 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.393 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -64.89 -45.75 84.66 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.223 178.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.98 -35.95 81.98 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.836 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 3.5 tp -67.48 -48.1 68.12 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.714 179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -66.73 -28.09 68.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.463 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.482 ' O ' ' HB2' ' A' ' 50' ' ' PHE . 0.2 OUTLIER -64.18 -50.71 67.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.558 178.815 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 38.2 mt -65.09 -39.08 84.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.865 179.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -68.81 -52.08 33.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.128 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -58.85 -43.45 96.61 Favored Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.17 178.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.482 ' HB2' ' O ' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -68.9 -36.8 78.47 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.542 0.21 . . . . 0.0 110.64 179.473 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -61.36 -45.71 95.88 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.541 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.43 -44.4 95.83 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.881 0.372 . . . . 0.0 110.78 179.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 95.9 t -65.91 -45.13 92.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.034 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -63.43 -30.26 71.42 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.271 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -78.4 -44.74 24.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.756 0.312 . . . . 0.0 110.682 179.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.33 -30.97 71.49 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.65 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.08 -18.48 27.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.866 0.365 . . . . 0.0 110.287 178.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.515 ' O ' ' HB2' ' A' ' 61' ' ' PHE . . . -75.03 -29.44 60.68 Favored Glycine 0 C--N 1.331 0.276 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.13 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.92 -55.61 43.0 Favored Pre-proline 0 CA--C 1.54 0.562 0 CA-C-O 119.872 -0.108 . . . . 0.0 111.166 178.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -69.83 -12.86 33.61 Favored 'Trans proline' 0 C--N 1.358 1.047 0 C-N-CA 122.186 1.924 . . . . 0.0 112.626 179.128 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.515 ' HB2' ' O ' ' A' ' 58' ' ' GLY . 0.1 OUTLIER -50.18 -34.26 21.97 Favored 'General case' 0 N--CA 1.47 0.533 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 179.926 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.22 -40.3 93.48 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.087 0.47 . . . . 0.0 110.871 179.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -84.61 -19.64 32.66 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.635 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.56 -18.37 62.25 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.91 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -64.05 -32.19 83.35 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 121.01 -0.614 . . . . 0.0 111.757 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -81.22 -22.9 59.92 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.794 179.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.421 HD13 ' HA ' ' A' ' 67' ' ' LEU . 1.1 mm? -82.5 -20.52 36.59 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.642 0.258 . . . . 0.0 110.921 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.3 tp -67.01 -22.54 65.9 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.898 179.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 9.0 m-85 -70.4 -38.45 74.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.861 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -123.1 62.96 1.0 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.139 179.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -78.36 153.11 31.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.804 -179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.1 mtp180 -109.1 130.09 55.48 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.111 -179.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . 0.452 ' O ' ' HG3' ' A' ' 77' ' ' ARG . 67.8 mt-30 -73.69 -21.86 60.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.859 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.13 -25.87 68.28 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.294 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -80.55 -30.25 37.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.723 179.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -78.06 -21.9 49.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.911 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.452 ' HG3' ' O ' ' A' ' 73' ' ' GLN . 88.0 mtt-85 -69.58 -23.09 63.49 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.201 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.474 ' O ' HG23 ' A' ' 82' ' ' VAL . 21.8 t -63.47 -36.37 76.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.878 0.37 . . . . 0.0 110.405 179.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -65.53 -35.43 91.24 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.738 -0.744 . . . . 0.0 111.712 178.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.435 ' O ' HG23 ' A' ' 84' ' ' VAL . . . -66.36 -38.48 93.66 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.788 -0.72 . . . . 0.0 111.324 178.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.403 HG23 ' O ' ' A' ' 77' ' ' ARG . 58.4 t -59.95 -43.71 92.92 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-O 120.907 0.384 . . . . 0.0 110.1 178.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 78' ' ' VAL . 33.0 t -61.98 -39.66 84.48 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.16 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.448 179.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.07 -43.72 97.77 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.519 179.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 80' ' ' GLY . 97.2 t -62.95 -43.28 98.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.176 0 CA-C-O 121.003 0.43 . . . . 0.0 110.05 178.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.5 mp -62.88 -40.42 97.49 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.467 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 56.1 t80 -63.47 -41.74 98.6 Favored 'General case' 0 C--N 1.333 -0.12 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 178.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -59.57 -40.32 96.18 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.7 178.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.451 ' HA ' HD12 ' A' ' 91' ' ' LEU . 10.8 mt -65.61 -37.22 85.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.753 0.311 . . . . 0.0 110.7 179.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -72.01 -36.05 69.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.912 0.387 . . . . 0.0 110.644 179.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 46.6 mmm -70.27 -22.03 62.91 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.86 179.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.451 HD12 ' HA ' ' A' ' 88' ' ' LEU . 4.1 mt -70.52 -2.99 15.77 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.084 178.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 88.67 10.71 66.98 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.916 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 17.3 mt -78.16 122.22 25.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.938 0.369 . . . . 0.0 110.569 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 57.8 mtp180 -117.43 135.47 23.22 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.785 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -69.92 104.64 1.38 Allowed 'Trans proline' 0 CA--C 1.531 0.339 0 C-N-CA 122.712 2.275 . . . . 0.0 112.587 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -80.02 -22.88 41.93 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.808 179.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 10.8 t-105 -131.03 121.83 25.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.725 179.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 179.3 -131.08 1.62 Allowed Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.891 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -96.96 93.01 3.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.961 0.41 . . . . 0.0 111.083 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.5 52.69 2.4 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.355 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.64 78.39 1.13 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.192 0.52 . . . . 0.0 110.527 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.58 173.33 11.84 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.618 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -92.21 -6.23 50.97 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.019 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . 0.453 ' HB3' ' H ' ' A' ' 105' ' ' GLY . 4.3 mt-10 61.84 -157.59 0.33 Allowed 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.297 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.453 ' H ' ' HB3' ' A' ' 104' ' ' GLU . . . 91.44 -132.92 11.52 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.255 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -124.54 15.36 8.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.926 0.393 . . . . 0.0 110.838 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -88.18 2.37 52.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.097 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.6 -20.56 50.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.975 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.414 ' N ' ' HD2' ' A' ' 110' ' ' PRO . 0.9 OUTLIER -77.89 -56.42 1.09 Allowed Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.665 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.414 ' HD2' ' N ' ' A' ' 109' ' ' ARG . 28.6 Cg_endo -62.35 -35.26 74.06 Favored 'Trans proline' 0 C--N 1.362 1.248 0 C-N-CA 122.012 1.808 . . . . 0.0 112.198 179.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -81.46 -21.85 38.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.085 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -68.4 -41.2 85.98 Favored Glycine 0 C--N 1.331 0.286 0 C-N-CA 120.772 -0.728 . . . . 0.0 111.369 178.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -72.3 -33.9 67.74 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.741 0.305 . . . . 0.0 110.521 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -70.76 -36.17 72.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.076 179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.1 tp -67.29 -48.46 67.57 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.711 179.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 12.0 mt -67.41 -29.54 69.06 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.448 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -72.68 -48.69 21.37 Favored Glycine 0 N--CA 1.451 -0.361 0 N-CA-C 111.331 -0.708 . . . . 0.0 111.331 178.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -61.73 -36.33 80.67 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 120.75 0.31 . . . . 0.0 110.738 178.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 90.7 m -64.73 -43.24 94.03 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.884 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.76 -29.65 68.09 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.806 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -77.5 -31.66 53.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.004 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -79.16 -24.83 43.0 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.04 179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -86.88 160.39 32.38 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.75 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -96.8 120.93 38.04 Favored 'General case' 0 C--N 1.327 -0.412 0 O-C-N 122.429 -0.454 . . . . 0.0 111.0 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.443 ' O ' HG22 ' A' ' 128' ' ' ILE . 0.2 OUTLIER -80.93 114.06 45.49 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.849 179.71 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -59.87 -16.94 41.02 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.763 2.308 . . . . 0.0 112.985 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 11.1 t -77.04 -26.55 53.79 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.753 0.311 . . . . 0.0 110.903 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.443 HG22 ' O ' ' A' ' 125' ' ' THR . 1.4 tp -99.98 -4.72 9.3 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.124 -179.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -56.57 -64.38 4.45 Favored Glycine 0 CA--C 1.523 0.546 0 CA-C-N 115.942 -0.572 . . . . 0.0 113.159 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -58.13 -37.95 93.47 Favored 'Trans proline' 0 C--N 1.355 0.872 0 C-N-CA 122.459 2.106 . . . . 0.0 112.413 179.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.497 ' O ' HG13 ' A' ' 135' ' ' ILE . 69.2 mt -61.94 -46.07 97.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.865 179.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.78 -39.97 95.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.001 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -62.94 -36.6 93.65 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 120.702 -0.761 . . . . 0.0 111.78 178.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -68.32 -39.9 81.83 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.576 0.227 . . . . 0.0 111.061 179.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.497 HG13 ' O ' ' A' ' 131' ' ' ILE . 70.4 mt -63.06 -32.97 58.11 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.075 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.37 -34.8 79.01 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.111 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -84.88 -22.07 29.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.904 178.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.9 -29.67 58.53 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.986 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -81.62 -16.22 52.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.04 0.448 . . . . 0.0 110.712 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -77.93 -28.6 49.7 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.666 179.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 7.3 m -102.6 4.87 10.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.986 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -169.68 97.73 0.13 Allowed Glycine 0 N--CA 1.45 -0.389 0 CA-C-N 115.98 -0.555 . . . . 0.0 112.182 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -85.42 81.25 1.75 Allowed Glycine 0 CA--C 1.517 0.187 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.685 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -124.57 106.6 0.94 Allowed Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.509 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -69.2 -23.77 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 121.011 0.434 . . . . 0.0 111.06 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -65.77 -30.36 77.07 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.139 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.26 -43.36 86.68 Favored 'General case' 0 C--N 1.333 -0.126 0 CA-C-O 120.788 0.328 . . . . 0.0 110.62 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.57 -40.24 92.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.9 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.69 -42.04 87.09 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.335 179.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.82 -32.75 74.36 Favored 'General case' 0 C--O 1.225 -0.192 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.447 179.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -63.32 -49.88 72.22 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.741 179.034 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 10.2 mt -61.02 -44.35 98.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.989 0.423 . . . . 0.0 110.535 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.3 -34.04 74.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.409 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -59.92 -36.93 91.74 Favored Glycine 0 C--N 1.334 0.471 0 C-N-CA 121.267 -0.492 . . . . 0.0 112.105 179.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.538 ' C ' ' HD2' ' A' ' 158' ' ' PRO . 5.5 mt -86.36 -22.6 26.57 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 120.842 0.354 . . . . 0.0 110.97 178.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -61.21 -49.55 76.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.052 179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.782 HG13 ' HD3' ' A' ' 158' ' ' PRO . 0.3 OUTLIER -54.6 -51.59 77.24 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -179.331 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.782 ' HD3' HG13 ' A' ' 157' ' ' VAL . 43.4 Cg_exo -58.96 -40.78 68.2 Favored 'Trans proline' 0 C--N 1.36 1.147 0 C-N-CA 122.138 1.892 . . . . 0.0 112.346 178.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -60.6 -40.38 91.59 Favored 'General case' 0 CA--C 1.522 -0.1 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.336 -179.498 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -65.65 -43.38 89.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.794 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 157' ' ' VAL . 40.1 t -63.37 -44.04 98.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.809 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 158' ' ' PRO . 84.9 t -67.73 -49.11 72.82 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.906 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.655 ' HB1' ' HB3' ' A' ' 39' ' ' PRO . . . -57.98 -32.26 67.71 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.644 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -70.4 -48.79 54.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.301 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -71.27 -33.65 69.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.702 0.287 . . . . 0.0 110.82 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.615 ' HA ' HG22 ' A' ' 169' ' ' ILE . . . -68.97 -21.03 64.2 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.019 179.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -72.31 -35.63 68.69 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.169 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 13.4 mmm180 -84.82 -42.71 14.86 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.23 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.615 HG22 ' HA ' ' A' ' 166' ' ' ALA . 3.3 tt -68.41 -19.99 24.95 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.277 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.43 ' HB2' ' O ' ' A' ' 166' ' ' ALA . 0.8 OUTLIER -57.46 -36.4 71.38 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.313 179.59 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -70.0 -30.28 70.13 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.579 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 1.4 m95 -86.82 -47.41 9.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.76 0.314 . . . . 0.0 111.469 -179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 4.7 mt -66.89 -16.49 64.35 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.701 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.43 ' HB2' ' O ' ' A' ' 170' ' ' LYS . 9.9 ttt-85 -56.79 -53.25 60.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.998 0.428 . . . . 0.0 110.984 178.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 8.1 mtm180 -93.77 -16.39 24.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.348 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -94.19 4.7 53.52 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.71 0.29 . . . . 0.0 111.554 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -83.13 9.5 60.58 Favored Glycine 0 CA--C 1.517 0.183 0 C-N-CA 120.985 -0.626 . . . . 0.0 112.681 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 22.2 mtt180 -67.79 -38.65 83.61 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.943 0.401 . . . . 0.0 110.611 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -81.39 -29.5 10.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.467 179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.95 -16.74 64.2 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.108 179.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . 0.468 ' O ' HG23 ' A' ' 185' ' ' VAL . 0.3 OUTLIER -57.27 -31.99 66.16 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.225 179.701 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -65.32 -44.2 88.61 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.045 0.45 . . . . 0.0 110.412 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 2.2 t -72.17 -19.67 19.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.781 179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.79 -44.82 31.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.133 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 181' ' ' HIS . 46.7 t -67.64 -41.24 85.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.549 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.455 ' O ' HG23 ' A' ' 190' ' ' VAL . 0.3 OUTLIER -60.9 -47.9 84.26 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.739 179.504 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -62.35 -36.45 82.26 Favored 'General case' 0 N--CA 1.457 -0.092 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.384 179.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.46 ' O ' HG23 ' A' ' 192' ' ' VAL . . . -64.0 -46.5 91.2 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.98 -0.629 . . . . 0.0 111.951 178.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 86.8 t -62.18 -48.95 86.06 Favored 'Isoleucine or valine' 0 C--O 1.232 0.133 0 CA-C-O 120.555 0.217 . . . . 0.0 110.616 179.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 186' ' ' LEU . 76.6 t -59.3 -38.33 74.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.898 179.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 2.7 tp -62.22 -46.07 90.49 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.778 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.46 HG23 ' O ' ' A' ' 188' ' ' GLY . 61.7 t -66.19 -38.38 81.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.256 179.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 9.0 mt -59.05 -54.24 49.35 Favored 'General case' 0 C--N 1.334 -0.094 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.308 179.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 32.6 m -68.56 -29.74 44.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.861 -179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -66.65 -47.08 70.66 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.449 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 6.1 p -72.17 -31.33 39.14 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 CA-C-O 120.722 0.296 . . . . 0.0 110.79 179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.431 HD23 ' HA ' ' A' ' 197' ' ' LEU . 11.9 mt -67.52 -38.09 83.75 Favored 'General case' 0 N--CA 1.458 -0.069 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.238 179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -75.77 -33.36 60.19 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 121.024 -0.27 . . . . 0.0 110.747 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 19.1 t80 -66.5 -47.16 73.89 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.792 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 10.1 t -81.76 -11.11 59.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.212 179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -87.79 -51.77 3.15 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.557 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 53.87 37.83 27.38 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.037 0.446 . . . . 0.0 111.229 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -139.72 -167.58 2.31 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.692 -179.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.48 56.21 1.37 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.686 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -82.37 -19.5 39.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.009 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 8.8 tp -70.65 -32.92 70.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.807 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -70.22 -40.79 74.31 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.017 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.8 -32.07 71.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.97 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . 0.443 ' O ' HG13 ' A' ' 213' ' ' ILE . 5.9 m-85 -80.84 -43.91 19.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.025 179.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -61.9 -32.7 73.11 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.458 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.77 -18.08 65.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.752 0.31 . . . . 0.0 111.188 179.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.48 -24.39 18.81 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.844 179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . 0.488 HD13 ' HD3' ' A' ' 19' ' ' PRO . 1.9 mt -92.4 -19.05 7.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.276 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 88.3 m -70.48 120.01 76.02 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.716 179.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -72.17 151.26 54.87 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.4 2.066 . . . . 0.0 112.076 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.06 -16.27 63.65 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.35 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 15.0 m95 -70.13 -25.46 63.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.16 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 1.3 mp -82.68 -23.47 34.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.961 0.41 . . . . 0.0 110.311 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 59.6 mt-30 -78.17 -21.98 49.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.393 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 36.5 mmt-85 -81.4 -2.88 51.07 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.954 179.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -94.36 -9.07 36.98 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.995 0.426 . . . . 0.0 110.762 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 1.3 mt -95.09 135.66 23.31 Favored Pre-proline 0 C--N 1.325 -0.471 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.689 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -70.07 77.29 1.19 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.68 2.253 . . . . 0.0 112.745 -179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 2.5 m . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.277 -0.868 . . . . 0.0 111.061 -179.966 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.485 1.298 0 CA-C-O 120.852 0.358 . . . . 0.0 110.738 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -114.61 23.93 12.28 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.994 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.7 mt -73.66 -21.95 60.12 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.499 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.88 -30.47 69.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.648 179.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -74.39 -44.1 53.56 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.666 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -58.32 -46.52 86.0 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.726 179.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -63.85 -47.94 78.72 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.932 179.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.605 ' HB1' ' HA3' ' A' ' 154' ' ' GLY . . . -58.58 -40.61 83.65 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.295 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.84 -49.78 64.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.498 179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 14.2 tp -57.5 -43.91 84.57 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.609 178.692 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.76 -45.88 91.98 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.062 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.8 -45.0 96.51 Favored Glycine 0 C--N 1.334 0.42 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.244 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 67.9 t -68.09 -39.42 81.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.521 0.2 . . . . 0.0 110.606 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.486 ' O ' ' HB2' ' A' ' 18' ' ' SER . 0.2 OUTLIER -61.16 -46.57 89.96 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.591 -0.277 . . . . 0.0 110.871 179.516 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 43.2 m -64.35 -36.12 83.09 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.728 0.299 . . . . 0.0 111.167 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.9 m-85 -72.18 -38.39 69.1 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.746 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.48 -11.66 59.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.847 0.356 . . . . 0.0 111.115 179.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.486 ' HB2' ' O ' ' A' ' 14' ' ' LEU . 0.2 OUTLIER -87.05 134.08 37.62 Favored Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.387 179.239 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.94 -7.96 22.05 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.653 2.236 . . . . 0.0 112.537 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -106.28 147.27 29.35 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.481 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.531 HG22 HG21 ' A' ' 125' ' ' THR . 6.5 t 60.65 65.69 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 CA-C-O 121.384 0.612 . . . . 0.0 110.874 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 30.5 mt -109.07 116.68 55.06 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.285 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.11 -24.31 44.89 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 122.767 2.311 . . . . 0.0 112.688 -179.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.81 -19.27 65.06 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.471 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 54.1 t -64.99 -60.15 8.65 Favored Pre-proline 0 CA--C 1.539 0.542 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.291 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -59.92 -24.91 77.92 Favored 'Trans proline' 0 C--N 1.361 1.196 0 C-N-CA 121.985 1.79 . . . . 0.0 112.547 178.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.7 m -65.2 -39.83 93.35 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 120.844 0.354 . . . . 0.0 110.815 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -69.02 -31.24 69.91 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.739 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.83 -41.48 44.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.369 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -59.48 -41.95 90.97 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.041 179.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -73.99 -28.7 61.59 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.806 179.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -71.68 -28.9 64.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.267 179.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.452 ' O ' ' HD3' ' A' ' 110' ' ' PRO . . . -74.1 -32.18 58.79 Favored Glycine 0 N--CA 1.448 -0.567 0 C-N-CA 120.852 -0.69 . . . . 0.0 112.066 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 92.69 83.86 1.52 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.328 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -124.5 -68.34 0.86 Allowed 'General case' 0 C--N 1.328 -0.341 0 O-C-N 122.923 -0.163 . . . . 0.0 111.246 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 18.8 mtt180 57.93 38.68 27.0 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.271 -179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -104.15 61.55 0.42 Allowed Glycine 0 C--N 1.332 0.308 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.359 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 58.38 82.82 0.23 Allowed Pre-proline 0 N--CA 1.468 0.451 0 C-N-CA 122.894 0.478 . . . . 0.0 111.522 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -57.36 -30.11 86.66 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.861 2.374 . . . . 0.0 112.586 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.9 -38.32 90.45 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.34 179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -77.13 -37.12 54.72 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.499 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 19.9 t30 -65.59 -36.06 82.66 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.222 179.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.566 ' O ' HG12 ' A' ' 47' ' ' ILE . . . -61.61 -54.83 37.68 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.615 178.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 74.2 mt -56.23 -39.75 73.02 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.2 179.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -63.95 -45.89 87.16 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 116.541 -0.3 . . . . 0.0 110.826 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -63.91 -42.73 97.35 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.948 179.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.566 HG12 ' O ' ' A' ' 43' ' ' ALA . 48.8 mm -64.89 -41.08 91.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.656 179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.3 tp -65.28 -45.98 82.29 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 110.137 -0.32 . . . . 0.0 110.137 179.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.535 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -60.74 -42.94 99.62 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.763 -0.732 . . . . 0.0 111.755 179.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.18 -40.83 86.62 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.619 0.247 . . . . 0.0 110.959 179.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -62.06 -39.38 97.53 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.95 -0.643 . . . . 0.0 111.86 179.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.9 -47.92 73.2 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.459 0.171 . . . . 0.0 110.88 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 49' ' ' GLY . 57.8 t -61.87 -40.23 86.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.033 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -66.33 -45.86 78.85 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.323 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -68.18 -38.54 82.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.4 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.54 -32.95 74.62 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.54 -0.3 . . . . 0.0 111.12 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.29 -18.75 26.35 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.977 0.418 . . . . 0.0 110.802 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -79.24 -25.3 59.63 Favored Glycine 0 C--N 1.331 0.3 0 C-N-CA 121.127 -0.558 . . . . 0.0 112.299 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.88 -56.41 29.11 Favored Pre-proline 0 CA--C 1.54 0.579 0 N-CA-C 111.464 0.172 . . . . 0.0 111.464 179.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -70.13 -14.03 34.44 Favored 'Trans proline' 0 C--N 1.362 1.253 0 C-N-CA 122.023 1.815 . . . . 0.0 112.646 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -63.76 -19.74 65.21 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.318 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.0 m -63.53 -45.14 91.95 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 121.012 0.434 . . . . 0.0 110.651 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -88.72 -21.18 24.0 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.102 179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.93 -18.05 58.53 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.785 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -63.25 -26.31 69.23 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.067 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -78.75 -24.53 62.18 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.89 -0.672 . . . . 0.0 111.769 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 54.9 mt -87.35 -20.73 26.33 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.69 0.281 . . . . 0.0 110.652 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.5 -19.32 64.66 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.647 179.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 19.6 m-85 -65.3 -17.45 64.52 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.837 178.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -84.33 179.07 7.53 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.268 0.556 . . . . 0.0 110.353 178.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -80.23 72.36 7.05 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.299 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.427 HH11 ' HD2' ' A' ' 72' ' ' ARG . 8.0 mtt180 -114.26 25.3 11.2 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.386 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -78.38 -18.19 55.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.985 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -64.35 -20.21 65.96 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.469 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.4 -28.32 67.83 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.662 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -85.1 -23.53 28.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.428 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -64.66 -29.21 70.21 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.157 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.1 t -63.73 -21.41 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.241 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.625 179.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -66.58 -29.61 75.05 Favored Glycine 0 C--N 1.336 0.546 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.715 179.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.503 ' O ' HG23 ' A' ' 84' ' ' VAL . . . -74.23 -38.69 45.94 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.51 -0.852 . . . . 0.0 111.169 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.9 t -59.13 -48.87 85.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-O 120.825 0.345 . . . . 0.0 111.05 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.2 m -69.07 -31.35 49.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.107 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.495 HD13 ' HA2' ' A' ' 195' ' ' GLY . 0.4 OUTLIER -64.72 -43.13 94.4 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.673 179.103 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 80' ' ' GLY . 74.1 t -65.54 -40.09 87.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.21 179.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.89 -41.02 95.21 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.636 179.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -66.25 -37.7 86.12 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.4 179.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -65.25 -39.65 96.16 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.713 178.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -63.53 -39.92 95.67 Favored 'General case' 0 N--CA 1.462 0.168 0 CA-C-O 120.738 0.304 . . . . 0.0 110.654 179.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -71.62 -32.03 67.54 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.554 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.87 -19.81 61.23 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.903 179.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -67.48 -3.5 8.71 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.375 178.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 108.49 6.43 31.14 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.681 -0.771 . . . . 0.0 113.147 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.96 121.06 12.04 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 117.083 0.441 . . . . 0.0 110.499 179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 6.9 mtt180 -125.69 143.09 43.94 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.663 -179.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -77.05 -178.33 4.5 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 122.353 2.036 . . . . 0.0 112.047 179.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 77.5 mtt-85 -85.79 -46.3 10.79 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.98 0.419 . . . . 0.0 111.376 -179.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -122.97 164.74 17.94 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.61 -179.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -173.1 -106.73 0.2 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.374 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 1.4 p -121.78 -44.32 2.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.899 0.38 . . . . 0.0 110.813 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.92 84.26 4.97 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.313 -179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.38 68.66 8.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.865 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 17.7 mtt180 70.71 -72.15 0.12 Allowed 'General case' 0 N--CA 1.471 0.624 0 O-C-N 123.819 0.699 . . . . 0.0 111.205 -179.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -102.98 166.22 10.57 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.22 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER 62.15 54.64 2.63 Favored 'General case' 0 N--CA 1.467 0.378 0 O-C-N 123.562 0.539 . . . . 0.0 110.896 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -85.62 124.4 6.8 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.967 -0.635 . . . . 0.0 111.855 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 48.6 mm-40 -109.34 161.37 15.34 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.909 0.385 . . . . 0.0 111.121 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.01 90.1 5.96 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.452 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -88.74 -2.48 58.61 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.062 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.464 ' N ' ' HD2' ' A' ' 110' ' ' PRO . 0.9 OUTLIER -64.39 -53.19 48.02 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.351 -179.745 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.464 ' HD2' ' N ' ' A' ' 109' ' ' ARG . 15.8 Cg_endo -57.88 -36.27 98.3 Favored 'Trans proline' 0 C--N 1.362 1.242 0 C-N-CA 122.171 1.914 . . . . 0.0 112.617 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -75.07 -31.11 61.16 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.34 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -74.48 -25.8 69.41 Favored Glycine 0 N--CA 1.45 -0.41 0 N-CA-C 111.325 -0.71 . . . . 0.0 111.325 178.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -64.31 -36.77 85.19 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.802 0.334 . . . . 0.0 110.887 179.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.17 -40.71 71.1 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.652 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.9 tp -68.79 -36.08 77.82 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.349 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.14 -22.13 61.36 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.201 0.525 . . . . 0.0 110.22 178.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -80.27 -44.31 8.91 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 178.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.79 -40.07 96.2 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.522 0.201 . . . . 0.0 111.17 179.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.4 p -65.31 -38.94 91.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.967 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -71.69 -24.79 61.88 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.654 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -80.21 -35.02 36.87 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.952 0.406 . . . . 0.0 110.371 179.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 72.5 mt -78.46 -26.14 46.05 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.314 179.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -76.71 160.35 50.45 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.768 178.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 14.9 p90 -112.62 154.38 26.13 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.978 0.418 . . . . 0.0 110.86 -179.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.574 ' HB ' ' SG ' ' A' ' 127' ' ' CYS . 0.8 OUTLIER -109.32 104.39 55.04 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.519 179.424 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.97 -18.26 56.44 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 123.115 2.543 . . . . 0.0 113.203 -179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . 0.574 ' SG ' ' HB ' ' A' ' 125' ' ' THR . 0.8 OUTLIER -64.88 -37.45 87.68 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.14 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 pt -103.45 4.79 10.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.24 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -58.89 -68.59 1.61 Allowed Glycine 0 C--N 1.334 0.472 0 CA-C-N 116.046 -0.525 . . . . 0.0 112.756 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.51 -31.61 92.63 Favored 'Trans proline' 0 C--N 1.35 0.619 0 C-N-CA 122.348 2.032 . . . . 0.0 111.878 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.401 ' O ' HG12 ' A' ' 135' ' ' ILE . 60.6 mt -63.69 -55.83 20.38 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.141 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.888 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.43 -34.7 77.76 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.708 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -61.88 -36.2 92.45 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.226 179.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -75.61 -36.7 60.19 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.833 0.349 . . . . 0.0 111.086 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.401 HG12 ' O ' ' A' ' 131' ' ' ILE . 46.7 mm -70.48 -35.33 61.38 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.212 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.971 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.97 -30.17 70.74 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.118 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.88 -26.97 64.44 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.941 0.4 . . . . 0.0 110.75 178.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 8.7 mt -84.52 -38.75 19.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.893 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 16.0 p -70.11 -16.3 63.09 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.473 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -75.86 -29.48 58.57 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.791 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 2.1 t -96.81 -32.77 4.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.592 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -150.15 90.76 0.14 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.318 179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -162.92 -97.59 0.12 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.601 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 111.56 -179.77 19.84 Favored Glycine 0 N--CA 1.453 -0.203 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.49 179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 6.2 t -75.0 -31.11 24.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 120.67 0.271 . . . . 0.0 111.0 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -60.44 -32.67 78.35 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.996 -0.621 . . . . 0.0 112.669 179.363 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -67.87 -40.87 83.55 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.853 0.358 . . . . 0.0 110.426 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.417 ' O ' HG13 ' A' ' 152' ' ' ILE . 17.0 mt -62.35 -42.52 99.46 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.486 179.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 30.7 mt -65.77 -39.82 91.41 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.508 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.18 -40.11 96.58 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.385 178.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -61.49 -44.8 96.43 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.026 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.417 HG13 ' O ' ' A' ' 148' ' ' LEU . 53.9 mt -64.39 -49.0 82.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.633 179.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.427 ' O ' HG23 ' A' ' 157' ' ' VAL . 0.1 OUTLIER -66.55 -34.57 78.2 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.928 -179.941 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.605 ' HA3' ' HB1' ' A' ' 8' ' ' ALA . . . -60.55 -44.82 97.34 Favored Glycine 0 C--O 1.223 -0.546 0 C-N-CA 121.176 -0.535 . . . . 0.0 112.189 179.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -73.45 -28.17 61.81 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.166 0.508 . . . . 0.0 110.561 178.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -64.4 -35.34 80.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.438 179.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.495 ' O ' HG23 ' A' ' 161' ' ' VAL . 96.7 t -55.38 -62.79 3.83 Favored Pre-proline 0 CA--C 1.542 0.643 0 O-C-N 123.272 0.358 . . . . 0.0 111.595 179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.478 ' CD ' ' HB ' ' A' ' 157' ' ' VAL . 18.0 Cg_endo -60.15 -36.09 89.96 Favored 'Trans proline' 0 C--N 1.359 1.127 0 C-N-CA 122.04 1.827 . . . . 0.0 112.225 179.11 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -59.66 -46.44 89.02 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-O 120.739 0.304 . . . . 0.0 110.944 179.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -63.57 -39.41 94.32 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.942 -179.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 157' ' ' VAL . 52.8 t -61.27 -43.59 96.8 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-O 120.927 0.394 . . . . 0.0 110.321 179.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 158' ' ' PRO . 61.0 t -68.36 -38.58 79.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.647 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -58.56 -35.6 72.62 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-O 120.779 0.323 . . . . 0.0 111.313 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 17.1 mt -78.96 -42.63 26.32 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.194 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -71.78 -19.24 62.04 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.438 -0.347 . . . . 0.0 111.224 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.556 ' HA ' HD12 ' A' ' 169' ' ' ILE . . . -66.01 -19.85 65.99 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.158 179.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -64.29 -39.76 94.58 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.782 179.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 16.5 mtt180 -69.16 -24.17 64.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.649 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.556 HD12 ' HA ' ' A' ' 166' ' ' ALA . 26.4 mt -83.38 -22.42 8.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.427 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 1.3 ttpp -62.76 -38.17 89.49 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.749 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -75.85 -36.23 42.7 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.664 -0.779 . . . . 0.0 111.882 179.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 1.8 m95 -73.92 -26.95 60.79 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.525 0.194 . . . . 0.0 111.525 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 2.3 tp -57.49 -36.53 71.62 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.709 0.29 . . . . 0.0 111.367 179.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 1.1 mtp-105 -87.07 -20.45 27.11 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.136 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -83.78 -34.13 24.84 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.921 179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.421 ' HB1' ' HB ' ' A' ' 179' ' ' ILE . . . -62.55 -65.19 0.72 Allowed 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.793 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 79.78 -64.85 3.81 Favored Glycine 0 CA--C 1.519 0.328 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.969 179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 9.4 mtm180 -81.18 -40.14 24.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.722 0.296 . . . . 0.0 111.285 -179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.421 ' HB ' ' HB1' ' A' ' 176' ' ' ALA . 14.3 mm -69.04 -31.4 50.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.051 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -63.33 -26.64 68.86 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 121.048 0.452 . . . . 0.0 111.092 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -84.8 -22.01 29.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.128 179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -75.63 -28.79 58.96 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.44 -0.346 . . . . 0.0 110.825 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 17.4 t -65.54 -25.37 36.62 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.703 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -82.41 -37.98 24.72 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.768 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 34.8 t -70.99 -46.3 68.28 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.891 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 5.2 tp -62.32 -52.67 62.72 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.282 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -64.42 -35.09 79.79 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.02 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.425 ' O ' HG23 ' A' ' 192' ' ' VAL . . . -62.41 -49.96 69.17 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.21 179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 96.4 t -62.0 -46.99 95.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-O 120.479 0.181 . . . . 0.0 110.783 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.471 ' O ' HG23 ' A' ' 194' ' ' VAL . 85.9 t -59.33 -43.15 89.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.878 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 5.4 tp -58.43 -48.85 79.34 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.756 0.312 . . . . 0.0 111.228 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.531 ' O ' HG23 ' A' ' 196' ' ' VAL . 41.4 t -66.06 -40.85 88.33 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.465 179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . 0.448 ' O ' ' HB2' ' A' ' 197' ' ' LEU . 2.2 tp -58.77 -50.08 75.28 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.681 179.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 190' ' ' VAL . 87.7 t -61.1 -39.75 83.41 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.105 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.434 179.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.495 ' HA2' HD13 ' A' ' 83' ' ' LEU . . . -57.86 -48.03 84.87 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.978 -0.629 . . . . 0.0 112.611 179.255 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 192' ' ' VAL . 4.2 t -73.87 -34.89 41.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.726 0.298 . . . . 0.0 110.517 179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . 0.539 ' O ' ' HA3' ' A' ' 201' ' ' GLY . 0.5 OUTLIER -63.1 -28.31 69.99 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.714 179.236 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.652 HD23 HD11 ' A' ' 206' ' ' LEU . 65.0 mt -80.38 -42.54 22.65 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.818 178.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 20.6 t80 -70.79 -57.6 4.48 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 111.831 0.308 . . . . 0.0 111.831 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 68.2 p -81.46 -9.26 59.75 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.803 0.335 . . . . 0.0 111.727 -179.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . 0.693 ' HA2' ' HB3' ' A' ' 205' ' ' ALA . . . -84.67 -54.21 3.0 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.623 -0.798 . . . . 0.0 112.436 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 28.5 m 67.23 -72.2 0.09 Allowed 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 122.845 0.458 . . . . 0.0 111.521 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -163.84 -50.19 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.523 179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.91 -46.2 90.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.35 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . 0.693 ' HB3' ' HA2' ' A' ' 201' ' ' GLY . . . -84.8 -19.52 32.41 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.738 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.652 HD11 HD23 ' A' ' 198' ' ' LEU . 1.1 mt -77.27 -36.86 54.01 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.889 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.98 -39.59 95.16 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.625 -0.261 . . . . 0.0 110.949 179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.52 -37.82 73.67 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.342 178.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 33.4 m-85 -87.04 -24.52 24.59 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.167 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -67.65 -17.19 64.51 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.978 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 4.0 mt -61.35 -30.84 70.77 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-O 121.019 0.437 . . . . 0.0 110.722 179.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 3.2 mtt180 -92.91 -3.61 54.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.711 179.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 37.0 mm -103.21 -20.16 5.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.941 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.56 119.7 45.9 Favored Pre-proline 0 C--N 1.331 -0.203 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.047 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -70.46 151.63 65.17 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.304 2.003 . . . . 0.0 112.254 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -64.61 -22.42 66.97 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.191 -179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 8.0 m-90 -63.55 -24.8 67.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.303 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 16.0 mt -89.53 -27.22 20.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.94 0.4 . . . . 0.0 110.399 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.04 -35.43 31.84 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.363 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 1.4 mtp180 -74.66 -7.26 52.68 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.03 179.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -87.92 -9.56 53.28 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.991 0.424 . . . . 0.0 110.301 179.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . 0.424 ' HA ' ' HD3' ' A' ' 223' ' ' PRO . 23.7 mt -89.51 129.19 48.06 Favored Pre-proline 0 C--N 1.325 -0.5 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.29 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 222' ' ' LEU . 32.3 Cg_exo -57.63 -38.57 93.02 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.836 2.358 . . . . 0.0 112.626 -179.716 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.024 -0.989 . . . . 0.0 110.599 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 121.099 0.476 . . . . 0.0 110.84 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.97 155.72 18.51 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.943 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 8.2 mt -76.17 -20.94 57.08 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.505 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.75 -26.21 64.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.687 179.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.8 mt -77.4 -46.1 23.78 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.562 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -60.51 -39.81 89.13 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.796 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -62.76 -46.02 89.97 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.737 178.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.97 -35.12 79.11 Favored 'General case' 0 C--N 1.334 -0.098 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.769 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.474 ' O ' HG23 ' A' ' 13' ' ' VAL . 1.2 m-85 -65.56 -51.74 57.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.18 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.43 -39.02 82.18 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.29 178.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.23 -44.17 97.7 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.425 178.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.81 -42.9 99.8 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 120.888 -0.672 . . . . 0.0 111.835 178.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 9' ' ' PHE . 49.1 t -65.61 -41.31 90.38 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.177 0 CA-C-O 120.719 0.295 . . . . 0.0 110.307 179.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.4 tp -63.99 -41.72 97.41 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.456 179.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 18.9 m -64.34 -35.78 81.98 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.726 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -72.04 -36.08 69.53 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.988 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.8 -4.86 59.27 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.811 0.339 . . . . 0.0 111.077 179.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.0 t -68.89 119.87 72.37 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.805 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.573 ' HD3' HG21 ' A' ' 213' ' ' ILE . 39.3 Cg_endo -67.3 -8.07 20.89 Favored 'Trans proline' 0 C--N 1.35 0.648 0 C-N-CA 122.84 2.36 . . . . 0.0 112.697 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 2.2 t -73.38 -25.31 60.52 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.841 179.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.4 m -130.82 5.78 2.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.526 -0.306 . . . . 0.0 111.666 -179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.411 ' N ' ' HD2' ' A' ' 23' ' ' PRO . 0.3 OUTLIER -70.77 -53.72 8.82 Favored Pre-proline 0 CA--C 1.538 0.504 0 N-CA-C 111.883 0.327 . . . . 0.0 111.883 179.896 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.411 ' HD2' ' N ' ' A' ' 22' ' ' LEU . 46.0 Cg_endo -68.97 -14.71 39.1 Favored 'Trans proline' 0 C--N 1.361 1.201 0 C-N-CA 121.888 1.725 . . . . 0.0 112.432 179.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.1 mp -81.28 -16.13 53.45 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.459 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.466 ' N ' ' HD2' ' A' ' 26' ' ' PRO . 95.0 t -62.86 -55.2 40.31 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-O 119.725 -0.179 . . . . 0.0 111.289 178.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.602 ' HA ' HD12 ' A' ' 29' ' ' LEU . 14.4 Cg_endo -58.05 -33.06 96.87 Favored 'Trans proline' 0 C--N 1.362 1.246 0 C-N-CA 122.275 1.984 . . . . 0.0 112.505 178.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.54 -36.64 65.69 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.791 0.329 . . . . 0.0 110.943 179.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.0 -28.5 68.3 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.021 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.602 HD12 ' HA ' ' A' ' 26' ' ' PRO . 8.3 mt -63.06 -37.52 87.51 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.718 179.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.58 -35.52 67.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.065 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -66.75 -37.14 84.05 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.336 178.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.63 -15.18 60.83 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.23 178.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -67.65 -24.96 74.08 Favored Glycine 0 C--N 1.332 0.346 0 N-CA-C 111.77 -0.532 . . . . 0.0 111.77 179.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -74.53 -16.35 80.1 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.985 -0.626 . . . . 0.0 111.54 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -126.9 51.39 1.87 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.975 0.417 . . . . 0.0 109.988 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -73.7 70.79 1.4 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.39 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -146.48 84.95 0.18 Allowed Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.548 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 1.2 mtp180 66.4 91.25 0.08 OUTLIER Pre-proline 0 N--CA 1.467 0.416 0 C-N-CA 122.922 0.489 . . . . 0.0 111.16 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -64.09 -30.24 65.67 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 122.434 2.089 . . . . 0.0 112.466 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.4 mp -62.55 -40.83 98.06 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.279 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -72.47 -37.35 68.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.615 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -67.57 -43.8 79.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.393 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -64.05 -50.68 67.44 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.769 179.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -55.74 -42.68 75.75 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.219 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -63.85 -41.31 97.84 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.876 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.28 -41.47 94.15 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.37 179.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 54.6 mt -62.96 -42.43 96.6 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.943 178.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.31 -44.07 92.74 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.468 179.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.514 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -59.27 -43.71 97.04 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.862 -0.685 . . . . 0.0 111.693 178.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.02 -37.24 81.16 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 120.76 0.314 . . . . 0.0 110.242 179.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -63.17 -41.93 99.55 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 111.398 -0.681 . . . . 0.0 111.398 178.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.42 -45.99 87.38 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-O 120.509 0.195 . . . . 0.0 110.635 178.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 49' ' ' GLY . 24.7 t -63.41 -43.02 98.29 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.173 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.837 179.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -66.04 -28.2 68.67 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.42 -0.354 . . . . 0.0 111.426 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -82.82 -47.39 11.94 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.606 -0.27 . . . . 0.0 110.561 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.59 -35.71 80.4 Favored 'General case' 0 C--O 1.227 -0.109 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.85 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.42 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 0.9 OUTLIER -89.52 -18.35 26.82 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.792 0.33 . . . . 0.0 110.497 178.488 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.28 -35.68 83.12 Favored Glycine 0 C--N 1.33 0.204 0 CA-C-N 116.03 -0.532 . . . . 0.0 112.41 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.406 ' CB ' ' HD3' ' A' ' 60' ' ' PRO . 0.5 OUTLIER -63.23 -55.63 34.65 Favored Pre-proline 0 CA--C 1.543 0.687 0 N-CA-C 111.49 0.182 . . . . 0.0 111.49 179.197 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.42 ' HD2' ' C ' ' A' ' 57' ' ' LEU . 13.6 Cg_exo -70.47 -13.96 33.4 Favored 'Trans proline' 0 C--N 1.361 1.185 0 C-N-CA 122.517 2.144 . . . . 0.0 112.629 179.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.63 -25.74 64.92 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.119 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.5 -34.72 76.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.032 0.444 . . . . 0.0 110.403 178.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.57 -19.81 25.84 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.618 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.402 ' HA ' HD12 ' A' ' 67' ' ' LEU . 0.3 OUTLIER -67.25 -17.78 64.94 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.863 179.874 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.32 -27.5 65.57 Favored Glycine 0 C--N 1.334 0.459 0 C-N-CA 120.947 -0.644 . . . . 0.0 111.901 179.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -78.38 -22.06 68.46 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.795 -0.717 . . . . 0.0 111.582 179.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.402 HD12 ' HA ' ' A' ' 64' ' ' LEU . 13.9 mt -87.12 -20.56 26.89 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.646 0.26 . . . . 0.0 110.415 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.86 -19.42 62.6 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.916 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -60.45 -26.0 66.42 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.758 178.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -97.59 125.18 42.17 Favored 'General case' 0 C--N 1.331 -0.214 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -74.59 98.74 3.45 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.026 0.441 . . . . 0.0 111.419 -179.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -87.1 64.79 8.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.984 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -67.45 -19.79 65.41 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.135 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 4.0 t -69.99 -17.76 63.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.3 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -84.53 -22.51 30.13 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.883 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.44 -22.4 38.18 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.862 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -67.61 -27.14 66.65 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.92 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.495 ' O ' HG23 ' A' ' 82' ' ' VAL . 3.3 t -63.0 -32.47 56.25 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.798 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -64.31 -34.98 91.37 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.875 -0.678 . . . . 0.0 112.033 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.446 ' O ' HG23 ' A' ' 84' ' ' VAL . . . -66.72 -38.9 93.49 Favored Glycine 0 C--N 1.332 0.31 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.666 179.286 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.9 t -62.53 -41.22 91.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-O 120.766 0.317 . . . . 0.0 110.462 179.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 78' ' ' VAL . 40.5 t -63.8 -40.54 89.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.383 179.208 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.1 -42.72 99.65 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.718 179.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 80' ' ' GLY . 94.5 t -64.02 -43.52 97.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.194 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.392 179.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.86 -43.33 98.53 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.952 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -66.15 -43.53 86.72 Favored 'General case' 0 C--N 1.334 -0.096 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.743 179.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -62.83 -40.14 98.87 Favored Glycine 0 C--N 1.333 0.404 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.148 179.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.2 -36.45 83.7 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.724 0.297 . . . . 0.0 110.613 179.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -74.74 -30.09 61.38 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.283 178.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 28.5 mmt -67.07 -27.94 67.78 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.29 178.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 1.4 mp -66.96 -10.51 50.07 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.265 178.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 84.41 20.22 59.02 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.85 -0.69 . . . . 0.0 113.259 179.661 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -78.42 124.14 27.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.93 0.365 . . . . 0.0 110.594 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.461 ' NH2' ' HA ' ' A' ' 96' ' ' ARG . 0.2 OUTLIER -128.24 122.07 21.86 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.679 -179.494 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -73.68 104.95 1.91 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.329 2.019 . . . . 0.0 112.417 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . 0.461 ' HA ' ' NH2' ' A' ' 94' ' ' ARG . 76.2 mtp180 -77.88 -20.46 52.94 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.455 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 8.6 m95 65.83 -90.44 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.44 0 O-C-N 123.746 0.654 . . . . 0.0 111.922 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.99 71.31 1.32 Allowed Glycine 0 C--N 1.329 0.19 0 C-N-CA 120.791 -0.719 . . . . 0.0 111.997 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -120.73 -89.64 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.84 0.352 . . . . 0.0 111.329 -179.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -92.87 150.61 20.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.752 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.1 tp -85.4 79.13 9.57 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.947 0.403 . . . . 0.0 110.546 179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 49.1 mtp180 -127.58 179.4 5.52 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.549 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -117.68 121.99 42.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.922 0.392 . . . . 0.0 110.872 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -96.04 75.59 3.06 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.341 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -86.87 70.03 2.98 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.676 -0.773 . . . . 0.0 111.843 179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -120.56 153.78 36.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.913 0.387 . . . . 0.0 111.113 -179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.43 71.39 10.71 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.054 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.25 -12.55 59.96 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.94 -0.573 . . . . 0.0 112.15 -179.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.419 ' CB ' ' HD3' ' A' ' 110' ' ' PRO . 0.0 OUTLIER -74.26 -58.46 1.93 Allowed Pre-proline 0 CA--C 1.539 0.53 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -179.571 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.419 ' HD3' ' CB ' ' A' ' 109' ' ' ARG . 23.8 Cg_exo -64.8 -40.21 22.8 Favored 'Trans proline' 0 C--N 1.358 1.047 0 C-N-CA 122.055 1.837 . . . . 0.0 112.34 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -74.17 -30.6 62.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.642 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' A' ' 116' ' ' LEU . . . -64.8 -40.71 97.55 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.909 -0.662 . . . . 0.0 111.974 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.51 -30.51 69.35 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.866 0.365 . . . . 0.0 110.919 179.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -80.5 -45.49 17.43 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.009 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 4.5 mt -65.66 -43.47 89.25 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.894 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.474 ' HB2' ' O ' ' A' ' 112' ' ' GLY . 1.9 mt -71.03 -22.87 62.09 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.944 0.402 . . . . 0.0 110.181 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -78.07 -46.13 9.6 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 178.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.22 -38.72 77.37 Favored 'General case' 0 C--O 1.232 0.139 0 CA-C-O 120.654 0.264 . . . . 0.0 111.304 178.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 1.3 p -68.55 -35.77 77.87 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.935 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.27 -33.1 61.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.478 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -71.27 -47.2 58.39 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.671 179.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.77 -24.01 60.89 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.834 179.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -78.88 89.03 1.16 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.944 -0.646 . . . . 0.0 111.73 179.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -59.3 126.29 27.08 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.082 0.468 . . . . 0.0 111.714 -179.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.52 ' O ' HG22 ' A' ' 128' ' ' ILE . 1.1 p -73.6 134.87 78.74 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.216 -179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -64.13 -19.27 65.91 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.757 2.305 . . . . 0.0 113.116 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 3.9 m -73.13 -14.95 61.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.089 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.52 HG22 ' O ' ' A' ' 125' ' ' THR . 3.7 tp -97.2 -3.95 9.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.363 179.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -51.79 -59.52 8.54 Favored Glycine 0 C--N 1.336 0.57 0 CA-C-N 115.894 -0.593 . . . . 0.0 113.091 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -56.73 -41.48 75.23 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.473 2.115 . . . . 0.0 112.236 179.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.459 ' O ' HG13 ' A' ' 135' ' ' ILE . 25.1 mm -65.48 -47.34 87.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.003 -179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -62.07 -44.12 97.36 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.535 179.655 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -58.74 -38.5 92.08 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.905 -0.664 . . . . 0.0 111.837 178.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.48 -40.58 89.41 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.86 0.362 . . . . 0.0 110.665 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.459 HG13 ' O ' ' A' ' 131' ' ' ILE . 78.6 mt -65.4 -37.44 80.09 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.213 179.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . 0.46 ' HA ' ' OG1' ' A' ' 139' ' ' THR . 0.3 OUTLIER -64.1 -31.42 72.61 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.983 179.49 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 3.2 m -65.46 -30.88 71.72 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.994 0.426 . . . . 0.0 110.741 178.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 18.4 mt -83.39 -37.16 23.66 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.992 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.46 ' OG1' ' HA ' ' A' ' 136' ' ' LEU . 0.6 OUTLIER -72.3 -20.35 61.52 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.948 179.848 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -68.56 -27.52 66.15 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.549 178.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 2.0 t -94.13 -29.4 4.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.246 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 146.92 -95.16 0.17 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.552 179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 100.33 -66.62 0.55 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.342 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 113.32 163.65 15.51 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.703 179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 12.3 p -68.14 -25.59 32.21 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 CA-C-O 120.801 0.334 . . . . 0.0 111.227 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -59.9 -34.29 82.33 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 121.161 -0.543 . . . . 0.0 112.708 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.99 -43.2 88.48 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-O 120.815 0.341 . . . . 0.0 110.424 179.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -63.52 -45.36 91.0 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.504 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.67 -40.36 95.28 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.979 179.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -61.15 -41.2 96.32 Favored 'General case' 0 C--O 1.226 -0.154 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.778 179.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -63.86 -43.54 95.81 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.985 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 59.4 mt -62.67 -50.84 78.16 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.733 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 71.6 mt -68.24 -32.71 73.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.306 -0.407 . . . . 0.0 111.463 -179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -60.69 -44.71 97.57 Favored Glycine 0 C--O 1.225 -0.415 0 C-N-CA 121.087 -0.578 . . . . 0.0 112.355 179.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.69 -21.66 44.38 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.716 0.293 . . . . 0.0 110.954 178.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -65.89 -37.23 85.57 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.484 179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.437 ' HB ' ' CD ' ' A' ' 158' ' ' PRO . 90.8 t -57.73 -59.15 13.95 Favored Pre-proline 0 CA--C 1.541 0.606 0 CA-C-O 119.518 -0.277 . . . . 0.0 111.685 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.437 ' CD ' ' HB ' ' A' ' 157' ' ' VAL . 15.5 Cg_endo -59.26 -36.69 94.41 Favored 'Trans proline' 0 C--N 1.361 1.192 0 C-N-CA 122.142 1.895 . . . . 0.0 112.178 178.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -63.95 -38.15 90.02 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 120.548 0.213 . . . . 0.0 110.972 179.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -65.59 -49.31 69.29 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.47 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 13.5 m -66.71 -32.67 59.07 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 120.728 -0.389 . . . . 0.0 111.06 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 3.9 t -67.73 -43.18 86.67 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 N-CA-C 109.881 -0.415 . . . . 0.0 109.881 178.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -60.09 -34.02 72.88 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.96 178.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 11.2 tp -75.78 -45.39 36.48 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.827 179.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -69.15 -19.15 64.01 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.083 179.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -63.64 -19.07 64.57 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.984 178.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.49 -40.42 94.49 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.468 179.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 2.0 ttt85 -69.12 -36.24 77.29 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.438 179.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 18.0 mt -70.66 -30.16 41.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.377 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -60.97 -36.91 80.64 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.442 179.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -81.5 -34.37 25.72 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.6 -0.809 . . . . 0.0 111.61 178.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 27.8 t-105 -70.09 -25.84 63.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.893 -0.153 . . . . 0.0 111.393 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -54.38 -37.53 65.11 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 120.726 0.298 . . . . 0.0 111.522 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 2.6 mpp_? -87.08 -19.86 27.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.368 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 3.8 mtt85 -86.21 -37.03 19.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.547 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.527 ' HB1' ' HB ' ' A' ' 179' ' ' ILE . . . -59.08 -70.1 0.17 Allowed 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.836 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 69.51 -83.3 0.27 Allowed Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.983 -0.627 . . . . 0.0 113.212 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.13 -40.38 82.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.546 0.212 . . . . 0.0 111.228 -179.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.556 ' O ' HG23 ' A' ' 183' ' ' VAL . 22.6 mt -59.44 -46.14 93.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.811 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -61.06 -41.44 96.61 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.085 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 6.4 m-70 -66.07 -32.49 73.99 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.259 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -70.27 -42.98 71.41 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.784 0.326 . . . . 0.0 110.834 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 179' ' ' ILE . 15.0 t -70.77 -19.97 21.81 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.828 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -67.56 -51.78 46.55 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.604 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.481 ' O ' HG23 ' A' ' 189' ' ' VAL . 5.3 t -75.37 -31.83 24.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.061 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.452 ' O ' HG23 ' A' ' 190' ' ' VAL . 0.6 OUTLIER -58.2 -47.91 81.96 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.912 179.78 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -63.08 -33.67 75.95 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.746 179.607 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.413 ' O ' HG23 ' A' ' 192' ' ' VAL . . . -66.84 -45.74 80.89 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 121.089 -0.577 . . . . 0.0 112.41 179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 185' ' ' VAL . 46.4 t -61.94 -47.6 92.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 CA-C-O 120.736 0.303 . . . . 0.0 110.937 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 186' ' ' LEU . 43.4 t -62.79 -40.98 90.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.774 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 3.7 mt -58.23 -45.96 86.77 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.543 -0.298 . . . . 0.0 111.321 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 188' ' ' GLY . 81.8 t -64.4 -42.38 95.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-O 120.771 0.32 . . . . 0.0 110.537 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.59 -44.07 91.81 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.066 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.407 HG23 ' O ' ' A' ' 190' ' ' VAL . 78.2 t -64.2 -38.84 83.54 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.097 0 N-CA-C 110.35 -0.241 . . . . 0.0 110.35 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -58.39 -44.04 95.43 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.233 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 61.8 t -73.56 -40.01 54.65 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-O 120.763 0.316 . . . . 0.0 110.681 179.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.39 -34.91 79.27 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.112 179.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.51 -41.11 48.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.071 179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.7 -41.6 95.89 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.08 179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 1.3 m -83.99 -13.76 52.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.982 0.42 . . . . 0.0 110.469 179.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -85.59 -49.32 4.4 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.55 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 4.7 m 70.57 -65.22 0.34 Allowed 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 122.946 0.498 . . . . 0.0 111.511 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -154.19 161.31 41.92 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 5.8 m 73.72 -41.42 0.49 Allowed 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 122.98 0.512 . . . . 0.0 111.663 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -60.98 -36.52 79.65 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.028 0.442 . . . . 0.0 110.862 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.06 -23.39 38.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.901 179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -75.21 -50.09 17.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.171 -179.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 1.7 m -61.57 -33.71 74.33 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.876 179.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -74.44 -36.28 63.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.989 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -70.32 -29.59 66.34 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.876 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 6.1 mt -65.25 -18.03 64.98 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.915 0.388 . . . . 0.0 111.219 179.604 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 12.1 mtt180 -92.29 -6.05 51.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.42 179.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . 0.573 HG21 ' HD3' ' A' ' 19' ' ' PRO . 8.1 mm -107.84 -12.47 10.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.69 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.43 128.12 66.98 Favored Pre-proline 0 C--O 1.233 0.192 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.78 179.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_exo -56.8 143.45 90.68 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.557 2.171 . . . . 0.0 112.43 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 8.3 mp0 -61.72 -25.7 67.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.846 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' TRP . . . . . 0.446 ' O ' ' HD1' ' A' ' 221' ' ' TYR . 4.5 m-90 -69.94 -22.29 63.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.949 179.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -81.48 -38.04 26.99 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.04 0.448 . . . . 0.0 109.81 179.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -71.47 -30.72 66.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.585 179.486 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.46 -1.8 35.44 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.05 179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.446 ' HD1' ' O ' ' A' ' 217' ' ' TRP . 0.7 OUTLIER -99.94 10.64 40.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.712 179.609 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.21 129.83 52.21 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.088 179.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -64.17 -48.95 4.17 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.703 2.269 . . . . 0.0 113.016 -179.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 24.7 m . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.108 -0.948 . . . . 0.0 111.324 -179.839 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.2 mmt . . . . . 0 N--CA 1.485 1.291 0 CA-C-O 120.75 0.309 . . . . 0.0 110.855 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.36 67.0 6.05 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.007 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.72 148.32 42.91 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.869 0.366 . . . . 0.0 111.13 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -69.57 -26.8 64.65 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.307 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.2 mt -64.73 -47.53 77.94 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.978 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -60.68 -46.52 90.03 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.685 179.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -60.34 -45.54 93.07 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.023 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.51 -43.3 97.24 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.015 179.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.413 ' O ' HG23 ' A' ' 13' ' ' VAL . 1.0 OUTLIER -62.62 -51.02 68.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.671 179.566 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.95 -40.21 88.2 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.702 179.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.47 -45.95 90.18 Favored 'General case' 0 N--CA 1.461 0.124 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.4 178.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.91 -42.98 99.57 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.944 -0.646 . . . . 0.0 112.018 179.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 9' ' ' PHE . 93.0 t -64.69 -42.64 95.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-O 120.732 0.301 . . . . 0.0 110.579 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.69 -40.11 95.98 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.564 179.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.6 m -69.08 -32.67 72.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.907 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 54.4 t80 -68.03 -42.69 80.21 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.982 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -85.02 -9.43 58.03 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.534 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -66.04 119.17 59.3 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 120.771 0.319 . . . . 0.0 110.884 179.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.31 -8.21 18.41 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.802 2.334 . . . . 0.0 112.489 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 96.6 m -82.43 44.84 0.91 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.034 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -94.78 54.66 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.94 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.549 HD11 HD21 ' A' ' 83' ' ' LEU . 0.3 OUTLIER -62.87 -51.19 73.25 Favored Pre-proline 0 CA--C 1.535 0.391 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.464 -179.57 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.615 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 51.2 Cg_exo -57.18 -31.8 91.62 Favored 'Trans proline' 0 C--N 1.361 1.203 0 C-N-CA 122.192 1.928 . . . . 0.0 113.018 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.86 -13.31 60.54 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.492 ' HB ' ' HD3' ' A' ' 26' ' ' PRO . 3.3 t -64.98 -53.9 38.58 Favored Pre-proline 0 CA--C 1.543 0.712 0 CA-C-O 119.613 -0.232 . . . . 0.0 111.314 179.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.615 ' HD2' ' O ' ' A' ' 23' ' ' PRO . 23.6 Cg_exo -65.77 -21.92 57.57 Favored 'Trans proline' 0 C--N 1.361 1.191 0 C-N-CA 121.919 1.746 . . . . 0.0 112.346 178.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -63.85 -24.67 67.84 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.392 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -66.12 -31.94 73.09 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.009 179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 2.1 mp -86.6 -22.74 26.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.161 0.505 . . . . 0.0 110.487 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -75.07 -20.05 59.7 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.339 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -82.18 -20.86 36.99 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.782 0.325 . . . . 0.0 110.779 -179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.618 ' HG ' HD21 ' A' ' 173' ' ' LEU . 0.4 OUTLIER -87.47 -36.46 17.65 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.011 0.434 . . . . 0.0 110.288 179.442 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -92.32 4.45 77.11 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.054 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -93.45 52.2 2.4 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.647 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -76.58 126.06 30.32 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 110.536 -0.172 . . . . 0.0 110.536 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 17.9 mtp180 62.23 32.72 17.09 Favored 'General case' 0 N--CA 1.467 0.405 0 O-C-N 123.577 0.548 . . . . 0.0 110.933 -179.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -102.36 -168.73 26.8 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.55 -179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.4 88.45 29.88 Favored Pre-proline 0 C--O 1.234 0.277 0 CA-C-O 120.559 0.218 . . . . 0.0 111.109 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.75 -33.95 96.17 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.684 2.256 . . . . 0.0 112.49 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.2 mt -62.17 -45.34 93.86 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.55 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -73.63 -39.84 64.23 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.026 -179.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.88 -42.67 97.43 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.832 0.349 . . . . 0.0 110.632 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -65.29 -51.55 59.97 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.716 -0.674 . . . . 0.0 110.835 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.29 -42.3 86.29 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.482 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -63.9 -42.85 97.33 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 120.49 0.186 . . . . 0.0 110.815 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.98 -42.08 94.86 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.706 179.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 91.0 mt -65.43 -42.55 93.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.159 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.231 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.44 -50.08 75.02 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.483 179.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.457 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -59.2 -45.91 94.62 Favored Glycine 0 C--N 1.333 0.396 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.749 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -69.17 -37.71 78.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.654 0.264 . . . . 0.0 110.947 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -61.64 -43.61 99.04 Favored Glycine 0 C--N 1.331 0.27 0 C-N-CA 121.086 -0.578 . . . . 0.0 111.821 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.57 -43.26 99.19 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.698 0.285 . . . . 0.0 110.674 178.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.457 HG23 ' O ' ' A' ' 49' ' ' GLY . 91.4 t -63.54 -43.94 98.49 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.043 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -65.76 -34.55 78.44 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.435 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -76.52 -43.33 39.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.703 0.287 . . . . 0.0 110.806 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.15 -28.87 69.12 Favored 'General case' 0 C--O 1.226 -0.151 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.907 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -89.05 -18.27 27.64 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-O 120.897 0.38 . . . . 0.0 109.976 178.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -74.91 -32.02 57.35 Favored Glycine 0 N--CA 1.452 -0.276 0 CA-C-N 115.912 -0.585 . . . . 0.0 111.998 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.21 -56.25 37.26 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 179.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -72.84 -13.71 26.69 Favored 'Trans proline' 0 C--N 1.361 1.189 0 C-N-CA 122.266 1.977 . . . . 0.0 112.735 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.66 -23.59 63.19 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.468 -0.333 . . . . 0.0 111.328 -179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -65.8 -41.68 91.61 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.957 0.408 . . . . 0.0 110.539 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -88.63 -21.53 23.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.765 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -81.65 -18.19 45.44 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.427 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -61.59 -32.29 80.84 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 121.253 -0.499 . . . . 0.0 112.566 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -71.97 -31.6 64.26 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.699 -0.762 . . . . 0.0 111.91 179.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.6 mt -84.69 -23.76 29.26 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.723 0.297 . . . . 0.0 110.226 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.18 -19.4 64.78 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.92 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -58.66 -21.89 55.38 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.266 179.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -127.84 146.41 50.62 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.33 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 61.95 57.46 2.11 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 123.375 0.422 . . . . 0.0 111.716 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -89.17 -28.39 20.05 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.79 0.328 . . . . 0.0 111.238 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -69.68 -20.06 63.57 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.545 -179.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -63.26 -32.58 74.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.51 179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.4 mp -81.76 -21.79 37.63 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.674 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -81.01 -28.47 35.47 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.555 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.449 ' O ' HG23 ' A' ' 81' ' ' VAL . 26.7 mtp85 -63.5 -39.02 93.33 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.994 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.463 ' O ' HG23 ' A' ' 82' ' ' VAL . 3.8 t -60.69 -37.9 77.09 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.437 179.355 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -64.55 -39.45 96.82 Favored Glycine 0 C--N 1.333 0.364 0 C-N-CA 120.858 -0.687 . . . . 0.0 111.604 179.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.49 ' O ' HG23 ' A' ' 84' ' ' VAL . . . -64.54 -42.94 97.22 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.896 -0.669 . . . . 0.0 111.596 179.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 77' ' ' ARG . 57.9 t -59.04 -42.95 87.88 Favored 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-O 120.806 0.336 . . . . 0.0 110.569 178.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.573 HG21 ' HA2' ' A' ' 123' ' ' GLY . 87.8 t -63.36 -38.74 82.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.414 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.549 HD21 HD11 ' A' ' 22' ' ' LEU . 8.3 mt -61.29 -42.3 98.42 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.527 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 80' ' ' GLY . 31.6 t -65.56 -43.53 94.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 120.941 0.4 . . . . 0.0 110.088 178.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.69 -40.38 96.95 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.604 179.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.33 -37.08 85.99 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.64 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -61.08 -42.21 99.71 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.699 178.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -66.46 -34.54 78.17 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.862 0.363 . . . . 0.0 110.605 179.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -70.0 -42.6 72.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.703 179.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.94 -24.22 63.32 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.938 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.71 -11.38 58.21 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.35 178.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 94.55 10.82 57.67 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.645 -0.788 . . . . 0.0 113.058 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.3 tp -77.92 125.06 28.78 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 117.04 0.42 . . . . 0.0 110.583 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.528 ' H ' ' HE ' ' A' ' 94' ' ' ARG . 0.3 OUTLIER -72.25 142.32 84.51 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.007 179.657 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -67.51 145.19 69.84 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.255 1.97 . . . . 0.0 112.153 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -85.39 137.34 33.0 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.796 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 4.8 m-90 59.28 41.08 20.54 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.378 -179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -157.71 73.15 0.23 Allowed Glycine 0 N--CA 1.451 -0.327 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.114 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 9.4 p -100.97 146.44 9.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.874 0.369 . . . . 0.0 110.824 -179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.63 40.53 0.85 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.119 179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 5.5 mt 59.36 -106.19 0.28 Allowed 'General case' 0 N--CA 1.467 0.392 0 O-C-N 123.56 0.537 . . . . 0.0 111.134 -179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -130.11 161.16 31.68 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.157 -0.312 . . . . 0.0 110.157 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -80.31 95.05 6.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.983 0.42 . . . . 0.0 111.053 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -134.61 173.33 11.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.431 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -80.25 71.39 2.8 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.455 179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -117.23 16.1 14.89 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.409 0.151 . . . . 0.0 111.409 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.43 ' O ' ' HD2' ' A' ' 110' ' ' PRO . 0.6 OUTLIER 59.52 70.98 0.6 Allowed 'General case' 0 N--CA 1.466 0.325 0 O-C-N 123.427 0.454 . . . . 0.0 111.385 -179.813 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -84.51 0.32 50.25 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.897 -179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.8 -51.77 73.48 Favored Pre-proline 0 CA--C 1.541 0.607 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.43 ' HD2' ' O ' ' A' ' 107' ' ' THR . 46.3 Cg_exo -58.29 -25.61 73.31 Favored 'Trans proline' 0 C--N 1.363 1.295 0 C-N-CA 122.241 1.96 . . . . 0.0 112.927 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.8 mt -68.46 -34.18 75.5 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-O 120.716 0.293 . . . . 0.0 110.588 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -66.85 -36.33 90.95 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.705 -0.76 . . . . 0.0 111.373 179.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -75.2 -35.43 61.52 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.707 0.289 . . . . 0.0 110.629 179.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -65.37 -47.04 77.76 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.001 179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 2.8 mp -64.63 -39.08 93.07 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.539 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.427 ' O ' ' HB2' ' A' ' 120' ' ' LEU . 0.6 OUTLIER -69.49 -31.59 69.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.397 179.209 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -74.64 -44.18 26.94 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.909 -0.662 . . . . 0.0 111.487 179.236 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -58.21 -42.94 87.3 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.945 0.402 . . . . 0.0 110.819 178.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 3.0 m -73.2 -27.68 61.76 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.142 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.427 ' HB2' ' O ' ' A' ' 116' ' ' LEU . 0.3 OUTLIER -76.4 -37.09 57.62 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.74 0.305 . . . . 0.0 110.96 179.642 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -73.27 -37.85 66.14 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.843 0.354 . . . . 0.0 111.226 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -82.95 -19.48 37.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.017 0.436 . . . . 0.0 110.738 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.573 ' HA2' HG21 ' A' ' 82' ' ' VAL . . . -92.04 95.62 2.06 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.701 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 4.8 t-105 -80.34 130.98 35.55 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.026 0.441 . . . . 0.0 111.31 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -79.2 119.88 78.67 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.083 179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.84 -15.98 48.7 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.98 2.454 . . . . 0.0 112.909 -179.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 8.0 m -62.74 -26.79 68.87 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.783 -179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.422 ' H ' HG13 ' A' ' 128' ' ' ILE . 1.4 mt -86.67 -0.83 7.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.785 0.326 . . . . 0.0 111.004 -179.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -59.65 -65.04 3.69 Favored Glycine 0 CA--C 1.523 0.556 0 C-N-CA 121.174 -0.536 . . . . 0.0 112.738 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.4 -38.56 73.51 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.618 2.212 . . . . 0.0 112.194 179.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 61.6 mt -60.93 -41.61 89.61 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.164 179.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.6 mt -63.18 -33.32 75.23 Favored 'General case' 0 N--CA 1.461 0.091 0 CA-C-O 120.687 0.279 . . . . 0.0 110.848 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -61.24 -38.07 95.05 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 121.118 -0.563 . . . . 0.0 111.967 178.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.53 -36.19 73.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.123 0.487 . . . . 0.0 109.967 178.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 45.6 mm -67.17 -42.41 88.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.156 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.337 179.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -61.67 -36.91 82.22 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.32 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 38.4 m -64.5 -38.34 90.68 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.252 178.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 7.8 mt -70.06 -30.83 68.18 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.618 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.1 m -79.99 -22.4 42.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.086 0.469 . . . . 0.0 110.551 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -72.18 -30.27 64.8 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.914 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 20.5 m -100.25 4.98 10.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.009 179.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 141.54 -92.6 0.18 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.46 -179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.98 -123.54 7.02 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.543 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 130.8 159.67 9.7 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.571 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 11.1 p -77.36 -23.41 14.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.684 0.278 . . . . 0.0 111.33 -179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -58.35 -37.52 87.81 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.745 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -68.62 -41.67 79.18 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.691 0.281 . . . . 0.0 110.423 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.409 ' O ' HG13 ' A' ' 152' ' ' ILE . 0.3 OUTLIER -60.86 -46.28 91.2 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.605 179.233 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.83 -40.63 95.5 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.729 179.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -62.43 -41.18 98.52 Favored 'General case' 0 C--O 1.226 -0.168 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.771 179.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -60.61 -44.91 95.75 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.091 179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.409 HG13 ' O ' ' A' ' 148' ' ' LEU . 23.9 mt -64.5 -44.06 96.91 Favored 'Isoleucine or valine' 0 C--O 1.231 0.125 0 CA-C-O 120.95 0.405 . . . . 0.0 110.341 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.92 -35.89 82.6 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.569 179.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.463 ' O ' ' HD2' ' A' ' 158' ' ' PRO . . . -60.56 -46.08 95.08 Favored Glycine 0 N--CA 1.449 -0.463 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.143 179.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -69.38 -29.88 67.75 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.059 0.457 . . . . 0.0 110.754 178.651 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -63.43 -35.21 79.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.589 179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.536 ' O ' HG23 ' A' ' 161' ' ' VAL . 95.1 t -55.38 -63.7 2.83 Favored Pre-proline 0 CA--C 1.543 0.685 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.473 ' CD ' ' HB ' ' A' ' 157' ' ' VAL . 19.1 Cg_endo -60.88 -36.38 83.83 Favored 'Trans proline' 0 C--N 1.359 1.109 0 C-N-CA 121.906 1.737 . . . . 0.0 112.384 179.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -58.08 -45.28 87.42 Favored 'General case' 0 N--CA 1.462 0.158 0 O-C-N 123.169 0.293 . . . . 0.0 111.19 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -70.47 -36.67 74.02 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.718 -0.219 . . . . 0.0 110.873 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.536 HG23 ' O ' ' A' ' 157' ' ' VAL . 96.5 t -64.91 -45.28 95.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 CA-C-O 120.731 0.3 . . . . 0.0 110.692 179.096 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 68.9 t -65.8 -39.4 84.66 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.49 179.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -61.07 -34.82 75.5 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.28 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.8 -42.79 39.26 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.188 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -71.95 -19.23 61.93 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.374 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -61.09 -19.16 61.13 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.414 179.683 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -64.19 -43.05 96.26 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.765 179.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 2.6 mtp180 -73.03 -31.98 64.79 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.992 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 11.8 mt -72.83 -26.32 23.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.787 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.42 -30.92 71.95 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.968 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -70.89 -38.98 65.06 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.813 179.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER -74.22 -24.07 59.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.63 0.252 . . . . 0.0 110.84 179.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.618 HD21 ' HG ' ' A' ' 32' ' ' LEU . 3.2 tp -59.71 -37.61 79.35 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.785 178.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 41.8 mtp180 -76.59 -21.86 55.02 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.816 179.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 35.6 mmt180 -84.87 -32.19 23.34 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.943 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.473 ' HB1' ' HB ' ' A' ' 179' ' ' ILE . . . -65.16 -33.81 76.89 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.642 179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 70.76 -98.77 0.71 Allowed Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.8 -0.714 . . . . 0.0 113.029 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -104.74 -6.01 20.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.558 0.218 . . . . 0.0 111.232 -179.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.473 ' HB ' ' HB1' ' A' ' 176' ' ' ALA . 50.2 mm -64.58 -41.54 92.55 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.119 0 CA-C-O 120.671 0.272 . . . . 0.0 110.819 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.492 ' O ' ' HG3' ' A' ' 184' ' ' GLU . 0.0 OUTLIER -61.65 -33.77 74.53 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.12 179.831 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . 0.465 ' HA ' ' OE2' ' A' ' 184' ' ' GLU . 11.7 m80 -66.64 -32.28 73.5 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.245 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.454 ' O ' ' HB2' ' A' ' 186' ' ' LEU . 4.9 m-85 -68.7 -41.43 79.12 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.75 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.434 HG23 ' H ' ' A' ' 183' ' ' VAL . 1.6 t -68.47 -20.09 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-O 120.927 0.394 . . . . 0.0 111.023 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . 0.492 ' HG3' ' O ' ' A' ' 180' ' ' SER . 41.9 mt-10 -76.42 -47.15 24.1 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.502 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.443 ' O ' HG23 ' A' ' 189' ' ' VAL . 6.1 t -77.11 -37.5 26.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.232 -179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.51 ' O ' HG23 ' A' ' 190' ' ' VAL . 0.6 OUTLIER -58.84 -48.91 79.69 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.616 -0.266 . . . . 0.0 111.431 -179.744 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -63.74 -33.52 75.83 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-O 120.873 0.368 . . . . 0.0 110.941 179.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -65.95 -44.91 90.78 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.797 -0.715 . . . . 0.0 111.849 179.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 185' ' ' VAL . 84.0 t -60.68 -43.98 96.13 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-O 120.484 0.183 . . . . 0.0 110.676 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.51 HG23 ' O ' ' A' ' 186' ' ' LEU . 48.2 t -60.82 -47.7 92.13 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.099 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.027 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . 0.479 HD12 ' HG ' ' A' ' 22' ' ' LEU . 0.7 OUTLIER -61.42 -42.62 99.04 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.236 -179.984 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.478 ' O ' HG23 ' A' ' 196' ' ' VAL . 71.9 t -65.59 -44.21 93.83 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 1.7 tp -58.54 -45.97 87.78 Favored 'General case' 0 N--CA 1.461 0.112 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.654 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.456 HG11 ' CE1' ' A' ' 209' ' ' PHE . 78.8 t -63.21 -40.04 87.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.124 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.502 179.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.45 ' HA3' HD22 ' A' ' 83' ' ' LEU . . . -59.44 -45.05 96.15 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.304 179.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.478 HG23 ' O ' ' A' ' 192' ' ' VAL . 22.4 t -71.57 -38.81 68.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 CA-C-O 120.755 0.312 . . . . 0.0 110.675 179.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.99 -23.95 63.24 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.376 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.46 -41.73 16.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.746 -0.206 . . . . 0.0 110.895 179.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . 0.406 ' CE1' ' HA ' ' A' ' 77' ' ' ARG . 22.5 t80 -68.55 -56.28 8.85 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 120.645 0.259 . . . . 0.0 111.37 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.41 -10.08 59.55 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.895 0.379 . . . . 0.0 111.306 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -91.05 -55.53 1.84 Allowed Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.262 179.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 18.8 m 68.37 -70.31 0.13 Allowed 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 123.049 0.54 . . . . 0.0 111.528 -179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -97.63 160.86 14.06 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 23.6 m 74.24 -40.33 0.45 Allowed 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 122.781 0.433 . . . . 0.0 111.173 -179.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -75.57 -36.1 60.45 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.145 -179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.446 ' O ' ' HB2' ' A' ' 210' ' ' PHE . 0.4 OUTLIER -60.46 -44.79 95.51 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.364 179.906 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -71.65 -38.74 70.68 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.755 0.312 . . . . 0.0 111.181 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 62.1 m -64.34 -43.03 95.9 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.946 179.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . 0.456 ' CE1' HG11 ' A' ' 194' ' ' VAL . 2.3 t80 -74.7 -30.91 61.71 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.237 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . 0.446 ' HB2' ' O ' ' A' ' 206' ' ' LEU . 0.1 OUTLIER -63.56 -24.53 67.84 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.712 -0.222 . . . . 0.0 111.257 -179.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -67.2 -22.25 65.74 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.884 0.373 . . . . 0.0 110.539 179.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.37 -7.05 51.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.917 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 2.5 mt -102.7 3.82 10.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.949 0.404 . . . . 0.0 110.901 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -71.88 117.84 61.43 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.785 179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -72.16 120.83 7.05 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.25 1.967 . . . . 0.0 112.183 179.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . 0.551 ' HA ' ' OE1' ' A' ' 219' ' ' GLN . 1.9 mt-10 -65.01 -26.35 68.24 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.467 -179.575 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 1.3 m-90 -72.67 -24.11 60.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.958 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.1 -33.27 24.38 Favored 'General case' 0 C--N 1.331 -0.206 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . 0.551 ' OE1' ' HA ' ' A' ' 216' ' ' GLU . 68.4 mt-30 -67.0 -30.3 70.37 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.363 179.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -78.77 -11.05 59.97 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.768 179.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -89.18 -13.02 39.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.58 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 13.3 mt -95.06 116.47 66.39 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.19 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_exo -60.5 -49.83 8.13 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.7 2.267 . . . . 0.0 112.749 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.247 0.922 0 CA-C-O 118.249 -0.881 . . . . 0.0 110.76 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.4 mtt . . . . . 0 N--CA 1.485 1.292 0 CA-C-O 120.759 0.314 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.65 57.5 2.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.502 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.12 -6.78 34.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.203 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.47 -37.54 87.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.475 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.2 -45.19 70.52 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.495 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.64 -47.05 87.14 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.667 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -61.74 -42.8 99.45 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.635 178.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.445 ' HB1' ' HA ' ' A' ' 151' ' ' TYR . . . -63.17 -48.38 78.62 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.888 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.45 ' O ' HG23 ' A' ' 13' ' ' VAL . 5.5 m-85 -55.95 -46.45 78.55 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.617 178.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.81 -44.4 96.27 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 120.815 0.341 . . . . 0.0 110.525 178.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.39 -39.75 94.25 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.677 178.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.09 -41.13 99.36 Favored Glycine 0 C--N 1.334 0.429 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.065 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 9' ' ' PHE . 98.0 t -65.03 -36.43 77.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 178.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.1 tp -63.77 -43.17 97.17 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.791 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.28 -35.05 79.06 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.793 0.33 . . . . 0.0 110.844 179.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.13 -28.84 63.52 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.889 179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.35 -13.21 50.23 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.046 0.451 . . . . 0.0 110.632 178.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 61.6 m -85.82 135.86 37.33 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.364 179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.63 -14.71 36.89 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.474 2.116 . . . . 0.0 113.027 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 6.3 t -90.16 132.9 35.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.352 179.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 12.1 t 61.46 65.28 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 O-C-N 123.724 0.64 . . . . 0.0 111.03 -179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 5.6 tp -109.78 105.34 57.07 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.896 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.476 ' O ' ' HD2' ' A' ' 26' ' ' PRO . 28.1 Cg_exo -63.05 -15.34 47.29 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 122.989 2.459 . . . . 0.0 112.81 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.2 tp -77.95 -15.38 59.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.148 179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.526 ' HB ' ' HD3' ' A' ' 26' ' ' PRO . 8.6 t -72.12 -52.35 7.43 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-N 116.684 -0.234 . . . . 0.0 111.327 179.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.526 ' HD3' ' HB ' ' A' ' 25' ' ' VAL . 22.9 Cg_exo -65.36 -38.68 25.38 Favored 'Trans proline' 0 C--N 1.36 1.14 0 C-N-CA 122.029 1.82 . . . . 0.0 112.59 179.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.1 p -65.85 -33.57 76.16 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.707 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -62.56 -36.05 81.43 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.877 0.37 . . . . 0.0 110.769 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.46 -42.62 18.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.573 179.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -57.8 -36.36 72.09 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.51 179.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -71.32 -33.08 69.33 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.804 0.335 . . . . 0.0 110.884 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -79.75 -22.6 43.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.487 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -78.0 -24.87 63.24 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 121.073 -0.584 . . . . 0.0 112.199 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 110.29 43.46 1.08 Allowed Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.715 -0.755 . . . . 0.0 113.004 179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -84.42 96.36 9.06 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.702 0.286 . . . . 0.0 111.181 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.14 122.06 40.82 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.639 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 170.87 -158.21 29.66 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 111.673 -0.571 . . . . 0.0 111.673 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 2.2 mmt180 -103.67 118.78 56.61 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.845 0.322 . . . . 0.0 110.75 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -67.06 -27.0 42.62 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 122.65 2.233 . . . . 0.0 112.79 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.07 -34.89 77.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.13 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -71.41 -38.22 71.45 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 120.795 0.331 . . . . 0.0 110.289 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -64.88 -43.77 91.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.283 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -66.81 -41.01 88.22 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.658 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.445 HD22 ' HA ' ' A' ' 44' ' ' LEU . 0.2 OUTLIER -58.58 -46.78 86.22 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.109 179.616 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -67.3 -36.28 81.18 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.871 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 15.7 t80 -65.18 -42.9 93.2 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.732 -0.213 . . . . 0.0 110.573 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 70.6 mt -60.42 -46.11 95.7 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.134 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.332 179.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -65.22 -42.44 93.44 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.472 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -60.44 -48.24 87.17 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 121.216 -0.516 . . . . 0.0 112.344 178.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.08 -34.85 75.78 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.734 0.302 . . . . 0.0 110.338 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -61.81 -46.44 94.15 Favored Glycine 0 N--CA 1.45 -0.39 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 178.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.58 -42.12 96.05 Favored 'General case' 0 N--CA 1.455 -0.206 0 CA-C-O 120.769 0.318 . . . . 0.0 110.463 178.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 24.6 t -62.69 -45.2 99.4 Favored 'Isoleucine or valine' 0 C--O 1.233 0.207 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.704 179.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -62.96 -33.41 75.32 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.466 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -80.96 -42.29 21.48 Favored 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 121.115 -0.234 . . . . 0.0 110.878 179.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.36 -37.1 85.97 Favored 'General case' 0 C--O 1.226 -0.168 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.08 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -89.39 -19.93 24.58 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.815 0.341 . . . . 0.0 110.86 179.101 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -70.22 -36.2 70.84 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.953 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.88 -57.63 22.94 Favored Pre-proline 0 CA--C 1.541 0.623 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -67.95 -13.68 39.02 Favored 'Trans proline' 0 C--N 1.359 1.108 0 C-N-CA 122.583 2.189 . . . . 0.0 113.063 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -58.29 -20.58 43.95 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-O 120.698 0.285 . . . . 0.0 111.536 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 11.6 p -66.63 -47.82 71.39 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 121.148 0.499 . . . . 0.0 110.27 178.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.5 mt -81.63 -19.22 42.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.67 -0.695 . . . . 0.0 110.621 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.24 -18.21 59.13 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.524 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -69.94 -36.38 73.3 Favored Glycine 0 C--N 1.334 0.417 0 C-N-CA 120.875 -0.679 . . . . 0.0 111.919 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.82 -25.71 64.19 Favored Glycine 0 C--N 1.331 0.292 0 C-N-CA 120.806 -0.711 . . . . 0.0 111.711 179.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.3 mt -76.23 -20.54 57.34 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.633 0.254 . . . . 0.0 110.703 179.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 28.9 mt -63.83 -19.66 65.2 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.028 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 34.6 m-85 -70.19 -17.67 63.16 Favored 'General case' 0 CA--C 1.531 0.226 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.775 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -95.52 39.84 1.12 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.558 179.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 73.4 160.87 0.24 Allowed 'General case' 0 N--CA 1.472 0.644 0 O-C-N 123.953 0.783 . . . . 0.0 111.149 -179.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 72' ' ' ARG . 3.1 ptt180 -139.22 12.05 2.59 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.38 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -69.4 -35.93 76.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.492 -179.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.19 -24.6 64.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.579 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.41 HD12 ' HA ' ' A' ' 75' ' ' LEU . 4.7 tp -82.56 -28.75 30.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.929 0.395 . . . . 0.0 110.798 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -79.85 -28.53 40.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.994 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 89.7 mtt180 -62.72 -34.84 78.01 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.277 179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 18.7 t -59.78 -37.87 73.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.568 179.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -66.44 -33.56 85.15 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.864 -0.684 . . . . 0.0 111.983 179.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.479 ' O ' HG23 ' A' ' 84' ' ' VAL . . . -66.41 -43.82 91.74 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.851 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 16.0 t -62.24 -39.9 85.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-O 121.039 0.447 . . . . 0.0 110.373 179.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 53.5 t -64.64 -41.64 92.81 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.715 179.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.0 -40.85 90.62 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.526 -0.307 . . . . 0.0 110.603 179.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.479 HG23 ' O ' ' A' ' 80' ' ' GLY . 61.5 t -63.82 -43.98 98.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.219 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.207 178.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.81 -40.41 95.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.804 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 25.9 t80 -60.22 -43.66 95.81 Favored 'General case' 0 C--O 1.231 0.122 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 178.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -65.38 -39.25 95.72 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.733 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . 0.804 ' HA ' HD12 ' A' ' 91' ' ' LEU . 1.0 OUTLIER -62.68 -40.63 97.73 Favored 'General case' 0 C--N 1.332 -0.152 0 CA-C-O 120.711 0.291 . . . . 0.0 111.024 179.368 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -72.3 -32.69 66.81 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.878 0.371 . . . . 0.0 110.665 179.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -73.45 -17.46 61.24 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.706 179.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.804 HD12 ' HA ' ' A' ' 88' ' ' LEU . 5.5 mt -67.08 -10.05 45.87 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.478 178.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 87.6 13.91 64.36 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.675 -0.774 . . . . 0.0 113.209 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 24.5 mt -88.22 122.89 32.28 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.837 0.351 . . . . 0.0 110.578 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -107.09 112.56 63.05 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.912 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -62.34 -55.27 1.01 Allowed 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.634 2.223 . . . . 0.0 112.446 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -136.92 118.31 14.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.067 0.46 . . . . 0.0 110.708 179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 4.8 p90 -95.86 -4.78 43.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.713 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -89.21 45.9 3.19 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.805 -179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 9.7 p -108.86 -22.59 4.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.031 0.443 . . . . 0.0 110.792 179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -103.4 -76.22 0.59 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.03 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.2 mt 58.5 -108.53 0.41 Allowed 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.862 -179.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 2.8 ttp85 58.07 -146.44 0.54 Allowed 'General case' 0 CA--C 1.532 0.283 0 O-C-N 123.386 0.429 . . . . 0.0 110.959 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -121.91 -59.64 1.65 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.826 0.346 . . . . 0.0 110.44 179.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -136.14 122.07 20.03 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.568 179.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -163.56 -70.63 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.894 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 58.97 29.48 19.01 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-O 121.079 0.466 . . . . 0.0 111.486 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -89.34 54.98 3.1 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.246 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.54 -11.99 50.03 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.333 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.425 ' N ' ' HD2' ' A' ' 110' ' ' PRO . 10.6 ttp180 -62.81 -54.73 44.65 Favored Pre-proline 0 CA--C 1.539 0.527 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.425 ' HD2' ' N ' ' A' ' 109' ' ' ARG . 28.0 Cg_endo -63.0 -38.21 48.11 Favored 'Trans proline' 0 C--N 1.361 1.195 0 C-N-CA 121.93 1.754 . . . . 0.0 112.489 179.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.72 -42.46 70.54 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.865 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -63.66 -41.83 98.92 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.927 -0.654 . . . . 0.0 111.961 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -68.02 -36.86 80.64 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.906 0.384 . . . . 0.0 110.607 179.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -67.06 -44.59 79.73 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.992 179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.04 -38.9 86.68 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.53 -0.305 . . . . 0.0 110.978 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -65.9 -37.33 85.82 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.97 0.414 . . . . 0.0 110.399 179.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -74.11 -36.49 51.2 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 121.002 -0.618 . . . . 0.0 111.75 179.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -55.25 -41.89 72.74 Favored 'General case' 0 N--CA 1.461 0.106 0 C-N-CA 122.362 0.265 . . . . 0.0 111.153 179.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.38 -46.41 86.6 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.828 179.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.07 -35.24 80.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.259 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -72.96 -29.74 63.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.994 179.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 3.2 mt -81.91 -27.4 33.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.667 179.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -78.1 138.38 21.23 Favored Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.05 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -82.86 -7.18 59.68 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 121.041 -0.264 . . . . 0.0 111.707 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 2.5 m 58.5 85.66 0.18 Allowed Pre-proline 0 C--O 1.233 0.187 0 O-C-N 123.508 0.505 . . . . 0.0 111.128 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_exo -59.13 -17.77 40.42 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 123.063 2.509 . . . . 0.0 113.156 -179.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 83.9 m -65.26 -43.21 92.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.071 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 11.6 pt -104.29 5.47 10.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.358 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -55.92 -67.35 2.26 Favored Glycine 0 CA--C 1.52 0.362 0 CA-C-N 116.122 -0.49 . . . . 0.0 113.112 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -62.5 -33.71 77.9 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.502 2.135 . . . . 0.0 112.101 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 26.9 mt -61.94 -40.09 85.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.031 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 6.3 mt -64.05 -29.32 70.47 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-O 120.682 0.277 . . . . 0.0 110.95 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -67.13 -30.16 75.39 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.902 -0.666 . . . . 0.0 111.778 179.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -79.74 -36.19 37.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.942 0.401 . . . . 0.0 110.355 179.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 45.3 mm -67.26 -30.93 50.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.711 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -58.61 -43.86 89.72 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.804 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -71.13 -24.77 62.34 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.077 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -76.21 -38.06 56.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.217 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 2.5 m -68.54 -18.03 64.28 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.942 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -66.27 -38.54 88.05 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.828 179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 4.1 m -102.24 -22.59 4.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.017 179.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -129.37 78.79 0.38 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 121.018 -0.61 . . . . 0.0 112.063 179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -111.18 121.36 5.77 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.533 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -156.16 141.6 8.12 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.178 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 6.3 t -66.84 -27.8 40.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.237 0 CA-C-O 120.882 0.372 . . . . 0.0 110.875 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -62.38 -28.56 71.26 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 121.052 -0.594 . . . . 0.0 112.584 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -68.33 -52.82 29.11 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.706 0.289 . . . . 0.0 110.599 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 20.1 mt -62.53 -37.25 85.37 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.757 179.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.01 -44.38 89.4 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.479 179.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.88 -39.27 93.81 Favored 'General case' 0 C--O 1.225 -0.23 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.787 179.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.445 ' HA ' ' HB1' ' A' ' 8' ' ' ALA . 2.8 m-85 -60.43 -47.54 85.65 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.069 179.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 48.5 mm -64.16 -44.86 97.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.455 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.27 -34.83 79.29 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.89 179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -61.0 -41.22 99.36 Favored Glycine 0 C--O 1.225 -0.415 0 CA-C-N 115.976 -0.557 . . . . 0.0 112.386 179.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.424 ' O ' ' HD2' ' A' ' 158' ' ' PRO . 0.0 OUTLIER -82.69 -27.69 31.08 Favored 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.831 0.348 . . . . 0.0 110.915 178.77 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -62.57 -38.9 91.87 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.855 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.556 ' HB ' ' HD3' ' A' ' 158' ' ' PRO . 6.9 t -57.44 -57.63 23.83 Favored Pre-proline 0 CA--C 1.541 0.619 0 CA-C-O 119.322 -0.37 . . . . 0.0 111.791 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.556 ' HD3' ' HB ' ' A' ' 157' ' ' VAL . 38.0 Cg_exo -58.44 -40.67 72.74 Favored 'Trans proline' 0 C--N 1.361 1.229 0 C-N-CA 122.024 1.816 . . . . 0.0 112.244 179.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -59.65 -45.29 92.45 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.151 -179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -66.34 -41.07 90.11 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.684 -0.234 . . . . 0.0 110.73 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.443 HG23 ' O ' ' A' ' 157' ' ' VAL . 98.0 t -63.51 -46.57 94.74 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.716 179.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 158' ' ' PRO . 78.9 t -64.73 -43.69 96.52 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.718 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -60.88 -33.56 73.29 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.649 0.261 . . . . 0.0 111.658 179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.2 tp -79.51 -45.89 18.45 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.096 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -68.3 -19.39 64.68 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.125 -179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . . . . . . . . . . . -65.51 -18.92 65.68 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.029 179.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -59.99 -40.56 89.6 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.005 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 1.2 mmt85 -87.6 -32.97 19.04 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.89 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 46.9 mm -67.1 -31.64 54.18 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.004 179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -59.93 -28.49 67.66 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.579 179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -70.69 -37.23 67.28 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.296 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -86.84 -34.07 19.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.555 0.217 . . . . 0.0 110.816 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.566 ' HA ' ' HB3' ' A' ' 176' ' ' ALA . 0.2 OUTLIER -59.87 -22.98 63.04 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.375 179.301 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.21 -53.15 61.18 Favored 'General case' 0 N--CA 1.461 0.1 0 CA-C-O 121.009 0.433 . . . . 0.0 110.167 178.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 7.3 mtm180 -78.57 -31.25 47.24 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.66 178.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.566 ' HB3' ' HA ' ' A' ' 173' ' ' LEU . . . -62.41 -41.07 98.4 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.494 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -42.52 -31.58 1.07 Allowed Glycine 0 C--N 1.34 0.765 0 O-C-N 123.91 0.756 . . . . 0.0 114.081 178.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 4.5 ttp180 -61.36 -56.46 20.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.105 0.479 . . . . 0.0 110.331 179.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -75.07 -27.75 20.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.011 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 19.5 m -71.27 -16.55 62.48 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.764 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -56.13 -37.35 69.33 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.764 0.316 . . . . 0.0 111.498 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -73.26 -24.56 60.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.118 0.485 . . . . 0.0 110.82 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 4.9 t -82.22 -21.7 9.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.249 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -70.06 -43.47 71.11 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.389 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 2.9 t -69.68 -41.92 80.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.81 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.416 ' O ' HG23 ' A' ' 190' ' ' VAL . 4.6 mt -58.98 -48.67 80.74 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.084 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -63.48 -39.67 95.07 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.644 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.509 ' O ' HG23 ' A' ' 192' ' ' VAL . . . -62.91 -45.12 96.33 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.976 -0.631 . . . . 0.0 112.064 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 54.2 t -60.51 -47.54 92.27 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-O 120.645 0.259 . . . . 0.0 110.629 179.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.419 ' O ' HG23 ' A' ' 194' ' ' VAL . 84.7 t -61.42 -44.06 97.84 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.95 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -57.0 -46.78 82.04 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.519 -0.31 . . . . 0.0 111.005 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.533 ' O ' HG23 ' A' ' 196' ' ' VAL . 45.0 t -67.05 -42.37 88.4 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.403 179.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.78 -42.64 89.46 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.037 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . 0.616 HG13 HD11 ' A' ' 206' ' ' LEU . 58.6 t -61.8 -43.85 97.91 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 178.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -61.86 -41.27 99.62 Favored Glycine 0 C--N 1.332 0.311 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.107 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 192' ' ' VAL . 61.2 t -68.63 -42.64 83.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.481 0.182 . . . . 0.0 110.814 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -64.27 -25.96 68.28 Favored 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.795 0.331 . . . . 0.0 111.403 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.68 -43.61 18.28 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.774 0.321 . . . . 0.0 110.385 178.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -71.2 -48.41 51.71 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.099 -0.501 . . . . 0.0 112.089 -179.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 69.3 p -84.2 -9.14 58.79 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.908 0.385 . . . . 0.0 111.314 -179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -87.09 -53.87 2.73 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.907 -0.664 . . . . 0.0 112.094 179.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 52.74 45.96 27.67 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.94 0.4 . . . . 0.0 111.634 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -151.05 -174.05 4.68 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.934 0.397 . . . . 0.0 110.911 -179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.26 10.46 10.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.67 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -58.63 -33.15 69.72 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.156 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.616 HD11 HG13 ' A' ' 194' ' ' VAL . 0.4 OUTLIER -78.13 -37.63 45.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.816 179.656 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -70.1 -35.78 74.4 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.609 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 5.9 m -69.09 -35.12 76.14 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.269 179.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -71.74 -29.35 64.43 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.955 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -69.43 -21.83 63.71 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.198 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -86.95 -11.2 51.28 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.9 0.381 . . . . 0.0 110.625 179.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 17.4 mtt180 -91.23 -14.11 31.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.127 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 6.8 pt -102.35 -6.72 9.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.371 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 1.3 p -87.36 118.21 69.6 Favored Pre-proline 0 C--N 1.328 -0.365 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.606 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.43 ' HG2' HD23 ' A' ' 218' ' ' LEU . 47.2 Cg_endo -70.54 149.08 61.33 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.379 2.053 . . . . 0.0 112.491 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -63.34 -22.13 66.69 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.977 0.418 . . . . 0.0 111.335 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -66.51 -18.7 65.51 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.407 -179.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.43 HD23 ' HG2' ' A' ' 215' ' ' PRO . 0.5 OUTLIER -76.2 -22.61 55.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.973 0.416 . . . . 0.0 110.249 179.539 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 56.4 mt-30 -84.31 -30.25 25.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.163 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 220' ' ' ARG . 0.0 OUTLIER -87.55 -2.19 58.45 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.856 179.519 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -94.18 2.53 55.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.071 0.462 . . . . 0.0 110.648 179.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.61 129.54 38.07 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.188 179.548 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.17 -46.49 32.55 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 122.804 2.336 . . . . 0.0 112.524 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.25 1.114 0 CA-C-O 118.202 -0.904 . . . . 0.0 111.003 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.9 mtm . . . . . 0 N--CA 1.487 1.4 0 CA-C-O 120.828 0.347 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.64 72.76 3.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.264 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 15.0 mt -90.45 48.28 1.53 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.032 0.444 . . . . 0.0 111.115 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.3 -22.01 58.03 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.009 -0.541 . . . . 0.0 111.137 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -65.84 -38.84 89.94 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.645 179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.27 -34.65 78.13 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.378 -0.373 . . . . 0.0 110.873 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -66.72 -49.27 66.59 Favored 'General case' 0 C--N 1.334 -0.1 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.697 179.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -68.7 -25.07 64.59 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.196 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.45 ' O ' HG23 ' A' ' 13' ' ' VAL . 0.3 OUTLIER -74.39 -50.83 17.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.068 179.823 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.42 HD21 ' HB3' ' A' ' 217' ' ' TRP . 7.9 mt -64.64 -34.65 78.79 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.424 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.81 -43.44 96.27 Favored 'General case' 0 C--O 1.231 0.088 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.518 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.49 -42.85 98.83 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.744 178.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 9' ' ' PHE . 59.1 t -64.87 -41.91 93.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.932 0.396 . . . . 0.0 110.078 179.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.1 mt -63.12 -39.57 95.06 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.844 179.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 28.7 m -65.97 -36.35 83.1 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.991 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -73.47 -31.28 63.69 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.75 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.2 mt -83.88 -14.66 50.56 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.06 179.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 38.4 m -61.43 146.68 89.06 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.776 179.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.48 -20.23 48.12 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 122.788 2.326 . . . . 0.0 113.081 -179.464 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.459 ' O ' ' HZ2' ' A' ' 124' ' ' TRP . 39.6 m -75.69 -38.81 58.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.427 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.612 HG12 ' H ' ' A' ' 22' ' ' LEU . 1.2 t 55.6 -155.71 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 O-C-N 123.294 0.371 . . . . 0.0 110.025 -178.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.612 ' H ' HG12 ' A' ' 21' ' ' VAL . 0.2 OUTLIER -173.62 -56.79 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.309 0 CA-C-O 119.328 -0.368 . . . . 0.0 111.326 179.606 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 22' ' ' LEU . 21.5 Cg_endo -61.19 -15.19 38.27 Favored 'Trans proline' 0 C--N 1.364 1.388 0 C-N-CA 122.647 2.231 . . . . 0.0 113.787 -179.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.3 tp -55.44 -46.75 76.71 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 123.207 0.317 . . . . 0.0 111.838 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -67.51 -55.44 14.76 Favored Pre-proline 0 CA--C 1.542 0.663 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_exo -51.23 -44.19 44.42 Favored 'Trans proline' 0 C--N 1.362 1.282 0 C-N-CA 122.418 2.079 . . . . 0.0 113.469 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 13.1 p -64.15 -37.66 88.25 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-O 120.69 0.281 . . . . 0.0 111.566 -179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 12.2 m-30 -73.19 -35.96 66.47 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.741 0.305 . . . . 0.0 110.686 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.628 HD21 HD22 ' A' ' 116' ' ' LEU . 1.8 mm? -70.34 -32.12 69.7 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.895 0.379 . . . . 0.0 110.137 179.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -61.04 -46.62 89.98 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.047 178.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.8 t80 -64.77 -34.89 79.41 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.723 178.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -68.21 -38.15 81.63 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.647 179.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -74.85 -33.25 55.75 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.104 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 72.01 31.49 64.28 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.656 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -133.9 131.58 39.27 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.698 0.285 . . . . 0.0 111.062 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 4.1 mtp180 -88.4 67.87 8.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.839 179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -74.94 150.82 41.62 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.812 -0.708 . . . . 0.0 111.844 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -69.95 115.27 32.07 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.715 0.258 . . . . 0.0 111.062 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_exo -60.83 -20.46 66.47 Favored 'Trans proline' 0 C--N 1.352 0.73 0 C-N-CA 123.042 2.495 . . . . 0.0 112.889 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.84 -34.9 76.8 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.225 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -68.9 -42.06 77.39 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 121.013 0.435 . . . . 0.0 110.406 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -66.92 -42.04 86.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.301 179.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.85 -44.69 92.39 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.041 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.04 -46.7 88.66 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.91 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -62.52 -39.45 93.59 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.861 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -67.08 -40.9 87.06 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.949 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 71.8 mt -60.84 -45.99 97.07 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.185 0 CA-C-O 120.778 0.323 . . . . 0.0 110.317 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.91 -46.95 73.27 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.529 179.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.455 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -58.54 -49.78 73.54 Favored Glycine 0 C--N 1.334 0.439 0 CA-C-N 115.786 -0.643 . . . . 0.0 112.913 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.52 -35.35 77.36 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.703 0.252 . . . . 0.0 110.844 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -60.28 -48.41 86.26 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.824 -0.703 . . . . 0.0 111.509 178.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.79 -46.0 92.2 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.523 0.201 . . . . 0.0 110.922 178.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 49' ' ' GLY . 85.6 t -61.76 -44.06 98.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.186 179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -62.72 -38.64 91.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.539 -0.301 . . . . 0.0 111.355 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -74.63 -40.36 61.55 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 120.634 0.254 . . . . 0.0 110.727 179.524 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.4 mt -64.41 -28.16 69.49 Favored 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.527 179.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.6 -19.91 24.36 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.469 178.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -71.59 -34.86 62.92 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 121.147 -0.549 . . . . 0.0 112.095 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.56 -56.16 37.94 Favored Pre-proline 0 CA--C 1.542 0.667 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 179.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.98 -13.81 29.06 Favored 'Trans proline' 0 C--N 1.36 1.154 0 C-N-CA 122.229 1.953 . . . . 0.0 112.961 179.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -55.59 -32.28 62.92 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 123.052 0.22 . . . . 0.0 111.379 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.28 -40.04 92.63 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.912 0.387 . . . . 0.0 110.73 178.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.2 mt -88.75 -19.4 26.11 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.705 179.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.9 tp -68.31 -17.36 64.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.779 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -60.27 -30.31 70.71 Favored Glycine 0 C--N 1.333 0.41 0 C-N-CA 120.843 -0.694 . . . . 0.0 111.6 179.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -76.63 -22.11 73.24 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.922 -0.656 . . . . 0.0 111.588 178.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 4.6 tp -73.74 -19.86 60.67 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.689 0.281 . . . . 0.0 110.401 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.9 -22.85 60.29 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.158 179.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -76.01 -36.3 59.21 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.98 0.419 . . . . 0.0 110.416 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -122.3 70.64 0.98 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.068 -0.514 . . . . 0.0 109.915 179.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 5.1 m-70 -61.4 125.96 25.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.374 -179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 18.3 mtm180 -78.88 100.64 7.3 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.435 -179.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -69.56 -18.0 63.61 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.075 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.485 ' O ' HG23 ' A' ' 78' ' ' VAL . 0.1 OUTLIER -61.45 -28.38 69.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.989 179.485 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 20.5 mt -67.68 -29.6 68.92 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.73 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -74.29 -32.22 62.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.45 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . 0.405 ' O ' HG23 ' A' ' 81' ' ' VAL . 9.6 ttt-85 -67.38 -39.65 85.65 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.487 179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 74' ' ' THR . 18.1 t -59.98 -39.74 81.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.483 179.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -63.43 -39.9 98.25 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 120.862 -0.685 . . . . 0.0 111.672 179.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -64.43 -42.71 97.49 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.726 179.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 77' ' ' ARG . 99.1 t -58.89 -44.41 90.67 Favored 'Isoleucine or valine' 0 C--O 1.234 0.288 0 CA-C-O 120.825 0.345 . . . . 0.0 110.649 178.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 79.1 t -65.51 -40.66 88.85 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.488 179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.55 -42.37 96.41 Favored 'General case' 0 N--CA 1.462 0.166 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.919 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 72.8 t -62.55 -46.22 96.91 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-O 120.774 0.321 . . . . 0.0 110.233 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.87 -40.77 94.19 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.675 179.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -65.32 -45.56 83.8 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.329 178.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -61.53 -39.38 97.26 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.202 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 1.8 mp -62.16 -42.51 99.33 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.693 0.282 . . . . 0.0 110.802 179.145 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -72.92 -31.99 65.02 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.979 179.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.31 -28.42 67.15 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-O 120.817 0.341 . . . . 0.0 110.881 179.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.67 -21.67 66.1 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.259 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.02 1.93 90.19 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.826 -0.702 . . . . 0.0 113.422 -179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 3.0 mt -97.21 160.1 14.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.999 0.399 . . . . 0.0 111.088 -179.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 3.1 mtp180 -98.58 119.04 62.31 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.303 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -69.77 -72.92 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.547 0 C-N-CA 122.408 2.072 . . . . 0.0 112.921 -179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 71.7 mmt-85 -134.64 -178.67 5.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.91 0.386 . . . . 0.0 110.657 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -85.05 76.23 10.28 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.566 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -98.17 57.55 1.04 Allowed Glycine 0 N--CA 1.453 -0.195 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.446 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.1 m -93.92 41.19 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.984 0.421 . . . . 0.0 111.646 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.86 3.12 41.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.146 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.2 mp -107.46 135.75 48.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.622 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.41 123.26 32.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.898 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 30.6 m-85 -115.07 132.68 56.52 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.712 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -140.75 155.02 46.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.5 -179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 113.95 154.72 11.26 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.528 179.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -110.92 -13.36 14.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.826 0.346 . . . . 0.0 111.148 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -92.28 52.38 1.93 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.271 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.62 -20.88 56.25 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.649 -179.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.48 -56.94 7.51 Favored Pre-proline 0 CA--C 1.539 0.544 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -64.15 -33.34 61.33 Favored 'Trans proline' 0 C--N 1.36 1.171 0 C-N-CA 121.99 1.793 . . . . 0.0 112.411 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 17.3 mt -75.23 -22.31 58.0 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.939 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -64.91 -35.77 92.3 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.955 -0.641 . . . . 0.0 111.899 179.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -69.56 -32.91 71.98 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.982 0.42 . . . . 0.0 110.712 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -80.83 -39.8 25.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.739 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.94 -47.47 71.58 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.636 -0.257 . . . . 0.0 110.464 179.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.628 HD22 HD21 ' A' ' 29' ' ' LEU . 1.2 mp -65.75 -31.68 72.79 Favored 'General case' 0 CA--C 1.523 -0.076 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -70.63 -43.63 59.73 Favored Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.956 -0.64 . . . . 0.0 111.609 178.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.42 -45.49 87.33 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.638 0.256 . . . . 0.0 110.871 179.187 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 3.2 m -64.18 -41.12 97.23 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.621 179.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -66.05 -35.43 80.52 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.604 179.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -64.77 -39.69 94.04 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.75 179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.24 -10.14 59.23 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.881 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -108.31 -0.49 33.18 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.851 179.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . 0.459 ' HZ2' ' O ' ' A' ' 20' ' ' CYS . 0.2 OUTLIER -94.17 -5.76 46.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.758 0.313 . . . . 0.0 110.8 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.13 -50.03 89.93 Favored Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 115.91 -0.586 . . . . 0.0 111.628 179.095 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -60.5 -25.1 79.86 Favored 'Trans proline' 0 C--N 1.361 1.232 0 C-N-CA 121.999 1.8 . . . . 0.0 112.176 178.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -70.15 -40.83 74.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.279 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.5 pt -96.09 4.82 8.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.832 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -57.14 -58.92 12.07 Favored Glycine 0 CA--C 1.52 0.363 0 CA-C-N 115.845 -0.616 . . . . 0.0 113.152 179.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.2 -25.59 78.69 Favored 'Trans proline' 0 C--N 1.353 0.789 0 C-N-CA 122.635 2.223 . . . . 0.0 112.283 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 37.9 mm -80.21 -35.54 15.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.011 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 5.1 tp -61.64 -24.99 67.08 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.154 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -63.14 -34.6 90.4 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.928 -0.653 . . . . 0.0 112.119 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -81.77 -22.37 37.24 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.005 0.431 . . . . 0.0 110.721 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 52.3 mt -80.28 -33.16 13.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.193 179.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -67.56 -28.35 67.72 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.236 179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -70.78 -20.19 62.63 Favored 'General case' 0 CA--C 1.529 0.136 0 CA-C-O 120.828 0.347 . . . . 0.0 110.681 179.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 89.6 mt -80.22 -18.24 50.06 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.952 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -82.79 -17.34 44.49 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.946 0.403 . . . . 0.0 110.696 179.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -82.28 -22.62 35.63 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.191 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 2.4 m -99.48 4.07 10.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.261 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 148.33 98.03 0.19 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.682 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -82.25 80.31 1.79 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.608 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -100.59 142.45 15.84 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.745 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 6.6 m -74.67 -18.7 16.62 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-O 120.774 0.321 . . . . 0.0 111.448 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -65.0 -30.38 77.86 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 121.026 -0.606 . . . . 0.0 112.531 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.47 -44.11 83.63 Favored 'General case' 0 N--CA 1.461 0.12 0 CA-C-O 120.779 0.323 . . . . 0.0 110.392 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . 0.446 ' O ' HG13 ' A' ' 152' ' ' ILE . 0.8 OUTLIER -62.09 -43.36 99.0 Favored 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.549 179.247 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.07 -42.21 89.71 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.927 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -63.28 -37.81 88.71 Favored 'General case' 0 CA--C 1.524 -0.05 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.532 179.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 33.3 t80 -61.09 -48.28 82.43 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.886 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.446 HG13 ' O ' ' A' ' 148' ' ' LEU . 42.0 mt -63.73 -45.01 98.49 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.154 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.566 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . . . . . . . . . 4.7 tp -64.82 -38.59 91.5 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.621 0.248 . . . . 0.0 110.915 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -59.52 -42.38 97.63 Favored Glycine 0 C--N 1.334 0.428 0 CA-C-N 116.031 -0.532 . . . . 0.0 112.424 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.467 ' O ' ' HD2' ' A' ' 158' ' ' PRO . 0.4 OUTLIER -80.95 -25.05 37.68 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.836 0.318 . . . . 0.0 111.179 178.963 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -62.93 -38.82 92.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.652 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.549 ' HB ' ' HD3' ' A' ' 158' ' ' PRO . 4.8 t -57.58 -56.72 31.31 Favored Pre-proline 0 CA--C 1.545 0.771 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.549 ' HD3' ' HB ' ' A' ' 157' ' ' VAL . 33.4 Cg_exo -61.04 -35.43 87.21 Favored 'Trans proline' 0 C--N 1.36 1.141 0 C-N-CA 122.131 1.887 . . . . 0.0 112.236 178.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -61.73 -42.93 99.61 Favored 'General case' 0 C--O 1.226 -0.142 0 CA-C-N 116.453 -0.339 . . . . 0.0 110.846 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -65.67 -38.15 88.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.627 0.251 . . . . 0.0 110.491 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 157' ' ' VAL . 91.7 t -60.82 -49.86 82.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.047 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.466 HG22 ' O ' ' A' ' 158' ' ' PRO . 11.8 m -72.64 -36.31 53.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 C-N-CA 120.931 -0.308 . . . . 0.0 111.539 -179.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.565 ' O ' ' HB2' ' A' ' 167' ' ' ASP . . . -57.79 -35.87 71.39 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 5.8 tp -80.05 -45.65 17.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.7 0.286 . . . . 0.0 111.048 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -65.36 -44.11 88.7 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.897 -179.213 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 170' ' ' LYS . . . -71.83 -19.15 62.02 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.388 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . 0.565 ' HB2' ' O ' ' A' ' 163' ' ' ALA . 14.1 t70 -76.63 -40.85 48.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.145 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 10.9 mmt-85 -69.55 -43.32 73.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.254 -179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . . . . . . . . . 4.6 pt -76.32 -18.91 15.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 112.091 0.404 . . . . 0.0 112.091 -179.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 166' ' ' ALA . 0.0 OUTLIER -60.1 -33.42 72.08 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.697 -0.229 . . . . 0.0 111.56 -179.676 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -63.79 -38.53 96.3 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.586 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -86.66 -38.77 16.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.625 0.25 . . . . 0.0 111.26 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -65.16 -16.81 63.91 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.663 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.43 -52.56 65.1 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 120.806 0.336 . . . . 0.0 110.632 178.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.92 -30.52 14.72 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.619 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -84.79 4.97 30.45 Favored 'General case' 0 N--CA 1.464 0.237 0 N-CA-C 111.825 0.306 . . . . 0.0 111.825 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -81.15 33.58 2.44 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 121.146 -0.55 . . . . 0.0 113.348 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . 0.408 ' O ' ' HB2' ' A' ' 181' ' ' HIS . 0.4 OUTLIER -80.29 -38.79 30.08 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.916 0.389 . . . . 0.0 110.718 179.867 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 19.5 mm -73.27 -30.27 30.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.847 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.08 -16.95 64.65 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.375 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . 0.408 ' HB2' ' O ' ' A' ' 178' ' ' ARG . 3.3 m80 -61.89 -38.38 88.1 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.086 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -75.66 -27.6 58.41 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-O 121.031 0.443 . . . . 0.0 110.477 179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 3.2 t -75.88 -18.54 15.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.47 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -83.4 -27.72 29.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.601 -179.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.506 ' O ' HG23 ' A' ' 189' ' ' VAL . 51.2 t -63.13 -47.79 90.77 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.196 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.547 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.468 ' O ' HG23 ' A' ' 190' ' ' VAL . 1.0 OUTLIER -62.04 -40.66 96.48 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.796 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -62.49 -38.2 88.95 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.506 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.52 ' O ' HG23 ' A' ' 192' ' ' VAL . . . -68.67 -42.88 78.51 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.035 179.202 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 185' ' ' VAL . 88.7 t -61.84 -49.66 83.35 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-O 120.763 0.316 . . . . 0.0 110.671 179.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 186' ' ' LEU . 50.4 t -63.35 -35.77 73.54 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.145 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.706 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.56 -46.83 83.46 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.568 -0.287 . . . . 0.0 110.804 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 188' ' ' GLY . 22.5 t -62.53 -42.29 95.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.16 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.345 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 23.5 mt -64.2 -44.57 91.56 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.788 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 69.0 t -63.77 -40.37 88.82 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.366 179.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -57.82 -45.52 93.43 Favored Glycine 0 C--N 1.333 0.395 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.159 179.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 192' ' ' VAL . 32.4 t -70.72 -40.09 76.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.682 0.277 . . . . 0.0 110.606 179.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -63.16 -39.04 93.52 Favored 'General case' 0 C--O 1.225 -0.205 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.044 179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.455 HD11 HD21 ' A' ' 206' ' ' LEU . 1.4 mp -72.83 -30.74 64.27 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.629 -0.26 . . . . 0.0 111.497 179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -59.12 -54.56 45.57 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-O 120.99 0.424 . . . . 0.0 111.055 179.77 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -89.19 -7.16 56.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.967 179.505 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -83.15 -4.56 89.71 Favored Glycine 0 N--CA 1.452 -0.256 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.712 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -67.64 68.64 0.1 Allowed 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.674 0.39 . . . . 0.0 111.59 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 6.5 t80 -165.23 -73.05 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.398 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 6.8 t -158.22 12.19 0.18 Allowed 'General case' 0 CA--C 1.534 0.357 0 CA-C-O 121.104 0.478 . . . . 0.0 111.302 -179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -84.16 -16.01 45.06 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.191 -179.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.477 ' O ' ' HB2' ' A' ' 210' ' ' PHE . 3.6 mt -74.89 -30.09 61.19 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.203 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -68.72 -34.87 76.35 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.169 -179.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.19 -40.24 93.18 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.312 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -87.13 -26.6 23.54 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.25 -179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . 0.477 ' HB2' ' O ' ' A' ' 206' ' ' LEU . 0.2 OUTLIER -66.62 -21.16 66.12 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.142 179.764 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -62.43 -27.54 69.18 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.981 0.42 . . . . 0.0 110.782 179.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 5.4 mmm180 -92.3 -4.47 53.9 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.666 179.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 10.4 mm -103.55 -11.07 9.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.014 -179.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . 0.407 ' HA ' ' HD3' ' A' ' 215' ' ' PRO . 0.2 OUTLIER -60.75 118.09 31.51 Favored Pre-proline 0 C--O 1.233 0.218 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.155 179.774 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 214' ' ' THR . 33.9 Cg_exo -61.67 155.74 51.93 Favored 'Trans proline' 0 C--N 1.352 0.759 0 C-N-CA 122.815 2.343 . . . . 0.0 112.476 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -60.94 -27.55 68.31 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.447 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' TRP . . . . . 0.454 ' O ' ' HB2' ' A' ' 221' ' ' TYR . 0.2 OUTLIER -68.73 -28.28 66.69 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.765 179.546 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -84.22 -29.24 26.71 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -67.71 -38.02 83.06 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.163 178.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 42.4 mtp180 -84.3 -3.59 58.33 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.058 179.375 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . 0.454 ' HB2' ' O ' ' A' ' 217' ' ' TRP . 0.3 OUTLIER -109.24 7.31 25.27 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.831 0.348 . . . . 0.0 110.757 179.759 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -87.09 118.41 69.98 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.394 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -70.13 143.47 49.14 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.415 2.076 . . . . 0.0 112.659 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.318 -0.849 . . . . 0.0 111.201 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.5 ttt . . . . . 0 N--CA 1.485 1.288 0 CA-C-O 120.83 0.348 . . . . 0.0 110.739 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.449 ' HB2' ' OG ' ' A' ' 4' ' ' SER . 0.0 OUTLIER -87.57 -31.95 19.6 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.812 179.786 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 62.61 24.99 14.88 Favored 'General case' 0 N--CA 1.469 0.488 0 O-C-N 123.838 0.711 . . . . 0.0 111.771 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . 0.449 ' OG ' ' HB2' ' A' ' 2' ' ' SER . 0.0 OUTLIER -75.45 -24.35 57.0 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.965 0.412 . . . . 0.0 111.028 179.702 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.6 mp -81.36 -42.87 19.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.383 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.39 -29.83 69.44 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.936 0.398 . . . . 0.0 110.532 179.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -69.65 -52.19 28.01 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.312 179.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.69 -27.85 69.53 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.995 179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -69.66 -49.23 55.57 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.526 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.658 ' HG ' HD21 ' A' ' 218' ' ' LEU . 0.2 OUTLIER -65.26 -37.32 86.84 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.482 179.404 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.67 -46.1 80.38 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 120.764 0.316 . . . . 0.0 110.992 179.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -65.41 -43.32 95.1 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.323 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -66.92 -31.79 55.05 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 120.77 0.319 . . . . 0.0 111.005 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.409 ' HB2' ' O ' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -67.43 -50.51 59.06 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.154 179.703 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.804 ' HB2' HD13 ' A' ' 155' ' ' LEU . 3.7 m -67.87 -24.83 65.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.76 0.314 . . . . 0.0 110.776 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -72.66 -41.12 65.77 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.215 179.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 11.7 mt -86.8 -7.86 57.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.107 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -61.64 130.02 91.82 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.404 178.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_endo -71.15 -8.03 22.64 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.497 2.131 . . . . 0.0 112.829 -179.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.8 m -66.85 150.46 49.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.06 0.457 . . . . 0.0 111.054 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.425 HG23 ' H ' ' A' ' 21' ' ' VAL . 0.2 OUTLIER -71.51 94.98 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.418 -179.578 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.44 ' H ' ' CD ' ' A' ' 23' ' ' PRO . 0.1 OUTLIER -143.63 -54.37 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.402 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.376 179.586 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . 0.44 ' CD ' ' H ' ' A' ' 22' ' ' LEU . 23.2 Cg_exo -66.25 -18.47 55.78 Favored 'Trans proline' 0 C--N 1.361 1.192 0 C-N-CA 122.256 1.971 . . . . 0.0 112.42 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.3 mt -88.02 -13.15 42.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.303 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.472 ' HB ' ' HD3' ' A' ' 26' ' ' PRO . 20.8 t -57.34 -50.1 90.09 Favored Pre-proline 0 CA--C 1.541 0.605 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.627 179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.472 ' HD3' ' HB ' ' A' ' 25' ' ' VAL . 52.0 Cg_exo -55.97 -40.63 83.85 Favored 'Trans proline' 0 C--N 1.363 1.318 0 C-N-CA 122.237 1.958 . . . . 0.0 112.907 179.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.75 -36.84 78.87 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.795 0.331 . . . . 0.0 111.406 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 9.9 m-85 -77.46 -41.01 41.22 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.265 -179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.54 -22.75 66.16 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.012 179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -64.94 -59.24 4.4 Favored 'General case' 0 C--N 1.333 -0.125 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 178.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -60.79 -33.22 72.65 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.099 179.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 4.2 mt -71.91 -16.38 62.11 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.879 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -93.7 -0.72 66.44 Favored Glycine 0 N--CA 1.452 -0.287 0 N-CA-C 111.47 -0.652 . . . . 0.0 111.47 178.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 66.67 -109.31 2.84 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 121.403 -0.427 . . . . 0.0 112.704 179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -119.13 10.58 12.13 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.011 0.434 . . . . 0.0 110.659 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 5.9 mmt180 -131.21 40.91 3.4 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.887 -179.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -100.15 99.77 2.09 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.214 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.81 129.47 29.81 Favored Pre-proline 0 C--N 1.326 -0.414 0 O-C-N 122.804 -0.233 . . . . 0.0 110.85 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -65.18 -23.43 60.05 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.817 2.344 . . . . 0.0 112.84 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -66.02 -44.48 84.6 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.081 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -72.17 -33.36 67.63 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.226 179.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.43 ' O ' ' HB2' ' A' ' 46' ' ' PHE . 8.0 t-20 -65.23 -50.25 66.57 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.319 178.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.81 -39.7 94.86 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.879 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.38 -50.48 71.39 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.974 179.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -66.19 -36.82 84.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.069 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.46 ' O ' ' HB2' ' A' ' 50' ' ' PHE . 0.2 OUTLIER -63.51 -49.83 72.0 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.239 179.462 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 1.2 tt -65.97 -28.73 44.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-O 120.728 0.299 . . . . 0.0 110.895 -179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.75 -55.46 5.62 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.511 -0.313 . . . . 0.0 110.701 179.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.423 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -57.54 -44.55 93.77 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.152 179.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.46 ' HB2' ' O ' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -70.92 -32.4 69.3 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 110.503 -0.184 . . . . 0.0 110.503 179.532 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -63.16 -48.62 78.18 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.804 -0.712 . . . . 0.0 111.517 179.013 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.28 -43.21 92.55 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.743 0.306 . . . . 0.0 110.752 178.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.423 HG23 ' O ' ' A' ' 49' ' ' GLY . 98.9 t -66.22 -43.3 91.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.029 179.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -65.7 -28.73 69.28 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.396 -179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -84.35 -45.07 13.16 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.526 0.203 . . . . 0.0 110.849 179.335 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.93 -39.16 93.52 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.198 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.33 -18.18 27.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.733 0.302 . . . . 0.0 110.381 178.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -68.95 -33.0 73.91 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 121.189 -0.529 . . . . 0.0 112.255 179.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.548 ' O ' HG22 ' A' ' 62' ' ' THR . 1.1 mm? -64.52 -57.69 16.21 Favored Pre-proline 0 CA--C 1.537 0.481 0 CA-C-O 119.453 -0.308 . . . . 0.0 111.509 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -67.86 -13.39 38.37 Favored 'Trans proline' 0 C--N 1.36 1.169 0 C-N-CA 122.064 1.842 . . . . 0.0 112.623 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.47 ' HA ' HD12 ' A' ' 64' ' ' LEU . 0.1 OUTLIER -55.7 -27.46 50.4 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.603 -0.271 . . . . 0.0 111.619 179.831 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.548 HG22 ' O ' ' A' ' 59' ' ' LEU . 8.6 t -66.32 -32.74 74.32 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 120.929 0.395 . . . . 0.0 110.64 179.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.86 -20.42 24.64 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.855 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.47 HD12 ' HA ' ' A' ' 61' ' ' PHE . 1.5 mt -64.88 -17.42 64.28 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.2 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -63.32 -30.14 76.65 Favored Glycine 0 C--N 1.334 0.442 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.474 179.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -75.08 -24.88 70.32 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 121.02 -0.61 . . . . 0.0 111.686 178.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 5.1 tp -85.11 -20.87 29.67 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.689 0.28 . . . . 0.0 110.569 179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.7 -19.58 64.03 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.977 179.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -64.22 -25.13 67.93 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.799 178.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -108.42 118.38 36.62 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 178.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -77.83 109.08 11.55 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.102 0.477 . . . . 0.0 110.92 -179.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 1.4 mmm180 -78.89 90.21 4.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.332 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -68.76 -18.28 64.18 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.821 179.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.416 ' O ' HG23 ' A' ' 78' ' ' VAL . 1.8 t -67.94 -26.21 65.85 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.163 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.1 tp -69.24 -35.84 76.56 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-N 116.53 -0.304 . . . . 0.0 110.924 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.79 -34.69 78.75 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.378 179.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -69.73 -43.35 72.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.433 179.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.44 ' O ' HG23 ' A' ' 82' ' ' VAL . 99.4 t -64.74 -45.24 95.75 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.187 179.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -60.73 -40.1 97.61 Favored Glycine 0 C--N 1.334 0.457 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.961 178.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.435 ' O ' HG23 ' A' ' 84' ' ' VAL . . . -64.49 -38.64 96.03 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 121.017 -0.611 . . . . 0.0 111.796 178.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 40.9 t -62.12 -41.78 92.57 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-O 120.699 0.285 . . . . 0.0 110.579 179.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 78' ' ' VAL . 67.9 t -60.5 -41.74 88.76 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.666 179.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.439 HD13 ' HA2' ' A' ' 195' ' ' GLY . 8.5 mt -64.32 -41.73 96.66 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.549 179.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 80' ' ' GLY . 93.6 t -66.98 -41.6 87.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.285 178.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -61.74 -41.16 97.29 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.708 179.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -61.95 -41.21 97.73 Favored 'General case' 0 CA--C 1.523 -0.091 0 N-CA-C 109.865 -0.42 . . . . 0.0 109.865 178.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.516 ' HA3' HG12 ' A' ' 192' ' ' VAL . . . -65.12 -40.6 97.0 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.852 -0.689 . . . . 0.0 111.812 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 53.8 mt -62.16 -38.23 88.23 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.808 0.337 . . . . 0.0 110.854 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -77.12 -30.42 55.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.659 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 8.9 mtp -72.3 -19.6 61.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.869 179.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -67.89 -7.06 25.11 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.132 178.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 89.79 19.16 48.97 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.913 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.77 130.51 43.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.808 0.304 . . . . 0.0 110.63 179.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.49 146.19 88.54 Favored Pre-proline 0 C--N 1.327 -0.379 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.19 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -63.02 111.95 1.54 Allowed 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.774 2.316 . . . . 0.0 112.378 179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 6.9 mtm180 -96.63 89.35 4.94 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.878 0.37 . . . . 0.0 110.809 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 4.3 t-105 -135.65 98.45 3.93 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.085 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 72.96 -140.01 28.08 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.701 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -116.19 152.23 17.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.617 0.246 . . . . 0.0 110.509 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.49 -19.1 65.28 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.44 179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 1.3 mt -78.27 -7.57 57.35 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.117 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 22.9 mtt180 -129.77 36.73 4.04 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.026 0.441 . . . . 0.0 110.426 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -76.2 114.71 15.17 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.536 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -113.95 125.34 53.92 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.987 -0.552 . . . . 0.0 110.844 -179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 154.02 119.95 0.74 Allowed Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.688 -179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -112.0 139.24 47.67 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.741 0.271 . . . . 0.0 110.49 -179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.43 ' O ' ' HD2' ' A' ' 110' ' ' PRO . 0.2 OUTLIER 58.62 73.0 0.49 Allowed 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 121.237 0.542 . . . . 0.0 110.852 -179.41 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.98 -1.63 33.01 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.973 -0.558 . . . . 0.0 112.213 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.9 ttp180 -62.03 -56.57 30.4 Favored Pre-proline 0 CA--C 1.54 0.583 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.43 ' HD2' ' O ' ' A' ' 107' ' ' THR . 38.5 Cg_endo -66.79 -26.97 44.59 Favored 'Trans proline' 0 C--N 1.361 1.199 0 C-N-CA 121.865 1.71 . . . . 0.0 112.049 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.2 mt -70.73 -33.37 70.77 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.625 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -64.41 -41.53 98.02 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.435 178.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -73.96 -36.36 64.59 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 120.724 0.297 . . . . 0.0 110.442 178.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -66.19 -43.89 85.51 Favored 'General case' 0 C--N 1.334 -0.094 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.907 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.39 -34.37 78.02 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.984 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.17 -30.45 68.68 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.989 0.423 . . . . 0.0 110.093 179.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -80.83 -42.04 10.17 Favored Glycine 0 N--CA 1.449 -0.458 0 N-CA-C 111.297 -0.721 . . . . 0.0 111.297 178.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -60.07 -42.9 95.54 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.621 0.248 . . . . 0.0 111.116 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 10.1 p -67.15 -38.56 85.72 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.049 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -69.82 -28.14 65.46 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.773 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -81.65 -34.41 30.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.833 179.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.84 -38.05 47.05 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.011 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -77.74 117.54 4.77 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.751 -0.737 . . . . 0.0 111.662 179.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . 0.542 ' O ' ' HD3' ' A' ' 126' ' ' PRO . 77.8 m95 -67.59 143.3 56.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.704 0.288 . . . . 0.0 111.167 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -90.65 102.79 5.64 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.354 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.542 ' HD3' ' O ' ' A' ' 124' ' ' TRP . 57.3 Cg_endo -75.06 -16.85 19.85 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.705 2.27 . . . . 0.0 112.869 -179.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -65.28 -48.02 74.63 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.112 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.431 HD12 HD12 ' A' ' 132' ' ' LEU . 4.8 pt -101.56 5.42 10.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.535 -179.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -58.91 -67.3 2.25 Favored Glycine 0 CA--C 1.52 0.362 0 CA-C-N 116.149 -0.478 . . . . 0.0 112.933 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -62.26 -29.63 80.42 Favored 'Trans proline' 0 C--N 1.349 0.57 0 C-N-CA 122.36 2.04 . . . . 0.0 112.286 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . . . . . . . . . 65.3 mt -66.73 -54.41 25.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.135 179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.431 HD12 HD12 ' A' ' 128' ' ' ILE . 15.1 mt -73.73 -31.22 63.25 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.095 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -63.69 -36.47 93.38 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.216 178.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.04 -43.23 71.68 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.836 0.351 . . . . 0.0 111.008 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . . . . . . . . . 23.2 mm -71.92 -29.85 34.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.194 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.47 -46.95 83.09 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.016 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.0 -22.69 67.03 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.868 0.366 . . . . 0.0 111.591 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . 0.513 ' O ' HG12 ' A' ' 141' ' ' VAL . 2.6 tp -86.13 -35.68 20.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.697 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 25.6 p -82.21 -20.01 38.61 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.354 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -82.84 -8.49 59.57 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.439 179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . 0.513 HG12 ' O ' ' A' ' 138' ' ' LEU . 1.4 p -88.42 -8.0 10.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 CA-C-O 121.163 0.506 . . . . 0.0 110.945 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -145.57 -64.28 0.02 OUTLIER Glycine 0 C--N 1.332 0.35 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.571 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 144.43 57.31 0.02 OUTLIER Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.187 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -82.74 62.08 4.66 Favored Glycine 0 N--CA 1.453 -0.173 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.734 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 9.5 m -70.26 -25.51 27.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.833 0.349 . . . . 0.0 111.28 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -63.61 -30.69 78.38 Favored Glycine 0 C--N 1.334 0.46 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.252 179.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -67.35 -42.49 83.42 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.822 0.344 . . . . 0.0 110.233 179.573 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -61.99 -40.95 97.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.58 179.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.445 ' O ' HG13 ' A' ' 152' ' ' ILE . 0.6 OUTLIER -68.3 -42.1 79.94 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.452 179.233 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -66.31 -29.82 70.11 Favored 'General case' 0 C--O 1.226 -0.158 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.638 179.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 6.8 t80 -64.63 -57.78 8.14 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.053 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.445 HG13 ' O ' ' A' ' 149' ' ' LEU . 0.9 OUTLIER -63.26 -42.75 97.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.377 -179.377 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.451 ' O ' HG23 ' A' ' 157' ' ' VAL . 0.4 OUTLIER -69.08 -32.97 72.78 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.745 -0.207 . . . . 0.0 110.74 179.605 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -60.42 -41.11 98.42 Favored Glycine 0 C--O 1.223 -0.547 0 C-N-CA 121.08 -0.581 . . . . 0.0 112.001 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.804 HD13 ' HB2' ' A' ' 15' ' ' SER . 29.6 tp -80.29 -29.0 38.21 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.693 0.282 . . . . 0.0 110.8 178.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -58.3 -39.36 79.13 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.425 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.528 ' O ' HG23 ' A' ' 161' ' ' VAL . 49.8 t -57.28 -63.81 3.3 Favored Pre-proline 0 CA--C 1.542 0.671 0 O-C-N 123.253 0.345 . . . . 0.0 111.817 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.525 ' CD ' ' HB ' ' A' ' 157' ' ' VAL . 20.7 Cg_endo -60.43 -33.56 93.98 Favored 'Trans proline' 0 C--N 1.362 1.272 0 C-N-CA 122.188 1.926 . . . . 0.0 112.637 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -60.35 -44.74 95.27 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-N 116.631 -0.258 . . . . 0.0 110.938 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -69.36 -35.08 75.51 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.758 0.314 . . . . 0.0 110.358 179.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.528 HG23 ' O ' ' A' ' 157' ' ' VAL . 89.4 t -62.21 -47.34 93.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.214 178.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 158' ' ' PRO . 58.2 t -67.04 -41.97 87.91 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.135 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.609 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -57.37 -39.37 75.86 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.511 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -77.49 -40.96 41.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.206 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -70.3 -19.77 63.07 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.658 0.266 . . . . 0.0 111.159 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.606 ' HA ' HD12 ' A' ' 169' ' ' ILE . . . -63.59 -26.47 68.7 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.145 178.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -66.91 -38.31 85.99 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.551 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 6.1 mtp180 -65.83 -34.16 77.51 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.728 178.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.606 HD12 ' HA ' ' A' ' 166' ' ' ALA . 6.6 mt -75.3 -28.06 20.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.787 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.97 -36.76 77.83 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.197 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -61.38 -49.64 75.18 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.348 179.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . 0.406 ' O ' ' HB2' ' A' ' 175' ' ' ARG . 52.6 m95 -72.26 -26.26 61.93 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.808 0.337 . . . . 0.0 111.156 179.491 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -71.83 -23.75 61.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.958 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 14.8 mtp85 -75.82 -17.93 59.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.026 179.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . 0.406 ' HB2' ' O ' ' A' ' 172' ' ' TRP . 0.0 OUTLIER -60.08 -43.83 95.22 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.063 0.459 . . . . 0.0 110.47 178.876 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -108.57 -76.55 0.61 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.116 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 98.51 -25.61 27.21 Favored Glycine 0 C--N 1.329 0.163 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.424 178.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 26.6 mtp180 -84.13 -10.56 57.68 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.966 0.412 . . . . 0.0 110.983 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . . . . . . . . . 1.6 pt -76.84 -18.86 14.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.214 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.02 -22.27 65.56 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.432 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . 0.501 ' O ' HG23 ' A' ' 185' ' ' VAL . 0.1 OUTLIER -84.18 -23.0 30.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.935 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -72.83 -42.62 63.61 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.867 0.365 . . . . 0.0 110.66 -179.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.421 HG22 ' H ' ' A' ' 183' ' ' VAL . 4.4 m -71.5 -19.14 20.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.073 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -80.33 -37.56 32.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.608 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 181' ' ' HIS . 91.6 t -68.98 -41.73 81.91 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.739 179.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.435 ' O ' HG23 ' A' ' 190' ' ' VAL . 1.7 mp -61.25 -38.98 88.63 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.752 179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -66.7 -36.28 82.12 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.16 178.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -66.35 -36.43 91.63 Favored Glycine 0 C--N 1.333 0.366 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.85 178.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 185' ' ' VAL . 98.7 t -61.81 -52.86 55.63 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.846 0.355 . . . . 0.0 110.695 179.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 186' ' ' LEU . 4.0 t -63.4 -31.2 51.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.977 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -61.34 -54.26 46.08 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.203 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . 0.516 HG12 ' HA3' ' A' ' 87' ' ' GLY . 35.0 m -68.29 -30.66 48.51 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.822 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.77 -50.75 69.82 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.19 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 58.8 t -66.46 -37.99 80.78 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.124 0 CA-C-O 120.883 0.373 . . . . 0.0 110.215 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . 0.439 ' HA2' HD13 ' A' ' 83' ' ' LEU . . . -59.55 -47.21 92.04 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.873 -0.68 . . . . 0.0 112.441 178.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 192' ' ' VAL . 91.4 t -72.08 -36.81 58.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.619 0.247 . . . . 0.0 111.022 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.32 -31.74 73.02 Favored 'General case' 0 N--CA 1.463 0.183 0 CA-C-O 120.699 0.285 . . . . 0.0 111.211 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.33 -33.91 21.97 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.68 -0.236 . . . . 0.0 111.296 179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -77.23 -47.22 20.76 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.4 -35.29 17.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.677 0.275 . . . . 0.0 111.627 -179.2 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -83.55 -63.64 1.69 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.405 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 54.3 -148.29 0.47 Allowed 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 122.403 0.281 . . . . 0.0 110.819 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 50.9 m-85 48.55 -111.07 0.41 Allowed 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 179.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.44 30.94 6.84 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.829 0.347 . . . . 0.0 110.975 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -69.71 -14.4 62.78 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.386 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . . . . . . . . . 1.1 mt -77.58 -16.12 58.81 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.956 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -64.84 -36.03 83.04 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.198 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 75.6 p -62.59 -36.96 84.36 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.122 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . 0.472 ' O ' HG12 ' A' ' 213' ' ' ILE . 1.6 m-85 -87.04 -22.71 25.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.057 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.02 -16.29 61.32 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.542 -179.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -66.49 -29.63 69.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.847 0.356 . . . . 0.0 110.731 179.271 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.88 -6.3 48.99 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.997 0.427 . . . . 0.0 110.355 179.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . 0.472 HG12 ' O ' ' A' ' 209' ' ' PHE . 11.1 mm -93.56 -3.68 10.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.743 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . 0.409 ' HA ' ' HD3' ' A' ' 215' ' ' PRO . 0.2 OUTLIER -63.46 116.98 29.91 Favored Pre-proline 0 CA--C 1.529 0.16 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.411 179.163 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 214' ' ' THR . 16.3 Cg_exo -69.3 122.24 9.04 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.564 2.176 . . . . 0.0 112.994 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -74.04 -22.7 59.45 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.794 179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -70.15 -24.54 63.18 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.955 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.658 HD21 ' HG ' ' A' ' 10' ' ' LEU . 1.8 mm? -76.13 -30.55 58.24 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.279 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -74.15 -23.15 59.22 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.059 179.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 5.2 mmm180 -87.09 -1.04 57.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.827 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -94.78 2.53 55.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.031 0.444 . . . . 0.0 110.843 179.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.61 136.66 30.95 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.583 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -63.27 100.99 0.28 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.871 2.38 . . . . 0.0 112.651 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.195 0 CA-C-O 118.22 -0.895 . . . . 0.0 111.103 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.5 mmt . . . . . 0 N--CA 1.485 1.285 0 CA-C-O 120.473 0.178 . . . . 0.0 110.569 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 58.91 -147.58 0.49 Allowed 'General case' 0 N--CA 1.462 0.147 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.422 -179.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -102.01 9.07 40.72 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.944 0.402 . . . . 0.0 110.43 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.89 -42.59 60.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.107 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.69 -42.25 64.44 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.793 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.54 -45.28 91.26 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.542 179.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -59.41 -40.59 87.16 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.61 178.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.523 ' HB2' ' HB1' ' A' ' 150' ' ' ALA . . . -61.02 -48.61 80.99 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.717 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -57.43 -46.82 83.14 Favored 'General case' 0 C--N 1.333 -0.124 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.776 179.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.0 mp -61.7 -45.8 92.43 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.509 178.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.25 -42.37 90.97 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.534 178.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -60.86 -44.28 98.26 Favored Glycine 0 C--N 1.334 0.417 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.887 178.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 74.4 t -63.5 -41.94 94.46 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-O 120.781 0.324 . . . . 0.0 110.517 179.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -63.94 -45.12 90.62 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.813 0.34 . . . . 0.0 110.522 179.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.541 ' HB2' HD21 ' A' ' 155' ' ' LEU . 9.9 m -64.42 -35.15 79.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.868 179.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -73.65 -34.13 64.82 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.327 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.6 mt -79.15 -14.86 58.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.979 0.419 . . . . 0.0 110.757 179.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.402 ' HA ' ' HD3' ' A' ' 19' ' ' PRO . 1.4 t -86.37 126.9 63.13 Favored Pre-proline 0 C--N 1.326 -0.421 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.873 178.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 18' ' ' SER . 30.8 Cg_exo -61.56 -14.84 37.75 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.784 2.323 . . . . 0.0 112.654 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 6.0 t -81.23 66.92 6.97 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.142 0.496 . . . . 0.0 110.633 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 18.1 m -89.98 161.53 2.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.864 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.65 -55.73 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.517 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PRO . . . . . . . . . . . . . 21.3 Cg_exo -66.58 -22.52 50.93 Favored 'Trans proline' 0 C--N 1.361 1.202 0 C-N-CA 122.289 1.993 . . . . 0.0 112.89 -179.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -74.17 -13.6 60.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.59 179.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.433 ' N ' ' HD2' ' A' ' 26' ' ' PRO . 73.7 t -74.51 -56.58 2.33 Favored Pre-proline 0 CA--C 1.541 0.623 0 CA-C-O 119.675 -0.202 . . . . 0.0 111.399 179.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 25' ' ' VAL . 17.1 Cg_endo -57.54 -23.43 56.39 Favored 'Trans proline' 0 C--N 1.362 1.254 0 C-N-CA 122.614 2.209 . . . . 0.0 113.449 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -61.04 -24.86 66.51 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 120.721 0.296 . . . . 0.0 111.416 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -76.84 -38.07 54.45 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.907 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -82.94 -22.47 33.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.448 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -53.61 -28.7 34.05 Favored 'General case' 0 N--CA 1.466 0.336 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.438 178.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -62.35 -33.53 74.89 Favored 'General case' 0 CA--C 1.529 0.163 0 CA-C-O 120.83 0.348 . . . . 0.0 110.854 178.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 21.9 mt -86.45 -22.99 26.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.622 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -93.94 3.27 70.27 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.999 -0.619 . . . . 0.0 111.683 178.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -81.59 65.7 3.97 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 121.399 -0.429 . . . . 0.0 112.505 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.405 ' HB2' ' HB3' ' A' ' 109' ' ' ARG . . . -89.62 -19.87 24.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.939 0.4 . . . . 0.0 111.188 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 9.4 mmm180 -109.51 -97.16 0.39 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.048 -0.523 . . . . 0.0 111.024 -179.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 165.17 -176.38 40.87 Favored Glycine 0 N--CA 1.448 -0.5 0 N-CA-C 111.467 -0.653 . . . . 0.0 111.467 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 4.9 ttm105 57.26 72.87 0.86 Allowed Pre-proline 0 N--CA 1.469 0.49 0 C-N-CA 122.575 0.35 . . . . 0.0 111.343 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.11 -23.99 39.15 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.487 2.125 . . . . 0.0 112.502 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 6.6 mt -66.26 -34.98 79.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.977 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -73.32 -37.57 66.11 Favored 'General case' 0 C--O 1.232 0.164 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.03 -36.59 84.88 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.99 178.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -63.44 -47.19 82.9 Favored 'General case' 0 C--N 1.333 -0.111 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.331 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -56.01 -42.32 76.25 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.162 178.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -69.47 -37.66 77.38 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 120.6 0.238 . . . . 0.0 110.947 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -65.05 -48.34 74.15 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.324 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 13.3 pt -68.29 -27.91 38.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.678 0.275 . . . . 0.0 110.92 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -70.47 -51.35 29.76 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.484 ' O ' HG23 ' A' ' 53' ' ' VAL . . . -61.66 -43.85 98.71 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.081 179.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -67.32 -35.64 79.84 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.632 0.253 . . . . 0.0 110.609 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -63.08 -42.72 99.48 Favored Glycine 0 C--N 1.334 0.428 0 N-CA-C 111.376 -0.69 . . . . 0.0 111.376 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.39 -44.88 92.71 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.672 0.273 . . . . 0.0 110.667 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 49' ' ' GLY . 26.5 t -65.49 -41.94 92.11 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.98 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -64.86 -34.68 78.95 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.917 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -76.56 -43.54 38.51 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.592 179.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 4.2 tp -61.12 -33.01 72.69 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.973 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.414 ' C ' ' HD2' ' A' ' 60' ' ' PRO . 3.8 mt -89.73 -18.4 26.44 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.083 178.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -72.01 -32.04 63.75 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 121.124 -0.56 . . . . 0.0 112.334 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -65.18 -54.55 32.3 Favored Pre-proline 0 CA--C 1.543 0.69 0 N-CA-C 111.698 0.258 . . . . 0.0 111.698 179.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.414 ' HD2' ' C ' ' A' ' 57' ' ' LEU . 17.2 Cg_exo -67.46 -13.6 39.7 Favored 'Trans proline' 0 C--N 1.361 1.223 0 C-N-CA 122.559 2.172 . . . . 0.0 112.528 179.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.493 ' HA ' HD12 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -57.69 -20.87 37.07 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.387 179.728 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 14.3 p -62.04 -35.9 79.99 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.227 0.537 . . . . 0.0 110.45 178.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.4 -19.54 26.45 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.682 179.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.493 HD12 ' HA ' ' A' ' 61' ' ' PHE . 70.6 mt -75.38 -17.42 60.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.993 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -62.61 -31.18 78.98 Favored Glycine 0 C--N 1.334 0.422 0 C-N-CA 120.828 -0.701 . . . . 0.0 111.912 179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -77.23 -29.61 56.14 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.974 -0.631 . . . . 0.0 112.146 179.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.4 tp -76.88 -25.07 52.63 Favored 'General case' 0 N--CA 1.461 0.094 0 CA-C-O 120.784 0.326 . . . . 0.0 110.817 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.406 HD13 ' HA ' ' A' ' 68' ' ' LEU . 0.5 OUTLIER -67.62 -19.25 65.2 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.945 179.902 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -71.29 -17.46 62.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.566 178.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -87.84 161.86 17.29 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.419 179.295 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' HIS . . . . . . . . . . . . . 9.1 m-70 -82.26 77.27 9.08 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.043 0.449 . . . . 0.0 111.36 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.2 mmp_? -96.7 49.15 1.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.829 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 3.5 mt-30 -73.01 -22.16 60.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.865 -179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -65.26 -24.64 67.37 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.329 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.19 -23.16 44.04 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.734 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -83.96 -30.32 26.34 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.056 179.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ARG . . . . . . . . . . . . . 1.5 mmt-85 -60.27 -27.65 67.44 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.493 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 5.3 t -63.47 -26.46 40.82 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 CA-C-O 120.964 0.411 . . . . 0.0 110.519 179.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -65.0 -34.81 90.87 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 120.919 -0.658 . . . . 0.0 111.824 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.477 ' O ' HG23 ' A' ' 84' ' ' VAL . . . -66.93 -39.45 93.31 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.794 -0.717 . . . . 0.0 111.417 179.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 13.8 t -61.57 -40.35 86.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 CA-C-O 120.875 0.369 . . . . 0.0 110.59 179.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 80.5 t -63.35 -39.68 86.21 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.386 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.98 -40.1 96.71 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.796 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.477 HG23 ' O ' ' A' ' 80' ' ' GLY . 53.1 t -63.59 -44.09 98.46 Favored 'Isoleucine or valine' 0 C--O 1.234 0.274 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.222 179.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -60.58 -41.1 93.95 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.593 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 13.6 t80 -65.57 -42.94 91.24 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.331 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -61.98 -38.29 95.81 Favored Glycine 0 C--N 1.332 0.355 0 C-N-CA 120.946 -0.645 . . . . 0.0 112.247 179.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.0 -38.47 91.05 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.813 0.339 . . . . 0.0 110.831 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -73.74 -30.14 62.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.345 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' MET . . . . . . . . . . . . . 6.7 mtp -71.11 -27.1 63.35 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.538 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . . . . . . . . . 65.0 mt -63.82 -16.23 60.75 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.26 178.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 81.37 16.08 74.81 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.751 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.4 mp -77.4 137.85 38.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.918 0.39 . . . . 0.0 110.505 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 15.6 mtp180 -107.82 115.31 59.09 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.889 -178.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -63.31 124.51 13.97 Favored 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.632 2.221 . . . . 0.0 112.114 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -92.78 132.11 37.25 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.814 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -137.26 -67.99 0.48 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.603 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -112.45 -175.58 19.65 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.235 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 2.7 t -75.79 96.9 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.005 0.431 . . . . 0.0 110.795 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -98.39 99.21 10.38 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.841 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -112.85 31.33 6.47 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.208 0.528 . . . . 0.0 110.522 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.9 ptp180 -132.31 157.41 44.51 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.938 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -101.42 -9.48 21.06 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.895 0.379 . . . . 0.0 111.264 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLU . . . . . . . . . . . . . 14.1 mp0 -127.61 -80.23 0.59 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.483 179.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 80.21 -61.6 4.36 Favored Glycine 0 C--N 1.331 0.295 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.606 179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -128.46 -174.98 3.38 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.728 0.299 . . . . 0.0 110.454 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.4 ' HB ' ' HD2' ' A' ' 110' ' ' PRO . 0.2 OUTLIER -77.34 105.45 8.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.404 -179.833 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -83.74 -40.23 19.08 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 112.19 0.441 . . . . 0.0 112.19 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.405 ' CB ' ' HD3' ' A' ' 110' ' ' PRO . 0.0 OUTLIER -58.61 -56.53 34.69 Favored Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 112.122 0.416 . . . . 0.0 112.122 -179.634 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.405 ' HD3' ' CB ' ' A' ' 109' ' ' ARG . 31.4 Cg_exo -60.91 -28.27 86.09 Favored 'Trans proline' 0 C--N 1.36 1.165 0 C-N-CA 122.32 2.014 . . . . 0.0 112.503 179.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.8 tp -69.09 -28.73 66.77 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.772 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -63.01 -33.79 88.21 Favored Glycine 0 C--N 1.336 0.572 0 C-N-CA 120.93 -0.652 . . . . 0.0 111.714 178.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -77.71 -34.17 52.81 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.94 0.4 . . . . 0.0 110.544 178.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -70.56 -38.35 74.12 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.708 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -72.29 -27.42 62.45 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.503 179.16 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.08 -44.88 94.46 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.305 179.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -71.65 -27.78 70.42 Favored Glycine 0 C--N 1.333 0.392 0 C-N-CA 120.775 -0.726 . . . . 0.0 111.556 178.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -68.06 -48.45 65.55 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.674 0.273 . . . . 0.0 110.809 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . . . . . . . . . 3.5 p -69.02 -31.88 71.0 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.866 0.365 . . . . 0.0 110.981 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -74.11 -39.88 63.06 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.778 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -65.16 -24.0 67.27 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.935 0.398 . . . . 0.0 110.962 178.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 43.5 mt -80.73 -18.36 48.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.477 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -95.78 81.23 0.81 Allowed Glycine 0 N--CA 1.448 -0.512 0 N-CA-C 111.437 -0.665 . . . . 0.0 111.437 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' TRP . . . . . . . . . . . . . 3.3 m0 -66.56 -82.71 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.729 0.3 . . . . 0.0 111.324 -179.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.497 HG22 ' HB ' ' A' ' 128' ' ' ILE . 0.7 OUTLIER -144.57 65.84 13.12 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 116.678 -0.237 . . . . 0.0 110.575 179.326 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -74.76 -57.4 0.06 OUTLIER 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.006 1.804 . . . . 0.0 112.492 -179.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -86.06 -16.94 36.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.051 0.453 . . . . 0.0 110.466 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.497 ' HB ' HG22 ' A' ' 125' ' ' THR . 1.2 mt -92.14 2.43 8.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.421 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.4 ' N ' ' HD2' ' A' ' 130' ' ' PRO . . . -57.14 -60.68 8.59 Favored Glycine 0 CA--C 1.521 0.413 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.426 178.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' PRO . . . . . 0.4 ' HD2' ' N ' ' A' ' 129' ' ' GLY . 19.0 Cg_endo -59.45 -35.03 97.13 Favored 'Trans proline' 0 C--N 1.352 0.711 0 C-N-CA 122.459 2.106 . . . . 0.0 112.141 178.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ILE . . . . . 0.494 ' O ' HG13 ' A' ' 135' ' ' ILE . 19.1 mt -68.42 -49.18 68.44 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.956 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.2 tp -63.92 -34.48 78.05 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.755 179.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLY . . . . . . . . . . . . . . . -61.17 -39.96 97.89 Favored Glycine 0 C--N 1.333 0.386 0 C-N-CA 120.854 -0.689 . . . . 0.0 111.599 178.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -71.38 -30.95 66.73 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.82 0.343 . . . . 0.0 110.683 178.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ILE . . . . . 0.494 HG13 ' O ' ' A' ' 131' ' ' ILE . 79.7 mt -72.06 -31.87 41.66 Favored 'Isoleucine or valine' 0 C--O 1.232 0.179 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.642 179.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LEU . . . . . . . . . . . . . 7.7 mt -60.37 -35.8 76.55 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.908 179.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.5 -22.59 63.59 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.809 178.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 3.5 tp -81.65 -27.35 34.14 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.382 179.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.59 ' HA ' ' O ' ' A' ' 143' ' ' GLY . 0.3 OUTLIER -76.3 -17.36 59.47 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.631 179.401 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ALA . . . . . . . . . . . . . . . -71.82 -17.99 62.12 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.358 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' VAL . . . . . . . . . . . . . 8.1 t -73.89 -28.8 24.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-O 120.984 0.421 . . . . 0.0 110.712 179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 129.36 64.77 0.11 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.148 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.59 ' O ' ' HA ' ' A' ' 139' ' ' THR . . . 113.13 -152.25 18.04 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.16 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 115.73 20.45 5.36 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.378 -0.915 . . . . 0.0 112.729 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' VAL . . . . . . . . . . . . . 11.7 p -66.12 -25.54 36.06 Favored 'Isoleucine or valine' 0 C--O 1.235 0.342 0 CA-C-O 120.961 0.41 . . . . 0.0 110.976 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -62.43 -30.32 75.98 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.093 179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -67.4 -42.6 83.03 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.605 0.24 . . . . 0.0 110.503 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' LEU . . . . . . . . . . . . . 3.8 tp -61.96 -43.75 98.19 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.512 179.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.522 ' O ' HG13 ' A' ' 152' ' ' ILE . 1.6 mp -67.95 -41.45 82.47 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.648 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.523 ' HB1' ' HB2' ' A' ' 8' ' ' ALA . . . -64.52 -35.14 80.0 Favored 'General case' 0 C--O 1.224 -0.238 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.477 178.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -61.05 -54.66 42.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.421 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.522 HG13 ' O ' ' A' ' 149' ' ' LEU . 0.5 OUTLIER -63.8 -42.67 96.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.564 -0.289 . . . . 0.0 110.874 -179.778 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' LEU . . . . . 0.431 ' O ' HG23 ' A' ' 157' ' ' VAL . 0.0 OUTLIER -64.44 -40.76 96.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.543 -0.299 . . . . 0.0 111.169 179.352 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -59.36 -41.51 96.99 Favored Glycine 0 C--N 1.334 0.429 0 CA-C-N 116.207 -0.451 . . . . 0.0 112.758 179.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.541 HD21 ' HB2' ' A' ' 15' ' ' SER . 7.0 mt -80.59 -26.67 37.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.814 0.34 . . . . 0.0 111.016 178.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ALA . . . . . . . . . . . . . . . -62.7 -37.35 86.13 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.314 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.499 ' HB ' ' CD ' ' A' ' 158' ' ' PRO . 96.5 t -54.8 -63.66 2.69 Favored Pre-proline 0 CA--C 1.541 0.601 0 O-C-N 123.382 0.426 . . . . 0.0 111.642 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' PRO . . . . . 0.499 ' CD ' ' HB ' ' A' ' 157' ' ' VAL . 28.7 Cg_endo -62.65 -36.64 62.57 Favored 'Trans proline' 0 C--N 1.358 1.077 0 C-N-CA 121.765 1.643 . . . . 0.0 112.578 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -58.92 -48.27 82.07 Favored 'General case' 0 N--CA 1.462 0.134 0 O-C-N 123.017 0.198 . . . . 0.0 111.37 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -65.8 -39.28 90.77 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.958 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 157' ' ' VAL . 92.9 t -63.61 -44.26 98.5 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.188 178.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 71.8 t -66.17 -44.91 91.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.284 178.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -58.02 -35.55 71.42 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.885 0.374 . . . . 0.0 111.377 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' LEU . . . . . . . . . . . . . 1.7 mt -69.12 -45.83 69.18 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.011 179.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -72.13 -34.47 68.59 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.926 0.393 . . . . 0.0 110.624 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 170' ' ' LYS . . . -69.93 -19.06 63.4 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.999 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -67.0 -26.34 66.74 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.372 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ARG . . . . . . . . . . . . . 1.1 tpt85 -79.19 -46.6 17.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.06 0.457 . . . . 0.0 110.668 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.438 HG12 ' HA ' ' A' ' 166' ' ' ALA . 20.7 pt -75.03 -18.77 16.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.288 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.468 ' O ' ' HG3' ' A' ' 174' ' ' ARG . 0.2 OUTLIER -57.44 -44.27 84.58 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.057 179.751 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -68.29 -25.36 74.69 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.917 -0.658 . . . . 0.0 112.672 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . . . . . . . . . 1.3 m-90 -86.9 -41.08 14.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.658 0.266 . . . . 0.0 111.201 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -70.82 -16.63 62.74 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.581 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.468 ' HG3' ' O ' ' A' ' 170' ' ' LYS . 0.0 OUTLIER -52.44 -54.69 28.96 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.764 0.316 . . . . 0.0 111.342 179.197 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ARG . . . . . . . . . . . . . 14.8 mtm180 -94.12 -16.36 23.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.567 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -92.21 1.37 57.26 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.72 0.295 . . . . 0.0 111.635 -179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . -85.09 55.43 4.96 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.599 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.5 -53.02 3.45 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.981 0.419 . . . . 0.0 110.41 179.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ILE . . . . . 0.429 ' H ' HG12 ' A' ' 179' ' ' ILE . 7.3 pt -74.26 -22.18 17.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.339 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.415 ' O ' ' HG3' ' A' ' 184' ' ' GLU . 0.3 OUTLIER -66.51 -18.71 65.51 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.467 179.975 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' HIS . . . . . 0.441 ' HA ' ' OE2' ' A' ' 184' ' ' GLU . 0.0 OUTLIER -63.85 -32.6 74.17 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.03 179.918 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -80.23 -25.31 39.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.93 0.395 . . . . 0.0 110.62 179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 11.9 t -74.67 -25.34 18.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.44 179.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' GLU . . . . . 0.441 ' OE2' ' HA ' ' A' ' 181' ' ' HIS . 32.7 mt-10 -74.41 -29.68 61.62 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.042 -0.527 . . . . 0.0 110.649 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' VAL . . . . . . . . . . . . . 11.4 t -69.62 -48.89 63.07 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.688 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.448 ' O ' HG23 ' A' ' 190' ' ' VAL . 2.7 mt -59.33 -43.18 92.77 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.841 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' ALA . . . . . . . . . . . . . . . -68.9 -40.76 78.96 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.704 179.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -62.69 -41.61 99.8 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 121.071 -0.585 . . . . 0.0 112.265 179.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' VAL . . . . . . . . . . . . . 54.4 t -61.49 -52.41 61.44 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.103 0 CA-C-O 120.43 0.157 . . . . 0.0 110.803 179.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 186' ' ' LEU . 54.8 t -58.16 -39.62 73.91 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.92 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' LEU . . . . . . . . . . . . . 1.8 mt -61.71 -47.39 85.5 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.173 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' VAL . . . . . . . . . . . . . 60.3 t -70.74 -35.89 62.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.657 0.265 . . . . 0.0 110.598 179.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' LEU . . . . . . . . . . . . . 2.4 tp -59.83 -51.79 68.23 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.131 179.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' VAL . . . . . . . . . . . . . 31.7 m -67.08 -29.61 46.71 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.585 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . -65.36 -49.65 59.94 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.703 178.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 46.2 t -67.09 -37.74 79.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 O-C-N 122.744 -0.268 . . . . 0.0 110.328 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -64.53 -31.12 72.2 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.776 179.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.464 HD13 HD13 ' A' ' 206' ' ' LEU . 0.5 OUTLIER -76.05 -29.78 58.15 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.075 0.464 . . . . 0.0 110.424 178.813 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -78.31 -41.17 34.51 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.602 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' THR . . . . . . . . . . . . . 66.9 p -86.24 -39.84 16.16 Favored 'General case' 0 N--CA 1.463 0.191 0 N-CA-C 111.842 0.312 . . . . 0.0 111.842 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' GLY . . . . . . . . . . . . . . . -91.08 -4.74 68.6 Favored Glycine 0 C--N 1.329 0.174 0 C-N-CA 121.223 -0.513 . . . . 0.0 112.707 -179.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 60.1 -142.44 0.56 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 122.69 0.396 . . . . 0.0 110.962 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -83.8 -11.41 57.09 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.769 0.319 . . . . 0.0 110.959 -179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.81 -43.23 80.15 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.46 179.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' ALA . . . . . . . . . . . . . . . -74.55 -30.36 61.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.838 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' LEU . . . . . 0.464 HD13 HD13 ' A' ' 198' ' ' LEU . 5.8 tp -73.17 -33.62 65.55 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.719 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -63.27 -41.38 99.01 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.786 0.327 . . . . 0.0 111.033 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 4.3 p -73.56 -25.36 60.34 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.076 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -87.44 -27.12 22.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.272 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -80.97 -15.64 55.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.494 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.17 -35.05 71.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.243 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.26 -6.37 55.27 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.245 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' ILE . . . . . . . . . . . . . 4.6 mt -106.94 7.44 9.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.124 0.488 . . . . 0.0 110.801 -179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' THR . . . . . . . . . . . . . 2.3 p -61.49 122.33 69.98 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.865 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_exo -60.16 145.9 97.47 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.367 2.044 . . . . 0.0 112.311 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -63.8 -21.16 66.29 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.329 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -73.2 -26.44 61.15 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.75 0.309 . . . . 0.0 110.913 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -90.21 -30.3 17.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.376 179.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.97 -22.79 63.12 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.518 179.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' ARG . . . . . . . . . . . . . 1.2 ttp180 -85.32 -16.15 40.95 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.729 179.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -102.21 13.4 34.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.033 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.92 120.38 69.35 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.681 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -77.81 69.58 7.33 Favored 'Trans proline' 0 CA--C 1.53 0.306 0 C-N-CA 122.645 2.23 . . . . 0.0 112.502 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.93 0 CA-C-O 118.154 -0.927 . . . . 0.0 111.381 179.988 . . . . . . . . 1 1 . 1 stop_ save_